Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,pulmonary valve development (GO:0003177),-0.70408113625259,-2.075346083300702,0.0,0.138501519879305,0.115,12/18,15.30%,NOTCH2;ROBO1;SMAD6;NOS3;BMP4;BMPR2;SLIT2;JAG1;STRA6;TNFRSF1A;TGFB2;HEY2
prerank,protein localization to cell-cell junction (GO:0150105),-0.6975897608357758,-1.9862089108005685,0.0,0.25262677225985236,0.33,7/15,11.99%,TJP1;CGNL1;CDH5;TJP2;PAK2;MPP7;ACTG1
prerank,vascular process in circulatory system (GO:0003018),-0.7369456397318058,-1.9798125854123305,0.0,0.13351546516365004,0.347,6/13,7.87%,ROCK2;ROCK1;NOS3;NPR1;ACE;AGTR1
prerank,regulation of tube diameter (GO:0035296),-0.7369456397318058,-1.9798125854123305,0.0,0.13351546516365004,0.347,6/13,7.87%,ROCK2;ROCK1;NOS3;NPR1;ACE;AGTR1
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.46342787333979807,-1.971979354687883,0.0,0.12055172290294708,0.383,49/91,27.55%,RPS14;RPL24;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;RPS2;RPL19;RPL5;RPL34;RPS25;RPS15;RPLP1;RPL31;RPL3;SRPRA;RPS6;SRP14;RPS8;RPL11;RPL12;SSR2;RPL7A;SRP68;RPL13;RPS21;RPL35A;RPL26;RPS9;RPL32;RPS29;RPS23;RPLP2;RPL8;SRP72;RPL41;SIL1;RPS17;RPS5;RPS15A;UBA52;RPL37A;SRP19;RPS10;RPL6;RPL9;RPS27
prerank,somite development (GO:0061053),0.8873963387741561,1.9278654241497766,0.0,0.2986003875141761,0.214,7/11,8.64%,PTCH1;MEOX1;MEOX2;SOX11;LOXL3;PPP2R3A;SMO
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.643708469340003,-1.9249172247506061,0.0,0.18356068101337225,0.584,7/18,10.10%,PTN;MTUS1;SLC8B1;LYN;SLIT2;CAMK1D;IL6R
prerank,pulmonary valve morphogenesis (GO:0003184),-0.6762377634268999,-1.9226466607926176,0.0033444816053511705,0.16224463757290017,0.596,10/17,15.30%,NOTCH2;ROBO1;SMAD6;NOS3;BMP4;SLIT2;JAG1;STRA6;TGFB2;HEY2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.7191772238467927,1.9177969246343087,0.0024968789013732834,0.18795396560358335,0.259,13/33,10.37%,RELN;CEL;NGF;NRG3;GRIK3;CACNA1A;GRIK5;GRIK2;LRRC4C;GRID2;NLGN1;GRIK1;PXK
prerank,regulation of glucose import (GO:0046324),-0.5590456541740981,-1.8980615223821409,0.004629629629629629,0.18877757159549272,0.7,13/30,9.62%,PRKAG2;OSBPL8;SORBS1;IGF1;OCLN;APPL2;GRB10;CREBL2;PRKCI;INSR;RHOQ;ARPP19;GSK3A
prerank,eosinophil chemotaxis (GO:0048245),0.8327700176778451,1.8709070690286727,0.0014814814814814814,0.25922185744555903,0.546,3/14,4.10%,LGALS3;CCL11;CCL4
prerank,eosinophil migration (GO:0072677),0.8327700176778451,1.8709070690286727,0.0014814814814814814,0.25922185744555903,0.546,3/14,4.10%,LGALS3;CCL11;CCL4
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.8476718086739905,1.8680157438304403,0.0,0.22071303724348806,0.58,3/12,3.45%,DCN;ADAMTS12;CADM4
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.6984847418789495,1.856465312788129,0.0,0.22564139315391626,0.625,9/35,9.73%,DCHS1;CDH19;CDH10;CDH22;PCDHGB4;CDH8;NLGN1;CDH20;CDH7
prerank,neuronal action potential (GO:0019228),0.7461431351669837,1.852853912354237,0.0,0.2067976793787498,0.652,9/22,8.46%,ANK3;KCNA2;SCN7A;SCN2A;KCNA1;SCN5A;SCN3A;KCNMB2;KCNMB3
prerank,regulation of chondrocyte differentiation (GO:0032330),0.733989411438316,1.8356058534051833,0.001349527665317139,0.2524574473724223,0.767,11/24,10.86%,SOX6;ADAMTS12;EFEMP1;PKDCC;SOX9;MBOAT2;PTHLH;ZBTB16;TRPS1;SOX5;PTPN11
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.765427284607581,1.8296043869626153,0.0,0.2482431125252697,0.804,6/18,5.72%,RELN;TSHZ3;CACNG7;NRXN1;CCR2;NLGN1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.6782315786301437,-1.8257492577574626,0.005747126436781609,0.3642897753981009,0.928,5/13,7.97%,PTGIS;NAMPT;NAXD;PARP10;PTGS2
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.6946735782172411,-1.8231312337596304,0.0058823529411764705,0.3359492866192422,0.932,6/13,4.03%,BMP6;DAB2;RBPMS;BMP4;NUP93;TGFBR1
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.5823074986851923,-1.822676296088117,0.010752688172043012,0.30702009643063394,0.933,11/20,12.47%,IGF1;NRP1;VTN;IGFBP3;SLIT2;IGFBP5;S100A11;ACE;PDGFRB;SERPINE1;CCN4
prerank,regulation of lymphocyte proliferation (GO:0050670),0.7767664376195544,1.8034982753665048,0.008356545961002786,0.3467243334630627,0.916,4/16,4.44%,LGALS3;FGF10;PTPN22;SOX11
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.5807441496519666,-1.8015195595625781,0.007434944237918215,0.3475464805504694,0.965,6/21,4.03%,BMP6;DAB2;RBPMS;BMP4;NUP93;TGFBR1
prerank,spinal cord development (GO:0021510),0.8343085918553736,1.8010914066869967,0.0,0.3265365226214158,0.929,7/12,8.80%,RELN;VIT;GLI2;SOX11;NF1;LOXL3;SOX12
prerank,endochondral bone morphogenesis (GO:0060350),-0.6958381210694194,-1.8010501456586383,0.011695906432748537,0.3224315382790221,0.966,6/11,15.98%,COL13A1;BMP4;BMPR2;INPPL1;TMEM119;TRPV4
prerank,response to sterol (GO:0036314),0.8294879095971319,1.7839040958590595,0.0015748031496062992,0.3901615095755618,0.967,4/11,6.38%,RORA;TGFB1;RORC;TGFBR2
prerank,regulation of NMDA receptor activity (GO:2000310),0.6746025508403819,1.7828689748146433,0.0,0.36438613382984597,0.968,10/32,5.72%,RELN;CRH;GRIA1;EPHB2;GRIA3;CAPN1;GRIN2B;CCR2;DLG2;NLGN1
prerank,regulation of T cell activation (GO:0050863),0.6569880185548954,1.780517834544661,0.0024390243902439024,0.3502998073588635,0.97,10/42,9.65%,LGALS3;PRKCQ;PYCARD;PTPN22;FGL1;TNFAIP8L2;CCR2;METTL3;LAX1;IL4I1
prerank,regulation of T cell migration (GO:2000404),0.7473324071574076,1.7735236298204369,0.0028530670470756064,0.36263680287320327,0.974,3/18,1.40%,APOD;CXCL10;PYCARD
prerank,alpha-amino acid catabolic process (GO:1901606),0.6823985305808842,1.7720028938127317,0.00648508430609598,0.3490314804701504,0.975,8/29,9.65%,AADAT;KYNU;CBS;DAO;SARDH;GOT2;MTRR;IL4I1
prerank,modified amino acid transport (GO:0072337),-0.6246151211824782,-1.769974553823938,0.005970149253731343,0.4059281688348317,0.99,5/15,13.58%,SLC16A12;SLC6A13;PDPN;SLC5A6;MGST1
prerank,connective tissue development (GO:0061448),0.6626491394135336,1.769008577493252,0.002430133657351154,0.343734350523172,0.98,13/35,8.90%,SOX6;SULF1;SOX8;SOX9;PGRMC2;ITGB8;HOXD3;ZBTB16;RORC;CREB3L2;DYRK1B;TRIP11;SOX5
prerank,negative regulation of lymphocyte activation (GO:0051250),0.7161361243401723,1.7588834846340218,0.0027739251040221915,0.37891433568411625,0.987,8/21,9.65%,LGALS3;PTPN22;FGL1;SOX11;TNFAIP8L2;SAMSN1;LAX1;IL4I1
prerank,lysine metabolic process (GO:0006553),0.8022535484125477,1.754462883855965,0.0029895366218236174,0.3637803102903287,0.99,5/12,3.36%,AADAT;GCDH;AASS;SLC25A21;DLST
prerank,lysine catabolic process (GO:0006554),0.8022535484125477,1.754462883855965,0.0029895366218236174,0.3637803102903287,0.99,5/12,3.36%,AADAT;GCDH;AASS;SLC25A21;DLST
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6934671765578234,1.7509228065641895,0.005434782608695652,0.364311799653218,0.99,9/24,11.10%,RORA;SULF1;EIF2AK3;TGFB1;NOX1;CYP1B1;BRCA1;HIF1A;IL6ST
prerank,smoothened signaling pathway (GO:0007224),0.6639121175121168,1.7447900539416268,0.0,0.3782798672068379,0.992,8/32,8.64%,PTCH1;PTCH2;GLI2;DHH;STK36;CC2D2A;GLI1;SMO
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.8171499648283919,1.7302163812826046,0.006144393241167435,0.4408630738970381,0.996,2/10,3.45%,DCN;CADM4
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6827244269405229,1.728197874924649,0.00684931506849315,0.4348951976187454,0.997,10/26,11.10%,RORA;SULF1;EIF2AK3;TGFB1;CCR2;NOX1;CYP1B1;BRCA1;HIF1A;IL6ST
prerank,myeloid cell development (GO:0061515),-0.5907522839908597,-1.7260596665374646,0.010752688172043012,0.5638304539939921,0.999,5/18,13.20%,FOXP1;KIT;ALAS1;APP;NCKAP1L
prerank,endothelial cell differentiation (GO:0045446),-0.6458099074590165,-1.7255688799213367,0.01875,0.5311533287371347,0.999,7/12,12.04%,ACVRL1;BMPR2;TIE1;KDR;KDM6B;JAG1;PROX1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7976451275461476,1.7253836229730746,0.009433962264150943,0.43350205125844465,0.997,5/12,13.88%,APOD;CBLB;PTPRJ;CBL;SNCA
prerank,cellular response to sterol (GO:0036315),0.7672767410190539,1.7250143612679583,0.011799410029498525,0.41905892073964846,0.997,8/13,16.11%,RORA;PTCH1;GRAMD1A;RORC;SMO;GRAMD1C;GRAMD1B;GPLD1
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.6195508901839081,-1.7227965319004932,0.00625,0.5117060859164346,0.999,8/15,24.24%,PRKCD;SIRT3;RACK1;TNFRSF1A;ORMDL3;SPHK1;ORMDL1;SPHK2
prerank,aspartate family amino acid catabolic process (GO:0009068),0.7238786488926273,1.7143963689552013,0.002797202797202797,0.4631294515681935,0.999,7/19,11.93%,AADAT;GCDH;AASS;SLC25A21;DLST;GOT2;PHYKPL
prerank,sprouting angiogenesis (GO:0002040),-0.4417623190287865,-1.7139999595153226,0.0,0.5229817390642558,0.999,18/51,5.90%,ROBO1;NRP1;TEK;CCBE1;VEGFC;ANGPT1;PIK3R3;RSPO3;CDH13;ACVRL1;VEGFD;BMP4;ENG;SLIT2;EPHB4;RNF213;KDR;THBS1
prerank,action potential (GO:0001508),0.6244616518919878,1.7131807878202006,0.001221001221001221,0.4539747454185705,0.999,13/44,10.70%,ANK3;GNA14;KCNA2;SCN7A;SCN2A;KCNA1;CHRNA4;SCN5A;KCND2;SCN3A;KCNMB2;KCNMB3;AKAP6
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.4110774044210865,-1.7113078169570788,0.0,0.5063615566787392,0.999,47/87,27.55%,RPS14;RPL24;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;RPS2;RPL19;RPL5;RPL34;RPS25;RPS15;RPLP1;RPL31;RPL3;RPS6;SEC61B;SRP14;RPS8;RPL11;RPL12;RPL7A;SRP68;RPL13;RPS21;RPL35A;RPL26;RPS9;RPL32;RPS29;RPS23;RPLP2;RPL8;SRP72;RPL41;RPS17;RPS5;RPS15A;UBA52;RPL37A;SRP19;RPS10;RPL6;RPL9;RPS27
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.7948981445180261,1.7102060765352551,0.010606060606060607,0.45621447443997154,0.999,3/11,1.04%,ANK3;PRKCA;PRKCQ
prerank,myelination in peripheral nervous system (GO:0022011),0.7839522407000594,1.7095633117286324,0.004545454545454545,0.44409962703969214,1.0,4/13,5.07%,LGI4;PRX;NF1;ARHGEF10
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.6324605053908138,1.7085845849197159,0.0,0.43569658798263267,1.0,14/39,17.22%,FXYD3;CHRM3;UTRN;ANK2;WNK3;FGF12;STK39;FXYD6;FXYD1;AHCYL1;TCAF1;NEDD4L;HOMER1;RIPK1
prerank,cartilage development (GO:0051216),0.6071876073862129,1.7065526999786467,0.002398081534772182,0.4331638307547878,1.0,13/49,9.68%,OSR2;SOX6;SULF1;FGF2;SOX9;TGFB1;ITGB8;HOXD3;ZBTB16;CREB3L2;TRIP11;SOX5;AMELX
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.8146813121143313,1.7059876072030304,0.0124804992199688,0.4231416690771643,1.0,3/10,2.79%,APOD;LRP1;PTPN2
prerank,diol biosynthetic process (GO:0034312),-0.6005644978543616,-1.7049120834608296,0.01910828025477707,0.5090207858604218,1.0,8/15,25.69%,ACER2;SPTLC2;ASAH2;SPR;QDPR;SPHK1;SPHK2;SPTLC1
prerank,artery development (GO:0060840),-0.5444618761426485,-1.702598833553724,0.004273504273504274,0.49470104776699575,1.0,13/23,12.76%,ROBO1;NRP1;ACVRL1;SMAD7;ENG;BMPR2;TGFBR1;TBX1;EFEMP2;STRA6;HECTD1;PDE2A;SLC2A10
prerank,pyroptosis (GO:0070269),-0.6156439835791059,-1.6967655897174887,0.01282051282051282,0.49719527427218146,1.0,10/15,36.49%,CASP4;AIM2;CASP8;GSDMD;GSDME;APIP;ZBP1;CASP1;TREM2;NLRC4
prerank,protein homotrimerization (GO:0070207),0.745055305952534,1.696653755192178,0.007309941520467836,0.44711370091581754,1.0,3/14,1.57%,SCARA5;STEAP4;SLC1A5
prerank,protein trimerization (GO:0070206),0.745055305952534,1.696653755192178,0.007309941520467836,0.44711370091581754,1.0,3/14,1.57%,SCARA5;STEAP4;SLC1A5
prerank,blood vessel diameter maintenance (GO:0097746),-0.4911364256795801,-1.6938194526667003,0.010362694300518135,0.48921145543455385,1.0,15/34,22.90%,ROCK2;ROCK1;NOS3;KLF2;NPR1;ACE;AGTR1;ECE1;NOS1;EDNRB;EDN1;GCLC;GPER1;ACE2;AGT
prerank,extracellular matrix assembly (GO:0085029),0.6829207412403132,1.6928425227796338,0.009370816599732263,0.45608766489152874,1.0,8/23,6.82%,NTN4;HAS2;PXDN;TGFB1;GPM6B;TNXB;NTNG2;NTNG1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.6316504389622801,1.692559861829754,0.004956629491945477,0.44530189863698955,1.0,10/39,9.57%,FXYD3;WNK2;ANK3;FGF13;UTRN;WNK3;FGF12;FGF14;STK39;FXYD6
prerank,neuron migration (GO:0001764),0.6066351634583953,1.689601091261413,0.005952380952380952,0.4496298289591336,1.0,19/48,11.86%,RELN;FGF13;ASTN2;MAP1B;NRCAM;VEGFA;SEMA3A;AUTS2;NTRK2;CEP85L;CDKL5;NAV1;DISC1;SDCCAG8;FGFR1;GPM6A;POMGNT2;ADGRL3;CDK5R1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.8076945885545754,1.689549865784431,0.004694835680751174,0.43842297375121,1.0,5/10,8.90%,SOX6;PKDCC;SOX9;ZBTB16;SOX5
prerank,presynapse assembly (GO:0099054),0.7176924171704977,1.6826964977761298,0.010218978102189781,0.46459417898746924,1.0,6/16,5.72%,CEL;LRP4;PTEN;IL1RAPL1;WNT5A;NLGN1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.6440103659022562,1.68232980833357,0.0025974025974025974,0.45564312032710175,1.0,5/29,7.02%,LGALS3;CXCL10;ANO6;CCR2;PLA2G7
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.7259370617863768,1.6790078060284688,0.012711864406779662,0.46191257356561866,1.0,5/16,10.41%,SEC16B;ANK2;PPP1R15A;GBF1;VAPA
prerank,positive regulation of glucose import (GO:0046326),-0.5468214573678891,-1.6787058201250182,0.0076045627376425855,0.5317535019899451,1.0,9/21,9.47%,OSBPL8;SORBS1;IGF1;OCLN;CREBL2;PRKCI;INSR;RHOQ;ARPP19
prerank,negative regulation of T cell activation (GO:0050868),0.6304949081911176,1.675314008954381,0.0024875621890547263,0.4720928983600735,1.0,8/35,9.65%,LGALS3;GLMN;PTPN22;FGL1;TNFAIP8L2;SDC4;LAX1;IL4I1
prerank,peripheral nervous system development (GO:0007422),0.675506756142942,1.6732788915959724,0.00823045267489712,0.4717956402309157,1.0,7/23,11.34%,ERBB3;SOX8;NGF;NF1;PMP22;GDNF;GPC1
prerank,epithelial structure maintenance (GO:0010669),-0.6642788632831511,-1.6719934035151989,0.024930747922437674,0.5387155117225448,1.0,3/11,8.35%,RBP4;CXADR;STRAP
prerank,acyl-CoA biosynthetic process (GO:0071616),0.7171447063706143,1.6690852237951639,0.008645533141210375,0.48407406942427594,1.0,8/16,11.38%,GCDH;ACACA;ACSS1;SCD5;ACLY;FASN;PPT2;DIP2A
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.6785088982610945,-1.6649896126118462,0.02531645569620253,0.547400622415284,1.0,4/10,7.85%,IGF2;PCGF3;PRMT7;PCGF5
prerank,macrophage migration (GO:1905517),0.7504249292205158,1.6648413867606047,0.01355421686746988,0.49657492331926933,1.0,5/13,13.84%,LGALS3;CCR2;TAFA4;CKLF;P2RY12
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.7174484608358583,1.6637942713595801,0.005856515373352855,0.49223933605156583,1.0,5/17,10.54%,LGALS3;PTPN22;PTPN2;PRNP;PTPRJ
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.5256122444291955,-1.6625078899685877,0.0040650406504065045,0.5388632466770827,1.0,12/25,22.44%,TLR4;INSR;KLF2;PTGS2;KLF4;DDAH2;HSP90AA1;ASS1;EDN1;HSP90AB1;CLU;AKT1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.7562960229368391,1.6624508607308885,0.015503875968992248,0.4891111390680224,1.0,4/12,12.59%,PRKCQ;CCR2;CARD9;ZBTB1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.6399488037797995,-1.6611847459267357,0.023809523809523808,0.5251581915195019,1.0,5/12,13.93%,FOXP1;MAP2K5;TLR4;KLF4;TIRAP
prerank,cellular amino acid catabolic process (GO:0009063),0.5518620569570832,1.655066075560857,0.0021551724137931034,0.5203271002030263,1.0,35/87,22.77%,AADAT;GCDH;AASS;KYNU;CBS;IVD;SLC25A21;DLST;BCKDHB;MCCC1;DAO;HMGCLL1;SARDH;GOT2;MTRR;MCCC2;IL4I1;HIBADH;PHYKPL;HIBCH;ALDH5A1;GLS2;GLS;DBT;GSTZ1;AUH;AMT;BCKDK;ALDH7A1;ASPA;HYKK;GLUD1;DDAH1;ALDH6A1;CARNS1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.605125437740522,-1.6512598843493904,0.033003300330033,0.5307378241774968,1.0,7/15,12.86%,SORBS1;PHACTR1;ITGB5;TNFAIP1;RHOA;PDLIM1;FAM171A1
prerank,stress fiber assembly (GO:0043149),-0.605125437740522,-1.6512598843493904,0.033003300330033,0.5307378241774968,1.0,7/15,12.86%,SORBS1;PHACTR1;ITGB5;TNFAIP1;RHOA;PDLIM1;FAM171A1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.626296072280217,1.6511229387351434,0.0037735849056603774,0.5316633048626194,1.0,9/37,8.17%,DCHS1;TENM2;TENM3;IL1RAPL1;GRID2;NLGN1;CADM3;HMCN1;CADM1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.679861289819509,1.648732561263367,0.014124293785310734,0.5351273649454509,1.0,5/19,6.26%,RELN;IL1RAPL1;OBSL1;CDKL5;CDKL3
prerank,homocysteine metabolic process (GO:0050667),0.7812653609134526,1.648028935237957,0.01726844583987441,0.5290363350605903,1.0,5/11,8.75%,CTH;TST;DPEP1;CBS;MTRR
prerank,acylglycerol homeostasis (GO:0055090),0.6846011451128858,1.6473574354148106,0.01694915254237288,0.5229198946025871,1.0,6/20,15.20%,RORA;MLXIPL;IL18;PNPLA8;MTLN;LIPC
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.4305275277091404,-1.644218273793224,0.011976047904191617,0.5437837737919345,1.0,17/45,21.38%,SP100;PRKCD;TRIM25;IRF2;CAMK2G;TRIM5;ICAM1;IRF1;CAMK2A;OAS2;PML;VCAM1;IRF9;TRIM21;TRIM68;MT2A;IFNGR2
prerank,regulation of synapse maturation (GO:0090128),0.7891656687549803,1.6441148486534207,0.016051364365971106,0.5319725350373914,1.0,4/10,11.79%,RELN;NRXN1;YWHAZ;ANAPC2
prerank,regulation of keratinocyte migration (GO:0051547),0.745303536141215,1.6429741519605594,0.019637462235649546,0.5280632331120072,1.0,4/12,2.99%,EPB41L4B;FGF10;PTEN;MAP4K4
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.6923470935121228,1.6397324403847056,0.014986376021798364,0.5375807831847623,1.0,4/18,3.77%,RELN;VEGFA;CRTC1;RPS6KA4
prerank,aortic valve development (GO:0003176),-0.4813451078816128,-1.6354069379086105,0.008968609865470852,0.5648784488277455,1.0,10/34,3.97%,ROBO1;ROCK2;SMAD6;ELN;ROCK1;NOS3;BMP4;BMPR2;SLIT2;TIE1
prerank,cellular response to ATP (GO:0071318),0.7143447760024512,1.6348663969540091,0.026509572901325478,0.5564786873198952,1.0,8/14,21.51%,P2RY2;HSP90B1;P2RY12;P2RY1;SSH1;TAF1;RYR3;P2RX7
prerank,negative regulation of cell communication (GO:0010648),0.6734380756890718,1.634061733996868,0.020804438280166437,0.5515659986975113,1.0,6/21,9.76%,UBASH3B;ERBB3;ACVR1;SOCS5;HHIP;PTPN1
prerank,negative regulation of signal transduction (GO:0009968),0.5081154495572513,1.632599889497166,0.0,0.5501774788540776,1.0,37/249,6.20%,APOD;DCN;GPC3;PTCH1;SOSTDC1;BMP5;UBASH3B;ADAMTS12;SULF1;PTCH2;ERBB3;PRKCQ;CREB3L1;TAX1BP3;FGF2;PTEN;RNF157;BCL2;VGLL4;ERBB2;EGFR;LRP1;PTPRT;ACVR1;FRZB;PTPN2;CADM4;IRAK3;TLE1;SOCS5;FBXW7;WIF1;SLC27A4;HHIP;SOCS1;SHISA2;METTL3
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5517073157483845,-1.6305041732225143,0.010452961672473868,0.5687795749710126,1.0,6/19,1.98%,TJP1;ROCK2;PRKCH;ROCK1;CLDN5;OCLN
prerank,ERBB2 signaling pathway (GO:0038128),0.6060333494425526,1.6302639995188586,0.02091503267973856,0.555229221098366,1.0,16/31,22.35%,PRKCA;ERBB3;ERBB2;EGFR;ERBIN;BTC;ERBB4;PIK3R1;PTPN18;MYOC;GAB1;HBEGF;GRB2;SOS1;CPNE3;NRG1
prerank,chondrocyte differentiation (GO:0002062),0.6172648725168508,1.6285961426805289,0.014102564102564103,0.5560440130376986,1.0,9/32,9.68%,OSR2;SOX6;SULF1;SOX9;EIF2AK3;TGFB1;CREB3L2;SOX5;AMELX
prerank,macrophage chemotaxis (GO:0048246),0.7782889611519335,1.6252766060658606,0.02047244094488189,0.5665271367243592,1.0,3/10,9.38%,LGALS3;TAFA4;CKLF
prerank,regulation of cholesterol esterification (GO:0010872),-0.6511540179371171,-1.6243768760340902,0.02680965147453083,0.5771439804852923,1.0,6/10,22.90%,AGTR1;ABCG1;STARD4;APOE;LAMTOR1;AGT
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.7069629283303255,1.6236942557309653,0.017673048600883652,0.566768599098413,1.0,4/14,7.90%,PTPN22;CCR2;TGFBR2;IL18
prerank,membrane depolarization (GO:0051899),0.6060829302344161,1.6200382928457198,0.0189873417721519,0.5791422159938177,1.0,8/32,6.94%,CACNA1E;SCN7A;SCN2A;CACNA1A;CHRNA4;SCN5A;CACNB4;SCN3A
prerank,myelination (GO:0042552),0.5808131166208051,1.6196655956500068,0.011764705882352941,0.5721352906694326,1.0,12/46,12.66%,LGI4;MPZ;SCN2A;PLP1;NF1;ARHGEF10;KLK6;EIF2B5;EPB41L3;PMP22;GPC1;MYOC
prerank,cellular response to increased oxygen levels (GO:0036295),-0.6471125895758087,-1.619384891925181,0.0339943342776204,0.5816430685125649,1.0,9/11,31.17%,ATP6V0D1;ATP6AP1;ATP6V0A2;CAV1;TMEM199;FAS;ATP6V1G1;CCDC115;ATP6V1A
prerank,muscle organ development (GO:0007517),0.5701279468366456,1.6181021447455708,0.009557945041816009,0.5732032250069863,1.0,14/54,11.39%,LAMA2;SOX6;CXCL10;CHODL;UTRN;SGCD;EGR3;EVC;ITGB1BP2;MKX;SGCE;CHD2;MRAS;EMD
prerank,aortic valve morphogenesis (GO:0003180),-0.4909705862239775,-1.6175301879090906,0.004,0.5737964078021964,1.0,9/30,3.97%,ROBO1;ROCK2;SMAD6;ELN;ROCK1;NOS3;BMP4;SLIT2;TIE1
prerank,urogenital system development (GO:0001655),0.7448772110678163,1.6168120927540655,0.01834862385321101,0.5723354382136664,1.0,3/11,3.35%,OSR2;SOX9;EPHB2
prerank,canonical glycolysis (GO:0061621),-0.5012319734119406,-1.6162875656283615,0.04780876494023904,0.5478828544278193,1.0,10/24,23.62%,FOXK1;PFKP;PGK1;PGAM1;GPI;PFKM;PFKL;ENO1;GAPDHS;ENO3
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.5012319734119406,-1.6162875656283615,0.04780876494023904,0.5478828544278193,1.0,10/24,23.62%,FOXK1;PFKP;PGK1;PGAM1;GPI;PFKM;PFKL;ENO1;GAPDHS;ENO3
prerank,type I interferon signaling pathway (GO:0060337),-0.4365997798499346,-1.6155612886241344,0.015706806282722512,0.5230371396722074,1.0,18/41,21.83%,SP100;IFIT2;IFI27;IFITM3;IRF2;SAMHD1;IRF1;IFITM2;OAS2;IRF9;STAT2;IFI35;ISG15;IFIT1;BST2;IFNAR1;IFNAR2;RSAD2
prerank,cellular response to type I interferon (GO:0071357),-0.4365997798499346,-1.6155612886241344,0.015706806282722512,0.5230371396722074,1.0,18/41,21.83%,SP100;IFIT2;IFI27;IFITM3;IRF2;SAMHD1;IRF1;IFITM2;OAS2;IRF9;STAT2;IFI35;ISG15;IFIT1;BST2;IFNAR1;IFNAR2;RSAD2
prerank,regulation of smoothened signaling pathway (GO:0008589),0.5785121133600309,1.615262421861175,0.009489916963226572,0.5726726830404658,1.0,11/50,8.64%,RORA;GPC3;PTCH1;PTCH2;STK36;EVC;GLI1;HHIP;UCHL5;RAB34;SMO
prerank,response to cholesterol (GO:0070723),0.6867012528457797,1.6145663082175277,0.03056768558951965,0.5682244511332801,1.0,8/17,16.11%,PTCH1;TGFB1;GRAMD1A;TGFBR2;SMO;GRAMD1C;GRAMD1B;GPLD1
prerank,organophosphate catabolic process (GO:0046434),0.7419831865297062,1.6139881746979299,0.024844720496894408,0.5635029689293182,1.0,2/11,2.67%,PLBD1;NUDT15
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.6976434249957606,1.6139527612506201,0.02586206896551724,0.5557840751238151,1.0,4/16,7.17%,RORA;PRKN;RORC;PDK3
prerank,axonogenesis (GO:0007409),0.504076051733678,1.6137778443173727,0.0,0.5489909318086955,1.0,64/237,13.44%,LAMA2;RELN;GFRA1;NTN4;ANK3;PRKCA;DOCK7;LGR6;ENAH;PRKCQ;GLI2;EFNA4;PTEN;SEMA3E;IRS2;EPHB6;GFRA4;SEMA6C;EFNA5;MAP1B;NRCAM;EPHB2;MAPK7;SEMA3A;AUTS2;NRXN1;CTNNA2;WNT5A;SPTBN1;BAIAP2;NTNG2;NTNG1;PPP3CB;S100A6;CNTN6;FYN;GAB2;CNTN2;TNR;DOK6;DOK4;SPG11;DSCAM;DCC;PALLD;PIK3R1;GDNF;KIF5C;USP33;PTPN11;GPC1;MAPK1;OPHN1;EFNB1;PLPPR4;CDK5R1;PTPRA;NRP2;UNC5C;EFNB3;RAB3A;DRD2;SH3KBP1;LYPLA2
prerank,protein targeting to ER (GO:0045047),-0.3719461559480408,-1.6135645356110118,0.0,0.5176038263899178,1.0,49/99,26.80%,RPS14;RPL24;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;SPCS2;RPS2;RPL19;RPL5;RPL34;RPS25;RPS15;RPLP1;RPL31;RPL3;SRPRA;RPS6;SRP14;RPS8;RPL11;RPL12;ZFAND2A;RPL7A;SRP68;RPL13;RPS21;RPL35A;RPL26;RPS9;RPL32;RPS29;RPS23;RPLP2;RPL8;SRP72;RPL41;RPS17;RPS5;RPS15A;UBA52;RPL37A;GET3;SRP19;RPS10;RPL6;RPL9
prerank,regulation of nervous system development (GO:0051960),0.5982841216371637,1.6134528141367366,0.011450381679389313,0.5435090974223984,1.0,3/37,0.75%,LGI4;NKX6-2;DOCK7
prerank,regulation of cartilage development (GO:0061035),0.6811683225990471,1.6116905513688844,0.01680672268907563,0.5465199343066467,1.0,7/18,8.90%,SOX6;SOX9;MBOAT2;PTHLH;ZBTB16;TRPS1;SOX5
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.6899124094900215,1.6098024086332172,0.023289665211062592,0.5490252907170035,1.0,2/16,1.40%,APOD;PYCARD
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.4355069469977333,-1.6065541402577426,0.011764705882352941,0.5305531554843244,1.0,24/39,30.62%,RPS14;NPM1;RPS16;RPS19;WDR3;RPS25;RPS15;RIOK3;RPS6;EMG1;SURF6;MRPS7;RIOK1;MRPS11;DDX52;RPS17;SNU13;RPS5;TSR3;RIOK2;PWP2;RPS27;NOL11;NOP14
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5994518239651824,1.6036348849905893,0.01575757575757576,0.5755597488169261,1.0,13/38,18.57%,RORA;PYCARD;TLE1;OTUD7B;NLRX1;PPM1B;ESR1;RHOH;PER1;RIPK1;OTUD7A;ZMYND11;MAPKBP1
prerank,cytoplasmic translation (GO:0002181),-0.3766089396530238,-1.602980371950803,0.0,0.5317169977133877,1.0,45/91,27.55%,RPS14;GSPT1;RPL24;DRG1;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;RPS2;FTSJ1;RPL19;RPL5;RPL34;RPS25;RPS15;RPLP1;RPL31;RPL3;DRG2;RPS6;RPS8;RPL11;RPL12;RPL7A;RPL13;RPS21;RPL35A;RPL26;RPS9;RPL32;RPS29;RPS23;RPL8;RPL41;RPS17;RPS5;RPS15A;UBA52;RPL37A;RPS10;RPL6;RPL9;RPS27
prerank,glial cell differentiation (GO:0010001),0.6188037665841637,1.601823863337475,0.022135416666666668,0.5780119382902705,1.0,7/28,7.61%,RELN;ERBB3;SOX8;FGF10;SOX9;SOX11;EIF2B5
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.570933402615821,1.5998205821277292,0.019393939393939394,0.5818631565841339,1.0,13/46,12.70%,RELN;TSHZ3;CACNG7;GRIK3;NRXN1;CCR2;SYT1;NLGN1;GRIK1;GRM5;DGKI;OPHN1;DRD2
prerank,cardiac atrium morphogenesis (GO:0003209),-0.5616425743499585,-1.598438441010601,0.015337423312883436,0.5364541596343336,1.0,7/16,19.44%,NOTCH2;ENG;BMPR2;PROX1;TGFB2;HEY2;ZFPM1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.6816095860013289,1.5978378402731253,0.02390998593530239,0.5855067858241593,1.0,3/18,2.35%,FFAR4;CRH;PRKN
prerank,regulation of protein export from nucleus (GO:0046825),-0.49661208005404023,-1.5957064649041053,0.011406844106463879,0.53430808557883,1.0,6/23,8.21%,SP100;PTPN14;XPO4;IFI27;GSK3B;CAMK1
prerank,prostanoid biosynthetic process (GO:0046457),-0.5706547167979825,-1.5955933416767134,0.029498525073746312,0.5230780879476501,1.0,5/15,7.97%,PLA2G4A;PTGIS;PTGDS;PTGS1;PTGS2
prerank,aggrephagy (GO:0035973),0.6280478171513412,1.5919500846173469,0.015789473684210527,0.6127589181965665,1.0,15/27,22.87%,DYNLL1;PRKN;WDFY3;ACBD5;ATG5;DYNC1I1;HDAC6;DYNC1I2;UBB;PARK7;PCNT;WDR81;VIM;UBQLN1;DYNC1H1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.7385531698657792,1.5908316473254582,0.025835866261398176,0.6119464731772003,1.0,3/11,13.23%,PRKCQ;CARD9;MALT1
prerank,membrane assembly (GO:0071709),0.5921475798849536,1.5889815852261504,0.013480392156862746,0.6148542354631235,1.0,9/34,8.19%,ANK3;CEL;LRP4;PTEN;IL1RAPL1;NRXN1;SPTBN1;NLGN1;GAK
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6909714864188451,1.586188835934658,0.01849217638691323,0.6161480256923931,1.0,3/16,1.66%,APOD;DLC1;PTEN
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6909714864188451,1.586188835934658,0.01849217638691323,0.6161480256923931,1.0,3/16,1.66%,APOD;DLC1;PTEN
prerank,glycosaminoglycan catabolic process (GO:0006027),0.561321510663509,1.5850382092862754,0.014942528735632184,0.6156863729761172,1.0,21/55,18.21%,DCN;GPC3;HSPG2;VCAN;LUM;FGF2;TGFB1;SDC2;SDC4;BCAN;GALNS;NCAN;GPC1;SDC3;GPC4;IDS;SPAM1;HYAL1;SLC9A1;CSPG4;SGSH
prerank,bicellular tight junction assembly (GO:0070830),-0.4159193088051766,-1.5815891895325402,0.01694915254237288,0.5655341209165359,1.0,12/46,8.89%,AFDN;PARD6G;CDH5;PECAM1;CLDN5;OCLN;ESAM;PRKCI;PARD3;CLDN14;PAK2;MPP7
prerank,negative regulation of cell projection organization (GO:0031345),0.5599608312493635,1.5812579632512627,0.013447432762836185,0.6303486316990384,1.0,20/48,20.14%,PTEN;GORASP1;LPAR1;SEMA3A;PRNP;MT3;GRIN2B;FYN;GAK;BAG5;DCC;HDAC2;FKBP4;MYLIP;STX1B;EFNB2;RTN4RL1;KANK1;DENND5A;PTPRS
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.6146491601838353,1.5800325780570053,0.02763157894736842,0.6300564810978733,1.0,10/27,6.82%,PTEN;IL1RAPL1;FRMD7;NCS1;PSEN1;CTNNA2;FBXO7;DISC1;NTNG2;NTNG1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6925402193137657,1.577367254105661,0.03687315634218289,0.6386986738374162,1.0,6/14,13.20%,SULF1;CREB3L1;FGF2;SHISA2;GPC1;GATA3
prerank,camera-type eye morphogenesis (GO:0048593),0.7475457077622732,1.5766165388449078,0.03927492447129909,0.6360825606975374,1.0,3/10,5.06%,TENM3;VEGFA;NF1
prerank,myotube cell development (GO:0014904),-0.6285555441129465,-1.5765416432695063,0.061224489795918366,0.5725652831810469,1.0,2/10,7.30%,IGF1;SIX1
prerank,regulation of neuron projection development (GO:0010975),0.4930522109239087,1.576440592966639,0.0,0.629970583827103,1.0,39/163,12.50%,ROR2;RELN;SIPA1L1;ROR1;TENM3;NTRK3;PTEN;IL1RAPL1;LPAR1;FRMD7;NCS1;SEMA3A;CSMD3;PSEN1;NTRK2;MT3;TANC2;CTNNA2;LRRC4C;WNT5A;FBXO7;PAK1;ALKAL2;CHN1;CDKL5;DISC1;NTNG2;NTNG1;RAP1A;GAK;BAG5;DCC;HDAC2;PPFIA2;FKBP4;MAGI2;CDK5R1;LZTS3;MYLIP
prerank,regulation of T cell differentiation (GO:0045580),0.5992896879487095,1.5753883122317338,0.0175,0.6295786185338369,1.0,11/33,17.76%,IL2RA;CBFB;CCR2;METTL3;ZMIZ1;RHOH;ZBTB1;GATA3;RUNX1;ABL1;MDK
prerank,negative regulation of lipid metabolic process (GO:0045833),0.6441859043439894,1.575348871908478,0.020804438280166437,0.6230504849506959,1.0,3/22,8.12%,APOD;PDE3B;ASXL3
prerank,smooth muscle contraction (GO:0006939),-0.5762218439493736,-1.5751560429860763,0.04559270516717325,0.5660811508013913,1.0,6/14,14.80%,ROCK2;ROCK1;PIK3C2A;MYLK;MYH11;ACTA2
prerank,negative regulation of cartilage development (GO:0061037),0.7091562385545358,1.5750264826788694,0.019637462235649546,0.6180862807841198,1.0,4/13,3.66%,ADAMTS12;EFEMP1;SOX9;PTHLH
prerank,ERBB signaling pathway (GO:0038127),0.5357024992679866,1.5750261039979299,0.01048951048951049,0.6115108948183313,1.0,17/64,12.64%,EFEMP1;PRKCA;ERBB3;REPS2;GAREM1;SOX9;ERBB2;EGFR;TGFB1;ERBIN;BTC;ERBB4;PIK3R1;CBL;PTPN11;MAPK1;PTPN18
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.7008403338035374,1.5728587638229332,0.023564064801178203,0.6169548868509558,1.0,4/14,3.66%,ADAMTS12;EFEMP1;SOX9;PTHLH
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.5687248601448397,1.572358463906151,0.020151133501259445,0.6132561828656333,1.0,11/41,9.79%,RELN;ERBB3;GPRC5B;FBXW7;NCF1;NTRK2;PRNP;FYN;BTC;PTPN1;GRM5
prerank,sulfur amino acid catabolic process (GO:0000098),0.7732159481225979,1.5723122858977456,0.022187004754358162,0.6071531250475914,1.0,4/10,8.75%,CTH;TST;CBS;MTRR
prerank,sulfur compound catabolic process (GO:0044273),0.5920838156136525,1.570336053636403,0.018094089264173704,0.612277718179702,1.0,8/38,7.19%,DCN;VCAN;CTH;LUM;TST;DPEP1;BCAN;GALNS
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.4824375351631861,-1.5703120010050091,0.04184100418410042,0.573241170598058,1.0,12/25,29.81%,FOXK1;PFKP;PGK1;PGAM1;GPI;PFKM;PFKL;ENO1;GAPDHS;ENO3;ADPGK;PKM
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.6995909679804104,1.5698116113387899,0.03488372093023256,0.6092751982036337,1.0,2/13,0.83%,APOD;MDFIC
prerank,nucleotide biosynthetic process (GO:0009165),-0.537639254033057,-1.5663150197095046,0.020618556701030927,0.576383579983994,1.0,10/18,22.57%,NMNAT2;ME1;PRPSAP2;RRM1;NMNAT1;RRM2B;PRPS2;GART;PRPS1;PRPS1L1
prerank,ephrin receptor signaling pathway (GO:0048013),0.5279513733156262,1.5660939436391266,0.009933774834437087,0.6236399549713549,1.0,28/82,14.33%,SIPA1L1;MMP2;DNM1;EFNA4;ARPC1B;EPHB6;EFNA5;EPHB2;ARHGEF28;PSEN1;SDC2;GRIN2B;PAK1;RASA1;CHN1;ITSN1;ANKS1B;FYN;VAV3;NCSTN;PTPN11;EFNB1;CDK5R1;ANKS1A;APH1A;EFNB3;EPHA10;PSEN2
prerank,positive regulation of calcium ion import (GO:0090280),0.7065068992515903,1.5640567760519908,0.031446540880503145,0.629664202720223,1.0,1/12,0.37%,LGALS3
prerank,negative regulation of viral genome replication (GO:0045071),-0.4264085471012681,-1.5638893031555356,0.010362694300518135,0.5756549324706622,1.0,15/40,21.83%,ZC3HAV1;PLSCR1;IFITM3;IFIH1;PARP10;TNIP1;IFITM2;OAS2;PROX1;HMGA2;TASOR;ISG15;IFIT1;BST2;RSAD2
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.5413724479811739,1.5633445936933599,0.011454753722794959,0.6275648286479643,1.0,11/57,5.72%,RELN;CRH;GRIA1;CACNG7;DLGAP1;GRIA3;CAPN1;SHISA9;GRIN2B;DLG2;NLGN1
prerank,regulation of cation channel activity (GO:2001257),0.5232391422874293,1.563277894150385,0.0021668472372697724,0.6217628077211009,1.0,18/89,6.55%,RELN;ANK3;CRH;FGF13;ANK2;GRIA1;CACNG7;GRIA3;CAPN1;HPCA;SHISA9;GRIN2B;DLG2;NLGN1;FGF12;JPH3;CACNB4;FGF14
prerank,divalent inorganic cation homeostasis (GO:0072507),0.6193529293042905,1.561847962038067,0.02860858257477243,0.6240818716514077,1.0,5/25,4.84%,ANK3;PRKN;KCNA1;TMTC2;MT3
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6362383707883214,-1.5615799444912024,0.0392156862745098,0.5628496580458098,1.0,4/10,10.31%,PRKCD;SIRT3;RACK1;TNFRSF1A
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.6362383707883214,-1.5615799444912024,0.0392156862745098,0.5628496580458098,1.0,4/10,10.31%,PRKCD;SIRT3;RACK1;TNFRSF1A
prerank,negative regulation of chemokine production (GO:0032682),0.6978651067561054,1.5610639260381398,0.03840472673559823,0.6223441332865962,1.0,1/14,0.03%,APOD
prerank,bicarbonate transport (GO:0015701),-0.48311291099759457,-1.560833137216438,0.035856573705179286,0.5551543830274922,1.0,11/25,24.59%,SLC26A7;SLC4A10;SLC4A3;SLC39A8;CYB5R4;CA4;SLC4A8;CYB5R1;SLC26A6;CA2;CYB5RL
prerank,negative regulation of intracellular protein transport (GO:0090317),0.6255083134111754,1.5604649040160246,0.030343007915567283,0.6202562913018868,1.0,2/22,0.83%,APOD;MDFIC
prerank,skeletal system development (GO:0001501),0.5017246261698106,1.5598041721356355,0.003089598352214212,0.6180268492989172,1.0,38/148,12.66%,SOX6;BMP5;SULF1;VCAN;ANKH;GLI2;PKDCC;SOX9;AKAP13;FRZB;PTHLH;EIF2AK3;EVC;SOX11;ITGB8;PAPSS2;EXT1;HHIP;WNT5A;HOXD3;COL9A2;ZBTB16;TRPS1;CREB3L2;BCAN;FGFR1;TRIP11;SOX5;ADAMTS4;BPNT2;SLC10A7;NCAN;MMP16;COL1A2;BMP7;KIAA1217;VKORC1;MYOC
prerank,protein localization to cell junction (GO:1902414),-0.5050212652218209,-1.5579798757708305,0.01858736059479554,0.5564199631494022,1.0,6/22,8.23%,TJP1;CGNL1;NLGN2;JAM3;TJP2;PAK2
prerank,positive regulation of mitochondrial fission (GO:0090141),0.6498932354414348,1.5554292193808916,0.03571428571428571,0.6374114349075535,1.0,4/18,7.73%,DCN;SPIRE1;PRKN;BNIP3
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5901082794677063,1.5548658939058053,0.018300653594771243,0.6347020261546538,1.0,10/32,12.66%,APOD;DLC1;PTEN;SEMA3E;HOXA7;MAP4K4;RASA1;NF2;AJAP1;MYOC
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5641918872292772,1.5546182444831875,0.019184652278177457,0.6303727392311627,1.0,12/46,9.89%,WNK2;PTEN;DUSP4;PTPN2;EPHB2;CNKSR3;DUSP6;LMO3;SPRED2;SPRED1;PTPN1;SPRED3
prerank,basement membrane organization (GO:0071711),0.6853510831385518,1.5530917374334903,0.03676470588235294,0.6329642197908303,1.0,5/14,6.82%,NTN4;PXDN;NID1;NTNG2;NTNG1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.7090205746142457,1.5526485832747097,0.027338129496402876,0.6297286142831037,1.0,3/14,3.54%,WNK2;ANK3;WNK3
prerank,positive regulation of nuclear division (GO:0051785),-0.4823422576810991,-1.5521935655767005,0.024291497975708502,0.5681380942473612,1.0,7/25,9.93%,IGF1;LRP5;IGF2;INSR;TGFA;RGCC;PDGFRB
prerank,base conversion or substitution editing (GO:0016553),0.7331157971603015,1.5506395292124384,0.028037383177570093,0.6355637884140553,1.0,4/11,13.08%,METTL3;APOBEC1;ADARB2;ADARB1
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6413760782851464,1.5502929877979998,0.034139402560455195,0.6317348685596288,1.0,3/19,4.08%,RAPSN;NQO1;CHRNA4
prerank,actomyosin structure organization (GO:0031032),-0.37302833511019823,-1.550277884266372,0.0,0.5656784145029103,1.0,15/75,6.22%,TJP1;SORBS1;PHACTR1;ROCK2;FRMD5;TMOD3;PGM5;MYH9;ROCK1;ITGB5;TNFAIP1;EPB41L5;EPB41;CIT;TPM1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6355537986775364,1.548756366319204,0.03927068723702665,0.6351234864073159,1.0,6/20,13.70%,SULF1;CREB3L1;FGF2;SHISA2;GPC1;SMOC2
prerank,muscle tissue morphogenesis (GO:0060415),-0.5461993262094127,-1.5487141483673055,0.05448717948717949,0.5621002022383021,1.0,7/16,19.44%,BMP4;MYLK;TBX1;EFEMP2;PROX1;HEY2;ZFPM1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6918827296126563,1.5481535425050807,0.04035874439461883,0.6330721417462419,1.0,14/14,30.87%,SEC24D;SEC31B;SEC24C;RAB1A;TBC1D20;SEC24A;SEC23B;MIA3;SEC23A;SCAP;SAR1A;SEC13;SEC31A;SEC24B
prerank,tight junction assembly (GO:0120192),-0.4021385007777343,-1.548094238288208,0.0111731843575419,0.5548740223751304,1.0,12/49,8.89%,AFDN;PARD6G;CDH5;PECAM1;CLDN5;OCLN;ESAM;PRKCI;PARD3;CLDN14;PAK2;MPP7
prerank,eye morphogenesis (GO:0048592),0.6546873670532488,1.5478552567777017,0.045779685264663805,0.6294205109200569,1.0,6/19,8.50%,EFEMP1;TENM3;COL5A2;VEGFA;NF1;RARG
prerank,acyl-CoA metabolic process (GO:0006637),0.5827928276928012,1.5476519475937545,0.020330368487928845,0.6252738957677136,1.0,14/35,21.01%,ACACA;DLST;THEM4;OXSM;ACOT11;ACSF2;SUCLA2;ACSL6;HMGCS2;GPAT4;GLYAT;DBI;ACOT8;ACBD6
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.6062349566489438,-1.5474079219763062,0.04986149584487535,0.5485386752570665,1.0,6/11,15.89%,PARP3;PARP4;PARP10;PARP6;PARP12;PARP14
prerank,T cell differentiation in thymus (GO:0033077),0.6769286193612538,1.547399767439207,0.05572289156626506,0.6214487083757544,1.0,5/14,12.09%,RAG2;FADD;RABL3;ZFP36L2;MR1
prerank,extracellular matrix organization (GO:0030198),0.4831727531092711,1.5450154953813289,0.0,0.6292189827078658,1.0,52/276,9.49%,LAMA2;VIT;DCN;COL15A1;TGFBI;MMP2;HSPG2;ADAMTS12;VCAN;A2M;ADAM19;HAS2;LUM;ADAMTS20;CREB3L1;FGF2;COL5A3;COL20A1;GSN;COL28A1;LAMC1;P4HA1;COL5A2;PXDN;RECK;HTRA1;CAPN1;COL4A2;COL27A1;COL26A1;TGFB1;GPM6B;ITGB8;NF1;COLGALT2;NID1;COL9A2;MMP15;PLEC;CTSK;ADAMTS1;LOXL3;BCAN;POSTN;CYP1B1;TNR;COL18A1;TLL2;ADAMTS4;COL3A1;PLOD1;SPARC
prerank,sphingoid biosynthetic process (GO:0046520),-0.5997382394267629,-1.5447407478728477,0.04776119402985075,0.5400064338252929,1.0,6/11,25.69%,ACER2;SPTLC2;ASAH2;SPHK1;SPHK2;SPTLC1
prerank,sphingosine biosynthetic process (GO:0046512),-0.5997382394267629,-1.5447407478728477,0.04776119402985075,0.5400064338252929,1.0,6/11,25.69%,ACER2;SPTLC2;ASAH2;SPHK1;SPHK2;SPTLC1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5787509772542561,-1.544104347792068,0.04153354632587859,0.5338194829948113,1.0,6/13,12.78%,SORBS1;SNX5;IGF2;GKAP1;PRKCZ;ECHDC3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.6956399599901258,1.5440664032187814,0.0290519877675841,0.6291460410171912,1.0,1/13,0.13%,SEC16B
prerank,modulation of chemical synaptic transmission (GO:0050804),0.5059464085443658,1.5436410745195523,0.007478632478632479,0.6262465498974297,1.0,32/107,15.57%,RELN;CEL;CLSTN2;PTEN;NGF;NRG3;GRIK3;DLGAP1;CACNA1A;GRIK5;GRIK2;SLC12A2;LRRC4C;GRID2;SYT1;NLGN1;SLC8A2;GRIK1;USP46;SYN1;NMU;GRM5;MCTP1;PXK;DGKI;RIMS1;OPHN1;DRD2;CLSTN1;ITGB1;HOMER1;STX1B
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4807200275741701,-1.5426293500599493,0.028225806451612902,0.5307207778365886,1.0,10/26,9.47%,OSBPL8;SORBS1;IGF1;OCLN;CLIP3;CREBL2;PRKCI;INSR;RHOQ;ARPP19
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.6016068687038949,-1.5425132852753773,0.04229607250755287,0.5229481629382244,1.0,5/12,11.03%,PARP3;PARP10;PARP1;PARP6;PARP12
prerank,positive regulation of sodium ion transport (GO:0010765),0.7214707921569166,1.5385959703461227,0.036753445635528334,0.6485348695903441,1.0,6/12,15.14%,ANK3;WNK3;CNKSR3;SCN5A;AHCYL1;PKP2
prerank,indolalkylamine catabolic process (GO:0046218),0.738418179999389,1.537108460897268,0.044233807266982623,0.6512147453243317,1.0,3/10,9.65%,AADAT;KYNU;IL4I1
prerank,negative regulation of viral process (GO:0048525),-0.38245855324008377,-1.5363786664438013,0.02027027027027027,0.5363771099421348,1.0,20/57,21.83%,ZC3HAV1;CHMP3;PLSCR1;IFITM3;PPIA;IFIH1;PARP10;TRIM5;TNIP1;IFITM2;LARP7;OAS2;PROX1;PML;TRIM21;ISG15;IFIT1;BST2;HEXIM1;RSAD2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.6313421171745036,1.534348807588087,0.03319502074688797,0.6614510745915966,1.0,6/20,8.60%,BMP5;SLC27A1;ERLIN2;FBXW7;ASXL3;BRCA1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.6357549295587401,1.5327354693022117,0.0379746835443038,0.6651823293234581,1.0,9/21,18.77%,CREB3L1;PRKN;EIF2AK3;SELENOS;HERPUD1;NCK1;OPA1;BCL2L11;PARK7
prerank,positive regulation of neuron projection development (GO:0010976),0.5096590908431134,1.5321186671139517,0.004449388209121246,0.6636959152186124,1.0,10/85,7.42%,ROR2;RELN;ROR1;BMP5;TENM3;NTRK3;NTRK2;WNT5A;ALKAL2;RAP1A
prerank,microtubule anchoring (GO:0034453),0.7103406619690147,1.5315177645059663,0.05409582689335394,0.6620062393897419,1.0,5/12,10.81%,SAXO2;BICD1;PCM1;CLASP1;BICD2
prerank,ubiquinone biosynthetic process (GO:0006744),-0.5565466390859306,-1.5291574371616927,0.053156146179401995,0.5533054247695953,1.0,10/15,26.68%,COQ8B;COQ10B;PDSS1;COQ9;COQ3;NDUFA9;FDXR;PDSS2;COQ6;COQ8A
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.623132200212642,1.5287774744567852,0.027700831024930747,0.6722310422404638,1.0,4/22,4.80%,LGALS3;PTPN22;PTPN2;PRNP
prerank,regulation of lymphocyte migration (GO:2000401),-0.6181097991392852,-1.5283785002846195,0.06376811594202898,0.5480324487467735,1.0,5/10,22.44%,WASL;SLC8B1;STK10;MSN;AKT1
prerank,negative regulation of signaling (GO:0023057),0.6160783108036536,1.5271708910132653,0.039509536784741145,0.6761362371894932,1.0,6/25,9.76%,UBASH3B;ERBB3;ACVR1;SOCS5;HHIP;PTPN1
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.5190117863035031,-1.526835711056766,0.03873239436619718,0.5458384470306235,1.0,5/20,10.64%,WNT4;CLK2;SIK1;GSK3A;C1QTNF3
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.4777888242130484,1.526077861858556,0.0010090817356205853,0.6773925982617969,1.0,35/214,7.42%,ROR2;FFAR4;ROR1;WNK2;CCL11;PRKCA;PDGFRA;GLIPR2;NTRK3;FGF2;PYCARD;FGF10;PTEN;PTPN22;GAREM1;DUSP4;ERBB2;EGFR;PTPN2;EPHB2;FBXW7;TGFB1;CCL4;NTRK2;MT3;CNKSR3;DUSP6;YWHAZ;ALKAL2;LMO3;SPRED2;CARD9;ACKR3;SPRED1;RAP1A
prerank,regulation of stem cell proliferation (GO:0072091),-0.5436816115643343,-1.5255747542377514,0.029239766081871343,0.5426606592409097,1.0,9/17,15.06%,GJA1;FBLN1;KDM1A;ZFP36L1;ACE;AGO3;PTPRC;HMGA2;TERT
prerank,serine family amino acid biosynthetic process (GO:0009070),0.7020216358198652,1.522613861896528,0.037993920972644375,0.6915364765461435,1.0,5/12,6.89%,CTH;CBS;PSPH;PSAT1;PHGDH
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.5920713679484406,-1.5221571336699156,0.059375,0.5470502254077262,1.0,5/12,9.29%,SORBS1;SNX5;IGF2;GKAP1;PRKCZ
prerank,regulation of myelination (GO:0031641),0.6097085241486255,1.52186996118687,0.03278688524590164,0.690848982797051,1.0,5/25,8.98%,LGI4;NKX6-2;EIF2AK3;TMEM98;NSUN5
prerank,regulation of adaptive immune response (GO:0002819),0.6471868445000503,1.5200731065540252,0.04782608695652174,0.6962366423357998,1.0,6/18,13.22%,PYCARD;FADD;SAMSN1;IL4I1;IL6ST;AHR
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.6739755250438351,1.5198361877136954,0.037921348314606744,0.6923606348297056,1.0,5/15,10.12%,EDA;GLI2;SCN5A;AMELX;HDAC2
prerank,negative regulation of cellular component movement (GO:0051271),-0.5513611187816874,-1.5180725607202332,0.052795031055900624,0.5537480492884038,1.0,5/15,9.35%,SP100;FRMD5;FBLN1;ACTN1;CCDC125
prerank,2-oxoglutarate metabolic process (GO:0006103),0.6752998667337651,1.516164762130316,0.0410958904109589,0.7079253571393699,1.0,5/13,13.63%,AADAT;IDH2;DLST;GOT2;GPT2
prerank,external encapsulating structure organization (GO:0045229),0.47907165912255373,1.5158403434244074,0.001017293997965412,0.7047612434384264,1.0,39/205,10.98%,LAMA2;VIT;DCN;COL15A1;TGFBI;MMP2;HSPG2;ADAMTS12;VCAN;ADAM19;LUM;ADAMTS20;FGF2;COL5A3;COL28A1;LAMC1;TGM1;COL5A2;PXDN;RECK;COL4A2;COL27A1;ITGB8;NF1;NID1;COL9A2;MMP15;ADAMTS1;BCAN;POSTN;TNR;COL18A1;HRNR;ADAMTS4;COL3A1;SPARC;NCAN;MMP16;COL1A2
prerank,RNA interference (GO:0016246),-0.5201632710116741,-1.513882348314907,0.05732484076433121,0.5611183197272385,1.0,10/17,30.18%,AGO1;NRDE2;AGO3;TERT;TARBP2;CLP1;MRPL44;AGO2;DICER1;AGO4
prerank,cell-cell junction maintenance (GO:0045217),-0.601083933398593,-1.5132886497371631,0.05865102639296188,0.5558379929534903,1.0,2/11,3.26%,TJP1;NLGN2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.48217398444476206,1.5131957591794558,0.006185567010309278,0.7140724149048024,1.0,23/151,7.42%,ROR2;FFAR4;ROR1;CCL11;PRKCA;PDGFRA;GLIPR2;NTRK3;FGF2;PYCARD;FGF10;PTPN22;GAREM1;EGFR;FBXW7;TGFB1;CCL4;NTRK2;MT3;ALKAL2;CARD9;ACKR3;RAP1A
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.6158431146605561,1.5102928590199867,0.059474412171507604,0.7254881944318372,1.0,11/21,22.31%,SULF1;HS6ST1;EXT1;EXTL3;GLCE;GPC1;HS2ST1;UGDH;SGSH;XYLT1;SULF2
prerank,lymphocyte chemotaxis (GO:0048247),0.5713901993280234,1.5094895838741489,0.030573248407643312,0.7250757352476686,1.0,6/34,10.16%,CCL11;CXCL10;CCL4;SLC12A2;CKLF;CYP7B1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6527064688253542,1.5078476511264838,0.049132947976878616,0.7295488225687192,1.0,5/15,10.04%,DCN;VCAN;BCAN;CSGALNACT1;NCAN
prerank,positive regulation of transporter activity (GO:0032411),0.6775063507709419,1.507511412616973,0.05067064083457526,0.7262077385660303,1.0,5/13,9.41%,SYNGR3;KMT2A;WNK3;STK39;SGK2
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.6874388294579594,1.5074469572088236,0.0578386605783866,0.7216361867034158,1.0,7/13,21.82%,VDAC2;BMF;BNIP3;RHOT2;BCL2L11;RHOT1;BNIP3L
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5601603127636982,1.5069662574548512,0.024484536082474227,0.7193695105258255,1.0,14/36,18.83%,RELN;EPHB2;FBXW7;NCF1;CCR2;BTC;HIF1A;HDAC2;HDAC6;ITGB1;HBEGF;NCOA3;PARK7;TAF1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.4939616395831032,-1.5067829028048334,0.0321285140562249,0.5703346797556224,1.0,10/22,24.25%,SNX9;ROCK1;TIMP3;ADRA2A;TIMP2;NRDC;APOE;TIMP4;SNX33;SH3D19
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.6014465622017022,-1.5058465374883634,0.060126582278481014,0.5664244495593853,1.0,3/10,8.34%,PODXL;WNK1;DPP4
prerank,cellular response to estradiol stimulus (GO:0071392),0.6427124544351452,1.5053809679387369,0.05436337625178827,0.7233720178900501,1.0,8/18,19.24%,SSTR1;EGFR;ESR1;NRIP1;LCOR;NCOA3;FAM210B;RUVBL2
prerank,diol metabolic process (GO:0034311),-0.5047492600843996,-1.5050195450778348,0.05782312925170068,0.5623871971304294,1.0,9/19,24.24%,PLPP1;NOS3;DEGS2;ASAH2;HSP90AA1;SPR;SPHK1;AKT1;SPHK2
prerank,cardiac conduction system development (GO:0003161),-0.47046442341701616,-1.5032900797333213,0.04406779661016949,0.5618883938637689,1.0,6/24,4.38%,NOTCH2;GJA1;BMP4;GJB6;MAML1;CACNA1G
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.57280942277194,1.5029582585277195,0.036410923276983094,0.7320455171222988,1.0,13/34,14.81%,UBASH3B;PTPN22;DUSP4;PTPRT;PTPN2;DUSP6;PTPN13;PTPN1;PTPRJ;PTPN11;PTPN18;PTPRZ1;PTPRF
prerank,regulation of mitochondrial depolarization (GO:0051900),0.7253919182450579,1.5025078425769816,0.050793650793650794,0.7295965173733208,1.0,2/10,1.76%,DCN;BCL2
prerank,extracellular matrix disassembly (GO:0022617),0.5288591457216483,1.5003691801418062,0.029171528588098017,0.7367134681101197,1.0,14/53,14.87%,MMP2;A2M;GSN;LAMC1;HTRA1;CAPN1;MMP15;CTSK;TLL2;ADAMTS4;MMP16;MMP19;SCUBE1;WASHC1
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5154667278601515,-1.5002673397272794,0.057692307692307696,0.5652108524754558,1.0,8/16,22.90%,NOS3;GUCY1B1;DDAH2;NOS1;APOE;NDNF;KCNC2;AGT
prerank,cellular component disassembly (GO:0022411),0.5293408936397282,1.4996706136943048,0.02910360884749709,0.7358290255684254,1.0,14/53,14.87%,MMP2;A2M;GSN;LAMC1;HTRA1;CAPN1;MMP15;CTSK;TLL2;ADAMTS4;MMP16;MMP19;SCUBE1;WASHC1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.4734979683192033,-1.499505090395326,0.032388663967611336,0.5607499066086272,1.0,9/22,4.56%,ROBO1;CDH5;NRP1;MYH9;PIK3R3;ID1;SLIT2;EPHB4;KDR
prerank,negative regulation of axonogenesis (GO:0050771),0.5835224571045333,1.4991318958350588,0.0559254327563249,0.7342090693382546,1.0,11/27,16.43%,FGF13;LRP4;PTEN;RNF6;MT3;CDKL3;DCC;NGFR;EFNB3;RTN4;DIP2B
prerank,sulfur amino acid metabolic process (GO:0000096),0.5991693148339524,1.4985557572577775,0.02997275204359673,0.7325785713264914,1.0,9/24,15.10%,CTH;TST;DPEP1;CBS;AHCY;SMS;MTRR;ADI1;MTR
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.6212536614935674,-1.4976521563633258,0.054945054945054944,0.5606001030978152,1.0,4/10,10.76%,PLPP1;GAP43;PARD3;DGKH
prerank,wound healing (GO:0042060),0.5154726588171153,1.497326928048731,0.03399765533411489,0.7347649716096786,1.0,19/62,13.72%,DCBLD2;PDGFRA;ERBB3;EPB41L4B;FGF2;FGF10;ERBB2;CLDN1;NF1;WNT5A;PAK1;PLEC;FZD7;PPP3CA;COL3A1;SYT11;ANXA6;RAB3A;CORO1B
prerank,sphingosine metabolic process (GO:0006670),-0.5096508162137273,-1.4969194446507577,0.04844290657439446,0.5566359397019163,1.0,7/17,25.69%,PLPP1;ACER2;SPTLC2;ASAH2;SPHK1;SPHK2;SPTLC1
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6807958703376175,1.4935989204468825,0.06567164179104477,0.7516137511889921,1.0,7/13,17.54%,DCN;VCAN;BCAN;NCAN;IDS;HYAL1;CSPG4
prerank,negative regulation of myoblast differentiation (GO:0045662),0.681232420021532,1.4934500171813958,0.0654490106544901,0.7474673130816025,1.0,6/13,12.80%,SOSTDC1;SOX8;SOX9;TGFB1;PRICKLE1;EID2B
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.7022412697547189,1.4896239658893264,0.07313432835820896,0.7651264757840538,1.0,3/10,5.93%,GCDH;IVD;ETFA
prerank,Golgi organization (GO:0007030),0.4902034355497273,1.4892580067447134,0.012752391073326248,0.7622598142305498,1.0,35/112,18.98%,SEC16B;TMED6;ATP8B1;GORASP1;HACE1;VAMP4;BLZF1;GOLGB1;OBSL1;YWHAZ;ARL1;GBF1;GAK;BAG5;TRIP11;TMED10;HUWE1;CLASP1;PI4K2A;GORASP2;ARHGAP21;RAB1A;ATL3;USP6NL;CSNK1A1;TBC1D20;TMED3;TMED2;SEC23IP;ARFGEF1;SURF4;HTT;STX17;RAB30;COG1
prerank,triglyceride homeostasis (GO:0070328),0.5967944431529383,1.4875915718364574,0.06089309878213803,0.7676651398832385,1.0,6/26,15.20%,RORA;MLXIPL;IL18;PNPLA8;MTLN;LIPC
prerank,regulation of metal ion transport (GO:0010959),0.6617958184904891,1.4873612922437622,0.053019145802650956,0.7641826229639557,1.0,4/16,1.85%,IL16;BCL2;CACNA2D1;ANK2
prerank,estrogen metabolic process (GO:0008210),0.6468396021641559,1.487310025370179,0.06576980568011959,0.7596438589769569,1.0,3/15,7.15%,HSD17B7;HSD17B11;CYP1B1
prerank,positive regulation of cation channel activity (GO:2001259),0.5534297833544054,1.487284426924342,0.03254067584480601,0.7550349968509242,1.0,5/40,5.22%,RELN;ANK3;ANK2;EPHB2;CCR2
prerank,regulation of sodium ion transport (GO:0002028),0.5691393474845211,1.4872335635835146,0.03816793893129771,0.7505734197478388,1.0,11/34,15.14%,WNK2;ANK3;NKAIN2;WNK3;CNKSR3;SCN5A;FGF12;DRD2;PER1;AHCYL1;PKP2
prerank,negative regulation of calcium ion transport (GO:0051926),-0.5495776169136078,-1.486388924263558,0.07023411371237458,0.5870090131113173,1.0,10/15,37.45%,ATP1A2;SLC30A1;ADRA2A;NOS1;CBARP;PLN;TMBIM6;STC1;EPO;LILRB1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5072796248809931,-1.485296151805772,0.05537459283387622,0.5838050888766639,1.0,6/17,10.77%,CACNA1C;ATP1A2;GJA1;ATP1A1;GJC1;GJD3
prerank,dorsal/ventral pattern formation (GO:0009953),0.6080200483816517,1.484684141018078,0.05825242718446602,0.7599582078727386,1.0,4/20,5.81%,PTCH1;GLI2;ACVR1;FBXL15
prerank,embryonic limb morphogenesis (GO:0030326),0.5602420838402369,1.481557582817649,0.05710659898477157,0.7735497163390652,1.0,4/34,1.94%,OSR2;PTCH1;AFF3;WDPCP
prerank,axon guidance (GO:0007411),0.46498233980147813,1.4807731180034518,0.0010193679918450561,0.7737530564058731,1.0,53/201,13.44%,LAMA2;RELN;GFRA1;NTN4;PRKCA;LGR6;ENAH;PRKCQ;GLI2;EFNA4;SEMA3E;IRS2;EPHB6;PLXNC1;GFRA4;SEMA6C;EFNA5;VEGFA;EPHB2;MAPK7;SEMA3A;NRXN1;WNT5A;SPTBN1;CHN1;CNTN6;FYN;GAB2;CNTN2;TNR;DOK6;SMO;DOK4;DSCAM;DCC;PALLD;PIK3R1;GDNF;KIF5C;USP33;PTPN11;GPC1;MAPK1;OPHN1;EFNB1;CDK5R1;PTPRA;NRP2;UNC5C;RHOH;EFNB3;SH3KBP1;LYPLA2
prerank,extracellular structure organization (GO:0043062),0.4686709974664707,1.479708475161307,0.0,0.7750666918432101,1.0,37/204,10.98%,LAMA2;VIT;DCN;COL15A1;TGFBI;MMP2;HSPG2;ADAMTS12;VCAN;ADAM19;LUM;ADAMTS20;FGF2;COL5A3;COL28A1;LAMC1;COL5A2;PXDN;RECK;COL4A2;COL27A1;ITGB8;NF1;NID1;COL9A2;MMP15;ADAMTS1;BCAN;POSTN;TNR;COL18A1;ADAMTS4;COL3A1;SPARC;NCAN;MMP16;COL1A2
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5266984664089646,1.479691910831281,0.033047735618115054,0.770461650249322,1.0,17/45,20.77%,EFEMP1;REPS2;GAREM1;SOX9;EGFR;TGFB1;ERBIN;BTC;PIK3R1;CBL;PTPN11;IQGAP1;GAB1;HBEGF;GRB2;AAMP;SOS1
prerank,positive regulation of B cell proliferation (GO:0030890),0.5610534199021826,1.4792044708521974,0.056818181818181816,0.7687008483796137,1.0,6/29,8.66%,BCL2;IRS2;BST1;EPHB2;CD320;VAV3
prerank,cellular lipid catabolic process (GO:0044242),0.5807943407651931,1.4789317875605232,0.06177606177606178,0.7656898055235218,1.0,6/27,8.14%,PLBD1;CEL;MT3;ACBD5;CYP1B1;ACOX1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.6052122673711419,1.4785328873535935,0.06032171581769437,0.7634634560905628,1.0,8/20,15.27%,GCDH;ACACA;SCD5;ACLY;FASN;PPT2;FAR1;ACSL3
prerank,serine family amino acid metabolic process (GO:0009069),0.6317160686281523,1.4783958511725206,0.07375886524822695,0.7596318824568231,1.0,4/16,5.59%,CTH;CBS;PSPH;DAO
prerank,positive regulation of lymphocyte migration (GO:2000403),0.6891309797806773,1.478333444984257,0.059375,0.7555569146018158,1.0,2/12,1.40%,CXCL10;PYCARD
prerank,positive regulation of vascular permeability (GO:0043117),-0.5737128116310332,-1.4781189820158358,0.06097560975609756,0.6018052087034732,1.0,6/12,7.66%,BMP6;TJP1;ANGPT1;OCLN;PDE3A;TJP2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.47262252883672196,1.477322359082011,0.002081165452653486,0.7570633366737267,1.0,31/159,10.12%,DCHS1;CDH19;MPZ;TENM2;CLDN19;TENM3;IL1RAPL1;PTPRT;ACVR1;DSG2;CDH10;CLDN1;CDH22;PCDHGB4;LRRC4C;GRID2;OBSL1;CDH8;NLGN1;CADM3;TGFBR2;KIRREL3;NTNG1;HMCN1;CNTN6;CADM1;CNTN2;CDH20;CDH7;DSCAM;PALLD
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.526138004291609,1.4772515819968504,0.045023696682464455,0.7531173550213035,1.0,21/51,16.91%,KIF20B;NGF;MAP4K4;GAS7;TNIK;NYAP1;PAK1;ALS2;CNTNAP2;GPM6A;EPB41L3;DCLK1;BMP7;TAOK3;WASF1;TRIO;SNX1;ANKRD27;UBB;SGK1;CTTN
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6991626144614389,1.4768418061699615,0.08293460925039872,0.7509772532837556,1.0,3/10,2.99%,EPB41L4B;FGF10;MAP4K4
prerank,embryonic appendage morphogenesis (GO:0035113),0.6863759239245725,1.47546329964818,0.06437125748502993,0.7544443188998949,1.0,1/12,0.46%,PTCH1
prerank,positive regulation of behavior (GO:0048520),0.69235023066956,1.4751080769382126,0.0660377358490566,0.7523649216735164,1.0,3/10,5.72%,SGIP1;CRH;NLGN1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.5679475772882402,-1.4747019680938933,0.07668711656441718,0.6076109436249897,1.0,4/12,5.30%,CDH5;MAP2;CLIP3;EML2
prerank,apical junction assembly (GO:0043297),-0.3745389404997128,-1.4743329086978898,0.01948051948051948,0.60221719948248,1.0,13/53,9.34%,AFDN;PARD6G;CDH5;PECAM1;CLDN5;OCLN;ESAM;PRKCI;PARD3;CLDN14;PAK2;MPP7;RHOA
prerank,vasculogenesis (GO:0001570),0.5591972547710632,1.4741982156045217,0.054987212276214836,0.7533773000906183,1.0,8/32,7.08%,HAS2;GLMN;VEGFA;TGFB1;ITGB8;RASA1;TGFBR2;SPRED1
prerank,cellular response to oxygen levels (GO:0071453),-0.5962307444024825,-1.4738662940222873,0.07887323943661972,0.5972434528692045,1.0,8/10,31.17%,ATP6V0D1;NDUFS2;ATP6AP1;ATP6V0A2;TMEM199;ATP6V1G1;CCDC115;ATP6V1A
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.6015816230465072,-1.4737438391537665,0.06593406593406594,0.5911367980910853,1.0,10/10,39.89%,NAF1;DKC1;RPUSD4;GAR1;TSR3;RPUSD1;NHP2;RPUSD2;RPUSD3;NOP10
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.6003986493628561,1.4729001619783713,0.06954102920723226,0.7565824370886624,1.0,6/21,10.04%,DCN;VCAN;BCAN;CSGALNACT1;CHSY1;NCAN
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.6156428202295754,1.4722655041827515,0.07758620689655173,0.7559079796014344,1.0,5/17,19.84%,ANK3;AKAP6;SUMO1;KCNRG;NOS1AP
prerank,negative regulation of neuron projection development (GO:0010977),0.5069275685088751,1.4715461607481912,0.030624263839811542,0.7559765114672546,1.0,21/56,20.14%,LRP4;PTEN;LPAR1;SEMA3A;MT3;NLGN1;GAK;BAG5;DCC;HDAC2;NGFR;FKBP4;MYLIP;EFNB3;RTN4;STX1B;EFNB2;RTN4RL1;KANK1;DENND5A;PTPRS
prerank,positive regulation of lymphocyte activation (GO:0051251),0.571671750165062,1.4715061571761645,0.06728232189973615,0.7519706910584697,1.0,10/28,21.41%,PRKCQ;PYCARD;FGF10;CCR2;XRCC6;SH3KBP1;TICAM1;SIRPA;HSPD1;TNIP2
prerank,positive regulation of cartilage development (GO:0061036),0.6309618867301557,1.4713503913408899,0.06047819971870605,0.7487416132523661,1.0,5/17,8.90%,SOX6;PKDCC;SOX9;ZBTB16;SOX5
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.48870819274802013,-1.470087800805117,0.0707070707070707,0.5973159613818959,1.0,9/19,16.19%,BMP6;AFDN;TJP1;RGCC;NOTCH4;NEXMIF;PTPRU;FLOT1;PPM1F
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.6369232797995448,1.4700696645694522,0.06973293768545995,0.7516944093060725,1.0,2/16,4.63%,CLDN19;CLDN1
prerank,quinone biosynthetic process (GO:1901663),-0.5444068710450675,-1.4678341456936486,0.06309148264984227,0.5980856936701119,1.0,9/14,26.68%,COQ8B;COQ10B;PDSS1;COQ9;COQ3;FDXR;PDSS2;COQ6;COQ8A
prerank,outer dynein arm assembly (GO:0036158),-0.5269292665437171,-1.4671616234207936,0.08227848101265822,0.5936919773854321,1.0,11/14,42.13%,LRRC49;ODAD1;DNAH8;DNAAF5;DNAH5;ODAD2;ODAD3;ODAD4;DNAH17;DNAAF4;CCDC63
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.657286219878681,1.4670113908256988,0.06119402985074627,0.764310063939172,1.0,1/13,0.13%,SEC16B
prerank,chordate embryonic development (GO:0043009),0.5132229215271452,1.4665751759014198,0.02715466351829988,0.7626075776352601,1.0,19/55,17.17%,PTCH1;BMP5;SULF1;SOX8;VEGFA;TGFB1;WNT5A;FGFR1;EGFL8;BRCA1;BMP7;KIAA1217;DVL1;GATA3;COL1A1;PKD1;DACT1;TGFB3;MYH6
prerank,tryptophan catabolic process (GO:0006569),0.6919108051950238,1.4663869758332961,0.07153965785381027,0.7595622029819575,1.0,3/11,9.65%,AADAT;KYNU;IL4I1
prerank,epithelium development (GO:0060429),0.47897923536289716,1.4660374065684574,0.008537886872998933,0.7573400445137856,1.0,22/107,9.88%,LGALS3;PTCH1;MEOX1;MEOX2;SOX8;FGF10;TST;CD34;SOX9;VEGFA;CNN3;TGFB1;SOX11;UPK1B;CASP6;LOXL3;GATA6;CTSB;PPP2R3A;SMO;RCN3;PIH1D1
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.6213585087597013,1.4659045819339418,0.05790960451977401,0.7540775192776921,1.0,3/18,6.17%,APOD;MDFIC;OTUD7B
prerank,negative regulation of fat cell differentiation (GO:0045599),0.557827817836725,1.465696342057561,0.045283018867924525,0.751197197547478,1.0,8/34,13.40%,RORA;TGFB1;WNT5A;ZFP36L2;WWTR1;ZFPM2;GATA3;TRIO
prerank,regulation of Rac protein signal transduction (GO:0035020),0.6339040043438676,1.465248523234157,0.08873239436619719,0.749435603832207,1.0,4/16,6.14%,ARHGAP24;CADM4;AUTS2;ALS2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5053788524523551,1.4646022478244975,0.03436426116838488,0.7491445022657797,1.0,11/72,4.52%,ROR2;DCN;ROR1;PDGFRA;ERBB3;NTRK3;FGF2;IRS2;SOX9;NCF1;NTRK2
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.6102469797461886,1.4638995650214408,0.0635593220338983,0.7490023912604021,1.0,4/17,7.02%,CXCL10;ANO6;CCR2;PLA2G7
prerank,regulation of leukocyte activation (GO:0002694),-0.5251140002215459,-1.4638696240111246,0.07407407407407407,0.5979847323401721,1.0,4/14,3.82%,CD200;MFHAS1;PLSCR1;LYN
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.6777882336980715,1.4630894312732285,0.08090614886731391,0.7494025051565599,1.0,4/10,13.88%,PRKN;MT3;HDAC6;SNCA
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.3456718312517154,-1.4622697905159592,0.0,0.5977900547279074,1.0,24/87,13.38%,PTPRK;GCNT2;SMAD6;CDH5;FMOD;CLDN5;ITGB5;APPL2;ACVRL1;SMAD7;ENG;ID1;USP9X;SMAD9;TGFBR1;PARD3;TWSG1;PRKCZ;RHOA;NLK;LRRC32;MAP3K7;TGFB2;USP15
prerank,positive regulation of dendritic spine development (GO:0060999),0.6070175802092739,1.4619736190427426,0.05307262569832402,0.7517062769786859,1.0,4/20,8.00%,RELN;PSEN1;NLGN1;CPEB3
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6813125422624076,1.4610215544609855,0.06891271056661562,0.753233167382038,1.0,3/10,14.57%,ANK3;SUMO1;KCNRG
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4875278501085655,1.4604859135803052,0.024498886414253896,0.7523039648904561,1.0,14/85,5.51%,OSR2;BMP5;EPB41L4B;FGF2;MYC;FGF10;SOX9;ERBB2;LAMC1;CDKN2B;EGFR;VEGFA;TGFB1;SCN5A
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.5148389034406026,1.4602598530952602,0.04567307692307692,0.7497212988891488,1.0,17/53,15.17%,GLMN;RAD23B;XPO1;PRKN;NUDT15;ARAF;FBXW7;UCHL5;UFL1;OPHN1;TMF1;PRKACA;TMTC3;PKD1;USP14;GABARAPL2;UBB
prerank,myoblast differentiation (GO:0045445),-0.5303958395031889,-1.4598450773583327,0.06944444444444445,0.5996192467308046,1.0,4/14,9.50%,IGF1;DDX5;JAG1;MAPK12
prerank,dopaminergic neuron differentiation (GO:0071542),0.6139916587759652,1.4586503367176815,0.06901408450704226,0.7545684795003716,1.0,3/19,5.30%,CDNF;VEGFA;PHOX2A
prerank,covalent chromatin modification (GO:0016569),0.6555680574633493,1.4581227697087706,0.07142857142857142,0.7537339830021933,1.0,10/14,27.43%,MT3;HLCS;UFL1;MBD2;HELLS;SETD5;PARK7;CHD1;HDAC1;SIRT1
prerank,negative regulation of neurogenesis (GO:0050768),0.5471456929880708,1.4576591400578438,0.05236270753512133,0.7524874717001662,1.0,9/34,14.56%,CCL11;LRP4;PTEN;GORASP1;PCM1;NF1;NGFR;EFNB3;RTN4
prerank,embryonic skeletal system development (GO:0048706),0.5432732495034293,1.4575833600513148,0.055487053020961775,0.7491764444113823,1.0,6/35,5.53%,OSR2;SULF1;PDGFRA;SOX11;WNT5A;HOXD3
prerank,positive regulation of protein secretion (GO:0050714),-0.3680141484491767,-1.4557143059725561,0.007518796992481203,0.6079788367485368,1.0,19/69,13.13%,BMP6;WLS;IGF1;MYRIP;RBP4;NLGN2;TLR4;EXOC1;PPIA;NNAT;ABCG1;C1QTNF3;UNC13B;APBB1;SYTL4;AACS;TGFB2;LRRC8A;MYH10
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5888728312681257,1.4556580769000627,0.0761904761904762,0.7558199721959566,1.0,7/22,12.46%,NTRK3;NGF;NTRK2;RAP1A;MAGI2;WASF1;ACAP2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.5412845675724084,1.4555106691848883,0.04974489795918367,0.7528916939952827,1.0,12/37,20.82%,APOD;PYCARD;CARD9;HIF1A;MAPK14;CHID1;PER1;TICAM1;ABCD2;PDCD4;STAT3;SIRPA
prerank,odontogenesis (GO:0042476),0.5508908949958944,1.4554951685696003,0.04797047970479705,0.7492863141096728,1.0,7/35,10.98%,OSR2;EDA;GLI2;SCN5A;AMELX;HDAC2;COL1A2
prerank,positive chemotaxis (GO:0050918),0.6195507120286077,1.455321207921239,0.08670520231213873,0.7464750424750554,1.0,7/17,15.00%,LGALS3;FGF10;VEGFA;PTPRJ;FGF7;SCRIB;MET
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.5802444689630089,1.453890656750818,0.05179282868525897,0.7504554748129396,1.0,6/24,14.77%,GFPT2;MYC;MT3;PID1;COX10;MTLN
prerank,regulation of lamellipodium organization (GO:1902743),-0.5445670756152103,-1.4532513657053099,0.06927710843373494,0.6105033933814558,1.0,6/14,27.66%,CAPZB;PDPN;CDC42;EPHA2;DMTN;TWF2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.4655332700338297,1.452737729623996,0.0071794871794871795,0.7529642715778886,1.0,44/173,15.86%,SEC16B;TMED6;DYNLL1;ANK3;ANK1;ANK2;GORASP1;PGAP1;GRIA1;SEC24D;VAMP4;COG5;COPZ2;GOLGB1;SPTBN1;TRAPPC6B;GBF1;COPB2;COPG2;TRIP11;TMED10;SEC24C;KDELR2;CUL3;DYNC1I1;VAPA;ARF4;BET1L;RAB1A;ATL3;PROS1;DCTN4;KLHL12;TBC1D20;TMED3;DYNC1I2;TMED2;COPA;ARFGAP3;ARFGAP1;COPG1;TRAPPC6A;KDELR3;CNIH4
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.5543603947580397,1.4525267348040805,0.05080213903743316,0.750370991856129,1.0,8/31,12.44%,RELN;SIPA1L1;PTEN;TANC2;NLGN1;PPFIA2;CDK5R1;LZTS3
prerank,embryonic organ morphogenesis (GO:0048562),0.5278623417065907,1.4521115853317055,0.061224489795918366,0.7490694102041875,1.0,7/42,8.50%,OSR2;EFEMP1;PDGFRA;ACVR1;SOX11;HOXD3;RARG
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.6709717443496428,1.4520982406190055,0.0804953560371517,0.7455622343263111,1.0,3/11,7.26%,SOX6;TGFB1;FZD7
prerank,sphingoid metabolic process (GO:0046519),-0.5612774420158808,-1.4519703966839832,0.06725146198830409,0.6091940386707435,1.0,9/12,37.21%,PLPP1;KDSR;DEGS2;ASAH2;SPHK1;SPHK2;PLPP2;SPTLC3;NAAA
prerank,SNARE complex assembly (GO:0035493),0.6835479066131233,1.4512861509515145,0.08722741433021806,0.746210149530434,1.0,2/10,3.39%,STXBP6;VAMP4
prerank,myelin maintenance (GO:0043217),0.6844822871843579,1.4512016571921666,0.07656967840735068,0.743127880204496,1.0,3/10,8.51%,PRX;PTEN;EPB41L3
prerank,protein heterotetramerization (GO:0051290),0.653542070240621,1.4491967255260019,0.10588235294117647,0.7500419627908614,1.0,5/13,14.69%,FARSA;CPSF6;GRIN2B;FARSB;PKD1
prerank,glial cell development (GO:0021782),0.5752287367569697,1.4490685401793726,0.08072916666666667,0.7472821723519639,1.0,7/25,8.98%,MXRA8;SOX11;MT3;NF1;CDK6;EIF2B5;NSUN5
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.6539019699803513,1.4484518188785296,0.08054711246200608,0.7468403129452553,1.0,4/12,10.04%,DCN;VCAN;BCAN;NCAN
prerank,mesonephric tubule development (GO:0072164),-0.5148974825876341,-1.4484445173850218,0.06291390728476821,0.6158442381129322,1.0,6/15,8.66%,OSR1;BMP4;SLIT2;SIX1;FGFR2;SALL1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.638347252002814,1.4478801527440766,0.08175182481751825,0.7462101707333544,1.0,6/14,18.77%,CREB3L1;PRKN;SELENOS;HERPUD1;OPA1;PARK7
prerank,endomembrane system organization (GO:0010256),0.4592955443573008,1.4474523269008475,0.012232415902140673,0.744962388350767,1.0,54/178,19.17%,SEC16B;TMED6;USP50;ANK3;DNM1;ATP8B1;GORASP1;SPAG4;HACE1;EIF2AK3;BLZF1;GOLGB1;OBSL1;SPTBN1;ALS2;LAPTM4B;NUP155;ARL1;GBF1;SEC31B;GAK;BAG5;TRIP11;TMED10;VPS11;HUWE1;VAPA;CLASP1;PI4K2A;GORASP2;ARHGAP21;PHETA2;RAB22A;SNX10;RAB1A;ATL3;USP6NL;AKTIP;CSNK1A1;OTOF;TBC1D20;TMED3;TMED2;SEC23IP;BNIP1;ARFGEF1;SURF4;DYSF;HTT;STX17;REEP5;RAB30;COG1;HOOK2
prerank,actin filament-based transport (GO:0099515),-0.474223779214821,-1.4469779306316197,0.05925925925925926,0.6149577186815305,1.0,11/21,27.07%,SYNE2;MYO1D;WASL;FNBP1L;MYO1E;MYO5B;MYO1C;ACTN4;MYO5C;MYO1F;MYO15A
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.365563654483942,-1.4465428639169478,0.015873015873015872,0.6103626195277169,1.0,10/56,4.03%,BMP6;DAB2;RBPMS;SMAD6;ACVRL1;SMAD7;BMP4;ENG;BMPR2;TGFBR1
prerank,cellular response to alcohol (GO:0097306),0.5259863866081167,1.4465038020306926,0.061004784688995214,0.7465364309614461,1.0,14/42,16.11%,PTCH1;PTGFR;GRAMD1A;BRCA1;SMO;GRAMD1C;GNAI1;GRAMD1B;AHR;JUP;KLF9;BLM;SPIDR;GPLD1
prerank,neuron cell-cell adhesion (GO:0007158),0.6309032921308833,1.4458431041630158,0.08608321377331421,0.7464325745544332,1.0,5/14,5.72%,CEL;ASTN2;NRXN1;NCAM2;NLGN1
prerank,establishment of endothelial barrier (GO:0061028),-0.42991811561616455,-1.4443788622895266,0.03463203463203463,0.6122036113655338,1.0,10/29,14.23%,AFDN;TJP1;PECAM1;RAP1B;PPP1R16B;TJP2;ICAM1;PDE2A;ROBO4;MSN
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.4946336527549341,-1.4438357313947356,0.0625,0.6081175579377578,1.0,8/18,20.69%,ANKRD17;DDX60;BIRC3;NOP53;USP15;UFD1;GPATCH3;RNF125
prerank,regulation of protein localization to membrane (GO:1905475),0.5596506143839041,1.4435802761058663,0.06982872200263504,0.7549916211694487,1.0,9/28,13.45%,GPC3;GSN;PRKN;SLC5A3;SPTBN1;FYN;GPC1;GPC4;STX8
prerank,endodermal cell fate commitment (GO:0001711),-0.6021759915792309,-1.4430535730694563,0.07384615384615385,0.605132926284095,1.0,5/10,16.80%,CTR9;LEO1;SOX17;RTF1;PAF1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.451442650086348,-1.442424231189415,0.04924242424242424,0.6013892787332873,1.0,8/24,8.23%,PHLDB2;TJP1;CGNL1;ARHGAP28;WASF2;RHPN2;ARAP1;PAK2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.5430934300631386,-1.4420389044354378,0.07894736842105263,0.5968768303434124,1.0,8/13,23.60%,PRPF3;SRSF10;PRPF31;DDX20;SRSF12;SART3;USP4;AAR2
prerank,secretory granule organization (GO:0033363),-0.5767717944360269,-1.4388881182529996,0.06628242074927954,0.6015787867528006,1.0,3/10,9.40%,ABCA1;DTNBP1;SRGN
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.4888906012767492,-1.4385523333627246,0.07801418439716312,0.5970355792345851,1.0,6/18,4.22%,ROCK2;CDH5;TEK;RAP1B;ROCK1;CYRIB
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5760087601294319,-1.438436036447449,0.07923497267759563,0.5919907508964827,1.0,2/10,1.73%,ROCK2;ROCK1
prerank,cell proliferation in forebrain (GO:0021846),0.6791555490103354,1.4381464473395291,0.08455284552845528,0.7803164602531858,1.0,3/10,5.44%,DOCK7;PCM1;NUMBL
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.47879828613689734,1.4366297112295148,0.02954048140043764,0.7850459180760613,1.0,22/100,12.66%,ROR2;DCN;ROR1;PDGFRA;ERBB3;NTRK3;FGF2;PTEN;IRS2;SOX9;EGFR;NCF1;NTRK2;PTPN13;FGFR1;IL18;PIK3R1;CBL;MAPK1;MYDGF;FBXL2;MYOC
prerank,positive regulation of DNA replication (GO:0045740),0.6219439073900437,1.4359936064803958,0.09197080291970802,0.7849142379035182,1.0,4/16,6.05%,GLI2;EGFR;GLI1;STN1
prerank,sodium-independent organic anion transport (GO:0043252),-0.5692009206778974,-1.4356618542008128,0.09668508287292818,0.5957511862657068,1.0,4/10,8.79%,SLCO3A1;SLCO2A1;SLCO1C1;SLC16A2
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.6703023987591666,1.4356145137660978,0.09198813056379822,0.7834463819655055,1.0,8/12,28.93%,H6PD;KPNB1;CLCN2;SREBF2;MBTPS1;SEC14L2;DGKQ;MBTPS2
prerank,tryptophan metabolic process (GO:0006568),0.6717578933730777,1.4350660857950206,0.10153846153846154,0.782803302844607,1.0,3/11,9.65%,AADAT;KYNU;IL4I1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5564468586200242,1.4337496356653763,0.06491885143570537,0.7863690847917147,1.0,15/33,20.00%,FGF10;STXBP4;EGFR;UBE2E2;PLCB1;GLI1;ADAMTS1;EIF4G1;CCND2;HYAL1;CDC73;RPTOR;KMT2E;RDX;PHB2
prerank,dermatan sulfate metabolic process (GO:0030205),0.6380517185262513,1.4331038999025885,0.07784431137724551,0.7863999199562857,1.0,4/13,10.04%,DCN;VCAN;BCAN;NCAN
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.5536673392165364,1.4328951376632009,0.05569948186528497,0.7806162983152427,1.0,11/29,21.01%,THEM4;OXSM;ACOT11;ACLY;ACSF2;ACSL6;GPAT4;GLYAT;DBI;ACOT8;ACBD6
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.5536673392165364,1.4328951376632009,0.05569948186528497,0.7806162983152427,1.0,11/29,21.01%,THEM4;OXSM;ACOT11;ACLY;ACSF2;ACSL6;GPAT4;GLYAT;DBI;ACOT8;ACBD6
prerank,embryonic digestive tract development (GO:0048566),0.6092245662894186,1.432555045921894,0.07681159420289856,0.7790163536028345,1.0,5/18,8.79%,PDGFRA;GLI2;PKDCC;SOX11;RARB
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6834384572924334,1.432340718029131,0.10492845786963434,0.7767149154479198,1.0,5/10,17.63%,KLF15;BRCA1;SNCA;TAF7;CTBP1
prerank,protein heterooligomerization (GO:0051291),0.6180460709213068,1.432127434955302,0.10586552217453506,0.7745249533741494,1.0,8/17,21.50%,FARSA;CPSF6;GRIN2B;FARSB;TMEM120A;PKD1;MAT2A;PKD2
prerank,positive regulation of synaptic transmission (GO:0050806),0.4813442390570514,1.4312706547009175,0.04630650496141125,0.7756592673870265,1.0,19/72,15.57%,RELN;TSHZ3;CLSTN2;CACNG7;EPHB2;NRXN1;GRIN2B;GRIK2;CCR2;MPP2;SYT1;NLGN1;SLC8A2;NMU;RIMS1;GRIN2D;CLSTN1;GRIN2A;STX1B
prerank,regulation of leukocyte migration (GO:0002685),0.6313040665999883,1.4312074212238959,0.0815450643776824,0.7726955066938076,1.0,4/16,12.13%,BST1;HOXA7;VEGFA;RHOH
prerank,regulation of small molecule metabolic process (GO:0062012),0.5601456856919701,1.430845067493171,0.06443298969072164,0.7713360171968134,1.0,4/28,7.17%,RORA;PRKN;RORC;PDK3
prerank,regulation of muscle cell differentiation (GO:0051147),-0.4203099947798351,-1.4285009811066893,0.06435643564356436,0.6146103874301216,1.0,11/31,13.33%,CDH2;BOC;CTNNB1;CDON;IGF2;BNIP2;CAMK1;FGFR2;MAPK12;ID2;CDC42
prerank,neutrophil chemotaxis (GO:0030593),0.5077190009241743,1.4283563819757363,0.053117782909930716,0.7815145708044424,1.0,8/53,11.60%,LGALS3;CCL11;CXCL10;CCL4;PDE4B;GBF1;CKLF;EDN3
prerank,neuropeptide signaling pathway (GO:0007218),0.49687119027284166,1.42802503279841,0.05647058823529412,0.7799744012721281,1.0,4/58,2.34%,SSTR1;SORCS2;SORCS1;SORCS3
prerank,cellular biogenic amine catabolic process (GO:0042402),0.6834469208729833,1.4277090618315262,0.09161490683229814,0.7783213059662157,1.0,6/10,19.40%,SMOX;COMT;SARDH;LRTOMT;SLC44A1;ALDH7A1
prerank,copper ion transport (GO:0006825),0.6699229968185543,1.4276219493322762,0.09921259842519685,0.775521622282116,1.0,3/11,2.60%,STEAP4;STEAP2;STEAP3
prerank,cyclooxygenase pathway (GO:0019371),-0.578468700628889,-1.4271489690459822,0.08379888268156424,0.6138877631917629,1.0,5/10,13.34%,PTGIS;PTGDS;PTGS1;PTGS2;HPGDS
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.5407010184362221,1.4257954907065673,0.06532663316582915,0.781583293170702,1.0,11/35,13.17%,GCDH;ACACA;ACSS3;HMGCLL1;SCD5;ACLY;FASN;PPT2;FAR1;ALOX5AP;GGTA1
prerank,positive regulation of telomere capping (GO:1904355),0.6166691627460686,1.425284729354403,0.08913649025069638,0.7807340162065454,1.0,5/17,14.21%,PRKCQ;MAPK1;NEK7;MAP3K4;RTEL1
prerank,cellular response to copper ion (GO:0071280),0.6121640967193156,1.4252031077891611,0.08442503639010189,0.7779271242019605,1.0,12/16,28.19%,PRNP;MT3;AOC1;SNCA;MT1X;MT1M;MT1E;MT1G;MT1H;MT1F;MT1B;MT1A
prerank,platelet degranulation (GO:0002576),-0.3148688467868711,-1.4248188534004371,0.0,0.616705960551704,1.0,33/118,14.90%,IGF1;ABCC4;VWF;PECAM1;VEGFC;STXBP1;VEGFD;VTI1B;LYN;GTPBP2;CYRIB;IGF2;TEX264;THBS1;F8;HABP4;ACTN1;TIMP3;CD109;APP;ACTN2;FN1;SRGN;MANF;TMX3;SOD1;TMSB4X;SERPINE1;SYTL4;TGFB2;BRPF3;LGALS3BP;QSOX1
prerank,organelle fission (GO:0048285),0.5691960624146005,1.4247648791131509,0.07733333333333334,0.7771714641934747,1.0,3/24,2.35%,SEC16B;DNM1;PRKN
prerank,cellular response to cadmium ion (GO:0071276),0.5713779586839988,1.4242534360449668,0.05420054200542006,0.7766160590642056,1.0,16/24,28.19%,EGFR;NCF1;MT3;MAPK9;MAPK1;SUMO1;CHUK;JUN;MT1X;MT1M;MT1E;MT1G;MT1H;MT1F;MT1B;MT1A
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.6892686873198811,1.4228259549541789,0.08294209702660407,0.780695751951072,1.0,3/10,6.38%,PRKCQ;SOCS1;TGFBR2
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.659493570369396,1.4224805688482611,0.09687034277198212,0.779227043303037,1.0,5/12,10.50%,SOX8;SOX9;VEGFA;SMO;GDNF
prerank,mesonephros development (GO:0001823),0.6705826376464632,1.4196949174724967,0.0890937019969278,0.7904265986848862,1.0,5/11,13.20%,OSR2;FGF10;ZBTB16;BMP7;GATA3
prerank,regulation of AMPA receptor activity (GO:2000311),0.564949458264912,1.4193428036203577,0.07422402159244265,0.7891097384569549,1.0,4/25,5.72%,RELN;CACNG7;SHISA9;NLGN1
prerank,central nervous system development (GO:0007417),0.4452223612354842,1.4193426074297337,0.005050505050505051,0.7859406230414651,1.0,50/250,14.69%,APOD;RELN;VIT;SOX6;PTCH1;HSPG2;VCAN;SOX8;PTEN;SOX9;GSN;PRKN;ADAM23;NRCAM;CHST8;THOC6;SOX11;GBA2;GRIN2B;EML1;NF1;ZBTB16;TGFBR2;PHGDH;LOXL3;BCAN;PAFAH1B3;CNTN6;KLK6;EIF2B5;DHX30;CNTNAP2;GRIK1;SMO;SOX12;NHEJ1;NCAN;PTPN11;DCLK1;ADGRL3;CDK5R1;PHF8;JARID2;PTPRZ1;ALDH5A1;GRIN2D;ZFHX2;GRIN2A;NES;PKD1
prerank,response to axon injury (GO:0048678),0.59384264939401,1.4193106017863097,0.10112359550561797,0.7829166872420235,1.0,1/18,0.03%,APOD
prerank,peptide biosynthetic process (GO:0043043),-0.3019960548014677,-1.4190879632189688,0.0,0.6305745371506696,1.0,66/153,26.80%,RPS14;GSPT1;RPL24;RPL18A;RPS16;RPL38;RPL28;RPS19;RPL37;RPS2;SARS1;MRPL10;RPL19;RPL5;RPL34;RPS25;RPS15;TNIP1;RPLP1;RPL31;PABPC4;RPL3;MRPL24;MRPL3;EEF1A1;RPS6;RPS8;EIF4EBP2;RPL11;RPL12;RPS6KB2;RPL7A;RPL13;MRPS7;COPS5;MRPL43;IGF2BP3;YARS2;RPS21;RPL35A;ASMT;RPL26;RPS9;MRPS17;RPL32;RPS29;RPS23;RPLP2;MRPS11;RPL8;MRPS16;PCSK1;RSL24D1;DMD;RPL41;RPS17;DHPS;RPS5;RPS15A;RPL37A;GGT5;RPS10;MRPL55;RPL6;WARS1;RPL9
prerank,negative regulation of cell junction assembly (GO:1901889),0.5718831998936326,1.418629854708235,0.07567567567567568,0.7834203258693015,1.0,3/25,1.66%,APOD;DLC1;PTEN
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5342014806096669,-1.4174912451695878,0.0718954248366013,0.6304111593458105,1.0,3/13,6.72%,ATP1A2;ATP1B3;ATP1A1
prerank,renal absorption (GO:0070293),0.6725478801744132,1.416937403742412,0.11045655375552282,0.7890661342116404,1.0,2/10,2.24%,HAS2;GSN
prerank,retinoid metabolic process (GO:0001523),0.4854079667626735,1.4168134647226285,0.041189931350114416,0.7866004375335064,1.0,14/71,12.81%,GPC3;CYP2S1;HSPG2;RHO;LRP1;SDC2;AKR1B10;SDC4;CYP1B1;RDH10;DHRS3;GPC1;SDC3;GPC4
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5674769629864863,1.4164760185995724,0.0846774193548387,0.7851889811778625,1.0,8/24,15.90%,CREB3L1;VEGFA;MAPK7;MT3;HIF1A;NFE2L2;GCN1;TP53
prerank,nervous system development (GO:0007399),0.44000499743646965,1.4162667413324879,0.0,0.7830837321697678,1.0,95/429,15.54%,DCHS1;RELN;MPZ;GFRA1;PRX;PCDHA4;SOX6;CHRM3;VCAN;RBFOX1;ERBB3;FGF13;FGF2;SOX8;LSAMP;PTEN;WDPCP;GSN;NGF;NAB1;PRKN;ADAM23;GFRA4;LPAR1;EFNA5;SCN2A;ATXN10;NRCAM;VEGFA;PCDHA1;CHST8;EPHB2;THOC6;MAB21L2;TGFB1;GPM6B;NRXN1;GBA2;GSS;NF1;ACVR1C;NUMBL;OBSL1;NLGN1;APAF1;FGF12;NAV1;ZBTB16;KIRREL3;BCAN;PAFAH1B3;BPNT1;LIMK1;CNTN6;KLK6;DHX30;SCD5;GRIK1;GPM6A;SMO;LDB2;PMP22;NHEJ1;DSCAM;NCAN;ERBB4;GDNF;DCLK1;OPHN1;ADGRL3;APC2;DVL1;JARID2;MYLIP;WWTR1;EFNB3;DRD2;BTBD1;PTPRZ1;ALDH5A1;NRSN2;TRPC5;APBA1;MSI1;RBM45;NES;PKD1;MET;MTR;ZEB2;POU3F1;NDUFV2;GFRA2;DACT1;FZD9
prerank,androgen metabolic process (GO:0008209),0.5978886640467382,1.4152551941725542,0.10267229254571027,0.7852075875856319,1.0,2/18,4.64%,HSD17B7;HSD17B11
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5499200049682011,-1.4149278778272927,0.09329446064139942,0.6337829549676998,1.0,2/12,0.13%,DAB2;FOXP1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6537411552291704,1.4143097939028695,0.10283159463487332,0.7871945919185817,1.0,3/12,3.54%,WNK2;ANK3;WNK3
prerank,DNA packaging (GO:0006323),0.6108412547250863,1.4120419231528016,0.09742120343839542,0.7960804240114148,1.0,6/16,17.73%,BANF2;HAT1;RBBP4;TP53;NAA10;AIFM1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5816384420348315,1.4108671160399484,0.0712290502793296,0.7992413541074609,1.0,7/22,17.76%,IL2RA;CBFB;SOCS1;SOX12;IL4I1;RUNX1;MDK
prerank,negative regulation of MAPK cascade (GO:0043409),0.4791287871965878,1.4107014811836251,0.023001095290251915,0.7970147585129131,1.0,19/87,11.42%,WNK2;MYC;PTEN;DUSP4;PTPN2;EPHB2;IRAK3;NF1;CNKSR3;DUSP6;LMO3;SPRED2;SPRED1;FOXM1;UCHL1;PTPN1;SPRED3;PTPRJ;BMP7
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.5588114485175095,1.4104147929481352,0.0814419225634179,0.7954494544843473,1.0,7/27,14.27%,FXYD3;UTRN;SCN5A;FGF12;FXYD6;FXYD1;NEDD4L
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6472458950088035,1.4100266702476723,0.0963855421686747,0.7944972982738413,1.0,3/12,3.35%,PTEN;EPHB6;EPHB2
prerank,kidney development (GO:0001822),0.4995134925228515,1.4098234177926245,0.037714285714285714,0.7925235751792877,1.0,11/65,6.27%,OSR2;SULF1;HAS2;GLI2;LRP4;FGF10;PRKX;VEGFA;ARL3;NF1;ZBTB16
prerank,branched-chain amino acid metabolic process (GO:0009081),0.5814609464721097,1.4089150240100874,0.0782122905027933,0.7913630469119977,1.0,10/20,22.14%,IVD;BCKDHB;MCCC1;MCCC2;HIBADH;HIBCH;DBT;AUH;BCKDK;ALDH6A1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.5814609464721097,1.4089150240100874,0.0782122905027933,0.7913630469119977,1.0,10/20,22.14%,IVD;BCKDHB;MCCC1;MCCC2;HIBADH;HIBCH;DBT;AUH;BCKDK;ALDH6A1
prerank,regulation of cellular pH (GO:0030641),-0.42401470610857106,-1.4086157637559036,0.06521739130434782,0.6501871688815402,1.0,14/29,25.90%,SLC4A10;SLC9A6;SLC9A2;SLC9A8;SLC4A3;SLC4A8;SLC9A9;SLC9A7;ATP6AP1;TM9SF4;SLC26A6;SLC9B1;CA2;LACC1
prerank,response to cadmium ion (GO:0046686),0.5583837803556896,1.4082773978370613,0.06747638326585695,0.7915667619955693,1.0,16/26,28.19%,EGFR;NCF1;MT3;MAPK9;MAPK1;SUMO1;CHUK;JUN;MT1X;MT1M;MT1E;MT1G;MT1H;MT1F;MT1B;MT1A
prerank,regulation of execution phase of apoptosis (GO:1900117),0.6494908512421108,1.408037747172757,0.10644677661169415,0.7898109276619463,1.0,2/11,1.18%,DLC1;FAP
prerank,iron ion transmembrane transport (GO:0034755),0.667425007342124,1.4072837669004887,0.11128526645768025,0.7906679511872798,1.0,1/10,0.17%,SCARA5
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6238610128408286,1.4069933664082057,0.09640287769784173,0.7892374554742722,1.0,4/13,15.46%,BMP5;ERLIN2;DKK3;ERLIN1
prerank,response to ATP (GO:0033198),0.5967611611846937,1.4069399838043704,0.08438818565400844,0.7865577293878454,1.0,8/18,21.51%,P2RY2;HSP90B1;P2RY12;P2RY1;SSH1;TAF1;RYR3;P2RX7
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.386610068937218,-1.4068915069100933,0.037914691943127965,0.6509152438132744,1.0,15/38,22.44%,ROCK2;PTGIS;TLR4;INSR;KLF2;PTGS2;KLF4;DDAH2;HSP90AA1;ASS1;CAV1;EDN1;HSP90AB1;CLU;AKT1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.45752221803385035,1.4068834795496203,0.03397027600849257,0.7839370041849263,1.0,26/108,11.59%,GPC3;SOSTDC1;SULF1;LGR6;MDFIC;TAX1BP3;CBFB;VGLL4;PRKN;DEPDC1B;LRP1;FRZB;TLE1;PSEN1;WIF1;SHISA2;DISC1;FZD7;OTULIN;SPIN1;FAM53B;DAAM2;SFRP4;ESR1;EMD;PPP1CA
prerank,V(D)J recombination (GO:0033151),0.6576526777686722,1.4062553983749102,0.11496062992125984,0.7842807674817297,1.0,1/11,0.19%,RAG2
prerank,glutamate receptor signaling pathway (GO:0007215),0.5203157544175608,1.4061279142123755,0.08625,0.782034475074913,1.0,12/37,15.49%,GRIK3;GRIA3;PLCB1;GRIN2B;GRIK2;GRID2;GRIK1;GRM5;CDK5R1;HOMER2;GRIN2A;HOMER1
prerank,regulation of steroid metabolic process (GO:0019218),0.564048485276068,1.4059471472929514,0.09016393442622951,0.7800549820470785,1.0,2/23,6.31%,RORA;RORC
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.6481362093119467,1.4050874964651505,0.11194029850746269,0.7758872546292086,1.0,8/12,23.63%,CUL3;ANAPC7;CDC23;CDC27;ANAPC4;ANAPC5;RB1;CDC16
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6481362093119467,1.4050874964651505,0.11194029850746269,0.7758872546292086,1.0,8/12,23.63%,CUL3;ANAPC7;CDC23;CDC27;ANAPC4;ANAPC5;RB1;CDC16
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6481362093119467,1.4050874964651505,0.11194029850746269,0.7758872546292086,1.0,8/12,23.63%,CUL3;ANAPC7;CDC23;CDC27;ANAPC4;ANAPC5;RB1;CDC16
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.586956883401347,1.4049457441207305,0.11016949152542373,0.7738818825295808,1.0,4/18,5.72%,RELN;PTEN;NRXN1;NLGN1
prerank,granulocyte chemotaxis (GO:0071621),0.4939746008359204,1.404339115035282,0.06659012629161883,0.7741630072130419,1.0,8/55,11.60%,LGALS3;CCL11;CXCL10;CCL4;PDE4B;GBF1;CKLF;EDN3
prerank,regulation of histone methylation (GO:0031060),0.6389477934356154,1.4039716939039082,0.10619469026548672,0.7731962299669258,1.0,4/13,12.25%,FAM47E;AASS;PIH1D1;JARID2
prerank,positive regulation of cell communication (GO:0010647),0.5532358342305647,1.4028697231181522,0.08248730964467005,0.7757543771673096,1.0,11/28,15.49%,ANK3;CLSTN2;SOX11;GRIK2;SYT1;NMU;RIMS1;EDN3;GATA3;CLSTN1;HOMER1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.6212456462120481,1.401787214729588,0.11908177905308465,0.7784006108172686,1.0,2/13,3.35%,RELN;EPHB2
prerank,response to UV-A (GO:0070141),0.636521991677451,1.40099526678553,0.11160058737151249,0.7793788700419756,1.0,3/14,8.92%,MMP2;EGFR;PPID
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6294524644763178,1.400984636510341,0.0975609756097561,0.7766788123159478,1.0,5/13,11.47%,FGF2;FGFR1;AKT3;SP1;SIRT6
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.5743711909757614,1.4007026392269561,0.0948509485094851,0.7753505843780635,1.0,8/21,13.71%,USP50;PYCARD;NGF;MT3;GRIN2B;FYN;NGFR;TTBK1
prerank,negative regulation of complement activation (GO:0045916),0.6565666687888413,1.4003197114670602,0.11556240369799692,0.7744607556761525,1.0,1/10,0.82%,A2M
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5292601684097195,-1.4002824430323841,0.09538461538461539,0.6682051993750363,1.0,4/12,5.85%,SORBS1;IGF1;IGF2;INSR
prerank,inositol lipid-mediated signaling (GO:0048017),-0.37038028495807246,-1.3996392470443828,0.03550295857988166,0.6647889811701015,1.0,17/50,10.58%,IGF1;IGF1R;ADAP2;PITPNM2;PLCL1;PI4KA;PIK3C2A;PLCB3;PLCD1;EXOC1;PLCL2;OGT;RPS6KB1;RHOA;PDGFRB;PIK3C2B;TNFAIP8L3
prerank,positive regulation of developmental process (GO:0051094),0.4472819769273134,1.399058639498911,0.017471736896197326,0.7779744994766522,1.0,33/164,15.06%,RELN;DCN;SOX6;BMP5;PHLDB1;SOX8;SPIRE1;SOX9;PRKN;ACVR1;VEGFA;PSEN1;NRXN1;PLCB1;WNT5A;NLGN1;ZBTB16;BNIP3;FGFR1;CPEB3;PPP1R13L;SOX5;GDNF;CLASP1;BMP7;EDN3;ANAPC2;DVL1;CORO1B;COBL;RTN4;BMPR1A;LMNA
prerank,regulation of protein import into nucleus (GO:0042306),0.5221826414245336,1.398848221346312,0.08004926108374384,0.7763301382051748,1.0,6/36,10.37%,APOD;MDFIC;TGFB1;PSEN1;FLNA;PIK3R1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.43871006046245953,1.3981317049330804,0.006048387096774193,0.7771748767468437,1.0,42/224,14.50%,MPZ;SLC6A2;CHRM3;RAPSN;CRH;SLC1A3;CEL;CACNA1E;HRH1;PDE7B;GRIA1;KCNA1;DLGAP1;GRIA3;CACNA1A;CHRNA4;PLP1;NRXN1;GRIN2B;GRIK2;PRKAR1B;DLG2;SYT1;NLGN1;CACNB4;KCND2;GRIK1;PMP22;SYN1;SPG11;GRM5;HTR2C;SLC12A4;MAPK1;PRKACA;PENK;APBA1;SNCA;RPS6KA2;NOVA1;GRIN2A;CALM1
prerank,regulation of glucose metabolic process (GO:0010906),0.5355558696998816,1.3981251686499974,0.06734434561626429,0.7745116244873056,1.0,6/34,9.85%,RORA;IRS2;PRKN;RORC;PDK3;SELENOS
prerank,neurotransmitter uptake (GO:0001504),0.6355629412127124,1.3980174929778912,0.10923076923076923,0.7723581504420326,1.0,3/12,5.90%,SLC22A3;SLC1A3;SLC29A1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.6022797444596477,1.3968508073347268,0.09748892171344166,0.7754582036875663,1.0,3/15,9.65%,AADAT;KYNU;IL4I1
prerank,protein alkylation (GO:0008213),-0.46144675055867546,-1.3963519896725771,0.0784313725490196,0.6704745051521189,1.0,10/22,14.77%,CAMKMT;GSPT1;FAM98A;METTL21A;PRMT2;LCMT1;SNRPD3;PCMT1;PRMT8;SNRPB
prerank,regulation of stress fiber assembly (GO:0051492),-0.33095233314089195,-1.3963311942819039,0.030612244897959183,0.6650955587465918,1.0,20/74,9.34%,PHLDB2;TJP1;CGNL1;ROCK2;ARHGAP28;NRP1;CCN2;ROCK1;LIMCH1;WASF2;TGFBR1;RHPN2;TPM1;FHOD1;ARAP1;RGCC;PAK2;PFN2;ARHGEF15;RHOA
prerank,cellular response to estrogen stimulus (GO:0071391),-0.5125749414862976,-1.3962308086415232,0.10850439882697947,0.6600178235074184,1.0,5/14,19.29%,PELP1;SERPINB9;SRA1;ARID5A;RARA
prerank,negative regulation of lipid storage (GO:0010888),-0.4661080382971613,-1.3956149644682188,0.09121621621621621,0.6570157539183339,1.0,9/19,20.71%,OSBPL8;ABCA1;NFKBIA;PPARD;ABCG1;NR1H2;TTC39B;PNPLA2;NR1H3
prerank,regulation of cell-substrate adhesion (GO:0010810),0.5102340381423979,1.394960144419937,0.08859223300970874,0.7817659393885674,1.0,7/42,9.97%,VIT;BST1;FBLN2;NF1;TSC1;FZD7;ARL2
prerank,negative regulation of cilium assembly (GO:1902018),-0.5400371232345503,-1.394894439303878,0.11304347826086956,0.6544394673611277,1.0,6/12,17.85%,ODF2L;EVI5L;CCP110;TBC1D7;TBC1D30;CDK10
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6673123904648134,1.394539152904969,0.11764705882352941,0.7810329863891204,1.0,1/10,0.03%,APOD
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5473829639879144,1.3942355900604593,0.09549071618037135,0.7799479465344775,1.0,6/27,10.04%,DCN;VCAN;BCAN;CSGALNACT1;CHSY1;NCAN
prerank,negative regulation of angiogenesis (GO:0016525),0.4733232188106938,1.3938901136407156,0.051535087719298246,0.7790400012173675,1.0,13/84,7.08%,DCN;HSPG2;SULF1;CXCL10;CREB3L1;SEMA3E;COL4A2;E2F2;CCR2;SLC12A2;PDE3B;ADAMTS1;SPRED1
prerank,secretion (GO:0046903),-0.5096746847736243,-1.3936713117996427,0.09090909090909091,0.6533520201071821,1.0,4/14,6.40%,SLC22A4;SLC22A6;PRKCI;NPR1
prerank,negative regulation of phosphorylation (GO:0042326),0.4703194422560862,1.3929259375496659,0.03489640130861505,0.7811738576475763,1.0,20/85,12.79%,DYNLL1;NTRK3;PIP5KL1;PTEN;IRS2;PRKN;CDKN2B;NPRL2;EPHB2;CADM4;TGFB1;PRNP;PTPN13;NIBAN1;CBFA2T3;MEN1;PID1;BMP7;WWTR1;PRDX3
prerank,positive regulation of cell projection organization (GO:0031346),0.45330445950602516,1.3927511936815735,0.027114967462039046,0.7794442295395129,1.0,16/115,7.42%,ROR2;RELN;ROR1;TENM3;NTRK3;CHODL;NGF;PLXNC1;IL1RAPL1;NTRK2;WNT5A;OBSL1;ALKAL2;CDKL5;CDKL3;RAP1A
prerank,metanephros development (GO:0001656),0.5586920634230796,1.3918938283285551,0.07863695937090433,0.7811132237678852,1.0,6/26,11.42%,OSR2;PTCH1;FGF10;NF1;GDNF;BMP7
prerank,axoneme assembly (GO:0035082),0.5420653990602445,1.3912909586618254,0.0888030888030888,0.7815051803400955,1.0,10/30,18.08%,DNAI4;CCDC39;RSPH1;CFAP46;CFAP74;CCDC65;FOXJ1;DNAAF2;RSPH9;DCX
prerank,response to reactive oxygen species (GO:0000302),0.49008404637523467,1.3909187324340446,0.05847953216374269,0.7807098779142052,1.0,12/54,12.84%,APOD;PDGFRA;EGFR;APTX;NCF1;FYN;MAPK9;HIF1A;MAPK1;ERCC6L2;PRDX3;SOD2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.5710728614689476,1.3894140277310412,0.11186903137789904,0.7852379358362408,1.0,4/23,5.28%,GPC3;PTCH1;PTCH2;HHIP
prerank,protein ADP-ribosylation (GO:0006471),-0.41794545032127894,-1.3894010398102061,0.07929515418502203,0.663422280221871,1.0,10/28,16.88%,ZC3HAV1;PARP3;PARP4;PARP10;PARP1;SIRT3;PARP6;PARP12;PARP14;SIRT4
prerank,metal ion homeostasis (GO:0055065),0.5094774467088831,1.3891682267449739,0.08082026537997587,0.7839029580040683,1.0,11/40,16.10%,ANK3;SLC12A3;LETM1;KCNA1;TMTC2;MT3;SLC12A2;SLC12A4;SLC7A8;SNCA;KCNH2
prerank,homologous chromosome segregation (GO:0045143),0.5763706501660492,1.388985293500166,0.1009549795361528,0.7822143838097309,1.0,7/20,23.01%,MEIOB;FMN2;PRDM9;SGO1;CENPC;PTTG1;MEI4
prerank,positive regulation of cellular component organization (GO:0051130),0.4563388454180995,1.3877395555714909,0.027659574468085105,0.7858026665616575,1.0,30/107,17.04%,RELN;GPC3;LGALS3;CLDN19;HRK;LRP4;LRP1;VEGFA;TGFB1;NRXN1;PPP1R15A;NOX1;BMF;BNIP3;BRK1;PIH1D1;SLF2;BMP7;ANAPC2;RHOC;SNCA;NEDD4L;SUMO1;MTLN;RUNX1;SPIDR;BCL2L11;TGFB3;HYAL1;SURF4
prerank,protein localization to chromatin (GO:0071168),0.5898863510587966,1.387484794642394,0.11396011396011396,0.7845010371374728,1.0,5/18,10.73%,FAM47E;LRWD1;MRNIP;PIH1D1;ESR1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4933779675858873,1.3872448751638822,0.0745721271393643,0.7831764103708995,1.0,5/53,9.86%,SSTR1;CHRM3;HRH1;TSHR;HTR2C
prerank,anterior/posterior pattern specification (GO:0009952),-0.3576862532894367,-1.387045304434414,0.020134228187919462,0.6668343564247892,1.0,16/53,20.26%,WLS;LRP5;HOXB9;HOXA3;BMPR2;TGFBR1;HOXC6;HOXC5;TBX1;HOXC4;HOXA9;HEY2;HOXB3;HOXA6;HOXD4;HHEX
prerank,regulation of ion transmembrane transport (GO:0034765),0.5203728481800972,1.386259639543765,0.08365019011406843,0.7854684887800402,1.0,9/33,16.10%,CHRM3;ANO6;WNK3;AKAP6;AHCYL1;KCNJ3;NEDD4L;KCNJ10;KCNH2
prerank,regulation of cell junction assembly (GO:1901888),-0.43226707225699257,-1.3860237011418834,0.07450980392156863,0.6654635795456306,1.0,8/27,1.98%,TJP1;ROCK2;PRKCH;PDLIM5;RAP1B;ROCK1;CLDN5;OCLN
prerank,B cell activation (GO:0042113),0.4811164184035921,1.385498632680158,0.05102040816326531,0.7866699309603842,1.0,13/68,13.23%,RAG2;FCRL1;BCL2;PTPN2;EPHB2;DNAJB9;CHRNA4;RABL3;LAX1;NHEJ1;PTPRJ;DCAF1;MALT1
prerank,blood circulation (GO:0008015),-0.3613838513154327,-1.3847347881570915,0.060810810810810814,0.6650779548793596,1.0,15/49,11.94%,MYOF;ROCK2;ELN;TBC1D8;ROCK1;ACVRL1;NOS3;COL4A3;NPR1;ACE;AGTR1;GUCY1B1;ADORA2A;SOD1;GPX1
prerank,collagen fibril organization (GO:0030199),0.46224192818894067,1.384722325549503,0.051648351648351645,0.7879883114874568,1.0,23/88,11.55%,COL15A1;LUM;COL5A3;COL20A1;COL28A1;P4HA1;COL5A2;PXDN;COL4A2;COL27A1;COL26A1;NF1;COLGALT2;COL9A2;PLEC;LOXL3;CYP1B1;COL18A1;TLL2;COL3A1;PLOD1;COL1A2;COL14A1
prerank,regulation of cytoplasmic transport (GO:1903649),-0.5408154219792911,-1.3847055381782565,0.10557184750733138,0.6601402139023069,1.0,4/11,8.34%,USP7;CHMP3;ATP9A;MAP2K1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.45150945420806726,1.3844885672055587,0.040382571732199786,0.7864923972862695,1.0,19/113,5.52%,OSR2;BMP5;CCL11;PRKCA;FGF2;MYC;FGF10;SOX9;STXBP4;ERBB2;LAMC1;EGFR;TGM1;VEGFA;EGR3;SOX11;CLDN1;SCN5A;WNT5A
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.4280958570744254,-1.3839214044849277,0.05928853754940711,0.6580592514445897,1.0,12/26,22.44%,TLR4;INSR;KLF2;PTGS2;KLF4;DDAH2;HSP90AA1;ASS1;EDN1;HSP90AB1;CLU;AKT1
prerank,cellular response to inorganic substance (GO:0071241),0.5642883700365784,1.3833450511793048,0.0978120978120978,0.7894413448174763,1.0,9/21,15.98%,DDX11;DPEP1;NSMCE3;MT3;AOC1;ATRX;MTR;BLM;SPIDR
prerank,cellular response to chemokine (GO:1990869),0.4975013366950971,1.3827521211187714,0.07074340527577938,0.7897965893516803,1.0,7/46,9.19%,CCL11;CXCL10;CCL4;CCR2;SLC12A2;ACKR3;STK39
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.6565990463878552,1.382635186766849,0.11196319018404909,0.7877675632671005,1.0,6/11,19.27%,ZRANB3;TIPIN;FBH1;BLM;FBXO5;LIG3
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.4240707469795695,-1.382140582695012,0.06097560975609756,0.659424340827146,1.0,9/27,8.23%,PHLDB2;TJP1;CGNL1;ARHGAP28;SHANK3;WASF2;RHPN2;ARAP1;PAK2
prerank,amino acid transmembrane transport (GO:0003333),-0.37180343620114875,-1.3815843340614413,0.04597701149425287,0.6562632905498875,1.0,14/45,14.83%,SLC7A11;SLC47A1;SLC6A6;SLC22A4;SLC6A13;SLC7A5;SLC38A11;SLC38A7;SLC16A2;SLC38A5;SLC25A12;SLC38A10;SLC36A4;SFXN3
prerank,COPII-coated vesicle budding (GO:0090114),0.47209880271765464,1.381508722530613,0.06818181818181818,0.7908101555842381,1.0,27/68,24.25%,SEC16B;GORASP1;GRIA1;ANKRD28;SEC24D;TRAPPC6B;SEC31B;TMED10;SEC24C;CUL3;VAPA;RAB1A;KLHL12;TBC1D20;TMED2;SEC23IP;TRAPPC6A;CNIH3;SEC24A;SEC23B;TRAPPC3;PEF1;TRAPPC2L;LMAN1;TRAPPC10;MIA3;PPP6R1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.561349897180764,-1.3812320129889337,0.11956521739130435,0.65273322174648,1.0,3/10,4.56%,TLR4;NAMPT;KDR
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.553037684451741,1.380956857531099,0.10133333333333333,0.7909069356353579,1.0,7/25,13.73%,WNK2;ANK3;ANK2;WNK3;STK39;NDUFA4;TCAF1
prerank,positive regulation of T cell migration (GO:2000406),0.5792962786526025,1.3808876780401798,0.11888111888111888,0.788722898356409,1.0,5/20,9.19%,CXCL10;PYCARD;CCR2;WNT5A;STK39
prerank,DNA alkylation (GO:0006305),0.5712117657433919,1.3807680473615092,0.12482468443197756,0.784314111973048,1.0,6/19,11.02%,GATAD2A;ATF7IP;ATRX;MTRR;TEX15;HELLS
prerank,DNA methylation or demethylation (GO:0044728),0.5712117657433919,1.3807680473615092,0.12482468443197756,0.784314111973048,1.0,6/19,11.02%,GATAD2A;ATF7IP;ATRX;MTRR;TEX15;HELLS
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6470370169304231,1.380631585661209,0.12363067292644757,0.7825305119026694,1.0,3/11,15.06%,MLIP;GLRX3;LMNA
prerank,positive regulation of cellular component movement (GO:0051272),-0.4469291471679799,-1.3798105539712986,0.06818181818181818,0.6524412327114403,1.0,14/24,26.76%,ETS1;LYN;TGFBR1;CCDC25;RPS19;PDPN;SPOCK2;CAVIN1;TWIST1;ACTN4;TUBB2B;CSF1R;STK11;CCL19
prerank,T cell differentiation (GO:0030217),0.5096543252633976,1.3797853841682184,0.08625,0.7841778598714847,1.0,10/40,13.20%,RAG2;PTPN22;FADD;PTPN2;RABL3;NHEJ1;ZFP36L2;MR1;RHOH;GATA3
prerank,chemical synaptic transmission (GO:0007268),0.42988569828136564,1.3797299084118197,0.0050150451354062184,0.7819736072346307,1.0,56/284,14.50%,MPZ;SLC6A2;CHRM3;RAPSN;CRH;SLC1A3;CEL;CACNA1E;PTEN;NQO1;HRH1;PDE7B;GRIA1;GRIK3;KCNA1;DLGAP1;GRIA3;CACNA1A;CHRNA4;PLP1;NRXN1;GRIN2B;GRIK5;GRIK2;PRKAR1B;GRID2;DLG2;CDH8;SYT1;NLGN1;CACNB4;KCND2;GRIK1;PDLIM4;PMP22;SYN1;SPG11;GRM5;HTR2C;RIMS1;SLC12A4;MAPK1;TSPOAP1;DVL1;PRKACA;RAB3A;DRD2;GRIN2D;PENK;APBA1;SNCA;RPS6KA2;CHAT;NOVA1;GRIN2A;CALM1
prerank,carnitine metabolic process (GO:0009437),-0.5287012778341545,-1.3787917789401587,0.09523809523809523,0.6510374341688955,1.0,5/12,12.61%,CPT1C;CPT1A;ACADM;TMLHE;ALDH9A1
prerank,regulation of T cell chemotaxis (GO:0010819),0.6473212700241794,1.378686986900489,0.12172573189522343,0.7845100124714928,1.0,4/11,9.19%,CXCL10;CCR2;WNT5A;STK39
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.5851041964277884,1.3785793907635173,0.10451977401129943,0.7826195781265712,1.0,6/18,8.05%,GRIK3;GRIK5;GRIK2;GRID2;CDH8;GRIK1
prerank,xenobiotic transport (GO:0042908),-0.47795975384463973,-1.3783104763218403,0.1254355400696864,0.6479240597887581,1.0,6/17,3.59%,ABCG2;ABCA3;SLC47A1;GJA1;SLC22A4;SLC7A5
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.5034469910359485,-1.3770629264891576,0.09907120743034056,0.6473719326610007,1.0,4/13,5.85%,SORBS1;IGF1;IGF2;INSR
prerank,regulation of cellular metabolic process (GO:0031323),0.49309551440923194,1.3766499456673695,0.07142857142857142,0.7891137788791361,1.0,14/45,14.54%,PRKN;PARL;ACACA;MKLN1;CYP1B1;PDK3;FOXM1;EIF6;ACLY;FASN;ARF4;PID1;SSH1;NCOR2
prerank,chemokine-mediated signaling pathway (GO:0070098),0.5028616813679316,1.3765969930256514,0.07785888077858881,0.7869718236182776,1.0,6/42,9.19%,CCL11;CXCL10;CCL4;CCR2;ACKR3;STK39
prerank,transition metal ion transport (GO:0000041),-0.3838340870921258,-1.3764451383091183,0.06756756756756757,0.6448002106199429,1.0,9/35,10.28%,SLC30A10;SLC31A1;ATP7A;SLC31A2;FTH1;SLC39A8;SLC30A1;TRPC6;TFRC
prerank,negative regulation of nervous system development (GO:0051961),0.5865036262866329,1.3760481425881228,0.10252808988764045,0.7871184586282655,1.0,2/17,4.93%,CCL11;PCM1
prerank,regulation of calcium ion import (GO:0090279),0.5662935839488779,1.3756944885496754,0.11479944674965421,0.7864215944348312,1.0,6/21,14.33%,LGALS3;WNK3;PRNP;FYN;PLPP4;PSEN2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6434378268403359,1.3756576497267199,0.12324492979719189,0.7841869277274203,1.0,4/12,14.80%,TGFB1;SELENOS;HDAC2;TAF7
prerank,L-serine metabolic process (GO:0006563),0.6533620547468919,1.3745701983468506,0.11827956989247312,0.7870522894316725,1.0,5/10,13.40%,CBS;PSPH;PSAT1;PHGDH;SRR
prerank,endothelial tube morphogenesis (GO:0061154),-0.5704758168312742,-1.3726564072144993,0.1111111111111111,0.6532121822634445,1.0,4/10,9.34%,ACVRL1;CTNNB1;BMP4;RHOA
prerank,aminoglycan catabolic process (GO:0006026),0.5311334317152431,1.3725877267318563,0.10714285714285714,0.7938182654019109,1.0,9/28,15.41%,GPC3;HSPG2;SDC2;SDC4;GPC1;CTBS;SDC3;GPC4;IDS
prerank,response to interleukin-1 (GO:0070555),0.4701253093919763,1.3725262595620151,0.05975197294250282,0.7917736169255296,1.0,8/73,4.10%,CCL11;ADAMTS12;PRKCA;HAS2;PYCARD;SOX9;IRAK3;CCL4
prerank,calcium-mediated signaling (GO:0019722),0.44957398047373076,1.3720410619129697,0.05077262693156733,0.7916913488214423,1.0,24/93,17.46%,CHRM3;ANK2;PPP1R9A;EGFR;EIF2AK3;PTGFR;PRNP;CCR2;PPP3CB;ACKR3;RCAN1;PPP3CA;RCAN3;GRM5;MCTP1;PTPRJ;PRKACA;TPCN2;P2RY12;PPP3CC;ACKR4;LAT2;STIMATE;SLC9A1
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.38130930462504026,-1.3712032821621427,0.07329842931937172,0.6532390286134024,1.0,14/39,16.19%,BMP6;PODXL;MAP2K5;CDH1;WNK1;RGCC;KLF4;JAG1;NOTCH4;NEXMIF;FXYD5;AKNA;ASS1;PPM1F
prerank,peptidyl-glutamic acid modification (GO:0018200),0.5553517120652931,1.37047641406644,0.09405255878284924,0.7969244669696258,1.0,10/24,17.33%,TTLL10;TTLL5;TTLL11;AGBL4;TTLL4;VKORC1;CFAP20;TPGS1;VKORC1L1;NAA10
prerank,pinocytosis (GO:0006907),0.6577637440060442,1.3699709510053415,0.12762762762762764,0.797003275546822,1.0,4/10,7.69%,PYCARD;MAPKAPK3;MAPKAPK2;RAB34
prerank,negative regulation of transferase activity (GO:0051348),0.5353773462317748,1.3697059915915404,0.11469072164948453,0.7958765606798324,1.0,14/28,20.39%,IRS2;NPRL2;ERCC4;LIMK1;MEN1;BAG5;PRDX3;ABL1;TP53;HNRNPU;EIF4A2;FBXO5;PARK7;ZFP36
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.521907898592789,1.3691410466013587,0.10759493670886076,0.7962476276043515,1.0,6/33,12.74%,LGALS3;PTPN22;PTPN2;PRNP;PTPRJ;NECTIN2
prerank,ear morphogenesis (GO:0042471),0.5541775267589036,1.367624370742099,0.11511789181692095,0.8012509488786639,1.0,2/20,3.35%,OSR2;EPHB2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.5732866673052507,-1.367296554999727,0.14325842696629212,0.6615986768767935,1.0,6/10,30.85%,KIT;LYN;CD40;BTLA;BAG6;FGR
prerank,neuron maturation (GO:0042551),0.5726069707258149,1.3670929769051985,0.12428571428571429,0.8014756971737576,1.0,4/18,12.08%,LGI4;ADGRB3;FARP2;ANKS1A
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.4769259438747371,1.366591300812184,0.07845433255269321,0.8014149045094207,1.0,19/55,19.24%,BST1;PRKN;PARL;MT3;TGFBR2;CYP1B1;PDK3;FOXM1;EIF6;BRCA1;MAPK14;ARF4;PID1;SNCA;TP53;PAX2;RIPK1;AATF;GRB2
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.6103238696061237,1.366576400344782,0.11849710982658959,0.7991298928211578,1.0,6/14,16.77%,DNAJB9;UFL1;PTPN1;TMEM33;BCL2L11;FICD
prerank,protein localization to vacuole (GO:0072665),-0.5017321616056963,-1.365805733762936,0.13664596273291926,0.6618042003965224,1.0,8/13,25.91%,LMBRD1;MFSD1;RNF128;KPTN;SH3GLB1;SH3BP4;ATP13A2;SZT2
prerank,ubiquinone metabolic process (GO:0006743),-0.4982723101617835,-1.3657862238100682,0.12459016393442623,0.657339597033747,1.0,9/15,26.68%,COQ8B;COQ10B;PDSS1;COQ9;COQ3;FDXR;PDSS2;COQ6;COQ8A
prerank,regulation of feeding behavior (GO:0060259),0.6278038620887131,1.363945491872717,0.13996889580093314,0.809378336102696,1.0,3/11,19.77%,SGIP1;CFAP20;STAT3
prerank,COPII vesicle coating (GO:0048208),0.4723864420784249,1.3637804978564652,0.08051341890315053,0.8030321101109396,1.0,21/61,22.17%,SEC16B;GORASP1;GRIA1;ANKRD28;SEC24D;TRAPPC6B;TMED10;SEC24C;CUL3;RAB1A;KLHL12;TBC1D20;TMED2;SEC23IP;TRAPPC6A;CNIH3;SEC24A;TRAPPC3;PEF1;TRAPPC2L;LMAN1
prerank,vesicle coating (GO:0006901),0.4723864420784249,1.3637804978564652,0.08051341890315053,0.8030321101109396,1.0,21/61,22.17%,SEC16B;GORASP1;GRIA1;ANKRD28;SEC24D;TRAPPC6B;TMED10;SEC24C;CUL3;RAB1A;KLHL12;TBC1D20;TMED2;SEC23IP;TRAPPC6A;CNIH3;SEC24A;TRAPPC3;PEF1;TRAPPC2L;LMAN1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.4723864420784249,1.3637804978564652,0.08051341890315053,0.8030321101109396,1.0,21/61,22.17%,SEC16B;GORASP1;GRIA1;ANKRD28;SEC24D;TRAPPC6B;TMED10;SEC24C;CUL3;RAB1A;KLHL12;TBC1D20;TMED2;SEC23IP;TRAPPC6A;CNIH3;SEC24A;TRAPPC3;PEF1;TRAPPC2L;LMAN1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.5409231984471335,1.363772043147103,0.11023622047244094,0.8007447228896766,1.0,9/27,15.42%,FGF13;ANK2;PDE4B;DSG2;SCN5A;CTNNA3;PDE4D;PKP2;JUP
prerank,regulation of double-strand break repair (GO:2000779),0.4955832388259758,1.3628569574115386,0.09777227722772278,0.8029652736178331,1.0,12/39,16.41%,DDX11;SPIRE1;FMN2;MRNIP;FOXM1;SETD2;SLF2;SIRT6;RPA2;RTEL1;SPIDR;TERF2IP
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.38499754764986016,-1.3623002131457167,0.06435643564356436,0.6651087953278843,1.0,13/34,17.75%,FLT1;NRP1;VEGFC;VEGFD;GAS1;MAP2K3;KDR;ERN1;NUS1;FLT4;ANXA1;SPHK1;HSPB1
prerank,neuron development (GO:0048666),0.43476091971393604,1.3620612555037024,0.04801670146137787,0.8045482709894013,1.0,28/141,13.06%,LGI4;ETV1;TENM2;CDNF;TENM3;DOCK7;GLI2;PPP1R9A;ATXN10;HS6ST1;ARL3;GPM6B;PLP1;NTRK2;GBA2;NLGN1;UNK;CNTNAP2;GPM6A;VAPA;GDNF;PRMT1;OPHN1;STMN4;CDK5R1;ATP8A2;MYOC;CDK16
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.6440522544045251,1.3619195091220861,0.14308426073131955,0.8028908964745375,1.0,3/10,11.42%,BMP5;SOX11;BMP7
prerank,stabilization of membrane potential (GO:0030322),0.5829764502119156,1.3617779693448533,0.12661870503597122,0.8012871684104405,1.0,2/16,3.10%,KCNK15;KCNK1
prerank,T cell migration (GO:0072678),0.629991409162807,1.3614202560664677,0.12058823529411765,0.8006837007530293,1.0,2/13,5.24%,CXCL10;SLC12A2
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.4811206820397011,-1.3614043393238648,0.10679611650485436,0.6635645250260714,1.0,7/15,29.37%,MKNK2;HNRNPA1;PPIF;ZFAND1;VCP;GSTO2;ATF3
prerank,regulation of mitochondrial fission (GO:0090140),0.5379354080944299,1.3613873187394592,0.11455525606469003,0.7985490412597089,1.0,5/24,11.05%,DCN;SPIRE1;PRKN;BNIP3;MYO19
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.5388117322237111,1.3609253902527683,0.12113055181695828,0.7985015157479121,1.0,8/25,14.39%,CHRNA4;GRIN2B;GRID2;MPP2;INSYN1;DRD2;GRIN2D;GRIN2A
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5247267085464724,1.359889099671993,0.10921052631578948,0.8011185300216462,1.0,7/29,14.70%,BMP5;PTEN;SPRED2;SPRED1;SPRED3;GATA3;LDLRAD4
prerank,energy reserve metabolic process (GO:0006112),0.557607177897682,1.3596724418258852,0.13535911602209943,0.7999153094937397,1.0,6/19,11.37%,PYGL;GFPT2;MYC;MT3;PHKB;PID1
prerank,adherens junction organization (GO:0034332),0.4872734465297134,1.3591725356596718,0.09177592371871275,0.799989211358136,1.0,11/48,9.73%,DCHS1;CDH19;CDH10;CDH22;CDH8;CADM3;CSK;CADM2;CADM1;CDH20;CDH7
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.5384344589080803,-1.3587915835841298,0.1322314049586777,0.6678041336763076,1.0,4/11,13.96%,NBL1;SLIT2;RIN3;PADI2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.5200693970828332,-1.3586779830330147,0.1393939393939394,0.6636623495229952,1.0,7/12,22.32%,IGF1R;INSR;IRGM;UVRAG;SMCR8;JMJD4;ADRB2
prerank,positive regulation of nervous system development (GO:0051962),0.4882135311930331,1.35843501786503,0.0851581508515815,0.8013105555665158,1.0,13/42,16.58%,CLSTN2;IL1RAPL1;EPHB2;SOX11;NRXN1;GRID2;NUMBL;NLGN1;SYNDIG1;CLSTN1;LRP2;IL1RAP;FAIM
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.6262452754368721,1.3575282901880716,0.15123456790123457,0.8033992129720515,1.0,2/11,3.68%,GFPT2;NAGK
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.48855595165613586,-1.3571099859655456,0.12238805970149254,0.660032637761667,1.0,4/15,12.83%,DTNBP1;BLOC1S5;SNAPIN;AP3D1
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.48855595165613586,-1.3571099859655456,0.12238805970149254,0.660032637761667,1.0,4/15,12.83%,DTNBP1;BLOC1S5;SNAPIN;AP3D1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.6526610460101437,1.3569294514830792,0.1297134238310709,0.8038907837334348,1.0,4/11,6.38%,MYC;SOX9;WNT5A;TGFBR2
prerank,embryonic eye morphogenesis (GO:0048048),0.6358049848411448,1.3562094042517467,0.13273001508295626,0.8049701672826873,1.0,5/11,23.46%,EFEMP1;RARG;ALDH1A3;FBN2;TBX2
prerank,regulation of nuclear division (GO:0051783),0.5566870732027787,1.3554854596841996,0.13333333333333333,0.8060703394077381,1.0,5/20,10.82%,KIF20B;OBSL1;CDK13;RCC1;PKMYT1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.3537040081720331,-1.3550381408999073,0.041666666666666664,0.6628230122077527,1.0,8/45,4.03%,BMP6;DAB2;RBPMS;ACVRL1;BMP4;ENG;BMPR2;TGFBR1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.5661902538225101,1.354996852945609,0.1289875173370319,0.8061260135342881,1.0,11/20,21.23%,HM13;TGFB1;PSEN1;NGFR;NCSTN;APH1A;PSEN2;SPPL2B;MBTPS1;NFKB1;RHBDD1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.4977098944481334,1.3541809662896869,0.11577608142493638,0.8077573473717886,1.0,7/38,9.79%,RELN;ERBB3;RAP2B;GPRC5B;PRNP;PTPN1;GRM5
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.5473496991988054,1.3537472823036871,0.09798657718120805,0.8075585305091727,1.0,5/24,8.06%,ANK3;ERBB2;C2CD5;PRNP;FYN
prerank,DNA catabolic process (GO:0006308),0.6423101005368135,1.353500380209115,0.1152073732718894,0.8064394665743942,1.0,4/11,10.68%,SETMAR;XRN2;REXO4;FBH1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.46346875272460825,-1.3529708709207193,0.09060402684563758,0.6651454549756941,1.0,5/18,7.97%,PLA2G4A;PTGIS;PTGDS;PTGS1;PTGS2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5066291511787202,1.3528996575078607,0.13317191283292978,0.8069846166993415,1.0,9/35,15.00%,ARHGAP24;DLC1;EPHB2;SYNGAP1;MAPKAP1;CUL3;MYOC;ARHGAP44;MET
prerank,histone lysine methylation (GO:0034968),0.5134412868018023,1.3526165601231066,0.09746835443037975,0.8061022938965672,1.0,14/33,20.49%,SUV39H1;KMT2A;SETD3;CXXC1;SETMAR;MEN1;PRDM9;TRMT112;KDM6A;WDR5B;ASH2L;N6AMT1;SETDB1;KMT2D
prerank,diterpenoid metabolic process (GO:0016101),0.4805501036418588,1.3524508240139594,0.08362779740871613,0.8047757313409717,1.0,12/55,12.81%,GPC3;HSPG2;RHO;LRP1;SDC2;AKR1B10;SDC4;RDH10;DHRS3;GPC1;SDC3;GPC4
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.5577155238616949,1.351888112994748,0.10818307905686546,0.8053733345032679,1.0,6/21,8.64%,STK36;EVC;GLI1;UCHL5;RAB34;SMO
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4564694306501444,-1.3508742288243314,0.132013201320132,0.6673735945502987,1.0,5/17,10.65%,PRKAG2;PPARD;PANK2;PRKAA2;ADIPOR2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5196770741565816,1.3507199701190375,0.10949868073878628,0.8086786948901369,1.0,7/29,11.65%,RELN;FGF10;IRS2;NGF;ERBIN;SHOC2;MMD2
prerank,neutrophil migration (GO:1990266),0.47551699754625515,1.3506261508284152,0.09988649262202043,0.8068844637875545,1.0,8/58,11.60%,LGALS3;CCL11;CXCL10;CCL4;PDE4B;GBF1;CKLF;EDN3
prerank,positive regulation of protein localization to membrane (GO:1905477),0.4426716176952234,1.3506145962663478,0.06479481641468683,0.8047569827255949,1.0,17/98,8.27%,LGALS3;ANK3;BCL2;ERBB2;PRKN;EGFR;SLC5A3;LRP1;C2CD5;EPHB2;WNK3;PRNP;SPTBN1;YWHAZ;DPP10;FYN;ZDHHC8
prerank,nuclear membrane organization (GO:0071763),-0.4521023742846362,-1.3503560243493447,0.1,0.664722063716123,1.0,11/19,27.59%,UBXN2A;TOR1B;VPS4A;DCTN1;TMEM43;UBXN2B;GPER1;CHMP7;TARDBP;NSFL1C;TOR1AIP1
prerank,metanephric mesenchyme development (GO:0072075),-0.5543534020627772,-1.3502084236269298,0.15151515151515152,0.6609186667606133,1.0,3/10,7.30%,WNT4;OSR1;SIX1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.5935782188228272,1.3496337080546206,0.14427157001414428,0.8070477499475394,1.0,5/15,10.50%,SOX8;SOX9;VEGFA;SMO;GDNF
prerank,regulation of protein targeting to membrane (GO:0090313),0.5281307007464799,1.3494727714004142,0.1070063694267516,0.8056004155397775,1.0,5/28,8.06%,ANK3;ERBB2;C2CD5;PRNP;FYN
prerank,limb development (GO:0060173),0.5277488613884429,1.3484145635926486,0.13144329896907217,0.8081421387490462,1.0,4/28,2.04%,PTCH1;LRP4;FGF10;KAT2B
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.5168411699749353,-1.3478411280328955,0.140625,0.6644286077207409,1.0,6/13,22.44%,NOS3;FPGS;HSP90AA1;SPR;QDPR;AKT1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.49596392812041734,1.3478218685243504,0.11735941320293398,0.8086579815585445,1.0,7/40,6.81%,GLMN;PTEN;RAD23B;XPO1;ARAF;FBXW7;UFL1
prerank,regulation of intracellular transport (GO:0032386),-0.3733446589190119,-1.347718743203861,0.08080808080808081,0.6607027723912849,1.0,11/38,10.96%,MAP2;RAB11B;GAS1;LAMP1;ATP9A;SCFD1;ATPSCKMT;WWC1;DYNLT2B;NUMA1;NUP214
prerank,oligodendrocyte differentiation (GO:0048709),0.5735920610565598,1.3476052948071593,0.12121212121212122,0.8075075401934316,1.0,6/19,13.02%,SOX6;SOX8;SOX9;EIF2B5;NSUN5;PTPRZ1
prerank,regulation of secretion (GO:0051046),0.6136214077419798,1.3467999910109456,0.14014598540145987,0.8091471777205175,1.0,6/13,16.80%,ERBB3;FGF10;ACSL3;GPLD1;OPRK1;SGK1
prerank,negative regulation of developmental growth (GO:0048640),0.515920441946498,1.3467267630376072,0.12648221343873517,0.8073411387666505,1.0,7/30,10.02%,PTCH1;FGF13;PTEN;RNF6;MT3;CDKL3;DCC
prerank,proteolysis (GO:0006508),0.42443781448045437,1.3465675901756682,0.012207527975584944,0.8059285999881209,1.0,59/252,19.68%,HGFAC;KLK12;PTCH1;MMP2;ADAMTS12;ADAM19;FAP;BACE2;CAPN5;HTRA3;HM13;PARL;HTRA1;CAPN1;MIPEP;NAALAD2;PSEN1;PCSK4;PCSK6;MMP15;CTSK;CTSO;CASP6;TRHDE;CTSB;UFSP2;SPCS3;LNPEP;CAPN6;THOP1;MMP16;NCSTN;RSPRY1;UBA3;FBXL2;APH1A;YME1L1;MALT1;MMP19;CPD;NEDD8;TYSND1;ADAM33;PSEN2;PAPPA2;CASP2;RNPEPL1;USP25;FAM111A;ATG4C;SUFU;MDM2;CASP7;ERMP1;CAPN11;SENP1;CPNE1;SPPL2B;MBTPS1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4708418301259252,1.3465454993421409,0.08136792452830188,0.8038868555907472,1.0,8/57,7.73%,DCN;HRK;PYCARD;SPIRE1;PRKN;FBXO7;BMF;BNIP3
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5454236654304638,-1.3463482811827265,0.14084507042253522,0.6609777283960012,1.0,5/11,5.90%,DAB2;WNT5B;RSPO3;MLLT3;NKD1
prerank,regulation of platelet activation (GO:0010543),0.5561896584263526,1.3460191303930422,0.13194444444444445,0.8042058895701525,1.0,4/21,4.19%,PRKCA;PDGFRA;PRKCQ;TEC
prerank,neuron projection morphogenesis (GO:0048812),0.43373989336016466,1.3436118366771215,0.047966631908237745,0.8131547558451522,1.0,49/137,19.95%,ANK3;DOCK7;LRP4;KIF20B;PTEN;NGF;MAP4K4;MAP1B;GAS7;NRCAM;EPHB2;SDC2;CTNNA2;TNIK;NYAP1;NLGN1;PAK1;ALS2;BAIAP2;DOCK10;NTNG2;NTNG1;S100A6;CNTNAP2;GPM6A;EPB41L3;DCC;DCLK1;DIP2A;BMP7;TAOK3;PLPPR4;DVL1;RAB3A;DRD2;TRIO;IQGAP1;ANKRD27;UBB;LRP2;SGK1;CTTN;PAX2;KLF7;CNTN4;NCKAP1;CPNE1;MAP6;SHTN1
prerank,regulation of filopodium assembly (GO:0051489),-0.37058897233992033,-1.343328462749897,0.07881773399014778,0.6673536587675134,1.0,10/38,3.56%,CAPZB;NRP1;MYO10;RAB5A;WASL;PPP1R16B;PRKCD;GAP43;AGRN;FNBP1L
prerank,alpha-amino acid metabolic process (GO:1901605),0.4769068842365916,1.3432654383760287,0.10336538461538461,0.8126452226404716,1.0,18/45,22.12%,AADAT;DPEP1;CBS;NAALAD2;GOT2;MTRR;ASNS;OAT;SRR;GPT2;KYAT3;GLS2;GLS;ASPA;RIMKLB;GLUD1;NAT8L;DDAH1
prerank,generation of neurons (GO:0048699),0.4249290602956385,1.342926191349834,0.024793388429752067,0.8120429569245057,1.0,27/190,8.16%,RELN;DOCK7;LHX5;FGF13;ASTN2;ERBB2;IL1RAPL1;OTP;MAP1B;NRCAM;SEMA3A;AUTS2;SOX11;NTRK2;EML1;CEP85L;WNT5A;NGRN;CDKL5;NAV1;DISC1;SDCCAG8;FZD7;TAFA1;CDK6;FGFR1;GPM6A
prerank,cAMP-mediated signaling (GO:0019933),0.5346998364214272,1.3421474069796975,0.12384716732542819,0.813474136171285,1.0,7/24,13.22%,SOX9;PDE7B;MAPK7;KSR1;AKAP6;PDE4D;AHR
prerank,ion homeostasis (GO:0050801),0.5167384522955654,1.341431527947817,0.1251596424010217,0.8148030326228503,1.0,4/30,7.95%,P2RY2;WNK2;WNK3;SLC30A4
prerank,negative regulation of cell development (GO:0010721),0.526600569549353,1.3409237015600761,0.13123359580052493,0.8149918660649903,1.0,4/25,4.93%,CCL11;PTHLH;FBXW7;PCM1
prerank,regulation of actin filament-based movement (GO:1903115),0.6354286222642086,1.3404610169067,0.152,0.8149934154734636,1.0,4/10,12.06%,ANK2;PDE4B;SCN5A;PDE4D
prerank,axon development (GO:0061564),0.4466058716995126,1.3401861427439357,0.07769145394006659,0.8140880799813922,1.0,23/78,18.90%,ANK3;DOCK7;MAP1B;NRCAM;EPHB2;PLP1;CTNNA2;BAIAP2;NTNG2;NTNG1;S100A6;DCC;PLPPR4;CDK5R1;RAB3A;DRD2;RTN4;MTR;PAX2;NREP;RTN4RL1;KLF7;CNTN4
prerank,defense response to tumor cell (GO:0002357),0.634893866325847,1.3394933475074167,0.15220700152207,0.8150780489843296,1.0,2/10,1.48%,DLEC1;RBMS3
prerank,amino sugar biosynthetic process (GO:0046349),0.6079506122419603,1.3384450989220924,0.16591251885369532,0.8177195573469994,1.0,2/12,3.68%,GFPT2;NAGK
prerank,regulation of dendrite extension (GO:1903859),0.5680793900309122,1.3382789109844138,0.14285714285714285,0.8163986434288497,1.0,9/18,23.57%,RNF157;SYT1;RIMS1;NEDD4L;PLAA;SYT2;RIMS2;CPNE5;SYT3
prerank,chromatin organization (GO:0006325),0.4377479725657459,1.3376739112337421,0.051961823966065745,0.817161829629192,1.0,42/132,20.30%,FAM47E;DDX11;PRDM16;MYC;KAT2B;LRWD1;SOX9;HMGN1;SUV39H1;SATB1;KDM5B;BAZ1A;EZH1;PAK1;KDM4B;MTA2;MCM3AP;ATRX;SETD2;PIH1D1;HDAC2;MYSM1;ESR1;SMARCC2;JARID2;ZBTB1;SETD5;RBBP4;SMARCC1;BAZ2B;KDM6A;BAZ1B;PHF19;SMARCE1;PBRM1;NUDT5;RUVBL2;HMG20A;TOP1;HP1BP3;SMARCA4;SETDB1
prerank,positive regulation of dendrite extension (GO:1903861),0.5734702665192598,1.337248368049604,0.12976022566995768,0.8170502185084343,1.0,9/17,23.57%,RNF157;SYT1;RIMS1;NEDD4L;PLAA;SYT2;RIMS2;CPNE5;SYT3
prerank,bone morphogenesis (GO:0060349),0.5914008162157333,1.3366520005434153,0.15629522431259044,0.8177908229977833,1.0,1/14,0.11%,OSR2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.43222539046705666,1.3366151717510424,0.046632124352331605,0.8158939823046978,1.0,29/140,13.66%,RELN;ARHGAP24;DLC1;ARHGAP32;ARHGAP19;A2M;RHOJ;RHOD;DEPDC1B;AKAP13;FGD4;CHN1;ITSN1;FOXM1;ARHGAP9;RABL3;ARHGEF11;VAV3;ARHGAP11A;RHOT2;MYO9B;MYO9A;ARHGAP21;OPHN1;RHOH;RHOC;TRIO;ARHGAP4;ARHGEF3
prerank,positive regulation of phospholipid transport (GO:2001140),-0.5396699706730015,-1.3354355491636876,0.1164021164021164,0.6901342647101982,1.0,5/10,21.90%,ABCA3;ABCB4;APOE;ABCA7;TMEM30A
prerank,organic anion transport (GO:0015711),-0.3206971860167444,-1.3350349378963469,0.03,0.6871714672195801,1.0,20/76,13.58%,SLCO3A1;ABCC4;ABCG2;SLC26A7;SLCO2A1;SLCO1C1;SLC4A10;SLC22A6;SLC35B4;SLC4A3;SLC39A8;SLC16A2;CYB5R4;ABCC6;CA4;SLC4A8;LRRC8C;SLC2A10;LRRC8A;MGST1
prerank,regulation of sequestering of calcium ion (GO:0051282),0.608101586775561,1.3345004290035545,0.13818722139673106,0.8237890884724777,1.0,4/12,14.77%,UBASH3B;ANK2;ANXA6;MTLN
prerank,response to interferon-beta (GO:0035456),-0.43287706919929303,-1.3343027843405328,0.12773722627737227,0.6854946931704412,1.0,14/22,28.37%,PLSCR1;IFITM3;AIM2;IRGM;IRF1;IFITM2;UBE2G2;BST2;HTRA2;IFNAR2;CDC34;IKBKE;XAF1;TRIM6
prerank,cation transmembrane transport (GO:0098655),-0.36680096236345755,-1.3336068641516041,0.043478260869565216,0.6836905087006935,1.0,16/44,24.09%,TRPM3;SLC7A2;ATP1A2;SLC7A5;ABCC9;SLC38A5;SLC25A20;SLC36A4;SFXN3;SLC6A5;SLC25A19;ATP1B1;TRPM2;KCNJ8;SLC25A29;ATP13A2
prerank,regulation of pH (GO:0006885),-0.523507686198625,-1.333246951906198,0.15588235294117647,0.6807199519696888,1.0,7/11,27.81%,CLCN3;SLC9A7;ATP6V0A4;ATP6AP1;PDK2;LACC1;PDK4
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6026794624160168,1.3321954334698731,0.16105417276720352,0.8321338471101556,1.0,5/13,14.61%,FGF2;GLI1;ERBB4;ZFPM2;BMPR1A
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5379257117452956,1.3319380879485236,0.14513981358189082,0.8312783538877659,1.0,7/21,19.84%,CACNA2D1;ANK2;SCN5A;FLNA;KCNH2;KCNA5;NOS1AP
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.588968695366062,1.330885910845479,0.14814814814814814,0.8341117669378878,1.0,3/15,8.60%,OSR2;FGFR1;BRCA1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5791217298256177,1.3307027610295086,0.12482065997130559,0.8329839756089079,1.0,3/16,8.90%,SOX6;SOX9;SOX5
prerank,cellular response to hormone stimulus (GO:0032870),-0.32390883320879293,-1.3298068480995084,0.026785714285714284,0.6882679600574652,1.0,20/69,19.29%,THRB;ATP1A2;CTSH;TFPI;SLIT2;RAMP1;LMO2;STAT5B;ZFP36L1;ATP1A1;SLC5A5;PELP1;SERPINB9;ADRA2A;SRA1;CTSS;CAV1;ARID5A;GPER1;RARA
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5334030209673983,1.3292682191192708,0.13704206241519673,0.8376814279261912,1.0,8/24,16.89%,FFAR4;RNF157;PRKAR1B;PDE3B;PDE4D;GNAI1;CGAS;APLNR
prerank,receptor clustering (GO:0043113),0.5279755203635539,1.3290643904525685,0.11864406779661017,0.8365814791653295,1.0,9/27,12.73%,LRP4;SAV1;NRXN1;DLG2;NLGN1;FLNA;MAGI2;DVL1;SCRIB
prerank,central nervous system myelination (GO:0022010),0.6153692320568596,1.3289931513413848,0.15846153846153846,0.8348117142605365,1.0,2/11,4.28%,PTEN;PLP1
prerank,morphogenesis of an epithelium (GO:0002009),0.5302822113806035,1.328180872622999,0.14713541666666666,0.8363329057947029,1.0,4/25,7.60%,SOX8;SOX9;PRKX;TBX18
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5429169280005038,1.3273543234888103,0.13395225464190982,0.8380959247687432,1.0,5/23,8.06%,UBASH3B;CACNA2D1;ANK2;PRNP;FYN
prerank,nerve growth factor signaling pathway (GO:0038180),0.6324651297668471,1.327117126790344,0.1753846153846154,0.8371786437329323,1.0,3/10,11.52%,NGF;RAP1A;MAGI2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.4824792244103145,-1.3271124814580681,0.1188118811881188,0.6928109836781654,1.0,7/14,16.08%,NRP1;VEGFC;VEGFD;KDR;MYO1C;NUS1;FLT4
prerank,positive regulation of macrophage differentiation (GO:0045651),0.6187403038905135,1.3269938390004863,0.1574074074074074,0.8356468207814176,1.0,3/11,4.08%,PRKCA;FADD;TGFB1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3642956359610785,-1.326604125385688,0.0625,0.6904554822025738,1.0,8/39,7.77%,TJP1;SNCAIP;ROCK2;RAP1B;ROCK1;TIE1;PARP10;IRGM
prerank,positive regulation of synapse assembly (GO:0051965),0.5153749704554981,1.3263568298293045,0.12093628088426528,0.8365783988116204,1.0,10/27,18.86%,CLSTN2;IL1RAPL1;EPHB2;NRXN1;GRID2;NLGN1;SYNDIG1;CLSTN1;IL1RAP;SEMA4D
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.4779026296113359,-1.3258961775867975,0.14488636363636365,0.6887990175230511,1.0,3/13,9.34%,ETS1;NFAT5;RHOA
prerank,regulation of neuroinflammatory response (GO:0150077),-0.44127091295159165,-1.3254382430902076,0.10357142857142858,0.6864750887528932,1.0,6/19,17.29%,IGF1;CD200;PTGS2;NUPR1;SPHK1;DAGLA
prerank,hydrogen peroxide metabolic process (GO:0042743),0.555390175183633,1.3253963179021093,0.15688949522510232,0.8390831006049975,1.0,7/19,18.77%,PXDN;NOX1;ACOX1;GPX3;PRDX3;CAT;PARK7
prerank,cellular response to organic cyclic compound (GO:0071407),0.42056646492667427,1.3253708631735865,0.049586776859504134,0.837217712335616,1.0,42/141,21.51%,RORA;P2RY2;SSTR1;HRH1;EGFR;TGFB1;AOC1;URI1;RORC;CASP6;CYP1B1;RAP1A;IL18;BRCA1;AKAP6;ESR1;ARL6IP5;NRIP1;GNAI1;HSP90B1;AHR;P2RY12;P2RY1;SSH1;LCOR;JUP;BLM;GABRG2;SPIDR;NCOA3;CASP7;FAM210B;TAF1;EGR1;RYR3;RUVBL2;HCN1;UBE2L3;ADCY8;TIPARP;PKD2;P2RX7
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.3649988123392851,-1.3248842083549315,0.07729468599033816,0.6843392306892246,1.0,9/38,14.04%,BMP6;SASH1;ANKRD17;DDX60;PLSCR1;RIOK3;CYBA;USP15;NMI
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.4488451229295,1.3246993965381502,0.09417040358744394,0.8382884681123313,1.0,18/75,12.70%,ANK3;DOCK7;LRP4;MAP1B;NRCAM;SDC2;CTNNA2;BAIAP2;NTNG2;NTNG1;S100A6;UNK;DCC;OPHN1;PLPPR4;DVL1;RAB3A;DRD2
prerank,muscle contraction (GO:0006936),-0.30387432049695695,-1.3244137307483277,0.0,0.6819590674547349,1.0,24/126,15.74%,CALD1;MYOF;SORBS1;ROCK2;TMOD3;TPM3;ROCK1;ITGB5;SNTA1;MYL6;TPM1;MYLK;ACTN2;MYL12B;MYL12A;GJC1;MYH11;ITGA1;LMOD1;ACTA2;TPM2;TMOD1;NOS1;DES
prerank,vesicle transport along actin filament (GO:0030050),-0.4413658318811561,-1.324284048295806,0.11920529801324503,0.6785173539172225,1.0,10/19,27.07%,MYO1D;WASL;FNBP1L;MYO1E;MYO5B;MYO1C;ACTN4;MYO5C;MYO1F;MYO15A
prerank,glycoprotein catabolic process (GO:0006516),0.5684870069651635,1.3237127407611744,0.1396011396011396,0.8409412833330971,1.0,4/17,11.74%,ADAMTS12;FBXO27;EDEM2;FBXO17
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5570861357837926,1.3235649528953781,0.16256830601092895,0.8396321092605307,1.0,3/17,5.51%,CACNA2D1;ANK2;SCN5A
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.40219462321932836,-1.3233985628528686,0.11787072243346007,0.6777425459401347,1.0,8/24,13.33%,CDH2;BOC;CTNNB1;CDON;BNIP2;CAMK1;MAPK12;CDC42
prerank,negative regulation of transport (GO:0051051),0.4681813307815791,1.3231651165795772,0.10095011876484561,0.8395185761201285,1.0,14/51,18.13%,LGALS3;ERBB3;PTEN;PRKN;CRYAB;SYT11;MCTP1;PXK;ARL6IP5;NDFIP1;SNCA;SNX12;DYSF;RAB7A
prerank,regulation of macrophage migration (GO:1905521),-0.5445283592772092,-1.32295846924388,0.14565826330532214,0.6752075004588737,1.0,2/10,1.32%,CD200;MTUS1
prerank,cellular response to UV-A (GO:0071492),0.6193707708197038,1.321493223993037,0.18535127055306427,0.8452152401422197,1.0,2/11,8.92%,MMP2;PPID
prerank,negative regulation of histone modification (GO:0031057),0.5867614136536424,1.3214515125222968,0.17378497790868924,0.8433781403899488,1.0,6/14,17.63%,AASS;BRCA1;JARID2;SNCA;TAF7;CTBP1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.5926462373892657,1.3213253160322163,0.16491754122938532,0.8419557203408501,1.0,2/13,3.68%,GFPT2;NAGK
prerank,camera-type eye development (GO:0043010),0.527336234123745,1.321082808014914,0.13315926892950392,0.8410991729204791,1.0,5/25,7.15%,EFEMP1;TENM3;VEGFA;NF1;CYP1B1
prerank,gastrulation (GO:0007369),0.5784016849098581,1.3201755546021123,0.16246498599439776,0.8432421323916346,1.0,1/15,0.27%,GPC3
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.44090517856543643,1.3198100368083194,0.07860262008733625,0.8429041169469097,1.0,23/88,18.77%,LGALS3;CLDN19;PRKCA;HRK;VEGFA;TGFB1;SDC4;BMF;LIMK1;BRK1;PIH1D1;SLF2;BMP7;RHOC;SUMO1;PDCD6IP;MTLN;SPIDR;BCL2L11;HYAL1;RAB7A;FNIP1;PARK7
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5646728894992727,1.319587740046463,0.13352272727272727,0.8418754956136558,1.0,5/18,9.65%,PTPN22;FGL1;TNFAIP8L2;LAX1;IL4I1
prerank,myelin assembly (GO:0032288),0.613006695135728,1.319028456496158,0.15709969788519637,0.8424471060020534,1.0,5/10,20.25%,EPB41L3;PMP22;GPC1;CD9;NCMAP
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.3280179621660821,-1.3188739832733456,0.02877697841726619,0.6844510364096476,1.0,19/61,17.47%,PRKAG2;PSMD14;AZIN1;OAZ1;PSMB3;PSMD12;PANK2;OAZ2;PSMD6;PSMA1;ODC1;PSMD7;PSMA5;PSMC5;FGFR4;CAV1;PSMC4;PDK2;PSMB6
prerank,regulation of interleukin-2 production (GO:0032663),0.4863976060752648,1.318404673411802,0.12424607961399277,0.8432047478158735,1.0,11/43,16.02%,GLMN;CD34;PDE4B;PRNP;CCR2;SPTBN1;PDE4D;MALT1;HOMER2;RUNX1;NAV3
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.5854013303312862,1.3178667705049056,0.16716417910447762,0.843754675380205,1.0,6/13,18.99%,TRIM44;WNT5A;AGPAT2;TAF9;CD74;AXL
prerank,endoderm development (GO:0007492),0.5975045336410911,1.31715719208025,0.18851251840942562,0.8449356955623275,1.0,2/13,2.38%,DUSP4;LAMC1
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.42770799323362124,-1.3163482853342168,0.11923076923076924,0.6889221218481889,1.0,9/23,13.93%,MOSPD2;SLIT2;MPP1;JAM3;DAPK2;CAMK1D;DPP4;NCKAP1L;TIRAP
prerank,superoxide anion generation (GO:0042554),0.6002207515185753,1.3160195776075352,0.15742128935532235,0.8480596902473095,1.0,4/13,9.77%,NCF1;NOX1;TAFA4;NCF2
prerank,mesoderm formation (GO:0001707),-0.4458810612545945,-1.3159629569990732,0.11846689895470383,0.6862556872142638,1.0,4/17,14.56%,ITGA3;BMPR2;KDM6B;HMGA2
prerank,histone H4-K16 acetylation (GO:0043984),0.5511519310469317,1.3152033192119736,0.16234652114597545,0.8499595010711981,1.0,11/19,23.68%,JADE1;KMT2A;JADE3;KAT8;PHF20;ING4;KANSL1;MSL3;MCRS1;KANSL2;KAT7
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.52661607097613,1.3151405035335064,0.14781491002570693,0.8482502812343891,1.0,11/26,19.14%,FGF10;EGFR;UBE2E2;PLCB1;ADAMTS1;EIF4G1;CCND2;HYAL1;RPTOR;KMT2E;RDX
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.4185982825542979,-1.3147980486181403,0.11469534050179211,0.6860441951354909,1.0,8/20,20.81%,ROCK2;ROCK1;FHOD1;RHOQ;NCKAP1L;IKBKB;LLGL2;LCP1
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.4715096059627301,-1.3139763606520367,0.1465798045602606,0.684849460109497,1.0,11/16,28.53%,PARP1;ATPSCKMT;FLCN;TMSB4X;ENO1;PINK1;AK4;SPHK2;ANTKMT;DNAJC30;VCP
prerank,peptidyl-tyrosine modification (GO:0018212),0.4574289108395144,1.3127298330866,0.12514619883040937,0.857396263589012,1.0,10/56,8.06%,RELN;EFEMP1;PDGFRA;PKDCC;ERBB2;EGFR;EPHB2;TEC;FGFR1;FYN
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.46923452510393304,1.3118254347222347,0.11842105263157894,0.8597936529700146,1.0,11/48,16.89%,UBASH3B;CXCL10;ANK2;JPH3;AKAP6;PDE4D;PRKACA;SNCA;CALM1;CALM2;APLNR
prerank,hydrogen peroxide catabolic process (GO:0042744),0.6085952761858946,1.3117475618544117,0.17073170731707318,0.8581583698326647,1.0,4/11,18.05%,PXDN;GPX3;PRDX3;CAT
prerank,regulation of dendrite development (GO:0050773),0.4821975836113165,1.3116688542274257,0.1229404309252218,0.8565528885599147,1.0,11/37,14.73%,BMP5;CSMD3;SDC2;TNIK;CDKL5;ADGRB3;DCC;BMP7;COBL;NEDD4L;RTN4IP1
prerank,positive regulation of neuron migration (GO:2001224),0.60633104592041,1.3114525385159086,0.16793893129770993,0.8555634746427828,1.0,5/11,19.95%,KIF20B;SEMA3A;PLAA;MDK;SHTN1
prerank,positive regulation of cell junction assembly (GO:1901890),0.4655102553527344,1.3114190819917158,0.1064327485380117,0.8537674020454649,1.0,17/56,16.55%,CLDN19;CLSTN2;IL1RAPL1;MAP4K4;VEGFA;EPHB2;NRXN1;GRID2;NLGN1;TSC1;CNTNAP2;PTPRJ;MYOC;SYNDIG1;CLSTN1;ABL1;IL1RAP
prerank,NAD biosynthetic process (GO:0009435),-0.43476923408569557,-1.31127007827912,0.12857142857142856,0.689768008893418,1.0,7/20,10.07%,PTGIS;NMNAT2;NAMPT;NAXD;PARP10;PTGS2;NMNAT1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.4054581254409195,-1.3110509956109901,0.12903225806451613,0.6867677331300517,1.0,8/23,18.16%,CLK2;SIK1;NUPR1;GSK3A;C1QTNF3;HDAC4;PGP;GIT1
prerank,negative regulation of wound healing (GO:0061045),0.5070887735527749,1.310692685771942,0.147247119078105,0.8550930798238708,1.0,8/28,11.17%,CLDN19;FGF2;PTEN;CD34;SLC12A2;SERPINE2;CLASP1;AJAP1
prerank,response to laminar fluid shear stress (GO:0034616),-0.5279470600130396,-1.3105803379212562,0.1658291457286432,0.6847635578937082,1.0,6/10,8.82%,SMAD6;ABCA1;SMAD7;MAP2K5;KLF2;KLF4
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4894294100729628,1.3100642493778667,0.15782828282828282,0.8560067514240787,1.0,2/33,1.66%,APOD;PTEN
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.4491678184206826,1.3098607310414339,0.09988518943742825,0.8549285409226123,1.0,9/63,11.10%,FGF10;BCL2;IRS2;BST1;EPHB2;CD320;IL18;VAV3;IL6ST
prerank,positive regulation of cell adhesion (GO:0045785),0.4445707120954038,1.3095959035633142,0.11036036036036036,0.8542154142519949,1.0,19/74,18.37%,VIT;PRKCA;EPB41L4B;RHOD;ERBB2;FBLN2;VEGFA;PPP3CA;MAGI1;ARL2;PTPRJ;P2RY12;CITED2;ATM;HYAL1;RELL2;RAC3;MDK;MEGF10
prerank,cilium-dependent cell motility (GO:0060285),0.534057059578226,1.3094712369501094,0.14049586776859505,0.8527758331657744,1.0,7/22,17.71%,EFHC1;DNAH2;CCDC39;RFX3;CCDC65;DNAAF2;RSPH9
prerank,regulation of postsynapse organization (GO:0099175),0.5090832892639897,1.3088122147814183,0.14056224899598393,0.8539160403120329,1.0,10/28,15.49%,SIPA1L1;IL1RAPL1;TANC2;WNT5A;CDKL5;PPFIA2;CDK5R1;LZTS3;ARHGAP44;HOMER1
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.42451092545460106,1.308229856648364,0.07805907172995781,0.8547217138171784,1.0,32/113,17.09%,LGALS3;USP50;HRK;VEGFA;GTF2H2;TGFB1;ERCC5;ERCC4;DDB2;RPA3;BMF;BRK1;XPA;PIH1D1;EIF4G1;SLF2;ESR1;RHOC;DDB1;TTBK1;RPA2;SNCA;SUMO1;DHX33;MTLN;MED25;ATM;TP53;SPIDR;BCL2L11;FSCN1;CUL4B
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.4262681432115252,-1.3080981487840788,0.12547528517110265,0.6891057026055436,1.0,6/21,17.77%,FOXP1;PRKCH;PRKCB;PTPRC;IKBKG;SLC39A10
prerank,negative regulation of response to stimulus (GO:0048585),0.4542229483300859,1.3076218527019985,0.11662817551963048,0.8556216984626775,1.0,13/60,9.97%,UBASH3B;ERBB3;CD34;ACVR1;MAP3K3;MAPK7;SOCS5;HHIP;CDK6;COL3A1;AKT3;PTPN1;MCTP1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4721764856437156,1.3074585743163614,0.12545235223160434,0.8543808229807275,1.0,12/44,17.39%,WNK2;ANK2;ANO6;WNK3;KCNMB2;KCNMB3;FLNA;AKAP6;KCNJ3;KCNJ10;KCNH2;KCNMA1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.4340662314293901,1.306727762343368,0.08519701810436635,0.8557910419754103,1.0,20/95,12.81%,DCN;GPC3;HSPG2;VCAN;HAS2;LUM;ST3GAL4;HS6ST1;SDC2;EXT1;SDC4;BCAN;CSGALNACT1;CHSY1;SLC10A7;NCAN;GLCE;GPC1;SDC3;GPC4
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.45641207720216387,-1.305899523703164,0.15824915824915825,0.6926267404888944,1.0,4/17,1.86%,ROCK2;CDH5;ROCK1;CLDN5
prerank,muscle tissue development (GO:0060537),0.5939192608953974,1.305521486530969,0.1903323262839879,0.8596097310837935,1.0,4/13,8.64%,PTCH1;CSRP1;NF1;SMO
prerank,striated muscle cell development (GO:0055002),-0.47031066534931687,-1.3050134594863043,0.14935064935064934,0.6917136227691956,1.0,5/14,19.73%,TMOD3;PGM5;LMOD1;TMOD1;SDC1
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.5228430359602543,-1.3044605601746375,0.1620879120879121,0.6901560203994255,1.0,4/11,17.18%,CLK2;SIK1;C1QTNF3;PGP
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.4935636734156692,-1.3033112595909655,0.1871345029239766,0.6902329500964967,1.0,7/12,23.41%,CYP26B1;KLF2;SNW1;CNOT1;TRIM16;CTBP2;CALR
prerank,renal filtration (GO:0097205),0.6249376942907656,1.303182211447849,0.16925465838509315,0.8683250606574469,1.0,2/10,1.88%,SULF1;CD34
prerank,interstrand cross-link repair (GO:0036297),0.4550868469807348,1.3028212232560221,0.12154031287605295,0.8680655746925402,1.0,13/53,16.45%,UBE2T;POLN;ERCC4;RPA3;XPA;FANCC;MSH6;ERCC6L2;XRCC3;RPA2;UBB;FANCI;USP1
prerank,endosome organization (GO:0007032),0.4710265384287527,1.3023618100657695,0.15365853658536585,0.868180895126438,1.0,10/41,12.88%,USP50;DNM1;ALS2;LAPTM4B;VPS11;PI4K2A;PHETA2;RAB22A;SNX10;AKTIP
prerank,cellular potassium ion homeostasis (GO:0030007),-0.4983183118025797,-1.3019381920905564,0.15384615384615385,0.6911488265909723,1.0,4/13,6.72%,ATP1A2;ATP1B3;KCNJ2;ATP1A1
prerank,regulation of macrophage differentiation (GO:0045649),0.5715679430786365,1.3013275338890042,0.17765042979942694,0.8709376166164344,1.0,3/15,2.79%,PRKCA;FADD;PTPN2
prerank,phagolysosome assembly (GO:0001845),0.5999096433732942,1.3007798625217466,0.17170111287758347,0.8716617965071976,1.0,5/12,18.13%,RAB14;RAB34;RAB39A;RAB7B;RAB7A
prerank,regulation of cholesterol storage (GO:0010885),-0.468063670914821,-1.2998441462803854,0.15269461077844312,0.6946076014989883,1.0,7/15,20.81%,ABCA1;PPARD;ABCG1;NR1H2;TTC39B;NR1H3;LPL
prerank,autonomic nervous system development (GO:0048483),0.5502043152981301,1.2994256275154978,0.16016713091922005,0.875979371814182,1.0,7/17,13.20%,SOX8;SEMA3A;SOX11;NF1;PHOX2A;GDNF;GATA3
prerank,DNA methylation (GO:0006306),0.5209069208530052,1.2974149401358765,0.17959183673469387,0.8834898510689528,1.0,8/23,19.53%,GATAD2A;ATF7IP;ATRX;MTRR;TEX15;HELLS;KMT2E;N6AMT1
prerank,negative regulation of response to external stimulus (GO:0032102),0.423462253551152,1.2969525167637843,0.08733624454148471,0.883735663759015,1.0,17/105,13.20%,RORA;FFAR4;CLDN19;FGF2;PTEN;PTPN2;MAPK7;IRAK3;TNFAIP8L2;CTNNA2;GRID2;OTULIN;PPM1B;SELENOS;AJAP1;DRD2;GATA3
prerank,regulation of dopamine secretion (GO:0014059),0.5141499231735731,1.2959796483636596,0.17066666666666666,0.8863136111962147,1.0,9/25,13.88%,KCNA2;PRKN;CHRNA4;SYT1;SYT11;SYT12;GDNF;DRD2;SNCA
prerank,positive regulation of kinase activity (GO:0033674),0.42549126790229574,1.294715973949491,0.09364908503767493,0.8901299691020303,1.0,17/107,7.80%,ROR2;RELN;ROR1;PDGFRA;ERBB3;NTRK3;EPHB6;ERBB2;EGFR;EPHB2;NTRK2;TRAF4;MRNIP;ALS2;VAC14;RAP1A;FGFR1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.4471152084176989,-1.2942007668701168,0.15309446254071662,0.709456722891755,1.0,8/17,26.76%,MOSPD2;DAPK2;CAMK1D;NCKAP1L;TIRAP;DNM1L;RIPOR2;CCL19
prerank,negative regulation of cellular protein localization (GO:1903828),-0.37197855324521373,-1.2935719928539995,0.10294117647058823,0.7078590217450126,1.0,11/34,9.20%,ROCK2;LZTFL1;MFHAS1;TTBK2;LATS2;COMMD1;LEPROTL1;GSK3B;ACTN2;GOPC;FLCN
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.49686289498557923,1.2931742236960555,0.17374517374517376,0.8953728483675917,1.0,8/29,9.44%,GCDH;ACACA;SCD5;ELOVL6;ACLY;FASN;PPT2;ELOVL5
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4386058610848609,-1.2929766082924823,0.13,0.7061806978951253,1.0,8/18,26.76%,MOSPD2;DAPK2;CAMK1D;NCKAP1L;TIRAP;DNM1L;RIPOR2;CCL19
prerank,membrane protein proteolysis (GO:0033619),0.48599726945117316,1.2929639372735866,0.14975247524752475,0.8944158585188359,1.0,11/37,14.33%,ADAM19;PRKCQ;BACE2;HM13;PARL;TGFB1;PSEN1;NGFR;NCSTN;APH1A;PSEN2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5414871790525193,1.2923651066732724,0.17337031900138697,0.8952066507255414,1.0,6/18,9.87%,SUV39H1;KMT2A;SETD3;SETMAR;PRDM9;SETD2
prerank,regulation of lymphocyte differentiation (GO:0045619),0.5540428860768758,1.2923158818854816,0.16235632183908047,0.8935079290067329,1.0,6/18,15.54%,CCR2;METTL3;IL4I1;ZFP36L2;XRCC6;ABL1
prerank,membrane repolarization (GO:0086009),-0.47201321170695676,-1.2917976104405988,0.1611842105263158,0.7061901290321915,1.0,4/15,6.72%,ATP1A2;ATP1B3;KCNJ2;ATP1A1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.49710320442802874,1.291551574191772,0.15844155844155844,0.8952029494068087,1.0,5/31,6.38%,OSR2;PDGFRA;SOX11;HOXD3;TGFBR2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.6106393440917858,1.2913870785760286,0.19152276295133439,0.8940521419805755,1.0,3/11,14.80%,TMEM106A;HDAC2;TAF7
prerank,pentose-phosphate shunt (GO:0006098),0.5934578567309694,1.290883498256203,0.2054794520547945,0.8944411995567653,1.0,8/11,25.69%,H6PD;RPE;SHPK;PGLS;TALDO1;RBKS;RPIA;PGM2
prerank,chondroitin sulfate metabolic process (GO:0030204),0.4958562653505683,1.290673385334069,0.15384615384615385,0.8933842627222338,1.0,11/30,18.15%,DCN;VCAN;BCAN;CSGALNACT1;CHSY1;NCAN;IDS;HYAL1;UGDH;CSPG4;CHSY3
prerank,negative regulation of metabolic process (GO:0009892),-0.33305910283005374,-1.2905723017281234,0.06578947368421052,0.7066686731637765,1.0,21/54,21.17%,ALDH1A1;PLCL1;ID1;NPR3;TLR4;IP6K1;PLCL2;ZNF423;LGR4;FLCN;ZDHHC7;CCDC3;NR1H2;NOVA2;PGAM5;RHEB;NRDC;PCTP;NR1H3;ATF4;FOXC2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.44818141777228,1.2905532676071862,0.12541993281075028,0.892066428470879,1.0,18/65,15.90%,RORA;MYC;SUV39H1;FMN2;SCN2A;VEGFA;MT3;TSC1;KCND2;GATA6;BNIP3;TBL2;HIF1A;BMP7;CPEB1;MDM4;LMNA;TP53
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.4328427884913127,-1.2903597379495677,0.13793103448275862,0.7036383408316985,1.0,8/19,26.76%,MOSPD2;DAPK2;CAMK1D;NCKAP1L;TIRAP;DNM1L;RIPOR2;CCL19
prerank,muscle cell development (GO:0055001),-0.3737306450175233,-1.2897569042213202,0.11914893617021277,0.702132755525511,1.0,6/30,3.87%,NEBL;MYOF;IGF1;CXADR;ENG;KDM1A
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.43705533153277987,1.2892078733955132,0.12797281993204984,0.8963288237749081,1.0,12/70,11.43%,RELN;NTN4;PEAK1;LAMC1;RILPL2;METTL3;MEGF9;NTNG2;NTNG1;UNK;PIK3R1;OPHN1
prerank,regulation of cytoplasmic translation (GO:2000765),0.5732727323722756,1.289109541868741,0.18614718614718614,0.8948864392023574,1.0,7/14,26.30%,UNK;CPEB3;CPEB1;CNBP;YBX3;FMR1;CPEB4
prerank,brain development (GO:0007420),0.4116785673459247,1.2887609373601208,0.08928571428571429,0.8945278133420415,1.0,24/136,15.56%,APOD;RELN;SOX6;PTCH1;HSPG2;PTEN;GRIN2B;EML1;CTNNA2;NF1;TGFBR2;PHGDH;PAFAH1B3;CNTNAP2;PTPN11;ADGRL3;CDK5R1;PHF8;GRIN2D;ZFHX2;GRIN2A;NES;SCYL2;MEIS3
prerank,positive regulation of immune effector process (GO:0002699),-0.3924221218735507,-1.2870864509793156,0.13617021276595745,0.7070620907719826,1.0,4/27,4.51%,ANKRD17;APPL2;DDX60;RPS19
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.5058619797472117,1.2870183971985476,0.17806451612903226,0.9007171821427926,1.0,6/26,10.95%,RELN;PTEN;NRXN1;NLGN1;SLC8A2;RIMS1
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.5150183168700495,-1.2870037977059983,0.20052770448548812,0.7038148634794715,1.0,4/10,16.31%,ERRFI1;ENG;ENPP1;CAV1
prerank,negative regulation of ion transport (GO:0043271),0.5184354174448034,1.2869931074708016,0.14647137150466044,0.8988930539529669,1.0,6/24,13.88%,WNK2;WNK3;GPM6B;SYT11;PXK;SNCA
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.283475058762451,-1.2868518808686036,0.0,0.7008369843333462,1.0,33/128,14.79%,BMP6;PTPRK;GCNT2;SMAD6;CDH5;CLDN5;ITGB5;APPL2;ACVRL1;SMAD7;BMP4;ENG;ID1;USP9X;SMAD9;BMPR2;TGFBR1;PARD3;DDX5;ACVR1B;TWSG1;STUB1;PRKCZ;RHOA;NLK;LRRC32;MAP3K7;TGFB2;INHBA;USP15;TMEM100;GDF1;HPGD
prerank,hexose metabolic process (GO:0019318),0.47341574376799095,1.2866869557100182,0.1343825665859564,0.8983337216407334,1.0,6/39,13.35%,APOD;IRS2;PGM1;GALM;FUCA2;BRAT1
prerank,negative regulation of protein polymerization (GO:0032272),-0.3927482576388316,-1.2856809497641264,0.14583333333333334,0.7012345664510983,1.0,8/27,5.30%,CDH5;MAP2;PRKCD;SLIT2;CLIP3;CYRIB;KANK3;EML2
prerank,regulation of axon regeneration (GO:0048679),-0.4958270367163865,-1.2853495432186082,0.17732558139534885,0.6988609302000527,1.0,3/12,7.20%,EPHA4;PTN;SCARF1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3957221844585229,1.2852706990215057,0.02004008016032064,0.9028250350376789,1.0,87/390,15.29%,ROR2;SIPA1L1;SHC4;ROR1;MMP2;UBASH3B;SULF1;PDGFRA;DNM1;ERBB3;NTRK3;EFNA4;FGF2;FGF10;ARPC1B;IRS2;EPHB6;NGF;ERBB2;EGFR;PTPRT;PTPN2;EFNA5;VEGFA;EPHB2;RAB14;EIF2AK3;COL4A2;ARHGEF28;MAPKAPK3;PSEN1;ATP6V1B2;NCF1;NTRK2;SDC2;MAPKAPK2;PLCB1;GRIN2B;PAK1;RASA1;POLR2B;CHN1;BAIAP2;SPRED2;ITSN1;SPRED1;FGFR1;ANKS1B;FYN;BRK1;CEP57;VAV3;GRB14;SHOC2;POLR2K;DOCK1;SHCBP1;NCF2;NCBP1;ERBB4;PIK3R1;PTPRJ;NGFR;NCSTN;CBL;MAPK14;PTPN11;STYK1;MAPK1;EFNB1;CDK5R1;FGF7;NRP2;ANKS1A;APH1A;EFNB3;PRLR;POLR2G;NCK1;EPHA10;PSEN2;COL1A1;GALNT3;CYFIP1;MET;ELMO1;GFRA2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.5270053922499207,-1.2844223840035625,0.14887640449438203,0.6983138003671516,1.0,5/10,12.98%,APPL2;GRB10;PRKCB;GSK3A;ENPP1
prerank,ameboidal-type cell migration (GO:0001667),0.4606581168393696,1.2840858622618228,0.13099415204678364,0.9064941495327637,1.0,16/51,18.86%,GPC3;SOX8;SEMA3E;SEMA6C;SEMA3A;PKN1;ERBB4;GDNF;ANXA6;PDXDC1;SEMA6D;ITGB7;SEMA4B;CENPV;PKN2;SEMA4D
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.6064682405450749,1.2839599650493807,0.17888563049853373,0.9052408205092514,1.0,3/12,12.01%,PTEN;GORASP1;RAB1A
prerank,regulation of integrin activation (GO:0033623),-0.47005962754932595,-1.2836616696519927,0.15673981191222572,0.6973504232721098,1.0,3/15,6.06%,RAP1B;JAM3;RASIP1
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.42214279955125117,-1.2835769785351938,0.15053763440860216,0.6941749963348778,1.0,4/22,11.87%,ALDH1A2;RBP1;CUBN;LGMN
prerank,dicarboxylic acid metabolic process (GO:0043648),0.4525733000422267,1.2835392254485802,0.13198573127229488,0.9053082851033022,1.0,11/52,15.45%,AADAT;IDH2;DLST;ALDH1L1;GOT2;ACLY;MTRR;MTHFD2L;ALDH5A1;GPT2;ALDH1L2
prerank,cellular response to metal ion (GO:0071248),0.4177212989595695,1.2831406497258782,0.08858057630736393,0.9052579658433375,1.0,44/123,23.57%,ANK3;CPNE8;DPEP1;PRKN;EGFR;KCNA1;HPCA;NCF1;PRNP;MT3;SLC12A2;DLG2;SCN5A;WNT5A;AOC1;SYT1;NLGN1;BNIP3;MAPK9;SYT11;SYT12;MAPK1;ALOX5AP;SNCA;SUMO1;IQGAP1;GPLD1;SLC25A24;CHUK;CPNE7;SYT2;RYR3;CPNE1;JUN;SYT13;ADCY8;CPNE3;PKD2;CACNA1H;PRKAA1;DLG4;CAMK2D;CPNE5;SYT3
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.471100348659991,-1.2818141972662715,0.15857605177993528,0.6965649579305739,1.0,7/15,27.31%,DAB2;WASL;SNAP91;HIP1R;TNK2;PIK3CB;BMP2K
prerank,neuron apoptotic process (GO:0051402),0.5434889530016607,1.2812228305117253,0.1713091922005571,0.9123786169955231,1.0,7/19,13.69%,ERBB3;BCL2;SCN2A;BNIP3;NAE1;NGFR;TRPC5
prerank,positive regulation of interleukin-17 production (GO:0032740),0.5149542739601793,1.280834092064172,0.1819484240687679,0.912297607865534,1.0,4/22,7.90%,PRKCQ;TGFB1;CARD9;IL18
prerank,response to peptide (GO:1901652),0.4902042520880483,1.2808090530786995,0.15769712140175218,0.9105036883651821,1.0,12/33,23.68%,MMP2;CACNA1A;PRNP;EIF2B5;FYN;ERBIN;GNAI1;EIF2B2;STAT3;STAT5A;STAT6;KAT7
prerank,mononuclear cell differentiation (GO:1903131),-0.40199230551479453,-1.280579763257097,0.102880658436214,0.6970195527556702,1.0,5/24,4.34%,MYH9;IL31RA;BMP4;LYN;RELB
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.534262717619388,1.2805474282967302,0.174931129476584,0.9098925115930125,1.0,8/21,14.33%,ADAM19;PRKCQ;BACE2;HM13;PSEN1;NCSTN;APH1A;PSEN2
prerank,actin filament bundle organization (GO:0061572),-0.3814881797632932,-1.2801156468554833,0.13170731707317074,0.695137140214138,1.0,12/33,20.87%,PAWR;CALD1;BAIAP2L1;NEDD9;EPS8;FAM107A;LIMA1;SHROOM2;AIF1L;ADD2;LCP1;RFLNA
prerank,granulocyte differentiation (GO:0030851),-0.42301407645749006,-1.2798735991082482,0.16608996539792387,0.6925867431221704,1.0,8/18,23.58%,LEF1;LBR;PML;CDK2;CDK4;TAL1;RARA;E2F1
prerank,positive regulation of cell killing (GO:0031343),0.5706870970795052,1.2795002208349338,0.20765832106038293,0.9128946303207035,1.0,3/13,7.26%,NOX1;WNT5A;FZD7
prerank,phasic smooth muscle contraction (GO:0014821),0.6188714505384365,1.279466808154005,0.1913946587537092,0.9111586342140447,1.0,4/10,12.70%,PTGER3;GDNF;EDN3;DRD2
prerank,regulation of dendrite morphogenesis (GO:0048814),0.48081686554090874,1.2791801810662917,0.16876574307304787,0.9106417351734682,1.0,8/32,8.91%,GORASP1;IL1RAPL1;SDC2;TNIK;OBSL1;CDKL5;CDKL3;ADGRB3
prerank,anion transport (GO:0006820),0.48339268560836124,1.2788011426098829,0.14160401002506265,0.9105553471055848,1.0,5/33,5.59%,SLC22A3;VDAC2;SLC17A5;LRRC8D;SLCO2B1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5460192944292531,1.2782535688650214,0.19827586206896552,0.9110916720846861,1.0,7/17,16.41%,MBD4;ERCC5;MPG;MUTYH;NEIL1;SMUG1;TERF2IP
prerank,negative regulation of secretion (GO:0051048),0.6087746957567015,1.2777507303004463,0.20949263502454993,0.9114888791861829,1.0,2/10,3.40%,ERBB3;PTGER3
prerank,serine family amino acid catabolic process (GO:0009071),0.6128427336255488,1.2771530920098317,0.18989280245022971,0.9122587187831134,1.0,2/10,5.59%,CBS;DAO
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.4384379108493163,1.2770244716583248,0.1309655937846837,0.9109563658293774,1.0,10/75,7.08%,DCN;HSPG2;SULF1;CXCL10;SEMA3E;COL4A2;CCR2;PDE3B;ADAMTS1;SPRED1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5293157624139359,1.2767847077121819,0.18975069252077562,0.9102194138675144,1.0,7/19,15.49%,FGF2;VGLL4;GLI1;ERBB4;ZFPM2;BMPR1A;RUNX1
prerank,Golgi to plasma membrane transport (GO:0006893),0.46095499135026485,1.2765800040043949,0.15947242206235013,0.9092610986758368,1.0,9/47,7.69%,STXBP6;ANK3;STEAP2;VAMP4;ARL3;BLZF1;OSBPL5;SPTBN1;RAB34
prerank,vesicle organization (GO:0016050),0.4625254956005802,1.27655224934065,0.1393643031784841,0.9075504950214781,1.0,12/46,12.88%,USP50;DNM1;CD34;ALS2;LAPTM4B;EPS15;VPS11;PI4K2A;PHETA2;RAB22A;SNX10;AKTIP
prerank,positive regulation of positive chemotaxis (GO:0050927),0.574370812864533,1.2761491382112222,0.20298507462686566,0.9075325430953312,1.0,3/15,3.14%,IL16;NTRK3;VEGFA
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.48826208522433523,1.2759765074715896,0.1784776902887139,0.9065170209521992,1.0,5/27,7.57%,PDGFRA;MYC;WNT5A;S100A6;CDK6
prerank,regulation of proteolysis (GO:0030162),0.46044575969532614,1.2758557814788782,0.16401468788249693,0.9052771932770175,1.0,11/48,13.91%,TBC1D10A;FADD;PARL;CSTB;SPOP;GSAP;SERPINE2;AURKAIP1;HDAC2;HDAC6;NEDD8
prerank,spermatid development (GO:0007286),0.48480218956327753,1.2754591224398661,0.16382699868938402,0.9052444504528087,1.0,7/32,14.95%,RSPH1;RFX2;CEP57;CDYL;DDX25;NECTIN2;DPY19L2
prerank,intestinal lipid absorption (GO:0098856),0.5819587508020041,1.2754541379356021,0.1964549483013294,0.9034483096588395,1.0,1/11,1.19%,CEL
prerank,cell-cell junction assembly (GO:0007043),0.43309536796623166,1.27532383465584,0.1422070534698521,0.9022570410030347,1.0,17/63,16.63%,DCHS1;CDH19;PRKCA;CDH10;CDH22;CDH8;PATJ;EPB41L3;CDH20;CDH7;RHOC;FBF1;CD9;PKP2;JUP;CDH18;FSCN1
prerank,regulation of interleukin-1 production (GO:0032652),-0.47501817555223574,-1.2753124120996793,0.1650485436893204,0.7042913874764932,1.0,4/15,16.23%,FOXP1;TLR4;CEACAM1;ANXA1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5422470846994362,1.2748838751980611,0.17916666666666667,0.9025462069985073,1.0,7/19,16.75%,HS6ST1;EXT1;EXTL3;CSGALNACT1;GLCE;HS2ST1;UGDH
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.3038264330450441,-1.2744222138972705,0.061855670103092786,0.7036661180735937,1.0,26/75,20.85%,GRK5;ROCK2;CAMKMT;ROCK1;ZDHHC3;RGS3;RGS5;MGRN1;GNG7;GRK4;ZDHHC7;MGLL;KCTD8;CAMK2A;RGS12;RGS4;FNTB;RPGRIP1L;FRMPD1;EDN1;GIT1;NMT1;RGS6;GPER1;ADCYAP1;MRAP2
prerank,regulation of interleukin-17 production (GO:0032660),0.47966158313908597,1.2741059531230428,0.16754617414248021,0.9043281846118651,1.0,5/31,7.90%,PRKCQ;TGFB1;PRNP;CARD9;IL18
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5176571166917714,-1.2740236582898876,0.1909814323607427,0.701600581809634,1.0,5/10,16.19%,BMP6;RGCC;NOTCH4;NEXMIF;PPM1F
prerank,substantia nigra development (GO:0021762),0.4824938348156271,1.2737576203692518,0.17097170971709716,0.9040932067125923,1.0,9/37,17.11%,DYNLL1;SYNGR3;NDRG2;PLP1;MAPKAP1;TTBK1;CALM1;CALM2;CNP
prerank,pharyngeal system development (GO:0060037),0.5564698437352,1.272828500159233,0.19940915805022155,0.90645212467533,1.0,5/15,14.61%,PTCH1;BMP5;BMP7;GATA3;BMPR1A
prerank,heart development (GO:0007507),0.4087780461174858,1.2725258277280511,0.07549120992761117,0.9060985888396065,1.0,33/150,15.27%,GPC3;DLC1;BMP5;ERBB3;NTRK3;GLI2;PTEN;KAT2B;SOX9;AKAP13;ACVR1;SGCD;VEGFA;TGFB1;NF1;SGCZ;FGF12;TGFBR2;PDLIM4;COL3A1;ERBB4;PTPN11;DAND5;SMYD4;BMP7;ZFPM2;KDM6A;SCUBE1;LDB3;PKD1;CITED2;PKP2;NDUFV2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4908482670269074,1.2721669996207017,0.1710691823899371,0.9057924723189215,1.0,10/29,17.09%,RAD23B;GTF2H2;ERCC5;DDB2;RPA3;XPA;DDB1;RPA2;UBB;CUL4B
prerank,protein K11-linked ubiquitination (GO:0070979),0.5045094929105206,1.2719776098731381,0.17079530638852672,0.9048714040550226,1.0,14/27,25.10%,UBE2T;PRKN;UBE2E2;ANAPC7;ANAPC2;CDC23;RNF4;UBE2L3;CDC27;ANAPC4;UBE2D3;ANAPC5;CDC16;ANAPC13
prerank,positive regulation of endocytosis (GO:0045807),0.46188742445981257,1.2707239462511295,0.15299877600979192,0.9086138184376931,1.0,11/45,14.27%,GPC3;SGIP1;BICD1;LRP1;ANO6;NLGN1;RAB21;HIP1;CBL;SNCA;NEDD4L
prerank,response to tumor necrosis factor (GO:0034612),0.42542318584703065,1.2694002316432766,0.10253583241455347,0.9127760388770888,1.0,17/91,17.27%,AFF3;CCL11;ADAMTS12;HAS2;PYCARD;CCL4;BRCA1;ERBIN;ZFP36L2;NFE2L2;PID1;GATA3;ZFAND6;CCL14;HYAL1;RIPK1;CHUK
prerank,neurotransmitter transport (GO:0006836),0.4298391559679641,1.2692078250846144,0.13769751693002258,0.911823835783819,1.0,17/73,17.00%,SLC6A2;SLC22A3;SLC1A3;NRXN1;SYT1;SLC29A1;SYN1;PPFIA2;RIMS1;TSPOAP1;DVL1;RAB3A;APBA1;CHAT;GLS2;GLS;SLC6A15
prerank,cognition (GO:0050890),0.4573888168078024,1.2692009807183366,0.16212871287128713,0.9100609110857023,1.0,14/42,14.94%,ST3GAL4;CHRNA4;NF1;RP9;GPR155;SLC8A2;NSUN5;MGAT3;GRM5;MAGT1;CBR3;SETD5;TUSC3;CYFIP1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.43506673998142,-1.2687359498827189,0.1875,0.7145798229197204,1.0,2/17,5.69%,PLA2G4A;CRLS1
prerank,positive regulation of ossification (GO:0045778),0.47035208459720773,1.268387741491319,0.16728167281672818,0.9118784789208377,1.0,16/39,16.21%,OSR2;PKDCC;ACVR1;ANO6;TGFB1;GPM6B;SOX11;WNT5A;ZBTB16;PTPN11;BMP7;ATRAID;ATP2B1;BMPR1A;FZD9;TGFB3
prerank,protein K48-linked deubiquitination (GO:0071108),0.5064345199199229,1.268249001752353,0.1935483870967742,0.9106764350153526,1.0,8/23,19.07%,USP50;OTUD7B;USP33;USP25;OTUD4;USP37;OTUD7A;USP5
prerank,positive regulation of ion transport (GO:0043270),0.46257531069675456,1.267713360596491,0.14553990610328638,0.9113457164940779,1.0,12/48,15.14%,ANK3;ANK2;ANO6;WNK3;CCL4;CNKSR3;SCN5A;GDNF;DRD2;ATP2B1;AHCYL1;PKP2
prerank,glutamate metabolic process (GO:0006536),0.5172535694164371,1.2676002131808966,0.16690042075736325,0.9100514444147864,1.0,6/19,16.78%,AADAT;GOT2;OAT;ALDH5A1;GLS2;GLS
prerank,purine ribonucleotide metabolic process (GO:0009150),0.43177930680842025,1.2660439169854496,0.15,0.9154758572105035,1.0,20/68,21.01%,ADSS1;THEM4;PTHLH;OXSM;NT5C2;ACOT11;BPNT1;PDE9A;ACLY;BPNT2;ACSF2;HINT1;AK3;OPA1;ACSL6;GPAT4;GLYAT;DBI;ACOT8;ACBD6
prerank,positive regulation of calcium ion transport (GO:0051928),0.48285930741599753,1.2651961365141806,0.175,0.9175767461482844,1.0,4/36,4.10%,LGALS3;ANK2;WNK3;CCL4
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5565995280059562,1.264890708033598,0.19327731092436976,0.9171599933520862,1.0,7/17,15.55%,CADM4;SPRED2;SPRED1;SPRED3;EIF4G1;CALM1;CALM2
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6010284967490223,1.2647386420528495,0.2175925925925926,0.916081308796613,1.0,2/10,4.08%,FAP;TGFB1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.39029207306111796,-1.2646776155090342,0.14767932489451477,0.7247378693621129,1.0,4/26,3.06%,DAB2;FOXP1;KANK2;CLOCK
prerank,receptor recycling (GO:0001881),-0.5083057378611833,-1.2646244613916875,0.17901234567901234,0.7215877888852578,1.0,7/10,22.20%,RAB11B;EHD3;NSG1;ARFGEF2;PHETA1;PLEKHJ1;REP15
prerank,acetyl-CoA metabolic process (GO:0006084),0.5545207558919837,1.2645199244345402,0.20497803806734993,0.9152250560012979,1.0,6/15,17.52%,ACACA;ACSS1;ACLY;DIP2A;PPCS;HMGCS2
prerank,neural tube development (GO:0021915),0.550565463574059,1.2644658160511364,0.21503759398496242,0.9137092539500229,1.0,6/15,15.39%,PTCH1;TGFB1;SOX11;DVL1;PKD1;DACT1
prerank,embryonic digit morphogenesis (GO:0042733),0.5348428212719512,1.2639617403847354,0.1896551724137931,0.9142453301183199,1.0,2/18,1.94%,OSR2;WDPCP
prerank,histone H4-K8 acetylation (GO:0043982),0.5534119499756721,1.263637028991845,0.21037868162692847,0.912180883485909,1.0,9/15,23.68%,JADE1;JADE3;KAT8;PHF20;ING4;KANSL1;MCRS1;KANSL2;KAT7
prerank,histone H4-K5 acetylation (GO:0043981),0.5534119499756721,1.263637028991845,0.21037868162692847,0.912180883485909,1.0,9/15,23.68%,JADE1;JADE3;KAT8;PHF20;ING4;KANSL1;MCRS1;KANSL2;KAT7
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5439181014044598,1.2630576793694768,0.20029455081001474,0.9130715643326425,1.0,4/15,10.68%,FAP;LRP1;TGFB1;CLASP1
prerank,zinc ion transmembrane transport (GO:0071577),-0.41404273421474846,-1.2627181525956392,0.16974169741697417,0.724369331527285,1.0,10/22,26.19%,SLC30A10;SLC39A8;SLC39A6;SLC30A1;SLC30A6;SLC39A3;SLC39A10;TRPM2;SLC39A13;SLC39A1
prerank,microvillus organization (GO:0032528),0.568896565448729,1.2620085212832264,0.2110236220472441,0.9159339501020792,1.0,4/13,7.42%,RAP2B;MAP4K4;TNIK;RAP1A
prerank,skeletal system morphogenesis (GO:0048705),0.4656792793656488,1.2607023192782487,0.16101694915254236,0.9202045771682823,1.0,7/42,10.32%,OSR2;PDGFRA;SOX11;HHIP;HOXD3;FGFR1;SFRP4
prerank,presynaptic endocytosis (GO:0140238),0.515118614184162,1.2605235663764662,0.18528610354223432,0.9192487903978904,1.0,9/24,18.64%,CEL;STON2;SYT1;NLGN1;STON1;OPHN1;SNCA;SYT2;SNCB
prerank,isotype switching (GO:0045190),0.5983535941842844,1.2602909189725826,0.21884984025559107,0.9184836652816718,1.0,6/10,27.57%,MSH6;BATF;HSPD1;EXOSC3;LIG4;RNF168
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4161009163747834,1.2598981140797623,0.14676889375684557,0.9184644985640789,1.0,27/93,21.50%,DOCK7;NTRK3;PTEN;NGF;EGFR;VEGFA;ARAF;TGFB1;CNKSR3;PAK1;MLXIPL;EIF4G1;HDAC6;PDE4D;TBK1;SNCA;NCK1;SH2D3C;RASSF2;TERF2IP;RPTOR;FNIP1;PARK7;INPP5J;BCAR3;NSD1;PRKD2
prerank,negative regulation of immune system process (GO:0002683),0.5519851051861586,1.2598669731238268,0.20930232558139536,0.9168671028513081,1.0,4/16,9.12%,SOX9;FADD;HOXA7;COL3A1
prerank,chromatin remodeling (GO:0006338),0.41971681619453544,1.2594904022802338,0.11879049676025918,0.9168364722497461,1.0,36/100,22.06%,MYC;KAT2B;SOX9;SATB1;KDM5B;BAZ1A;EZH1;PAK1;KDM4B;MTA2;CHD3;ATRX;MBD2;PIH1D1;POLE3;HDAC2;MYSM1;ESR1;SMARCC2;JARID2;ZBTB1;RBBP4;SMARCC1;BAZ2B;KDM6A;BAZ1B;SMARCE1;PBRM1;NUDT5;RUVBL2;TOP1;SMARCA4;HNRNPC;GATAD2B;NPM3;ACTR5
prerank,regulation of response to biotic stimulus (GO:0002831),-0.38731377767104347,-1.2589958532744794,0.13513513513513514,0.7333464879187348,1.0,9/28,9.67%,FOXP1;ERAP1;APPL2;BIRC3;TRIM5;CD55;SAMHD1;CASP8;IRF1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.49713711031063984,-1.2587438922864376,0.17484662576687116,0.7308174992513596,1.0,4/10,5.12%,VTN;GRB10;PRKCB;ARNT
prerank,T-helper cell differentiation (GO:0042093),-0.4703451454705127,-1.2586156502381314,0.1752873563218391,0.7278582236886285,1.0,3/14,5.12%,FOXP1;LEF1;ATP7A
prerank,actin cytoskeleton reorganization (GO:0031532),0.42913471343422227,1.2583514117668024,0.14430665163472378,0.9202054506998494,1.0,15/63,10.31%,SIPA1L1;CLDN19;FGF10;GSN;GPR65;AUTS2;TNIK;THSD7A;PAK1;MKLN1;PDLIM4;FLNA;THSD7B;PTPN1;FARP2
prerank,digestive tract morphogenesis (GO:0048546),0.5582602479289565,1.258303113933233,0.212481426448737,0.9187064286602117,1.0,3/14,4.96%,PDGFRA;SOX11;GLI1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5100330459622313,1.2582405068344822,0.21132596685082872,0.9172801135305878,1.0,9/21,18.77%,PRKN;MT3;BRCA1;HDAC6;ABCD2;PAX2;TRAP1;AATF;PARK7
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5796364958584664,1.2580974972905992,0.21068249258160238,0.9162011611392296,1.0,4/13,15.55%,ANK3;PDE4D;CALM1;CALM2
prerank,cell projection organization (GO:0030030),0.48091342618912725,1.2580297155719662,0.17045454545454544,0.9148173732901872,1.0,10/30,20.41%,RHOJ;GSN;PACSIN2;RHOH;P2RY12;CYFIP1;ITGB1;RAC3;NCKAP1;RHOU
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.49397747692230964,1.2578731501216491,0.20079787234042554,0.9138227625134968,1.0,4/27,5.22%,HAS2;PRKCQ;PYCARD;CCR2
prerank,regulation of protein neddylation (GO:2000434),-0.51325651639036,-1.2577714032817753,0.20588235294117646,0.727206930404115,1.0,4/10,13.12%,DCUN1D3;RPL5;DCUN1D1;RPL11
prerank,regulation of axonogenesis (GO:0050770),0.4450639190704572,1.256076582632103,0.15130023640661938,0.9202368966162506,1.0,10/51,6.05%,SIPA1L1;CHODL;LRP4;PTEN;NGF;PLXNC1;NTRK2;LRRC4C;PAK1;CHN1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5166403729577003,-1.2559028097583924,0.2236503856041131,0.7299055052868182,1.0,7/10,30.55%,ATP7A;GIPC1;APPL1;OPN3;CDH3;MFSD12;RAPGEF2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4640992608693673,-1.2555326430016147,0.18272425249169436,0.7278695838622117,1.0,3/14,13.38%,ANKRD17;DDX60;USP15
prerank,aorta morphogenesis (GO:0035909),-0.43623359659263217,-1.255371523366928,0.16778523489932887,0.7251247073281014,1.0,9/17,15.30%,ACVRL1;ENG;MYLK;TBX1;EFEMP2;JAG1;PDGFRB;PROX1;HEY2
prerank,carbohydrate derivative transport (GO:1901264),0.5368928007891286,1.2551711954672382,0.21107784431137724,0.9225175288271364,1.0,3/18,9.66%,SLC28A1;SLC29A1;SLC10A7
prerank,transcription preinitiation complex assembly (GO:0070897),0.5825290637438247,1.2551683308255015,0.20155038759689922,0.9208203362956748,1.0,7/12,28.19%,GTF2B;TAF11;TAF7;TAF1;TBP;DR1;BDP1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.29593595387210303,-1.2545412465326709,0.06779661016949153,0.7246645745009469,1.0,52/110,26.80%,RPS14;GSPT1;RPL24;RPL18A;UPF3B;RPS16;RPL38;RPL28;RPS19;RPL37;CTIF;RPS2;RPL19;RPL5;RPL34;RPS25;RPS15;EIF4A3;RPLP1;RPL31;RPL3;HELZ2;RPS6;RPS8;RPL11;RPL12;PNRC2;SMG9;RPL7A;RPL13;RPS21;RPL35A;RPL26;RPS9;RPL32;RPS29;RPS23;RPLP2;RPL8;SMG5;RPL41;SMG8;RPS17;RPS5;RPS15A;UBA52;RPL37A;PPP2CA;RPS10;EIF3E;RPL6;RPL9
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.4341835607912504,1.2544214037989612,0.15148063781321183,0.9223971050046863,1.0,18/69,18.77%,ERBB3;BCL2;CRLF1;NGF;PRKN;NTRK2;MT3;RASA1;HIF1A;SNX6;GDNF;GRN;SOD2;PTPRZ1;FZD9;TGFB3;MDK;PARK7
prerank,protein polyglutamylation (GO:0018095),0.59964505265683,1.2543064884151327,0.20222929936305734,0.9212065505726901,1.0,5/11,14.55%,TTLL5;TTLL11;TTLL4;CFAP20;TPGS1
prerank,negative regulation of leukocyte migration (GO:0002686),0.6077268405496403,1.25238597915586,0.2127329192546584,0.9279187384670101,1.0,2/10,2.97%,BMP5;HOXA7
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5677045824804012,1.2519952313662783,0.20930232558139536,0.9279645888124044,1.0,5/13,14.00%,DNAJB9;PPP1R15A;UFL1;PTPN1;NCK1
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.3837417708908616,-1.2519594215201588,0.1568627450980392,0.7299250719529448,1.0,8/24,12.98%,SORBS1;IGF1;IGF2;INSR;GSK3B;PPP1R3B;GSK3A;ENPP1
prerank,sensory perception of pain (GO:0019233),0.5095870112619469,1.2517365471748874,0.20413793103448277,0.9273778835141872,1.0,7/21,21.51%,KCNA2;CHRNA4;CCR2;NIPSNAP1;OPRK1;PTGES;P2RX7
prerank,ceramide transport (GO:0035627),-0.4749527876792996,-1.2515096299936097,0.17302052785923755,0.7281250651431079,1.0,5/12,25.76%,PLTP;GLTP;ABCB4;CERT1;PLEKHA8
prerank,myeloid leukocyte differentiation (GO:0002573),-0.31778627505386636,-1.2510622637564779,0.1092436974789916,0.7263359881642388,1.0,16/65,14.49%,FOXP1;LEF1;KIT;MYH9;IL31RA;BMP4;GLO1;PARP1;TNFRSF11A;SBNO2;CASP8;CAMK4;OSTM1;CDC42;PML;CDK2
prerank,ganglioside biosynthetic process (GO:0001574),-0.45050700649053443,-1.2509508943139407,0.2282958199356913,0.7235561322547085,1.0,3/15,5.04%,ST6GALNAC3;ST8SIA4;ST3GAL1
prerank,heterochromatin assembly (GO:0031507),0.5174282047480383,1.2508802908978673,0.21664275466284075,0.9294494482457824,1.0,6/20,11.02%,SUV39H1;EZH1;ZNFX1;MBD2;POLE3;HELLS
prerank,gliogenesis (GO:0042063),0.5445156794920679,1.2508738882962178,0.22986822840409957,0.9277843269673458,1.0,3/15,7.57%,RELN;METTL3;CDK6
prerank,protein import into peroxisome matrix (GO:0016558),-0.4803124320030157,-1.2507950954222915,0.1676300578034682,0.7209112502211645,1.0,8/12,27.25%,PEX13;PEX7;PEX14;PEX26;PEX2;PEX10;PEX6;PEX16
prerank,synaptic vesicle endocytosis (GO:0048488),0.471898246812081,1.2507730169063895,0.19148936170212766,0.9265422175654197,1.0,10/33,13.88%,DNM1;CEL;STON2;SYT1;NLGN1;STON1;ITSN1;GAK;OPHN1;SNCA
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5470123797655375,1.2503420561058693,0.2291970802919708,0.9267876624917352,1.0,5/15,12.86%,ERBB2;MVB12B;EGFR;PTPN18;MVB12A
prerank,regulation of mononuclear cell migration (GO:0071675),0.50069756837085,1.2499937860195955,0.1962864721485411,0.9266572928006821,1.0,2/23,0.52%,LGALS3;BMP5
prerank,regulation of B cell proliferation (GO:0030888),0.4530013868628603,1.2497076580390614,0.18450184501845018,0.926198840120538,1.0,10/44,17.21%,BCL2;IRS2;BST1;EPHB2;CD320;VAV3;AHR;ATM;CD74;RC3H1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.5071294517836019,1.2496648414094997,0.19696969696969696,0.9247406312012859,1.0,7/23,17.46%,PRKN;PDE4B;MAPK1;PRKACA;SNCA;ABL1;SLC9A1
prerank,positive regulation of interleukin-1 production (GO:0032732),0.44438204987521046,1.2492568579946937,0.17064439140811455,0.9249035313457953,1.0,6/51,9.17%,USP50;IL16;PYCARD;WNT5A;TMEM106A;TMED10
prerank,toxin transport (GO:1901998),0.6020994967979842,1.2492248506972121,0.2370486656200942,0.9233760504149376,1.0,4/10,19.52%,SLC22A3;ANTXR2;ANTXR1;RAB40B
prerank,regulation of kinase activity (GO:0043549),0.42086472593420676,1.2490405404656448,0.13581599123767799,0.9225657597994155,1.0,13/89,6.17%,ROR2;ROR1;PDGFRA;ERBB3;NTRK3;IRS2;EPHB6;ERBB2;EGFR;NPRL2;EPHB2;NTRK2;VAC14
prerank,platelet aggregation (GO:0070527),0.47237569562950354,1.2488796331720584,0.18781725888324874,0.9215807907388891,1.0,4/33,2.62%,UBASH3B;PDGFRA;CSRP1;RAP2B
prerank,amyloid-beta metabolic process (GO:0050435),0.5356383863432668,1.2488634015045932,0.20416666666666666,0.9199910544741613,1.0,6/16,14.33%,BACE2;PSEN1;MGAT3;NCSTN;APH1A;PSEN2
prerank,regulation of focal adhesion assembly (GO:0051893),0.4405237790412142,1.24885740586585,0.1672394043528064,0.9183810027840962,1.0,14/54,12.66%,APOD;DLC1;PTEN;PEAK1;EFNA5;MAP4K4;VEGFA;GPM6B;TSC1;SLK;PTPRJ;CLASP1;PTPRA;MYOC
prerank,regulation of ossification (GO:0030278),0.4753954674763143,1.2486888384162842,0.16978776529338327,0.9174677100143698,1.0,9/36,10.86%,ANKH;LRP4;SOX9;ACVR1;SOX11;WNT5A;ZBTB16;CHSY1;PTPN11
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.5724757575913851,1.248622160189204,0.22507552870090636,0.9161013075690664,1.0,5/12,14.09%,SETMAR;NAE1;STK33;ORC1;TOPBP1
prerank,response to steroid hormone (GO:0048545),-0.3650815501425619,-1.2483642928325194,0.15584415584415584,0.7252443222770881,1.0,11/31,20.71%,ATP1A2;PAQR7;TFPI;THBS1;ATP1A1;PAQR8;TGFB2;CAV1;ABHD2;CATSPER3;NR1H3
prerank,MAPK cascade (GO:0000165),0.3862459953662099,1.248340032553264,0.05527638190954774,0.9156647146731088,1.0,53/295,11.99%,GFRA1;PDGFRA;ERBB3;PRKCQ;IL2RA;FGF13;FGF2;MYC;FGF10;IRS2;SOX9;ERBB2;EGFR;GFRA4;MAP4K4;MAP3K3;ARAF;TGFB1;MT3;MAPKAPK2;GRIN2B;NF1;DUSP6;TNIK;DLG2;SPTBN1;PAK1;SYNGAP1;RASA1;KSR1;SPRED1;MEN1;FGFR1;RGL1;IL18;LYPLA1;FYN;LAMTOR2;SHOC2;PSMB7;BTC;CUL3;ARL2;ZFP36L2;MRAS;ERBB4;PIK3R1;GDNF;MAPK1;TAOK3;CCM2;PTPRA;FGF7
prerank,response to estradiol (GO:0032355),0.4840730580509767,1.248223445377048,0.20557029177718833,0.9145423852559805,1.0,10/31,19.77%,SSTR1;EGFR;TGFB1;ESR1;NRIP1;LCOR;NCOA3;FAM210B;RUVBL2;STAT3
prerank,positive regulation of interferon-beta production (GO:0032728),-0.35564127653488586,-1.2480465682282371,0.17061611374407584,0.7231259871188087,1.0,11/33,19.60%,TOMM70;TLR4;IFIH1;TRIM56;RIOK3;IRF1;OAS2;HSP90AA1;FLOT1;POLR3D;ISG15
prerank,negative regulation of bone remodeling (GO:0046851),0.5766379987472559,1.2472106538945165,0.20902255639097744,0.9172533181277984,1.0,1/11,0.55%,UBASH3B
prerank,negative regulation of DNA binding (GO:0043392),-0.38883199923053596,-1.2469095972483168,0.15879828326180256,0.7236603361082617,1.0,11/28,18.78%,SP100;LEF1;NFKBIA;KDM1A;HABP4;MDFI;SUMO3;HMGA2;HEY2;TFAP4;SIN3A
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.47182589425875443,1.2465986476966282,0.18147684605757197,0.9182450666573051,1.0,6/35,10.65%,SGIP1;BICD1;MKLN1;RAB21;HIP1;CBL
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.5211023500283241,1.2456708307981568,0.2085048010973937,0.920847298927815,1.0,7/18,14.37%,ERBB2;EIF2AK3;FLNA;HEATR1;POLR2K;PHF8;DHX33
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.5471592360471916,1.2456516446013215,0.21511627906976744,0.9192995772062006,1.0,3/15,3.61%,PIEZO2;LHFPL5;KCNA1
prerank,positive regulation of telomere maintenance (GO:0032206),0.4790443688807046,1.2451655146304383,0.2088607594936709,0.9198095256037215,1.0,14/31,26.16%,PRKCQ;ATRX;MAPK1;SIRT6;NEK7;MAP3K4;RTEL1;ATM;RAD50;GNL3;PKIB;SLX4;HNRNPA2B1;NABP2
prerank,postsynaptic membrane organization (GO:0001941),0.5291837675456889,1.2451646094260376,0.21377331420373027,0.9181941038252047,1.0,6/17,13.54%,CEL;LRP4;NRXN1;NLGN1;LHFPL4;GPHN
prerank,microvillus assembly (GO:0030033),0.5541217328162897,1.2449546869474029,0.21792890262751158,0.9175694288618903,1.0,4/14,7.42%,RAP2B;MAP4K4;TNIK;RAP1A
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.41262633535356197,-1.243924839872509,0.16319444444444445,0.7301516022355157,1.0,6/19,7.52%,IL34;MPP1;JAM3;THBS1;CAMK1D;AKIRIN1
prerank,regulation of myotube differentiation (GO:0010830),-0.39901051256981634,-1.2431308510972163,0.1444866920152091,0.7298358217925918,1.0,9/24,23.01%,SIK1;MAML1;HDAC4;ATP11A;TMEM119;HDAC3;DMPK;HDAC5;SMYD1
prerank,gas transport (GO:0015669),0.5924900988963229,1.242800250606309,0.20911949685534592,0.9255234675111361,1.0,2/10,14.43%,MYC;MB
prerank,negative regulation of cell differentiation (GO:0045596),0.3904442893863538,1.2424002350064411,0.0950920245398773,0.9257968285635826,1.0,31/181,13.40%,RORA;PTCH1;SOSTDC1;BMP5;ADAMTS12;EFEMP1;SOX8;PTEN;HOXB8;SOX9;EGFR;COL5A2;PTHLH;TGFB1;WNT5A;ZBTB16;SPRED2;TWIST2;SPRED1;CDK6;MEN1;SPRED3;ZFP36L2;PTPN11;ABCA5;BMP7;WWTR1;EID2B;ZFPM2;GATA3;TRIO
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3354503882288899,-1.2421757058262815,0.125,0.7298044154616504,1.0,5/41,2.50%,AFDN;TJP1;GCNT2;PODXL;SMAD7
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.5850252733206581,1.242140572850264,0.22913256955810146,0.9253330504024819,1.0,1/10,1.69%,RHO
prerank,regulation of endocytosis (GO:0030100),0.43207149969065656,1.2419529130573903,0.16842105263157894,0.9245093594388347,1.0,17/61,15.54%,GPC3;LGALS3;LRP1;STON2;PACSIN2;STON1;HIP1;SYT11;PTPN1;MCTP1;OPHN1;RAB4B;RAB4A;SNCA;NEDD4L;ARFGAP1;ABL1
prerank,magnesium ion transport (GO:0015693),0.5723477072057581,1.2414176406633133,0.2325925925925926,0.9253851270159672,1.0,5/12,13.79%,MRS2;NIPA1;NIPAL2;MAGT1;TUSC3
prerank,embryonic axis specification (GO:0000578),0.5450877934704684,1.2413382210070614,0.21745350500715308,0.9240827267084374,1.0,2/15,2.36%,PTCH1;RIPPLY2
prerank,detection of calcium ion (GO:0005513),0.5678356091543775,1.241103257123735,0.23372781065088757,0.9235058333638098,1.0,5/13,15.55%,SYT1;KCNMB2;KCNMB3;CALM1;CALM2
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.5605100915918038,1.2406127143167618,0.2365747460087083,0.9240449233513714,1.0,3/14,12.72%,SLC27A1;SELENOI;ETNK1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.5068240690213047,1.240330557756867,0.20135135135135135,0.9237397336839162,1.0,12/22,25.67%,DDX11;ERBB2;EIF2AK3;HEATR1;PIH1D1;PHF8;DHX33;UBTF;SMARCA4;WDR75;MTOR;SMARCB1
prerank,selective autophagy (GO:0061912),0.43732298476226095,1.2397221046478857,0.17757009345794392,0.9248332883260226,1.0,20/56,22.87%,DYNLL1;PRKN;WDFY3;ACBD5;UFL1;ATG5;DYNC1I1;HDAC6;DYNC1I2;UBB;ATM;NBR1;RAB7A;PARK7;PHB2;PCNT;WDR81;VIM;UBQLN1;DYNC1H1
prerank,epithelial cell morphogenesis (GO:0003382),0.5354300790386648,1.239436028527377,0.20875912408759123,0.9244710456504339,1.0,3/17,8.43%,COL15A1;RILPL2;COL18A1
prerank,histone mRNA metabolic process (GO:0008334),-0.37745098598838117,-1.238652643694941,0.168,0.7383475117143845,1.0,12/27,15.66%,XRN1;LSM1;MTPAP;ERI1;SLBP;DCP2;CPSF2;TUT7;SNRPD3;SNRPE;SNRPB;EXOSC10
prerank,positive regulation of response to external stimulus (GO:0032103),-0.2688836882772844,-1.2374700980099143,0.022222222222222223,0.7390580766157914,1.0,27/128,14.04%,BMP6;PTN;SASH1;ETS1;ANKRD17;DDX60;THBD;NFKBIA;PLSCR1;GPR4;TLR4;THBS1;APP;SCARF1;AGTR1;RIOK3;TNIP1;PDGFRB;TNFRSF1A;CYBA;OPTN;LRSAM1;SERPINE1;PDE2A;CCN4;USP15;NMI
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.522768209431937,1.2370944367915955,0.20723226703755215,0.9314062096130069,1.0,9/21,17.09%,GTF2H2;ERCC5;ERCC4;DDB2;RPA3;XPA;DDB1;RPA2;CUL4B
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.522768209431937,1.2370944367915955,0.20723226703755215,0.9314062096130069,1.0,9/21,17.09%,GTF2H2;ERCC5;ERCC4;DDB2;RPA3;XPA;DDB1;RPA2;CUL4B
prerank,positive regulation of phospholipase C activity (GO:0010863),0.46606814030315186,1.2367585904452385,0.19172932330827067,0.9312885794529725,1.0,8/40,10.73%,PDGFRA;NTRK3;FGF2;EGFR;LPAR1;NTRK2;FGFR1;ESR1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5985290976060516,1.2367541269163869,0.20958083832335328,0.9297110623896809,1.0,3/10,6.38%,MYC;SOX9;TGFBR2
prerank,signal peptide processing (GO:0006465),0.5839411274258839,1.2363430334106067,0.2199367088607595,0.929894583566723,1.0,3/11,8.76%,HM13;PARL;SPCS3
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.5206589168817858,1.2359911523654028,0.2260748959778086,0.9297817924850177,1.0,8/18,18.77%,PRKN;MAPK7;BAG5;HIF1A;NFE2L2;SOD2;TRAP1;PARK7
prerank,retinoic acid metabolic process (GO:0042573),0.542099338230691,1.2354877649255773,0.22033898305084745,0.9304164067758808,1.0,1/14,0.28%,CYP2S1
prerank,glycine transport (GO:0015816),0.5797886527545019,1.2351324073068608,0.23667711598746083,0.9303903618724563,1.0,4/10,19.25%,SLC36A2;SLC25A38;SLC7A8;SLC6A9
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5917735849549255,1.2351127560156885,0.2381679389312977,0.9288968112434093,1.0,3/11,8.28%,PTPRT;SOCS1;NF2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.569860038953153,1.234875354813003,0.2469879518072289,0.9282893624620655,1.0,8/12,24.44%,BICD1;PCM1;BICD2;CCDC120;KIF3A;NIN;HOOK3;BBS4
prerank,regulation of osteoblast differentiation (GO:0045667),-0.29450496303129764,-1.2347726109729673,0.08080808080808081,0.7447278879294286,1.0,17/82,8.91%,BMP6;RANBP3L;CRIM1;SMOC1;IGF1;WNT4;SMAD6;LRP5;TMEM64;BMP4;NOCT;BMPR2;SUCO;ZHX3;DDX5;FGFR2;CCN1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.5150421879608773,1.2339749378251712,0.22521246458923513,0.9305764542308667,1.0,1/19,0.29%,FFAR4
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.4673145592580754,-1.233931389591354,0.20426829268292682,0.7445380036978507,1.0,6/13,18.87%,PLPP1;BMP4;CALCOCO1;NR3C2;ABHD2;GPER1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.31023311770226086,-1.233039872831911,0.10738255033557047,0.7442301586875518,1.0,21/54,24.41%,NXN;DCUN1D3;CTNNB1;SMAD7;HDAC8;OGT;RPL5;SH3RF2;SQSTM1;RPL11;PINX1;CAV1;TRIM21;ISG15;AKT1;COPS9;TNFAIP3;U2AF2;USP4;VPS28;SIRT7
prerank,regulation of endopeptidase activity (GO:0052548),-0.3077199019828827,-1.2329077790495198,0.09243697478991597,0.7416126837173695,1.0,18/59,24.09%,VTN;BIRC3;TIMP3;SERPIND1;SPOCK2;SERPINB9;APH1B;SERPINE1;TIMP2;SERPINI1;NRDC;PSENEN;TIMP4;AKT1;AGT;SERPINC1;PSMB9;ATP13A2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.3959461604133786,-1.2328361952916007,0.17132867132867133,0.7388206837558371,1.0,5/22,10.05%,EPHA4;ROCK2;LYN;GSK3A;ABCG1
prerank,phospholipid transport (GO:0015914),-0.32178800802233254,-1.2325551851037058,0.13095238095238096,0.7366782316544267,1.0,22/52,20.42%,OSBPL8;ATP10A;ABCA3;ABCA1;PLTP;PITPNA;ATP9A;ABCA4;OSBPL2;ABCG1;TNFAIP8L3;ATP11A;ATP8B2;ATP11B;MFSD2A;ABCB4;PRELID2;ATP10B;ATP8A1;APOE;ABCA7;PCTP
prerank,cell-substrate junction assembly (GO:0007044),0.4723389389454647,1.2306069916102882,0.1918158567774936,0.9435215657294981,1.0,7/33,9.13%,DLC1;RHOD;PEAK1;LAMC1;TESK2;PLEC;TRIP6
prerank,regulation of blood coagulation (GO:0030193),0.48677775462895023,1.2305944444304613,0.20610687022900764,0.9419832788043967,1.0,5/27,8.22%,FAP;ST3GAL4;CD34;EPHB2;SERPINE2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5254973579928683,1.2303598113781373,0.2320675105485232,0.9414197834982951,1.0,4/18,3.25%,RHOJ;FGF2;VEGFA;MAP3K3
prerank,regulation of cardiac conduction (GO:1903779),0.42958230780770235,1.2303293186685957,0.1937354988399072,0.9399666759300979,1.0,12/54,13.53%,FXYD3;CORIN;ANK2;NPR2;ATP2B3;TMEM65;SLC8A2;FXYD6;FXYD1;PRKACA;ATP2B1;AHCYL1
prerank,positive regulation of interferon-gamma production (GO:0032729),0.44347222978567535,1.2300423272137249,0.18478260869565216,0.9396585766157534,1.0,8/48,12.73%,PYCARD;PTPN22;FADD;PDE4B;CCR2;IL18;PDE4D;SCRIB
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.42897560929250594,1.2298253326302355,0.18757327080890973,0.9389899427721883,1.0,17/54,19.84%,DPP10;BIN1;KCNMB2;KCNMB3;FLNA;STK39;AKAP6;KCNAB2;KCNJ3;KCNIP4;NEDD4L;KCNJ10;KCNH2;KCNMA1;CD63;CAB39;NOS1AP
prerank,neuron fate commitment (GO:0048663),-0.4553315265779823,-1.229654328558224,0.2140845070422535,0.7431098363248366,1.0,10/14,45.95%,TGFBR1;ID2;POU3F2;DLL4;DLL1;SHH;POU4F1;PAX6;ASCL1;ISL1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.42932604036922795,1.2289681033619921,0.17790697674418604,0.9410234857354673,1.0,8/56,6.92%,RTKN;ANK3;EFHC1;SPIRE1;ARL3;SPTBN1;RASA1;SON
prerank,cellular modified amino acid catabolic process (GO:0042219),0.5399852362705535,1.2288818518185134,0.2489208633093525,0.9398069951062307,1.0,3/15,8.25%,DPEP1;SARDH;GOT2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.43649833884679956,1.2288657823835805,0.18928164196123148,0.9383154717858792,1.0,22/56,23.63%,FGF10;EGFR;UBE2E2;PLCB1;ADAMTS1;CUL3;ANAPC7;EIF4G1;CDC25B;CDC23;CCND2;HYAL1;FBXO5;RPTOR;KMT2E;RDX;CDC27;PHB2;ANAPC4;ANAPC5;RB1;CDC16
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.4727180071919444,1.2275735162838084,0.20659062103929024,0.9422565540067077,1.0,5/32,3.25%,RHOJ;MEOX2;FGF2;VEGFA;MAP3K3
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.49999089806405705,1.2274149463545556,0.21643835616438356,0.9414058601665776,1.0,7/23,11.47%,FGF2;SOX8;SOX9;VEGFA;SMO;GDNF;SIRT6
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.4954080459841017,-1.226422035394818,0.2155688622754491,0.7506377007156246,1.0,2/11,0.18%,AFDN;TJP1
prerank,neuron differentiation (GO:0030182),0.39248203930781295,1.2262143690770329,0.11740473738414006,0.9451938768164759,1.0,16/165,7.26%,TENM2;CDNF;TENM3;LHX5;GLI2;ERBB2;IL1RAPL1;OTP;VEGFA;HS6ST1;SOX11;NTRK2;PHOX2A;WNT5A;NGRN;FZD7
prerank,protein methylation (GO:0006479),-0.34212162626979253,-1.2259145684049217,0.16374269005847952,0.7492180840706685,1.0,15/40,14.77%,CAMKMT;GSPT1;PRMT7;FAM98A;ATPSCKMT;NTMT1;METTL21A;NSD3;PRMT5;PRMT2;LCMT1;SNRPD3;PCMT1;PRMT8;SNRPB
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.483551817680365,1.225819324531648,0.2223667100130039,0.9453235032390621,1.0,8/26,12.84%,PRKN;MAPK7;FBXO7;FYN;BAG5;GPR37;NFE2L2;SOD2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.4664853029218003,1.2257253784071045,0.1966794380587484,0.9441327765206232,1.0,9/32,23.37%,CXCL10;AKAP6;SNCA;CALM1;CALM2;APLNR;HTT;PKD2;CEMIP
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.48425546673916475,-1.2240363028796495,0.21703296703296704,0.7523000458657103,1.0,5/11,22.44%,NOS3;HSP90AA1;SPR;QDPR;AKT1
prerank,outflow tract septum morphogenesis (GO:0003148),-0.3902365305931048,-1.2237865024955845,0.16666666666666666,0.7502710766512483,1.0,8/24,8.70%,ROBO1;SMAD6;NRP1;BMP4;ENG;BMPR2;FGFR2;TBX1
prerank,regulation of endothelial cell migration (GO:0010594),-0.2919765153834435,-1.2236501845718137,0.0963855421686747,0.7477929740837075,1.0,18/85,6.75%,FOXP1;PTPRM;ANXA3;SP100;PTN;ROCK2;SASH1;ETS1;NRP1;TEK;ANGPT1;ACVRL1;BMP4;BMPR2;SLIT2;KDR;THBS1;BCAR1
prerank,monocarboxylic acid transport (GO:0015718),-0.322173529639627,-1.2228714980584436,0.15862068965517243,0.747321093335691,1.0,10/51,5.22%,SLCO3A1;ABCC4;ABCG2;SLC16A12;SLC16A6;SLC6A12;SLCO2A1;SLCO1C1;SLC6A13;SLC16A11
prerank,regulation of macrophage cytokine production (GO:0010935),0.5540018274992751,1.222801554949666,0.2564491654021244,0.9553758890851142,1.0,6/13,17.15%,IRAK3;GPRC5B;TGFB1;WNT5A;TGFB3;CD74
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.379218675368287,-1.2226751903814086,0.19367588932806323,0.7450194613621931,1.0,4/24,8.85%,DAB2;LZTFL1;NUMB;RHOQ
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.49127370075766863,1.2224365044712269,0.21502590673575128,0.9553748532361428,1.0,8/25,15.42%,FGF13;ANK2;DSG2;CTNNA3;TBX18;CALM1;PKP2;JUP
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.48882014844933136,1.222386879580821,0.22470433639947437,0.9540238043864336,1.0,9/26,18.13%,PRKCA;CCDC57;CUL3;ASNS;CDC25B;SMOC2;USP2;PKN2;MDM2
prerank,regulated exocytosis (GO:0045055),-0.25131195065689255,-1.2220192019525025,0.03571428571428571,0.74414184190647,1.0,40/173,12.58%,IGF1;ABCC4;VWF;MYH9;PECAM1;VEGFC;RAB11B;SYT9;STXBP1;VEGFD;RAB31;VTI1B;ARHGAP17;LYN;GTPBP2;CYRIB;IGF2;TEX264;THBS1;F8;HABP4;ACTN1;TIMP3;CD109;APP;ACTN2;SDF4;FN1;SRGN;MANF;CPLX1;TMX3;SOD1;SYT10;TMSB4X;SERPINE1;SYTL4;SNAPIN;TGFB2;SYT6
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.5022324131298327,1.22196734645189,0.24789915966386555,0.9542761181348146,1.0,10/19,26.82%,ZMIZ1;RHOH;ZBTB1;XRCC6;GATA3;MDK;AXL;PRKDC;SYK;MMP14
prerank,endoplasmic reticulum organization (GO:0007029),0.4115794220116645,1.221685277895406,0.17988826815642459,0.9539674726647359,1.0,27/72,24.86%,SEC16B;EIF2AK3;WDR83OS;PRNP;SEC31B;GAK;VAPA;TMEM33;UBE2J2;EMD;ATL3;OTOF;CCDC47;RTN4;SEC61G;BNIP1;REEP5;CYB5A;SHTN1;SGTA;LMAN1;RAB18;ZBED3;STX18;MIA3;REEP3;ATL1
prerank,peptide hormone secretion (GO:0030072),0.480339865584611,1.220752122883163,0.22739018087855298,0.9564242175024331,1.0,6/26,18.77%,FFAR4;EDN3;RAB1A;CDK16;RIMS2;PARK7
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.4833693711583301,1.2207016234163854,0.21087533156498675,0.9550486644713972,1.0,5/25,16.89%,CXCL10;ANK2;AKAP6;SNCA;APLNR
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5473027667073432,1.2206251549707918,0.2444113263785395,0.9538070842154388,1.0,7/13,19.85%,CBLB;RANBP2;KPNB1;KPNA6;KPNA1;IPO5;KPNA3
prerank,manganese ion transport (GO:0006828),-0.44302042591392954,-1.2201999002212711,0.22356495468277945,0.747144813144188,1.0,5/14,17.62%,SLC30A10;SLC39A8;TRPC6;TRPC3;TRPC7
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.42043269114612936,1.2198196130223826,0.19473081328751432,0.9555458321677454,1.0,17/62,18.77%,CREB3L1;BCL2;PRKN;MAPK7;URI1;ACKR3;BAG5;SELENOS;HERPUD1;NFE2L2;RTKN2;SOD2;OPA1;NDUFA13;DNAJA1;MDM2;PARK7
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.39821186291920896,-1.2193014140789318,0.19696969696969696,0.7472781612186001,1.0,4/21,7.52%,MTUS1;IL34;THBS1;AKIRIN1
prerank,hyaluronan metabolic process (GO:0030212),0.4982578858486249,1.2188203216417945,0.21115537848605578,0.9582515561446835,1.0,3/23,4.08%,HAS2;FGF2;TGFB1
prerank,artery morphogenesis (GO:0048844),-0.3641493150026061,-1.2182074787544201,0.17857142857142858,0.7479125355207433,1.0,13/30,15.30%,NRP1;SMAD7;BMP4;ENG;BMPR2;TGFBR1;TBX1;JAG1;PDGFRB;STRA6;TGFB2;HPGD;HEY2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4082875685626603,1.218071288199114,0.19750283768444948,0.9598721463154019,1.0,17/73,18.77%,DOCK7;NTRK3;NGF;EGFR;VEGFA;ARAF;TGFB1;PAK1;EIF4G1;HDAC6;TBK1;SNCA;SH2D3C;TERF2IP;RPTOR;FNIP1;PARK7
prerank,cellular response to BMP stimulus (GO:0071773),0.4253216087082371,1.2177849067091469,0.19862227324913892,0.9595547862373971,1.0,8/66,4.73%,BMP5;ADAMTS12;RGMB;SOX9;HIVEP1;ACVR1;TGFB1;GDF9
prerank,response to copper ion (GO:0046688),0.5040773811817622,1.2177588134302328,0.24225352112676057,0.9580951301852553,1.0,12/20,28.19%,PRNP;MT3;AOC1;SNCA;MT1X;MT1M;MT1E;MT1G;MT1H;MT1F;MT1B;MT1A
prerank,regulation of sprouting angiogenesis (GO:1903670),0.4704374552148562,1.2173418503201738,0.21722846441947566,0.9583524099201718,1.0,5/33,5.21%,RHOJ;CREB3L1;FGF2;VEGFA;E2F2
prerank,cell differentiation in spinal cord (GO:0021515),0.5822624661994216,1.217180887939845,0.249597423510467,0.9574864003038598,1.0,2/10,6.66%,SOX6;MDGA2
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4809395676743192,1.2168083514482102,0.23412698412698413,0.9575427699681418,1.0,6/27,13.50%,SLC27A1;SELENOI;PLAAT5;PLAAT3;ETNK1;PNPLA8
prerank,cell junction assembly (GO:0034329),0.4025684772532595,1.2164591761423584,0.1737242128121607,0.9575553870082354,1.0,20/100,12.70%,DCHS1;CDH19;PTEN;NRCAM;CDH10;NRXN1;CDH22;OBSL1;CDH8;NLGN1;KIRREL3;GPM6A;FLNA;CDH20;CDH7;DSCAM;MYO9A;OPHN1;ADGRL3;DRD2
prerank,muscle cell differentiation (GO:0042692),0.46490433745886556,1.216084418253982,0.22860791826309068,0.9576611799706592,1.0,5/32,7.60%,RORA;GLMN;SGCZ;GATA6;TBX18
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.41041721216511,1.2160498733631655,0.1735261401557286,0.9562620523019398,1.0,15/79,16.36%,SOSTDC1;ADAMTS12;SULF1;CREB3L1;FGF2;HTRA3;CADM4;SHISA2;PTPN1;DAND5;GPC1;BMPER;BMPR1A;LRP2;VWC2
prerank,regulation of smooth muscle contraction (GO:0006940),0.512156210860618,1.2156645826511063,0.24551724137931036,0.9563866137516064,1.0,5/20,16.91%,CHRM3;SETD3;NMU;ATP2B1;CTTN
prerank,cellular response to cytokine stimulus (GO:0071345),0.37782542835420213,1.2154342805235094,0.054,0.9558938624059636,1.0,86/416,17.36%,RORA;MMP2;CCL11;ADAMTS12;CXCL10;IL16;HAS2;IL2RA;FGF2;PYCARD;MYC;BCL2;SOX9;CRLF1;IL20RB;IL1RAPL1;PTPRT;PTPN2;EPRS1;VEGFA;NPR2;IRAK3;SOCS5;TGFB1;CCL4;TEC;CCR2;SLC12A2;AQP4;ZEB1;PTPN13;NUMBL;WNT5A;SOCS1;YWHAZ;RORC;CSK;IL1RL2;CSF3R;IL18;FYN;GAB2;BRCA1;UBE2K;ERBIN;STK39;HIF1A;NDN;ZFP36L2;PIK3R1;PTPRJ;TYK2;CBL;AKAP6;NFE2L2;PTPN11;COL1A2;IL6ST;PID1;UPF1;TBK1;PRKACA;PTPN18;PRLR;HSP90B1;PTPRZ1;SHPK;GATA3;TXLNA;KHSRP;ZFAND6;UBB;CCL14;ITGB1;TP53;BCL2L11;NDUFA13;PNPT1;HNRNPU;HYAL1;IL1RAP;FSCN1;RC3H1;RIPK1;CHUK;SELPLG
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.4953689293134323,-1.2153065522083841,0.24064171122994651,0.7549227434678931,1.0,2/10,2.98%,EPHA4;RIC1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.40505491941003346,-1.2148971661979078,0.2111111111111111,0.7532507155879324,1.0,4/20,8.85%,DAB2;LZTFL1;NUMB;RHOQ
prerank,histone H3-K4 methylation (GO:0051568),0.4897198318258539,1.2148644911837847,0.23087071240105542,0.9568043476795012,1.0,11/26,20.49%,KMT2A;CXXC1;SETMAR;MEN1;PRDM9;KDM6A;TET3;WDR5B;ASH2L;SETD4;KMT2D
prerank,negative regulation of binding (GO:0051100),-0.2892885375482319,-1.2147726755712862,0.07920792079207921,0.7508215520598396,1.0,15/81,9.45%,DAB2;SP100;ARHGAP28;LEF1;ROCK1;WAPL;PRKCD;NFKBIA;IFIT2;KDM1A;HABP4;PEX19;GSK3B;CAMK1;RACK1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.4520663739488638,1.2146285381096644,0.2243667068757539,0.9562909248005524,1.0,11/40,17.24%,DDX11;ZRANB3;TIPIN;SETMAR;ATRX;FBH1;EXD2;RTEL1;BLM;FAM111A;WRN
prerank,insulin secretion (GO:0030073),-0.3955973766293086,-1.2142785555923161,0.19850187265917604,0.7495276097345281,1.0,6/19,20.12%,RAB11B;SELENOT;CAMK2G;CYB5R4;ANXA1;ADCYAP1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4313593295633834,1.2141050928296542,0.20983213429256595,0.9570670831662627,1.0,12/52,12.88%,LGALS3;GPSM2;EGFR;LRP1;EPHB2;WNK3;SPTBN1;DPP10;ZDHHC8;PIK3R1;EPB41L2;GNAI1
prerank,sympathetic nervous system development (GO:0048485),0.5243432301615194,1.2137161510051369,0.25,0.9572354641561075,1.0,6/15,13.20%,SEMA3A;SOX11;NF1;GDNF;NRP2;GATA3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.45645058625039986,1.2134209525292026,0.21355498721227623,0.9569646209702662,1.0,12/33,19.17%,CBFB;RNF6;PKN1;UFL1;UFSP2;CARM1;NCOA2;ESR1;HDAC6;RUNX1;PARK7;KLK2
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.4420205486912125,1.2132980375933107,0.20634920634920634,0.9560177357994298,1.0,10/41,17.39%,ANK3;ANK2;KCNMB2;KCNMB3;FLNA;AKAP6;KCNJ3;KCNJ10;KCNH2;KCNMA1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.4601922983931005,-1.2129389853022758,0.240625,0.7507228129476335,1.0,4/13,7.84%,ZC3HAV1;MOV10;CNOT1;GTPBP1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.5480577481353909,1.212811440314736,0.2626728110599078,0.9566044019115049,1.0,3/13,6.38%,CBFB;SOCS1;TGFBR2
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.5238097935716612,1.2127862752664784,0.2378917378917379,0.9551878283640335,1.0,3/16,9.99%,MEIOB;ERCC4;HFM1
prerank,cellular response to misfolded protein (GO:0071218),-0.4057313683888585,-1.2116913269172054,0.1958041958041958,0.7516805235538148,1.0,13/20,30.73%,POMT2;RNF185;DNAJB12;STUB1;UBE2W;AUP1;UFD1;KLHL15;UGGT1;RNF5;RNF126;VCP;BAG6
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4063758177698014,1.211231769448995,0.19167579408543264,0.960357229292783,1.0,17/86,11.99%,RELN;FGF10;BST1;EGFR;RAP2B;ACVR1;EFNA5;VEGFA;CADM4;TGFB1;TEC;PRNP;SAMSN1;FYN;PTPRJ;PTPN11;FGF7
prerank,regulation of phospholipase C activity (GO:1900274),0.5353043793540475,1.211150597255292,0.25401459854014596,0.9591826957564921,1.0,6/15,10.73%,PDGFRA;NTRK3;FGF2;BICD1;FGFR1;ESR1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.448044188189294,1.2111110120990458,0.2334963325183374,0.9578447207021112,1.0,8/39,6.38%,GLI2;FGF2;MYC;FGF10;SEMA3E;VEGFA;PAK1;TGFBR2
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.4505808437129824,-1.21093729637726,0.21301775147928995,0.751345994123046,1.0,5/13,18.89%,FEZ2;SCFD1;NUPR1;SMCR8;PINK1
prerank,motile cilium assembly (GO:0044458),0.5509194213182844,1.2103201344554246,0.27606461086637296,0.9597695140908472,1.0,3/12,8.05%,CCDC39;SPATA6;BBS5
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.4721545572141036,1.2097217750276628,0.21818181818181817,0.9609536702218775,1.0,7/29,10.86%,FADD;PTPN2;WNT5A;METTL3;UBE2K;PTPN1;PTPN11
prerank,positive regulation of interleukin-2 production (GO:0032743),0.4881088102054039,1.2091364865698953,0.24302788844621515,0.9619571837943586,1.0,7/25,15.49%,GLMN;PDE4B;CCR2;SPTBN1;PDE4D;MALT1;RUNX1
prerank,myeloid dendritic cell activation (GO:0001773),0.5484558099312513,1.2090164755665553,0.26106870229007634,0.9609780654927553,1.0,2/12,6.38%,PYCARD;TGFBR2
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.45585236756541553,1.209003105397697,0.2377892030848329,0.9595437047115422,1.0,13/34,21.87%,CHRNA4;GRIN2B;GRID2;MPP2;INSYN1;DRD2;GRIN2D;GRIN2A;GABRG2;GABRA3;GABRA2;RAB3GAP1;ARRB2
prerank,regulation of myoblast differentiation (GO:0045661),0.4610823064613529,1.208855603499113,0.2282051282051282,0.9586993387165742,1.0,6/32,4.92%,SOSTDC1;SOX8;SOX9;XKR8;TGFB1;PLCB1
prerank,regulation of fat cell differentiation (GO:0045598),0.4111299338737329,1.2074780565720327,0.18262806236080179,0.9629748655060896,1.0,24/74,23.35%,RORA;FRZB;WDFY2;TGFB1;WNT5A;ZBTB16;RORC;LMO3;CARM1;ZFP36L2;WWTR1;ZFPM2;GATA3;TRIO;ASXL2;CCDC85B;PPARG;TAF8;CCDC71L;ZFP36;RARRES2;TRPM4;CEBPB;BMP2
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.325010652433928,-1.2074738520832773,0.17073170731707318,0.7597941559633439,1.0,19/46,21.17%,ALDH1A1;PLCL1;ID1;NPR3;TLR4;IP6K1;PLCL2;ZNF423;LGR4;FLCN;NR1H2;NOVA2;PGAM5;RHEB;NRDC;PCTP;NR1H3;ATF4;FOXC2
prerank,activation of GTPase activity (GO:0090630),0.3977990015907734,1.2068584074736781,0.1886195995785037,0.9642120364654152,1.0,11/89,6.35%,ARHGAP24;SIPA1L1;DOCK7;NTRK3;TAX1BP3;TBC1D10A;GPR65;SLC27A4;ARHGEF10;MTSS2;TSC1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.42367107049647534,1.2067036404712446,0.21336459554513482,0.9633209119923732,1.0,12/61,9.12%,FGF10;IRS2;NGF;AKAP13;LPAR1;MAP4K4;GPR65;AUTS2;ALS2;ERBIN;SHOC2;COL3A1
prerank,phagosome-lysosome fusion (GO:0090385),0.5723265027930282,1.2060625510340428,0.2905844155844156,0.9645507252473687,1.0,5/10,23.60%,RAB34;RAB39A;RAB7B;RAB7A;ARL8B
prerank,ether lipid biosynthetic process (GO:0008611),-0.49796288555666324,-1.2060120354572113,0.25336927223719674,0.7615639345611017,1.0,4/10,8.33%,PLA2G4A;PEX7;DHRS7B;GNPAT
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.4152679931263549,-1.2052518436586948,0.23355263157894737,0.7611418713679929,1.0,4/17,6.72%,ATP1A2;TFPI;BMP4;ATP1A1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.4593987185528421,-1.2048022433695764,0.24404761904761904,0.7598431997429401,1.0,4/12,11.12%,ABCA1;NFKBIA;ABCG1;NR1H2
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.29540073122925986,-1.2047823575924521,0.12949640287769784,0.7570493076602812,1.0,7/66,1.35%,FLT1;PDGFD;ROBO1;SASH1;MAP3K5;KIT;IL34
prerank,regulation of ion transport (GO:0043269),0.4055422837994944,1.2046304891320703,0.19732441471571907,0.9691059199701167,1.0,17/76,14.64%,ANK3;KCNA2;NKAIN2;PRKN;CHRNA4;SYT1;SYT11;SYT12;SNX6;PXK;GDNF;DRD2;PER1;KCNJ3;SNCA;NEDD4L;KCNJ10
prerank,T cell mediated immunity (GO:0002456),-0.4428745592321329,-1.2045120908601978,0.21686746987951808,0.7551123458841253,1.0,3/13,9.24%,CTSH;CD55;JAG1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.4883276871768037,-1.2043754631655095,0.2563380281690141,0.7528327058328447,1.0,4/10,24.29%,ADGRV1;SOD1;PDZD7;TSKU
prerank,negative regulation of defense response (GO:0031348),0.4061495349605994,1.2038777302958075,0.20112359550561798,0.9707614440099638,1.0,9/77,9.85%,RORA;FFAR4;PTPN2;MAPK7;IRAK3;TNFAIP8L2;OTULIN;PPM1B;SELENOS
prerank,regulation of lipid metabolic process (GO:0019216),0.4000651901785423,1.2036168336557673,0.18927789934354486,0.9702945448799766,1.0,16/88,11.00%,RORA;IRS2;NCOA1;C1QTNF2;SQLE;ACACA;IDI1;RORC;ELOVL6;FASN;CARM1;NCOA2;CHD9;SIN3B;TGS1;SP1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4187456351996886,1.203110875491547,0.1893424036281179,0.971034782707601,1.0,9/62,8.35%,LGALS3;PRKCQ;CBFB;HOXB8;KAT2B;KMT2A;ZBTB16;CDK6;EIF6
prerank,DNA biosynthetic process (GO:0071897),-0.432171140632411,-1.2024688490460438,0.20833333333333334,0.7559668492872024,1.0,11/16,34.55%,POLD3;PPIA;POLH;POLA1;TERT;RFC3;POLD2;POLE;POLD4;POLD1;POLL
prerank,negative regulation of axon extension (GO:0030517),0.46766828579482184,1.2019216595151074,0.24187256176853056,0.974599043675376,1.0,12/30,20.14%,SEMA3E;SEMA6C;SEMA3A;RNF6;MT3;CDKL3;RTN4;SEMA6D;DIP2B;SEMA4B;SEMA4D;PTPRS
prerank,positive regulation of MAPK cascade (GO:0043410),0.37592595480396174,1.2010485384724268,0.10101010101010101,0.9768584778141858,1.0,39/245,11.87%,ROR2;FFAR4;ROR1;CCL11;PRKCA;PDGFRA;GLIPR2;NTRK3;FGF2;PYCARD;FGF10;PTPN22;GAREM1;ERBB2;EGFR;LPAR1;VEGFA;FBXW7;TGFB1;CCL4;NTRK2;MT3;TMEM106A;ALKAL2;KSR1;CARD9;ACKR3;RAP1A;FGFR1;HTR2C;ERBB4;GPR37;PTPRJ;PTPN11;MTURN;ARL6IP5;EDN3;TAOK3;MYDGF
prerank,positive regulation of metabolic process (GO:0009893),0.39243919048160875,1.2007739513659326,0.17777777777777778,0.9764872116384877,1.0,17/103,13.94%,EBF2;FFAR4;PRDM16;VEGFA;ACACA;CCR2;PTH2R;PRKAB2;IL18;TSHR;ELOVL6;ACLY;FASN;SIRT6;CNOT3;PRLR;PIGA
prerank,lipid transport (GO:0006869),0.3973018573488048,1.2002857855780775,0.1826086956521739,0.977013978368175,1.0,14/97,9.20%,ABCA6;ABCA9;SLC27A1;ATP8B1;NCOA1;PITPNB;SLC27A4;OSBPL5;SLCO2B1;PEX3;GM2A;GOT2;MTTP;NCOA2
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.41018169962244183,1.2001378083598073,0.21052631578947367,0.9761582232739426,1.0,10/67,8.06%,RELN;EFEMP1;PDGFRA;PKDCC;ERBB2;EGFR;EPHB2;TEC;FGFR1;FYN
prerank,positive regulation of dendrite development (GO:1900006),0.567384864687474,1.2000357841014317,0.2618296529968454,0.975098845174719,1.0,3/10,14.10%,BMP5;BMP7;COBL
prerank,L-glutamate transmembrane transport (GO:0015813),0.5621414698400422,1.1997721252441704,0.2583081570996979,0.9746780964394842,1.0,3/10,12.95%,SLC1A3;ARL6IP5;PRAF2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5208376715835618,1.1981631196598448,0.27453769559032715,0.9801257169453423,1.0,4/16,12.97%,PRDX6;TRA2B;NCBP1;DAZAP1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.4954789787185263,1.1978126347602511,0.2226775956284153,0.9801898543480653,1.0,3/18,6.19%,CCDC39;AQP4;RFX3
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.4306980295056979,1.1978107924507984,0.22743259085580306,0.9787105748372116,1.0,11/48,11.00%,PRKCA;RHOJ;FGF2;VEGFA;MAP3K3;TGFB1;FGFR1;AKT3;HIF1A;MAPK14;SP1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.37940607350763206,1.197727956044067,0.12081218274111676,0.9776012569497503,1.0,47/208,19.56%,RORA;ROR1;PYCARD;S100A4;PRKN;AKAP13;FADD;LPAR1;ALPK1;MAP3K3;GPRC5B;TLE1;TNFRSF10B;TRAF4;SLC44A2;WNT5A;TMEM106A;OTUD7B;NLRX1;UFL1;CARD9;PELI1;PPM1B;FLNA;VAPA;MID2;ESR1;RHOH;RHOC;TBK1;PER1;MALT1;NDFIP1;GOLT1B;ZFAND6;TICAM1;PIM2;TERF2IP;CD74;RIPK1;CHUK;OTUD7A;ZMYND11;MAPKBP1;TAB3;CPNE1;BCL10
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.4724227879472456,1.1977266292242879,0.23560910307898258,0.9761332762984319,1.0,8/26,12.38%,CBLB;SOCS5;FBXW7;NCF1;BTC;SNX6;CBL;ZGPAT
prerank,protein localization to organelle (GO:0033365),0.38758009904633234,1.1976870415102912,0.16350210970464135,0.9748446278897109,1.0,34/133,15.35%,BICD1;ANK2;ARL3;PACSIN2;IFT140;WDR83OS;PRNP;PPP1R15A;OBSL1;BBS9;FAM83H;ARL1;GBF1;LAMP5;GAK;XPA;WDR35;VAPA;BICD2;UBE2J2;TSPAN17;TOLLIP;EMD;BMP7;SNX10;SYS1;DVL1;OTOF;CCDC47;RPA2;COL1A1;GABARAPL2;LMNA;SEC61G
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.5233502173944891,1.1971614097396763,0.26285714285714284,0.9755667717719921,1.0,4/16,15.46%,SOX9;ERLIN2;BRCA1;ERLIN1
prerank,focal adhesion assembly (GO:0048041),0.4984142546781342,1.196911841702283,0.2629370629370629,0.9751111459950853,1.0,5/21,9.13%,DLC1;RHOD;PEAK1;TESK2;TRIP6
prerank,Ras protein signal transduction (GO:0007265),0.3802145608014987,1.1966085690130182,0.18286311389759666,0.9749601406527908,1.0,43/137,20.77%,USP50;RTKN;TAX1BP3;FGF2;RHOD;GPSM2;RAP2B;HACE1;CTNNAL1;PLD1;NF1;KSR1;EPS8L1;RALB;LIMK1;RAP1A;BRK1;ARHGEF11;SHOC2;MRAS;MYO9B;FARP2;NGFR;MAPK14;COL1A2;RHOH;WASF1;KPNB1;ARHGAP4;ARHGEF3;CYFIP1;CDC42EP1;ELMO1;TP53;NRAS;KRAS;PARK7;NCKAP1;GRB2;JUN;SHTN1;SETDB1;SOS1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.4833609796656427,1.196425241621017,0.24899598393574296,0.9742402128251783,1.0,6/26,10.86%,GAREM1;SOX9;ERBB2;EGFR;ZFP36L2;PTPN11
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.4661407927558714,-1.1962059386714197,0.23863636363636365,0.7728425545006361,1.0,5/12,22.57%,PRPSAP2;PRPS2;GART;PRPS1;PRPS1L1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.4962426757176518,1.1958536783886817,0.25237449118046135,0.9752453686987401,1.0,6/20,13.39%,BCL2;PACS2;PSEN1;THADA;HERPUD1;CCDC47
prerank,entry into host (GO:0044409),-0.447800820586997,-1.1958445684413817,0.22413793103448276,0.7710506444574573,1.0,4/13,7.58%,CTNNB1;CDH1;PPIA;CTNND1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.41136640108900974,1.195458389590425,0.2062937062937063,0.9755238447455091,1.0,20/70,20.04%,SLC27A1;PLBD1;MBOAT2;SLC44A2;PLA2G7;PLA2G12A;PCYT1B;PLAAT3;CHPT1;PNPLA8;CHAT;LIPC;GPLD1;GPAT4;SLC44A1;CSNK2A2;LPCAT2;DBI;PLA2G4E;STARD7
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5077894952772055,1.1951550216023823,0.2557142857142857,0.9753716826544423,1.0,5/17,16.10%,ANK2;SCN5A;NEDD4L;PKP2;KCNH2
prerank,zymogen activation (GO:0031638),0.4409087994647744,1.1945572457711173,0.22992700729927007,0.9765161139921807,1.0,4/39,7.58%,HGFAC;TBC1D10A;FADD;KLK1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5589896983546951,1.1943176073622255,0.27058823529411763,0.9760580695560976,1.0,3/11,8.10%,SESTD1;CACNA2D1;BIN1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5395341860149253,1.1937127859711085,0.27071005917159763,0.9771722342565284,1.0,2/13,9.15%,FAM47E;ZMIZ1
prerank,polyamine metabolic process (GO:0006595),0.5353439729483689,1.19356308805204,0.26865671641791045,0.9763303318044756,1.0,5/13,11.21%,SMOX;SMS;AOC1;PAOX;HDAC6
prerank,axonal transport (GO:0098930),-0.33735900214157705,-1.193296131716126,0.20192307692307693,0.7764132354834068,1.0,10/36,12.83%,KIF3B;PAFAH1B1;DTNBP1;KIF1B;BLOC1S5;DCTN1;SOD1;SNAPIN;MAPT;AP3D1
prerank,positive regulation of integrin activation (GO:0033625),-0.46941200064938815,-1.192830107067285,0.256797583081571,0.7750323450014102,1.0,2/11,6.06%,RAP1B;RASIP1
prerank,cholesterol homeostasis (GO:0042632),0.4132147214568645,1.192826270023615,0.20436280137772675,0.9779661968975617,1.0,11/64,16.67%,RORA;NPC1;CYP39A1;IL18;MTTP;CYP7B1;ABCA5;GRAMD1B;LIPC;TMEM97;ABCG4
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.3995973416496392,-1.1927748899754902,0.2226148409893993,0.7724410417825205,1.0,6/20,12.43%,WTIP;MOV10;AGO1;CNOT1;NRDE2;AGO3
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.49133128308888585,1.1927186307350686,0.26573426573426573,0.9770126800118789,1.0,8/19,18.94%,PRKN;FBXW7;FBXO7;HDAC6;SREBF2;HTT;PARK7;CSNK2A2
prerank,placenta development (GO:0001890),0.5469540052887866,1.1926282311286855,0.2740963855421687,0.9759235230036609,1.0,1/12,1.00%,ADAM19
prerank,cellular protein catabolic process (GO:0044257),0.42007542786013385,1.192205648584633,0.2321219226260258,0.9761573942141196,1.0,19/59,22.27%,ADAMTS12;FAP;PRKN;CTSK;CTSO;BNIP3;CTSB;RSPRY1;AFG1L;MYLIP;YME1L1;MALT1;RIPK1;RAB7A;MDM2;MAGEC2;UBE2G1;BNIP3L;RNF123
prerank,inositol phosphate-mediated signaling (GO:0048016),0.4991084297471349,1.1919730746185675,0.260431654676259,0.9756661741297806,1.0,6/19,13.97%,HRH1;PPP3CB;PPP3CA;NFATC3;EDN3;PPP3CC
prerank,mitotic cytokinesis (GO:0000281),0.4286749403833065,1.1917483162926747,0.22023809523809523,0.9751493980138852,1.0,7/47,6.92%,RTKN;ANK3;EFHC1;ARL3;SPTBN1;RASA1;SON
prerank,lipid catabolic process (GO:0016042),0.5019132394205843,1.191586630583698,0.2641770401106501,0.9744354785070486,1.0,4/18,15.20%,CEL;MT3;PLAAT3;LIPC
prerank,sterol homeostasis (GO:0055092),0.4109378029629522,1.1915012427137333,0.2061503416856492,0.9733665869714448,1.0,11/65,16.67%,RORA;NPC1;CYP39A1;IL18;MTTP;CYP7B1;ABCA5;GRAMD1B;LIPC;TMEM97;ABCG4
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3944524070048572,1.191471724058024,0.1827956989247312,0.9720532262282902,1.0,10/90,8.18%,EBF2;FFAR4;PRDM16;VEGFA;CCR2;PTH2R;PRKAB2;IL18;TSHR;ELOVL6
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.45669294128426796,1.1912855364103014,0.24673629242819844,0.9714303187737631,1.0,8/29,10.73%,CBFB;PAK1;UFL1;UFSP2;BRCA1;CARM1;VPS11;ESR1
prerank,regulation of receptor binding (GO:1900120),-0.48867158400272165,-1.1912630723686926,0.2727272727272727,0.7744804989455965,1.0,5/10,22.56%,GREM2;ADAM15;ATP2A3;HFE;ATP2A2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.4439884993210421,1.1911221205939202,0.25093167701863356,0.9706723900319094,1.0,11/36,19.29%,PRKN;FADD;TRIM44;WNT5A;AGPAT2;UBE2K;HIF1A;CD74;RIPK1;AXL;CPNE1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.44308191355864956,1.1910109586111122,0.2421972534332085,0.9696898759049267,1.0,4/36,4.25%,BCL2L14;PYCARD;BCL2;DEPTOR
prerank,regulation of ruffle assembly (GO:1900027),0.4778282714000255,1.1906008069762406,0.27235772357723576,0.9700071208308055,1.0,3/23,6.47%,ARHGAP24;NLGN1;EPS8L1
prerank,amyloid fibril formation (GO:1990000),0.42509488953952645,1.1903383039786566,0.22727272727272727,0.9697138600671692,1.0,4/51,2.35%,TGFBI;HSPG2;GSN;PRKN
prerank,positive regulation of T cell differentiation (GO:0045582),0.4404939030092144,1.190045176089225,0.2323856613102596,0.9694621239858495,1.0,10/36,18.11%,GLI2;SOCS1;SOX12;ZMIZ1;IL4I1;RHOH;ZBTB1;GATA3;MDK;SART1
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.431694279714014,-1.1899345234062944,0.23270440251572327,0.7760190338146857,1.0,2/14,0.89%,IGF1;CD200
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.41387197763392725,-1.189368472997996,0.21172638436482086,0.7750048631227704,1.0,8/17,12.47%,DOCK4;IGF1;NRP1;VTN;IGFBP5;S100A11;PDGFRB;CCN4
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.4431135490312488,-1.1893106918872458,0.22611464968152867,0.7724348479257309,1.0,6/14,26.45%,MOXD1;ALDH9A1;NOS1;DAGLA;SLC22A2;DAGLB
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.37687819464457645,-1.1891055340318393,0.18250950570342206,0.7703562971040588,1.0,10/24,28.68%,PECAM1;ROCK1;ICAM1;TNIP1;MSN;VCAM1;GFUS;CERCAM;FERMT3;ITGB2
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.4065009351203196,1.188782171227468,0.2215909090909091,0.9733467910621095,1.0,18/72,14.75%,FGF2;FGF10;RAB14;POLR2B;SPRED2;SPRED1;FGFR1;CEP57;SHOC2;POLR2K;SHCBP1;NCBP1;CBL;PTPN11;MAPK1;FGF7;POLR2G;GALNT3
prerank,actin filament organization (GO:0007015),-0.2656041945712038,-1.1886465864257925,0.10714285714285714,0.769097957609498,1.0,41/151,15.98%,NEBL;CGNL1;RHOBTB1;BAIAP2L1;TMOD3;TPM3;MYO1D;NEDD9;WASL;ARHGAP17;SHROOM4;SHROOM3;TPM1;ACTN1;FHOD1;BCAR1;INPPL1;VILL;EPS8;RHOA;ABI2;MYO1E;DSTN;ARPC4;EVL;EFS;PROX1;WHAMM;CDC42EP2;CDC42;MYO5B;MYO1C;GAS2;SHROOM2;AVIL;LMOD1;MPRIP;TPM2;TMOD1;HIP1R;TRPV4
prerank,alcohol catabolic process (GO:0046164),0.5722695484753263,1.1886188189396094,0.28526148969889065,0.9726234363791246,1.0,3/10,14.24%,CEL;MT3;CYP27A1
prerank,monocyte chemotaxis (GO:0002548),0.45650035390759025,1.188497226453623,0.2388250319284802,0.9717513555767473,1.0,3/32,4.10%,LGALS3;CCL11;CCL4
prerank,nuclear transport (GO:0051169),0.5017949639060348,1.1882126489942937,0.2600297176820208,0.9715357821863541,1.0,6/16,16.73%,XPO1;RSRC1;PSIP1;NUP205;NXT1;AAAS
prerank,regulation of potassium ion transport (GO:0043266),0.458037293166587,1.188204113985332,0.24744897959183673,0.9701706853927196,1.0,9/31,19.21%,ANK3;ANK2;DPP10;DRD2;KCNAB2;KCNIP4;KCNH2;KCNA5;CD63
prerank,integrin-mediated signaling pathway (GO:0007229),-0.29972801745464034,-1.187938198941682,0.14814814814814814,0.7686237279611489,1.0,19/73,16.15%,DAB2;PTN;NRP1;MYH9;FBLN1;NEDD9;ITGB5;SEMA7A;FYB1;BCAR1;ITGA10;FN1;ADAM10;LAMA3;CDC42;ADAM15;CEACAM1;PTK2B;ITGA11
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.5082926764005964,1.1878334484272624,0.2606837606837607,0.9703320306104305,1.0,2/18,7.26%,SOX6;FZD7
prerank,negative regulation of T cell proliferation (GO:0042130),0.4624549400935282,1.18782250241421,0.2570694087403599,0.9689711976111454,1.0,6/28,17.21%,GLMN;PRNP;SDC4;IL4I1;SCRIB;RC3H1
prerank,bone development (GO:0060348),0.4439407855758773,1.1871322187656705,0.2550251256281407,0.9703871368619653,1.0,7/39,12.66%,OSR2;SULF1;AKAP13;SLC10A7;SFRP4;VKORC1;MYOC
prerank,negative regulation of secretion by cell (GO:1903531),0.4424672997203303,1.186842147679625,0.2538659793814433,0.9701875221883803,1.0,6/38,13.88%,STXBP6;IL1RAPL1;PNKD;SYT11;DRD2;SNCA
prerank,negative regulation of hippo signaling (GO:0035331),-0.4540171871591433,-1.1866928176984626,0.22740524781341107,0.7697797431353847,1.0,6/12,9.58%,WWC2;MAP2K3;WTIP;CIT;SHANK2;WWC1
prerank,actin nucleation (GO:0045010),0.48901534914584144,1.1866541569337274,0.2661064425770308,0.9695654438162566,1.0,3/21,4.87%,SPIRE1;ARPC1B;IQGAP2
prerank,proteoglycan metabolic process (GO:0006029),0.46559866164053754,1.1864287566748535,0.2582781456953642,0.9691232262597747,1.0,4/26,7.77%,ADAMTS12;SULF1;CHST8;CSGALNACT1
prerank,response to interferon-alpha (GO:0035455),-0.41097365460836266,-1.1863465516024072,0.21428571428571427,0.7682217635972117,1.0,7/16,22.45%,IFITM3;KLHL20;IFITM2;BST2;IFNAR1;IFNAR2;PDE12
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.4334830432032999,1.1861531808324617,0.25365853658536586,0.9689028339850317,1.0,3/39,1.98%,FFAR4;CRH;IRS2
prerank,response to fatty acid (GO:0070542),0.5116800063166052,1.1856999353833086,0.2548209366391185,0.9692942617274477,1.0,3/17,11.37%,SOX9;PDK3;PID1
prerank,regulation of lipase activity (GO:0060191),0.5406105791080584,1.1854280202191336,0.2667660208643815,0.9690233929379447,1.0,6/13,21.05%,PCSK6;LMF1;RHOC;SNCA;LIPC;FURIN
prerank,positive regulation of signaling (GO:0023056),0.4384179597711438,1.1848610677367655,0.25030674846625767,0.9700504461618684,1.0,12/37,15.49%,CLSTN2;SOX11;GRIK2;SYT1;NMU;RIMS1;EDN3;SCRIB;GATA3;SNCA;CLSTN1;HOMER1
prerank,maintenance of blood-brain barrier (GO:0035633),0.45511009356045157,1.1848370931228944,0.25384615384615383,0.968762212954482,1.0,5/30,5.24%,LAMA2;LAMC1;WNK3;CLDN1;SLC12A2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5310413226580998,1.1840016698726512,0.2688953488372093,0.9708050837844688,1.0,4/14,9.19%,CCL4;CCR2;WNT5A;STK39
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.5485737167549813,1.1838812870006445,0.28075253256150506,0.9699404090947771,1.0,1/12,0.67%,PRKCA
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.4042884611748987,1.1837292574191858,0.2054176072234763,0.9691900982209959,1.0,26/71,23.04%,ADAMTS12;FAP;HM13;PRKN;OTUD7B;CTSK;CTSO;CTSB;RSPRY1;HDAC6;YME1L1;DDB1;MALT1;NEDD8;PDCD6IP;UBB;CHMP4C;CUL4B;MDM2;ZER1;OTUD7A;PSMA8;RHBDD1;FBXO44;RNF123;ZYG11B
prerank,regulation of DNA recombination (GO:0000018),0.4482975743402551,1.1833695295242566,0.23876765083440307,0.9693646332008812,1.0,10/32,16.41%,ZRANB3;SETD2;MSH6;SIRT6;RPA2;RTEL1;BLM;KPNA1;SPIDR;TERF2IP
prerank,macrophage differentiation (GO:0030225),-0.44845654074972774,-1.1822031027819402,0.23582089552238805,0.7789945344954232,1.0,5/13,13.33%,IL31RA;BMP4;PARP1;CASP8;CDC42
prerank,positive regulation of neuron differentiation (GO:0045666),0.4333278063040557,1.181396420924478,0.2518610421836228,0.9762255068527185,1.0,12/40,20.22%,NGF;NRCAM;GPRC5B;SOX11;ZEB1;HOXD3;FGFR1;MMD2;VWC2;HEYL;CPNE1;PCP4
prerank,phospholipid catabolic process (GO:0009395),0.4765712761077635,1.180966949896505,0.2696011004126547,0.9765500336024431,1.0,2/24,1.15%,PRDX6;PLBD1
prerank,excitatory postsynaptic potential (GO:0060079),0.4896324484896943,1.1809637365960202,0.2713068181818182,0.9751893323675651,1.0,8/19,21.87%,GRIN2B;GRID2;MPP2;DRD2;GRIN2D;GRIN2A;RAB3GAP1;ARRB2
prerank,regulation of mitochondrial fusion (GO:0010635),0.5468885351020575,1.1809502315025555,0.26461538461538464,0.9738825948654048,1.0,5/11,17.55%,PRKN;BNIP3;HUWE1;PID1;ADCK1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.5503109502033834,1.1807993142869926,0.2560240963855422,0.9731059993887508,1.0,7/12,24.47%,FADS2;ACOX1;ELOVL5;ACOT8;SCP2;ELOVL1;HSD17B4
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4838051902803268,1.1806522111141549,0.26685393258426965,0.9723383338595571,1.0,5/23,13.50%,PLBD1;MBOAT2;PLA2G12A;PLAAT3;PNPLA8
prerank,inhibitory synapse assembly (GO:1904862),0.5459305498655935,1.1806384736823075,0.29339477726574503,0.971028906570175,1.0,5/11,20.51%,FGF13;WNT5A;GABRG2;CBLN4;GABRA2
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.48553785851003006,1.1805267204360161,0.2804232804232804,0.9701463286023739,1.0,2/22,2.40%,DYNLL1;CDKN2B
prerank,long-term synaptic potentiation (GO:0060291),0.48048382093251146,1.1804369373884334,0.2706043956043956,0.9691531548616731,1.0,7/21,18.11%,TSHZ3;GRIN2B;MPP2;SLC8A2;GRIN2D;GRIN2A;SLC24A2
prerank,amino sugar metabolic process (GO:0006040),0.5584365437461052,1.1803532056502546,0.2794348508634223,0.9681546797047058,1.0,3/10,15.44%,GFPT2;CSGALNACT1;GNE
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.2865201404584622,-1.1803117456301842,0.0625,0.7822836089651205,1.0,21/80,10.68%,EPHA4;ROCK2;SAMD4A;PRKCD;LARP4B;ZCCHC4;YTHDF1;NPM1;UPF3B;THBS1;RBM3;METTL14;SIRT3;RPL5;RPS6KB1;RACK1;GSK3A;ABCG1;EIF4A3;TNFRSF1A;ELAVL1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.40782538050197,1.1802084163550521,0.24358974358974358,0.9673844584256124,1.0,18/64,12.66%,UTRN;SEMA3E;PEAK1;BST1;EFNA5;HOXA7;MAP4K4;GPM6B;NF1;RASA1;TSC1;CDK6;NF2;SLK;CLASP1;AJAP1;PTPRA;MYOC
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.513888573152754,1.1800094871012363,0.28152492668621704,0.9668897914862908,1.0,1/15,0.50%,USP50
prerank,sodium ion transport (GO:0006814),0.39931637926657226,1.179809068970131,0.221850613154961,0.9664219249285559,1.0,11/85,7.96%,SLC6A2;FGF13;SCN7A;SLC12A3;SCN2A;KCNK1;ANO6;SLC12A2;SCN5A;SCN3A;SLC8A2
prerank,protein localization to kinetochore (GO:0034501),-0.4305920269571751,-1.1797006868583289,0.2219020172910663,0.7813947970435102,1.0,7/14,34.35%,BUB3;IK;CENPT;KNL1;ZW10;TTK;SPDL1
prerank,B cell differentiation (GO:0030183),0.4272444002616737,1.179626676904611,0.2541766109785203,0.9658003098158563,1.0,10/46,18.69%,RAG2;PTPN2;DNAJB9;RABL3;NHEJ1;PTPRJ;DCAF1;ITGB1;MS4A1;FNIP1
prerank,regulation of hippo signaling (GO:0035330),-0.41487791465995766,-1.1793948230162294,0.20761245674740483,0.7796840024142591,1.0,8/17,9.58%,WWC2;SCHIP1;MOB3B;MAP2K3;WTIP;CIT;SHANK2;WWC1
prerank,regulation of signal transduction (GO:0009966),0.3744496883978564,1.1789946959023219,0.1653061224489796,0.9669836316842906,1.0,29/190,10.73%,RORA;PTCH1;UBASH3B;SULF1;MDFIC;ERBB3;ZFAND2B;CBFB;BST1;ACVR1;PTPN2;SIK2;SOCS5;TGFB1;PRNP;PLCB1;GLI1;HHIP;RGS11;CSK;FRRS1L;SLC8A2;FYN;DHRS3;CASTOR2;PTPN1;GDNF;USP33;ESR1
prerank,neuron projection regeneration (GO:0031102),-0.48370997351744943,-1.1789572627683849,0.26519337016574585,0.7783403344058655,1.0,2/10,2.86%,PTN;GAP43
prerank,glycerol metabolic process (GO:0006071),-0.48474339211756223,-1.1789131776971942,0.2750642673521851,0.7758445826432151,1.0,5/10,27.49%,COQ3;PGP;GOT1;ANGPTL3;TKFC
prerank,GTP metabolic process (GO:0046039),-0.4165775281944455,-1.1779491163926104,0.22686567164179106,0.7760942152842327,1.0,7/15,19.64%,GTPBP1;RHOQ;ENTPD7;GNAI3;IMPDH1;AK4;IMPDH2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.3798416387860821,-1.1764302829415096,0.2454212454212454,0.7782934554637478,1.0,6/21,8.98%,FOXP1;PRKCH;LYN;PRKCB;GPS2;ELF1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3961912455501668,1.1763507073108381,0.2292358803986711,0.9763049733006186,1.0,18/85,11.65%,DLC1;FGF10;IRS2;NGF;AKAP13;EPHB2;CADM4;ARHGEF28;SYNGAP1;MAPKAP1;EPS8L1;FOXM1;RABL3;ERBIN;SHOC2;MYO9B;OPHN1;MMD2
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3764715549431295,1.1754068043024641,0.19267015706806281,0.9788135983200256,1.0,14/138,4.52%,ROR2;SHC4;ROR1;PDGFRA;ERBB3;NTRK3;EPHB6;NGF;ERBB2;EGFR;PTPRT;NPR2;EPHB2;NTRK2
prerank,regulation of synapse assembly (GO:0051963),0.4193916372525265,1.174877171169549,0.24758454106280192,0.9795886628294551,1.0,13/46,14.19%,CLSTN2;IL1RAPL1;EPHB2;NRXN1;GRID2;NLGN1;LHFPL4;EIF4G1;SETD5;GPC4;SYNDIG1;SNCA;CLSTN1
prerank,snRNA 3'-end processing (GO:0034472),0.4768925091678928,1.1747999851285365,0.28450704225352114,0.9785337737333425,1.0,6/19,13.92%,USB1;INTS6;EXOSC8;EXOSC2;INTS2;INTS8
prerank,positive regulation of ATPase activity (GO:0032781),0.4341671851633747,1.1747153190207702,0.2588957055214724,0.9775613132187966,1.0,12/41,21.53%,DYNLL1;FGF10;SETMAR;TNNT3;MSH6;AHSA1;GABARAPL2;HNRNPU;DNAJC10;SSBP1;VMP1;DNAJC9
prerank,negative regulation of interleukin-1 production (GO:0032692),0.47455235195698053,1.17462613557303,0.270687237026648,0.9765954882575621,1.0,1/23,0.29%,FFAR4
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.493305523692132,1.1745715384590583,0.2755681818181818,0.9754644183227438,1.0,2/19,3.45%,DCN;CADM4
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.46944292959849976,1.1745137692845025,0.27308192457737324,0.9743628415925603,1.0,4/25,7.77%,HAS2;EXT1;B3GNT9;CSGALNACT1
prerank,spliceosomal snRNP assembly (GO:0000387),-0.3252593768459823,-1.1742637201293171,0.19545454545454546,0.7823809529900431,1.0,19/38,32.25%,PRPF3;PRMT7;SRSF10;STRAP;PRMT5;PRPF31;SNRPD3;SNRPE;DDX20;SNRPB;SRSF12;SART3;USP4;AAR2;SNRPD1;SNRPC;PRPF19;LSM4;SNRPG
prerank,carboxylic acid catabolic process (GO:0046395),0.5356062785038072,1.1742128398450618,0.2773497688751926,0.9742925768739279,1.0,5/12,20.98%,NAGK;IL4I1;GNPDA1;BCKDK;ACOT8
prerank,negative regulation of myotube differentiation (GO:0010832),-0.44771076803210114,-1.1741113569703574,0.26519337016574585,0.7802546504452119,1.0,4/12,22.42%,HDAC4;TMEM119;HDAC3;HDAC5
prerank,regulation of fatty acid oxidation (GO:0046320),-0.4192351526978174,-1.1739874240866073,0.21754385964912282,0.7779592938777352,1.0,3/16,5.49%,PRKAG2;APPL2;LONP2
prerank,digestive tract development (GO:0048565),0.44636645893468935,1.1739223651795203,0.2503225806451613,0.9741184965286476,1.0,9/32,14.69%,GLI2;PKDCC;CCDC39;GLI1;GATA6;SMO;RARB;COBL;PKD1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.5566930953862106,1.1737049316158699,0.30864197530864196,0.9737082341253827,1.0,3/10,8.28%,PTPN2;SOCS1;NF2
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.4143071790917472,1.1724395607868778,0.2523148148148148,0.9774441258903125,1.0,13/57,14.39%,USP50;PYCARD;MYC;TBC1D10A;FADD;GRIN2B;ACVR1C;CARD9;FYN;ARL6IP5;MALT1;TTBK1;GRIN2A
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5264665153053324,1.1723597931163894,0.2952522255192878,0.9764509200902243,1.0,5/12,24.34%,SNAP23;SNAP29;STX1B;STX2;SNAP47
prerank,Rac protein signal transduction (GO:0016601),0.49543886363595124,1.1720913220827465,0.2865412445730825,0.976252598722085,1.0,8/18,19.03%,HACE1;BRK1;FARP2;RHOH;WASF1;CYFIP1;ELMO1;NCKAP1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.48039088082114373,1.171592538798118,0.28454172366621067,0.9769688528691741,1.0,5/20,15.00%,RNF157;BICD1;SNCA;CRY1;MET
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.4342482368781158,1.1705909804940924,0.2765957446808511,0.9797738701376981,1.0,9/35,13.22%,SOX9;PDE7B;MAPK7;KSR1;PDE9A;HTR2C;AKAP6;PDE4D;AHR
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.24627027749819622,-1.1704862968698106,0.043478260869565216,0.7861737989819719,1.0,45/182,12.99%,FOXP1;NOTCH2;IGF1;ROBO1;ROCK2;WNT4;CLDN5;OCLN;ACVRL1;BMP4;ENG;NOCT;REL;SLC7A5;ANXA7;MOV10;SETDB2;KDR;AGO1;ERP29;TERF2;APP;PARP10;RIN3;MAP2K1;MTMR2;TET1;KLF4;FLCN;RACK1;ADAM10;XDH;SLC24A3;PRKAA2;CCDC3;OPTN;ATOH8;LGMN;GATA2;AGO3;MAPT;TGFB2;ID2;SLC2A10;VHL
prerank,aorta development (GO:0035904),-0.43155048311758404,-1.1704008920080144,0.23961661341853036,0.7838219303150714,1.0,7/14,12.43%,ROBO1;TBX1;EFEMP2;JAG1;PDGFRB;HECTD1;PDE2A
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.535344811446554,1.1703321832787226,0.29235382308845576,0.9794388482241453,1.0,3/12,3.35%,GLI2;EPHB6;EPHB2
prerank,protein processing (GO:0016485),0.3844611024540343,1.1699190878224952,0.21972132904608788,0.9797988823128587,1.0,20/102,15.30%,HGFAC;PTCH1;ADAM19;HM13;PARL;PSEN1;PCSK4;PCSK6;ATP23;KLK1;KLK6;SPCS3;MMP16;NCSTN;APH1A;YME1L1;CPD;TYSND1;PSEN2;CASP2
prerank,cell-cell junction organization (GO:0045216),0.39439942620873664,1.1691709184765113,0.2407199100112486,0.9815821020491095,1.0,14/79,9.73%,DCHS1;CDH19;TGFB1;DSG2;CDH10;CLDN1;CDH22;CDH8;CADM3;CSK;CADM2;CADM1;CDH20;CDH7
prerank,tRNA wobble uridine modification (GO:0002098),-0.43351979680870284,-1.1688211211937847,0.26517571884984026,0.7862921202020221,1.0,6/14,16.43%,TRMT9B;URM1;ELP3;ELP1;MTO1;DPH3
prerank,protein K48-linked ubiquitination (GO:0070936),0.4096182782699951,1.1679288466857356,0.23592814371257484,0.9853802397168927,1.0,9/54,9.84%,UBE2T;PRKN;UBE2E2;HACE1;RNF6;FBXO38;PELI1;UBE2K;CUL3
prerank,adipose tissue development (GO:0060612),0.545507675291563,1.1677419518569738,0.29709035222052066,0.9848189831559938,1.0,4/11,7.04%,SOX8;PGRMC2;RORC;DYRK1B
prerank,negative regulation of leukocyte activation (GO:0002695),-0.4172173995995893,-1.1670776515257635,0.24836601307189543,0.7891521132813725,1.0,6/15,20.71%,CD200;IL31RA;CD300A;GPER1;HAVCR2;NR1H3
prerank,RNA biosynthetic process (GO:0032774),-0.3400944337965425,-1.1666732002146414,0.19736842105263158,0.7877708773488582,1.0,13/31,24.58%,NCOA6;BRF1;PRIM2;POLA1;TAF13;PRMT5;HELB;POLA2;TERT;SMARCA5;BRF2;TAF10;TBPL1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.4113935717367692,-1.166591312580528,0.2643312101910828,0.7854448709213642,1.0,6/16,25.47%,KIF5B;TUBB4B;PLEKHM2;CEBPG;VAMP7;ULBP1
prerank,negative regulation of protein modification process (GO:0031400),0.39039225976144504,1.1663442348320505,0.24118942731277532,0.9892373293340683,1.0,18/79,12.62%,NTRK3;PIP5KL1;PTEN;PRKN;EPHB2;CADM4;TGFB1;PRNP;PPP1R15A;PTPN13;NIBAN1;MEN1;ENSA;PPP1R8;CDYL;PID1;FXYD1;WWTR1
prerank,protein localization to condensed chromosome (GO:1903083),-0.44567976153905264,-1.1658395335827885,0.2571428571428571,0.7853319579606514,1.0,10/12,47.90%,BUB3;IK;KNL1;ZW10;TTK;SPDL1;CDK1;MTBP;AURKB;CHAMP1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.4375514612894581,1.1653213726289315,0.2548780487804878,0.9921988572107107,1.0,11/38,16.10%,CACNA2D1;ANK2;DSG2;SCN5A;CTNNA3;KCND3;BIN1;KCNJ3;PKP2;JUP;KCNH2
prerank,cytoskeleton organization (GO:0007010),0.37934339343880963,1.164424294337367,0.21752903907074975,0.9944716330822315,1.0,24/114,13.65%,CCL11;ANK1;RHOD;WDPCP;RND3;FGD4;RHOBTB3;PAK4;FMNL2;MAST2;PACSIN2;PAK5;TNIK;OBSL1;PDZD8;BIN1;EPB41L3;PALLD;ZMYM6;RHOH;RHOC;NECTIN2;SH3KBP1;ARHGAP4
prerank,PERK-mediated unfolded protein response (GO:0036499),0.5629026961498163,1.164171523942669,0.29431438127090304,0.9941373386562806,1.0,4/10,16.49%,EIF2AK3;HERPUD1;NFE2L2;QRICH1
prerank,regulation of cellular component movement (GO:0051270),-0.29867032578300823,-1.1640640949349408,0.1893491124260355,0.7883251377151317,1.0,16/49,9.34%,SP100;ROCK2;ETS1;ROCK1;DIAPH1;LYN;YTHDF1;TGFBR1;ABL2;RPS19;ZSWIM6;PDPN;ACTN1;ARAP1;ZSWIM4;RHOA
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.26162383243123283,-1.1640013872817092,0.09090909090909091,0.7859366377770095,1.0,27/112,12.51%,PTPRK;GCNT2;WNT4;SMAD6;CDH5;CLDN5;ITGB5;APPL2;ACVRL1;SMAD7;ENG;ID1;USP9X;SMAD9;TGFBR1;PDCD5;PARD3;ZFP36L1;PDE3A;TWSG1;PRKCZ;RHOA;NLK;LRRC32;MAP3K7;PDE2A;TGFB2
prerank,Golgi inheritance (GO:0048313),0.5383615075326139,1.1639538204999336,0.3102409638554217,0.9937085897115776,1.0,2/11,7.30%,YWHAZ;GBF1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.5017360266126718,1.1639184881312854,0.31798561151079136,0.9925372448876572,1.0,3/17,3.73%,MAML3;KAT2B;MAML2
prerank,limb morphogenesis (GO:0035108),0.49495819317651474,1.1636350099296857,0.27209944751381215,0.99231094402482,1.0,1/20,0.46%,PTCH1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.49411698018390304,1.1635557435558004,0.3016759776536313,0.9912895822564117,1.0,6/18,17.24%,MYC;NF1;EMD;MED25;TP53;CDC73
prerank,inner dynein arm assembly (GO:0036159),0.5563093096247056,1.1632745543301972,0.305111821086262,0.9911219278304289,1.0,1/10,2.93%,CCDC39
prerank,regulation of actin filament-based process (GO:0032970),0.39767147941096903,1.1629095655339226,0.2542759407069555,0.9913220563472945,1.0,11/70,6.44%,DLC1;RHOD;BST1;LRP1;RND3;EFNA5;RHOBTB3;GPM6B;IQGAP2;PAK1;BAIAP2
prerank,actin filament bundle assembly (GO:0051017),-0.35207689390296754,-1.1628773264799186,0.22596153846153846,0.7869710673863632,1.0,4/33,2.13%,PAWR;CALD1;BAIAP2L1;NEDD9
prerank,histone H3-K36 demethylation (GO:0070544),0.5590592542357256,1.162760998520516,0.3059210526315789,0.9906422309848039,1.0,4/10,19.51%,KDM8;KDM4B;PHF8;RIOX2
prerank,negative regulation of blood pressure (GO:0045776),-0.4393973200927313,-1.1620839406950276,0.29102167182662536,0.78691961916259,1.0,3/13,15.27%,NOS3;BMPR2;NOS1
prerank,anterior/posterior axis specification (GO:0009948),-0.41481992051066724,-1.1620177179533249,0.24342105263157895,0.7845697395324028,1.0,2/15,3.72%,WLS;TBX3
prerank,regulation of lipid storage (GO:0010883),0.47981538961122583,1.1616366579426827,0.2767732962447844,0.9940376556880715,1.0,3/22,5.00%,PTPN2;FBXW7;MEST
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.45626329443778824,1.1614977004315206,0.2734274711168164,0.9932425788863004,1.0,5/28,6.95%,BCL2;NGF;FADD;TNFRSF10B;DEDD
prerank,aminoglycan biosynthetic process (GO:0006023),0.41979482362021214,1.1613720576707678,0.2576832151300236,0.9924712412237104,1.0,10/49,12.81%,GPC3;HSPG2;HS6ST1;SDC2;EXT1;B3GNT9;SDC4;GPC1;SDC3;GPC4
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.2797327473340723,-1.1611193840471092,0.16161616161616163,0.7848993187806073,1.0,18/75,13.07%,ATP1A2;ATP1B3;SLC8A3;SLC12A7;SLC9A6;SLC9A2;KCNJ2;ABCC9;ATP1A1;SLC12A9;SLC39A8;SLC39A6;SLC9A9;SLC9A7;KCNK9;SLC6A1;TRPV2;SLC12A8
prerank,carboxylic acid transport (GO:0046942),-0.3058706926563288,-1.1609705739925855,0.2,0.782817738823374,1.0,17/55,18.92%,SLC13A3;SLC16A12;SLC16A6;SLC6A12;SLC6A6;SLC6A13;SLC7A5;SLC16A11;SLC16A2;SLC6A11;SLC66A1;SLC38A5;SLC16A9;SLC36A4;SLC6A7;SLC16A7;LLGL2
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.4952438689784257,1.1606967729639872,0.3045897079276773,0.9938863801086628,1.0,4/17,10.32%,FGF2;SOX9;RFX3;SFRP4
prerank,protein insertion into membrane (GO:0051205),0.43997189732099246,1.160184484345096,0.2790091264667536,0.9946565332546771,1.0,12/32,20.61%,EGFR;WDR83OS;PRNP;COX18;VAPA;UBE2J2;EMD;OTOF;CCDC47;SEC61G;CYB5A;SGTA
prerank,organelle transport along microtubule (GO:0072384),0.44836914646439596,1.1600439080063727,0.28350515463917525,0.9939028629601573,1.0,13/31,18.48%,BICD1;NDE1;COPG2;RHOT2;DYNC1I1;BICD2;ARHGAP21;RAB1A;COPG1;UBB;TRAK2;RHOT1;HTT
prerank,regulation of neutrophil migration (GO:1902622),0.5584676485360109,1.1595440196293618,0.2917341977309562,0.9945316600619759,1.0,3/10,12.13%,OLFM4;BST1;RHOH
prerank,positive regulation of chromosome organization (GO:2001252),0.5006367252281416,1.1593193846145293,0.3096590909090909,0.9941469322539335,1.0,4/15,14.21%,DDX11;ATRX;SIRT6;RTEL1
prerank,regulation of protein autophosphorylation (GO:0031952),-0.3346228783930745,-1.1591532697237927,0.20812182741116753,0.7860295260031297,1.0,4/36,3.05%,PDGFD;EPHA7;ERRFI1;ENG
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.27361022395066614,-1.158915680585281,0.17204301075268819,0.7842417727299182,1.0,21/84,12.04%,FOXP1;ANXA3;ROCK2;SASH1;ETS1;NRP1;TEK;ANGPT1;NOS3;BMP4;MAP2K3;BMPR2;KDR;THBS1;BCAR1;GPI;ATOH8;TMSB4X;LGMN;GATA2;PROX1
prerank,lung development (GO:0030324),0.44160746386796884,1.1589087374809903,0.28991060025542786,0.9944781787298703,1.0,9/33,11.99%,GLI2;FGF2;FGF10;CCDC39;VEGFA;SOX11;LOXL3;RCN3;FGF7
prerank,response to light stimulus (GO:0009416),0.41870142212191486,1.1587797906231063,0.27526132404181186,0.9937135383363283,1.0,14/55,17.26%,RHO;ZRANB3;GTF2H2;ERCC5;ERCC4;DDB2;MEN1;MSH6;GPR88;DRD2;CRY1;FECH;USP1;REV1
prerank,amino acid import across plasma membrane (GO:0089718),-0.35512636057321867,-1.1584416012951841,0.22813688212927757,0.7831592778903077,1.0,6/24,3.59%,SLC7A2;SLC47A1;SLC6A6;SLC22A4;SLC6A13;SLC7A5
prerank,apoptotic process (GO:0006915),0.3669379080739843,1.1582429105504854,0.1773049645390071,0.9946996347926699,1.0,59/203,21.08%,DLC1;BCL2L14;ERBB3;IL2RA;MAGI3;FAP;PYCARD;MYC;BCL2;FADD;EFNA5;SCN2A;JADE1;PAK4;TNFRSF10B;PAK5;PPP1R15A;BNIPL;APAF1;ZBTB16;TGFBR2;BMF;CASP6;BNIP3;NAE1;HIP1;DCC;NGFR;ING4;CASP12;YARS1;RFK;AHR;BRAT1;AHCYL1;TRPC5;PAX3;TRAF7;RTN4;ELMO1;CASP2;BNIP1;IFT57;BCL2L11;AKAP1;RIPK1;AIFM1;MRPS30;MDM2;IRF3;CASP7;NCKAP1;HK2;PDCD4;TRAIP;IER3;HSPD1;DPF2;KREMEN1
prerank,positive regulation of axon extension (GO:0045773),-0.37536255625894555,-1.158148317627608,0.2440677966101695,0.7816425902793595,1.0,4/22,3.01%,MACF1;NRP1;GOLGA4;SEMA7A
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.45185394783490057,-1.1579761628812002,0.27531645569620256,0.7797028800641591,1.0,3/12,4.61%,THRB;CTSH;LMO2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.48056576455336586,1.157903751448068,0.3130311614730878,0.9947608581214071,1.0,3/18,11.86%,CHRM3;PLCB1;CDK5R1
prerank,regulation of viral life cycle (GO:1903900),-0.38763301807056016,-1.157730716894228,0.23550724637681159,0.7780664750060168,1.0,10/21,28.37%,TSG101;TRIM25;PPIA;TRIM5;VPS4A;TRIM21;TRIM68;KPNA2;TYRO3;TRIM6
prerank,cellular response to hydroxyurea (GO:0072711),0.5647661291542977,1.1573850206664533,0.31490015360983103,0.9955281452314005,1.0,5/10,15.98%,DDX11;NSMCE3;ATRX;BLM;SPIDR
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5433432405530513,1.1571852995382668,0.296411856474259,0.995027151862111,1.0,3/10,9.88%,KMT2A;BRCA1;PIH1D1
prerank,monocyte differentiation (GO:0030224),-0.4720681221174102,-1.1568472939636232,0.2768361581920904,0.7783837846814372,1.0,3/10,2.72%,MYH9;IL31RA;BMP4
prerank,histone H4 acetylation (GO:0043967),0.4192362350093707,1.156531556351656,0.2727272727272727,0.9964125188146978,1.0,15/47,15.62%,JADE1;KMT2A;HAT1;JADE3;KAT8;BRD8;MORF4L2;ATF2;PHF20;ING4;EPC1;PER1;KANSL1;TRRAP;MSL3
prerank,epithelial cell-cell adhesion (GO:0090136),-0.4632685581572732,-1.1565231225887767,0.2886297376093295,0.7769569412157632,1.0,2/11,2.17%,KIT;ITGB5
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.49838472908048737,1.1562899656780719,0.30428360413589367,0.9960693971999055,1.0,2/15,5.22%,HSPH1;CCR2
prerank,peptidyl-arginine modification (GO:0018195),-0.42123451940703593,-1.1561296717907283,0.2686084142394822,0.7756571388169811,1.0,5/15,13.96%,PRMT7;PRMT5;KRTCAP2;PRMT8;PADI2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.38574238828972973,1.155685178676044,0.25277161862527714,0.9971598031486728,1.0,13/87,6.44%,DLC1;PDGFRA;SEMA3E;RHOD;BST1;LRP1;RND3;EFNA5;RHOBTB3;GPM6B;IQGAP2;PAK1;BAIAP2
prerank,response to thyroid hormone (GO:0097066),-0.44127844883318873,-1.1552518526193387,0.28431372549019607,0.7760482536497249,1.0,3/13,4.61%,THRB;CTSH;LMO2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3910517076595303,1.1544660273929983,0.25817361894024804,1.0,1.0,12/69,8.26%,PDGFRA;ERBB3;PTEN;IRS2;NGF;ERBB2;PLCB1;NF1;NYAP1;PI4KB;FGFR1;GAB2
prerank,mesenchymal cell differentiation (GO:0048762),-0.3074545169384112,-1.1537070350721303,0.21428571428571427,0.7785321446533984,1.0,17/51,15.30%,RANBP3L;ROCK2;LEF1;WNT4;ROCK1;CTNNB1;ENG;TGFBR1;DDX5;GSK3B;FBXL17;FGFR2;NOTCH4;TGFB2;AKNA;HMGA2;HEY2
prerank,inner ear morphogenesis (GO:0042472),0.46792228766410315,1.153626219207568,0.29748603351955305,1.0,1.0,4/22,7.60%,SOX9;EPHB2;TTC39C;TBX18
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.38919975802162565,-1.1536071301675812,0.2542372881355932,0.7764137127067606,1.0,4/21,4.25%,OSBPL8;PLA2G4A;PLA1A;OSBPL10
prerank,positive regulation of interleukin-10 production (GO:0032733),0.4448303958625098,1.153294727528702,0.27479892761394104,1.0,1.0,2/30,1.88%,PYCARD;CD34
prerank,regulation of neuron apoptotic process (GO:0043523),0.38350329953606993,1.1531371991426727,0.25163398692810457,1.0,1.0,19/96,13.02%,ERBB3;BCL2;CRLF1;NGF;PRKN;NTRK2;PRNP;MT3;NF1;GRID2;RASA1;TRIM2;NAE1;SNX6;GDNF;CDK5R1;GRN;SOD2;PTPRZ1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5231030099395246,1.153022034987302,0.31305637982195844,1.0,1.0,5/13,12.38%,CBLB;SOCS5;SNX6;CBL;ZGPAT
prerank,protein homooligomerization (GO:0051260),0.37785850553020983,1.152766419478397,0.24130663856691253,1.0,1.0,30/114,20.23%,SCARA5;STEAP4;CTH;PYCARD;SLC1A5;ACACA;LETM1;AQP4;MPP2;ALS2;CARD9;PRMT1;ATL3;ALOX5AP;ZBTB1;SOD2;TMEM120A;NACC2;PDCD6IP;BLM;PNPT1;ALDH1A3;GLS;FUS;RYR3;MLKL;HCN1;BCL10;ADCY8;DISP1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.4436839406748762,1.1519933030452032,0.26851851851851855,1.0,1.0,9/32,20.04%,SLC27A1;SLC44A2;PCYT1B;CHPT1;CHAT;GPAT4;SLC44A1;CSNK2A2;STARD7
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.3716134999592991,-1.1519233591330809,0.25396825396825395,0.7796289145760845,1.0,20/26,39.36%,APPL2;BIRC3;GPS2;LGR4;GPR108;IRF1;LRRC14;FLOT1;APPL1;CACTIN;NLRP2B;TYRO3;SMPDL3B;TLR3;BIRC2;IRF7;TREM2;CD36;NFKBIL1;TLR5
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.5603911339302983,1.1518218223900416,0.3146417445482866,1.0,1.0,6/10,21.95%,KLF15;DIP2A;SETD5;DIP2B;PARK7;PRKAA1
prerank,regulation of T cell proliferation (GO:0042129),0.3974854424410393,1.1512159741902068,0.26741573033707866,1.0,1.0,6/61,14.00%,LGALS3;GLMN;SDC4;IL4I1;IL6ST;NCK1
prerank,neurogenesis (GO:0022008),0.4176992965844201,1.1511860576942603,0.2800982800982801,1.0,1.0,4/43,7.57%,DCHS1;LPAR1;METTL3;CDK6
prerank,positive regulation of neurogenesis (GO:0050769),0.3930348876851346,1.1509861160395587,0.28265765765765766,1.0,1.0,13/68,6.62%,CHODL;SOX8;NGF;PLXNC1;IL1RAPL1;VEGFA;SOX11;NTRK2;NUMBL;OBSL1;CDKL5;CDKL3;DISC1
prerank,lamellipodium assembly (GO:0030032),-0.3516675730952081,-1.150095652809788,0.23684210526315788,0.7828379486827464,1.0,9/26,14.82%,ABLIM1;KIT;CDH13;PARVB;ARHGEF6;ABLIM2;WHAMM;PTPRO;S1PR1
prerank,synaptic vesicle recycling (GO:0036465),0.4446539527447887,1.1500921223899625,0.27626459143968873,1.0,1.0,10/31,18.64%,CEL;STON2;SYT1;NLGN1;STON1;OPHN1;RAB3A;SNCA;SYT2;SNCB
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.469454950441588,1.1493444343026376,0.3125,1.0,1.0,8/23,20.97%,RAD23B;DDB2;XPA;DDB1;UBB;CUL4B;COPS6;COPS7A
prerank,regulation of acrosome reaction (GO:0060046),0.5497916493023332,1.1492999389031746,0.3157894736842105,1.0,1.0,1/10,4.92%,PLCB1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.2811265268965166,-1.1490594511438008,0.17266187050359713,0.783807801300963,1.0,26/65,29.99%,PSMD14;FBXL7;USP47;PSMB3;PSMD12;VPS4A;PSMD6;PSMA1;PSMD7;NABP1;PSMA5;PSMC5;PINX1;PSMC4;PSMB6;PSMA4;CHFR;PSMB1;PSMB9;AVEN;ZFYVE19;PSMC6;PSMD3;PSMD10;PSME3;CHEK1
prerank,homotypic cell-cell adhesion (GO:0034109),0.4256175712941213,1.1488747709445024,0.29,1.0,1.0,4/39,2.62%,UBASH3B;PDGFRA;CSRP1;RAP2B
prerank,regulation of neurogenesis (GO:0050767),0.4002942070717549,1.1487224592149936,0.28211284513805523,1.0,1.0,5/55,5.44%,CCL11;DOCK7;SOX11;PCM1;NUMBL
prerank,protein localization to plasma membrane (GO:0072659),0.37042168588554886,1.1482624049287724,0.22741433021806853,1.0,1.0,30/129,15.42%,PTCH1;ANK3;ANK1;FGF13;ANK2;GORASP1;C2CD5;WNK3;PACS2;TSPAN32;TNIK;SPTBN1;DPP10;RAP1A;RAB34;GAK;EPB41L3;FLNA;RAB3D;TSPAN17;GORASP2;RAB3A;MAP7;KCNIP4;P2RY1;TMED2;TTC7A;EHD2;PKP2;JUP
prerank,response to histamine (GO:0034776),0.5438260053963294,1.1482462003750473,0.3128834355828221,1.0,1.0,4/10,15.82%,HRH1;AOC1;DRD2;GABRG2
prerank,global genome nucleotide-excision repair (GO:0070911),0.4622151734309056,1.1477376254738885,0.3036649214659686,1.0,1.0,9/26,17.09%,RAD23B;GTF2H2;ERCC4;DDB2;XPA;DDB1;UBB;RNF111;CUL4B
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.43472699639583817,1.1475592200933826,0.289171974522293,1.0,1.0,4/34,5.52%,PTPN22;EPHB2;DNAJB9;WNT5A
prerank,cellular response to calcium ion (GO:0071277),0.39849509684615664,1.147017308565635,0.2634593356242841,1.0,1.0,26/67,24.09%,CPNE8;DPEP1;HPCA;SCN5A;WNT5A;SYT1;NLGN1;SYT11;SYT12;ALOX5AP;IQGAP1;GPLD1;SLC25A24;CPNE7;SYT2;RYR3;CPNE1;SYT13;ADCY8;CPNE3;PKD2;PRKAA1;CAMK2D;CPNE5;SYT3;MEF2A
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.3950701335331528,1.1463315102695244,0.26971428571428574,1.0,1.0,15/67,17.76%,VIT;UTRN;OLFM4;FBLN2;DOCK5;CDK6;FLNA;DOCK1;ARL2;MYOC;JUP;ABL1;RELL2;RAC3;MDK
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.452862271167498,1.1462268672740556,0.3190104166666667,1.0,1.0,4/26,7.57%,MYC;PTPN2;HOXA7;CDK6
prerank,positive regulation of transferase activity (GO:0051347),0.3654868873254074,1.1460072107370858,0.23204994797086367,1.0,1.0,15/142,4.52%,ROR2;ROR1;PDGFRA;ERBB3;PRKCQ;NTRK3;MYC;EPHB6;ERBB2;EGFR;EPHB2;FBXW7;CHTF18;TGFB1;NTRK2
prerank,chloride transport (GO:0006821),0.38913427833935693,1.1456426563486435,0.24888392857142858,1.0,1.0,14/74,15.82%,FXYD3;ANO2;SLC1A3;SLC12A3;ANO6;SLC12A2;TTYH3;TTYH1;SLC12A4;FXYD1;ANO10;CLIC1;CLCN2;GABRG2
prerank,regulation of isotype switching (GO:0045191),-0.42448564026422836,-1.1456403306665144,0.29141104294478526,0.7920655508150429,1.0,5/14,24.28%,RIF1;PARP3;TFRC;PAXIP1;MAD2L2
prerank,mitochondrion disassembly (GO:0061726),0.4301703472310023,1.1455625764182693,0.2874845105328377,1.0,1.0,8/34,14.98%,PRKN;FBXO7;WIPI1;CTSK;BNIP3;ATG5;ATG3;GABARAPL2
prerank,regulation of bone mineralization (GO:0030500),0.4002675879936308,1.1455127474325497,0.2763761467889908,1.0,1.0,7/55,4.11%,OSR2;ANKH;PKDCC;ACVR1;ANO6;TGFB1;GPM6B
prerank,negative regulation of immune effector process (GO:0002698),0.5068683882682112,1.145224407518932,0.30346820809248554,1.0,1.0,1/13,0.37%,LGALS3
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.4426023020789435,1.1449280109652153,0.31125827814569534,1.0,1.0,8/29,19.95%,PLBD1;MBOAT2;PLA2G12A;PLAAT3;PNPLA8;LPCAT2;DBI;PLA2G4E
prerank,positive regulation of B cell activation (GO:0050871),0.4017385590271965,1.1448973895335264,0.30011723329425555,1.0,1.0,5/50,3.90%,BCL2;IRS2;BST1;EPHB2;CD320
prerank,ribosomal small subunit assembly (GO:0000028),-0.3957585787871951,-1.1447292355020984,0.22727272727272727,0.7926996835876239,1.0,8/16,27.55%,RPS14;RPS19;RPS15;MRPS7;MRPS11;RPS5;PWP2;RPS27
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.3132654087125931,-1.1446993913302865,0.2331288343558282,0.7903808807492837,1.0,14/46,12.61%,FOXP1;IGF1;ELN;CDH13;CTNNB1;BMP4;IGFBP3;IGFBP5;THBS1;OGN;PDGFRB;IL6R;CCN4;ID2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4282335399088504,1.1440914354765859,0.2938271604938272,1.0,1.0,3/36,4.08%,DCN;FGF2;TGFB1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.5064711107464457,1.144016676186403,0.30416068866571017,1.0,1.0,5/15,15.00%,FGF2;VEGFA;FGFR1;SMOC2;MET
prerank,ESCRT III complex disassembly (GO:1904903),-0.4582553574889852,-1.1436734294521453,0.31016042780748665,0.7889382333585527,1.0,5/10,23.97%,VPS4A;CHMP1A;VPS4B;CHMP7;CHMP2B
prerank,ESCRT complex disassembly (GO:1904896),-0.4582553574889852,-1.1436734294521453,0.31016042780748665,0.7889382333585527,1.0,5/10,23.97%,VPS4A;CHMP1A;VPS4B;CHMP7;CHMP2B
prerank,negative regulation of cell population proliferation (GO:0008285),0.3554255836309089,1.1436448558612637,0.15045135406218657,1.0,1.0,64/351,16.21%,APOD;ROR2;DLC1;SSTR1;WNK2;BMP5;CLDN19;FAP;GLMN;MYC;PTEN;KAT2B;SOX9;NGF;VGLL4;CDKN2B;FRZB;PTPN2;PTHLH;TGFB1;SOX11;NUPR2;NF1;ACVR1C;WNT5A;PAK1;BNIPL;PODN;TSC1;ADAMTS1;CYP1B1;CBFA2T3;GATA6;CDK6;MEN1;NF2;COL18A1;RARG;ERBB4;SFRP4;PTPRJ;EMD;ATRAID;MAGI2;ING4;ATP8A2;DRD2;SOD2;ATF5;ADARB1;STRN;GATA3;RBBP4;NACC2;RPS6KA2;PDS5B;MDM4;CD164;LMNA;MED25;PIM2;TP53;GPLD1;TGFB3
prerank,pre-miRNA processing (GO:0031054),-0.42282726119344516,-1.1431422621489156,0.3217391304347826,0.788235163480839,1.0,9/14,30.18%,AGO1;TUT7;AGO3;TARBP2;LIN28B;MRPL44;AGO2;DICER1;AGO4
prerank,negative regulation of neuron death (GO:1901215),0.3812222488077256,1.1431306104463417,0.26229508196721313,1.0,1.0,22/93,19.36%,ERBB3;BCL2;CD34;CRLF1;NGF;PRKN;NTRK2;MT3;FBXO7;RASA1;SNX6;EIF4G1;GDNF;GRN;SOD2;PTPRZ1;SNCA;FZD9;TGFB3;MDK;PARK7;BTBD10
prerank,cell-matrix adhesion (GO:0007160),0.3785013848749413,1.1431219597954312,0.26366559485530544,1.0,1.0,21/95,17.75%,DLC1;ADAMTS12;RHOD;CD34;PEAK1;ITGB8;TESK2;HOXD3;TSC1;MKLN1;COL3A1;TRIP6;SGCE;PPFIA2;TMEM8B;PKD1;ITGB1;ZYX;CTTN;ITGB7;PIP5K1A
prerank,regulation of developmental growth (GO:0048638),-0.3330009724754569,-1.142449150680603,0.22549019607843138,0.7879935508487371,1.0,12/29,18.78%,IGF1;LATS2;INSR;STAT5B;APP;SIX1;GSK3B;SOD1;DNM2;MFSD2A;APOE;SIN3A
prerank,snRNA metabolic process (GO:0016073),0.4873355802852411,1.142355866951458,0.30701754385964913,1.0,1.0,7/17,15.74%,INTS11;INTS6;INTS4;INTS2;INTS8;RBM7;MEPCE
prerank,lymphocyte differentiation (GO:0030098),0.39175903207193025,1.1421709976844114,0.2984409799554566,1.0,1.0,21/68,25.79%,RAG2;PTPN22;PTPN2;DNAJB9;RABL3;NHEJ1;PTPRJ;DCAF1;RHOH;GATA3;ITGB1;MS4A1;AXL;PBX1;CR2;KAT7;NFAM1;LMBR1L;SOX4;TPD52;ITGA4
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4874851534369159,1.1418493543884312,0.29753265602322204,1.0,1.0,3/18,7.73%,BCL2;THEM4;BNIP3
prerank,natural killer cell mediated immunity (GO:0002228),-0.4158064992576306,-1.1416888141463635,0.26791277258566976,0.7879563585378523,1.0,5/15,25.47%,KIF5B;TUBB4B;PLEKHM2;CEBPG;ULBP1
prerank,regulation of establishment of cell polarity (GO:2000114),-0.3966678141189479,-1.1414536122058412,0.3412969283276451,0.7863369883370344,1.0,5/16,4.22%,ROCK2;CDH5;RAP1B;ROCK1;CYRIB
prerank,lymphocyte migration (GO:0072676),0.4429192704499649,1.1414076790443473,0.30739299610894943,1.0,1.0,5/32,15.18%,CCL11;CCL4;CKLF;GATA3;CCL14
prerank,positive regulation of natural killer cell activation (GO:0032816),0.5103395948829527,1.1411109740976288,0.32272727272727275,1.0,1.0,5/13,18.99%,AP1G1;IL18;ZBTB1;TICAM1;AXL
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3721273006572991,1.140810705563825,0.26040554962646745,1.0,1.0,24/110,16.07%,LGALS3;HRK;GSN;VEGFA;TGFB1;ATF7IP;RALB;BMF;BRK1;ANKRA2;CRYAB;PIH1D1;FARP2;SLF2;PTPN11;HDAC6;RHOC;HJURP;SUMO1;GFAP;MTLN;STX1B;SPIDR;BCL2L11
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.4603100827131867,-1.1404111530541554,0.2959770114942529,0.782782643463613,1.0,5/11,18.21%,PANK1;PANK2;PANK3;PPCDC;PANK4
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.4603100827131867,-1.1404111530541554,0.2959770114942529,0.782782643463613,1.0,5/11,18.21%,PANK1;PANK2;PANK3;PPCDC;PANK4
prerank,coenzyme A biosynthetic process (GO:0015937),-0.4603100827131867,-1.1404111530541554,0.2959770114942529,0.782782643463613,1.0,5/11,18.21%,PANK1;PANK2;PANK3;PPCDC;PANK4
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4515798293583742,1.1400524787556992,0.3089005235602094,1.0,1.0,13/26,26.93%,SUV39H1;KMT2A;SETD3;PRDM9;SETD2;SETD5;TET3;SETD4;KMT2D;TET2;KMT5B;VCPKMT;KMT5C
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5471783187783803,1.1399357743821228,0.32148626817447495,1.0,1.0,4/10,17.29%,FBXW7;NCF1;BTC;HBEGF
prerank,lipid oxidation (GO:0034440),0.5251513941003039,1.1398728970492311,0.346969696969697,1.0,1.0,2/12,8.14%,PLA2G7;ACOX1
prerank,metal ion transport (GO:0030001),0.3833286599388736,1.1396795949729392,0.276013143483023,1.0,1.0,17/86,14.33%,CACNA1E;CACNA2D1;MRS2;CACNG7;NIPA1;CACNA1A;CHRNA4;PSEN1;MT3;NIPAL2;SLC8A2;FYN;MAGT1;NDFIP1;TRPC5;TUSC3;PSEN2
prerank,regulation of cellular component organization (GO:0051128),0.3648504070000293,1.1396795525590167,0.2647058823529412,1.0,1.0,37/135,16.93%,PTCH2;PRKCQ;ANGPTL7;STON2;NRG3;PAK4;IRAK3;PACSIN2;PAK5;WNT5A;URI1;STON1;RAP1A;LAMTOR2;ARHGEF11;BAG5;HIP1;ANKRA2;SGK3;SGK2;PTPN1;PTPN11;OPHN1;HJURP;RAB4B;CHPT1;SETD5;ATF5;RAB4A;ARFGAP1;GFAP;PAPPA2;TMEM97;ABL1;HNRNPU;SGK1;SNX12
prerank,positive regulation of phospholipase activity (GO:0010518),0.4662117985375873,1.1395884978580646,0.289437585733882,1.0,1.0,7/22,10.80%,PDGFRA;NTRK3;FGF2;ARL1;FGFR1;ESR1;ARF4
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.48827507360964595,1.1395225404920017,0.3236994219653179,1.0,1.0,2/16,1.34%,BMP5;ZFAND2B
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.37291097219041336,-1.1392085685556217,0.28975265017667845,0.7843677080369484,1.0,11/22,23.13%,APPL2;MFHAS1;LYN;WDFY1;TIRAP;FLOT1;APPL1;IFI35;NINJ1;NR1H3;TNFAIP3
prerank,positive regulation of bone mineralization (GO:0030501),0.4280611810698047,1.1391571621537127,0.29345088161209065,1.0,1.0,12/35,16.21%,OSR2;PKDCC;ACVR1;ANO6;TGFB1;GPM6B;BMP7;ATRAID;ATP2B1;BMPR1A;FZD9;TGFB3
prerank,protein localization to membrane (GO:0072657),0.36168655310591014,1.1390735523314108,0.22324159021406728,1.0,1.0,42/187,15.42%,PTCH1;ANK3;ANK1;HPS6;FGF13;ANK2;RAB38;C2CD5;SAV1;WNK3;ARL3;PACS2;NPC1;NRXN1;TSPAN32;TNIK;DLG2;SPTBN1;NLGN1;NUP155;DPP10;RAP1A;RAB34;GAK;EPB41L3;FLNA;RAB3D;ARL5C;NDC1;TSPAN17;MAGI2;DVL1;RAB3A;SCRIB;MAP7;KCNIP4;P2RY1;TMED2;TTC7A;EHD2;PKP2;JUP
prerank,intracellular sterol transport (GO:0032366),-0.42859576919990033,-1.1386556857181034,0.27300613496932513,0.7838908205010795,1.0,6/13,12.31%,ABCA1;OSBP;OSBPL2;VPS4A;ABCG1;STARD4
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.4656757862803055,1.1382973796330393,0.31550068587105623,1.0,1.0,11/21,27.69%,H6PD;RPE;SHPK;PGLS;HK2;TALDO1;HK1;RBKS;RPIA;PGM2;GCK
prerank,response to muramyl dipeptide (GO:0032495),0.5269947781356354,1.1382126735390932,0.3201219512195122,1.0,1.0,3/12,11.28%,PTPN22;ERBIN;TRIM41
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.43246835564453057,-1.1380976543188719,0.2861271676300578,0.7833320078444365,1.0,4/12,18.70%,NOTCH2;PTK2B;LFNG;MFNG
prerank,linoleic acid metabolic process (GO:0043651),0.49366584333739777,1.1380463975703305,0.3392330383480826,1.0,1.0,3/17,13.50%,FADS2;ELOVL5;PNPLA8
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.4145161475158266,1.1367092693428351,0.30387409200968524,1.0,1.0,14/43,19.24%,CBLB;EGFR;PTPN2;SOCS5;EPS15;BTC;SNX6;PTPRJ;CBL;ZGPAT;SH3KBP1;HBEGF;RAB7A;GRB2
prerank,regulation of microtubule depolymerization (GO:0031114),0.44599056310208524,1.1364537357562612,0.3077956989247312,1.0,1.0,8/25,18.73%,FGF13;MAP1B;CLASP1;APC2;KATNB1;NAV3;ATXN7;CAMSAP1
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.3981814990975767,-1.1362224667930805,0.24761904761904763,0.7869875687462154,1.0,9/16,28.53%,ATP7A;SLC25A33;NUPR1;PINK1;AK4;PDE12;COX7A2;PPIF;VCP
prerank,hippo signaling (GO:0035329),0.4490825371596058,1.136060800846049,0.330749354005168,1.0,1.0,2/26,3.17%,DCHS1;SAV1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.44616922831801265,1.1354689854602196,0.2938775510204082,1.0,1.0,7/25,13.88%,GLMN;EGFR;PSEN1;FZD7;DSCAM;KCTD20;SNCA
prerank,positive regulation of catabolic process (GO:0009896),0.3867866015012154,1.1352659834611143,0.2809633027522936,1.0,1.0,12/65,16.25%,GPC3;PRKN;HACE1;WNT5A;ASB5;HUWE1;APC2;DDB1;NEDD4L;AREL1;DACT1;NDUFA13
prerank,muscle filament sliding (GO:0030049),-0.3151900756286596,-1.1349507157437175,0.23157894736842105,0.786649868640667,1.0,20/38,41.92%,TPM3;MYL6;TPM1;ACTN2;TPM2;TMOD1;DES;MYBPC1;DMD;MYL4;TNNI1;TTN;MYL1;NEB;TNNC1;TNNI3;MYBPC2;TCAP;MYL3;ACTA1
prerank,actin-myosin filament sliding (GO:0033275),-0.3151900756286596,-1.1349507157437175,0.23157894736842105,0.786649868640667,1.0,20/38,41.92%,TPM3;MYL6;TPM1;ACTN2;TPM2;TMOD1;DES;MYBPC1;DMD;MYL4;TNNI1;TTN;MYL1;NEB;TNNC1;TNNI3;MYBPC2;TCAP;MYL3;ACTA1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.39230010505236657,1.1348479854515798,0.28782707622298065,1.0,1.0,7/63,4.25%,LGALS3;BCL2L14;PYCARD;FADD;ACVR1;TNFRSF10B;DEPTOR
prerank,positive regulation of endopeptidase activity (GO:0010950),0.44908831569401086,1.1346818611864589,0.3018134715025907,1.0,1.0,7/26,13.71%,USP50;PYCARD;GRIN2B;FYN;NCSTN;APH1A;TTBK1
prerank,T cell homeostasis (GO:0043029),0.5454544594684352,1.1345838085531292,0.3328220858895706,1.0,1.0,2/10,7.55%,FADD;ZC3H8
prerank,amyloid precursor protein catabolic process (GO:0042987),0.5064043823165003,1.1345398837640301,0.3251088534107402,1.0,1.0,5/14,14.33%,ADAM19;PSEN1;NCSTN;APH1A;PSEN2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.37844830011085284,1.1344403649935635,0.27192008879023305,1.0,1.0,27/87,21.63%,FGF2;FGF10;EGR3;RAB14;POLR2B;SPRED2;SPRED1;FGFR1;CEP57;SHOC2;POLR2K;SHCBP1;NCBP1;ZFP36L2;CBL;PTPN11;MAPK1;FGF7;POLR2G;GALNT3;HYAL1;POLR2A;GRB2;ZFP36;FLRT1;RBFOX2;FGF9
prerank,cellular response to heat (GO:0034605),-0.32664477263818686,-1.1344237015698222,0.23333333333333334,0.7858608447607552,1.0,23/35,39.77%,ANO1;THBS1;STUB1;MAPT;HSP90AA1;TRPV4;HSP90AB1;HTRA2;TCIM;PDCD6;POLR2D;IER5;ZFAND1;VCP;SLU7;FGF1;HSPA1B;HMOX1;BAG3;ATXN3;HSF1;HSBP1L1;IL1A
prerank,steroid hormone biosynthetic process (GO:0120178),0.43754408187565463,1.1342906954106184,0.30066225165562915,1.0,1.0,3/29,11.55%,HSD17B7;HSD17B11;TSPOAP1
prerank,regulation of interleukin-6 production (GO:0032675),0.3770934433418046,1.1341525763160023,0.26572668112798264,1.0,1.0,22/96,20.91%,IL16;PYCARD;PTPN22;IRAK3;MAPKAPK2;WNT5A;TMEM106A;CARD9;SYT11;SELENOS;TLR1;PTPN11;IL33;FOXJ1;CD74;RAB7B;LBP;SETD4;BCL10;STAT3;SIRPA;HSPD1
prerank,neural tube closure (GO:0001843),0.4282303235764471,1.1341201096196483,0.30051150895140666,1.0,1.0,10/34,21.47%,DLC1;TGFB1;PRICKLE1;DVL1;SCRIB;COBL;LRP2;PAX2;BCL10;DVL3
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.46936754752421955,1.1340813100571556,0.3302139037433155,0.9998062682367573,1.0,8/22,21.50%,ANK2;AKAP6;CALM1;CALM2;SLC9A1;HTT;VMP1;PKD2
prerank,negative regulation of anoikis (GO:2000811),0.5033220954974248,1.1340092377360074,0.3136966126656848,0.9988955061100444,1.0,2/14,3.82%,BCL2;TLE1
prerank,regulation of cell-cell adhesion (GO:0022407),-0.31858585743732215,-1.13352087147114,0.26153846153846155,0.786396374634823,1.0,6/39,3.20%,AFDN;EPHA7;PTPRG;PODXL;SMAD7;CDH1
prerank,protein localization to cell periphery (GO:1990778),0.3655868031523786,1.1334506389983547,0.24974093264248703,0.9999666506758895,1.0,29/133,15.42%,PTCH1;ANK3;ANK1;FGF13;ANK2;C2CD5;WNK3;ARL3;PACS2;TSPAN32;TNIK;SPTBN1;DPP10;RAP1A;RAB34;GAK;EPB41L3;FLNA;RAB3D;TSPAN17;RAB3A;MAP7;KCNIP4;P2RY1;TMED2;TTC7A;EHD2;PKP2;JUP
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5120286186665748,1.1323296015433804,0.30712166172106825,1.0,1.0,2/12,5.04%,SLC22A3;SMS
prerank,histone acetylation (GO:0016573),0.3890498589870901,1.1321883492461318,0.28208092485549136,1.0,1.0,18/69,15.62%,KAT2B;JADE1;HAT1;TADA1;TAF5L;JADE3;KAT8;BRD8;MORF4L2;POLE3;ATF2;PHF20;TAF9;ING4;EPC1;PER1;TRRAP;MSL3
prerank,cellular response to dsRNA (GO:0071359),-0.4059890840956154,-1.1321305642899386,0.26755852842809363,0.7885267802534287,1.0,9/15,23.11%,NPM1;IFIH1;RIOK3;FLOT1;CAV1;IFIT1;COLEC12;PDE12;MUL1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.41256626281172387,1.1320433720735914,0.2921760391198044,1.0,1.0,21/42,28.07%,MTA2;CHD3;VPS72;MBD2;HDAC2;SMARCC2;ANP32E;RBBP4;SMARCC1;SMARCE1;PBRM1;NASP;SMARCA4;HNRNPC;GATAD2B;ACTR5;SMARCB1;SPTY2D1;HDAC1;SMARCA1;INO80B
prerank,response to calcium ion (GO:0051592),0.37364108869644247,1.1318158059204286,0.26652452025586354,1.0,1.0,36/102,24.09%,CPNE8;DPEP1;HPCA;SCN5A;WNT5A;SYT1;NLGN1;PPP3CA;KCNMB2;KCNMB3;ANXA11;SYT11;SYT12;ALOX5AP;AHCYL1;CALM1;IQGAP1;HOMER1;CALM2;GPLD1;SLC25A24;KCNMA1;CPNE7;SYT2;RYR3;CPNE1;SYT13;ADCY8;PEF1;CPNE3;PKD2;PRKAA1;CAMK2D;CPNE5;SYT3;MEF2A
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3975724855563625,1.1317923593752726,0.31116389548693585,1.0,1.0,9/52,10.37%,LGALS3;EGFR;LRP1;EPHB2;WNK3;SPTBN1;DPP10;ZDHHC8;PIK3R1
prerank,positive regulation of double-strand break repair (GO:2000781),0.419887420027771,1.1317206470190067,0.29301745635910226,0.999503124381407,1.0,7/39,10.56%,DDX11;SPIRE1;FMN2;MRNIP;SETMAR;FOXM1;SLF2
prerank,mRNA splice site selection (GO:0006376),0.441373825451195,1.131426983084657,0.311284046692607,0.9995061819912291,1.0,11/30,20.56%,CELF5;LUC7L2;PSIP1;CELF6;SRSF6;YTHDC1;LUC7L;PRPF39;SF3A1;SF1;CELF4
prerank,inflammatory response (GO:0006954),0.35682011279216136,1.131407942560781,0.24821246169560776,0.9984019155308372,1.0,20/195,10.44%,HSPG2;CCL11;CXCL10;CRH;IL2RA;TAC1;HRH1;PTGER3;NFX1;TGFB1;CCL4;PTGFR;MAPKAPK2;CCR2;NOX1;LOXL3;IL18;NFATC3;PXK;TLR1
prerank,regulation of innate immune response (GO:0045088),-0.2858367862568722,-1.1309803604382103,0.2345679012345679,0.7898625928167011,1.0,25/57,27.49%,ERAP1;APPL2;BIRC3;PLSCR1;ABCE1;SAMHD1;CASP8;RIOK3;IRF1;TIRAP;NMI;TRIM21;APPL1;USP18;IFI35;POLR3D;HSP90AB1;IFNAR2;CACTIN;MUL1;TNFAIP3;TYRO3;LYAR;PTPN6;TKFC
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.442978373430021,1.1309494539251814,0.3271276595744681,0.9989581322729341,1.0,10/27,24.05%,KAT2B;KAT8;BRD8;MORF4L2;PHF20;TRRAP;MSL3;RUVBL2;KAT7;ATAT1
prerank,primary neural tube formation (GO:0014020),0.43627000803802224,1.1297666007648441,0.31748071979434445,1.0,1.0,8/30,19.56%,DLC1;TGFB1;PRICKLE1;SCRIB;COBL;LRP2;PAX2;BCL10
prerank,second-messenger-mediated signaling (GO:0019932),0.3764870244400521,1.1294591099971538,0.2807215332581736,1.0,1.0,13/82,14.06%,CHRM3;HRH1;PPP1R9A;EIF2AK3;CCR2;ACKR3;RCAN1;RCAN3;MCTP1;EDN3;TPCN2;P2RY12;ACKR4
prerank,negative regulation of RNA metabolic process (GO:0051253),0.47616816184132343,1.1292674884126395,0.3319386331938633,1.0,1.0,5/18,14.54%,KAT2B;TGFB1;SHQ1;ESR1;NCOR2
prerank,epithelial cell differentiation (GO:0030855),0.3782091294416552,1.1291320380091348,0.2679738562091503,1.0,1.0,18/88,14.14%,LGALS3;TST;VEGFA;CNN3;GLI1;UPK1B;CASP6;FZD7;GATA6;CTSB;PIH1D1;HDAC2;ERBB4;TOLLIP;SCRIB;GATA3;SCUBE1;PTER
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.5285216575637138,1.1290884016931475,0.33700787401574805,1.0,1.0,1/10,0.88%,GFPT2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.38948532139308045,1.1290305400303515,0.30580357142857145,0.9994322856916573,1.0,18/72,15.17%,RNASE6;GTF2H2;ERCC5;DXO;ERCC4;DDB2;RPA3;SETMAR;XRN2;XPA;DCP1B;REXO4;EDC4;FBH1;DDB1;EXD2;RPA2;UBB
prerank,positive regulation of glucose metabolic process (GO:0010907),0.5084536878470179,1.1286923245911242,0.3445255474452555,0.9995987037247254,1.0,4/14,16.11%,IRS2;PTPN2;DDB1;GPLD1
prerank,negative regulation of cell migration (GO:0030336),0.3608897772325801,1.1282645461276317,0.2639175257731959,1.0,1.0,30/137,14.78%,DLC1;CLDN19;SULF1;FGF2;PIP5KL1;PTEN;DPEP1;LRP1;PTPRT;RAP2B;HOXA7;RECK;NF1;ACVR1C;PODN;CYP1B1;NF2;COL3A1;MCTP1;PTPRJ;NGFR;CLASP1;MAGI2;DRD2;ADARB1;ARHGAP4;TCAF1;BMPR1A;LDLRAD4;CITED2
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3507535913796569,1.1278795911533777,0.20361083249749248,1.0,1.0,34/308,8.90%,EBF2;FFAR4;SOX6;ETV4;GLIPR2;CRH;SLC27A1;GLMN;FGF2;SOX8;PRDM16;SOX9;LRP1;ACVR1;VEGFA;TGFB1;SOX11;PLCB1;CCR2;WNT5A;NLGN1;AGPAT2;RFX3;PTH2R;ZBTB16;TGFBR2;PRKAB2;CARD9;IL18;TSHR;CADM1;ELOVL6;SMO;SOX5
prerank,Rho protein signal transduction (GO:0007266),0.3927445169141748,1.1278583304340022,0.29545454545454547,0.9992853009154203,1.0,14/53,15.08%,RTKN;RHOJ;TAX1BP3;RHOD;CTNNAL1;EPS8L1;LIMK1;ARHGEF11;MYO9B;NGFR;COL1A2;ARHGAP4;ARHGEF3;CDC42EP1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.43088035307186934,1.1277647204032,0.3208279430789133,0.9984870150249896,1.0,4/30,8.57%,HSD17B7;SQLE;IDI1;ACLY
prerank,positive regulation of leukocyte migration (GO:0002687),0.44556995398395804,1.1277505300582402,0.316622691292876,0.9973815281450344,1.0,2/27,3.14%,LGALS3;VEGFA
prerank,tube closure (GO:0060606),0.4324398163645574,1.1270602831422372,0.3209242618741977,0.9989282178986074,1.0,8/31,19.56%,DLC1;TGFB1;PRICKLE1;SCRIB;COBL;LRP2;PAX2;BCL10
prerank,organic substance transport (GO:0071702),0.3682676779133733,1.1267074297857362,0.2719665271966527,0.99915308146839,1.0,15/121,11.37%,ABCA6;SLC6A2;ABCA9;SLC22A3;RAB38;CD320;SCAMP2;SLCO2B1;PEX3;GM2A;SLC50A1;RCN3;ABCA5;NDC1;ARL6IP5
prerank,transport along microtubule (GO:0010970),0.5092598859637141,1.1265625818420575,0.3333333333333333,0.9986186334347892,1.0,7/13,15.04%,COPG2;SPG11;DYNC1I1;ARHGAP21;APBA1;DYNC1I2;COPG1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.3841910314723027,-1.1263130835773012,0.2993421052631579,0.8021339403382344,1.0,4/17,7.73%,BMP6;SASH1;TRIM5;CD55
prerank,regulation of hemopoiesis (GO:1903706),0.5523751437607105,1.1260630543710017,0.3395348837209302,0.9993348668914597,1.0,2/10,1.89%,LGALS3;CBFB
prerank,microtubule polymerization (GO:0046785),0.43599670210663677,1.1259749725449928,0.3144736842105263,0.9984963967075084,1.0,7/28,13.07%,FGF13;CCDC57;NDE1;TUBGCP5;CLASP1;SLAIN2;CKAP5
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.45950271805408993,1.1257975039798875,0.32816901408450705,0.9980223743727134,1.0,2/20,4.92%,CHRM3;PLCB1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.45086635086121085,1.1255780283782346,0.32249674902470743,0.9977382676413862,1.0,8/27,14.00%,PRKCQ;PTPN2;SLC27A4;SOCS1;GRB14;PTPN1;PID1;NCK1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.3572923164826396,-1.1253246419364582,0.234375,0.8028040189295207,1.0,4/22,8.82%,GCNT2;MAP2K5;WNK1;KLF4
prerank,regulation of dephosphorylation (GO:0035303),-0.4158482047505422,-1.1252077936148435,0.2916666666666667,0.8008933487932741,1.0,6/15,25.32%,PPP1R16B;MTMR2;IGBP1;MTMR9;SMG5;MTMR3
prerank,response to hydroxyurea (GO:0072710),0.5379853130855238,1.1251460619260238,0.3424242424242424,0.998294678528495,1.0,5/11,15.98%,DDX11;NSMCE3;ATRX;BLM;SPIDR
prerank,regulation of protein catabolic process (GO:0042176),0.3660807469828135,1.124924890508967,0.2802617230098146,0.9980208848797049,1.0,26/99,21.29%,GPC3;PRKN;EGFR;FMN2;HACE1;IRAK3;WNT5A;ASB5;FLNA;HUWE1;APC2;DDB1;MDM4;NEDD4L;GFAP;AREL1;DACT1;NDUFA13;SNX12;AZIN2;RAB7A;MDM2;SF3B3;FURIN;AGAP2;TIPARP
prerank,skeletal muscle tissue development (GO:0007519),-0.3279075515478671,-1.1244792310368052,0.27403846153846156,0.8009033871940311,1.0,22/32,50.29%,MYL6;SIX1;LEMD2;CAV1;CFLAR;MYH14;SIX4;FOXL2;KLHL41;MSC;MEF2C;MYORG;POPDC3;RYR1;POPDC2;ACTA1;MYLK2;LMOD3;MYOZ2;CSRP3;MYL6B;EGR2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3639889875672686,1.1239241051874125,0.2677248677248677,1.0,1.0,29/118,14.83%,SIPA1L1;PHLDB1;FGF2;ERBB2;EFNA5;FMNL2;TGFB1;SDC2;TANC2;NF1;TNIK;LRRC4C;PAK1;CHN1;PDZD8;ADGRB3;SPARC;BCL9L;PPFIA2;GDNF;CLASP1;MYO19;PID1;ZMYM6;CDK5R1;LZTS3;BMPER;NEDD4L;ARHGAP44
prerank,regulation of extracellular matrix organization (GO:1903053),0.49048765646633075,1.1235758417924318,0.3362193362193362,1.0,1.0,3/15,2.97%,FAP;LRP1;ANGPTL7
prerank,regulation of exocytosis (GO:0017157),0.4017764440429315,1.123399457703435,0.29856115107913667,1.0,1.0,12/46,18.88%,STXBP6;IL1RAPL1;SYT1;RAB21;RAB3D;CLASP1;STXBP5;RAB3A;SNCA;UNC13D;RIMS2;RAB3B
prerank,ERK1 and ERK2 cascade (GO:0070371),0.4582863166293422,1.1228892100983232,0.31684491978609625,1.0,1.0,6/21,11.41%,MYC;FGF10;SOX9;MT3;ZFP36L2;MAPK1
prerank,negative regulation of blood coagulation (GO:0030195),0.4209644557147637,1.1228419779643695,0.31880448318804483,1.0,1.0,3/38,1.88%,A2M;PDGFRA;CD34
prerank,glucose metabolic process (GO:0006006),0.38806020799891916,1.1224570222330488,0.3190751445086705,1.0,1.0,9/58,16.03%,APOD;IRS2;PGM1;GOT2;GALM;SLC25A10;BRAT1;CRY1;SLC25A11
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4507476157580792,1.1224387060625924,0.3279785809906292,0.9997200032012828,1.0,7/24,18.77%,CREB3L1;PRKN;SELENOS;HERPUD1;OPA1;USP25;PARK7
prerank,regulation of wound healing (GO:0061041),0.40834534652070165,1.1223818873444091,0.31365313653136534,0.9987871096689973,1.0,10/42,17.29%,CLDN19;FGF2;EPHB2;CADM4;CLDN1;AJAP1;SRSF6;ITGB1;ARFGEF1;HBEGF
prerank,response to retinoic acid (GO:0032526),-0.2839623028348384,-1.122041058845822,0.23770491803278687,0.8062771546919278,1.0,11/59,8.70%,WNT5B;CTSH;RBP4;EPHA3;ACER2;LYN;ABL2;WNT6;SNW1;WNT9A;TBX1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.44274153146770817,1.121946196376864,0.32171581769436997,0.9992888488698023,1.0,4/24,7.02%,CXCL10;ANO6;CCR2;PLA2G7
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5118093764049945,1.1217703914954407,0.34146341463414637,0.9988165322731085,1.0,2/12,1.89%,PTPN22;CBFB
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.47897603378442205,1.121039386302309,0.3389570552147239,1.0,1.0,5/17,13.00%,HM13;DERL2;SELENOS;HERPUD1;HSP90B1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.38463971565792027,1.1208239872822379,0.2958380202474691,1.0,1.0,5/66,5.57%,FFAR4;USP50;PYCARD;WNT5A;TMEM106A
prerank,leukotriene metabolic process (GO:0006691),0.46793606691130957,1.1206531811218803,0.33518776077885953,0.9995647016611893,1.0,6/19,17.07%,DPEP1;MAPKAPK2;LTA4H;DPEP2;ALOX5AP;ABCC1
prerank,protein destabilization (GO:0031648),0.42776384596553696,1.1195777983347985,0.3207792207792208,1.0,1.0,10/32,18.48%,GSN;PRKN;KDM8;PRNP;CUL3;SNCA;SENP2;CDC73;MDM2;HTT
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.4047175951466711,-1.1191343692307976,0.3116883116883117,0.8132777858866358,1.0,6/15,24.25%,SNX9;ADRA2A;NRDC;APOE;SNX33;SH3D19
prerank,cell projection assembly (GO:0030031),0.4512900245156228,1.1190360402652066,0.3258575197889182,1.0,1.0,7/22,20.41%,RHOJ;GSN;RHOH;CYFIP1;RAC3;NCKAP1;RHOU
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.3771675185918427,-1.1190271538580427,0.2953846153846154,0.8112808688848864,1.0,4/18,10.05%,EPHA4;ROCK2;GSK3A;ABCG1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4140490145194442,1.1189723545188532,0.32196969696969696,1.0,1.0,14/38,22.17%,PRKN;PARL;FBXW7;VPS11;HUWE1;UBE2J2;SREBF2;CSNK2A2;UBE2L3;MICALL2;RHOU;NPEPPS;UBE2D3;LMAN1
prerank,mitochondrion transport along microtubule (GO:0047497),0.5099191439688979,1.1186046904595195,0.3546511627906977,1.0,1.0,6/13,22.75%,HIF1A;RHOT2;OPA1;UBB;RHOT1;SYBU
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.43387625444330646,1.1184084393214622,0.32936507936507936,1.0,1.0,9/28,18.73%,MAP1B;GBA2;ARL2;CLASP1;FKBP4;STMN4;ABL1;MAPRE3;CAMSAP1
prerank,protein acetylation (GO:0006473),0.4242189296106807,1.118402461026105,0.3260025873221216,1.0,1.0,8/30,18.53%,KAT2B;HAT1;NAA35;NAA16;GTF2B;ING4;NAA10;NAA15
prerank,hyaluronan catabolic process (GO:0030214),0.4726030327852913,1.118315792990634,0.3537234042553192,1.0,1.0,8/18,25.75%,FGF2;TGFB1;SPAM1;HYAL1;SLC9A1;CEMIP;HEXB;CEMIP2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.34649420578616474,1.1181204187938707,0.19019019019019018,1.0,1.0,86/336,18.83%,UBE2T;DDX11;MYC;BCL2;STXBP4;SUV39H1;UBE2E2;ZRANB3;FMN2;APTX;MBD4;WAC;POLE2;CHRNA4;PSEN1;NUPR2;NSMCE3;MAPKAPK2;PPP1R15A;MRNIP;ERCC4;PAK1;DDB2;METTL3;NUDT1;UFL1;MUTYH;MEN1;BRCA1;VAV3;XPA;TLK2;REXO4;TDP1;POLE3;ZBTB38;FBXO45;ENDOV;ATF2;SLF2;FBH1;MAPK14;FANCC;TAF9;ASF1A;MSH6;UPF1;TAOK3;STK33;ZBTB1;AKTIP;DDB1;HPF1;BRAT1;XRCC3;TOPBP1;PDS5B;RTEL1;SUMO1;CRY1;BAZ1B;CGAS;CASP2;ATM;TRRAP;ABL1;CSNK1E;RAD52;BLM;TP53;SPIDR;BCL2L11;XIAP;FAM111A;CUL4B;CEP63;WRN;NSMCE4A;UBA1;FBXO31;IRF3;ASH2L;AATF;PARK7;BATF;TAF1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.4599145524913829,1.1180628562349264,0.34075104311543813,0.9991664936489266,1.0,9/20,26.59%,PTPN22;TGFB1;IL18;TICAM1;LBP;BCL10;PRKCE;HCK;IRAK1
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.37457354000654525,-1.1179215330858339,0.28368794326241137,0.8125536942156312,1.0,9/20,18.72%,BIRC3;OGT;STUB1;NUPR1;CASP8;HSP90AA1;FLOT1;SPATA2;CFLAR
prerank,membrane lipid catabolic process (GO:0046466),0.5307557957809252,1.1177659470176544,0.3562874251497006,0.9991395382312495,1.0,3/10,12.21%,NAGA;CYP1B1;PDXDC1
prerank,positive regulation of viral process (GO:0048524),0.39098882874666674,1.1175240002578646,0.3184931506849315,0.9989131187689799,1.0,16/60,18.99%,MDFIC;FKBP6;PABPC1;POLR2B;PPID;POLR2K;ADARB1;DDB1;TBC1D20;KPNA6;POLR2G;PPIH;PKN2;RAB7A;POLR2A;AXL
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5276195646908233,1.1173572875575841,0.345679012345679,0.9984318824067484,1.0,1/11,1.22%,CREB3L1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.5124426930312949,1.1173319224542233,0.36229749631811486,0.9974201208668113,1.0,3/13,12.74%,FADD;MR1;NECTIN2
prerank,response to amyloid-beta (GO:1904645),0.40261557953215854,1.1171966490976861,0.3220338983050847,0.9968728215854165,1.0,10/44,10.58%,MMP2;CACNA2D1;LRP1;CACNA1A;PSEN1;PRNP;FYN;GRM5;SNX6;NGFR
prerank,anterograde axonal transport (GO:0008089),-0.32152531396304757,-1.116626053636655,0.29207920792079206,0.8144044988588394,1.0,10/37,12.83%,KIF3B;KIF1C;TRAK1;DTNBP1;KIF1B;KIF5B;BLOC1S5;SOD1;SNAPIN;AP3D1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4655800431909929,-1.116543786201331,0.35106382978723405,0.8123622367786902,1.0,3/10,6.90%,SHANK3;RAB5A;APP
prerank,cranial nerve development (GO:0021545),0.5216891845390204,1.1165107583359504,0.3283582089552239,0.9983582089783571,1.0,1/11,1.00%,ERBB3
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.5124527869748642,1.1161394406349587,0.34984984984984985,0.9986068963542363,1.0,4/12,16.07%,PTPN1;PIK3R1;TMEM33;BCL2L11
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.458675697399711,1.1158490459148294,0.34081902245706736,0.9986064825644153,1.0,7/22,17.09%,RAD23B;GTF2H2;DDB2;XPA;DDB1;UBB;CUL4B
prerank,potassium ion transport (GO:0006813),0.3625045428033147,1.1154551827481225,0.29485834207764955,0.9989174829692378,1.0,33/120,22.91%,KCNK15;SLC1A3;KCNA2;KCNH8;KCNK1;KCNA1;KCNA6;KCND1;KCND2;KCND3;KCNMB2;KCNMB3;KCNAB2;KCNJ3;KCNJ10;SLC9A5;KCNH2;KCNMA1;SLC9A1;SLC24A4;SLC24A2;KCNA5;HCN1;KCNS3;KCNH7;KCNK10;LRRC55;PKD2;KCNQ3;KCNK6;KCNA4;KCNC1;KCNJ13
prerank,regulation of platelet aggregation (GO:0090330),0.47371176524,1.115380810601147,0.33994334277620397,0.9981000373195679,1.0,3/17,8.22%,PRKCA;PRKCQ;SERPINE2
prerank,regulation of DNA repair (GO:0006282),-0.30068873804518803,-1.114851216780606,0.27461139896373055,0.8156331293147041,1.0,13/44,15.20%,EYA1;EYA2;PARG;ERCC8;EYA4;NPAS2;BABAM1;POLH;ABRAXAS1;WRAP53;PML;PCNA;UBE2N
prerank,regulation of protein kinase activity (GO:0045859),0.36524520330123383,1.1147378154508887,0.2953311617806732,0.9993719154160823,1.0,24/106,18.77%,RELN;UBASH3B;RAP2B;DEPTOR;TRAF4;NF1;MRNIP;ALS2;SPRED1;RAP1A;MMD2;DVL1;WWTR1;XRCC6;SNCA;TAF7;IQGAP1;RASSF2;PYDC1;DBNDD2;JTB;PPM1E;MAPRE3;PARK7
prerank,renal system development (GO:0072001),0.40569454719938336,1.1146786155388848,0.3083235638921454,0.9984917763901241,1.0,6/52,3.63%,SULF1;HAS2;GLI2;LRP4;VEGFA;ARL3
prerank,atrioventricular valve development (GO:0003171),0.4992332185373586,1.1145943278087398,0.3561847988077496,0.9976700458820803,1.0,6/14,17.58%,ACVR1;TGFBR2;MDM4;BMPR1A;APLNR;HEYL
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.3851007419257165,-1.1139420402704063,0.2664233576642336,0.8161450898666105,1.0,6/17,4.56%,ROBO1;NRP1;PIK3R3;SLIT2;EPHB4;KDR
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.516304254717824,1.1139045182607519,0.347068145800317,0.9991840383944116,1.0,2/12,7.90%,CCR2;IL18
prerank,tRNA aminoacylation (GO:0043039),0.4213138968019303,1.1136510249127176,0.3473423980222497,0.9990245932012467,1.0,9/37,14.04%,IARS2;EPRS1;FARSA;GATB;SARS2;FARSB;FARS2;YARS1;HARS1
prerank,positive regulation of cellular respiration (GO:1901857),-0.43407705897682314,-1.1134703834481559,0.3288409703504043,0.8153153581677285,1.0,7/11,36.46%,NUPR1;IL10RB;PINK1;IFNAR1;VCP;IFNLR1;ISCU
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.46611190176737316,1.112371603547655,0.33097595473833097,1.0,1.0,2/19,3.68%,GFPT2;NAGK
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.493284053237413,1.1118063651628312,0.34876989869753977,1.0,1.0,2/13,2.66%,TBC1D10A;FADD
prerank,P-body assembly (GO:0033962),0.5081957040762703,1.1117755570841144,0.3558282208588957,1.0,1.0,7/12,22.87%,ATXN2;LSM3;EIF4ENIF1;RC3H1;LIMD1;DDX6;DYNC1H1
prerank,membrane lipid biosynthetic process (GO:0046467),-0.2781419206903961,-1.1116800330645258,0.23529411764705882,0.8188547476698013,1.0,14/58,9.46%,SGMS1;ELOVL7;PLPP1;CERS5;KDSR;ACER2;HACD4;SPTLC2;DEGS2;CERS4;SPNS2;ALDH3A2;SGPL1;VAPB
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3542269800674978,1.1110994122917743,0.2813141683778234,1.0,1.0,40/150,18.99%,UBASH3B;NTRK3;PIP5KL1;PTEN;PRKN;EPHB2;CADM4;TGFB1;DEPTOR;PRNP;NF1;CNKSR3;PTPN13;NIBAN1;MLXIPL;SPRED2;SPRED1;SAMSN1;MEN1;SPRED3;EIF4G1;PID1;PDE4D;DVL1;WWTR1;SNCA;NCK1;CALM1;LDLRAD4;TAF7;RASSF2;CALM2;TERF2IP;PYDC1;DBNDD2;PPM1E;PARK7;SEMA4D;DNAJC10;TESK1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3557139176387097,1.110665243471598,0.30407523510971785,1.0,1.0,25/128,14.60%,DYNLL1;CDKN2B;HAUS3;CNTRL;KDM8;CCDC57;PLCB1;PCM1;FBXL15;NDE1;SDCCAG8;PHLDA1;FOXM1;ENSA;CEP57;PPP2R2A;CLASP1;PKMYT1;CDC25B;TAF2;PRKACA;CKAP5;CEP76;DYNC1I2;NES
prerank,negative regulation of innate immune response (GO:0045824),0.41332151691370195,1.110069256094435,0.31305449936628643,1.0,1.0,4/34,6.20%,A2M;PTPN2;IRAK3;METTL3
prerank,sphingolipid biosynthetic process (GO:0030148),-0.2724532521492593,-1.1095358326427618,0.2540983606557377,0.8236356350462334,1.0,24/71,21.94%,SGMS1;ELOVL7;PLPP1;CERS5;KDSR;ACER2;HACD4;SPTLC2;DEGS2;CERS4;SPNS2;ALDH3A2;SGPL1;VAPB;ASAH2;CERS1;SPHK1;A4GALT;SPTSSB;ST6GALNAC5;CERT1;CLN8;LARGE1;ALDH3B1
prerank,activation of phospholipase C activity (GO:0007202),0.4386369141148436,1.1092954490672486,0.3463541666666667,1.0,1.0,3/29,4.52%,EGFR;LPAR1;NTRK2
prerank,positive regulation of gene expression (GO:0010628),0.3438922402533848,1.1091200397244922,0.19519519519519518,1.0,1.0,63/442,11.42%,OSR2;SEC16B;CLDN19;ANK3;ADAM19;NTRK3;EPB41L4B;GLMN;FGF2;MYC;RBMS3;FGF10;PTPN22;ANK2;CD34;KAT2B;SOX9;GSN;NGF;ERBB2;PRKN;EGFR;VEGFA;EPHB2;ELAVL4;EIF2AK3;TLE1;UPF3A;PLD1;TGFB1;PSEN1;SOX11;NTRK2;ITGB8;MT3;TAF1A;NIBAN1;WNT5A;HOXD3;AGPAT2;METTL3;CARD9;EIF3C;CPEB3;CADM1;EIF6;BRCA1;SMO;NSUN5;PASK;POLR2K;MAPK9;HIF1A;SFRP4;PIK3R1;ATF2;NFE2L2;MAPK14;RIMS1;SP1;PID1;MAPK1;BMP7
prerank,retinol metabolic process (GO:0042572),0.4823983529469299,1.1089543648022364,0.35797101449275365,1.0,1.0,3/14,8.30%,CYP1B1;RDH10;DHRS3
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.4269158060686222,-1.1087217152794246,0.3287292817679558,0.8240039184356538,1.0,4/11,10.56%,MAP3K5;PRKCD;DIABLO;GSKIP
prerank,carnitine shuttle (GO:0006853),-0.4442212438087256,-1.1086119074054923,0.3157894736842105,0.8221115381196278,1.0,5/11,12.85%,PRKAG2;CPT1A;ACACB;PRKAA2;SLC25A20
prerank,positive regulation of biomineral tissue development (GO:0070169),0.413989568584301,1.1085596466785843,0.33825338253382536,1.0,1.0,13/40,16.21%,OSR2;PKDCC;ACVR1;ANO6;TGFB1;GPM6B;AMELX;BMP7;ATRAID;ATP2B1;BMPR1A;FZD9;TGFB3
prerank,negative regulation of interleukin-2 production (GO:0032703),0.4675523061809917,1.10822369998385,0.35893854748603354,1.0,1.0,5/18,20.39%,CD34;PRNP;HOMER2;NAV3;ZFP36
prerank,regulation of telomere capping (GO:1904353),0.45137438010816333,1.1079627526452571,0.3583662714097497,1.0,1.0,7/23,16.26%,PRKCQ;MAPK1;NEK7;MAP3K4;RTEL1;ATM;SMG6
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.36096502083101245,-1.1077709150158237,0.3017543859649123,0.8227794728014676,1.0,8/21,11.99%,MACF1;ROCK2;ROCK1;LIMCH1;EPHA3;DUSP3;RHOA;ACTG1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.4380439922662828,1.1076386123044262,0.34375,1.0,1.0,9/25,21.58%,CBLB;EPHB2;SOCS5;SNX6;CBL;ZGPAT;SLC6A9;PPARG;CNRIP1
prerank,copper ion homeostasis (GO:0055070),-0.39295019012266164,-1.1071775627262619,0.31333333333333335,0.8224719764111386,1.0,5/17,7.08%,SLC31A1;ATP7A;COMMD1;APP;SLC31A2
prerank,negative regulation of DNA replication (GO:0008156),-0.4243103848606157,-1.1061572278122633,0.3610223642172524,0.8233617220038023,1.0,2/13,6.25%,WAPL;S100A11
prerank,regulation of catecholamine secretion (GO:0050433),0.4307646035874086,1.105300394168981,0.3440721649484536,1.0,1.0,8/29,13.88%,KCNA2;PRKN;CHRNA4;SYT1;SYT11;SYT12;DRD2;SNCA
prerank,cell cycle G2/M phase transition (GO:0044839),0.3544680030304509,1.1047959924299064,0.31551362683438156,1.0,1.0,25/129,14.60%,DYNLL1;CDKN2B;HAUS3;CNTRL;KDM8;CCDC57;PLCB1;PCM1;FBXL15;NDE1;SDCCAG8;PHLDA1;FOXM1;ENSA;CEP57;PPP2R2A;CLASP1;PKMYT1;CDC25B;TAF2;PRKACA;CKAP5;CEP76;DYNC1I2;NES
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.5246126127506756,1.104611603798299,0.35101404056162244,1.0,1.0,3/11,9.48%,PRKN;FBXO7;HIF1A
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4837044753565631,1.104549744337718,0.35135135135135137,1.0,1.0,2/16,7.59%,PRKCA;KLK6
prerank,regulation of B cell activation (GO:0050864),0.4362687214913727,1.10448774431918,0.3360323886639676,1.0,1.0,7/25,21.41%,SAMSN1;IL4I1;ZFP36L2;AHR;SH3KBP1;FOXJ1;TNIP2
prerank,response to organonitrogen compound (GO:0010243),0.41201299819150766,1.1042712923995353,0.3424317617866005,1.0,1.0,14/38,25.64%,KYNU;PRKN;IRAK3;HLCS;RCN3;DRD2;CCDC47;GLRB;UBXN6;RHBDD1;KAT7;MTOR;IRF5;ERLEC1
prerank,fat cell differentiation (GO:0045444),0.39236529993630737,1.1037687904335856,0.3325330132052821,1.0,1.0,10/57,14.36%,FFAR4;STEAP4;SOX8;PRDM16;BBS9;FAM120B;PID1;TMEM120A;ATF5;SENP2
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.5080285024884441,1.1037539510605938,0.3866057838660578,1.0,1.0,2/12,4.92%,BMP5;PLCB1
prerank,regulation of axon guidance (GO:1902667),-0.45084944511742336,-1.1036271975411753,0.3438395415472779,0.8293982863815816,1.0,4/10,8.49%,NRP1;YTHDF1;ZSWIM6;ZSWIM4
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.42020387573164947,1.1035197519788242,0.34002509410288584,1.0,1.0,12/33,20.24%,FGF2;TGFB1;KLF5;HIF1A;NGFR;GATA3;TP53;EGR1;PPARG;JUN;STAT3;SMARCA4
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.47954606772597835,1.1033682364370963,0.3500717360114778,1.0,1.0,6/16,14.61%,FGF2;GLI1;ERBB4;AKAP6;ZFPM2;BMPR1A
prerank,potassium ion export across plasma membrane (GO:0097623),0.5022754563067398,1.1033233598138332,0.3652173913043478,1.0,1.0,4/13,19.16%,KCND3;KCNT2;KCNH2;KCNA5
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.41300844737026965,1.1032449876722286,0.34950248756218905,1.0,1.0,4/38,3.96%,LGALS3;BMP5;FADD;TNFRSF10B
prerank,rRNA modification (GO:0000154),-0.36895571355999507,-1.1028872411124755,0.3142857142857143,0.8294567011559905,1.0,11/21,30.33%,ZCCHC4;NSUN3;DKC1;BUD23;DIMT1;GAR1;METTL5;TFB2M;TSR3;MRM2;NHP2
prerank,positive regulation of embryonic development (GO:0040019),-0.3757542252888739,-1.1027038134876799,0.3111888111888112,0.8278078625244577,1.0,4/19,14.73%,WNT4;OSR1;RACK1;RBM19
prerank,chromosome organization (GO:0051276),0.36771662934710686,1.1025343354660206,0.3099352051835853,1.0,1.0,24/99,20.97%,MYC;RAD23B;LRWD1;HMGN1;SUV39H1;SATB1;EZH1;DDB2;NUP155;XPA;POLE3;HDAC2;MSH6;DDB1;UBB;ABL1;PHF19;CUL4B;CENPV;NUF2;HMG20A;COPS6;SMARCA4;COPS7A
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.5104924574196039,1.1024645869887502,0.35843373493975905,1.0,1.0,3/12,15.46%,ERLIN2;BRCA1;ERLIN1
prerank,epithelial cell migration (GO:0010631),-0.30439981160880986,-1.102405121779992,0.2872340425531915,0.8265233126373671,1.0,10/37,9.34%,KANK2;NRP1;KIT;ROCK1;CDH13;NOS3;GIPC1;DPP4;TNFSF12;RHOA
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.45523893054050923,1.1023525838795476,0.3516949152542373,1.0,1.0,6/19,17.25%,PTGFR;PRNP;GRM5;PTPRJ;PRKACA;STIMATE
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.2679715712151616,-1.102310482680808,0.25210084033613445,0.8245874143971252,1.0,24/67,19.66%,CAPZB;PODXL;TBC1D8;MYO10;RAB5A;TBC1D14;PPP1R16B;TBC1D1;GAP43;TBC1D15;DCDC2;TBC1D13;DYNC2LI1;DYNLT2B;CDC42;RABEP2;CAV1;TBC1D10B;FXR2;TBC1D2;ABITRAM;TBC1D22B;TBC1D16;EPHA2
prerank,hemopoiesis (GO:0030097),-0.2617438967839871,-1.102245449933982,0.20481927710843373,0.8225579273389588,1.0,21/87,14.37%,FLT1;NOTCH2;MECOM;TEK;KIT;NCOA6;BMP4;ETV6;KDR;KITLG;FLT3LG;MKNK2;FGFR2;FLCN;JAG1;NOTCH4;TGFB2;INHBA;PTPRC;TIRAP;BMI1
prerank,intracellular cholesterol transport (GO:0032367),-0.3970474406120085,-1.101938642836744,0.3375796178343949,0.8212799429916882,1.0,6/15,12.31%,ABCA1;OSBP;OSBPL2;VPS4A;ABCG1;STARD4
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.33475684413094775,-1.1018783992196741,0.2874015748031496,0.819240552797339,1.0,6/27,11.12%,PRKCH;ABCA1;NFKBIA;AGTR1;ABCG1;NR1H2
prerank,positive regulation of histone methylation (GO:0031062),0.4475764995120462,1.1016549660996124,0.3562005277044855,1.0,1.0,5/24,12.25%,FAM47E;KMT2A;AUTS2;BRCA1;JARID2
prerank,epithelial tube morphogenesis (GO:0060562),0.41723710343488823,1.1014851993902457,0.34314980793854033,1.0,1.0,10/32,15.00%,GLI2;FGF10;ACVR1;PRKX;PAK1;CCM2;SCRIB;GATA3;PKD1;MET
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.29904500959282637,-1.1010396906401245,0.25365853658536586,0.8195989515104543,1.0,9/44,7.84%,ROCK2;ZC3HAV1;ROCK1;YTHDF1;MOV10;ZFP36L1;METTL14;CNOT1;GTPBP1
prerank,regulation of phospholipase activity (GO:0010517),0.5274637158847887,1.1009908188431492,0.3825396825396825,1.0,1.0,3/10,13.88%,LRP1;FGFR1;SNCA
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.3050729809429961,-1.1003604166249408,0.30337078651685395,0.8196380342803281,1.0,8/40,9.24%,DAB2;GCNT2;LEF1;CTNNB1;TGFBR1;PDPN;RGCC;JAG1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5203804419911897,1.1002554871372496,0.3644859813084112,1.0,1.0,5/11,17.98%,HAT1;ATRX;ASF1A;RBBP4;NASP
prerank,regulation of neuron migration (GO:2001222),0.4395533669335356,1.0999812938734939,0.35286284953395475,1.0,1.0,6/26,9.12%,KIF20B;SEMA3A;CTNNA2;NTNG2;NTNG1;COL3A1
prerank,mitochondrial protein processing (GO:0034982),0.5187280365843887,1.0998083749970937,0.3848531684698609,1.0,1.0,6/11,22.68%,MIPEP;ATP23;PMPCB;YME1L1;PMPCA;IMMP2L
prerank,regulation of cation transmembrane transport (GO:1904062),0.4204318811793164,1.099697765769794,0.3545568039950062,1.0,1.0,9/29,19.21%,WNK3;SCN5A;FGF12;DPP10;KCNAB2;KCNIP4;HOMER1;KCNH2;CD63
prerank,positive regulation of protein kinase activity (GO:0045860),0.35119105290322783,1.0994292890276904,0.3247156153050672,1.0,1.0,30/148,15.55%,RELN;ERBB3;SLC27A1;MAP4K4;VEGFA;PAK4;GPRC5B;PAK5;TRAF4;PRNP;MRNIP;TNIK;PAK1;ALS2;TGFBR2;RALB;RAP1A;SLC8A2;PTPN1;GRM5;PIH1D1;MMD2;TAOK3;XRCC6;TTBK1;SNCA;CALM1;IQGAP1;RASSF2;CALM2
prerank,nuclear membrane disassembly (GO:0051081),0.49170945481085615,1.0993069302019067,0.37219101123595505,1.0,1.0,1/14,0.67%,PRKCA
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3615318858976477,1.0991503115811303,0.3265086206896552,1.0,1.0,37/100,23.13%,GLMN;RAD23B;XPO1;PRKN;ARAF;WAC;SOCS5;UCHL5;UFL1;CBFA2T3;BAG5;TLK2;HERPUD1;TAF9;PRICKLE1;DVL1;CSNK1A1;DET1;DDA1;SUMO1;RNF19A;RCHY1;CSNK1E;N4BP1;FBXO22;MDM2;ZER1;PARK7;TAF1;USP5;NKD2;BBS7;UBQLN4;CAMLG;ELOB;ZYG11B;COP1
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.3423596730027456,-1.0990697593011185,0.2862595419847328,0.821629122162311,1.0,8/26,14.50%,ROCK2;SHANK3;ROCK1;FHOD1;PFN2;ACTG1;CDC42;SYNPO2
prerank,ureteric bud morphogenesis (GO:0060675),0.4724043097676226,1.099019962965343,0.3631123919308357,1.0,1.0,7/16,23.35%,FGF2;MYC;GDNF;GATA3;PAX2;PKD2;BMP2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.408056165312541,1.0989670604117898,0.353393085787452,1.0,1.0,14/36,23.72%,MYC;PTPN22;PRKN;MEN1;FOXM1;TAOK3;PER1;DACT1;FKTN;ZMYND11;DUSP1;SIRPA;CYLD;AIDA
prerank,skin development (GO:0043588),0.37351504172510636,1.0988836016546255,0.3400900900900901,1.0,1.0,13/65,15.00%,COL5A3;CERS3;TGM1;COL5A2;CLDN1;WNT5A;GATA6;HRNR;COL3A1;COL1A2;COL1A1;PKD1;MET
prerank,cellular response to glucose starvation (GO:0042149),-0.2974752628375442,-1.0985235034227248,0.32748538011695905,0.8210925566282183,1.0,17/41,25.91%,PRKAG2;NUAK1;SIK1;NIM1K;BECN1;PRKAA2;SESN2;PRKAG3;ATG14;KPTN;ATF4;NUAK2;HNRNPA1;SH3GLB1;BRSK2;MTMR3;SZT2
prerank,lymphocyte mediated immunity (GO:0002449),-0.43111816006853854,-1.098483228504179,0.36023054755043227,0.8190425879582581,1.0,4/12,29.97%,CD55;JAG1;GNL1;MSH2
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.434471503891539,-1.0981897582913178,0.34472934472934474,0.8178234837664806,1.0,10/11,56.58%,RTP4;PKD2L1;PKD1L3;LPO;RTP3;TAS1R2;GNAT3;GNAT2;PIGR;TAS1R3
prerank,regulation of protein localization (GO:0032880),-0.2819064663992365,-1.0981003085545926,0.30935251798561153,0.8159929440210624,1.0,21/58,20.12%,AFDN;MAP2;KDM1A;TRIM25;RABGAP1L;PARP1;TRIM5;CAMK1;RACK1;ZDHHC7;VPS4A;RAB9A;HSP90AA1;ATCAY;PPM1F;TRIM21;PLEKHM2;TRIM17;HSP90AB1;TRIM68;ADCYAP1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.33953129464539566,1.0980418243161365,0.2316950852557673,1.0,1.0,47/348,11.52%,OSR2;SEC16B;CLDN19;ANK3;ADAM19;NTRK3;EPB41L4B;FGF2;MYC;RBMS3;FGF10;PTPN22;ANK2;CD34;SOX9;GSN;NGF;PRKN;VEGFA;EPHB2;MAPK7;EIF2AK3;TLE1;TGFB1;PSEN1;SOX11;NTRK2;ITGB8;MT3;ATF7IP;WNT5A;HOXD3;BRCA1;SMO;MAPK9;HIF1A;PTPN1;SFRP4;ATF2;NFE2L2;MAPK14;RIMS1;SP1;PID1;MAPK1;BMP7;MAGI2
prerank,neuromuscular process controlling balance (GO:0050885),0.5049917910549918,1.097724331321965,0.35161290322580646,1.0,1.0,2/12,4.74%,PCDH15;NRXN1
prerank,regulation of urine volume (GO:0035809),0.5248258346581126,1.097169034035812,0.362095531587057,1.0,1.0,1/10,1.03%,HAS2
prerank,"wound healing, spreading of cells (GO:0044319)",0.4394779448776547,1.0970515944504327,0.39054054054054055,1.0,1.0,1/24,0.13%,ARHGAP24
prerank,cellular response to growth factor stimulus (GO:0071363),0.3507683304306273,1.0969069449696205,0.30721649484536084,1.0,1.0,28/151,11.52%,SOX6;ADAMTS12;HAS2;NTRK3;GAREM1;SOX9;ERBB2;EGFR;ACVR1;VEGFA;EGR3;MAPK7;TGFB1;NTRK2;MAPKAPK2;ACVR1C;WNT5A;URI1;MTSS2;TGFBR2;RAP1A;SOX5;ZFP36L2;MAPK14;PTPN11;EMD;BMP7;MAGI2
prerank,clathrin coat assembly (GO:0048268),0.4778195132809059,1.0965164431594312,0.36656891495601174,1.0,1.0,3/15,8.72%,SGIP1;EPS15;HIP1
prerank,organophosphate ester transport (GO:0015748),-0.3440816590513252,-1.0963379094093673,0.3237410071942446,0.8194371907219457,1.0,6/24,10.58%,OSBPL8;ABCA3;PLTP;PITPNA;OSBPL2;TNFAIP8L3
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.37234590345362234,1.0957840635088496,0.3377777777777778,1.0,1.0,28/80,20.44%,PITPNB;ATP9B;COPZ2;GBF1;COPB2;COPG2;TMED10;KDELR2;NBAS;ARF4;BICD2;RAB1A;TMED3;TMED2;COPA;ARFGAP3;ARFGAP1;KIF22;COPG1;BNIP1;KDELR3;SURF4;HTT;KIF3A;KIF2A;ERGIC3;RINT1;COG4
prerank,icosanoid metabolic process (GO:0006690),0.4052838749829556,1.0957500377735636,0.3375,1.0,1.0,8/40,13.50%,CYP2S1;DPEP1;MAPKAPK2;LTA4H;CYP1B1;DPEP2;ALOX5AP;PNPLA8
prerank,regulation of keratinocyte proliferation (GO:0010837),0.44645002385901666,1.0954674538109888,0.3544827586206897,1.0,1.0,4/22,2.73%,EPB41L4B;FGF10;STXBP4;TGM1
prerank,pyruvate metabolic process (GO:0006090),-0.2851775633031042,-1.0943607148343222,0.2896551724137931,0.8235906316172948,1.0,10/52,10.55%,BSG;ME1;GLO1;HAGH;PDHX;PGK1;PGAM4;PGAM1;GPI;PDHA1
prerank,sphingolipid catabolic process (GO:0030149),-0.38531292885859586,-1.0943239006872814,0.34615384615384615,0.8215665533179288,1.0,7/15,30.06%,ACER2;SGPL1;ASAH2;SPHK1;SMPDL3A;PPT1;GLA
prerank,protein kinase B signaling (GO:0043491),0.42660713076697676,1.0935102621206085,0.3557312252964427,1.0,1.0,4/23,4.84%,PTEN;THEM4;TGFB1;MT3
prerank,negative regulation of response to wounding (GO:1903035),0.4509853938635986,1.0929395754870483,0.3526912181303116,1.0,1.0,2/19,1.27%,CLDN19;FGF2
prerank,organelle organization (GO:0006996),0.3384589009205415,1.092687126909562,0.262,1.0,1.0,109/388,21.75%,SEC16B;TMED6;CCL11;ANK1;HPS6;MYC;ATP8B1;WDPCP;GORASP1;PRKN;RAB38;FGD4;PAK4;HACE1;PITPNB;RAB14;EIF2AK3;FMNL2;MAST2;PACSIN2;BLZF1;PAK5;GOLGB1;TNIK;OBSL1;PEX3;ARL1;PDZD8;GBF1;EPS15;RAB34;SEC31B;BIN1;GAK;TFAM;BAG5;TRIP11;PPID;TMED10;VPS11;RHOT2;PALLD;HUWE1;VAPA;KIF5C;CLASP1;PI4K2A;AFG1L;GORASP2;ARHGAP21;MREG;ZMYM6;HPS3;RAB1A;PLAAT3;ATL3;USP6NL;NECTIN2;PRDX3;CSNK1A1;YME1L1;SH3KBP1;POLRMT;TBC1D20;ARHGAP4;TMED3;TMED2;POLG2;PDCD6IP;SEC23IP;OPA1;CHMP4C;CFAP61;BNIP1;DIAPH3;ARFGEF1;ABCD2;GABPB1;SURF4;ADCK1;MDK;RAB7A;PEX1;RHOT1;CLUH;HTT;KIF3A;ATXN7;STX17;CAMSAP1;PARK7;REEP5;RAB30;PEX11A;COG1;CHMP1B;PHB2;CEP78;RHOU;COG4;RAB3GAP1;LIMD1;SSBP1;VMP1;TANGO2;WDR81;PKD2;CDC42BPB;MTFR1
prerank,defense response to fungus (GO:0050832),0.4650176512473879,1.0925550968188158,0.38966480446927376,1.0,1.0,5/17,26.38%,CARD9;BCL10;RARRES2;FAM3A;RNASE7
prerank,N-terminal protein amino acid modification (GO:0031365),0.48524176004616654,1.0922963696094947,0.362555720653789,1.0,1.0,8/14,27.27%,NAA35;NAA16;NAA10;NAA15;METAP1;METAP1D;NAA40;NAA50
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.25343304150870316,-1.0918172045756867,0.25925925925925924,0.8273262705710602,1.0,76/168,27.90%,SAMD4A;RPS14;GSPT1;RPL24;RPL18A;XRN1;UPF3B;RPS16;LSM1;RPL38;RPL28;RPS19;RPL37;AGO1;MTPAP;CTIF;ERI1;ZFP36L1;DCP2;RPS2;EXOSC7;DDX5;CNOT1;RPL19;RPL5;PATL1;RPL34;RPS25;RPS15;EIF4A3;RPLP1;RPL31;RPL3;HELZ2;TUT7;RPS6;PAN2;RPS8;RPL11;RPL12;PNRC2;SMG9;EXOSC10;RPL7A;RPL13;CNOT11;CNOT9;RPS21;TENT4B;RPL35A;RPL26;RPS9;RPL32;RPS29;RC3H2;RPS23;RPLP2;PDE12;POLR2D;RPL8;SMG5;RPL41;SMG8;RPS17;RPS5;RPS15A;UBA52;RPL37A;PPP2CA;RPS10;EIF3E;RPL6;RPL9;RPS27;PAN3;PELO
prerank,establishment of apical/basal cell polarity (GO:0035089),0.4732707204937763,1.091813145414705,0.3502235469448584,1.0,1.0,6/14,16.83%,PATJ;MYO9A;OPHN1;SCRIB;FSCN1;FOXJ1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.3286786405919179,-1.0917315901745597,0.31275720164609055,0.8254404276755148,1.0,16/31,29.31%,TOMM70;TIMM23;PEX7;DNAJC15;PEX14;PEX26;TIMM17A;PEX2;PEX10;ROMO1;GRPEL1;PEX6;PEX16;DNLZ;TOMM40L;TOMM40
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.31212325437418337,-1.0916447042286916,0.315,0.8235871512311639,1.0,13/36,18.75%,WASL;NOS3;NPR3;NOSTRIN;TERF2;DNM2;DDAH2;HSP90AA1;TERT;NUS1;SPR;CAV1;APOE
prerank,presynapse organization (GO:0099172),0.5187321767724083,1.0915409238926082,0.39937106918238996,1.0,1.0,4/10,16.30%,WNT5A;NLGN1;DVL1;LRRTM3
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4569373172331463,1.091460160694613,0.3606102635228849,1.0,1.0,4/20,10.76%,VEGFA;MT3;HIF1A;NFE2L2
prerank,peroxisome organization (GO:0007031),0.43290041406659946,1.0909695555844037,0.3771353482260184,1.0,1.0,7/25,20.98%,SEC16B;PEX3;PLAAT3;ABCD2;PEX1;PEX11A;ACOT8
prerank,epiboly involved in wound healing (GO:0090505),-0.38761854009653013,-1.090772802989617,0.3498452012383901,0.8242157799460175,1.0,6/16,14.78%,PDPN;ARHGAP35;CCN1;RHOA;DDR1;CEACAM1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.3592999065525044,1.0903375880267079,0.33689839572192515,1.0,1.0,18/109,12.36%,PLEKHA4;INPP4B;SLC27A1;PLBD1;FGF2;PTEN;PGAP1;RAB14;MTMR14;PLCB1;PTPN13;PI4KB;VAC14;PLA2G12A;PIK3R1;PI4K2A;MTMR12;PLAAT3
prerank,ceramide metabolic process (GO:0006672),-0.2840758315370288,-1.0903129757507857,0.25903614457831325,0.8236621463443865,1.0,14/49,18.52%,SGMS1;ST6GALNAC3;PLPP1;CERS5;ACER2;SPTLC2;DEGS2;CERS4;SGPL1;ASAH2;CERS1;ORMDL3;PLA2G15;SPTSSB
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.5120353756404423,1.0901364051679017,0.38,1.0,1.0,5/11,19.42%,BIN1;STK39;NEDD4L;KCNH2;CAB39
prerank,small GTPase mediated signal transduction (GO:0007264),0.35670472864994107,1.0899209311778457,0.33584499461786865,1.0,1.0,14/103,10.79%,ARHGAP32;USP50;FGF2;RAB38;ARL3;PLD1;NUCB1;NF1;KSR1;RALB;RGL1;SHOC2;MRAS;MAPK14
prerank,positive regulation of blood coagulation (GO:0030194),0.46905504294552947,1.0895282653864407,0.35804195804195804,1.0,1.0,2/17,3.47%,ST3GAL4;ANO6
prerank,cholesterol biosynthetic process (GO:0006695),0.4117001436800145,1.0889717745640544,0.3632862644415918,1.0,1.0,4/31,8.57%,HSD17B7;SQLE;IDI1;ACLY
prerank,sulfur compound biosynthetic process (GO:0044272),0.3611915056810335,1.0885160349677068,0.3329764453961456,1.0,1.0,17/104,13.26%,DCN;VCAN;CTH;LUM;ST3GAL4;CBS;GSS;PAPSS2;BCAN;CSGALNACT1;CHSY1;SLC10A7;NCAN;GLCE;GGCT;GGTA1;SLC35B3
prerank,positive regulation of axonogenesis (GO:0050772),-0.3013920207789942,-1.0882276174388221,0.3048128342245989,0.8280534755881757,1.0,12/43,13.22%,MACF1;PLXNA2;ROBO1;GOLGA4;SEMA7A;SLIT2;RHOA;PLXNB1;ZFYVE27;MAPT;PLXNA1;PLXNA4
prerank,C-terminal protein amino acid modification (GO:0018410),0.5095804815012983,1.0878309750512198,0.39176829268292684,1.0,1.0,4/11,16.11%,ATG5;AGBL4;AGBL1;GPLD1
prerank,cardiac muscle cell development (GO:0055013),0.4492734669970863,1.0877086761695298,0.366120218579235,1.0,1.0,3/20,5.54%,PDGFRA;VEGFA;OBSL1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3987907202488241,1.087557341651289,0.35148514851485146,1.0,1.0,9/39,12.66%,SEMA3E;EFNA5;HOXA7;MAP4K4;RASA1;FZD7;NF2;AJAP1;MYOC
prerank,negative regulation by host of viral process (GO:0044793),0.5233003228645958,1.087270292062948,0.37816455696202533,1.0,1.0,2/10,10.41%,PRKN;VAPA
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.4128861743355714,-1.0872285865021678,0.35135135135135137,0.8290305261346972,1.0,3/12,19.97%,GCNT2;FLOT1;SKAP1
prerank,protein localization to Golgi apparatus (GO:0034067),0.4277560592761449,1.0871833590044948,0.3726790450928382,1.0,1.0,8/27,11.98%,OBSL1;ARL1;GBF1;GAK;TMED10;ARL5C;BICD2;SYS1
prerank,mitochondrial gene expression (GO:0140053),0.39825847163388645,1.0871764653195781,0.3475177304964539,1.0,1.0,10/42,14.97%,MRPL47;IARS2;MRPS18A;MRPL16;GATB;MRPS28;TFAM;POLRMT;HARS1;MRPL51
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.4760903824923891,1.086526410688691,0.37117903930131,1.0,1.0,5/15,18.13%,BCL2;PRKN;TAF9;CD74;MDM2
prerank,glycoprotein biosynthetic process (GO:0009101),-0.25684162873218624,-1.086474712548008,0.21875,0.8294077174785488,1.0,18/79,16.55%,IGF1;GCNT2;ST3GAL6;ST8SIA4;FAM20B;BMPR2;ATP7A;CHST11;MGAT1;ST6GALNAC2;TNIP1;SERP1;FOXL1;CHST12;B4GALT7;NUS1;B3GALT1;B3GALT2
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.3514672504259785,-1.0863428590560704,0.3402777777777778,0.8277357026435558,1.0,4/20,6.72%,ATP1A2;ATP1B3;KCNJ2;ATP1A1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.36849032173203733,1.0860906314958365,0.3325766174801362,1.0,1.0,19/69,15.67%,INTS11;SNAPC2;RPRD1A;POLR2B;INTS6;ZC3H8;GTF2B;POLR2K;NCBP1;INTS4;SP1;TAF9;TAF11;INTS2;POLR2G;INTS8;ELL;GTF2E2;GTF2E1
prerank,photoreceptor cell development (GO:0042461),0.48138381927498086,1.0857804215197582,0.3802612481857765,1.0,1.0,2/14,3.63%,VEGFA;ARL3
prerank,vasodilation (GO:0042311),-0.4159036689962802,-1.0855838555911694,0.37735849056603776,0.828142313132708,1.0,6/13,22.32%,NOS3;KLF2;SOD1;NOS1;GPER1;ADRB2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.3915110957230927,1.0854935649606858,0.34404761904761905,1.0,1.0,4/45,5.57%,USP50;PYCARD;WNT5A;TMEM106A
prerank,snRNA transcription (GO:0009301),0.3674075798833079,1.085154573912253,0.33220338983050846,1.0,1.0,19/70,15.67%,INTS11;SNAPC2;RPRD1A;POLR2B;INTS6;ZC3H8;GTF2B;POLR2K;NCBP1;INTS4;SP1;TAF9;TAF11;INTS2;POLR2G;INTS8;ELL;GTF2E2;GTF2E1
prerank,cation transport (GO:0006812),0.34359394149706135,1.0850701586499552,0.3230769230769231,1.0,1.0,19/167,8.46%,SLC22A3;PIEZO2;FGF13;KCNA2;SCN7A;SLC12A3;SCN2A;KCNK1;ANO6;KCNA1;KCNA6;SLC36A2;SLC12A2;SCN5A;SCN3A;KCND3;SLC8A2;KCNMB2;KCNMB3
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.4165588356431995,-1.0847267400754306,0.3586626139817629,0.8288658432308291,1.0,2/12,3.82%,IL34;LYN
prerank,tricarboxylic acid metabolic process (GO:0072350),0.48984693827521014,1.0846787990895814,0.3684210526315789,1.0,1.0,4/12,14.45%,IDH2;IDH3B;ACLY;IDH3A
prerank,negative regulation of cell motility (GO:2000146),0.35449159534514296,1.0844564104110532,0.3450854700854701,1.0,1.0,24/108,14.78%,DLC1;CLDN19;SULF1;PIP5KL1;PTEN;DPEP1;PTPRT;RAP2B;RECK;NF1;PODN;CYP1B1;NF2;MCTP1;PTPRJ;NGFR;MAGI2;DRD2;ADARB1;GATA3;ARHGAP4;TCAF1;LDLRAD4;CITED2
prerank,regulation of tumor necrosis factor production (GO:0032680),0.35627060990654774,1.084433854248108,0.3474128827877508,1.0,1.0,16/112,10.86%,PYCARD;PTPN22;CD34;FADD;EPHB2;IRAK3;PSEN1;MAPKAPK2;CCR2;WNT5A;TMEM106A;SYT11;SELENOS;TLR1;PTPRJ;PTPN11
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.3483136500687738,-1.0843533211874754,0.3333333333333333,0.8257780769471224,1.0,5/21,6.61%,EYA1;EYA2;MAP2K5;EYA4;MCL1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.3483136500687738,-1.0843533211874754,0.3333333333333333,0.8257780769471224,1.0,5/21,6.61%,EYA1;EYA2;MAP2K5;EYA4;MCL1
prerank,smooth muscle tissue development (GO:0048745),0.5225248349721564,1.0838919559893752,0.38362760834670945,1.0,1.0,3/10,8.64%,PTCH1;NF1;SMO
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.34528540826815074,-1.0837595614758677,0.32432432432432434,0.825469058480658,1.0,5/21,6.08%,ROCK2;ROCK1;ERRFI1;BMP4;ZFP36L1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5242084620655686,1.08335715065143,0.3944805194805195,1.0,1.0,4/10,17.24%,CPEB3;NCBP1;CPEB1;CDC73
prerank,protein-DNA complex disassembly (GO:0032986),0.46287875130739065,1.0833491231856256,0.3953488372093023,1.0,1.0,5/16,20.24%,MYC;SMARCC2;SMARCC1;SMARCE1;SMARCA4
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.43977334835104603,1.0832032204619237,0.3755047106325707,1.0,1.0,8/24,18.86%,SEMA3E;SEMA6C;VEGFA;SEMA3A;DSCAM;SEMA6D;SEMA4B;SEMA4D
prerank,regulation of defense response to virus (GO:0050688),0.48178330176611656,1.082531243228982,0.3710879284649776,1.0,1.0,2/14,8.39%,ELMOD2;PPM1B
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.38590775716549386,-1.082359892201196,0.3400673400673401,0.8278097341666182,1.0,7/16,21.70%,SOX13;SIX1;PTGS2;FLCN;RREB1;VSTM2A;ZBTB7B
prerank,snRNA processing (GO:0016180),0.4630492816779979,1.0822920910968803,0.3556851311953353,1.0,1.0,5/16,13.92%,INTS11;INTS6;INTS4;INTS2;INTS8
prerank,cellular response to oxygen-containing compound (GO:1901701),0.33745795026536474,1.082285911538244,0.29838709677419356,1.0,1.0,73/291,21.51%,RORA;P2RY2;SSTR1;CXCL10;PDGFRA;PYCARD;DPEP1;SOX9;EGFR;NCF1;PDE4B;MT3;WNT5A;AOC1;RORC;PDK3;FZD7;RAP1A;CPEB3;LAMTOR2;TSHR;MAPK9;SELENOS;AKAP6;ESR1;MAPK14;TRIM41;PID1;MAPK1;UPF1;ERCC6L2;NRIP1;PRDX3;HSP90B1;SHPK;AHR;CPEB1;P2RY12;P2RY1;SSH1;LCOR;TICAM1;PLAA;MTR;ATM;GPLD1;NDUFA13;PAX2;CDC73;CHUK;NCOA3;SPAAR;RPTOR;LBP;FAM210B;TAF1;AXL;EGR1;RYR3;RUVBL2;IPO5;PDCD4;HCN1;BCL10;JUN;RRAGA;ZFP36;SIRPA;NFKB1;TNIP2;PKD2;PXN;P2RX7
prerank,regulation of fibroblast proliferation (GO:0048145),0.3884943877903786,1.082185510577033,0.35515151515151516,1.0,1.0,11/45,17.24%,PDGFRA;MYC;NF1;WNT5A;S100A6;CDK6;EMD;MED25;TP53;CD74;CDC73
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.4199801230160132,-1.0819375294270466,0.3878787878787879,0.8271048270545941,1.0,7/13,22.11%,USP19;NUPR1;MANF;NR1H2;AQP11;NR1H3;CLU
prerank,bile acid and bile salt transport (GO:0015721),0.43089509461473996,1.08164303683319,0.3715415019762846,1.0,1.0,5/24,14.50%,ATP8B1;NCOA1;SLCO2B1;NCOA2;SLC10A1
prerank,oligodendrocyte development (GO:0014003),0.4736637083354476,1.081399696936403,0.383638928067701,1.0,1.0,5/15,20.64%,PLP1;EIF2B5;NSUN5;EIF2B2;B4GALT6
prerank,positive regulation of cytokine production (GO:0001819),0.33704343961561084,1.0812067239578387,0.31350806451612906,1.0,1.0,56/292,19.04%,RORA;SULF1;IL16;PRKCQ;GLMN;PYCARD;PTPN22;CD34;FADD;EIF2AK3;TGFB1;PDE4B;PLCB1;CCR2;NOX1;WNT5A;SPTBN1;TMEM106A;AGPAT2;CARD9;CYP1B1;LRRFIP1;IL18;CADM1;BRCA1;TMED10;POLR2K;HIF1A;TLR1;MAPK14;PTPN11;IL6ST;RAB1A;PDE4D;TBK1;XRCC6;DRD2;SCRIB;GATA3;MALT1;DHX33;TICAM1;CGAS;IL33;RUNX1;CD74;RIPK1;POLR1C;MDK;RAB7B;IRF3;LBP;PARK7;BATF;SETD4;EGR1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3560941536427295,1.0811732863995245,0.367237687366167,1.0,1.0,33/107,21.77%,CREB3L1;BCL2;PRKN;DNAJB9;EIF2AK3;TNFRSF10B;PPP1R15A;NIBAN1;CREB3L2;UFL1;EIF2B5;RCN3;SELENOS;HERPUD1;PIK3R1;TMEM33;GORASP2;HSP90B1;CCDC47;TMTC3;NCK1;TMEM117;TP53;BCL2L11;QRICH1;FICD;AIFM1;DNAJC10;MBTPS1;JUN;UBXN6;RHBDD1;ERO1A
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.3141729147340623,-1.0804542787744895,0.3286384976525822,0.8295676009694246,1.0,9/32,12.29%,SNCAIP;RAB5A;DTNBP1;GSK3B;SLC30A1;CPLX1;CAMK2A;MCTP2;SNAPIN
prerank,chloride transmembrane transport (GO:1902476),0.38912103377485163,1.0802564397665897,0.36310904872389793,1.0,1.0,5/48,5.24%,ANO2;SLC1A3;SLC12A3;ANO6;SLC12A2
prerank,cochlea morphogenesis (GO:0090103),0.5277262607116051,1.0801659395695586,0.38613861386138615,1.0,1.0,3/10,16.98%,SOX9;TBX18;PAX2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.2999638600559521,-1.080039779344144,0.2751322751322751,0.8287106126630439,1.0,13/39,17.41%,PI4KA;PIK3R3;PIK3C2A;TTC7B;IP6K1;SOCS7;SOCS4;PIK3C2B;EFR3B;TMEM150A;ITPKC;PIP4K2B;ITPKB
prerank,regulation of angiogenesis (GO:0045765),0.3458572439772421,1.0797559696803922,0.31129196337741605,1.0,1.0,40/192,16.89%,DCN;HSPG2;SULF1;PRKCA;CXCL10;RHOJ;FGF2;SEMA3E;CD34;ERBB2;VEGFA;PAK4;COL4A2;ITGB8;NF1;HSPB6;CCR2;PDE3B;WNT5A;ADAMTS1;SPRED1;CYP1B1;GATA6;BRCA1;HIF1A;SPARC;ATF2;SP1;MYDGF;GRN;SMOC2;PDCL3;BMPER;ITGB1;JUP;RUNX1;GAB1;HTATIP2;HYAL1;APLNR
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.4329861752239043,-1.0796368236450447,0.36486486486486486,0.8279291745862368,1.0,4/10,16.67%,ABCA3;MTMR2;MTMR9;MFSD2A
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.40772828178983317,1.0788656254535838,0.3713927227101631,1.0,1.0,9/37,12.39%,NUDT15;RNASE6;ENTPD2;NUDT1;XRN2;PPP1R8;NCBP1;NUDT9;RNASEH2C
prerank,regulation of membrane repolarization (GO:0060306),0.4925563923713424,1.0788474947052522,0.3830104321907601,1.0,1.0,4/13,16.10%,CACNA2D1;AKAP6;NEDD4L;KCNH2
prerank,regulation of transmembrane transport (GO:0034762),0.414687499643145,1.078327893758835,0.3763157894736842,1.0,1.0,6/31,14.64%,FFAR4;BCL2;KCNJ3;SNCA;NEDD4L;KCNJ10
prerank,positive regulation of T cell activation (GO:0050870),0.36981882395870824,1.0782120457163216,0.3620488940628638,1.0,1.0,9/62,14.00%,PRKCQ;PYCARD;CCR2;ZMIZ1;IL6ST;RHOH;ZBTB1;GATA3;NCK1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.4701286410451117,1.078043904688266,0.39657631954350925,1.0,1.0,5/15,15.64%,GPC3;DAAM2;SFRP4;DACT1;CSNK1E
prerank,establishment of protein localization to extracellular region (GO:0035592),0.39825861349928715,1.077414429323477,0.34793187347931875,1.0,1.0,19/39,28.76%,STEAP3;COPG2;MTTP;RCN3;RAB3D;RAB3A;ARFGAP3;COPG1;TANGO6;RAB3B;TANGO2;TVP23A;MIA3;MON1A;SCG2;SEL1L;LTBP2;PREB;RAB13
prerank,cellular response to drug (GO:0035690),0.43214198248265456,1.0772546026608705,0.3764861294583884,1.0,1.0,7/25,18.16%,MYC;DPEP1;PDE4B;TP53;KCNH2;GPLD1;PPM1E
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.42135231247346455,-1.0771581895399973,0.3734567901234568,0.8338489134019479,1.0,4/11,13.93%,MFHAS1;LYN;CYBA;TIRAP
prerank,amyloid precursor protein metabolic process (GO:0042982),0.4535766969700419,1.0771048209652105,0.3803009575923393,1.0,1.0,6/18,14.33%,ADAM19;PSEN1;KLK6;NCSTN;APH1A;PSEN2
prerank,regulation of gastrulation (GO:0010470),-0.3939231213628035,-1.0769739783771284,0.3560371517027864,0.8323982281156048,1.0,2/14,1.38%,PHLDB2;OSR1
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.29172802979799123,-1.0768385055817358,0.2983425414364641,0.830785883410865,1.0,8/43,5.92%,BMP6;IGF1;WNT4;LRP5;BMP4;BMPR2;SUCO;ZHX3
prerank,regulation of dendritic spine development (GO:0060998),0.4536225586391671,1.0763034506529259,0.391304347826087,1.0,1.0,5/19,10.42%,PSEN1;TANC2;NLGN1;CPEB3;PPFIA2
prerank,cellular sodium ion homeostasis (GO:0006883),-0.38043527221572765,-1.075938167296363,0.33865814696485624,0.8314707910087612,1.0,3/15,6.72%,ATP1A2;ATP1B3;ATP1A1
prerank,regulation of DNA binding (GO:0051101),-0.2901114302530735,-1.0749751670013001,0.3333333333333333,0.8323392756819082,1.0,20/44,24.39%,IGF1;SP100;LEF1;NFKBIA;KDM1A;HABP4;DOT1L;MDFI;SUMO3;HMGA2;NME1;CEBPG;TFAP4;HMGB2;TXN;CSNK2B;EGF;E2F1;PLAUR;MAPK8
prerank,organonitrogen compound catabolic process (GO:1901565),0.37834557801881197,1.0749581415579137,0.3695395513577332,1.0,1.0,21/57,23.96%,CTH;TST;NAGK;LTA4H;PLA2G7;TRHDE;IL4I1;LNPEP;UCHL3;PDXDC1;PNPLA8;LIPC;GNPDA1;TXN2;BCKDK;NPEPPS;RIDA;SIAH1;TPP1;CLN6;MTOR
prerank,development of primary male sexual characteristics (GO:0046546),0.4121161395507141,1.0736192619763403,0.3843236409608091,1.0,1.0,12/34,21.63%,SOX8;SOX9;WNT5A;MAMLD1;GATA6;GATA3;LRP2;LHFPL2;NR5A1;CSDE1;MEA1;FGF9
prerank,positive regulation of bone resorption (GO:0045780),0.4969259591594789,1.0734528741467173,0.39751552795031053,1.0,1.0,1/11,0.67%,PRKCA
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3612310184863909,1.0728545372689844,0.3718371837183718,1.0,1.0,12/88,7.60%,STXBP6;STEAP2;SNAP23;SORCS1;RAB14;ARL3;GOLGB1;OSBPL5;SCAMP2;AP1G1;GBF1;EPS15
prerank,protein localization to chromosome (GO:0034502),0.4091276876079169,1.0727723883735045,0.3895939086294416,1.0,1.0,7/34,16.41%,FAM47E;MRNIP;ATRX;SLF2;ESR1;RPA2;TERF2IP
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.37503530075503094,-1.072263038566548,0.3782894736842105,0.8388787080736552,1.0,8/17,34.47%,BUB3;IK;BOD1;KNL1;ZW10;TTK;SPDL1;CENPA
prerank,positive regulation of mRNA processing (GO:0050685),0.4443598644628547,1.072254015379503,0.39667128987517336,1.0,1.0,4/21,12.97%,PRDX6;TRA2B;NCBP1;DAZAP1
prerank,regulation of microtubule-based process (GO:0032886),-0.30272334596287087,-1.0716484020133428,0.3548387096774194,0.8387840756423881,1.0,12/36,12.62%,PHLDB2;MACF1;ROCK1;DIAPH1;EPHA3;TRIM36;KLHL42;GSK3B;PRKAA2;MARK2;MAPT;FAM107A
prerank,potassium ion homeostasis (GO:0055075),-0.346077826113342,-1.0712434742587436,0.33189655172413796,0.838055216015321,1.0,6/23,7.72%,ATP1A2;ATP1B3;SLC12A7;KCNJ2;ATP1A1;SLC12A9
prerank,negative regulation of epithelial cell migration (GO:0010633),0.40593570983193816,1.0711670680203687,0.38596491228070173,1.0,1.0,2/33,1.66%,DCN;PTEN
prerank,regulation of MAPK cascade (GO:0043408),0.3418362875013876,1.071129763803861,0.35677352637021714,1.0,1.0,30/157,14.88%,ROR2;ROR1;NTRK3;FGF2;FGF10;ERBB2;EGFR;LPAR1;MAP4K4;PAK4;PAK5;NTRK2;NF1;TNIK;TMEM106A;PAK1;YWHAZ;KSR1;SPRED1;FGFR1;GPR37;PTPRJ;MAPK1;TAOK3;MYDGF;MYOC;PRDM11;DHX33;TRAF7;IQGAP1
prerank,metal ion export (GO:0070839),-0.3170822278785581,-1.0709525334819783,0.33004926108374383,0.8368979490314731,1.0,5/31,7.25%,ATP1A2;ATP1B3;ATP7A;ATP1A1;SLC40A1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.4121584213230529,-1.070860896207848,0.3697478991596639,0.8351547976196572,1.0,5/12,24.37%,RECQL5;LARP7;NELFCD;HEXIM1;EAPP
prerank,DNA duplex unwinding (GO:0032508),0.37791586585721143,1.0708584324915158,0.37775202780996525,1.0,1.0,12/50,17.24%,DDX11;RAD23B;GTF2H2;DDB2;XPA;MCM4;DDB1;RTEL1;UBB;BLM;CUL4B;WRN
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3361150045566328,-1.0705523546961733,0.3625,0.8340474755095199,1.0,7/24,12.07%,CDH5;TEK;ANGPT1;KDR;ICAM1;GATA2;SERPINE1
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.3559722226006947,-1.0705023767126856,0.35766423357664234,0.8321890456855712,1.0,8/21,15.38%,ROCK2;ROCK1;NOS3;ASPN;SRGN;ENPP1;HEY2;PTK2B
prerank,prostanoid metabolic process (GO:0006692),0.48864293176657664,1.0704141177667177,0.3815987933634992,1.0,1.0,4/13,17.79%,CYP2S1;ACOX1;PLAA;PTGES
prerank,circulatory system development (GO:0072359),0.34639427532723305,1.070295727894695,0.37829293993677554,1.0,1.0,25/118,15.14%,HSPG2;ERBB3;NTRK3;GLI2;PTEN;KAT2B;SOX9;AKAP13;ACVR1;FBXW7;TGFB1;NF1;FGF12;TGFBR2;PDLIM4;COL3A1;ERBB4;PTPN11;SMYD4;ZFPM2;KDM6A;LDB3;PKD1;CITED2;PKP2
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3452924019069422,1.0701402637011488,0.368532206969377,1.0,1.0,19/144,11.39%,SEC16B;ANK3;KIF20B;BCL2;ERBB2;C2CD5;FBXW7;TGFB1;PSEN1;PRNP;PCM1;YWHAZ;FYN;FLNA;VPS11;HUWE1;PIK3R1;UBE2J2;EMD
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.33515323856332374,1.0701172113460735,0.3544813695871098,1.0,1.0,52/259,15.42%,DYNLL1;PTPDC1;RHOD;RHO;WDPCP;GSN;STK36;RAP2B;CC2D2A;FGD4;MAP4K4;ANO6;ARL3;NEK1;CCDC57;RFX2;TTC39C;IFT140;EMP1;PCM1;TNIK;RILPL2;SNAP29;BBS9;RFX3;DISC1;GBF1;RAP1A;CPLANE1;BBS5;FLNA;PMP22;SPATA13;WDR35;ARF4;HDAC6;OPHN1;SNX10;RAB1A;CEP89;CFAP20;FBF1;TRAPPC14;P2RY12;CCDC28B;RAB11FIP3;PKD1;EHD2;CYFIP1;CCDC65;ITGB1;CDC14A
prerank,lipoprotein transport (GO:0042953),0.5070325004511687,1.0701128025447029,0.4155251141552511,1.0,1.0,6/10,25.43%,LRP1;PPARG;VMP1;UNC119B;MIA3;ZDHHC17
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.4132487967656778,1.0700816019214134,0.3777490297542044,1.0,1.0,6/31,17.21%,GLMN;SOX11;SDC4;IL4I1;ATM;RC3H1
prerank,DNA double-strand break processing (GO:0000729),0.44883932231714435,1.0697546654587997,0.39657631954350925,1.0,1.0,10/18,25.97%,SETMAR;BRCA1;EXD2;ATM;RAD52;BLM;RAD50;BARD1;SLX4;RBBP8
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4056500101279487,1.069727605913838,0.3691931540342298,1.0,1.0,15/37,19.42%,CADM4;WNK3;TGFB1;SPRED2;SPRED1;UBE2K;SPRED3;EIF4G1;MAPK1;BMP7;CALM1;CALM2;RPTOR;S1PR2;CAB39
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.49953425226950476,1.0694957687303388,0.4,1.0,1.0,3/11,6.38%,ACVR1;TGFB1;TGFBR2
prerank,protein localization to phagophore assembly site (GO:0034497),0.49860502334290685,1.0694442797132149,0.38664596273291924,1.0,1.0,2/11,5.78%,PACS2;WIPI1
prerank,regulation of intracellular signal transduction (GO:1902531),0.33240668485522895,1.069238293437986,0.2962962962962963,1.0,1.0,100/420,18.31%,ARHGAP24;DLC1;ARHGAP32;ARHGAP19;A2M;RHOJ;NTRK3;PYCARD;PTEN;RHOD;PTPN22;BST1;DEPDC1B;EGFR;AKAP13;FGD4;MAP4K4;VEGFA;PAK4;ARAF;PAK5;NTRK2;TRAF4;PRKAR1B;TNIK;PTPN13;NOP2;WNT5A;NLGN1;PAK1;CHN1;MAPKAP1;MTA2;RPA3;PRKAB2;UFL1;ITSN1;SPRED1;ARHGAP9;CHD3;NF2;ARHGEF11;CASTOR2;TBCK;PPP1R13L;BRCA1;VAV3;RCN3;ARHGAP11A;RHOT2;HDAC2;MYO9B;PHF20;AKAP6;MAPK14;TAF9;MYO9A;ARHGAP21;TAF11;TAF2;MAPK1;OPHN1;TAOK3;CDK5R1;FBXL2;RHOH;RHOC;MYOC;GNAI1;RBBP4;TRIO;PRDM11;ARHGAP4;ARHGEF3;RPA2;TOPBP1;MDM4;TAF7;ARHGAP44;ZFAND6;RASSF2;ATM;GPAT3;TAF4;BLM;TP53;TAF4B;TTI1;XIAP;SGK1;USP2;ARHGEF4;WRN;RAC3;PLEKHG2;PIP5K1A;TP53RK;BOP1;MDM2;RHOT1
prerank,negative regulation of vascular permeability (GO:0043116),-0.42507558799838496,-1.0690327232122065,0.36416184971098264,0.8346360655518061,1.0,6/12,14.78%,CLDN5;ANGPT1;SLIT2;PDE3A;PDE2A;CEACAM1
prerank,cGMP-mediated signaling (GO:0019934),-0.40017957504447355,-1.0685917229678352,0.3753581661891118,0.8340389228590273,1.0,6/13,19.53%,IRAG1;PDE3A;GUCY1B1;PDE2A;APOE;KCNC2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4056578019943168,1.068525629925998,0.38972431077694236,1.0,1.0,7/33,13.20%,ERBB3;PTEN;ERBB2;NF1;NYAP1;PIK3R1;GATA3
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3666611275818205,1.0679643368193221,0.370242214532872,1.0,1.0,14/65,15.17%,PRDM16;HTRA3;TGFB1;TGFBR2;SPRED2;SPRED1;PEG10;BCL9L;SPRED3;SNX6;DAND5;LTBP1;LDLRAD4;UBB
prerank,cholesterol metabolic process (GO:0008203),0.3626065255595107,1.067963917557115,0.38850574712643676,1.0,1.0,9/68,10.89%,CEL;HSD17B7;SQLE;GBA2;MT3;OSBPL5;IDI1;ACLY;ABCA5
prerank,regulation of interferon-gamma production (GO:0032649),0.3662720730814544,1.0677577819954365,0.38346727898966704,1.0,1.0,9/71,12.73%,PYCARD;PTPN22;FADD;PDE4B;PRNP;CCR2;IL18;PDE4D;SCRIB
prerank,positive regulation of cell population proliferation (GO:0008284),0.3306354150693539,1.0675390996755811,0.2901606425702811,1.0,1.0,70/423,12.89%,OSR2;BMP5;PDGFRA;ERBB3;HAS2;NTRK3;FGF2;SOX8;MYC;FGF10;KIF20B;PTEN;BCL2;GAREM1;IRS2;SOX9;CRLF1;BST1;ERBB2;LAMC1;EGFR;VEGFA;MAP3K3;PTHLH;CAPN1;SAAL1;TGFB1;TIPIN;PTGFR;SOX11;NTRK2;GDF9;GLI1;NOX1;NOP2;SCN5A;WNT5A;PAK1;CDK13;TGFBR2;MLXIPL;UFL1;S100A6;CDK6;FOXM1;FGFR1;IL18;TSHR;GAB2;BTC;DERL2;CUL3;HDAC2;ERBB4;GDNF;IL6ST;PRMT1;CDC25B;PID1;SIRT6;S1PR3;EDN3;FGF7;GRN;RTKN2;WWTR1;GLP2R;PRLR;PRDX3;ZFPM2
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.4023312721709815,-1.0668398988273677,0.36283185840707965,0.8374271276528625,1.0,3/12,2.81%,WAPL;CTNNB1;HDAC8
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.31850009305523186,-1.066254819910017,0.3073770491803279,0.8372693879743747,1.0,6/26,6.83%,EYA1;EYA2;MAP2K5;EYA4;MCL1;PPP2R1B
prerank,erythrocyte development (GO:0048821),-0.43474139246857024,-1.0660287393966525,0.3817663817663818,0.8359622757682358,1.0,7/10,42.04%,ALAS1;NCKAP1L;DMTN;LYAR;ALAS2;ZBTB7A;SH2B3
prerank,neuron projection development (GO:0031175),0.3357115294522062,1.0660112856307222,0.3577319587628866,1.0,1.0,34/168,13.40%,CDNF;DOCK7;KIF20B;PTEN;NGF;PPP1R9A;MAP4K4;GAS7;ATXN10;EPHB2;GPM6B;PLP1;TNIK;NYAP1;NLGN1;PAK1;ALS2;DOCK10;CNTNAP2;GPM6A;EPB41L3;VAPA;GDNF;DCLK1;PRMT1;DIP2A;BMP7;OPHN1;STMN4;TAOK3;CDK5R1;MYOC;CDK16;TRIO
prerank,sodium ion transmembrane transport (GO:0035725),0.3626531450265353,1.0657438734248685,0.37583148558758317,1.0,1.0,10/84,7.96%,SLC6A2;SCN7A;SLC12A3;SCN2A;KCNK1;ANO6;SLC12A2;SCN5A;SCN3A;SLC8A2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.3995758840359524,-1.065458562714817,0.3708206686930091,0.8358612673087582,1.0,3/13,4.56%,TLR4;NAMPT;KDR
prerank,myotube differentiation (GO:0014902),-0.36128055208500554,-1.065373040161708,0.3312302839116719,0.8341445579386297,1.0,4/17,15.27%,IGF1;MYEF2;SORT1;NOS1
prerank,negative regulation of locomotion (GO:0040013),-0.41619665481161283,-1.0651798018141245,0.40350877192982454,0.83282793168783,1.0,4/12,9.35%,FRMD5;FBLN1;DUSP3;CCDC125
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.4031976886235906,-1.0648844237925172,0.4146981627296588,0.831817316380067,1.0,4/12,10.96%,PTPN14;BMP4;IFI27;NUP214
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.3125783859155853,-1.064757765504045,0.31555555555555553,0.8302574396655932,1.0,15/31,24.39%,PPP1R13B;YWHAQ;GSK3B;CASP8;GSK3A;TFDP2;BID;HIP1R;BOK;NMT1;BBC3;E2F1;BAK1;PPP3R1;MAPK8
prerank,regulation of macrophage activation (GO:0043030),-0.31292474484300614,-1.0646038549103156,0.3632286995515695,0.8288008795865132,1.0,5/30,5.90%,CD200;IL31RA;MFHAS1;TLR4;THBS1
prerank,replication fork processing (GO:0031297),0.3979134848350824,1.0645244074357447,0.3931203931203931,1.0,1.0,10/38,17.24%,DDX11;ZRANB3;SETMAR;ATRX;FBH1;EXD2;RTEL1;BLM;FAM111A;WRN
prerank,secondary alcohol metabolic process (GO:1902652),0.38456880452935677,1.064467336713833,0.38089330024813894,1.0,1.0,8/42,14.45%,IDH2;SQLE;GBA2;OSBPL5;IDH3B;ABCA5;CYP27A1;IDH3A
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.3892364532773514,-1.0644578160897689,0.3653250773993808,0.8273304153552976,1.0,11/14,51.68%,ATP6AP1;TYROBP;CSF1;POU4F1;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;IL12B
prerank,regulation of T cell mediated immunity (GO:0002709),0.5073726213980325,1.0643600545726357,0.4157814871016692,1.0,1.0,2/10,12.59%,CCR2;ZBTB1
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.3090381844694411,-1.0642906479127787,0.29493087557603687,0.8258745547719596,1.0,7/34,9.93%,IGF1;LRP5;IGF2;INSR;TGFA;RGCC;PDGFRB
prerank,translation (GO:0006412),-0.2201035946834771,-1.0641777747942343,0.1,0.8242682825129601,1.0,88/208,26.80%,RPS14;GSPT1;RPL24;DRG1;RPL18A;RPS16;GTPBP2;RPL38;RPL28;RPS19;RPL37;ABCE1;RARS2;RPS2;FTSJ1;SARS1;MRPL10;GTPBP1;RPL19;RPL5;RPL34;RPS25;MRPS24;RPS15;TNIP1;EEF1G;RPLP1;RPL31;PABPC4;RPL3;MRPL24;MRPL3;QRSL1;EEF1A1;DRG2;FASTKD2;RPS6;GFM2;LARS1;RPS8;EIF4EBP2;AARS1;RARS1;RPL11;RPL12;KARS1;RPS6KB2;TSFM;RPL7A;RPL13;EEF1B2;MRPS7;COPS5;MRPL43;IGF2BP3;YARS2;RPS21;NOA1;RPL35A;ASMT;RPL26;RPS9;MRPS17;RPL32;RPS29;RPS23;EEF1E1;RPLP2;MRPS11;MRPL2;RPL8;MRPS16;RSL24D1;RPL41;VARS1;RPS17;GATC;DHPS;RPS5;RPS15A;UBA52;RPL37A;MRPL57;RPS10;MRPL55;RPL6;WARS1;RPL9
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.48135522627601257,1.06416483276275,0.42451420029895365,1.0,1.0,5/12,25.72%,TIPIN;BLM;WRNIP1;KAT7;WDR18
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.35752505701867643,1.0635495428384716,0.383025027203482,1.0,1.0,30/84,26.11%,PRDX6;RBFOX1;CELF5;QKI;TRA2B;SON;KHDRBS3;NCBP1;PCBP4;DAZAP1;CELF6;RBM7;NOVA1;SRSF6;YTHDC1;HNRNPU;RNPS1;SF1;RBFOX3;CELF4;HNRNPL;RBFOX2;SRSF3;RBM25;FMR1;CIRBP;NSRP1;RBM4;RBM15;TRA2A
prerank,cellular response to organonitrogen compound (GO:0071417),0.35200766866222216,1.0634585549246547,0.4058127018299246,1.0,1.0,26/99,19.80%,P2RY2;SOX9;HRH1;AOC1;RAP1A;CPEB3;LAMTOR2;TSHR;BRCA1;AKAP6;HSP90B1;AHR;CPEB1;P2RY12;P2RY1;SSH1;JUP;GABRG2;SPAAR;RPTOR;TAF1;EGR1;RYR3;IPO5;HCN1;RRAGA
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.3206762241491186,-1.0633727185707091,0.3474576271186441,0.8247775149289637,1.0,6/30,6.82%,FLT1;KIT;MLLT3;BMP4;KDR;ACE
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.4569019761710971,1.0629946657693252,0.4096045197740113,1.0,1.0,7/17,21.95%,ERLIN2;KPNB1;ERLIN1;SREBF2;MBTPS1;SEC14L2;PRKAA1
prerank,response to growth factor (GO:0070848),0.3873802697097705,1.0629413260240494,0.40456182472989194,1.0,1.0,10/41,11.39%,MYC;ERBB2;ACVR1;MAPK7;ACVR1C;URI1;TGFBR2;GATA6;HDAC6;EMD
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.5003767198056914,1.0627717194508557,0.3993993993993994,1.0,1.0,2/11,5.21%,CREB3L1;E2F2
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.461524924351803,1.0617198048216963,0.3994082840236686,1.0,1.0,5/16,18.53%,KAT2B;NAA35;NAA16;NAA10;NAA15
prerank,plasma membrane repair (GO:0001778),-0.3986121376286018,-1.0616938315889908,0.36231884057971014,0.8278338436904491,1.0,4/13,12.27%,MYOF;MYH9;AHNAK2;SYTL4
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.347408888644389,-1.0616904200963146,0.3617886178861789,0.8240266002551868,1.0,10/23,20.22%,DAB2;THBS1;SNW1;GIPC1;ING2;FLCN;SLC2A10;CREBBP;HSP90AB1;TGFB1I1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.347408888644389,-1.0616904200963146,0.3617886178861789,0.8240266002551868,1.0,10/23,20.22%,DAB2;THBS1;SNW1;GIPC1;ING2;FLCN;SLC2A10;CREBBP;HSP90AB1;TGFB1I1
prerank,DNA geometric change (GO:0032392),0.41877459389316063,1.0616577128445643,0.396505376344086,1.0,1.0,10/24,26.70%,DDX11;ZRANB3;RTEL1;BLM;WRN;RAD50;SUPV3L1;RECQL;HNRNPA2B1;DDX1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.3979166726510043,-1.0616351786461724,0.3746397694524496,0.8222927569580926,1.0,5/13,24.37%,RECQL5;LARP7;NELFCD;HEXIM1;EAPP
prerank,nucleotide-sugar metabolic process (GO:0009225),0.4766297416000068,1.0615384987371852,0.40956651718983555,1.0,1.0,2/12,7.77%,GFPT2;CSGALNACT1
prerank,GPI anchor metabolic process (GO:0006505),0.4188581638589652,1.0615281049680876,0.3847167325428195,1.0,1.0,9/26,19.96%,PGAP1;PIGC;PIGP;PIGN;PIGA;PIGU;GPLD1;DPM1;PIGO
prerank,inositol phosphate metabolic process (GO:0043647),0.38322891299522116,1.0614470856666878,0.4028950542822678,1.0,1.0,5/46,4.92%,ITPK1;INPP4B;FGF2;PTEN;PLCB1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.43032853874187177,-1.0613797690909141,0.37209302325581395,0.8212072777680415,1.0,4/10,12.22%,ATP5MC3;ATP5PD;VPS9D1;ATP5F1D
prerank,cellular response to chemical stress (GO:0062197),0.34913599396659223,1.0613364500602551,0.39934711643090315,1.0,1.0,25/96,18.85%,PRDX6;SRXN1;LRRC8D;NCF1;MT3;NOX1;GPX3;MGAT3;NCF2;SELENOS;NFE2L2;FANCC;PRDX3;SOD2;SNCA;ATM;ABL1;VKORC1L1;RAD52;PNPT1;SLC25A24;TXNRD1;CAT;PARK7;ERMP1
prerank,negative regulation of protein secretion (GO:0050709),-0.2929762030869345,-1.0612566609539376,0.34782608695652173,0.8196855899800686,1.0,14/38,23.90%,CD200;MIDN;ERP29;OPRM1;ADRA2A;KCNB1;RHBDF2;DPH3;SIRT4;APOE;NR1H3;RSAD2;RAB11FIP1;SERGEF
prerank,peptidyl-serine modification (GO:0018209),0.33794708802934,1.0611815063083385,0.38461538461538464,1.0,1.0,49/166,19.43%,PRKCA;STK32B;PRKCQ;PRKX;EIF2AK3;RPS6KA4;MAPKAPK3;MAST2;MAPKAPK2;DYRK4;PKN1;TGFBR2;DYRK1B;GALNT1;PDK3;STK39;TLK2;MAPK9;AKT3;SGK3;SGK2;MAPK14;STK32A;MAPK1;CDK5R1;TBK1;CSNK1G1;GALNT13;PRKACA;CSNK1A1;HPF1;TTBK1;RPS6KA2;PKD1;GALNT3;ATM;CSNK1E;CSNK1G2;SGK1;CHUK;NAA10;POGLUT2;PKN2;VRK3;TAF1;CSNK2A2;CSNK1G3;CAB39;TOP1
prerank,positive regulation of transport (GO:0051050),0.35441140341564925,1.0609797769201659,0.38453038674033146,1.0,1.0,6/85,3.05%,GPC3;SYNGR3;PYCARD;LRP1;C2CD5;KMT2A
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.2413894140354944,-1.0607251947856038,0.26865671641791045,0.8193041597784503,1.0,18/102,9.76%,SORBS1;TBC1D4;ADCY9;SLC30A10;PRKCD;RAB31;PRKAR1A;PRKCI;INSR;LPIN2;ZFP36L1;PARP1;SLC25A33;RHOQ;RPS6KB1;GSK3A;ADCY4;INSIG2
prerank,ribosome assembly (GO:0042255),-0.2831902085937326,-1.060629345613507,0.33136094674556216,0.8177205452044944,1.0,24/47,27.55%,RPS14;RPL24;NPM1;RPS19;RPL5;EIF2A;RPS15;RPL3;MRPL20;NOP53;RPL11;MRPS7;DHX37;MRPS11;MRPL22;RSL24D1;NLE1;PPAN;MPV17L2;RPS5;RPF2;RPL6;PWP2;RPS27
prerank,autophagy of mitochondrion (GO:0000422),0.39254460892991977,1.0605874143713685,0.38357843137254904,1.0,1.0,8/38,14.98%,PRKN;FBXO7;WIPI1;CTSK;BNIP3;ATG5;ATG3;GABARAPL2
prerank,cilium organization (GO:0044782),0.33591266719792906,1.0601579564014258,0.38139059304703476,1.0,1.0,39/209,15.58%,DYNLL1;PTPDC1;RHO;WDPCP;GSN;STK36;CC2D2A;ARL3;NEK1;CCDC57;RFX2;TTC39C;IFT140;PCM1;RILPL2;SNAP29;BBS9;RFX3;DISC1;GBF1;CPLANE1;BBS5;FLNA;WDR35;ARF4;HDAC6;SNX10;RAB1A;CEP89;CFAP20;FBF1;TRAPPC14;CCDC28B;RAB11FIP3;PKD1;EHD2;CCDC65;CDC14A;CFAP61
prerank,regulation of cardiac muscle contraction (GO:0055117),0.4039415442799934,1.0600801641354005,0.3972772277227723,1.0,1.0,8/34,17.46%,ANK2;PDE4B;SCN5A;PDE4D;PRKACA;CALM1;CALM2;SLC9A1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.297411124858515,-1.0599881308112846,0.34375,0.8178036289077015,1.0,10/39,12.07%,CDH5;TEK;ANGPT1;KDR;PRKCI;THBS1;ICAM1;RGCC;GATA2;SERPINE1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.49825225126153955,1.0595292043785056,0.4278996865203762,1.0,1.0,2/11,15.49%,CBFB;RUNX1
prerank,cilium assembly (GO:0060271),0.3304463209081834,1.0595162399213494,0.3430290872617854,1.0,1.0,56/296,15.65%,DYNLL1;PTPDC1;RHO;WDPCP;GSN;STK36;CC2D2A;CCDC39;RSPH1;HAUS3;CNTRL;ARL3;NEK1;CCDC57;RFX2;TTC39C;IFT140;PCM1;RILPL2;SNAP29;NDE1;BBS9;RFX3;DISC1;SDCCAG8;GBF1;SPATA6;CPLANE1;BBS5;FLNA;CEP57;TRIP11;CFAP46;WDR35;CFAP74;CLASP1;ARF4;HDAC6;SNX10;RAB1A;CEP89;PRKACA;CFAP20;CKAP5;FBF1;TRAPPC14;CEP76;DYNC1I2;CCDC28B;RAB11FIP3;PKD1;EHD2;CCDC65;CDC14A;CSNK1E;IFT57
prerank,respiratory tube development (GO:0030323),0.4134880674391347,1.0594567633612275,0.3914174252275683,1.0,1.0,5/28,6.97%,GLI2;FGF2;CCDC39;VEGFA;LOXL3
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3154728835771296,-1.0594009317591808,0.34080717488789236,0.8176024234014361,1.0,12/30,19.33%,ACVRL1;DACH1;BMPR2;XRN1;TERF2;DCP2;CERS1;PINX1;EXOSC10;TEN1;TINF2;TENT4B
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.3944569643701623,-1.0592914698307712,0.382262996941896,0.8160609823882229,1.0,8/14,23.36%,RBMX;SRSF10;SRSF4;SAP18;PTBP1;SRSF12;SRSF7;U2AF2
prerank,cAMP biosynthetic process (GO:0006171),-0.43036717343978337,-1.0588506206659571,0.38858695652173914,0.8156345126356841,1.0,3/10,18.27%,ADCY9;ADCY4;ADCY3
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.472164963240621,1.058821469463465,0.4212121212121212,1.0,1.0,5/13,22.15%,MBD4;NEIL1;SMUG1;NT5C;TDG
prerank,cellular response to reactive oxygen species (GO:0034614),0.3617270922454231,1.0588080484894111,0.3806752037252619,1.0,1.0,21/59,21.51%,PDGFRA;EGFR;MAPK7;NCF1;CYP1B1;MAPK9;NFE2L2;HDAC6;MAPK1;ERCC6L2;PRDX3;ABL1;PAX2;RIPK1;CHUK;PARK7;OSER1;JUN;SIRPA;PKD2;PXN
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4203562782596835,1.0586013058113122,0.4069767441860465,1.0,1.0,8/28,14.00%,PRKCQ;PTPN2;SLC27A4;SOCS1;GRB14;PTPN1;PID1;NCK1
prerank,"phagocytosis, engulfment (GO:0006911)",0.40030345692420866,1.0583866706414105,0.3967861557478368,1.0,1.0,4/36,2.81%,XKR7;GULP1;GSN;XKR8
prerank,regulation of cellular catabolic process (GO:0031329),-0.26685680078199187,-1.0582394185123674,0.3262411347517731,0.8157115640170889,1.0,21/62,20.00%,DAPK1;ITPR1;ROCK1;ACER2;RRAGC;ABL2;LONP2;DAPK2;NUPR1;KEAP1;RAB8A;MAPT;RMC1;DRAM2;PIP4K2B;BOK;OSBPL7;SMCR8;HSPB1;GPR137;RRAGB
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.41282692940664584,1.0578619475189468,0.4049159120310479,1.0,1.0,14/29,21.38%,MYC;TLE1;MEN1;BCL9L;BCL9;TRRAP;PYGO1;TLE3;CDC73;TLE4;ASH2L;SMARCA4;KMT2D;PYGO2
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.3815650373734557,1.0573039645006086,0.37484885126964934,1.0,1.0,6/46,6.82%,NTN4;PEAK1;LAMC1;MEGF9;NTNG2;NTNG1
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.4769072754205508,1.0572286351508349,0.44036697247706424,1.0,1.0,3/13,11.10%,CRLF1;TYK2;IL6ST
prerank,synapse organization (GO:0050808),0.34343221372560684,1.0571708137604565,0.4069767441860465,1.0,1.0,29/125,14.94%,ANK3;PDZRN3;LRP4;PTEN;SEMA3E;NRCAM;PSEN1;NRXN1;LRRC4C;OBSL1;NLGN1;APBB2;CACNB4;KIRREL3;NTNG1;SLC8A2;GPM6A;CNTN2;DSCAM;GRM5;PPFIA2;ADGRL3;DVL1;DRD2;GPC4;GPHN;SNCA;PTPRF;CYFIP1
prerank,regulation of autophagosome maturation (GO:1901096),-0.3941861193173431,-1.057111156894618,0.3716012084592145,0.8172971575684084,1.0,6/13,22.32%,IRGM;TBC1D25;UVRAG;SMCR8;RUBCN;ADRB2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.47391832910754933,1.057026871917736,0.4162962962962963,1.0,1.0,4/14,9.89%,ZEB1;SPRED2;SPRED1;SPRED3
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.42902828364345386,1.0569230007541643,0.39207650273224043,1.0,1.0,10/21,26.34%,FGF13;CLASP1;APC2;KATNB1;NAV3;ATXN7;CAMSAP1;TAOK1;CIB1;APC
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.3676107506332692,-1.0568348416309312,0.3993808049535604,0.8162248583825253,1.0,4/16,7.52%,RANBP3L;BOC;IGFBP3;AKIRIN1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.4946888357435614,1.0566323097787718,0.4121122599704579,1.0,1.0,7/12,25.23%,WAC;RPA2;RPS27L;TP53;FBXO31;PLK5;PRKDC
prerank,regulation of cell death (GO:0010941),0.3475829960418113,1.0564791448635096,0.37365010799136067,1.0,1.0,20/94,16.38%,FGF2;OLFM4;PRKN;LRP1;SOX11;MT3;TSC1;BNIP3;ATG5;PACRG;CRYAB;DCC;EIF4G1;BMP7;TBK1;SNCA;NCK1;SRSF6;UBB;SLC25A24
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.4064456624007991,-1.0563499989749952,0.3884057971014493,0.8159257770214127,1.0,4/12,14.92%,ZDHHC7;LAMA3;ACTG1;FUZ
prerank,amino acid transport (GO:0006865),-0.2804744751303869,-1.0561984844848273,0.34615384615384615,0.814594215928706,1.0,12/49,14.60%,SLC7A11;SLC7A2;SLC6A12;SLC6A6;SLC7A5;SLC38A11;PDPN;SLC38A7;SLC38A5;SLC25A47;SLC38A10;SLC36A4
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4333506284762673,1.055650044295555,0.4134742404227213,1.0,1.0,3/21,6.93%,MMP2;FGF2;ADAMTS1
prerank,glucose import (GO:0046323),0.4743436733919103,1.055520359677653,0.4144144144144144,1.0,1.0,3/13,12.42%,SLC27A1;SLC27A4;RAB4B
prerank,positive regulation of response to wounding (GO:1903036),-0.34344191226037357,-1.0552637928512811,0.3815261044176707,0.8156943676968375,1.0,7/24,11.99%,PTN;VTN;OCLN;SCARF1;MYLK;ADRA2A;ACTG1
prerank,regulation of cell communication (GO:0010646),-0.30153158138420305,-1.0552050411737257,0.37823834196891193,0.8140762312365416,1.0,8/35,11.23%,GRK5;IGFBP7;CXADR;SCG5;GRK4;GRK2;MGLL;UGCG
prerank,regulation of macromolecule metabolic process (GO:0060255),0.334544977077274,1.0547439422493055,0.3965341488277268,1.0,1.0,42/170,20.82%,AFF3;MYC;DHH;HNRNPDL;C1D;PTHLH;TRIM44;PSEN1;RFXANK;HNRNPAB;RASA1;UBAP2;MKLN1;TRIM11;CDK6;SLC8A2;ZNF462;ANKRA2;HIF1A;ZFP64;PRDM9;GDNF;PCBP4;POGZ;ATRAID;EDN3;AHR;PRDM11;KDM6A;NOVA1;KHSRP;STX1B;ZUP1;APLNR;FUBP1;CGGBP1;MARF1;HMG20A;PRDM2;FUBP3;AFF1;SIRPA
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.34793765416301303,1.0546087058889868,0.4189189189189189,1.0,1.0,20/122,9.18%,GLI2;FGF2;MYC;IRS2;HSPH1;ERBB2;EGFR;UPF3A;PLD1;GLI1;NOX1;NIBAN1;TMEM106A;STN1;METTL3;EIF3C;CPEB3;EIF6;NSUN5;PASK
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3413831937178819,1.054582495219239,0.38941798941798944,1.0,1.0,19/121,11.99%,RELN;ERBB3;FGF10;CRLF1;ACVR1;EFNA5;VEGFA;GPRC5B;TGFB1;TEC;PRNP;IL18;PTPN1;GRM5;ERBB4;PTPRJ;PTPN11;IL6ST;FGF7
prerank,positive regulation of lyase activity (GO:0051349),-0.3861173724462519,-1.0545084789100974,0.40384615384615385,0.8142955788813484,1.0,5/14,15.85%,CACNA1C;NOS3;STIM1;NOS1;FXN
prerank,female gamete generation (GO:0007292),0.408447335083712,1.0544381739865336,0.41025641025641024,1.0,1.0,11/29,23.40%,FMN2;GDF9;METTL3;DIAPH2;PRDM9;MDK;MARF1;KMT2D;SPO11;MEI4;TOB2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.4911365922981528,1.0541437593977174,0.4094955489614243,1.0,1.0,3/11,18.77%,GSN;PIH1D1;PARK7
prerank,positive regulation of cell migration (GO:0030335),0.3300089374733829,1.054091488523981,0.35923309788092833,1.0,1.0,47/253,15.48%,ROR2;CCL11;PRKCA;LGR6;PDGFRA;GLIPR2;HAS2;NTRK3;FGF10;KIF20B;SEMA3E;RHOD;SOX9;EGFR;ACVR1;SEMA6C;MAP4K4;VEGFA;EPHB2;SEMA3A;TGFB1;CLDN1;DOCK5;CCR2;PAK1;FAM83H;TWIST2;PPP3CA;SMO;TRIP6;DOCK1;HIF1A;CLASP1;HDAC6;GRN;RHOC;MYOC;SOD2;RTN4;SPAG9;ELP5;COL1A1;SEMA6D;WASHC1;PLAA;ITGB1;ATM
prerank,neurotrophin signaling pathway (GO:0038179),0.4319443514548784,1.053782602580083,0.4171270718232044,1.0,1.0,5/21,11.52%,NGF;NTRK2;RAP1A;NGFR;MAGI2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.4377882940610297,1.053749368725293,0.41134751773049644,1.0,1.0,6/18,17.22%,EGFR;TGFB1;ESR1;NCOR2;TP53;RIPK1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.3797661970675244,-1.0536983878619086,0.35294117647058826,0.81483018067046,1.0,6/14,12.07%,IGFBP3;SLIT2;IGFBP5;TPM1;PRKG1;SERPINE1
prerank,cobalamin metabolic process (GO:0009235),0.44919012329975694,1.0534995356781502,0.3994252873563218,1.0,1.0,5/17,17.07%,MMAB;CD320;MTRR;MTR;ABCC1
prerank,protein dephosphorylation (GO:0006470),0.34082953151434214,1.053498892493948,0.3818565400843882,1.0,1.0,30/135,14.81%,PTPRH;UBASH3B;PTEN;PTPN22;DUSP4;PTPRT;PTPN2;PPP1R15A;DUSP6;PTPN13;RPRD1A;PPP3CB;PPP3CA;PPM1B;PPM1J;PPP2R3A;PPP2R2A;PTPN1;DUSP11;PTPRJ;PTPN11;PPP1CA;PTPRA;PTPN18;PTPRZ1;PTPN21;PPP3CC;NCK1;SSH1;PTPRF
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.3541976756493862,-1.0534837866227624,0.33650793650793653,0.813682059376051,1.0,6/19,8.82%,MAP2K5;SLCO1C1;MTPN;KLF2;APP;KLF4
prerank,negative regulation of kinase activity (GO:0033673),0.36443798477088324,1.0534763190663883,0.39767441860465114,1.0,1.0,16/62,18.77%,UBASH3B;IRS2;NPRL2;DEPTOR;NF1;SPRED1;DVL1;WWTR1;PRDX3;SNCA;TAF7;HNRNPU;PYDC1;DBNDD2;PPM1E;PARK7
prerank,negative regulation of endocytosis (GO:0045806),0.4192954882833987,1.0533985344030483,0.3943472409152086,1.0,1.0,3/24,9.97%,LGALS3;SYT11;MCTP1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5069321468522675,1.0529297222561527,0.42496050552922593,1.0,1.0,3/10,9.19%,CCR2;WNT5A;STK39
prerank,dicarboxylic acid transport (GO:0006835),-0.31347328335178404,-1.0527298603989854,0.3541666666666667,0.8142156574557508,1.0,6/28,6.64%,SLC13A3;SLC26A7;GJA1;SLC22A6;PDPN;GIPC1
prerank,regulation of protein kinase B signaling (GO:0051896),0.3317651887069701,1.0523589070383113,0.3922369765066394,1.0,1.0,37/193,16.13%,PDGFRA;ERBB3;NTRK3;FGF2;FGF10;PTEN;IRS2;ERBB2;EGFR;THEM4;TGFB1;NTRK2;FGFR1;IL18;FYN;GAB2;HIP1;BTC;RCN3;ERBB4;PIK3R1;PTPRJ;ESR1;PTPN11;MAGI2;MYDGF;FGF7;MYOC;DRD2;STRN;GATA3;P2RY12;RTN4;MET;ITGB1;GAB1;LRP2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.37913459325222065,-1.0520845132277281,0.38175675675675674,0.8142769180786309,1.0,8/16,27.83%,NPR3;TERF2;TERT;NUS1;APOE;AKT1;PIK3CB;HTR2B
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.3032860208943057,-1.0519924253602766,0.3284313725490196,0.8127900947836366,1.0,10/36,12.43%,LEF1;CTNNB1;PLCB3;MOV10;AGO1;FZD6;NLK;CAMK2A;MAP3K7;AGO3
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.47712350367112843,1.0517745505521723,0.41131498470948014,1.0,1.0,2/12,7.90%,CARD9;IL18
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.36682901598079204,-1.0514077450520798,0.40131578947368424,0.8127887442755155,1.0,9/17,25.06%,COX7B;COX6B1;COX6A1;COX4I1;COX7C;COX5B;COX5A;COX6C;CYCS
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.36160455005313497,-1.0513646489510968,0.38387096774193546,0.8111011890210389,1.0,6/17,14.57%,ATP5MC3;ATP5PD;STOML2;VPS9D1;ATP5F1D;ATP5MF
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3345696129079864,1.0512952550337884,0.39315352697095435,1.0,1.0,36/150,19.29%,PDGFRA;ERBB3;FGF2;FGF10;IRS2;ERBB2;EGFR;THEM4;TGFB1;FGFR1;IL18;FYN;GAB2;HIP1;BTC;ERBB4;PIK3R1;PTPRJ;ESR1;PTPN11;MYDGF;FGF7;MYOC;STRN;GATA3;P2RY12;RTN4;MET;ITGB1;GAB1;LRP2;HBEGF;PARK7;AXL;GRB2;CPNE1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.3508153526847513,-1.0511284026271692,0.36524822695035464,0.8100124095606197,1.0,9/19,22.04%,XRN1;TERF2;DCP2;PINX1;EXOSC10;TEN1;TINF2;TENT4B;HNRNPA1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.40969651018982606,1.050755057886175,0.42473118279569894,1.0,1.0,3/28,3.89%,PTEN;PRKN;FBXW7
prerank,protein localization to lysosome (GO:0061462),-0.3118881169320729,-1.0505652986075875,0.404,0.8098075474849147,1.0,14/28,32.72%,LMBRD1;M6PR;MFSD1;VPS4A;RNF128;KPTN;LAPTM5;SH3BP4;ATP13A2;SZT2;NAGPA;LAMTOR4;NEDD4;SORL1
prerank,sulfur compound transport (GO:0072348),-0.31834699952733053,-1.0504837279173362,0.34893617021276596,0.808260019307802,1.0,9/27,13.58%,ABCG2;SLC26A7;SLC6A6;SLC6A13;SLC25A26;SLC25A30;SLC13A4;SLC5A6;MGST1
prerank,mRNA catabolic process (GO:0006402),0.3772528504038847,1.0503820012618483,0.4106699751861042,1.0,1.0,9/44,11.48%,DHX34;DXO;METTL3;XRN2;TUT4;MRTO4;ZFP36L2;NBAS;UPF1
prerank,detection of mechanical stimulus (GO:0050982),0.4424870077229432,1.0493276249417167,0.40353260869565216,1.0,1.0,4/19,15.42%,PIEZO2;LHFPL5;PKD1;JUP
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.47851769418497436,1.0488623583262118,0.4098101265822785,1.0,1.0,3/12,15.28%,IL18;TTBK1;IL33
prerank,regulation of calcium ion transport (GO:0051924),0.3779172293222638,1.0486154711165057,0.41031652989449,1.0,1.0,6/54,4.10%,IL16;BCL2;CACNA2D1;ANK2;WNK3;CCL4
prerank,protein insertion into ER membrane (GO:0045048),0.38519793072237124,1.0485173747737628,0.4032258064516129,1.0,1.0,17/37,23.30%,WDR83OS;PRNP;VAPA;UBE2J2;EMD;OTOF;CCDC47;SEC61G;EMC10;CYB5A;EMC1;SGTA;EMC8;EMC3;CAMLG;EMC6;EMC2
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.3355236438378402,-1.0483168085415422,0.39776951672862454,0.8110361830354382,1.0,7/22,15.14%,ZDHHC14;ZDHHC3;CLIP3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.3355236438378402,-1.0483168085415422,0.39776951672862454,0.8110361830354382,1.0,7/22,15.14%,ZDHHC14;ZDHHC3;CLIP3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,protein monoubiquitination (GO:0006513),0.3883395637734173,1.0481172548646946,0.4120603015075377,1.0,1.0,9/36,17.24%,UBE2T;PRKN;WAC;CUL3;HUWE1;KLHL12;KLHL22;UBE2O;CDC73
prerank,potassium ion transmembrane transport (GO:0071805),0.3387860127718762,1.0478902304692188,0.40207253886010363,1.0,1.0,34/135,22.91%,KCNK15;SLC1A3;KCNA2;KCNH8;SLC12A3;KCNK1;KCNA1;KCNA6;SLC12A2;KCND1;KCND2;KCND3;KCNT2;SLC12A4;KCNAB2;KCNJ3;KCNJ10;SLC9A5;KCNH2;SLC9A1;SLC24A4;SLC24A2;KCNA5;HCN1;KCNS3;KCNH7;KCNK10;LRRC55;PKD2;KCNQ3;KCNK6;KCNA4;KCNC1;KCNJ13
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.41294444268695574,-1.0478652032825535,0.42105263157894735,0.8106088005805042,1.0,9/11,26.73%,UQCRB;UQCR11;CYC1;UQCR10;UQCRH;UQCRFS1;UQCRC1;CYCS;UQCC3
prerank,mitotic cell cycle phase transition (GO:0044772),0.3267136255208007,1.0478265662071364,0.40161453077699294,1.0,1.0,48/203,20.15%,DYNLL1;CRLF3;MYC;CDKN2B;ACVR1;CCNJ;HAUS3;CNTRL;KDM8;CCDC57;PLCB1;PCM1;FBXL15;NDE1;SDCCAG8;CDK6;PHLDA1;FOXM1;ENSA;CEP57;PPP2R2A;CUL3;ANAPC7;RCC1;CLASP1;PKMYT1;CDC25B;TAF2;PHF8;PRKACA;CKAP5;CEP76;DYNC1I2;NES;PIM2;CSNK1E;CDC23;CCND2;CUL4B;CEP63;NASP;USP37;TUBA1A;DBF4;FBXL12;CDC27;CEP78;SSNA1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.3611326515292206,1.0478083979738242,0.39417693169092943,1.0,1.0,15/68,20.91%,IL16;PYCARD;WNT5A;TMEM106A;CARD9;TLR1;PTPN11;IL33;CD74;RAB7B;LBP;SETD4;BCL10;STAT3;HSPD1
prerank,RNA transport (GO:0050658),0.35871808365899494,1.0476132008109835,0.40770101925254815,1.0,1.0,19/71,20.39%,RBFOX1;TST;THOC6;ATXN2;TGFBR2;NUP155;SRSF11;CASC3;NCBP1;KIF5C;CKAP5;SRSF6;POM121;PNPT1;NXF1;RNPS1;THOC7;SRRM1;ZFP36
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.47814429856121116,1.0467953863638157,0.4371165644171779,1.0,1.0,8/12,26.02%,METTL3;BRCA1;CDYL;YTHDC1;HNRNPU;LRIF1;SMCHD1;RBM15
prerank,substrate-dependent cell migration (GO:0006929),-0.3804241367045441,-1.0466476289869329,0.3944099378881988,0.8122825223772243,1.0,5/14,16.15%,NRP1;VEGFC;EPHA8;PTPRC;ITGA11
prerank,positive regulation of chemotaxis (GO:0050921),0.3815511328378443,1.0463740931233416,0.4055354993983153,1.0,1.0,10/43,15.00%,NTRK3;FGF2;VEGFA;TGFB1;CCR2;DSCAM;EDN3;SMOC2;P2RY12;MET
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.45459780871311184,1.0462092518109187,0.418705035971223,1.0,1.0,2/16,1.47%,FGF2;MYC
prerank,negative regulation of double-strand break repair (GO:2000780),-0.31806089622356115,-1.0461948798941363,0.3671875,0.8117996123384069,1.0,16/30,28.92%,RIF1;HELB;HMGA2;POLQ;KLHL15;TWIST1;TRIP12;OGG1;ERCC6;FANCB;MAD2L2;RNF169;UBR5;NUDT16L1;RMI2;PARPBP
prerank,positive regulation of actin filament polymerization (GO:0030838),0.3796344280433749,1.0458807540965023,0.43253012048192774,1.0,1.0,6/44,8.10%,CCL11;PYCARD;SPIRE1;GSN;BAIAP2;BIN1
prerank,regulation of cell migration (GO:0030334),0.32258430957221484,1.0456108519488965,0.37612838515546637,1.0,1.0,76/382,15.19%,ROR2;DLC1;CLDN19;CCL11;SULF1;PRKCA;LGR6;PDGFRA;HAS2;NTRK3;FGF2;PIP5KL1;FGF10;PTEN;SEMA3E;RHOD;DPEP1;PLXNC1;EGFR;PTPRT;RAP2B;ACVR1;SEMA6C;PRKX;MAP4K4;VEGFA;HACE1;EPHB2;RECK;SEMA3A;TGFB1;CLDN1;CTNNA2;NF1;PAK1;PODN;FAM83H;DOCK10;TWIST2;NTNG2;NTNG1;CYP1B1;PPP3CA;SERPINE2;NF2;FLNA;SMO;TRIP6;LDB2;SGK3;MGAT3;SPATA13;MCTP1;ERBB4;SLK;PTPRJ;NGFR;MAGI2;FGF7;GRN;RHOC;MYOC;DRD2;SOD2;ADARB1;ARHGAP4;TCAF1;SPAG9;ELP5;COL1A1;LDLRAD4;CITED2;SEMA6D;WASHC1;LMNA;ITGB1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.4522572183157128,1.0455032629564758,0.4229137199434229,1.0,1.0,3/16,12.74%,AP1G1;CADM1;NECTIN2
prerank,protein complex oligomerization (GO:0051259),0.3550063049341693,1.0450743916435907,0.413984461709212,1.0,1.0,34/85,25.00%,PYCARD;LETM1;LRRC8D;CLDN1;CPSF6;MPP2;ALS2;CARD9;PRMT1;ATL3;ZBTB1;TMEM120A;YME1L1;NACC2;SNCA;PDCD6IP;OPA1;HOMER1;BLM;PNPT1;UGDH;SLC9A1;FUS;MS4A1;BCL10;ADCY8;MAT2A;PKD2;CARD11;KCNC1;G3BP2;ALAD;ATL1;CPSF7
prerank,monosaccharide transmembrane transport (GO:0015749),0.44744613330062,1.0448464244406308,0.43509272467902993,1.0,1.0,3/16,10.56%,SLC5A3;SLC50A1;SLC2A2
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.2472866212811107,-1.0447639587054538,0.3333333333333333,0.8143225036131123,1.0,29/91,20.45%,BMP6;ABCG2;SLC30A10;SLC31A1;FLVCR1;ATP7A;FBXL5;ATP6V0D1;APP;SLC31A2;SLC40A1;FTH1;SLC39A8;FTL;SLC39A6;SLC30A1;TFRC;SOD1;CYB561A3;FRRS1;ATP6AP1;ATP6V0A2;FXN;SLC39A10;SLC22A17;ACO1;ABCB7;HFE;TMEM199
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.33264945695480785,-1.044194613758807,0.3754646840148699,0.8142894999016822,1.0,4/24,5.69%,PLA2G4A;ABCA3;GPAM;CRLS1
prerank,inorganic anion transport (GO:0015698),0.3668598504635034,1.0441629353150998,0.40613931523022434,1.0,1.0,11/53,16.03%,FXYD3;ANO6;TTYH3;TTYH1;FXYD1;SLC25A10;ANO10;XPR1;CLIC1;CLCN2;SLC25A11
prerank,glycolipid biosynthetic process (GO:0009247),0.3861183723099485,1.0440617182531273,0.4012345679012346,1.0,1.0,11/38,20.64%,ST3GAL4;SCCPDH;PIGC;PIGP;ST8SIA1;PIGN;PIGA;PIGU;DPM1;PIGO;B4GALT6
prerank,tRNA wobble base modification (GO:0002097),-0.37419299006298673,-1.044030382879291,0.38125,0.8130966497879856,1.0,5/14,16.43%,TRMT9B;URM1;ELP3;MTO1;DPH3
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.4667806494578511,1.0439234084192803,0.42255639097744363,1.0,1.0,3/14,8.56%,BST1;LOXL3;FLNA
prerank,Notch signaling involved in heart development (GO:0061314),-0.41763047293718614,-1.0437919331958945,0.39803439803439805,0.8120550389383048,1.0,3/11,15.30%,NOTCH2;JAG1;HEY2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3846433175568581,1.0437770043866408,0.42197253433208487,1.0,1.0,9/39,13.39%,ERBB2;EGFR;PTPN2;EPS15;BTC;PTPRJ;CBL;PTPN18;SH3KBP1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3238958753252196,1.0436482378483078,0.36736736736736736,1.0,1.0,91/417,17.68%,NKX6-2;MDFIC;TSHZ3;SCML4;CREB3L1;RCOR2;SOX8;PRDM16;ATP8B1;SOX9;NAB1;VGLL4;SUV39H1;HOXA7;KDM8;TLE1;FOXP2;TGFB1;GATAD2A;MT3;PLCB1;MBD1;ATF7IP;ZEB1;WNT5A;EED;CIPC;RFX3;ZBTB16;MLXIPL;MLX;TWIST2;LOXL3;CBFA2T3;KAT8;GATA6;CBX4;ZC3H8;MEN1;FOXM1;KCTD1;BRCA1;MBD2;CRYAB;DKK3;LANCL2;SNX6;HDAC2;ZBTB38;MBTD1;SMARCC2;SFPQ;HDAC6;RBAK;BMP7;PRICKLE1;ING4;CREBZF;CDK5R1;MIDEAS;L3MBTL4;EPC1;JARID2;ZGPAT;PATZ1;XRCC6;EID2B;ZFPM2;ATF5;PER1;SCML2;GATA3;AHR;PRDM11;NACC2;SUMO1;CRY1;NCOR2;CITED2;TAF7;TP53;SP3;MTA3;NDUFA13;EIF4A2;PAX2;SMARCE1;CCDC85B;HEYL;CTBP1;SFMBT2
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3456764599106411,1.043446771522742,0.39181916038751347,1.0,1.0,27/101,24.34%,CXCL10;PYCARD;PTPN22;TGFB1;PDE4B;WNT5A;IL18;SELENOS;MAPK14;TRIM41;UPF1;SHPK;TICAM1;PLAA;CDC73;LBP;AXL;PDCD4;BCL10;ZFP36;SIRPA;NFKB1;TNIP2;VIM;CARD16;PRKCE;HCK
prerank,neural crest cell development (GO:0014032),0.3836883252098899,1.0433982538837385,0.4192355117139334,1.0,1.0,10/44,14.86%,SOX8;SEMA3E;SEMA6C;SEMA3A;SOX11;ERBB4;GDNF;ANXA6;KLHL12;SEMA6D
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.4399970962886992,1.0432423824231303,0.4178470254957507,1.0,1.0,3/20,3.81%,SEMA3E;SEMA6C;SEMA3A
prerank,protein-containing complex assembly (GO:0065003),0.3266438701020089,1.0432231227843731,0.4050251256281407,1.0,1.0,77/259,23.03%,SEC16B;MYC;REPS2;SOX9;GORASP1;LAMC1;FADD;GRIA1;WIPF1;ANKRD28;EPRS1;KMT2A;SEC24D;ANO6;TLE1;CLDN1;TRAPPC6B;MEN1;PPID;TMED10;MAGI1;SEC24C;BCL9L;CUL3;FARP2;RIMS1;FANCC;BCL9;RAB1A;WASF1;CSNK1A1;KLHL12;TBC1D20;DET1;TMED2;MDM4;SEC23IP;OPA1;TRRAP;TRAPPC6A;NIFK;BLM;TP53;LPXN;PYGO1;PPIH;IL1RAP;TLE3;CD74;RIPK1;CDC73;SLC9A1;CNIH3;TLE4;RSPH9;SEC24A;MDM2;ASH2L;SKAP2;TRAPPC3;KPNA3;ADCY8;SMARCA4;NAPG;KMT2D;PEF1;TRAPPC2L;MITF;PYGO2;P2RX7;LMAN1;LLGL1;DLG4;SH3PXD2B;ELOB;KIFAP3;WASF3
prerank,skeletal muscle organ development (GO:0060538),-0.32467325058558016,-1.0430889556051683,0.37551020408163266,0.8123728723037051,1.0,12/26,36.68%,MYL6;SIX1;STRA6;CAV1;CFLAR;LARGE1;MYH14;SIX4;FOXL2;MSC;MEF2C;FXR1
prerank,organic hydroxy compound transport (GO:0015850),0.388508027414208,1.0429833766829435,0.42216687422166876,1.0,1.0,7/36,14.50%,ATP8B1;NCOA1;SLC5A3;SLCO2B1;NCOA2;SLC16A1;SLC10A1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.39911006800835996,1.0429417038969129,0.41507024265644954,1.0,1.0,8/31,15.61%,ANK1;DLG2;ERBIN;MYO9A;OPHN1;SCRIB;PDCD6IP;PARD3B
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.36089259250593897,1.0429089646606298,0.40266963292547275,1.0,1.0,18/66,19.14%,FGF10;PTEN;CDKN2B;EGFR;UBE2E2;JADE1;PLCB1;ADAMTS1;CDK6;EIF4G1;PKD1;DACT1;CCND2;HYAL1;CDC73;RPTOR;KMT2E;RDX
prerank,regulation of synapse organization (GO:0050807),0.4091655779299146,1.0427681365555796,0.41025641025641024,1.0,1.0,5/26,6.15%,IL1RAPL1;CTNNA2;WNT5A;YWHAZ;CDKL5
prerank,regulation of collagen biosynthetic process (GO:0032965),0.43277708139370924,1.042690477773018,0.4201909959072306,1.0,1.0,6/19,16.21%,CREB3L1;TGFB1;AMELX;HDAC2;RUNX1;TGFB3
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.32586362221625,1.0423420316753111,0.4018218623481781,1.0,1.0,60/248,19.46%,GPC3;WNK2;TPBGL;LGR6;PLEKHA4;RBMS3;LRP4;FGF10;SOX9;PRKN;EGFR;FRZB;JADE1;GPRC5B;TLE1;TGFB1;PSEN1;GLI1;WNT5A;LGR5;FZD7;OTULIN;FAM53B;PPM1B;PSMB7;DKK3;CUL3;DAAM2;SFRP4;TMEM131L;EMD;PRICKLE1;PPP1CA;APC2;DVL1;CSNK1G1;WWTR1;CSNK1A1;KLHL12;COL1A1;PSMD2;ZEB2;SCYL2;PSMC1;DACT1;JUP;FZD9;CSNK1E;CSNK1G2;XIAP;TLE3;PSMB2;TLE4;MDK;PSMD9;RUVBL2;CSNK1G3;KANK1;NKD2;PSME4
prerank,negative regulation of protein depolymerization (GO:1901880),0.41809482530722814,1.0421097952381762,0.4209809264305177,1.0,1.0,12/24,27.18%,FGF13;CLASP1;APC2;PLEKHH2;KATNB1;NAV3;ATXN7;CAMSAP1;TAOK1;CIB1;APC;PIK3CA
prerank,insulin receptor signaling pathway (GO:0008286),-0.2534672400968512,-1.0419560269557357,0.3968253968253968,0.8138325833274085,1.0,14/69,9.62%,SORBS1;IGF1R;PIK3R3;PIK3C2A;GRB10;NAMPT;IGF2;INSR;ATP6V0C;ATP6V0D1;BCAR1;GSK3B;RHOQ;GSK3A
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.42311237104505894,-1.041951538824161,0.44192634560906513,0.8121284046842496,1.0,8/11,30.73%,POMT2;RNF185;AUP1;UFD1;UGGT1;RNF5;VCP;BAG6
prerank,angiogenesis involved in wound healing (GO:0060055),0.4910515212086707,1.0417707047408071,0.43815201192250375,1.0,1.0,2/11,3.14%,CD34;VEGFA
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.4248992765960943,-1.041089939878669,0.4022346368715084,0.8112841701878402,1.0,3/10,8.82%,MAP2K5;WNK1;KLF4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.4248992765960943,-1.041089939878669,0.4022346368715084,0.8112841701878402,1.0,3/10,8.82%,MAP2K5;WNK1;KLF4
prerank,proteoglycan biosynthetic process (GO:0030166),-0.3087860418010797,-1.040332770259776,0.3794642857142857,0.8119005650457594,1.0,12/31,18.00%,IGF1;FAM20B;BMPR2;NDST3;PXYLP1;CHST11;FOXL1;CHST12;B4GALT7;HS3ST3B1;B3GAT1;CHST10
prerank,glycolipid metabolic process (GO:0006664),0.3793185551185143,1.0398051485766506,0.4189675870348139,1.0,1.0,8/47,9.90%,ST3GAL4;PGAP1;GBA2;NAGA;GM2A;ST6GALNAC6;SCCPDH;GALC
prerank,amino acid import (GO:0043090),-0.3377927761046566,-1.039804724640165,0.3942652329749104,0.8117060143668653,1.0,8/21,14.83%,SLC47A1;SLC6A6;SLC22A4;SLC6A13;SLC7A5;SLC16A2;SLC6A1;SFXN3
prerank,regulation of telomerase activity (GO:0051972),0.3767956283006782,1.0395722248501285,0.4245049504950495,1.0,1.0,11/45,16.26%,PRKCQ;MYC;ERCC4;MEN1;PARM1;MAPK1;NEK7;MAP3K4;ATM;TP53;SMG6
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.45012061751889393,1.0393174819936628,0.4144927536231884,1.0,1.0,6/16,16.21%,CREB3L1;TGFB1;AMELX;HDAC2;RUNX1;TGFB3
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.33537406991371854,1.0391813282837628,0.43350785340314135,1.0,1.0,30/129,19.46%,GPC3;WNK2;LGR6;PLEKHA4;FGF10;EGFR;GPRC5B;TGFB1;LGR5;FAM53B;PPM1B;PSMB7;DAAM2;SFRP4;CSNK1G1;COL1A1;PSMD2;ZEB2;PSMC1;DACT1;JUP;FZD9;CSNK1E;CSNK1G2;XIAP;PSMB2;PSMD9;CSNK1G3;KANK1;PSME4
prerank,extracellular transport (GO:0006858),-0.3925929769330809,-1.0390645352782308,0.39820359281437123,0.8121543684356918,1.0,10/12,42.05%,TSG101;ARRDC1;CABYR;WWP2;ROPN1L;ADCY10;SPAG17;SPA17;CCDC40;DNAAF4
prerank,positive regulation of protein catabolic process (GO:0045732),0.3445827615916638,1.0389274119356968,0.41602634467618005,1.0,1.0,15/84,16.25%,GPC3;VGLL4;PRKN;HACE1;WNT5A;ASB5;VPS11;HUWE1;APC2;DDB1;NEDD4L;AREL1;DACT1;GPLD1;NDUFA13
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3665368954400704,1.0388811194630212,0.4238258877434135,1.0,1.0,12/54,16.75%,GPC3;HSPG2;HS6ST1;SDC2;EXT1;SDC4;GPC1;SDC3;GPC4;IDS;HS2ST1;UGDH
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.3628545012729414,-1.0385906389108046,0.39864864864864863,0.8118837653491146,1.0,5/16,9.93%,PDGFD;NRP1;PIK3C2A;BCAR1;PDGFRB
prerank,dopamine metabolic process (GO:0042417),0.4454830384908508,1.0385278445259694,0.4263005780346821,1.0,1.0,6/18,13.89%,PRKN;COMT;DAO;DRD2;SNCA;LRTOMT
prerank,regulation of response to oxidative stress (GO:1902882),0.48108652823104525,1.038525630971561,0.42492492492492495,1.0,1.0,2/11,9.97%,PRKN;MCTP1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.41833756473154077,1.0384557667605046,0.43203230148048455,1.0,1.0,4/25,7.73%,HRK;PYCARD;BMF;BNIP3
prerank,regulation of cellular component size (GO:0032535),0.40566265234123294,1.0382855153815824,0.43256997455470736,1.0,1.0,13/30,23.96%,PTEN;PPP1R15A;RARG;VAV3;RAB22A;PPP1CA;RPTOR;PEX11A;RAB3B;RDX;HP1BP3;VAV2;MTOR
prerank,positive regulation of phosphorylation (GO:0042327),0.3276016300222811,1.0382214663823481,0.4112903225806452,1.0,1.0,30/240,7.80%,ROR2;ROR1;CLDN19;PDGFRA;ERBB3;NTRK3;GLMN;FGF2;FGF10;ZBTB20;SOX9;EPHB6;ERBB2;EGFR;EFNA5;WDFY2;VEGFA;EPHB2;TGFB1;PSEN1;NTRK2;MT3;TNIK;NIBAN1;PAK1;VAC14;MLXIPL;RALB;FZD7;FGFR1
prerank,fatty acid transport (GO:0015908),0.44403324152875356,1.0379421194492795,0.4287749287749288,1.0,1.0,3/17,8.25%,SLC27A1;SLC27A4;GOT2
prerank,positive regulation of catalytic activity (GO:0043085),0.3836654802562417,1.0379330738593182,0.4109090909090909,1.0,1.0,12/37,17.96%,SLC5A3;PSEN1;MT3;NHEJ1;NCSTN;MAPK14;MSH6;APH1A;PSEN2;ABL1;WRN;AZIN2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3873499826952986,1.0378990215622963,0.43672456575682383,1.0,1.0,5/37,10.02%,DYNLL1;IFT140;PCM1;TRIP11;WDR35
prerank,regulation of lymphocyte activation (GO:0051249),-0.39958091455089706,-1.0375653042067132,0.40978593272171254,0.8131401148527351,1.0,7/12,44.25%,KAT2A;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,negative regulation of synaptic transmission (GO:0050805),0.42013162369048007,1.0373599692343016,0.4232309746328438,1.0,1.0,5/23,12.70%,PTEN;GRIK3;PNKD;SYT11;DRD2
prerank,regulation of peptide hormone secretion (GO:0090276),0.3559337172357905,1.037039906100202,0.41262683201803835,1.0,1.0,10/67,10.56%,PRKCA;CACNA1E;CACNA1A;RFX3;PPP3CB;RAP1A;ENSA;PASK;HTR2C;SLC2A2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.38751999093200573,1.03688165964536,0.42401960784313725,1.0,1.0,11/37,19.72%,MMP2;FGF2;PTEN;ADAMTS1;SOD2;BMPR1A;TGFB3;TAFA5;PDCD4;PPARG;JUN
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.449882796096977,1.036695075092986,0.413953488372093,1.0,1.0,4/15,15.49%,GRIK3;GRM5;HOMER2;HOMER1
prerank,modulation by host of viral genome replication (GO:0044827),0.47621869461920485,1.036491024352057,0.4333821376281113,1.0,1.0,4/13,13.56%,PRKN;VAPA;FBXL2;TBC1D20
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.3495260333715576,-1.0363778518060847,0.425,0.8149072377963067,1.0,5/20,4.03%,ACVRL1;BMP4;ENG;TBX3;TGFBR1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.31692388133481625,1.036139222319363,0.274,1.0,1.0,352/1646,20.38%,EBF2;RORA;OSR2;FAM47E;ETV1;MLF2;SOX6;NKX6-2;EFEMP1;KLF15;MDFIC;MEOX1;EBF4;ETV4;MEOX2;TSHZ3;PRKCQ;SCML4;LHX5;TLX3;GLI2;CREB3L1;RCOR2;FGF2;IFRD1;SOX8;PRDM16;CRLF3;MYC;DMRT2;TGIF2;ATP8B1;RGMB;EBF1;CBFB;HOXB8;ZNF25;ZBTB20;SOX9;SSBP2;NAB1;VGLL4;ERBB2;NCOA1;EGFR;SUV39H1;HIVEP1;ACVR1;ZBTB37;HOXA7;KMT2A;SATB1;VEGFA;CCNC;TFCP2;EGR3;WAC;KDM8;RPS6KA4;NFX1;TRIM44;TLE1;ZNF326;FOXP2;KDM5B;GTF2H2;TGFB1;BAZ1A;RFX2;GATAD2A;PSEN1;FANK1;NCF1;SOX11;NUPR2;MED31;SETD3;BICRAL;RFXANK;ZNF276;RNF6;MT3;PLCB1;MBD1;GLI1;RAI1;E2F2;ATF7IP;ZEB1;PHOX2A;CXXC1;NOP2;WNT5A;HOXD3;PGBD1;URI1;EED;HNRNPAB;CIPC;PKN1;APBB2;ZFP14;RFX3;ZBTB16;MAMLD1;RORC;MLXIPL;MLX;TRPS1;CREB3L2;TADA1;TAF5L;TWIST2;DRAP1;PPP3CB;LOXL3;DYRK1B;NAA16;E2F6;CBFA2T3;FZD7;KAT8;LRRFIP1;GATA6;CBX4;ZC3H8;TBX18;MEN1;BICRA;FOXM1;ZSCAN20;CHD3;SPIN1;MKX;ZBTB41;ATMIN;CDK15;ARHGEF11;ATRX;KCTD1;TFAM;PPP1R13L;BRCA1;MBD2;SOX12;SOX5;CRYAB;CARM1;ZMIZ1;NCOA2;POLR2K;DKK3;ZNF569;BBX;LANCL2;KLF5;REXO4;HIF1A;DBX2;PIAS2;ARID4B;ZBTB6;CHD2;SNX6;HDAC2;ERBB4;ZSCAN26;ZBTB38;MBTD1;MED13;NFATC3;ELP2;HINT1;ZNF260;PSIP1;ATF2;ZKSCAN8;PHF20;ESR1;NFE2L2;MAPK14;MYT1;LIN9;SMARCC2;SP1;ZNF112;SFPQ;HDAC6;RBAK;NSD2;BMP7;PRICKLE1;ING4;CREBZF;CDK5R1;MIDEAS;FGF7;ZFHX4;L3MBTL4;EPC1;RHOH;PHF8;DVL1;JARID2;SIX5;KLF13;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;WWTR1;SETD5;XRCC6;EID2B;SOD2;ZFPM2;ATF5;CDK16;PER1;SCML2;GATA3;AHR;ZNF83;SALL2;ZNF250;ZBTB39;PRDM11;SMARCC1;BAZ2B;ELP4;NACC2;ORC1;TGFBRAP1;PAX3;LCOR;ZFHX2;MDM4;HIVEP3;SUMO1;PCBD2;CRY1;NCOR2;COL1A1;BAZ1B;CITED2;TAF7;CREM;MED12;SLTM;IRX5;HOXB7;ZNF235;ZEB2;POU3F1;RUNX1;TRRAP;ABL1;MEIS3;PIM2;PURG;MSL3;KLF9;BLM;MED21;TP53;ZFX;LCORL;SP3;PHF19;KCNH2;ZXDB;MTA3;HTATIP2;TGFB3;NDUFA13;SREBF2;RNF111;TERF2IP;ING1;QRICH1;USP21;NFIA;FOXJ1;PAX2;CD74;RNF10;SMARCE1;CHUK;NFIX;CCDC85B;ZKSCAN1;HEYL;NR5A1;CTBP1;PCID2;SFMBT2;CSRNP3;SUFU;TCEA2;MLF1;FBXO5;FUS;APBB3;KLF16;MDM2;IRF3;MED30;ZNF697;ELOC;ZNF496;EPC2;EID2;KLF7;ZMYND11;NAA15;AATF;RNF4;MAPRE3;PSMD9;RFX7;BATF;POLR2A;KMT2E;EGR1;PHC2;MED8;RUVBL2;HMG20A;CNBP;PDCD4;BCL10;PRRX1;BCOR;UBE2L3;FOXJ3;PPARG;JUN;STAT3;PRDM2;YEATS2;ONECUT2;PHB2;POLR3G;TFE3;HP1BP3;CTDSP1;SMARCA4;JDP2;BBS7;USP13;FUBP3
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.44264936871970095,1.0360099311256263,0.42595204513399154,1.0,1.0,3/17,12.74%,AP1G1;CADM1;NECTIN2
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.2172540163194484,-1.0355801068637562,0.5,0.8155268331947161,1.0,125/306,28.00%,THRB;RPS14;POLD3;GSPT1;RPL24;RRAGC;DRG1;RPL18A;RECQL5;RPS16;ALAS1;GTPBP2;RPL38;RPL28;RPS19;CREBL2;RPL37;MMS19;RPS2;SARS1;MRPL10;GTPBP1;RPL19;RPL5;RPL34;PTMS;RPS25;RPS15;POLA1;PWP1;TNIP1;EEF1G;MCM6;RPLP1;RPL31;PABPC4;RPL3;MRPL24;MRPL3;RMI1;EEF1A1;RPS6;HELB;RPS8;HUS1;MED20;EIF4EBP2;RPL11;RPL12;INHBA;ORC6;CDK2;RPS6KB2;TSFM;POLA2;TERT;RPL7A;RPL13;BAZ2A;POLR2C;EEF1B2;CLSPN;CDC7;MRPS7;KAT5;NT5M;DTX1;COPS5;MRPL43;IGF2BP3;APOE;YARS2;RPS21;RPL35A;DONSON;POLR2E;ASMT;RPL26;RPS9;MRPS17;RPL32;RPS29;RNASEH2A;LARGE1;RPS23;RPLP2;MRPS11;POLR2J;XAB2;DNA2;PTMA;GAL3ST2;POLR2D;RPL8;MRPS16;NBN;RFC3;TIMELESS;RSL24D1;ING5;E2F1;RPL41;TOP1MT;RPS17;RAD9B;DHPS;RPS5;RPS15A;THAP1;RPL37A;INHA;RPS10;MRPL55;POLD2;TBRG1;RPL6;WARS1;RPL9;MCM8;RAD9A;RPS27;RMI2;MRE11;CDC45;MRPL36
prerank,positive regulation of apoptotic process (GO:0043065),0.3234803779744223,1.0354379118174688,0.40781563126252507,1.0,1.0,71/293,18.00%,DLC1;HRK;FAP;PIP5KL1;PYCARD;NGF;AKAP13;FADD;FRZB;FGD4;ANO6;TNFRSF10B;PSEN1;SLC27A4;FANK1;PRNP;NF1;DUSP6;ACVR1C;APAF1;BMF;ITSN1;CYP1B1;SHQ1;PHLDA1;BNIP3;BIN1;ARHGEF11;RARG;VAV3;PPID;UBE2Z;SFRP4;NGFR;NCSTN;ARL6IP5;ING4;CDK5R1;GRN;APH1A;SCRIB;TRIO;PRDM11;ARHGEF3;SNCA;RPS6KA2;PSEN2;ITGB3BP;TRAF7;UBB;ITGB1;CASP2;CRADD;RASSF2;ATM;FZD9;ABL1;TP53;BCL2L11;GPLD1;TGFB3;QRICH1;ARHGEF4;RIPK1;RNPS1;KCNMA1;ADAMTSL4;PLEKHG2;CSRNP3;AIFM1;DNAJA1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.3702926138781111,1.0350816617006957,0.4158767772511848,1.0,1.0,12/49,20.49%,PRKCQ;CBFB;KAT2B;KMT2A;EIF6;MTURN;PRMT1;RUNX1;RAB7B;ASH2L;KMT2E;KMT2D
prerank,response to nitric oxide (GO:0071731),0.46966723232702523,1.0345634325021327,0.4568452380952381,1.0,1.0,2/13,4.84%,DPEP1;MT3
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.4601685794302176,1.0342326526381889,0.4260869565217391,1.0,1.0,4/14,9.85%,KMT2A;AUTS2;BRCA1;PRDM9
prerank,melanocyte differentiation (GO:0030318),0.4783685373296519,1.0339143137472995,0.4501510574018127,1.0,1.0,5/11,21.28%,HPS6;SLC24A5;MREG;USP13;MITF
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.43126187395326115,1.0336315312952373,0.4486486486486487,1.0,1.0,6/21,15.43%,PTEN;CNKSR3;MLXIPL;PDE4D;NCK1;RASSF2
prerank,cardiac muscle cell contraction (GO:0086003),0.44263648737310113,1.033143740069103,0.42997198879551823,1.0,1.0,4/19,6.08%,CACNA2D1;GSN;SCN5A;FGF12
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.44470998891036423,1.0330926220516639,0.43982808022922637,1.0,1.0,6/16,22.13%,RSRC1;CDK13;SFPQ;SRSF6;CELF4;RBM17
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.29861149520116703,-1.0329277586535939,0.3459715639810427,0.8218857976268032,1.0,8/33,12.07%,CDH5;TEK;ANGPT1;KDR;ICAM1;NUPR1;GATA2;SERPINE1
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.34802318341067523,-1.0326890058135851,0.43050847457627117,0.8208538673388946,1.0,4/18,8.41%,DAB2;CHMP3;MAP2K1;MTMR2
prerank,peptidyl-asparagine modification (GO:0018196),0.39391964277729125,1.0322530066934035,0.4105793450881612,1.0,1.0,13/31,27.09%,UGGT2;STT3A;MAGT1;ALG5;TUSC3;ALG8;DPM1;RPN1;LMAN1;MGAT5;ST6GAL1;HIF1AN;UBE2J1
prerank,tetrapyrrole metabolic process (GO:0033013),0.4363712609254119,1.0322104905849872,0.42592592592592593,1.0,1.0,5/18,17.07%,MMAB;CD320;MTRR;MTR;ABCC1
prerank,endoderm formation (GO:0001706),0.38760221454529153,1.0320715580044522,0.4141791044776119,1.0,1.0,5/35,9.87%,MMP2;DUSP4;COL4A2;MMP15;SETD2
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.2776711806553625,-1.0319263677492039,0.3865979381443299,0.8213317182332118,1.0,11/39,13.86%,ROBO1;TSPAN5;NOS3;MAML1;PRKCI;SNW1;JAG1;JAG2;NOTCH4;TGFB2;NEPRO
prerank,regulation of cell motility (GO:2000145),0.3314849816394817,1.031257925773222,0.43135135135135133,1.0,1.0,25/121,13.20%,ERBB3;FGF2;FGF10;ERBB2;PLXNC1;EGFR;PRKX;HACE1;CADM4;TGFB1;PKN1;DOCK10;CDK6;SERPINE2;FLNA;BTC;LDB2;SGK3;MGAT3;SPATA13;ERBB4;SLK;FGF7;CFAP20;GATA3
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.48239780215613537,1.0312460352748771,0.43804034582132567,1.0,1.0,5/12,15.42%,DSG2;CTNNA3;BIN1;PKP2;JUP
prerank,apical protein localization (GO:0045176),0.491987935355768,1.0312065224616844,0.4529505582137161,1.0,1.0,2/10,3.59%,ATP8B1;INSC
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3296530694478633,1.03099297835688,0.42783505154639173,1.0,1.0,44/153,19.43%,PRKCA;STK32B;PRKCQ;PRKX;EIF2AK3;RPS6KA4;MAPKAPK3;MAST2;MAPKAPK2;DYRK4;PKN1;TGFBR2;DYRK1B;PDK3;STK39;TLK2;MAPK9;AKT3;SGK3;SGK2;MAPK14;STK32A;MAPK1;CDK5R1;TBK1;CSNK1G1;PRKACA;CSNK1A1;TTBK1;RPS6KA2;PKD1;ATM;CSNK1E;CSNK1G2;SGK1;RIPK1;CHUK;PKN2;VRK3;TAF1;CSNK2A2;CSNK1G3;CAB39;TOP1
prerank,regulation of microtubule-based movement (GO:0060632),-0.4124498984828184,-1.0308161328993877,0.4114583333333333,0.8228973759387014,1.0,5/11,15.59%,MAP2;LAMP1;DYNLT2B;NEFH;IGBP1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4603511051969644,1.030714352564174,0.4383561643835616,1.0,1.0,3/13,10.21%,CPSF6;NCBP1;FIP1L1
prerank,cellular response to lipid (GO:0071396),0.32701767685781163,1.0306650709013425,0.42538071065989846,1.0,1.0,43/191,21.41%,RORA;SSTR1;CXCL10;PYCARD;SOX9;EGFR;PDE4B;WNT5A;URI1;RORC;PDK3;FZD7;SELENOS;ESR1;MAPK14;TRIM41;PID1;UPF1;NRIP1;GNAI1;SHPK;AHR;LCOR;TICAM1;PLAA;ATM;GPLD1;NDUFA13;PAX2;CDC73;NCOA3;LBP;FAM210B;AXL;RUVBL2;PDCD4;BCL10;UBE2L3;ADCY8;ZFP36;SIRPA;NFKB1;TNIP2
prerank,regulation of cellular response to heat (GO:1900034),0.3492553326652124,1.0306192234274467,0.43191964285714285,1.0,1.0,19/77,18.03%,CD34;HSPH1;RANBP2;MAPKAPK2;RPA3;NUP155;BAG5;CRYAB;NUP205;FKBP4;NDC1;NUP160;MAPK1;DNAJB6;RPA2;ATM;POM121;AAAS;RPTOR
prerank,cellular response to peptide (GO:1901653),0.36114247295589097,1.030555623340033,0.4339622641509434,1.0,1.0,12/56,11.28%,DDX11;PTPN22;CACNA2D1;LRP1;CACNA1A;PSEN1;PRNP;FYN;GRM5;SNX6;NGFR;TRIM41
prerank,peptide metabolic process (GO:0006518),0.34898435471821154,1.030369226218734,0.43861607142857145,1.0,1.0,15/75,15.29%,BACE2;DPEP1;HM13;PARL;MIPEP;PSEN1;LTA4H;TRHDE;SPCS3;MGAT3;LNPEP;THOP1;CPD;PSEN2;ABCB9
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3707480325211819,1.030121843411418,0.4483985765124555,1.0,1.0,11/48,16.07%,PYCARD;BCL2;BRCA1;MSH6;CASP2;AEN;ATM;ABL1;RPS27L;TP53;BCL2L11
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.317435200200296,1.0290713875780353,0.41041041041041043,1.0,1.0,117/476,21.47%,RORA;OSR2;MDFIC;GLI2;FGF2;SOX8;PRDM16;CRLF3;MYC;RGMB;SOX9;NCOA1;EGFR;ACVR1;KMT2A;WAC;KDM8;TRIM44;TGFB1;PSEN1;FANK1;NCF1;SOX11;SETD3;BICRAL;RNF6;MT3;PLCB1;GLI1;RAI1;ATF7IP;CXXC1;WNT5A;HNRNPAB;RFX3;ZBTB16;RORC;MLXIPL;CREB3L2;PPP3CB;DYRK1B;NAA16;FZD7;KAT8;GATA6;BICRA;FOXM1;SPIN1;ATMIN;ARHGEF11;TFAM;BRCA1;ZMIZ1;HIF1A;HDAC2;ERBB4;MED13;ESR1;SMARCC2;SP1;BMP7;FGF7;EPC1;PHF8;XRCC6;ATF5;GATA3;AHR;PRDM11;SMARCC1;PAX3;HIVEP3;PCBD2;COL1A1;CITED2;MED12;POU3F1;RUNX1;PIM2;BLM;TP53;SP3;KCNH2;TGFB3;RNF111;ING1;QRICH1;USP21;PAX2;CD74;RNF10;CHUK;PCID2;MED30;ZNF496;NAA15;RNF4;MAPRE3;PSMD9;KMT2E;EGR1;CNBP;BCL10;PPARG;JUN;STAT3;TFE3;SMARCA4;FUBP3;CD38;NR1D2;SEC14L2;NFKB1;MITF;ZXDC;NSD1;DVL3
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.4084164936232954,1.0287351239451084,0.44133333333333336,1.0,1.0,3/27,8.08%,CSTF3;RNASE6;ZC3H12B
prerank,regulation of multicellular organism growth (GO:0040014),0.4555364046718115,1.028348808743973,0.417027417027417,1.0,1.0,1/15,0.46%,PTCH1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.43773356819800374,1.0282101291953576,0.4305177111716621,1.0,1.0,2/18,2.59%,FFAR4;C2CD5
prerank,positive regulation of GTPase activity (GO:0043547),0.32408276061565455,1.0281697981390587,0.43820224719101125,1.0,1.0,22/188,8.54%,ARHGAP24;SIPA1L1;CCL11;DOCK7;NTRK3;TAX1BP3;TBC1D10A;ERBB2;MAP4K4;GPR65;CCL4;SLC27A4;NF1;ARHGEF10;ALS2;CDKL5;MTSS2;TSC1;DOCK10;RAP1A;ZC3H15;TBCK
prerank,RNA processing (GO:0006396),0.3262143087157096,1.027447940751531,0.42842430484037075,1.0,1.0,60/176,25.67%,CSTF3;BICD1;DHX8;USB1;ELAVL4;CPSF6;RNGTT;RSRC1;RP9;METTL3;XRN2;SON;IVNS1ABP;RNPC3;TUT4;DDX54;SRSF11;APOBEC1;AURKAIP1;ALKBH5;NCBP1;ADARB2;DUSP11;SFPQ;SNRNP40;LSM3;PRKACA;PRPF6;PRPF18;ADARB1;NOVA1;TSEN2;KHSRP;SF3A1;HNRNPU;RNPS1;FUS;DDX23;TENT2;PRMT9;SYNCRIP;SRRM1;HNRNPUL1;SF3B3;HNRNPC;TSEN34;HNRNPL;SNRPN;RBMS1;SF3B2;WBP4;PPP2R1A;TUT1;TFIP11;MAGOHB;SCAF11;SNRPA1;NONO;DROSHA;RBM4
prerank,positive regulation of collagen metabolic process (GO:0010714),0.43792766988489185,1.0272976763873753,0.4243281471004243,1.0,1.0,6/17,16.21%,CREB3L1;TGFB1;AMELX;HDAC2;RUNX1;TGFB3
prerank,positive regulation of epithelial cell migration (GO:0010634),0.3455091395626388,1.0271893123924756,0.45217391304347826,1.0,1.0,24/92,16.48%,PRKCA;GLIPR2;EPB41L4B;FGF2;FGF10;SOX9;MAP4K4;VEGFA;DOCK5;WNT5A;DOCK1;HIF1A;SPARC;CLASP1;HDAC6;FGF7;NRP2;GRN;GATA3;SMOC2;RTN4;ABL1;GPLD1;HYAL1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.4860076249520774,1.0270416449690791,0.4736,1.0,1.0,4/10,13.97%,PPP3CB;PPP3CA;NFATC3;PPP3CC
prerank,calcineurin-mediated signaling (GO:0097720),0.4860076249520774,1.0270416449690791,0.4736,1.0,1.0,4/10,13.97%,PPP3CB;PPP3CA;NFATC3;PPP3CC
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.42635795353274303,1.026899972411105,0.45816186556927296,1.0,1.0,7/21,17.76%,VEGFA;DISC1;DRD2;NES;FZD9;LRP2;MDK
prerank,response to lipid (GO:0033993),-0.23543923324784044,-1.0268421555501486,0.4155844155844156,0.8328156113790608,1.0,16/105,7.40%,FOXP1;SMAD6;CTSH;RBP4;CTNNB1;PAQR7;NOS3;ACER2;NOCT;TLR4;PPARD;OTUD5;STAT5B;ALPL;LIAS;TNFRSF11A
prerank,positive regulation of vasoconstriction (GO:0045907),-0.3811312973985153,-1.0267603158902543,0.4171779141104294,0.8313519673004494,1.0,3/13,17.26%,ADRA1B;CAV1;TBXA2R
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.40084918788828844,1.026543343320466,0.4193121693121693,1.0,1.0,6/29,23.01%,MEIOB;TEX11;PRDM9;SYCE2;SYCP2;MEI4
prerank,cellular copper ion homeostasis (GO:0006878),-0.39003791318793807,-1.026422440624308,0.40445859872611467,0.8306057937864474,1.0,4/14,7.08%,SLC31A1;ATP7A;APP;SLC31A2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.40583752133135886,1.026383666133983,0.45144356955380577,1.0,1.0,8/27,15.55%,ANK2;HPCA;JPH3;CACNB4;PDE4D;PRKACA;CALM1;CALM2
prerank,erythrocyte differentiation (GO:0030218),-0.2753505531808667,-1.026191932760331,0.38636363636363635,0.829564180970477,1.0,15/44,19.44%,KIT;RPS14;MFHAS1;FLVCR1;LYN;ALAS1;RPS19;ACIN1;ID2;NCKAP1L;INHBA;TAL1;CEBPG;UBA5;ZFPM1
prerank,regulation of response to interferon-gamma (GO:0060330),0.45442343608531477,1.0260210471314113,0.44571428571428573,1.0,1.0,3/14,14.36%,PTPN2;SOCS1;SUMO1
prerank,cellular response to insulin stimulus (GO:0032869),-0.22568427214500808,-1.0258007477738142,0.35714285714285715,0.8290548656511381,1.0,24/124,9.78%,SORBS1;IGF1R;TBC1D4;PIK3R3;RAB31;PIK3C2A;GRB10;NAMPT;IGF2;PRKCI;INSR;LPIN2;ZFP36L1;ATP6V0C;ATP6V0D1;BCAR1;PARP1;GSK3B;SLC25A33;RHOQ;RPS6KB1;GSK3A;INSIG2;ZDHHC7
prerank,response to gamma radiation (GO:0010332),0.40962867358790034,1.0257700491431925,0.4483695652173913,1.0,1.0,9/24,18.13%,MYC;MEN1;CRYAB;TLK2;XRCC6;ATM;TP53;WRN;MDM2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.41606246937138586,1.0256323585027596,0.4375,1.0,1.0,2/20,1.76%,ERBB3;BCL2
prerank,atrial septum morphogenesis (GO:0060413),-0.4375271977108239,-1.0250570182293834,0.41329479768786126,0.8293988983536561,1.0,5/10,19.44%,NOTCH2;BMPR2;TGFB2;HEY2;ZFPM1
prerank,microtubule nucleation (GO:0007020),0.42571218776206554,1.0250419583633625,0.4547945205479452,1.0,1.0,5/19,11.67%,CCDC57;NDE1;TUBGCP5;CLASP1;SLAIN2
prerank,peptidyl-proline modification (GO:0018208),-0.31908076504079486,-1.0250101140059502,0.3723849372384937,0.8278513969970402,1.0,6/25,8.49%,PPIC;PPIL2;OGFOD1;CWC27;PPIA;NTMT1
prerank,vasoconstriction (GO:0042310),-0.3960544579959844,-1.024901597774571,0.44476744186046513,0.8264671665996263,1.0,4/11,18.08%,PIK3C2A;ACTA2;EDNRB;EDN1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.36444700435500793,-1.0248610853743456,0.4043887147335423,0.8249072179717334,1.0,4/17,9.24%,TLR4;BACH2;CD55;JAG1
prerank,synapse assembly (GO:0007416),0.3539532417677809,1.02484355007903,0.4340909090909091,1.0,1.0,17/67,16.30%,FGF13;PTEN;NRCAM;NRXN1;GRID2;WNT5A;OBSL1;NLGN1;KIRREL3;GPM6A;DSCAM;ADGRL3;DVL1;DRD2;GABRG2;CBLN4;LRRTM3
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.48841058485902983,1.0246359443982005,0.4642313546423135,1.0,1.0,1/11,1.09%,IL2RA
prerank,cellular response to interleukin-2 (GO:0071352),0.48841058485902983,1.0246359443982005,0.4642313546423135,1.0,1.0,1/11,1.09%,IL2RA
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.3164215840575774,-1.0245711672837383,0.4103585657370518,0.8240728738044552,1.0,10/25,24.37%,RECQL5;WDR43;EAF2;EAF1;LEO1;LARP7;CDK12;NELFCD;HEXIM1;EAPP
prerank,regulation of steroid biosynthetic process (GO:0050810),0.48265015155383506,1.0244851492005191,0.46504559270516715,1.0,1.0,1/11,0.52%,BMP5
prerank,positive regulation of secretion by cell (GO:1903532),-0.25530734801294036,-1.0232430528748329,0.4015748031496063,0.8263184601558935,1.0,22/70,19.65%,BMP6;IGF1;RAB5A;DTNBP1;EXOC1;PPIA;RGCC;GRK2;ABCG1;UNC13B;RAB9A;KCNB1;APBB1;SYTL4;TGFB2;MYH10;ATP6AP1;STX1A;EDN1;DNM1L;GPER1;BAIAP3
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.47881103447178386,1.0231755895549386,0.4572317262830482,1.0,1.0,5/10,19.63%,RNF157;PDE3B;PDE4D;APLNR;PDE11A
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.4706079330145876,1.0230781374700837,0.44298245614035087,1.0,1.0,2/13,9.76%,CADM4;PTPN1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.4299486189477556,-1.0228687846908684,0.4346590909090909,0.8241256770052754,1.0,4/10,13.33%,CDC42EP4;CDC42EP3;CDC42EP2;CDC42
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.4299486189477556,-1.0228687846908684,0.4346590909090909,0.8241256770052754,1.0,4/10,13.33%,CDC42EP4;CDC42EP3;CDC42EP2;CDC42
prerank,negative regulation of cellular process (GO:0048523),0.31640162156426105,1.0228178856296253,0.421,1.0,1.0,100/521,17.87%,ROR2;TGFBI;DLC1;DCBLD2;SSTR1;WNK2;BMP5;CLDN19;ERBB3;GLMN;FGF2;CRLF3;MYC;PTEN;BCL2;CD34;KAT2B;NGF;VGLL4;PRKN;CDKN2B;PLXNC1;FRZB;PTPN2;JADE1;EPHB2;PTHLH;EIF2AK3;TGFB1;SOX11;NUPR2;MT3;PDE3B;BNIPL;APBB2;RASA1;PODN;TSC1;TMEM98;ADAMTS1;CYP1B1;CBFA2T3;CDK6;MEN1;BNIP3;FOXM1;ATG5;NF2;COL18A1;PACRG;RARG;CRYAB;TEX15;SYT11;DSCAM;ERBB4;SFRP4;PTPRJ;ANXA6;BMP7;MAGI2;ING4;ATP8A2;DRD2;SOD2;ATF5;ADARB1;STRN;GATA3;RBBP4;PRDM11;NACC2;CD9;RPS6KA2;NCK1;PDS5B;MDM4;SRSF6;RTN4;CD164;LMNA;PIM2;BLM;TP53;LPXN;GPLD1;TGFB3;NDUFA13;ING1;HYAL1;DYSF;CDC73;CCDC85B;FKTN;RNF167;NUDT6;CTBP1;MDK;PBRM1;FBXO5
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.48264701558669476,1.0226550669313985,0.45054945054945056,1.0,1.0,2/10,3.52%,MAPK7;IRAK3
prerank,folic acid metabolic process (GO:0046655),0.4333711717807376,1.0226063880979837,0.44971264367816094,1.0,1.0,5/18,20.81%,ALDH1L1;MTRR;MTHFD2L;ALDH1L2;SLC25A32
prerank,mitochondrial fission (GO:0000266),0.44048222665935177,1.0225452544667002,0.4418938307030129,1.0,1.0,2/16,2.35%,DNM1;PRKN
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.2875732499500457,-1.0222489909611192,0.4279475982532751,0.8242059246193586,1.0,7/35,11.15%,FLT1;PTPRM;COL4A3;THBS1;RGCC;XDH;ATOH8
prerank,cardiac muscle cell differentiation (GO:0055007),0.42146511396167874,1.0221424215051043,0.45095367847411444,1.0,1.0,3/21,3.14%,AKAP13;ACVR1;VEGFA
prerank,regulation of cell morphogenesis (GO:0022604),0.3981176419134883,1.0214198353641526,0.45265888456549935,1.0,1.0,9/30,11.82%,EFNA5;FMNL2;NTNG2;NTNG1;PDZD8;SPARC;BCL9L;MYO9A;ZMYM6
prerank,neuromuscular junction development (GO:0007528),0.41330917708356907,1.0213564930863084,0.4587280108254398,1.0,1.0,6/24,13.54%,ANK3;PDZRN3;LRP4;CACNB4;DVL1;GPHN
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.43479065426620794,1.0212150112175493,0.4246376811594203,1.0,1.0,3/17,10.32%,SULF1;PCSK6;SFRP4
prerank,lipoxygenase pathway (GO:0019372),-0.38009952073406084,-1.0211436016754885,0.4243421052631579,0.8257676246312958,1.0,5/14,22.01%,PTGS2;GPX1;HPGD;GPX4;ALOX12
prerank,spliceosomal complex assembly (GO:0000245),0.36989271001290147,1.0211305119682537,0.4657863145258103,1.0,1.0,22/46,29.77%,CELF5;LUC7L2;TXNL4A;NCBP1;PRPF6;CELF6;SRSF6;YTHDC1;LUC7L;SF3A1;SF1;DDX23;CELF4;SNRNP200;SCAF11;DDX1;SRSF5;RBM5;CELF2;CELF1;USP39;SRSF9
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3797983609252333,-1.0206494461946825,0.4315068493150685,0.8255308599556638,1.0,3/14,7.52%,IL34;THBS1;AKIRIN1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.4708716637297716,1.020594582829147,0.4523809523809524,1.0,1.0,3/12,16.67%,IRS2;MTLN;ABCD2
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.2895534337387931,-1.020571829768487,0.4174757281553398,0.8240945066173626,1.0,13/35,20.37%,ETS1;LYN;ARNT;STAT5B;ZFP36L1;ACVR1B;NCKAP1L;INHBA;TAL1;MAFB;ANKRD54;ZFPM1;HMGB2
prerank,respiratory system development (GO:0060541),0.3905437339887088,1.0204228591249775,0.44274809160305345,1.0,1.0,5/32,6.97%,GLI2;FGF2;CCDC39;VEGFA;LOXL3
prerank,polyol metabolic process (GO:0019751),0.369627260841388,1.020346454057906,0.4509090909090909,1.0,1.0,5/46,4.92%,ITPK1;INPP4B;PTEN;SLC5A3;PLCB1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.42838938971348617,1.0203435285766536,0.4425531914893617,1.0,1.0,7/18,20.39%,ZFP36L2;KLF9;BCL2L11;HNRNPU;PCK2;UBE2L3;ZFP36
prerank,catecholamine metabolic process (GO:0006584),0.4527950277410526,1.0203090573713023,0.436046511627907,1.0,1.0,4/14,13.89%,PRKN;COMT;DRD2;LRTOMT
prerank,muscle cell migration (GO:0014812),-0.4183739225733156,-1.0197793088042524,0.4101123595505618,0.8248425039859659,1.0,3/10,13.65%,ROCK1;SIX1;DDR1
prerank,cytoplasmic translational initiation (GO:0002183),0.43386621886261495,1.0197444651394298,0.4585152838427948,1.0,1.0,10/17,29.69%,EIF3M;EIF4G1;EIF4A2;DENR;DHX29;RBM4;MCTS1;EIF2S2;EIF3I;EIF2D
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.41623732225317406,-1.0191875912589181,0.438953488372093,0.8247428168477067,1.0,6/11,23.28%,TOMM70;TIMM9;TIMM22;TIMM10B;TIMM8B;ROMO1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.4885704372718835,1.0191349028207286,0.4403225806451613,1.0,1.0,4/10,17.59%,GALNT1;GALNT13;GALNT3;POGLUT2
prerank,cellular response to organic substance (GO:0071310),0.32884597794659265,1.0190736657011574,0.4458464773922187,1.0,1.0,23/116,12.64%,ERBB2;NCOA1;IL1RAPL1;ACVR1;PTPN2;MAPK7;TGFB1;PTPN13;ACVR1C;URI1;TGFBR2;IL1RL2;CYP1B1;IL18;NCOA2;AKAP6;PTPN11;HDAC6;ARL6IP5;PID1;EMD;TBK1;PTPN18
prerank,regulation of cilium assembly (GO:1902017),-0.25535657555946484,-1.0189858245156702,0.4166666666666667,0.8237019323693126,1.0,22/62,19.25%,TBC1D8;ODF2L;TBC1D14;TBC1D1;TBC1D15;DCDC2;ARHGAP35;EVI5L;CCP110;TBC1D13;DYNC2LI1;DYNLT2B;RABEP2;TBC1D7;FUZ;TBC1D30;TBC1D10B;CDK10;CROCC;TBC1D2;TBC1D22B;TBC1D16
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3529562137537666,1.018956513854264,0.44431418522860494,1.0,1.0,12/60,15.48%,PRKCQ;FGF2;MYC;CCT7;CHTF18;PARM1;MAPK1;NEK7;SMOC2;MAP3K4;POLG2;ATM
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.4184087225158595,-1.018852724490662,0.4479166666666667,0.8224553528252172,1.0,2/10,1.38%,ATP1A2;OSR1
prerank,respiratory chain complex IV assembly (GO:0008535),0.4197977125592904,1.018613410680513,0.45698166431593795,1.0,1.0,5/21,13.42%,COX20;COX18;SCO1;COX19;COX10
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.3899462932842608,1.0184671575103412,0.4648241206030151,1.0,1.0,4/33,4.96%,PTEN;STXBP4;FBXW7;GLI1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3176462134304703,1.018036457314682,0.43618090452261304,1.0,1.0,75/327,21.45%,RORA;MLF2;SOX6;NKX6-2;EFEMP1;PRKCQ;TGIF2;SSBP2;NAB1;RPS6KA4;NFX1;SOX11;RNF6;CXXC1;APBB2;RFX3;MLXIPL;MLX;TAF5L;DRAP1;FZD7;CHD3;SPIN1;ATRX;SOX12;CARM1;ZMIZ1;NCOA2;REXO4;HIF1A;ZSCAN26;ZBTB38;HINT1;ATF2;ESR1;MYT1;SP1;SFPQ;RBAK;NSD2;RHOH;DVL1;PATZ1;WWTR1;ATF5;AHR;TGFBRAP1;CREM;HOXB7;TRRAP;ABL1;MSL3;TP53;SP3;PHF19;TERF2IP;NFIA;SUFU;MLF1;FUS;APBB3;POLR2A;HMG20A;CNBP;UBE2L3;STAT3;PRDM2;HP1BP3;USP13;KMT2D;NR1D2;ZSCAN21;LIMD1;MITF;NSD1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.439054603952447,1.0175415661160243,0.4596541786743516,1.0,1.0,3/17,12.36%,PLBD1;PLA2G12A;PLAAT3
prerank,positive regulation of cholesterol efflux (GO:0010875),0.40963023558959444,1.0172683795540256,0.4470426409903714,1.0,1.0,3/21,8.27%,PTCH1;LRP1;ZDHHC8
prerank,chemical homeostasis (GO:0048878),0.3555382546781179,1.017092354459512,0.45062429057888764,1.0,1.0,8/61,9.74%,WNK2;IRS2;ZBTB20;WNK3;FBXW7;AQP4;ACOX1;THADA
prerank,regulation of muscle contraction (GO:0006937),0.40051103904608676,1.0169832394353675,0.4609164420485175,1.0,1.0,4/26,11.40%,MYBPH;KCNA1;TNNT3;ANXA6
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.32755349169551745,1.016965516030487,0.4602510460251046,1.0,1.0,22/142,15.54%,PDGFRA;TAC1;LPAR1;PTGER3;ATP2B3;CACNA1A;PTGFR;CCR2;WNT5A;ACKR3;CD52;SLC8A2;ESR1;S1PR3;PRKACA;DRD2;ATP2B1;TRPC5;P2RY1;ACKR4;FZD9;ABL1
prerank,positive regulation of DNA repair (GO:0045739),0.36983365613016494,1.0167564869035348,0.4573170731707317,1.0,1.0,8/46,10.56%,DDX11;FGF10;SPIRE1;EGFR;FMN2;FOXM1;BRCA1;SLF2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3245537039225788,1.0166324447161055,0.46321243523316064,1.0,1.0,31/152,17.24%,GPC3;WNK2;SULF1;LGR6;PLEKHA4;FGF10;DEPDC1B;EGFR;GPRC5B;TGFB1;DISC1;LGR5;SPIN1;FAM53B;PPM1B;PSMB7;DAAM2;SFRP4;CSNK1G1;COL1A1;PSMD2;ZEB2;PSMC1;DACT1;JUP;FZD9;CSNK1E;CSNK1G2;XIAP;PSMB2;CDC73
prerank,positive regulation of protein deacetylation (GO:0090312),-0.37630459627179746,-1.016314313521491,0.44476744186046513,0.8282957981619741,1.0,7/14,30.75%,SAP30BP;ING2;ZBTB7B;FNTA;BRMS1;NIPBL;NNMT
prerank,regulation of response to cytokine stimulus (GO:0060759),0.42363777028896155,1.0158332092138256,0.4431818181818182,1.0,1.0,5/19,15.49%,CBFB;MAPK7;WNT5A;TAF9;RUNX1
prerank,negative regulation of histone methylation (GO:0031061),0.49334452866543027,1.0157076198015498,0.44976816074188564,1.0,1.0,3/10,12.25%,AASS;BRCA1;JARID2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.48134122181631844,1.0152963478327228,0.4481132075471698,1.0,1.0,4/10,21.36%,ATF7IP;ESR1;TP53;THRA
prerank,maturation of SSU-rRNA (GO:0030490),-0.28437142519501196,-1.015225951934136,0.39790575916230364,0.8298379787226661,1.0,16/34,26.89%,RPS14;RPS16;RPS19;NGDN;WDR3;RIOK3;HELB;RPS8;RIOK1;DHX37;MRPS11;DDX52;SNU13;TSR3;RIOK2;PWP2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.42738223779413986,1.0150830032822977,0.4596541786743516,1.0,1.0,4/18,11.11%,CD34;ITGB8;HIF1A;LTBP1
prerank,nucleosome organization (GO:0034728),0.3590458842199268,1.0148664284712403,0.45368171021377673,1.0,1.0,13/55,17.98%,SOX9;VPS72;MCM3AP;ATRX;PRDM9;SETD2;POLE3;SMARCC2;ASF1A;ANP32E;SMARCC1;SMARCE1;NASP
prerank,regulation of protein dephosphorylation (GO:0035304),0.38454620090417235,1.0147901674477042,0.4635352286773795,1.0,1.0,11/37,18.48%,DLC1;TGFB1;PPP1R15A;TSC1;ENSA;PPP1R8;HSP90B1;CALM1;CALM2;TIPRL;HTT
prerank,negative regulation of catabolic process (GO:0009895),0.3645815877744832,1.0147228465220097,0.4672435105067985,1.0,1.0,15/47,24.10%,EGFR;FMN2;IRAK3;PDE3B;CBFA2T3;FLNA;MDM4;SNX12;AZIN2;SF3B3;PFKFB1;AGAP2;PRKAA1;PRKCG;HMGCR
prerank,negative regulation of macrophage activation (GO:0043031),-0.35348816673652134,-1.0146479826647032,0.4077669902912621,0.8298924168253523,1.0,2/16,1.53%,CD200;IL31RA
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.35828962206658566,-1.0146136181682945,0.4364820846905538,0.8283529257438983,1.0,4/16,9.62%,PLCB3;BMPR2;ACE;GSK3A
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4257687613346469,1.014540646379051,0.4495677233429395,1.0,1.0,5/19,20.81%,ALDH1L1;MTRR;MTHFD2L;ALDH1L2;SLC25A32
prerank,apoptotic mitochondrial changes (GO:0008637),0.38576288693985733,1.0143225550975419,0.43828715365239296,1.0,1.0,11/32,21.73%,BCL2;THEM4;BNIP3;ERBB4;ATG3;SOD2;GGCT;FZD9;HK2;HSPD1;AIFM2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.34437294084050907,1.0141122309346275,0.4693181818181818,1.0,1.0,19/73,19.69%,DLC1;PYCARD;NGF;FADD;EIF2AK3;TNFRSF10B;APAF1;HIP1;NGFR;CASP12;SNCA;CASP2;CRADD;IFT57;RPS27L;RIPK1;AIFM1;SENP1;PPARG
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.45121636816350474,1.0141031320579512,0.4583941605839416,1.0,1.0,4/14,12.35%,NUDT15;ENTPD2;NUDT1;NUDT9
prerank,positive regulation of potassium ion transport (GO:0043268),0.3725712033440212,1.0139500892644373,0.4438964241676942,1.0,1.0,10/38,19.84%,ANK2;KCNMB2;KCNMB3;FLNA;AKAP6;KCNJ3;KCNJ10;KCNH2;KCNMA1;NOS1AP
prerank,cellular response to retinoic acid (GO:0071300),-0.2680898943497504,-1.0135004820424052,0.42011834319526625,0.8300049832567052,1.0,8/42,8.70%,WNT5B;EPHA3;LYN;ABL2;WNT6;SNW1;WNT9A;TBX1
prerank,ncRNA transcription (GO:0098781),0.4639758221265743,1.0133535908748108,0.45454545454545453,1.0,1.0,5/13,17.83%,SNAPC2;SPIN1;GTF3C1;NIFK;POLR1G
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3404873876605394,1.0131120181380895,0.4618834080717489,1.0,1.0,15/74,14.70%,BMP5;GLIPR2;PHLDB1;PTEN;TGFB1;TGFBR2;SPRED2;SPRED1;BCL9L;SPRED3;CLASP1;WWTR1;GATA3;COL1A1;LDLRAD4
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.32528240790067375,1.0129306433547585,0.4722513089005236,1.0,1.0,18/140,14.06%,PDGFRA;TAC1;CACNA2D1;LPAR1;PTGER3;GPR65;CACNA1A;PTGFR;CCR2;JPH3;ACKR3;CD52;HTR2C;ESR1;S1PR3;DRD2;P2RY1;ACKR4
prerank,cellular response to interleukin-1 (GO:0071347),0.3286488125609442,1.0128898771383885,0.46638655462184875,1.0,1.0,32/143,21.41%,CCL11;ADAMTS12;HAS2;PYCARD;SOX9;MAP3K3;IRAK3;RPS6KA4;CCL4;PLCB1;PELI1;PSMB7;HIF1A;TOLLIP;UPF1;PSMD2;UBB;CCL14;PSMC1;HYAL1;IL1RAP;PSMB2;RC3H1;CHUK;PSMD9;TAB3;EGR1;PSME4;PSMA8;SIRPA;NFKB1;TNIP2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.29092062010795666,-1.0126309184347126,0.4147465437788018,0.8309572824496764,1.0,6/35,9.01%,PLPP1;PPARGC1B;CALCOCO1;DDX5;EGLN2;NR3C2
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.3635065346144012,1.012617559659224,0.46751740139211134,1.0,1.0,19/56,28.12%,ALPK1;MAPKAPK3;MAPKAPK2;CTSK;CTSB;TLR1;HSP90B1;UNC93B1;UBB;LBP;TAB3;BCL10;RPS6KA3;TAB2;IRAK2;IRAK1;TRAF6;TAB1;CTSL
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.35640067447041046,1.0125715524255914,0.46689895470383275,1.0,1.0,10/54,11.00%,PRKCA;FGF2;VEGFA;TGFB1;NF1;FGFR1;AKT3;HIF1A;MAPK14;SP1
prerank,regulation of telomere maintenance (GO:0032204),0.3963859621473859,1.012308471082994,0.44805194805194803,1.0,1.0,8/26,16.41%,MYC;ERCC4;ATRX;SIRT6;UPF1;RTEL1;SMG6;TERF2IP
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.3614086404454012,-1.0122275819264397,0.4236111111111111,0.8305478068205122,1.0,5/15,7.23%,IGF1;ROCK2;ROCK1;MTPN;PARP1
prerank,regulation of gene expression (GO:0010468),0.31033440984338523,1.012222030204698,0.46,1.0,1.0,141/903,15.62%,RORA;OSR2;SEC16B;RAG2;PRX;MLF2;SOX6;NKX6-2;AFF3;CLDN19;ANK3;EFEMP1;ADAM19;PRKCQ;NTRK3;EPB41L4B;GLMN;CREB3L1;FGF2;MYC;RBMS3;TGIF2;FGF10;DHH;PTPN22;ANK2;CD34;SOX9;SSBP2;GSN;NGF;NAB1;PRKN;HNRNPDL;C1D;VEGFA;EPHB2;TRA2B;PTHLH;EIF2AK3;RPS6KA4;NFX1;TRIM44;TLE1;ZNF326;FBXW7;TGFB1;PSEN1;SOX11;NTRK2;ITGB8;RFXANK;RNF6;MT3;CXXC1;WNT5A;HOXD3;HNRNPAB;APBB2;UBAP2;RFX3;MLXIPL;MLX;TAF5L;DRAP1;SON;FZD7;TRIM11;CDK6;CHD3;SPIN1;SLC8A2;ATRX;ZNF462;BRCA1;SMO;SOX12;ANKRA2;CARM1;NCOA2;MAPK9;REXO4;HIF1A;ZFP64;PRDM9;ZSCAN26;ZBTB38;SFRP4;HINT1;GDNF;ATF2;PCBP4;ESR1;NFE2L2;MAPK14;MYT1;RIMS1;SP1;SFPQ;HDAC6;POGZ;RBAK;NSD2;PID1;DIP2A;MAPK1;BMP7;ATRAID;EDN3;FGF7;RHOH;DVL1;PATZ1;WWTR1;ATF5;PER1;GATA3;AHR;SPOUT1;NDFIP1;PRDM11;TTBK1;TGFBRAP1;KDM6A;PDCL3;NOVA1;YTHDC1;BMPR1A;CITED2;CREM;KHSRP;TICAM1;HOXB7;POU3F1;IL33;ATM;RUNX1;TRRAP;ABL1;STX1B;MSL3
prerank,response to organophosphorus (GO:0046683),-0.36087566432459417,-1.0121643629345638,0.4368231046931408,0.8291437861847955,1.0,5/16,25.42%,ABCC9;TRIM16;TRPC3;RFC3;VGF
prerank,cellular component assembly (GO:0022607),0.31597173391447025,1.0121190293968643,0.4591321897073663,1.0,1.0,53/253,18.13%,ANK3;RHOJ;HAS2;RHOD;REPS2;SOX9;GSN;LAMC1;WIPF1;EPRS1;KMT2A;RSPH1;TGFB1;GPM6B;WNT5A;SPTBN1;NLGN1;YWHAZ;BAIAP2;FLNA;TEX11;PPID;CFAP46;MAGI1;CFAP74;RIMS1;FANCC;MYO9A;GORASP2;OPHN1;RHOH;DVL1;WASF1;RBBP4;DET1;CORO1B;MDM4;RTN4;CYFIP1;PKP2;NIFK;TP53;LPXN;PPIH;LRRTM3;IL1RAP;FSCN1;FOXJ1;CD74;RAC3;RSPH9;DCX;MDM2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.31166765475539226,1.0118915210011137,0.469,1.0,1.0,84/509,16.13%,ROR2;RELN;DCN;FFAR4;ROR1;PDGFRA;ERBB3;NTRK3;FGF2;S100A4;FGF10;BCL2;IRS2;SOX9;ERBB2;PRKN;EGFR;AKAP13;FADD;LPAR1;ALPK1;VEGFA;MIOS;MAP3K3;THEM4;GPRC5B;TRIM44;TNFRSF10B;TGFB1;CCL4;NCF1;SOX11;NTRK2;SLC44A2;WNT5A;TMEM106A;NLGN1;KSR1;CARD9;BMF;FGFR1;IL18;PELI1;FYN;LAMTOR2;GAB2;FLNA;HIP1;BTC;TRIP6;ERBB4;PIK3R1;VAPA;MID2;GPR37;PTPRJ;CBL;ESR1;PTPN11;MYDGF;FGF7;RHOC;TBK1;RTKN2;MYOC;STRN;GATA3;MALT1;NDFIP1;P2RY12;DHX33;GOLT1B;TRAF7;RTN4;IQGAP1;TICAM1;MET;ITGB1;CGAS;PIM2;GAB1;TP53;BCL2L11;LRP2
prerank,nucleic acid-templated transcription (GO:0097659),-0.2687460457635465,-1.0118114834967233,0.4198895027624309,0.8284838822622167,1.0,17/42,23.58%,THRB;RRAGC;DRG1;CREBL2;MMS19;PWP1;MED20;TERT;BAZ2A;POLR2C;DTX1;POLR2E;POLR2J;XAB2;PTMA;POLR2D;E2F1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.38720747355452545,-1.0117076371665228,0.43209876543209874,0.8271321482976999,1.0,6/13,21.70%,SOX13;SIX1;PTGS2;RREB1;VSTM2A;ZBTB7B
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.26467751503011255,-1.011559143172246,0.45569620253164556,0.8259353647560816,1.0,10/47,7.97%,SOX13;LRP5;TMEM64;NOCT;CREBL2;PPARD;CDS1;ZFP36L1;SIX1;PTGS2
prerank,tRNA 5'-leader removal (GO:0001682),0.45836290465421703,1.0111764921877955,0.45112781954887216,1.0,1.0,7/13,27.33%,RPP38;PRORP;POP1;RPP21;SSB;RPP30;RPP14
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3744763121961749,1.01089754451045,0.4536213468869123,1.0,1.0,15/33,28.38%,AADAT;GOT2;OAT;ALDH5A1;GLS2;GLS;RIMKLB;GLUD1;DDAH1;DGLUCY;GCLM;NIT2;CAD;RIMKLA;PYCR2
prerank,positive regulation of cellular protein localization (GO:1903829),0.34308539757851275,1.010879245091139,0.45300113250283125,1.0,1.0,24/69,26.61%,BICD1;PRKN;SLC5A3;EIF2AK3;TGFB1;FYN;SYT11;NGFR;WWTR1;RTN4;RIC3;PARK7;TESK1;CCDC88A;PRKAA1;LIMK2;GNL3L;KAT7;GPR137B;GNL3;CARD10;ENTR1;APC;CDK5RAP3
prerank,ventricular septum morphogenesis (GO:0060412),-0.31011415122446756,-1.0106041047700427,0.4,0.8269506778224109,1.0,6/27,4.03%,ROBO1;SMAD7;BMP4;BMPR2;SLIT2;TGFBR1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.32607140783789956,1.0099992756167633,0.48468848996832103,1.0,1.0,20/125,14.45%,DYNLL1;EFHC1;XPO1;GPSM2;TBCE;RANBP2;EML1;NDE1;SETD2;DYNC1I1;RCC1;CLASP1;NUP160;SGO1;ZWINT;CKAP5;KPNB1;BUB1B;DYNC1I2;ITGB3BP
prerank,activin receptor signaling pathway (GO:0032924),0.4421623804735356,1.0096542169740983,0.46629986244841815,1.0,1.0,2/15,5.43%,ACVR1;ACVR1C
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.3782307943326662,-1.0096289505181644,0.42729970326409494,0.8281432032106352,1.0,5/13,18.89%,NOS3;TMSB4X;NOS1;ENO1;PINK1
prerank,peptidyl-threonine modification (GO:0018210),0.3480228394402628,1.0095983246023719,0.4586206896551724,1.0,1.0,15/66,14.75%,PRKCA;GALNTL6;ACVR1;WNK3;DYRK4;TGFBR2;DYRK1B;GALNT1;STK39;MAPK1;CDK5R1;TBK1;GALNT13;TTBK1;GALNT3
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.29786849772141305,-1.009483052952657,0.41818181818181815,0.8269067095737622,1.0,12/29,18.97%,TERF2;PPIA;RFC1;DKC1;WRAP53;HSP90AA1;CDK2;TERT;PINX1;GAR1;HSP90AB1;TINF2
prerank,dendritic spine morphogenesis (GO:0060997),0.4394165948083321,1.0091288027374943,0.462882096069869,1.0,1.0,4/15,11.38%,PTEN;EPHB2;DOCK10;DIP2A
prerank,O-glycan processing (GO:0016266),0.35689559674032534,1.0086895035194852,0.46099290780141844,1.0,1.0,11/54,15.02%,ST3GAL4;GALNT9;GALNT1;GALNT15;GALNT7;C1GALT1;GALNT13;GALNT6;GALNT3;MUC3B;MUC3A
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.32894934780176693,1.0085873339602636,0.4668094218415418,1.0,1.0,20/104,16.36%,SOSTDC1;PRDM16;HTRA3;ACVR1;TGFB1;TGFBR2;SPRED2;SPRED1;PEG10;BCL9L;SPRED3;SNX6;DAND5;MAGI2;BMPER;BMPR1A;LDLRAD4;UBB;LRP2;VWC2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.3878684963999841,1.0084431895874966,0.4409148665819568,1.0,1.0,11/30,24.98%,UGGT2;STT3A;MAGT1;ALG5;TUSC3;ALG8;DPM1;RPN1;LMAN1;MGAT5;ST6GAL1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.45233437630083995,1.0084044274960715,0.45426829268292684,1.0,1.0,4/12,19.77%,TGFB1;ESR1;NCOR2;STAT3
prerank,lysosome organization (GO:0007040),0.3737132320939137,1.0083210433370269,0.4444444444444444,1.0,1.0,16/36,23.96%,GNPTAB;VPS33A;ACP2;GRN;TPCN2;AKTIP;CLVS1;HPS1;HOOK2;MBTPS1;CLVS2;HOOK1;HOOK3;TPP1;CLN6;MTOR
prerank,positive regulation of programmed cell death (GO:0043068),0.3147336108415712,1.0082700669539237,0.485456369107322,1.0,1.0,68/272,18.71%,HRK;PIP5KL1;PYCARD;NGF;AKAP13;FADD;FRZB;FGD4;ANO6;TNFRSF10B;PSEN1;SLC27A4;FANK1;NF1;DUSP6;ACVR1C;APAF1;BMF;ITSN1;CYP1B1;SHQ1;PHLDA1;BNIP3;BIN1;ARHGEF11;RARG;VAV3;PPID;UBE2Z;SFRP4;NGFR;NCSTN;HDAC6;ARL6IP5;ING4;APH1A;SCRIB;TRIO;ARHGEF3;SNCA;RPS6KA2;PSEN2;ITGB3BP;UBB;ITGB1;CASP2;CRADD;RASSF2;ATM;FZD9;ABL1;TP53;BCL2L11;GPLD1;HTATIP2;TGFB3;QRICH1;ARHGEF4;RIPK1;RNPS1;KCNMA1;ADAMTSL4;PLEKHG2;CSRNP3;AIFM1;DNAJA1;HTT;MAP3K11
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.4187700960282511,1.0079681032688232,0.4535367545076283,1.0,1.0,2/21,2.13%,PTEN;GORASP1
prerank,negative regulation of ATPase activity (GO:0032780),0.44105377408294133,1.0079159870393335,0.47467438494934877,1.0,1.0,5/16,17.48%,TSC1;THADA;PXK;TP53;PAM16
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3438178886405812,1.0078119984471627,0.47613636363636364,1.0,1.0,14/68,15.45%,ACP5;MMAB;PDXK;CD320;ALDH1L1;MCCC1;HLCS;PNPO;MTRR;MCCC2;MTHFD2L;RFK;MTR;ALDH1L2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.4755183930596003,1.0077759677749059,0.4696485623003195,1.0,1.0,2/10,5.68%,CBFB;SOCS1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.364851062679604,1.0075462504222645,0.45246690734055356,1.0,1.0,12/47,18.74%,MYC;EGFR;MAP4K4;CARD9;FOXM1;ARL6IP5;MAPK1;TAOK3;PER1;KLHDC10;NBR1;MID1
prerank,histone mRNA catabolic process (GO:0071044),-0.36458596713606983,-1.0074498113591623,0.46706586826347307,0.831004874018516,1.0,8/15,19.33%,XRN1;LSM1;MTPAP;ERI1;DCP2;TUT7;EXOSC10;TENT4B
prerank,negative regulation of translation (GO:0017148),-0.23471888234751537,-1.0074352000850917,0.44047619047619047,0.8294540888270132,1.0,13/87,11.09%,DAPK1;ROCK2;SAMD4A;ROCK1;YBX1;YTHDF1;CAPRIN1;IGFBP5;METTL14;CNOT1;RACK1;EIF4A3;BTG2
prerank,establishment of protein localization to membrane (GO:0090150),-0.24923521399889917,-1.0073014237404168,0.41025641025641024,0.8282834939456863,1.0,21/66,18.07%,AFDN;RAB11B;ZDHHC14;ZDHHC3;RFTN1;PRKCI;SYNE3;PARD3;NECTIN3;VPS37C;ZDHHC18;ZDHHC7;AQP11;OXA1L;ZDHHC20;MYO1C;BID;ZDHHC4;MICALL1;FRMPD1;TAOK2
prerank,heart morphogenesis (GO:0003007),0.36544681968640524,1.0072256791531724,0.46144721233689207,1.0,1.0,4/50,3.14%,DLC1;SOX9;ACVR1;VEGFA
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.2938395881586885,-1.007085255569551,0.4228855721393035,0.8273305189078358,1.0,11/32,18.87%,PRKAG2;SORBS1;CREBL2;PRKAA2;ADIPOR2;AVIL;CEACAM1;SIRT4;MID1IP1;APOE;GPER1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.4612288732929524,1.006423810292937,0.47655068078668683,1.0,1.0,3/12,6.93%,DOCK7;DOCK5;ADAMTS1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.371946623593598,1.006296928285751,0.46897374701670647,1.0,1.0,8/40,11.52%,SGIP1;BICD1;VEGFA;RAB21;HIP1;SFRP4;CBL;MAGI2
prerank,gland development (GO:0048732),0.3514696655013306,1.0058883293290992,0.48509174311926606,1.0,1.0,14/59,16.21%,GLI2;FGF10;SOX9;FADD;PRKCSH;NF1;HOXD3;DKK3;IGSF3;ZBTB1;COBL;CITED2;MET;TGFB3
prerank,regulation of cell projection organization (GO:0031344),-0.3756758165270725,-1.0051941356251513,0.4375,0.8311734252613904,1.0,2/13,3.91%,MACF1;MOV10
prerank,positive regulation of coagulation (GO:0050820),0.48319722102210133,1.004522053149073,0.47192716236722304,1.0,1.0,1/10,1.60%,ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),0.48319722102210133,1.004522053149073,0.47192716236722304,1.0,1.0,1/10,1.60%,ST3GAL4
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.3455373342768723,1.0040935989614668,0.4609286523216308,1.0,1.0,19/72,19.48%,PYCARD;CBFB;FADD;PTPN2;IRAK3;TRIM44;SOCS1;AGPAT2;OTULIN;PTPN1;PTPN11;TAX1BP1;SUMO1;RUNX1;CD74;RIPK1;CHUK;AXL;SPPL2B
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.3487938105783939,1.0040016819333912,0.465324384787472,1.0,1.0,10/69,10.86%,PYCARD;FADD;EPHB2;PSEN1;CCR2;WNT5A;TMEM106A;TLR1;PTPRJ;PTPN11
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.25762748569697325,-1.0038573490777196,0.4034090909090909,0.8333428830263581,1.0,15/50,19.43%,PSMD14;AZIN1;OAZ1;PSMB3;PSMD12;OAZ2;PSMD6;PSMA1;ODC1;PSMD7;PSMA5;PSMC5;PSMC4;PSMB6;PSMA4
prerank,RNA destabilization (GO:0050779),-0.34596437359468335,-1.003648759850792,0.46601941747572817,0.8323752479037305,1.0,4/18,6.60%,ROCK2;ROCK1;YTHDF1;METTL14
prerank,synaptic vesicle transport (GO:0048489),-0.3954406865353897,-1.0034895765156153,0.4186046511627907,0.8312541805662026,1.0,5/11,14.88%,SYNJ1;KIF5B;DNM2;SNAPIN;TMEM230
prerank,mRNA stabilization (GO:0048255),0.3784575369686904,1.0034459622242422,0.46568627450980393,1.0,1.0,15/40,22.59%,ELAVL4;PABPC1;MAPKAPK2;GDNF;MAPK14;EIF4ENIF1;HNRNPU;FUS;TENT5D;SYNCRIP;TENT5A;HNRNPC;ZFP36;TENT5C;YBX3
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.47773673513928744,1.0033909950037962,0.4899536321483771,1.0,1.0,3/10,17.21%,PRNP;SCRIB;RC3H1
prerank,regulation of cell growth (GO:0001558),0.31467703984069756,1.0031775698961933,0.4770173646578141,1.0,1.0,39/204,16.80%,DCBLD2;PTCH2;PRKCQ;CRLF3;BCL2;VGLL4;ERBB2;EGFR;FRZB;JADE1;NRG3;PAK4;TGFB1;PAK5;MT3;URI1;APBB2;LAMTOR2;ARHGEF11;DERL2;SGK3;SGK2;NCBP1;EIF4G1;EXOSC2;PTPRJ;AKAP6;CHPT1;BRAT1;PRDM11;RTN4;PAPPA2;KLHL22;TMEM97;TP53;NDUFA13;ING1;HYAL1;SGK1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.4518357958938535,1.0030999708554922,0.4525316455696203,1.0,1.0,2/13,4.44%,PSEN1;SOX11
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.2584106400136007,-1.0027387476913747,0.425,0.8317909995540922,1.0,16/53,19.43%,PSMD14;AZIN1;OAZ1;PSMB3;PSMD12;OAZ2;PSMD6;PSMA1;ODC1;PSMD7;PSMA5;PSMC5;PSMC4;PSMB6;PPM1K;PSMA4
prerank,regulation of B cell apoptotic process (GO:0002902),-0.38098215341023034,-1.0024165623375032,0.4078549848942598,0.8311614448645486,1.0,2/12,3.82%,FOXP1;LYN
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3732309564328218,1.0022211749849261,0.45588235294117646,1.0,1.0,8/40,15.54%,PIP5KL1;BCL2;ARL6IP5;PID1;PRDX3;MTLN;UBB;ABL1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.2986389967514621,-1.002156151517708,0.4641350210970464,0.8303634730929341,1.0,6/30,11.46%,DAB2;FOXP1;KDM1A;DDX5;KDM4C;PRMT2
prerank,regulation of cellular respiration (GO:0043457),0.42199238215028795,1.0015716886696766,0.4660056657223796,1.0,1.0,4/17,17.50%,PRDM16;CBFA2T3;PNPT1;TRAP1
prerank,cellular protein localization (GO:0034613),0.31064974787718896,1.001459606150293,0.5015166835187057,1.0,1.0,64/285,17.15%,TMED6;HPS6;FGF10;TBC1D10A;BICD1;ANK2;ARMCX3;RAB38;EGFR;RAB14;PACS2;VPS33A;COPZ2;SNX15;VPS29;GRID2;WNT5A;WIPI1;ARL1;ITSN1;RAB21;COPB2;SEC31B;CNTNAP2;LAMTOR2;RABL3;CNTN2;EPB41L3;TBCK;FLNA;TMED10;SNX6;COX18;VPS26B;ARL5C;NGFR;ARF4;BICD2;HDAC6;RAB22A;FGF7;RAB1A;USP6NL;STX8;SYNDIG1;CORO1B;RAB3GAP2;TMED3;TMED2;TRIM23;COPA;ARFGAP3;SNX1;SEC23IP;UNC93B1;SGSM1;RIC3;STX1B;PIGU;FOXJ1;TM9SF2;CTTN;AP4M1;CD74
prerank,response to alcohol (GO:0097305),0.39024164429119546,1.0013845389437728,0.48089591567852435,1.0,1.0,5/27,14.39%,TGFB1;GRIN2B;TGFBR2;GOT2;GRIN2A
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.44328838142642774,1.0013643553609237,0.4582743988684583,1.0,1.0,5/15,20.00%,STXBP4;GLI1;CUL3;CDC73;PHB2
prerank,iron ion homeostasis (GO:0055072),-0.25168107507619875,-1.001306731672416,0.46808510638297873,0.831210765015842,1.0,21/58,20.45%,BMP6;ABCG2;FLVCR1;FBXL5;ATP6V0D1;SLC40A1;FTH1;FTL;BDH2;TFRC;SOD1;CYB561A3;FRRS1;ATP6AP1;ATP6V0A2;FXN;SLC22A17;ACO1;ABCB7;HFE;TMEM199
prerank,apoptotic cell clearance (GO:0043277),0.39171405253155556,1.0011643077087966,0.48828125,1.0,1.0,3/30,2.81%,XKR7;LRP1;XKR8
prerank,negative regulation of RNA splicing (GO:0033119),-0.3405688108652586,-1.00108269675746,0.44333333333333336,0.8302953436527817,1.0,9/19,23.36%,RBMX;SRSF10;SRSF4;SAP18;PTBP1;PTBP3;SRSF12;SRSF7;U2AF2
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.4288278063160114,1.0010247733785236,0.46074074074074073,1.0,1.0,6/16,11.48%,IRAK3;ETF1;BNIP3;CLEC16A;HDAC6;UPF1
prerank,negative regulation of JNK cascade (GO:0046329),0.38410258511185497,1.0009691453592127,0.47368421052631576,1.0,1.0,13/31,23.72%,PTPN22;PRKN;MEN1;TAOK3;PER1;DACT1;FKTN;DNAJA1;ZMYND11;PDCD4;SIRPA;CYLD;AIDA
prerank,plasma membrane organization (GO:0007009),0.34896107893578876,1.0003677636473058,0.4805045871559633,1.0,1.0,15/61,17.10%,ANK3;ANK2;PLSCR4;ANO6;PACSIN2;SPTBN1;BIN1;EPB41L3;SYT11;ANXA6;RAB3A;OTOF;EHD2;ABCD2;DYSF
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.2613007670251118,-1.0002203564767806,0.4647887323943662,0.8311209560171158,1.0,21/55,29.32%,PSMD14;FBXL7;USP47;PSMB3;PSMD12;PSMD6;PSMA1;PSMD7;PSMA5;PSMC5;PINX1;PSMC4;PSMB6;PSMA4;PSMB1;PSMB9;AVEN;PSMC6;PSMD3;PSMD10;PSME3
prerank,regulation of lamellipodium assembly (GO:0010591),-0.29131751999818006,-1.0001531108177024,0.4492753623188406,0.8297564040363248,1.0,9/34,16.92%,CAPZB;OCLN;SLIT2;WASF2;AKIRIN1;ABI2;CDC42;AVIL;ABI3
prerank,heart process (GO:0003015),0.4382734316783373,1.0000891229180389,0.4651851851851852,1.0,1.0,3/14,8.06%,SGCD;SGCZ;FYN
prerank,nuclear body organization (GO:0030575),0.4620810149156887,1.0000402639319241,0.47518796992481205,1.0,1.0,1/12,0.50%,USP50
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.31083952862013237,0.9998018330970174,0.5020040080160321,1.0,1.0,82/366,20.99%,RORA;MLF2;SOX6;NKX6-2;EFEMP1;PRKCQ;TGIF2;SSBP2;NAB1;RPS6KA4;NFX1;SOX11;RNF6;CXXC1;APBB2;ATXN2;RFX3;TSC1;MLXIPL;MLX;TAF5L;DRAP1;FZD7;CHD3;SPIN1;RABL3;ATRX;SOX12;CARM1;NCOA2;REXO4;HIF1A;GRM5;ZSCAN26;ZBTB38;HINT1;ATF2;ESR1;MYT1;SP1;SFPQ;RBAK;NSD2;DDX25;RHOH;DVL1;PATZ1;WWTR1;ATF5;AHR;RBM4B;TGFBRAP1;CREM;CYFIP1;HOXB7;TRRAP;ABL1;MSL3;TP53;SP3;PHF19;TERF2IP;NFIA;SUFU;MLF1;FBXO5;FUS;APBB3;USP37;POLR2A;HMG20A;CNBP;UBE2L3;STAT3;PRDM2;HP1BP3;USP13;CCDC88A;KMT2D;NR1D2;ZSCAN21;LIMD1
prerank,neural crest cell migration (GO:0001755),0.3800048444753726,0.9997904173656709,0.489281210592686,1.0,1.0,10/36,18.86%,SOX8;SEMA3E;SEMA6C;SEMA3A;ERBB4;GDNF;ANXA6;SEMA6D;SEMA4B;SEMA4D
prerank,cytosolic transport (GO:0016482),0.3292593779575276,0.9996488177258577,0.4851380042462845,1.0,1.0,36/108,23.31%,TBC1D10A;DENND2A;RHOBTB3;RAB14;VPS29;ARL1;CCDC91;AP1G1;GBF1;EPS15;GAK;HEATR5A;SNX6;VPS26B;PHETA2;BET1L;SYS1;AKTIP;STX8;SPAG9;SNX1;WASHC1;ANKRD27;UBE2O;AP4M1;RBSN;RAB7A;SNX16;HOOK2;DENND5A;WDR81;CORO7;RAB6A;HOOK1;HOOK3;ERC1
prerank,regulation of neuron differentiation (GO:0045664),0.33811244319351436,0.9996217767690795,0.49217002237136465,1.0,1.0,19/76,20.22%,NGF;NRCAM;GPRC5B;SOX11;ZEB1;HOXD3;NLGN1;FGFR1;BIN1;BMP7;MMD2;CDK5R1;ZFHX2;VWC2;NREP;HEYL;CNTN4;CPNE1;PCP4
prerank,regulation of interleukin-12 production (GO:0032655),0.36109598739444904,0.9994462809262954,0.4830917874396135,1.0,1.0,4/47,4.92%,IL16;IRAK3;MAST2;PLCB1
prerank,epidermal cell differentiation (GO:0009913),0.36836746759663846,0.9992737699588357,0.46551724137931033,1.0,1.0,6/41,10.12%,CERS3;TGM1;GLI1;WNT5A;GATA6;HDAC2
prerank,protein import into mitochondrial matrix (GO:0030150),-0.3551648977652766,-0.9985945293880827,0.45217391304347826,0.8326907392192435,1.0,9/18,29.31%,TOMM70;TIMM23;DNAJC15;TIMM17A;ROMO1;GRPEL1;DNLZ;TOMM40L;TOMM40
prerank,modulation by symbiont of entry into host (GO:0052372),-0.34811487957785425,-0.9985788405805539,0.4603174603174603,0.8311924149675664,1.0,6/16,20.01%,TRIM25;TRIM5;EXOC2;CAV1;TRIM21;TRIM68
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.36521142031459686,0.998388929854654,0.4742014742014742,1.0,1.0,5/41,9.85%,PTPN22;CD34;IRAK3;SYT11;SELENOS
prerank,intracellular lipid transport (GO:0032365),-0.32727553017264854,-0.9980896357017108,0.41132075471698115,0.8310091192758302,1.0,5/21,12.85%,PRKAG2;CPT1A;ACACB;PRKAA2;SLC25A20
prerank,response to ketone (GO:1901654),-0.3109439036132399,-0.9978995204761114,0.4126984126984127,0.8299852339659076,1.0,8/24,20.71%,SLIT2;THBS1;TGFB2;CAV1;ABHD2;ABCB4;CATSPER3;NR1H3
prerank,regulation of programmed cell death (GO:0043067),0.3215445432617588,0.9978033683888238,0.5036119711042312,1.0,1.0,36/161,17.24%,BCL2L14;RTKN;CXCL10;OLFM4;SOX9;PRKN;STEAP3;TNFRSF10B;FANK1;APAF1;CASP6;BNIP3;NAE1;NF2;CTSB;RARG;HIP1;SLK;ANP32E;MALT1;TM7SF3;DDX42;RTN4;CASP2;CRADD;ATM;ABL1;IFT57;TP53;BCL2L11;HTATIP2;GLS2;SGK1;PAX2;RIPK1;WRN
prerank,histone deacetylation (GO:0016575),0.3663643773465155,0.9977331119046239,0.4792408066429419,1.0,1.0,12/43,16.16%,RCOR2;MTA2;MORF4L2;HDAC2;SIN3B;SFPQ;HDAC6;SIRT6;MIDEAS;PER1;MSL3;MTA3
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3915542002218097,0.9977247823563596,0.47044025157232705,1.0,1.0,12/29,25.30%,DHX34;PABPC1;GDNF;NBAS;EIF4ENIF1;HNRNPU;FUS;TENT5D;TENT5A;TENT5C;FMR1;CIRBP
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.24178088224998012,-0.997595365676959,0.43137254901960786,0.8293440289148413,1.0,32/72,33.17%,PSMD14;BIRC3;REL;RELB;PSMB3;PSMD12;ZFP91;PSMD6;MAP3K7;PSMA1;TIRAP;PSMD7;PSMA5;PSMC5;PSMC4;PSMB6;NFKB2;PSMA4;AKT1;PSMB1;PSMB9;PSMC6;PSMD3;PSMD10;PSME3;DICER1;TLR3;BTRC;FBXW11;BIRC2;PSMA6;PSME2
prerank,regulation of amyloid-beta formation (GO:1902003),-0.2927652588800028,-0.9968980603593527,0.4337899543378995,0.829888841299537,1.0,4/34,1.73%,EPHA4;IGF1;ROCK2;ROCK1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.407921696413027,-0.9968962555468819,0.4477211796246649,0.8283605008919872,1.0,4/10,17.29%,APPL2;RAB31;NCKAP1L;CD300A
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.3237012868652202,0.9968116201554073,0.4925053533190578,1.0,1.0,32/109,22.72%,PRKCQ;TEC;PAK1;PPP3CB;PPP3CA;GAB2;VAV3;PSMB7;MAPK9;NFATC3;PIK3R1;MAP2K4;MAPK1;MALT1;CALM1;PSMD2;PSMC1;LAT2;PSMB2;CHUK;PSMD9;TAB3;GRB2;PSME4;BCL10;JUN;PSMA8;SOS1;NFKB1;VAV2;CARD11;TAB2
prerank,regulation of heart contraction (GO:0008016),0.3328917355131277,0.9963841698766669,0.4870689655172414,1.0,1.0,17/90,17.17%,FXYD3;CORIN;ANK2;NPR2;ATP2B3;TMEM65;SLC8A2;FXYD6;PDE4D;FXYD1;PRKACA;ATP2B1;AHCYL1;CALM1;CALM2;NPPC;MYH6
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.3900777419481313,-0.9961640603615405,0.43820224719101125,0.8289397436258688,1.0,5/11,36.54%,LYN;ANXA1;PIK3CB;RAPGEF2;MEF2C
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.33676017156031535,0.9957997719821355,0.47802197802197804,1.0,1.0,20/80,18.13%,TBC1D10A;DENND2A;RHOBTB3;VPS29;ARL1;GBF1;HEATR5A;SNX6;VPS26B;PHETA2;BET1L;SPAG9;SNX1;WASHC1;UBE2O;SNX12;SURF4;RBSN;RAB7B;RAB7A
prerank,regulation of cell population proliferation (GO:0042127),0.30736366372585777,0.9957359109963941,0.52,1.0,1.0,120/691,16.21%,ROR2;OSR2;DLC1;SSTR1;WNK2;BMP5;CLDN19;CXCL10;PDGFRA;ERBB3;HAS2;NTRK3;GLMN;FGF2;MYC;FGF10;KIF20B;PTEN;BCL2;GAREM1;IRS2;KAT2B;SOX9;CRLF1;NGF;BST1;ERBB2;CDKN2B;EGFR;SQLE;FRZB;PTPN2;VEGFA;CADM4;PTHLH;CAPN1;TGFB1;TIPIN;PTGFR;SOX11;NUPR2;NTRK2;GDF9;GLI1;NOX1;NOP2;PAK1;BNIPL;KSR1;CDK13;PODN;TSC1;TGFBR2;MLXIPL;UFL1;ADAMTS1;CYP1B1;CBFA2T3;CDK6;MEN1;FOXM1;FGFR1;TSHR;GAB2;NF2;COL18A1;RARG;BTC;DERL2;SGK3;SGK2;AMELX;SHCBP1;CUL3;HDAC2;ERBB4;SFRP4;GDNF;PTPRJ;IL6ST;PRMT1;CDC25B;MAGI2;S1PR3;EDN3;ING4;FGF7;ATP8A2;RTKN2;WWTR1;XRCC6;DRD2;GLP2R;PRLR;PRDX3;SOD2;ATF5;ADARB1;STRN;GATA3;RBBP4;TRAPPC14;NACC2;RPS6KA2;PDS5B;MDM4;BMPR1A;CD164;LMNA;CCL14;JUP;RUNX1;MEIS3;PIM2;TP53;CCND2;GPLD1;XIAP;TRNP1;TGFB3
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.34070481199950925,-0.9956682827316546,0.45425867507886436,0.8288296898547569,1.0,8/18,15.66%,DCP2;NAF1;DKC1;RUVBL1;CCT8;CCT6A;CCT4;EXOSC10
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.376441683287134,-0.9956340155701789,0.4626865671641791,0.8273888011591315,1.0,2/13,4.02%,IGF1;RAMP1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.26617358785927236,-0.9956319903707598,0.46551724137931033,0.8258843098382485,1.0,18/48,23.42%,ROBO1;SLIT2;GPS2;SAMHD1;CCDC3;NR1H2;PTPRC;PADI2;PARP14;STAT2;USP18;PELI3;ISG15;NR1H3;RFFL;CACTIN;MUL1;NLRP2B
prerank,sulfate transport (GO:0008272),-0.36642475261581064,-0.9954966405707867,0.4553846153846154,0.8247532988012817,1.0,7/14,26.34%,SLC26A7;SLC26A2;SLC25A30;SLC13A4;SLC26A6;RACGAP1;SLC26A8
prerank,protein phosphorylation (GO:0006468),0.3086004750599217,0.9954188839285377,0.525,1.0,1.0,82/478,13.06%,RELN;WNK2;CCL11;EFEMP1;PRKCA;PDGFRA;STK32B;PRKCQ;PKDCC;PEAK1;STK36;ERBB2;EGFR;ACVR1;PRKX;MAP4K4;PAK4;MAP3K3;EPHB2;IRAK3;WNK3;SIK2;EIF2AK3;RPS6KA4;MAPKAPK3;MAST2;NEK1;TGFB1;TEC;PAK5;NTRK2;MAPKAPK2;DYRK4;TESK2;PRKAR1B;TNIK;EEF2K;ACVR1C;PAK1;PKN1;YWHAZ;CDKL5;CDK8;CDKL3;CDK13;TGFBR2;CSK;PPP3CB;DYRK1B;PDK3;LIMK1;CDK6;FGFR1;FYN;CDK15;TBCK;CDK19;PASK;STK39;TLK2;MAPK9;AKT3;SGK3;SGK2;ERBB4;SLK;PXK;TYK2;MAPK14;DCLK1;STK32A;CDC25B;MAPK1;TAOK3;CDK5R1;TBK1;STK33;CSNK1G1;PRKACA;CSNK1A1;NEK7;CDK16
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4619260676630076,0.995360104349017,0.4711388455538221,1.0,1.0,2/11,4.11%,TAX1BP3;GPM6B
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3066968350745639,0.9950347210354109,0.527,1.0,1.0,192/834,21.50%,RORA;OSR2;DCN;ETV1;BMP5;MLIP;KLF15;CXCL10;ETV4;MEOX2;MAML3;GLI2;MACC1;FGF2;SOX8;CRLF3;MYC;KAT2B;SOX9;SSBP2;PRKN;NCOA1;CDKN2B;EGFR;FADD;HIVEP1;ACVR1;HOXA7;KMT2A;VEGFA;CCNC;TFCP2;MAPK7;CRTC1;MAML2;RPS6KA4;TGFB1;AUTS2;SOX11;SETD3;RFXANK;GLI1;E2F2;PHOX2A;WNT5A;HOXD3;CDK8;RFX3;CDK13;MLXIPL;MLX;DRAP1;PPP3CB;KAT8;GATA6;MEN1;FOXM1;IL18;ASXL3;PPP3CA;ATMIN;ATRX;ZNF462;RARG;BRCA1;RARB;SOX12;ZMIZ1;NCOA2;LDB2;KLF5;BRD8;HIF1A;ZFP64;IL4I1;BCL9L;HDAC2;ZBTB38;MED13;NFATC3;PIK3R1;MYSM1;GDNF;ATF2;NGFR;ESR1;NFE2L2;ARF4;SP1;TAF9;SFPQ;POGZ;PID1;MYDGF;BCL9;EPC1;TMF1;DVL1;TBK1;WWTR1;XRCC6;NRIP1;PRPF6;ZFPM2;ATF5;PER1;GATA3;AHR;SALL2;NCK1;PAX3;BMPR1A;PKD1;CITED2;TAF7;MED12;MET;HOXB7;ELL;ZEB2;UBB;IL33;MED25;JUP;ATM;RUNX1;ABL1;MEIS3;GCN1;MEPCE;MED21;TP53;SP3;TET3;HTATIP2;TGFB3;SREBF2;RNF111;HNRNPU;ASXL2;NFIA;WWOX;FOXJ1;PAX2;GABPB1;GABPB2;RNF10;RIPK1;CDC73;CHUK;NFIX;NCOA3;SLC9A1;HEYL;NR5A1;CSRNP3;IRF3;MED30;KLF7;AATF;RNF4;PARK7;EGR1;SENP1;RUVBL2;CNBP;FOXJ3;PPARG;JUN;STAT3;PRDM2;ONECUT2;MCRS1;TFE3;SMARCA4;FUBP3;KMT2D;PBX1;ZBED4;NR1D2;MEIS1;ZSCAN21;DPF2;NFKB1;MITF;THRA;DCAF6;TNIP2;RPS6KA3;DVL3;PRKD2;PKD2
prerank,male gonad development (GO:0008584),0.3809513237347903,0.9947928557110991,0.4937185929648241,1.0,1.0,11/34,21.63%,SOX8;SOX9;WNT5A;MAMLD1;GATA6;GATA3;LRP2;NR5A1;CSDE1;MEA1;FGF9
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.4103767022827539,-0.9947404382338094,0.46547314578005117,0.8254347484502323,1.0,5/10,12.74%,ACER2;WNK1;JAM3;SERPINE1;NEXMIF
prerank,regulation of cell adhesion (GO:0030155),0.3226735708542401,0.9946190341849259,0.497907949790795,1.0,1.0,18/129,10.86%,TGFBI;PRKCA;ERBB3;EPB41L4B;RHOD;ERBB2;PLXNC1;PRKX;EFNA5;VEGFA;EPHB2;PDE3B;RASA1;IL18;PPP3CA;DSCAM;PTPRJ;PTPN11
prerank,response to interferon-gamma (GO:0034341),0.33861239756183675,0.9938949381044869,0.49105145413870244,1.0,1.0,6/67,5.52%,CCL11;KYNU;EPRS1;CCL4;AQP4;WNT5A
prerank,ceramide biosynthetic process (GO:0046513),-0.27139944734972166,-0.9934856146953364,0.4550561797752809,0.8272942566917219,1.0,7/40,7.92%,SGMS1;ST6GALNAC3;ST8SIA4;CERS5;SPTLC2;DEGS2;CERS4
prerank,recombinational repair (GO:0000725),0.3338537003585112,0.9930470136098922,0.48152295632698766,1.0,1.0,18/77,17.24%,POLN;MEIOB;AP5S1;ERCC5;REV3L;ERCC4;RPA3;BRCA1;FBH1;SFPQ;HELQ;XRCC3;EXD2;RPA2;RAD52;BLM;SPIDR;WRN
prerank,positive regulation of cell motility (GO:2000147),0.31235522520337267,0.9928410392963063,0.5153061224489796,1.0,1.0,21/205,6.75%,ROR2;CCL11;PRKCA;LGR6;PDGFRA;HAS2;NTRK3;SEMA3E;RHOD;EGFR;ACVR1;SEMA6C;MAP4K4;VEGFA;EPHB2;SEMA3A;TGFB1;CLDN1;PAK1;FAM83H;TWIST2
prerank,regulation of interleukin-10 production (GO:0032653),0.35754955396840504,0.9927376445902152,0.47784431137724553,1.0,1.0,2/44,1.88%,PYCARD;CD34
prerank,regulation of mRNA processing (GO:0050684),0.37559259906395837,0.9924795560631587,0.4975186104218362,1.0,1.0,9/32,17.62%,QKI;SON;KHDRBS3;NCBP1;AHCYL1;YTHDC1;SLTM;PAPOLA;SF1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3048937608707348,0.9924680061961186,0.554,1.0,1.0,252/1082,21.50%,RORA;OSR2;DCN;ETV1;BMP5;MLIP;KLF15;CXCL10;MDFIC;ETV4;MEOX2;MAML3;GLI2;MACC1;FGF2;SOX8;PRDM16;CRLF3;MYC;RGMB;KAT2B;SOX9;SSBP2;HMGN1;ERBB2;PRKN;NCOA1;CDKN2B;EGFR;FADD;HIVEP1;ACVR1;HOXA7;KMT2A;VEGFA;CCNC;TFCP2;MAPK7;WAC;KDM8;EIF2AK3;CRTC1;MAML2;RPS6KA4;TRIM44;TGFB1;AUTS2;PSEN1;FANK1;NCF1;SOX11;SETD3;BICRAL;RFXANK;RNF6;MT3;PLCB1;GLI1;RAI1;E2F2;ATF7IP;PHOX2A;CXXC1;WNT5A;HOXD3;HNRNPAB;CDK8;RFX3;ZBTB16;RORC;MLXIPL;MLX;CREB3L2;DRAP1;PPP3CB;DYRK1B;NAA16;FZD7;KAT8;GATA6;ZC3H8;MEN1;BICRA;FOXM1;SPIN1;IL18;ASXL3;PPP3CA;ATMIN;ARHGEF11;ATRX;ZNF462;TFAM;RARG;BRCA1;HEATR1;RARB;SOX12;ZMIZ1;NCOA2;LDB2;KLF5;BRD8;HIF1A;ZFP64;IL4I1;BCL9L;HDAC2;ERBB4;ZBTB38;MED13;NFATC3;PIK3R1;MYSM1;GDNF;ATF2;ESR1;NFE2L2;ARF4;SMARCC2;SP1;TAF9;ASF1A;SFPQ;POGZ;PID1;BMP7;MYDGF;BCL9;FGF7;EPC1;TMF1;PHF8;DVL1;TBK1;WWTR1;XRCC6;NRIP1;PRPF6;ZFPM2;ATF5;PER1;GATA3;AHR;SALL2;PRDM11;SMARCC1;NCK1;PAX3;HIVEP3;DHX33;PCBD2;BMPR1A;COL1A1;PKD1;CITED2;TAF7;MED12;MET;HOXB7;ELL;ZEB2;UBB;POU3F1;IL33;MED25;JUP;ATM;RUNX1;ABL1;MEIS3;PIM2;BLM;MED21;TP53;SP3;TET3;KCNH2;HTATIP2;TGFB3;SREBF2;RNF111;HNRNPU;ING1;ASXL2;QRICH1;USP21;NFIA;WWOX;FOXJ1;PAX2;GABPB1;GABPB2;CD74;RNF10;RIPK1;CHUK;NFIX;NCOA3;SLC9A1;HEYL;NR5A1;PCID2;CSRNP3;RPTOR;IRF3;MED30;ZNF496;KLF7;NAA15;AATF;RNF4;MAPRE3;PSMD9;PARK7;KMT2E;EGR1;SENP1;RUVBL2;CNBP;BCL10;FOXJ3;PPARG;JUN;STAT3;PRDM2;ONECUT2;MCRS1;UBTF;TFE3;SMARCA4;FUBP3;KMT2D;CD38;PBX1;ZBED4;NR1D2;MEIS1;ZSCAN21;DPF2;SEC14L2;NFKB1;MITF;ZXDC;THRA;DCAF6;TNIP2;RPS6KA3;NSD1;DVL3;PRKD2;PKD2
prerank,defense response to bacterium (GO:0042742),-0.2327041871066169,-0.9923551259424289,0.46875,0.8287609203760106,1.0,23/105,21.77%,ANXA3;ANKRD17;PRKCD;TLR4;RPS19;DEFA6;IRGM;IL6R;PGLYRP1;PPP1R11;OPTN;STAB1;OAS2;SERPINE1;TIRAP;CFP;GSDMD;MPEG1;ISG15;HMGB2;NOD1;FCER1G;COLEC12
prerank,negative regulation of protein metabolic process (GO:0051248),0.3504770101144339,0.992312652791025,0.4817073170731707,1.0,1.0,22/48,27.73%,EGFR;FMN2;IRAK3;PRNP;FLNA;CRYAB;MDM4;SNX12;AZIN2;SF3B3;CD84;NFKB1;AGAP2;PRKCG;INHBB;FLOT2;HMGCR;PFDN2;PIN1;CYP51A1;ITGAV;PFDN1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3032390406904373,0.9917716808883245,0.551,1.0,1.0,315/1668,18.89%,EBF2;RORA;OSR2;DCN;ETV1;SOX6;NKX6-2;PTCH1;TENM2;BMP5;MLIP;KLF15;CXCL10;MEOX1;EBF4;ETV4;MEOX2;TSHZ3;LHX5;TLX3;MAML3;GLI2;MACC1;CREB3L1;RCOR2;FGF2;IFRD1;SOX8;AASS;PRDM16;CRLF3;MYC;DMRT2;TGIF2;PTEN;EBF1;CBFB;HOXB8;ZNF25;ZBTB20;KAT2B;SOX9;SSBP2;ERBB2;PRKN;RIPPLY2;NCOA1;CDKN2B;EGFR;SUV39H1;FADD;HIVEP1;ACVR1;OTP;ZBTB37;HOXA7;KMT2A;SATB1;VEGFA;CCNC;TFCP2;EGR3;MAPK7;CRTC1;MAML2;RPS6KA4;NFX1;FOXP2;KDM5B;GTF2H2;TGFB1;AUTS2;BAZ1A;RFX2;GATAD2A;PSEN1;EZH1;SOX11;NUPR2;MED31;SETD3;RFXANK;ZNF276;GLI1;RAI1;E2F2;ZEB1;PHOX2A;NOP2;WNT5A;HOXD3;RPRD1A;PGBD1;URI1;EED;PKN1;ZFP14;OTUD7B;CDK8;RFX3;ZBTB16;MAMLD1;CDK13;RORC;MTA2;MLXIPL;MLX;TRPS1;CREB3L2;TADA1;TWIST2;DRAP1;PPP3CB;E2F6;KAT8;LRRFIP1;GATA6;CBX4;TBX18;MEN1;FOXM1;ZSCAN20;CHD3;VPS72;IL18;MKX;CPEB3;ASXL3;PPP3CA;ZBTB41;ATMIN;ATRX;KCTD1;ZNF462;RARG;PPP1R13L;BRCA1;MBD2;RARB;SOX12;SOX5;PPID;ZMIZ1;NCOA2;ZNF569;BBX;LDB2;KLF5;BRD8;HIF1A;ZFP64;DBX2;PIAS2;IL4I1;ARID4B;BCL9L;ZBTB6;CHD2;HDAC2;ZSCAN26;ZBTB38;MED13;NFATC3;ELP2;PIK3R1;ZNF260;PSIP1;MYSM1;GDNF;ATF2;ZKSCAN8;PHF20;ESR1;NFE2L2;MAPK14;ARF4;MYT1;SIN3B;LIN9;SMARCC2;SP1;ZNF112;TAF9;SFPQ;POGZ;RBAK;PID1;SIRT6;DCAF1;CREBZF;MYDGF;BCL9;MIDEAS;ZFHX4;EPC1;TMF1;PHF8;DVL1;PER3;TBK1;SIX5;KLF13;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;WWTR1;XRCC6;NRIP1;PRPF6;SOD2;ZFPM2;ATF5;PER1;GATA3;AHR;ZNF83;SALL2;ZNF250;ZBTB39;SMARCC1;BAZ2B;ELP4;NACC2;SNCA;NCK1;PAX3;LCOR;ZFHX2;MDM4;NEDD4L;HIVEP3;SUMO1;CRY1;NCOR2;BMPR1A;PKD1;BAZ1B;CITED2;TAF7;CREM;MED12;SLTM;MET;IRX5;HOXB7;ZNF235;ZEB2;UBB;POU3F1;IL33;MED25;DACT1;JUP;ATM;RUNX1;ABL1;MEIS3;PURG;KLF9;MED21;TP53;ZFX;LCORL;SP3;TET3;ZXDB;MTA3;HTATIP2;TGFB3;SREBF2;RNF111;HNRNPU;ASXL2;NFIA;WWOX;FOXJ1;USP2;PAX2;GABPB1;GABPB2;RNF10;SMARCE1;RIPK1;CDC73;CHUK;NFIX;NCOA3;ZKSCAN1;SLC9A1;HEYL;NR5A1;CTBP1;CSRNP3;SUFU;FUS;KLF16;MDM2;IRF3;MED30;ZNF697;ELOC;ZNF496;EPC2;KLF7;AATF;RNF4;RFX7;FNIP1;PARK7;BATF;TAF1;SEMA4D;CGGBP1
prerank,cellular response to mechanical stimulus (GO:0071260),0.35873796516945683,0.9917528012749983,0.5067319461444308,1.0,1.0,9/46,17.46%,PIEZO2;SOX9;FADD;TNFRSF10B;BNIP3;MAP2K4;CASP2;CRADD;SLC9A1
prerank,autophagy of nucleus (GO:0044804),0.4239589525383482,0.9915830582782785,0.4738372093023256,1.0,1.0,3/16,12.66%,WIPI1;ATG5;ATG3
prerank,Golgi to endosome transport (GO:0006895),0.4297101801435096,0.991464395280731,0.4883401920438957,1.0,1.0,7/16,17.58%,RAB14;WIPI1;GBF1;EPS15;SYS1;AP4M1;AP1AR
prerank,response to interleukin-4 (GO:0070670),-0.410680259719155,-0.9913982969543309,0.5,0.8299091361904118,1.0,1/10,0.63%,LEF1
prerank,import into cell (GO:0098657),0.3598697477900731,0.9912330906469211,0.4763636363636364,1.0,1.0,8/41,11.78%,SLC1A3;SLC27A1;SLC5A3;LRRC8D;SLC29A1;NEURL1B;SLC12A4;SLC7A8
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.23869223354445135,-0.9908370896857911,0.5294117647058824,0.8299371726120264,1.0,22/80,14.92%,NRP1;OCLN;WASL;AGRN;PLEKHM1;FNBP1L;CDC42EP4;WASF2;ARHGAP35;ARAP1;FAM98A;AKIRIN1;CCP110;RHOQ;EPS8;CDC42EP3;ABI2;EPS8L2;CDC42EP2;CDC42;AVIL;FUZ
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3424746965483929,0.9905068914412835,0.4782122905027933,1.0,1.0,16/73,19.77%,PYCARD;FADD;EPHB2;PSEN1;CCR2;WNT5A;TMEM106A;TLR1;PTPRJ;PTPN11;IL33;RIPK1;LBP;SETD4;BCL10;STAT3
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.3696053097506833,0.9900016184135406,0.5018587360594795,1.0,1.0,12/41,21.77%,FGF2;CACNA2D1;GRIN2B;SLC8A2;HTR2C;DRD2;GRIN2D;GRIN2A;SLC24A2;RYR3;PKD2;ERO1A
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.32546524328778464,0.9898304531379001,0.5053533190578159,1.0,1.0,27/108,19.69%,DLC1;PYCARD;MYC;GSN;NGF;FADD;EIF2AK3;TNFRSF10B;ACVR1C;APAF1;CARD9;HIP1;NGFR;ARL6IP5;CASP12;MALT1;SNCA;CASP2;CRADD;IFT57;RPS27L;NDUFA13;RIPK1;AIFM1;SENP1;BCL10;PPARG
prerank,cellular response to hypoxia (GO:0071456),0.32069632381335716,0.9897777071642132,0.5089005235602094,1.0,1.0,35/126,23.13%,RORA;MYC;SUV39H1;FMN2;SCN2A;VEGFA;MT3;KCND2;GATA6;BNIP3;TBL2;PSMB7;HIF1A;BMP7;CPEB1;MDM4;PSMD2;LMNA;UBB;PSMC1;TP53;PSMB2;MDM2;ELOC;PSMD9;ACAA2;PSME4;HP1BP3;NPEPPS;PSMA8;LIMD1;BNIP3L;ELOB;UBQLN1;CARD16
prerank,negative regulation of organelle assembly (GO:1902116),-0.28135506718712333,-0.9897352258402363,0.4594594594594595,0.831579125530929,1.0,14/35,22.58%,ODF2L;FEZ2;SCFD1;EVI5L;CCP110;NUPR1;RBM14;TBC1D7;TBC1D30;SMCR8;CDK10;PINK1;KAT2A;STYXL1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.39267093613374193,0.9895795983142797,0.4961139896373057,1.0,1.0,14/29,26.91%,COG5;COPZ2;COPB2;COPG2;COPA;GABARAPL2;COPG1;COG1;TRAPPC3;NAPG;RAB6A;TRAPPC10;GOSR1;COG6
prerank,actin crosslink formation (GO:0051764),0.4523140452038692,0.9893827632528064,0.4848024316109423,1.0,1.0,3/12,8.56%,GAS2L3;BAIAP2;FLNA
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.36372670642349986,0.9889065534453586,0.5096385542168674,1.0,1.0,8/42,14.04%,IARS2;EPRS1;FARSA;SARS2;FARSB;FARS2;YARS1;HARS1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.41721027436827873,0.988827023178509,0.4979020979020979,1.0,1.0,3/18,7.90%,PYCARD;FADD;IL18
prerank,regulation of neuroblast proliferation (GO:1902692),0.43915051573998326,0.9887450511175756,0.48444444444444446,1.0,1.0,5/15,12.70%,VEGFA;NF1;DISC1;TAFA1;DRD2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.33305126638706584,0.9883345593725713,0.4786995515695067,1.0,1.0,16/70,15.54%,ARPC1B;WIPF1;PAK1;BAIAP2;LIMK1;FYN;BRK1;VAV3;DOCK1;PIK3R1;MAPK1;PLPP4;NCK1;CYFIP1;ELMO1;ABL1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.39154241642384624,0.9882900978354685,0.47870967741935483,1.0,1.0,11/26,23.63%,CUL3;ANAPC7;CDC23;FBXO5;CDC27;DUSP1;ANAPC4;CDK5RAP2;ANAPC5;RB1;CDC16
prerank,cellular component maintenance (GO:0043954),-0.38625895012554184,-0.9881896133972684,0.4632768361581921,0.8343471306810655,1.0,4/12,8.41%,IGF1R;ITGA3;INSR;MTMR2
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3583735267738263,0.9880029432939724,0.47980416156670747,1.0,1.0,5/43,9.85%,PTPN22;CD34;IRAK3;SYT11;SELENOS
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.33096936139028293,0.9879637341933338,0.5087912087912088,1.0,1.0,23/82,23.32%,DYNLL1;HAUS3;CNTRL;PCM1;NDE1;SDCCAG8;CEP57;CLASP1;PRKACA;ATF5;CKAP5;CEP76;DYNC1I2;CSNK1E;TP53;CEP63;TUBA1A;CEP78;SSNA1;PCNT;CDK5RAP2;DYNC1H1;PPP2R1A
prerank,potassium ion import across plasma membrane (GO:1990573),-0.27310353663159576,-0.987943504070103,0.4508670520231214,0.8335001538060335,1.0,9/41,13.07%,ATP1A2;ATP1B3;SLC12A7;KCNJ2;ABCC9;ATP1A1;SLC12A9;KCNK9;SLC12A8
prerank,negative regulation of cell activation (GO:0050866),-0.3660591466829936,-0.9871968720744486,0.4745222929936306,0.8342297147614257,1.0,3/14,2.67%,CD200;THBD;NOS3
prerank,inner mitochondrial membrane organization (GO:0007007),-0.26001934645628383,-0.9868815826364632,0.45294117647058824,0.833592495295371,1.0,17/47,23.28%,MTX2;TOMM70;MICOS10;DNAJC11;ATP5MC3;SPG7;IMMT;TMEM11;ATP5PD;ATP5F1D;ATP5MF;TIMM9;TIMM22;MTX1;TIMM10B;TIMM8B;ROMO1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.33256418431131757,0.9867949857480394,0.5022026431718062,1.0,1.0,7/74,3.96%,LGALS3;BMP5;BCL2;FADD;ACVR1;MAPK7;TNFRSF10B
prerank,negative regulation of mRNA processing (GO:0050686),-0.3650700619802609,-0.9867636926672008,0.445859872611465,0.8323966121404529,1.0,8/15,23.36%,RBMX;SRSF10;SRSF4;SAP18;PTBP1;SRSF12;SRSF7;U2AF2
prerank,negative chemotaxis (GO:0050919),0.37731740615971404,0.9863834688541714,0.4921875,1.0,1.0,4/33,3.81%,LGR6;SEMA3E;SEMA6C;SEMA3A
prerank,regulation of immunoglobulin production (GO:0002637),0.397528196637556,0.9863376844077711,0.49592391304347827,1.0,1.0,2/23,3.65%,EPHB2;DNAJB9
prerank,cortical cytoskeleton organization (GO:0030865),0.35727800563127354,0.9863332820947369,0.5053507728894173,1.0,1.0,8/41,12.14%,RHOD;RND3;RHOBTB3;FMNL2;NLGN1;EPB41L3;RHOH;RHOC
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.4318423304445179,0.9860462016846152,0.4861111111111111,1.0,1.0,2/15,3.14%,FGF2;VEGFA
prerank,sphingolipid metabolic process (GO:0006665),-0.23205403176851364,-0.9860184787699461,0.5205479452054794,0.8330569631769027,1.0,31/108,19.91%,SGMS1;ST6GALNAC3;ELOVL7;PLPP1;CERS5;KDSR;ACER2;HACD4;SPTLC2;ESYT2;DEGS2;CERS4;SPNS2;ALDH3A2;ESYT1;GLTP;SGPL1;SUMF2;VAPB;GAL3ST1;UGCG;ASAH2;CERS1;ORMDL3;ESYT3;PLA2G15;SPHK1;SERINC1;SPTSSB;CTSA;CERT1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.3570783383159228,-0.9858499437757517,0.4620253164556962,0.8305280606160358,1.0,2/14,6.99%,ABCG2;BLVRA
prerank,heme catabolic process (GO:0042167),-0.3570783383159228,-0.9858499437757517,0.4620253164556962,0.8305280606160358,1.0,2/14,6.99%,ABCG2;BLVRA
prerank,purine nucleotide catabolic process (GO:0006195),0.44490286290459885,0.98561885854397,0.5057803468208093,1.0,1.0,3/13,10.39%,NUDT15;NT5C2;HINT1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.3787298105291845,0.9855728730751396,0.4744429882044561,1.0,1.0,2/32,3.93%,CXCL10;RNASE6
prerank,regulation of osteoclast differentiation (GO:0045670),0.37291785764724306,0.9852729474111205,0.4827144686299616,1.0,1.0,1/33,0.55%,UBASH3B
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.38539607293232736,0.9850861198952536,0.49483204134366926,1.0,1.0,2/28,3.35%,RELN;EPHB2
prerank,positive regulation of protein transport (GO:0051222),-0.2488294501536031,-0.9847994976154085,0.4896551724137931,0.8318593168827624,1.0,14/67,13.13%,BMP6;IGF1;OAZ1;EXOC1;PPIA;RACK1;ABCG1;CNST;UNC13B;OAZ2;APBB1;SYTL4;TGFB2;MYH10
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.46368327674233917,0.9847548482931042,0.48973143759873616,1.0,1.0,2/10,8.10%,SESTD1;BIN1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.42542138834836885,0.9846660615309623,0.511921458625526,1.0,1.0,4/15,15.35%,ZFAND2B;SPCS3;RAB3GAP2;SEC61G
prerank,positive regulation of interleukin-12 production (GO:0032735),0.37230786727374265,0.9844747653747045,0.49483204134366926,1.0,1.0,3/31,10.79%,IL16;PLCB1;MAPK14
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.33812229927421933,0.9843539552657733,0.5244988864142539,1.0,1.0,13/76,16.76%,GNA14;HRH1;LPAR1;PTGER3;GPR65;GRM5;HTR2C;ESR1;DRD2;P2RY12;P2RY1;HOMER1;OPRK1
prerank,regulation of actomyosin structure organization (GO:0110020),-0.3695696981290348,-0.984127148119081,0.456973293768546,0.8321878556152285,1.0,5/13,13.33%,ROCK2;ROCK1;FHOD1;ACTG1;CDC42
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.4407960597460861,0.9840463980175292,0.48180494905385735,1.0,1.0,2/13,7.55%,GLI2;ZC3H8
prerank,inorganic cation transmembrane transport (GO:0098662),0.3071496481722395,0.9837556148490668,0.5336683417085427,1.0,1.0,23/268,7.96%,SCARA5;KCNK15;SLC6A2;SLC1A3;KCNA2;SCN7A;KCNH8;SLC12A3;SCN2A;KCNK1;ANO6;KCNA1;CACNA1A;KCNA6;SLC36A2;SLC12A2;SCN5A;KCND1;KCND2;SCN3A;KCND3;SLC30A4;SLC8A2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.3300513086538243,-0.983584530931554,0.4862068965517241,0.8322210688586323,1.0,11/19,34.55%,POLD3;AMPD3;TERT;DCK;APRT;CDA;POLD2;POLD1;PNP;ADA;POLL
prerank,epidermis development (GO:0008544),0.3478148756658754,0.9832849308803852,0.4882075471698113,1.0,1.0,8/56,11.99%,CERS3;PTHLH;EMP1;GLI1;GATA6;PLOD1;HDAC2;FGF7
prerank,regulation of endocytic recycling (GO:2001135),-0.3936720074046133,-0.9831352027710234,0.4823529411764706,0.8320192505020877,1.0,3/11,8.12%,RAB11B;ATP9A;ACTN2
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.36858918805303387,0.9830546470609836,0.4835443037974684,1.0,1.0,9/36,11.98%,ANK3;GORASP1;VAMP4;BLZF1;RILPL2;SPTBN1;RAB34;GORASP2;SYS1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.3614987360699046,-0.9829902143708579,0.4896755162241888,0.830983715116981,1.0,3/13,1.46%,CACNA1C;GJA1;CACNB2
prerank,regulation of fibrinolysis (GO:0051917),0.44363137083979076,0.9825909921823758,0.49702380952380953,1.0,1.0,1/13,1.18%,FAP
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4312274010359947,0.9824734213793103,0.4899135446685879,1.0,1.0,3/16,8.28%,PTPN2;SOCS1;NF2
prerank,dephosphorylation (GO:0016311),0.3146401666567122,0.9823889662969049,0.5104384133611691,1.0,1.0,44/147,22.24%,PTPRH;PTEN;PTPN22;DUSP4;PSPH;PTPRT;ACP2;DUSP6;PTPN13;PPP3CB;PPP3CA;PPM1B;PPM1J;PPP2R3A;PPP2R2A;PTPN1;DUSP11;PTPRJ;PLPP4;PPP1CA;PLPPR4;PTPRA;PTPN18;HDHD2;PTPRZ1;PTPN21;PPP3CC;SSH1;PTPRF;PPM1E;DUSP16;NT5C;DAPP1;DUSP12;DUSP1;PTPRS;PLPPR2;CTDSP1;PPP4R1;PTPRN2;SSH2;PPM1A;PLPPR1;CTDSP2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.300660656467489,0.9822451893695484,0.577,1.0,1.0,155/807,17.79%,OSR2;NKX6-2;PTCH1;TENM2;MLIP;MDFIC;TSHZ3;SCML4;GLI2;CREB3L1;RCOR2;SOX8;AASS;PRDM16;MYC;TGIF2;ATP8B1;CBFB;ZNF25;SOX9;NAB1;VGLL4;PRKN;RIPPLY2;SUV39H1;HIVEP1;OTP;HOXA7;SATB1;VEGFA;KDM8;NFX1;TLE1;FOXP2;TGFB1;GATAD2A;PSEN1;EZH1;SOX11;NUPR2;MT3;PLCB1;MBD1;ATF7IP;ZEB1;WNT5A;URI1;EED;CIPC;OTUD7B;RFX3;ZBTB16;RORC;MTA2;MLXIPL;MLX;TRPS1;TWIST2;DRAP1;LOXL3;E2F6;CBFA2T3;KAT8;LRRFIP1;GATA6;CBX4;ZC3H8;MEN1;FOXM1;CHD3;VPS72;CPEB3;KCTD1;RARG;FLNA;BRCA1;MBD2;RARB;PPID;CRYAB;DKK3;LDB2;LANCL2;SNX6;HDAC2;ZBTB38;MBTD1;ESR1;SIN3B;SMARCC2;SFPQ;HDAC6;RBAK;BMP7;SIRT6;PRICKLE1;ING4;DCAF1;CREBZF;CDK5R1;MIDEAS;L3MBTL4;EPC1;PER3;JARID2;ZGPAT;PATZ1;FOXP4;ZBTB1;NR6A1;XRCC6;NRIP1;EID2B;ZFPM2;ATF5;PER1;SCML2;GATA3;AHR;PRDM11;NACC2;SNCA;LCOR;MDM4;NEDD4L;SUMO1;CRY1;NCOR2;CITED2;TAF7;CREM;ZEB2;UBB;IL33;MED25;DACT1;RUNX1;TP53;SP3;MTA3;NDUFA13;SREBF2;HNRNPU;WWOX;FOXJ1;USP2;PAX2;SMARCE1;CDC73;NFIX;CCDC85B;HEYL;CTBP1;SFMBT2;SUFU
prerank,regulation of cell size (GO:0008361),0.3968767684648249,0.9819997041749119,0.48601864181091875,1.0,1.0,9/23,23.96%,PTEN;DEPTOR;RARG;VAV3;PRR16;RPTOR;RDX;VAV2;MTOR
prerank,nitrogen compound transport (GO:0071705),0.32004377549606217,0.9818168210949775,0.5114345114345115,1.0,1.0,28/141,18.48%,SLC6A2;SLC22A3;SLC1A5;RAB38;SLC38A4;SLC16A10;CD320;LRRC8D;SLC44A2;SLC36A2;SLC12A2;SCAMP2;SLC43A1;SEC14L1;RCN3;SLC7A7;NDC1;ARL6IP5;SLC7A8;HSP90B1;LRP2;SLC6A15;ABCC1;DENND10;RAB7A;SLC44A1;SLC6A4;KIF3A
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4402644145167722,0.9814938546363093,0.4826629680998613,1.0,1.0,6/14,22.59%,ELAVL4;MAPKAPK2;MAPK14;HNRNPC;ZFP36;YBX3
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3262784797296389,0.981487873995723,0.5107066381156317,1.0,1.0,18/101,10.27%,TBC1D10A;VGLL4;ERBB2;FADD;UPF3A;PLD1;TGFB1;NIBAN1;METTL3;EIF3C;CPEB3;EIF6;NSUN5;PASK;VPS11;AURKAIP1;HDAC2;EIF4G1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.4688526244796296,0.9813341375590049,0.5072697899838449,1.0,1.0,4/10,18.78%,MEOX1;UFL1;TP53;BATF
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.4526084496899379,0.9811100265844284,0.5096011816838996,1.0,1.0,4/12,19.69%,TGFB1;ESR1;NCOR2;PPARG
prerank,regulation of interferon-beta production (GO:0032648),-0.26021939122182836,-0.9810536049099974,0.45121951219512196,0.8347876748252133,1.0,12/46,15.26%,TOMM70;REL;RELB;TLR4;IFIH1;TRIM56;RIOK3;IRF1;OAS2;TIRAP;HSP90AA1;FLOT1
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.4054888473822402,-0.9808821251702841,0.46814404432132967,0.8338463314299833,1.0,5/10,29.54%,TERT;TARBP2;MRPL44;AGO2;DICER1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.29381838757665923,-0.9807897635144508,0.5116279069767442,0.8326342037757473,1.0,11/26,25.69%,NOS3;ACER2;SPTLC2;DDAH2;ASAH2;NOS1;SPR;SPHK1;AKT1;SPHK2;SPTLC1
prerank,intraciliary retrograde transport (GO:0035721),-0.3840506114040808,-0.9804052639486761,0.4782608695652174,0.8321889290703887,1.0,6/12,13.39%,WDR19;IFT43;DYNC2LI1;DYNLT2B;IFT122;DYNC2I2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3584205263626334,0.9803738632176181,0.5036496350364964,1.0,1.0,14/43,20.24%,FGF2;SOX9;TGFB1;KLF5;HIF1A;NFATC3;NGFR;GATA3;TP53;EGR1;PPARG;JUN;STAT3;SMARCA4
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.3653490066918022,-0.9802269068001933,0.4984709480122324,0.8312260727055711,1.0,5/13,13.22%,PLXNA2;NRP1;PLXNB1;PLXNA1;PLXNA4
prerank,protein import into nucleus (GO:0006606),0.3359402797063004,0.9800949462577613,0.4907621247113164,1.0,1.0,20/66,21.12%,CBLB;RANBP2;NUP155;FAM53B;IPO9;PRICKLE1;KPNB1;IPO13;KPNA6;NXT1;EIF4ENIF1;KPNA1;POM121;TNPO3;IPO5;CSE1L;STAT3;KPNA3;PHB2;HEATR3
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3119808159236758,0.9799508574852143,0.5289928789420142,1.0,1.0,49/190,22.08%,RORA;PYCARD;PTEN;RNF157;BCL2;VGLL4;NPRL2;THEM4;TLE1;DEPTOR;NF1;PDE3B;URI1;OTUD7B;NLRX1;TSC1;SPRED1;PPM1B;HERPUD1;PTPRJ;ESR1;MAPK14;BMP7;MAGI2;PDE4D;RHOH;RTKN2;DRD2;PER1;NDUFA13;APLNR;RIPK1;MDM2;PIK3IP1;OTUD7A;ZMYND11;MAPKBP1;FNIP1;CPNE1;PDE11A;DUSP1;LIMD1;ARHGAP12;P2RX7;PDE10A;DEPDC5;ARRB2;PRKAA1;PPM1A
prerank,positive regulation of lipid localization (GO:1905954),0.46058955614815134,0.979923831528308,0.5184615384615384,1.0,1.0,1/11,2.54%,LRP1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.43937243013466426,0.9796019850917155,0.5022026431718062,1.0,1.0,2/15,3.89%,SLC27A1;FBXW7
prerank,cellular response to interferon-gamma (GO:0071346),-0.22309425511789863,-0.979211307453179,0.4533333333333333,0.8324497284529343,1.0,18/88,15.57%,DAPK1;SP100;CCL25;PRKCD;TLR4;TRIM25;CCL15;IRF2;CAMK2G;TRIM5;ICAM1;GBP3;IRF1;CAMK2A;OAS2;PML;VCAM1;IRF9
prerank,regulation of embryonic development (GO:0045995),0.3705657218763978,0.9791826535940189,0.49746192893401014,1.0,1.0,4/34,4.92%,PHLDB1;WDPCP;RAB14;PLCB1
prerank,protein polymerization (GO:0051258),0.34614836741139093,0.9790745243148238,0.5082547169811321,1.0,1.0,10/55,15.99%,FGF13;SPIRE1;GSN;PRKN;GAS7;UBE2K;WASF1;CKAP5;COBL;DIAPH3
prerank,hemidesmosome assembly (GO:0031581),0.4681532578605617,0.9790724107267337,0.5038759689922481,1.0,1.0,2/11,6.45%,LAMC1;PLEC
prerank,protein deacetylation (GO:0006476),0.3662326902603452,0.9787546252976801,0.5135135135135135,1.0,1.0,11/41,16.16%,RCOR2;MTA2;FLNA;MORF4L2;HDAC2;SIN3B;HDAC6;SIRT6;MIDEAS;MSL3;MTA3
prerank,regulation of supramolecular fiber organization (GO:1902903),0.39596177409769545,0.9786725187112126,0.5257452574525745,1.0,1.0,8/22,18.77%,AKAP13;MAP1B;GBA2;ARL2;ABL1;MAPRE3;CAMSAP1;PARK7
prerank,regulation of hormone secretion (GO:0046883),0.4281831716576068,0.9784090483786767,0.4802919708029197,1.0,1.0,3/15,11.60%,SOX11;SNX6;EDN3
prerank,positive regulation of protein metabolic process (GO:0051247),0.3178435606957119,0.9783727621086857,0.5448648648648649,1.0,1.0,20/110,16.25%,GPC3;PRKN;HACE1;MAPK7;TGFB1;PSEN1;WNT5A;ASB5;CARD9;IL18;HUWE1;EIF4G1;PRMT1;APC2;RAB1A;DDB1;NEDD4L;AREL1;DACT1;NDUFA13
prerank,positive regulation of interleukin-8 production (GO:0032757),0.3503568756858052,0.978247233036152,0.5096385542168674,1.0,1.0,13/49,24.52%,PYCARD;FADD;TLR1;RAB1A;CD74;RIPK1;LBP;PARK7;BCL10;STAT3;PRKD2;MAVS;HSPA1A
prerank,iron ion transport (GO:0006826),0.34761698790855944,0.9782359509950898,0.5048309178743962,1.0,1.0,4/47,7.97%,SCARA5;STEAP3;ATP6V1B2;TTYH1
prerank,thymus development (GO:0048538),0.4505351996321656,0.9776669580693398,0.4954128440366973,1.0,1.0,2/13,2.66%,FGF10;FADD
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.3829077362363246,-0.9776132590248054,0.5014409221902018,0.8353658848558663,1.0,3/11,13.49%,CTNNB1;RYK;FZD1
prerank,cellular glucose homeostasis (GO:0001678),0.35898972489898034,0.9775600912072808,0.503052503052503,1.0,1.0,14/41,22.84%,ZBTB20;TRA2B;LRRC8D;PDK3;HIF1A;PIK3R1;NGFR;PRKACA;PAX2;PCK2;HK2;ADCY8;PRKAA1;HK1
prerank,lamellipodium organization (GO:0097581),-0.29230433524538424,-0.9773404090623591,0.5186915887850467,0.8346973545321639,1.0,9/29,14.82%,ABLIM1;KIT;CDH13;PARVB;ARHGEF6;ABLIM2;WHAMM;PTPRO;S1PR1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.38442574763257686,-0.97732264847171,0.4846153846153846,0.8332943943538387,1.0,5/11,13.59%,DKC1;WRAP53;CCT8;CCT6A;CCT4
prerank,Golgi to lysosome transport (GO:0090160),0.45712202224002185,0.9767337494400917,0.48286604361370716,1.0,1.0,5/11,17.06%,CCDC91;AP1G1;GAK;AP4M1;RBSN
prerank,nucleic acid metabolic process (GO:0090304),0.337112682634939,0.9765075224092855,0.5123318385650224,1.0,1.0,23/69,21.27%,DXO;ATXN2;POLR2B;METTL3;SETMAR;XRN2;DDX54;DDX24;POLR2K;NCBP1;DUSP11;HNRNPA3;EXD2;POLR2G;TOPBP1;POLG;HNRNPU;WRN;POLR2A;HNRNPC;HNRNPH2;HNRNPL;RBFOX2
prerank,regulation of water loss via skin (GO:0033561),0.4264216381186618,0.9763991839219903,0.5095729013254786,1.0,1.0,3/15,15.00%,CLDN1;HRNR;MET
prerank,establishment of skin barrier (GO:0061436),0.4264216381186618,0.9763991839219903,0.5095729013254786,1.0,1.0,3/15,15.00%,CLDN1;HRNR;MET
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.34864361650057046,0.9763062028249067,0.5394431554524362,1.0,1.0,20/52,26.02%,RBFOX1;CELF5;TRA2B;KHDRBS3;CELF6;RBM7;NOVA1;SRSF6;YTHDC1;HNRNPU;RNPS1;RBFOX3;CELF4;HNRNPL;RBFOX2;RBM25;FMR1;NSRP1;RBM4;RBM15
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.4041104313413689,0.9760739858982649,0.49056603773584906,1.0,1.0,4/22,13.23%,FADD;FBXO38;ZBTB1;MALT1
prerank,determination of left/right symmetry (GO:0007368),0.3697126726777751,0.9757843146696168,0.5081148564294632,1.0,1.0,10/36,21.50%,CCDC39;RFX3;SMO;DAND5;ENKUR;CITED2;FOXJ1;GALNT11;BBS7;PKD2
prerank,response to unfolded protein (GO:0006986),0.3494186395730164,0.975433968712733,0.5059523809523809,1.0,1.0,13/48,21.23%,HSPH1;PRKN;DNAJB4;PACRG;PTPN1;HERPUD1;HSPA4;TM7SF3;DNAJC4;DNAJA1;HSPA9;HSPD1;RHBDD1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.34762262574575326,-0.9747380360481689,0.45514950166112955,0.8390014010884841,1.0,5/16,15.26%,SNCAIP;CPLX1;CAMK2A;MCTP2;FLOT1
prerank,positive regulation of hydrolase activity (GO:0051345),-0.2149639818399429,-0.9740985234541447,0.5652173913043478,0.8392636181630313,1.0,27/137,12.39%,AFDN;PKP4;CD200;CTSH;SNX9;CCL25;AGRN;RIC1;MTCL1;ITGA6;CCL15;SNX18;NET1;ARAP1;EVI5L;ARHGAP27;GSK3B;TGM2;FLCN;RHOA;RACK1;MAPK12;PLXNB1;RSU1;LARS1;RALBP1;RASGRF1
prerank,histone H3 acetylation (GO:0043966),0.3617800284429044,0.9740256650303918,0.5132408575031526,1.0,1.0,9/40,13.12%,KAT2B;JADE1;TADA1;TAF5L;JADE3;POLE3;TAF9;ING4;PER1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.3430258977178333,-0.9739247266380848,0.47019867549668876,0.8383135793985149,1.0,7/14,20.92%,NOS3;ACE;ENPEP;AGTR1;ECE1;EDN1;ACE2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.32777858485959754,0.9738731866612848,0.511731843575419,1.0,1.0,16/71,15.54%,ARPC1B;WIPF1;PAK1;BAIAP2;LIMK1;FYN;BRK1;VAV3;DOCK1;PIK3R1;MAPK1;PLPP4;NCK1;CYFIP1;ELMO1;ABL1
prerank,cellular response to nitrogen compound (GO:1901699),0.4033783470669404,0.9738633756905307,0.4979811574697174,1.0,1.0,6/20,15.98%,DDX11;NSMCE3;AOC1;ATRX;BLM;SPIDR
prerank,cellular response to amino acid stimulus (GO:0071230),0.3734761821225999,0.973563111478235,0.4917825537294564,1.0,1.0,14/33,26.30%,CPEB3;FYN;LAMTOR2;CASTOR2;CPEB1;KLHL22;SPAAR;RPTOR;IPO5;RRAGA;MTOR;SESN1;SLC38A9;CPEB4
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.36884789426426834,0.9734246841943195,0.522697795071336,1.0,1.0,6/32,23.37%,CXCL10;AKAP6;SNCA;APLNR;P2RX7;CEMIP
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.319967069789399,0.9733998839081868,0.5307443365695793,1.0,1.0,25/94,23.45%,DYNLL1;CC2D2A;HAUS3;CNTRL;PCM1;NDE1;SDCCAG8;CEP57;CLASP1;CEP89;PRKACA;CKAP5;FBF1;CEP76;DYNC1I2;CSNK1E;CEP63;TUBA1A;CEP78;SSNA1;PCNT;CDK5RAP2;DYNC1H1;PPP2R1A;CEP97
prerank,nuclear migration (GO:0007097),0.4382884454795384,0.9733365107316944,0.5,1.0,1.0,2/13,4.93%,DOCK7;PCM1
prerank,positive regulation of cholesterol transport (GO:0032376),0.37585994181550253,0.9732308605293414,0.5,1.0,1.0,4/27,10.89%,PTCH1;LRP1;ZDHHC8;ABCA5
prerank,BMP signaling pathway (GO:0030509),0.3389865653561948,0.9730581200982832,0.5153234960272418,1.0,1.0,6/62,4.73%,BMP5;RGMB;HIVEP1;ACVR1;TGFB1;GDF9
prerank,membrane fusion (GO:0061025),0.3690570528045803,0.9730109259692267,0.49362244897959184,1.0,1.0,10/33,17.10%,DNM1;SNAP23;HACE1;SNAP29;HUWE1;VAPA;RIMS1;OTOF;OPA1;DYSF
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.41203329649795073,0.9720718005930118,0.5185714285714286,1.0,1.0,4/18,12.26%,COX20;COX18;SCO1;COX19
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.282255837544976,-0.9719567266356176,0.49261083743842365,0.8422248768373666,1.0,12/34,23.42%,MFHAS1;LYN;TLR4;GPS2;LGR4;GPR108;LRRC14;CD300A;GRAMD4;CACTIN;TNFAIP3;NLRP2B
prerank,regulation of centriole replication (GO:0046599),0.40715833625211006,0.9718992915317641,0.5049365303244006,1.0,1.0,5/17,13.91%,KAT2B;BRCA1;CEP295NL;CEP76;MDM1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.31438823548453576,0.9717646957446249,0.5434782608695652,1.0,1.0,32/138,19.73%,RORA;MAML3;KAT2B;MAML2;GTF2H2;E2F2;POLR2B;RORC;GTF2B;RARG;RARB;POLR2K;ESR1;TAF9;TAF11;TAF2;NR6A1;WWTR1;NR2C2AP;POLR2G;NCOR2;TAF7;GTF2E2;GTF2E1;TAF4;TAF4B;NR5A1;NRBF2;TAF1;POLR2A;PPARG;TAF8
prerank,actin filament polymerization (GO:0030041),0.37693622359826295,0.9717457910062464,0.5103896103896104,1.0,1.0,10/29,23.03%,SPIRE1;GSN;GAS7;WASF1;COBL;DIAPH3;WASHC3;MICALL2;CORO7;WASF3
prerank,regulation of cytoskeleton organization (GO:0051493),0.31736501600362793,0.9716904569313725,0.5303514376996805,1.0,1.0,23/108,15.54%,DLC1;PHLDB1;RHOD;BICD1;BST1;LRP1;RND3;EFNA5;RHOBTB3;GPM6B;IQGAP2;PAK1;BAIAP2;CAPN6;CLASP1;BICD2;MAPK1;RHOH;RHOC;ARHGAP44;IQGAP1;MAP6D1;ABL1
prerank,mRNA polyadenylation (GO:0006378),0.38150457198196014,0.9715198080149955,0.519053876478318,1.0,1.0,10/26,23.44%,CSTF3;PABPC1;FIP1L1;AHCYL1;PAPOLA;PNPT1;CDC73;TENT2;SYMPK;TUT1
prerank,RNA polyadenylation (GO:0043631),0.38150457198196014,0.9715198080149955,0.519053876478318,1.0,1.0,10/26,23.44%,CSTF3;PABPC1;FIP1L1;AHCYL1;PAPOLA;PNPT1;CDC73;TENT2;SYMPK;TUT1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.33625017126269635,0.9709758639024884,0.5063437139561707,1.0,1.0,7/57,13.84%,CHRM3;LPAR1;FLNA;GPR37;DRD2;GNAI1;P2RY12
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.34160722646096037,-0.9709319198295893,0.45016077170418006,0.8435367128605069,1.0,3/15,8.21%,XPO4;GSK3B;CAMK1
prerank,regulation of nervous system process (GO:0031644),-0.32855639288830557,-0.9708316884180098,0.49635036496350365,0.842323408384321,1.0,4/18,6.90%,ROCK2;SLC8A3;NOS3;APP
prerank,zinc ion transport (GO:0006829),-0.31591553012850326,-0.9704592603562918,0.4626334519572954,0.841861176613886,1.0,9/21,26.19%,SLC30A10;SLC39A8;SLC39A6;SLC30A1;SLC30A6;SLC39A3;TRPM2;SLC39A13;SLC39A1
prerank,positive regulation of cell cycle process (GO:0090068),-0.22891565718122853,-0.9700622409141685,0.5227272727272727,0.8416471743712173,1.0,17/91,11.27%,IGF1;PKP4;LRP5;MAP3K20;PLSCR1;USP19;CIT;IGF2;INSR;GIPC1;TGFA;RGCC;RHOA;DYNC1LI1;PDGFRB;NUMA1;WIZ
prerank,regulation of mast cell activation (GO:0033003),-0.3979369686890345,-0.9700458958138435,0.4858757062146893,0.8402501300859652,1.0,2/10,3.82%,PLSCR1;LYN
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.3737744679959591,0.9699574064231171,0.4895833333333333,1.0,1.0,5/30,7.69%,ANK3;VAMP4;BLZF1;SPTBN1;RAB34
prerank,positive regulation of heart contraction (GO:0045823),-0.324784190856008,-0.9694631583619517,0.4810606060606061,0.8404064237645693,1.0,6/19,25.41%,ATP1A2;GSK3A;TGFB2;EDN1;ATP2A2;SCN3B
prerank,macrophage activation (GO:0042116),-0.27846735403063677,-0.9694260356482384,0.5327510917030568,0.8390860937707335,1.0,9/34,19.44%,FOXP1;TLR4;APP;CD93;SBNO2;MAPT;NMI;IFI35;C1QA
prerank,supramolecular fiber organization (GO:0097435),0.299142658668913,0.9691147197623693,0.5837512537612839,1.0,1.0,49/333,12.31%,COL15A1;TGFBI;HSPG2;LUM;FGF13;COL5A3;RHOD;COL20A1;GSN;COL28A1;PRKN;PPP1R9A;RND3;P4HA1;COL5A2;RHOBTB3;PXDN;COL4A2;COL27A1;COL26A1;PCM1;NF1;COLGALT2;TNXB;COL9A2;PLEC;LOXL3;CYP1B1;COL18A1;TLL2;HIP1;COL3A1;PLOD1;KATNAL1;BFSP1;TUBGCP5;SLK;NCSTN;COL1A2;MYO19;STMN4;COL14A1;DNAJB6;FIGN;SLAIN2;RHOH;RHOC;APH1A;KATNB1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.3785322566501388,0.9690868144588801,0.5102599179206566,1.0,1.0,10/27,21.85%,EGFR;TGFB1;EIF4G1;EIF4ENIF1;TP53;RIPK1;STAT3;ZFP36;LIMD1;DDX6
prerank,mRNA destabilization (GO:0061157),-0.27730729011902766,-0.9686974755737899,0.5147058823529411,0.8395133010338615,1.0,7/38,7.65%,ROCK2;ROCK1;YTHDF1;MOV10;ZFP36L1;METTL14;CNOT1
prerank,positive regulation of viral genome replication (GO:0045070),0.3791379955805081,0.9684317077125586,0.5224646983311938,1.0,1.0,7/29,17.81%,FKBP6;PABPC1;PPID;ADARB1;DDB1;PPIH;PKN2
prerank,plasma membrane invagination (GO:0099024),0.3763537115304515,0.9683542874471113,0.5128865979381443,1.0,1.0,3/29,2.24%,SPIRE1;GULP1;GSN
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.458261070272569,0.9682563580145003,0.5259146341463414,1.0,1.0,6/11,21.41%,FADD;UNC93B1;TICAM1;RIPK1;SCARA3;TNIP2
prerank,DNA modification (GO:0006304),0.39274538806243475,0.9680357492971365,0.5081743869209809,1.0,1.0,9/22,23.61%,MBD4;MPG;MUTYH;NEIL1;SMUG1;TERF2IP;TDG;EXOSC3;ACD
prerank,osteoclast differentiation (GO:0030316),-0.3108161577464431,-0.9680164894612256,0.4864864864864865,0.8399089588758165,1.0,5/22,12.36%,FOXP1;GLO1;TNFRSF11A;SBNO2;OSTM1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.45665691054435775,0.9678412112478776,0.4952681388012618,1.0,1.0,4/10,23.72%,PTPN22;DNAJA1;PDCD4;AIDA
prerank,JNK cascade (GO:0007254),-0.26913427236393384,-0.9678225218086862,0.5161290322580645,0.838994318767719,1.0,15/40,25.16%,MAP3K5;TNFRSF19;GPS2;ARHGEF6;MAP3K7;UBE2N;IKBKG;MINK1;MAPK10;NOD1;CRKL;MAP3K13;GPS1;MAPK8;UBA52
prerank,endocytic recycling (GO:0032456),0.34612888571664274,0.9673150542761827,0.5242603550295858,1.0,1.0,24/50,29.09%,RAB14;VPS29;EPS15;VPS39;DENND1C;ACAP2;RAB11FIP3;EHD2;WASHC1;ANKRD27;SNX12;RAB7A;MICALL2;SNX4;EIPR1;DENND1A;ENTR1;VPS35;DENND1B;VPS53;VPS26C;RAB13;STX6;SNF8
prerank,histone monoubiquitination (GO:0010390),0.39274692150610574,0.9672839637988787,0.5135135135135135,1.0,1.0,12/24,27.85%,WAC;DDB2;DDB1;CUL4B;CDC73;BCOR;UBE2E1;RNF2;PCGF1;RNF20;RNF168;TRIM37
prerank,negative regulation of cation channel activity (GO:2001258),0.3885943481844025,0.967263079400472,0.5096525096525096,1.0,1.0,8/26,25.03%,EPHB2;DRD2;CALM1;CALM2;SLC6A9;PKD2;UBQLN1;FMR1
prerank,phospholipid homeostasis (GO:0055091),-0.3765986622181554,-0.9670252927818176,0.5013623978201635,0.8396932348776026,1.0,5/11,25.85%,ABCA1;ABCG1;TLCD1;TLCD2;ANGPTL3
prerank,protein K63-linked ubiquitination (GO:0070534),0.3494468608465499,0.9667797500390463,0.5049627791563276,1.0,1.0,4/41,7.91%,UBE2T;PRKN;UBE2E2;PELI1
prerank,negative regulation of histone acetylation (GO:0035067),0.4565009235271348,0.9661083122786833,0.517829457364341,1.0,1.0,4/11,17.63%,BRCA1;SNCA;TAF7;CTBP1
prerank,negative regulation of viral entry into host cell (GO:0046597),0.4439147400156709,0.9659537437501559,0.5195369030390738,1.0,1.0,3/12,10.42%,GSN;TRIM11;MID2
prerank,regulation of gluconeogenesis (GO:0006111),-0.30468685306127163,-0.9659485724113166,0.5242290748898678,0.8412675899577015,1.0,8/27,17.18%,USP7;CLK2;SIK1;OGT;ARPP19;C1QTNF3;PDK2;PGP
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.4493094021200186,0.9659068841250492,0.4943820224719101,1.0,1.0,4/11,17.22%,EGFR;TGFB1;TP53;RIPK1
prerank,protein tetramerization (GO:0051262),0.33111611223330184,0.9657902141813164,0.5366666666666666,1.0,1.0,20/67,23.20%,CTH;ACACA;FARSA;CPSF6;GRIN2B;AQP4;FARSB;SOD2;SNCA;PKD1;HOMER1;ALDH1A3;GLS;MS4A1;RYR3;HCN1;SSBP1;PKD2;KCNC1;TRPM4
prerank,engulfment of apoptotic cell (GO:0043652),0.43186586373592223,0.9656685779489463,0.5211678832116788,1.0,1.0,2/15,2.81%,XKR7;XKR8
prerank,lytic vacuole organization (GO:0080171),0.3638527800758577,0.9656568986420465,0.506426735218509,1.0,1.0,15/32,23.96%,GNPTAB;ACP2;GRN;TPCN2;AKTIP;CLVS1;HPS1;HOOK2;MBTPS1;CLVS2;HOOK1;HOOK3;TPP1;CLN6;MTOR
prerank,RNA splicing (GO:0008380),0.3173201707822833,0.965566005607788,0.54004329004329,1.0,1.0,32/95,25.59%,DHX8;USB1;TRA2B;RSRC1;RP9;IVNS1ABP;RNPC3;SRSF11;TXNL4A;NCBP1;SFPQ;SNRNP40;PRPF6;PRPF18;NOVA1;KHSRP;RNPS1;FUS;DDX23;SYNCRIP;SRRM1;SF3B3;DBR1;HNRNPC;SNRPN;SF3B2;WBP4;PPP2R1A;MAGOHB;SCAF11;SNRPA1;NONO
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.3726883964444599,-0.9643400266524168,0.5269121813031161,0.8441651287391717,1.0,3/12,8.35%,RBP4;TLR4;STRAP
prerank,central nervous system neuron development (GO:0021954),0.4192241335205128,0.964287896944277,0.5058139534883721,1.0,1.0,3/15,4.78%,PTEN;NTRK2;GBA2
prerank,regulation of phosphorylation (GO:0042325),0.31475988990383247,0.9641246783368769,0.5505735140771637,1.0,1.0,19/120,11.42%,DYNLL1;GLMN;CDKN2B;EGFR;CADM4;PSEN1;RANBP2;SOCS1;NUP155;FZD7;EIF6;LDB2;HIF1A;DSCAM;GRM5;NUP205;NDC1;NUP160;BMP7
prerank,mRNA transport (GO:0051028),0.3161855266662009,0.9640650470727796,0.5487674169346195,1.0,1.0,37/101,26.38%,THOC6;RANBP2;NUP155;MCM3AP;SRSF11;CASC3;ALKBH5;NCBP1;FIP1L1;KIF5C;NUP205;NDC1;NUP160;UPF1;DDX25;NXT1;SRSF6;YTHDC1;POM121;SMG6;AAAS;NXF1;RNPS1;THOC7;SRRM1;ZFP36;SRSF3;FYTTD1;NUP42;GLE1;SYMPK;THOC5;MAGOHB;FMR1;NUP35;HNRNPA2B1;RAE1
prerank,positive regulation of acute inflammatory response (GO:0002675),0.4275775782670829,0.9639382573678741,0.5211678832116788,1.0,1.0,3/14,18.77%,PTGER3;IL6ST;PARK7
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.36021192900965565,-0.963875268067909,0.4864864864864865,0.8439284664365584,1.0,5/13,18.91%,GTPBP1;RHOQ;ENTPD7;GNAI3;AK4
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.34674651253478506,0.9636410291933764,0.535024154589372,1.0,1.0,12/44,18.69%,DPEP1;NGF;VEGFA;MT3;NGFR;DNAJB6;SNCA;XIAP;PAX2;PCID2;CAST;FNIP1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.44127046199249503,0.9635948378225503,0.5182926829268293,1.0,1.0,1/11,1.27%,FGF2
prerank,regulation of aerobic respiration (GO:1903715),-0.3431456973716882,-0.9634914411855978,0.5369774919614148,0.8434784460269136,1.0,7/15,28.53%,ATP7A;SLC25A33;NOP53;PINK1;AK4;COX7A2;VCP
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.3801331215664525,-0.9634323226210549,0.4789915966386555,0.8422398264112783,1.0,7/11,29.99%,SERTAD2;SMARCD1;PADI2;SERTAD1;ELOF1;CDCA4;CHEK1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3024634073413875,0.9632535322058965,0.6002034587995931,1.0,1.0,21/199,9.89%,FFAR4;PTCH1;SOSTDC1;BMP5;DOCK7;LRP4;PTEN;SOX9;EGFR;HOXA7;RPS6KA4;TGFB1;ACVR1C;SPRED2;ACOT11;SPRED1;TBX18;CHSY1;SYT11;LNPEP;SPRED3
prerank,synaptic vesicle exocytosis (GO:0016079),0.348242641375319,0.9631979312002539,0.5130434782608696,1.0,1.0,11/40,18.29%,SNAP23;SYT1;SNAP29;RIMS1;RAB3A;OTOF;SNCA;DOC2B;STX1B;SYT2;RIMS2
prerank,regulation of protein polymerization (GO:0032271),-0.272085843191919,-0.9629233733982755,0.521978021978022,0.8422061667724042,1.0,9/35,15.01%,ARHGAP28;FCHSD2;MAP2;ESAM;PFN2;MAPT;HAX1;HSP90AA1;PRUNE1
prerank,negative regulation of cytokine production (GO:0001818),0.30711941934704795,0.9629015321351174,0.5628865979381443,1.0,1.0,29/163,20.83%,APOD;FFAR4;PYCARD;PTPN22;CD34;IRAK3;RPS6KA4;PRNP;OTUD7B;NLRX1;SYT11;SELENOS;CHID1;TAX1BP1;TBK1;ATP2B1;HOMER2;NAV3;SSC5D;ABCD2;FOXJ1;N4BP1;IRF3;MAPKBP1;AXL;PDCD4;ZFP36;SIRPA;CD84
prerank,retinal metabolic process (GO:0042574),0.4377884544090718,0.9626901961237955,0.5044117647058823,1.0,1.0,3/12,16.54%,CYP1B1;RDH10;ALDH1A3
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.32859308532037756,0.9625720459249205,0.5316315205327414,1.0,1.0,13/75,12.07%,CCL11;PRKCA;FGF2;VEGFA;EGR3;WNT5A;FGFR1;AKT3;HIF1A;SP1;SIRT6;MYDGF;NRP2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.37398714148703444,0.9618572549689486,0.5295629820051414,1.0,1.0,9/30,18.37%,TGFB1;SOX11;PCSK6;DKK3;SFRP4;BCL9;XIAP;NREP;EID2
prerank,regulation of apoptotic process (GO:0042981),0.2958491954084123,0.9614634904704439,0.641,1.0,1.0,154/676,18.99%,FFAR4;BCL2L14;RTKN;HRK;CXCL10;PIP5KL1;SOX8;PYCARD;MYC;OLFM4;RNF157;BCL2;DPEP1;SOX9;NGF;PRKN;EGFR;AKAP13;STEAP3;FADD;FRZB;FGD4;FMN2;MAP4K4;VEGFA;EGR3;ANO6;ARAF;THOC6;WNK3;TNFRSF10B;ERCC5;PSEN1;SLC27A4;FANK1;MT3;NF1;DUSP6;GRID2;ACVR1C;WNT5A;YWHAZ;RASA1;APAF1;NAA35;BMF;SON;ITSN1;CASP6;TRIM2;NAA16;CYP1B1;SHQ1;GATA6;CBX4;PHLDA1;BNIP3;NAE1;BIN1;NF2;ARHGEF11;CTSB;RARG;FLNA;VAV3;HIP1;PPID;CRYAB;PRDM9;ASNS;HDAC2;UBE2Z;SLK;SFRP4;PIK3R1;GDNF;NGFR;NCSTN;CBL;ARF4;TAF9;IL6ST;ARL6IP5;ING4;ANP32E;MYDGF;TAX1BP1;APH1A;SCRIB;PRLR;PRDX3;ATF5;HSP90B1;YME1L1;MALT1;TRIO;ARHGEF3;DDX42;SNCA;RPS6KA2;PSEN2;ITGB3BP;RTN4;CITED2;OPA1;ZFAND6;UBB;ITGB1;CASP2;AREL1;CRADD;UBE2O;RASSF2;ATM;FZD9;ABL1;PIM2;BNIP1;IFT57;TP53;CCND2;BCL2L11;GPLD1;LRP2;XIAP;HTATIP2;TGFB3;QRICH1;GLS2;SGK1;PAX2;ARHGEF4;CD74;RIPK1;WRN;RNPS1;KCNMA1;ADAMTSL4;PLEKHG2;PCID2;CSRNP3;AIFM1;DNAJA1;HSPA9;CAT;IRF3;HTT;NAA15;AATF;CHM;MAP3K11;PARK7;SEMA4D;AXL
prerank,gene silencing by miRNA (GO:0035195),-0.2880311513555091,-0.9614036229636982,0.5021645021645021,0.8450223232202739,1.0,7/32,12.43%,WTIP;MOV10;AGO1;ZC3H7B;CNOT1;NOTCH4;AGO3
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.32207536491117417,0.9610283378683641,0.5178173719376392,1.0,1.0,16/73,15.54%,ARPC1B;WIPF1;PAK1;BAIAP2;LIMK1;FYN;BRK1;VAV3;DOCK1;PIK3R1;MAPK1;PLPP4;NCK1;CYFIP1;ELMO1;ABL1
prerank,positive regulation of cell death (GO:0010942),0.3325583455312615,0.9609219805673989,0.5325714285714286,1.0,1.0,13/59,17.22%,LRP1;PRNP;MT3;GRIN2B;WNT5A;BNIP3;FYN;RARG;EIF4G1;SNCA;HTATIP2;EFNB2;RIPK1
prerank,positive regulation of signal transduction (GO:0009967),0.30050074815066086,0.960778669776898,0.6090909090909091,1.0,1.0,45/238,15.57%,RELN;SULF1;PRKCA;LGR6;NTRK3;MAML3;PTEN;KAT2B;STK36;DEPDC1B;MAML2;TRIM44;EVC;NRXN1;MT3;GLI1;NLGN1;AGPAT2;UCHL5;LMO3;DISC1;LOXL3;KLK6;RAB34;SPIN1;FLNA;SMO;ZMIZ1;LANCL2;HIF1A;PIH1D1;PIK3R1;PTPN11;RIMS1;IL6ST;LY86;GATA3;SMOC2;TRAF7;CITED2;TM2D3;DACT1;CRADD;HOMER1;STX1B
prerank,regulation of viral release from host cell (GO:1902186),-0.31807381460166495,-0.9606308249910945,0.5114503816793893,0.8456611465074024,1.0,7/21,17.26%,CHMP3;TSG101;TRIM25;TRIM5;VPS4A;PML;TRIM21
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.3296431594401753,-0.9604984375246213,0.5018181818181818,0.8445453344853675,1.0,8/18,24.02%,GSK3B;GSK3A;BID;HIP1R;BOK;SLC35F6;MUL1;BAK1
prerank,positive regulation of RNA splicing (GO:0033120),0.37624400302725386,0.9604385338518348,0.5233881163084703,1.0,1.0,5/29,12.97%,PRDX6;TRA2B;NCBP1;PIK3R1;DAZAP1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.4298447184237119,0.9601800331726481,0.5334346504559271,1.0,1.0,6/13,24.52%,PABPC1;CPEB3;POLR2G;EIF4ENIF1;ZFP36;TNRC6A
prerank,negative regulation of cell adhesion (GO:0007162),0.3246150077753292,0.9600221394098196,0.5463687150837989,1.0,1.0,11/72,9.78%,TGFBI;ERBB3;PLXNC1;EPHB2;TGFB1;PDE3B;RASA1;CYP1B1;FZD7;NF2;DSCAM
prerank,protein maturation (GO:0051604),0.3180565145087952,0.9598530048740829,0.5728155339805825,1.0,1.0,20/95,17.33%,PTCH1;ADAM19;PSEN1;TSPAN32;PCSK4;PCSK6;NAA35;NAA16;LMF1;MMP16;NCSTN;TSPAN17;APH1A;CPD;TYSND1;GLRX3;PSEN2;CASP2;CIAO2B;NAA10
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.39859328288133766,0.9598047312512002,0.5,1.0,1.0,8/20,20.71%,HOXB8;ZBTB16;CDK6;PRMT1;CDC73;HSPA9;ZFP36;MEIS1
prerank,histone H2A acetylation (GO:0043968),0.4235748010063106,0.9597222060184062,0.5259365994236311,1.0,1.0,6/16,19.24%,BRD8;MORF4L2;EPC1;TRRAP;MSL3;RUVBL2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.42838019906757435,0.9596509281170038,0.524517087667162,1.0,1.0,4/14,16.67%,IRS2;TYSND1;MTLN;ABCD2
prerank,transcription by RNA polymerase II (GO:0006366),0.3000932909635175,0.9591926800633627,0.6054216867469879,1.0,1.0,70/305,19.76%,RORA;CSTF3;MAML3;CBFB;KAT2B;INTS11;TFCP2;MAML2;NFX1;GTF2H2;SNAPC2;MBD1;RNGTT;E2F2;TAF1A;RPRD1A;POLR2B;CDK13;RORC;TAF5L;INTS6;DRAP1;ZC3H8;GTF2B;RARG;TRIP11;RARB;SOX5;POLR2K;NCBP1;SETD2;FIP1L1;ELP2;INTS4;ESR1;SP1;TAF9;TAF11;TAF2;KLF13;ZBTB1;NR6A1;WWTR1;NR2C2AP;INTS2;ELP4;POLR2G;INTS8;NCOR2;TAF7;RNMT;ELL;GTF2E2;PAPOLA;GTF2E1;TAF4;TAF4B;CDC73;NFIX;NR5A1;PCID2;ELOC;NRBF2;TAF1;POLR2A;MLLT1;PRRX1;PPARG;TAF8;ELL2
prerank,Fc receptor signaling pathway (GO:0038093),0.3119245774380742,0.9587425082730836,0.5494623655913978,1.0,1.0,32/110,22.72%,PRKCQ;TEC;PAK1;PPP3CB;PPP3CA;GAB2;VAV3;PSMB7;MAPK9;NFATC3;PIK3R1;MAP2K4;MAPK1;MALT1;CALM1;PSMD2;PSMC1;LAT2;PSMB2;CHUK;PSMD9;TAB3;GRB2;PSME4;BCL10;JUN;PSMA8;SOS1;NFKB1;VAV2;CARD11;TAB2
prerank,protein autoubiquitination (GO:0051865),0.32890468545565504,0.9583789871693504,0.5510907003444316,1.0,1.0,9/61,10.00%,UBE2T;RNF157;PRKN;NFX1;DDB2;BRCA1;RNFT1;CUL3;UHRF2
prerank,neutrophil mediated immunity (GO:0002446),0.2946607907223959,0.9582235291452753,0.633,1.0,1.0,59/432,13.18%,PRDX6;DYNLL1;LGALS3;CRISPLD2;PYGL;PYCARD;OLFM4;SNAP23;GSN;BST1;RAP2B;TMEM63A;PDXK;ANO6;RAB14;CAPN1;PLD1;PSEN1;SLC44A2;IQGAP2;PGM1;CSTB;LTA4H;AOC1;SNAP29;AGPAT2;APAF1;GM2A;CDK13;CARD9;GALNS;PTGES2;RAP1A;ARHGAP9;LAMTOR2;GDI2;CTSB;ACLY;HRNR;PSMB7;RAB3D;CKAP4;MAGT1;HUWE1;VAPA;PTPRJ;NCSTN;MAPK14;COMMD3;TOLLIP;MAPK1;GRN;FUCA2;RAB4B;ARL8A;RAB3A;XRCC6;KCNAB2;KPNB1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.42479041343352114,0.9580515479296643,0.5170370370370371,1.0,1.0,2/15,4.87%,ARPC1B;IQGAP2
prerank,neutrophil degranulation (GO:0043312),0.29468786856325824,0.9580155477137159,0.636,1.0,1.0,58/425,13.18%,PRDX6;DYNLL1;LGALS3;CRISPLD2;PYGL;PYCARD;OLFM4;SNAP23;GSN;BST1;RAP2B;TMEM63A;PDXK;ANO6;RAB14;CAPN1;PLD1;PSEN1;SLC44A2;IQGAP2;PGM1;CSTB;LTA4H;AOC1;SNAP29;AGPAT2;APAF1;GM2A;CDK13;GALNS;PTGES2;RAP1A;ARHGAP9;LAMTOR2;GDI2;CTSB;ACLY;HRNR;PSMB7;RAB3D;CKAP4;MAGT1;HUWE1;VAPA;PTPRJ;NCSTN;MAPK14;COMMD3;TOLLIP;MAPK1;GRN;FUCA2;RAB4B;ARL8A;RAB3A;XRCC6;KCNAB2;KPNB1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.40048310960522165,0.9579396187104731,0.5415512465373962,1.0,1.0,3/21,8.14%,CEL;ACBD5;ACOX1
prerank,regulation of activated T cell proliferation (GO:0046006),0.3698267171765579,0.9578806316974796,0.5334190231362468,1.0,1.0,5/30,12.73%,PYCARD;FADD;PRNP;IL18;SCRIB
prerank,negative regulation of cellular metabolic process (GO:0031324),0.35584857809230286,0.9578249224992367,0.5413533834586466,1.0,1.0,10/37,22.43%,PRKN;MT3;ATXN2;BRCA1;PAX2;TRAP1;AP1AR;AATF;NFKB1;DLG4
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.32561548912720606,0.9577283677521117,0.5305895439377085,1.0,1.0,18/77,18.94%,LGALS3;BCL2;PRKN;ACVR1;URI1;HERPUD1;PIH1D1;RTKN2;OPA1;FZD9;NDUFA13;MPV17L;RIPK1;HTT;ZMYND11;PARK7;ACAA2;CSNK2A2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.4355151160623104,0.9569610272870284,0.5303030303030303,1.0,1.0,3/13,6.38%,SEMA3E;VEGFA;TGFBR2
prerank,amide transport (GO:0042886),-0.29335300708721446,-0.9568431493537246,0.5254237288135594,0.8527084588961884,1.0,7/26,12.64%,ABCG2;PLTP;PDPN;GLTP;AQP11;SLC38A5;SLC5A6
prerank,regulation of mRNA polyadenylation (GO:1900363),0.40405942929229266,0.9566861973253149,0.5090152565880721,1.0,1.0,9/17,26.76%,CPSF6;CPEB3;NCBP1;CPEB1;VIRMA;CDK9;CPSF7;RNF20;NELFE
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3064791799149339,0.9565367614838443,0.5922131147540983,1.0,1.0,40/166,19.99%,RORA;MAML3;KAT2B;MAML2;GTF2H2;E2F2;TAF1A;POLR2B;RORC;GTF2B;TFAM;RARG;RARB;POLR2K;ESR1;TAF9;TAF11;TAF2;NR6A1;WWTR1;NR2C2AP;POLRMT;POLR1B;POLR2G;NCOR2;TAF7;GTF3C1;GTF2E2;GTF2E1;TAF4;TAF4B;POLR1C;NR5A1;POLR1G;NRBF2;TAF1;POLR2A;PPARG;TAF8;UBTF
prerank,neutrophil activation involved in immune response (GO:0002283),0.2940056209081042,0.9563833712552542,0.64,1.0,1.0,58/428,13.18%,PRDX6;DYNLL1;LGALS3;CRISPLD2;PYGL;PYCARD;OLFM4;SNAP23;GSN;BST1;RAP2B;TMEM63A;PDXK;ANO6;RAB14;CAPN1;PLD1;PSEN1;SLC44A2;IQGAP2;PGM1;CSTB;LTA4H;AOC1;SNAP29;AGPAT2;APAF1;GM2A;CDK13;GALNS;PTGES2;RAP1A;ARHGAP9;LAMTOR2;GDI2;CTSB;ACLY;HRNR;PSMB7;RAB3D;CKAP4;MAGT1;HUWE1;VAPA;PTPRJ;NCSTN;MAPK14;COMMD3;TOLLIP;MAPK1;GRN;FUCA2;RAB4B;ARL8A;RAB3A;XRCC6;KCNAB2;KPNB1
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.4103903877910843,0.9560971036939467,0.541029207232267,1.0,1.0,4/16,9.88%,KMT2A;AUTS2;BRCA1;PIH1D1
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.40899042057448404,0.9558288186720432,0.5305232558139535,1.0,1.0,6/17,19.69%,PTEN;SOD2;TGFB3;TAFA5;PDCD4;PPARG
prerank,gonad development (GO:0008406),0.35356620952888923,0.9558263967361617,0.5297691373025516,1.0,1.0,12/41,21.63%,SOX8;SOX9;WNT5A;MAMLD1;GATA6;GATA3;IRX5;LRP2;NR5A1;CSDE1;MEA1;FGF9
prerank,negative regulation of B cell activation (GO:0050869),-0.3069039735149996,-0.9558148008642551,0.5291970802919708,0.8540031324034335,1.0,10/21,25.63%,LYN;PARP3;ID2;INHBA;CD300A;LAPTM5;TNFAIP3;TNFRSF21;TYROBP;INHA
prerank,response to metal ion (GO:0010038),0.3251555271764374,0.9557189743299035,0.5516853932584269,1.0,1.0,16/67,18.64%,BCL2;MT3;SLC30A4;PPP3CA;ANXA11;HIF1A;PPP1CA;AHCYL1;GPHN;SNCA;NEDD4L;CALM1;HOMER1;CALM2;KCNMA1;SNCB
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.35210846158507375,0.9557121829512385,0.5390070921985816,1.0,1.0,9/43,11.37%,PRKCQ;PTPN2;SIK2;SLC27A4;SOCS1;GRB14;PTPN1;PTPN11;PID1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.39580636695045496,-0.9556246901839897,0.4883720930232558,0.8530260375006238,1.0,3/10,13.49%,CTNNB1;RYK;FZD1
prerank,negative regulation of heart contraction (GO:0045822),-0.3825313194845037,-0.9552902280486089,0.5183098591549296,0.8525144612300696,1.0,6/11,33.64%,ATP1A2;GRK2;SRI;PLN;SPX;PIK3CG
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3572486686473308,0.9552038063729806,0.5365239294710328,1.0,1.0,3/33,4.08%,MEOX2;FGF2;TGFB1
prerank,regulation of endothelial cell proliferation (GO:0001936),0.32087274432606955,0.9551058570256858,0.5808903365906624,1.0,1.0,13/88,12.07%,CCL11;SULF1;PRKCA;FGF2;VEGFA;EGR3;NF1;WNT5A;AKT3;HIF1A;SPARC;MYDGF;NRP2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.45370608284610814,0.9549723833067588,0.5195007800312013,1.0,1.0,3/10,16.11%,IRS2;SNCA;GPLD1
prerank,respiratory electron transport chain (GO:0022904),-0.3479777206226168,-0.9548510043138468,0.5356037151702786,0.8523085926800789,1.0,7/14,23.06%,SDHB;SLC25A12;ETFRF1;ETFB;SDHA;UQCRFS1;SLC25A18
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.30335047032936296,-0.9547325302042166,0.5019157088122606,0.8512568530202977,1.0,5/21,9.13%,MICU1;SLC8A3;SLC8B1;TGM2;MCUB
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.3154007842584501,0.9546640702245256,0.5614798694232862,1.0,1.0,29/96,22.58%,THOC6;RANBP2;NUP155;MCM3AP;SRSF11;CASC3;ALKBH5;NCBP1;FIP1L1;NUP205;NDC1;NUP160;UPF1;DDX25;NXT1;SRSF6;YTHDC1;POM121;SMG6;AAAS;NXF1;RNPS1;THOC7;SRRM1;SRSF3;FYTTD1;NUP42;GLE1;SYMPK
prerank,microtubule-based transport (GO:0099111),0.4348187176649751,0.9545794894595165,0.5318840579710145,1.0,1.0,4/12,18.48%,DYNC1I1;DYNC1I2;DNAAF2;HTT
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.24663350610570842,-0.9545689797626608,0.5483870967741935,0.8503034990468253,1.0,7/59,4.37%,ROCK2;ROCK1;BIRC3;NFKBIA;REL;RELB;TLR4
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.3089096705554165,-0.9542710508122308,0.5,0.849674021467986,1.0,6/21,10.93%,MFHAS1;PPP1R16B;PTPA;GSK3B;ARPP19;PPP1R11
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.3630068847258361,-0.9541724810966916,0.5095890410958904,0.8485681099931395,1.0,2/12,1.73%,ROCK2;ROCK1
prerank,positive regulation of viral transcription (GO:0050434),0.38115367133977035,0.9538666485398724,0.5206611570247934,1.0,1.0,4/25,13.86%,MDFIC;POLR2B;POLR2K;POLR2G
prerank,necroptotic process (GO:0070266),0.418552541572369,0.9538130103823946,0.5163120567375886,1.0,1.0,5/16,23.28%,ITPK1;TICAM1;RIPK1;MLKL;CYLD
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.30571292021218555,0.953784669338358,0.5822130299896587,1.0,1.0,28/158,17.27%,ROR1;S100A4;PRKN;AKAP13;FADD;LPAR1;ALPK1;MAP3K3;GPRC5B;TNFRSF10B;SLC44A2;TMEM106A;CARD9;PELI1;FLNA;VAPA;MID2;RHOC;TBK1;MALT1;NDFIP1;GOLT1B;TICAM1;PIM2;TERF2IP;CD74;RIPK1;CHUK
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.39742234099712337,0.9534081028827011,0.5538881309686221,1.0,1.0,4/20,12.99%,SLC27A1;GSS;PTDSS1;GGCT
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.4464415172528455,0.9529815098733665,0.5286821705426357,1.0,1.0,4/10,19.24%,SHQ1;PIH1D1;TAF9;RUVBL2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.35689142264527973,0.9528893954227535,0.5359801488833746,1.0,1.0,15/38,23.87%,NDUFS5;NDUFA4;NDUFB2;NDUFA8;NDUFS8;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5;NDUFV1;NDUFAF1
prerank,cellular response to oxidative stress (GO:0034599),0.30914451916136826,0.9527381411513454,0.5712754555198285,1.0,1.0,30/118,18.85%,PRDX6;PDGFRA;SRXN1;EGFR;NCF1;MT3;GPX3;MAPK9;HIF1A;MGAT3;NCF2;SELENOS;NFE2L2;FANCC;MAPK1;ERCC6L2;PRDX3;SOD2;SNCA;ABL1;VKORC1L1;RAD52;TP53;PNPT1;SLC25A24;CHUK;TXNRD1;CAT;PARK7;ERMP1
prerank,negative regulation of autophagy (GO:0010507),0.3330031847382699,0.9526455723242356,0.5501165501165501,1.0,1.0,17/54,22.72%,PTPN22;BCL2;MT3;TSC1;BMF;TLK2;EIF4G1;SNCA;WASHC1;MET;KLHL22;TAB3;STAT3;RRAGA;EIF4G3;NRBP2;TAB2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.38041978330794174,-0.9525505106759755,0.5258620689655172,0.8514691995370824,1.0,2/11,0.40%,IGF1;IGF1R
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.39321851325350243,0.9524370391290695,0.5306122448979592,1.0,1.0,8/22,22.08%,DUSP4;DUSP6;PPM1B;PPP1CA;PPM1E;DUSP16;DUSP1;PPM1A
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.39233268484960604,-0.9523751195517385,0.5382653061224489,0.850567075307232,1.0,5/10,13.59%,DKC1;WRAP53;CCT8;CCT6A;CCT4
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.28610212875772256,-0.9522479277588057,0.5347826086956522,0.8495212505276719,1.0,8/27,18.07%,MAP3K5;MAP3K20;MAP3K8;MAP3K7;IKBKB;CCDC88C;IKBKG;TAOK2
prerank,glycogen biosynthetic process (GO:0005978),0.4399910111916035,0.9519925319390097,0.540090771558245,1.0,1.0,7/12,30.99%,PGM1;GYS1;PGM2;GYG1;PER2;NR1D1;UGP2
prerank,glucan biosynthetic process (GO:0009250),0.4399910111916035,0.9519925319390097,0.540090771558245,1.0,1.0,7/12,30.99%,PGM1;GYS1;PGM2;GYG1;PER2;NR1D1;UGP2
prerank,regulation of coagulation (GO:0050818),0.4470970708105518,0.9517819554049968,0.5311572700296736,1.0,1.0,1/11,3.35%,EPHB2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.4089800119988912,0.9516288884392229,0.5322812051649928,1.0,1.0,6/16,20.39%,CPEB3;ZFP36L2;UPF1;KHSRP;RC3H1;ZFP36
prerank,positive regulation of cellular process (GO:0048522),0.2935657972354928,0.9515057534379446,0.661,1.0,1.0,77/565,12.79%,OSR2;BMP5;PRKCA;PDGFRA;ERBB3;HAS2;NTRK3;EPB41L4B;FGF2;PYCARD;MYC;FGF10;KIF20B;PTEN;RHOD;BCL2;GAREM1;IRS2;SOX9;CRLF1;BST1;ERBB2;EGFR;LRP1;TGM1;VEGFA;ACACA;PTHLH;CAPN1;TGFB1;TIPIN;PTGFR;SOX11;NTRK2;GDF9;MT3;GLI1;NOX1;NOP2;WNT5A;PAK1;CDK13;TGFBR2;MLXIPL;UFL1;FZD7;FOXM1;FGFR1;TSHR;PPP3CA;GAB2;PPP1R13L;ACLY;FASN;BTC;DERL2;NCBP1;CUL3;HDAC2;ERBB4;EIF4G1;EXOSC2;GDNF;PTPRJ;AKAP6;IL6ST;PRMT1;CDC25B;S1PR3;EDN3;FGF7;GRN;RTKN2;WWTR1;GLP2R;PRLR;PRDX3
prerank,regulation of cell killing (GO:0031341),0.40985054799415455,0.9513298649376666,0.541029207232267,1.0,1.0,3/16,7.26%,NOX1;WNT5A;FZD7
prerank,glycerophospholipid catabolic process (GO:0046475),0.3718216876744762,0.9509096634534953,0.5421686746987951,1.0,1.0,8/27,21.33%,PRDX6;PLA2G7;ENPP6;PNPLA8;LIPC;GDPD3;PLA2G4E;ABHD16A
prerank,L-amino acid transport (GO:0015807),0.36673426271770276,0.9508637764206631,0.5329883570504528,1.0,1.0,5/28,12.95%,SLC1A3;SLC36A2;ARL6IP5;SLC7A8;PRAF2
prerank,DNA repair (GO:0006281),0.2951982128320364,0.9508396761358027,0.6255020080321285,1.0,1.0,61/284,17.49%,UBE2T;RAD23B;POLN;ZRANB3;APTX;MBD4;POLE2;GTF2H2;CHRNA4;ERCC5;NSMCE3;ERCC4;MPG;KDM4B;DDB2;RPA3;NUDT1;MUTYH;MEN1;BRCA1;XPA;REXO4;TDP1;ALKBH5;SETD2;HUWE1;NEIL1;ENDOV;FBH1;FANCC;ASF1A;MSH6;NSD2;UPF1;ERCC6L2;ZBTB1;DDB1;HPF1;MDC1;XRCC3;EXD2;RPA2;TOPBP1;PDS5B;SUMO1;SMUG1;BAZ1B;UBB;ATM;TRRAP;ABL1;CSNK1E;RAD52;BLM;TP53;FANCI;USP1;FAM111A;CUL4B;WRN;NSMCE4A
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.3693680468444108,0.9508283626378915,0.5417721518987342,1.0,1.0,5/30,13.66%,AKAP13;LPAR1;GPR65;COL3A1;ARHGEF3
prerank,negative regulation of reproductive process (GO:2000242),0.40341704434642406,0.9507883625429644,0.5512820512820513,1.0,1.0,2/17,5.43%,SULF1;ACVR1C
prerank,long-chain fatty acid import into cell (GO:0044539),0.45227272898254434,0.9504019576688308,0.5453100158982512,1.0,1.0,2/10,4.35%,SLC27A1;SLC27A4
prerank,regulation of intracellular pH (GO:0051453),-0.2760456064118587,-0.9500824696041207,0.4766355140186916,0.8538146484936727,1.0,8/34,11.85%,SLC4A10;SLC9A6;SLC9A2;SLC9A8;SLC4A3;SLC4A8;SLC9A9;SLC9A7
prerank,chromatin assembly (GO:0031497),0.3578217634395021,0.9497868409075432,0.5516811955168119,1.0,1.0,8/38,15.90%,SOX9;EZH1;ATRX;PRDM9;POLE3;ASF1A;RBBP4;TP53
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.30025235631183056,-0.9496277729189192,0.5093632958801498,0.8535808067110139,1.0,7/23,20.04%,SASH1;MAP3K5;TNFRSF11A;MAP3K7;ARHGEF5;EDN1;DVL2
prerank,microtubule anchoring at centrosome (GO:0034454),0.46101324875208244,0.9494624035837335,0.5273311897106109,1.0,1.0,6/10,24.44%,PCM1;CCDC120;KIF3A;NIN;HOOK3;BBS4
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.4180351178134491,0.9494048371519492,0.5223880597014925,1.0,1.0,3/14,10.21%,CPSF6;NCBP1;FIP1L1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.29325514436735794,-0.9493866364366794,0.5101214574898786,0.8528865040679524,1.0,5/28,9.11%,ARHGAP28;FCHSD2;ESAM;ARHGAP35;PFN2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3886741468084055,0.9490887417449793,0.5398936170212766,1.0,1.0,5/22,14.08%,MLIP;PRKCA;PDE9A;IL6ST;GLRX3
prerank,error-prone translesion synthesis (GO:0042276),0.3792017116555567,0.9490248009848731,0.5389876880984952,1.0,1.0,6/21,17.26%,POLE2;REV3L;RPA3;RPA2;UBB;REV1
prerank,lipid droplet formation (GO:0140042),-0.3892621129732183,-0.9488772054609894,0.518324607329843,0.852786234875554,1.0,4/10,12.08%,ZFYVE1;CDS1;BSCL2;AUP1
prerank,vasculature development (GO:0001944),-0.3394563952476537,-0.9488547966879759,0.532051282051282,0.8514777134227905,1.0,7/16,12.34%,CDH5;ERRFI1;ACVRL1;BMPR2;PDGFRB;STRA6;NOTCH4
prerank,positive regulation of vacuole organization (GO:0044090),0.44397224252202205,0.9482247942852766,0.5332302936630603,1.0,1.0,4/10,20.54%,RALB;GRN;RAB3GAP2;RAB3GAP1
prerank,immunoglobulin mediated immune response (GO:0016064),0.44548913673239077,0.9480737132505601,0.5298013245033113,1.0,1.0,2/10,17.15%,CARD9;CD74
prerank,membrane organization (GO:0061024),0.29775186997645864,0.9477358600872665,0.6075050709939148,1.0,1.0,33/227,11.39%,ANK3;SGIP1;DNM1;ANK2;REPS2;SNAP23;EGFR;SPAG4;STON2;HACE1;VAMP4;PACSIN2;NPC1;WNT5A;SPTBN1;SYT1;SNAP29;SGCZ;NUP155;ITSN1;EPS15;BIN1;GAK;CNTN2;HIP1;BTC;COX18;HUWE1;VAPA;CBL;TMEM33;RIMS1;EMD
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.3751255707801275,-0.9475739503345316,0.533724340175953,0.8534562264459129,1.0,4/10,24.41%,USP7;OGT;PDK2;SIRT7
prerank,DNA replication initiation (GO:0006270),0.3538243584143617,0.9473917324631813,0.5563725490196079,1.0,1.0,11/37,20.13%,LRWD1;POLE2;RPA3;POLE3;MCM4;RPA2;ORC1;TOPBP1;ORC4;DBF4;ORC2
prerank,regulation of biomineral tissue development (GO:0070167),0.37621979420139756,0.9472680198717961,0.5407608695652174,1.0,1.0,3/26,4.08%,ANKH;SOX9;TGFB1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.4167421160369214,0.9470127133487973,0.5355029585798816,1.0,1.0,5/15,20.77%,NGF;NTRK2;NGFR;GRB2;SOS1
prerank,cellular response to gamma radiation (GO:0071480),0.4034046287575609,0.9469204862984388,0.5475177304964539,1.0,1.0,7/17,18.13%,CRYAB;TLK2;XRCC6;ATM;TP53;WRN;MDM2
prerank,cellular amide metabolic process (GO:0043603),0.31024209541609493,0.9467114089422631,0.5746753246753247,1.0,1.0,26/102,21.01%,THEM4;MIPEP;OXSM;ALDH1L1;MCCC1;HLCS;ACOT11;MTRR;MCCC2;ACSF2;THOP1;PLAAT5;MTHFD2L;PLAAT3;CPD;ABCB9;GNE;ALDH1L2;ACSL6;GPAT4;GLYAT;DBI;PLA2G4E;SLC25A32;ACOT8;ACBD6
prerank,growth hormone receptor signaling pathway (GO:0060396),0.42346336876256996,0.9463805683063247,0.5256222547584187,1.0,1.0,8/14,22.77%,PTPN1;PIK3R1;PRLR;STAT3;STAT5A;PXN;GHR;STAT6
prerank,organic acid transport (GO:0015849),0.3142744129652392,0.9462039132178293,0.5703544575725027,1.0,1.0,17/94,13.24%,SLC27A1;ATP8B1;SLC1A5;NCOA1;SLC38A4;SLC16A10;LRRC8D;SLC27A4;SLC36A2;SLCO2B1;SLC43A1;GOT2;NCOA2;SLC7A7;SLC7A8;SLC25A10;SLC16A1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.29292706340137137,0.9458258935444119,0.692,1.0,1.0,87/497,14.80%,NKX6-2;MDFIC;TSHZ3;SCML4;CREB3L1;RCOR2;SOX8;PRDM16;ATP8B1;SOX9;NAB1;VGLL4;SUV39H1;HOXA7;EPRS1;KDM8;EIF2AK3;TLE1;FOXP2;TGFB1;GATAD2A;MT3;PLCB1;MBD1;ATF7IP;ZEB1;WNT5A;EED;CIPC;RFX3;ZBTB16;TSC1;MLXIPL;MLX;TWIST2;LOXL3;CBFA2T3;KAT8;GATA6;CBX4;ZC3H8;MEN1;FOXM1;CPEB3;KCTD1;BRCA1;MBD2;CRYAB;PASK;DKK3;LANCL2;SELENOS;SNX6;HDAC2;ZBTB38;MBTD1;SMARCC2;SFPQ;HDAC6;RBAK;BMP7;PRICKLE1;ING4;CREBZF;CDK5R1;MIDEAS;L3MBTL4;EPC1;JARID2;ZGPAT;PATZ1;XRCC6;EID2B;ZFPM2;ATF5;PER1;SCML2;GATA3;AHR;PRDM11;NACC2;PUS7;SUMO1;CRY1;NCOR2;CITED2;TAF7
prerank,sodium ion import across plasma membrane (GO:0098719),-0.32238942709091645,-0.9456978967357929,0.5084175084175084,0.8572040303183341,1.0,5/17,12.22%,SLC9A6;SLC9A2;SLC9A9;SLC9A7;SLC6A1
prerank,methylguanosine-cap decapping (GO:0110156),-0.3939763131933305,-0.9456631701483174,0.5404624277456648,0.855939392854105,1.0,5/10,18.97%,LSM1;DCP2;PATL1;PNRC2;EDC3
prerank,negative regulation of ossification (GO:0030279),0.38763286988267,0.9454953007639202,0.5336021505376344,1.0,1.0,3/23,8.61%,LRP4;SOX9;CHSY1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.41534390554776063,0.9454164380297951,0.5289017341040463,1.0,1.0,2/15,4.08%,IRAK3;TGFB1
prerank,mesenchymal cell development (GO:0014031),0.4001887852182918,0.9453983534195533,0.55049786628734,1.0,1.0,6/18,22.35%,SOX8;SOX11;KLHL12;HEYL;PEF1;NRG1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3165467724788093,0.9453884373304616,0.5711135611907387,1.0,1.0,11/78,11.37%,LGALS3;EGFR;LRP1;EPHB2;WNK3;TGFB1;SPTBN1;DPP10;ZDHHC8;PIK3R1;PID1
prerank,cardiac myofibril assembly (GO:0055003),0.41770359562339354,0.9453199984609388,0.5228951255539144,1.0,1.0,2/15,5.54%,PDGFRA;OBSL1
prerank,regulation of anoikis (GO:2000209),0.3960007174185741,0.9448818593502619,0.5492371705963939,1.0,1.0,2/19,3.82%,BCL2;TLE1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.3743383069588351,0.9448467310910654,0.5479632063074902,1.0,1.0,6/26,9.44%,ERLIN2;MLXIPL;PRKAB2;EIF6;BRCA1;ELOVL5
prerank,regulation of viral genome replication (GO:0045069),-0.24207576899183061,-0.9447491480424222,0.5611510791366906,0.8567842298223863,1.0,18/56,22.45%,ZC3HAV1;PLSCR1;IFITM3;PPIA;IFIH1;PARP10;TNIP1;VAPB;IFITM2;OAS2;PROX1;PPIE;TARBP2;ISG15;IFIT1;BST2;RSAD2;PDE12
prerank,keratinocyte differentiation (GO:0030216),0.3672776106103695,0.9445544007078298,0.5560053981106613,1.0,1.0,3/29,5.52%,CERS3;TGM1;WNT5A
prerank,ketone body metabolic process (GO:1902224),0.460444705028659,0.9444371738714494,0.5347003154574133,1.0,1.0,3/10,17.52%,ACSS3;HMGCLL1;HMGCS2
prerank,regulation of inflammatory response (GO:0050727),0.29709669338513056,0.9444283146342509,0.6174974567650051,1.0,1.0,35/190,19.69%,RORA;FFAR4;ADAMTS12;IL16;BST1;PTPN2;MAPK7;GPRC5B;TNFAIP8L2;CCR2;WNT5A;IL1RL2;UFL1;PLA2G7;OTULIN;IL18;SELENOS;SNX6;CASP12;GRN;SHPK;GATA3;SNCA;IL33;AREL1;XIAP;ABCC1;RIPK1;MDK;PTGES;LRFN5;PARK7;SETD4;PDCD4;PPARG
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.34064530119404,0.9442348728515154,0.5587188612099644,1.0,1.0,19/48,25.53%,OLFM4;IL1RAPL1;DOCK5;OBSL1;CDKL5;CDKL3;FLNA;DOCK1;MYOC;ABL1;RAC3;MDK;TESK1;TRIOBP;CRK;CIB1;PRKDC;FBXW8;ARHGEF7
prerank,regulation of neuron death (GO:1901214),0.317126887895424,0.9442155367279487,0.5830546265328874,1.0,1.0,20/82,19.36%,CD34;PRKN;PRNP;GRIN2B;GRID2;WNT5A;TSC1;TRIM2;NAE1;FYN;DCC;EIF4G1;TBK1;SNCA;UBB;EFNB2;SNCB;PARK7;EGR1;BTBD10
prerank,positive regulation of cellular catabolic process (GO:0031331),0.304467704694996,0.9438447758507138,0.59958071278826,1.0,1.0,27/132,17.21%,DCN;IRS2;ZBTB20;VGLL4;NPRL2;PSEN1;DXO;MLXIPL;UFL1;BNIP3;VPS11;HIF1A;PTPN1;MID2;UPF1;ZC3H18;SNCA;MTLN;KHSRP;TICAM1;DACT1;PIM2;GPLD1;PNPT1;ZSWIM8;ABCD2;RC3H1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.36410596809474577,0.9436907927946278,0.5452229299363057,1.0,1.0,5/30,8.28%,PTPN2;CADM4;SOCS1;SAMSN1;NF2
prerank,regulation of cytokine production (GO:0001817),0.3060020747814849,0.9434576979541051,0.5942492012779552,1.0,1.0,16/126,13.20%,FFAR4;GLMN;DTX4;RPS6KA4;MAST2;MAPKAPK2;CCR2;AGPAT2;CARD9;CADM1;SYT11;MAPK14;TBK1;ATP2B1;PER1;GATA3
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3124993535976275,0.9433703345973201,0.5845147219193021,1.0,1.0,22/95,17.14%,PRDM16;HTRA3;CDKN2B;TGFB1;SOX11;TGFBR2;SPRED2;SPRED1;MEN1;PEG10;DKK3;BCL9L;SPRED3;SNX6;DAND5;BCL9;LDLRAD4;CITED2;ZEB2;UBB;RNF111;NREP
prerank,regulation of cell development (GO:0060284),-0.2728622075815591,-0.9432430935953485,0.5607476635514018,0.8593489350926773,1.0,8/36,16.03%,NOTCH2;CTNNB1;CLOCK;RPS19;RHEB;PRUNE1;HEY2;ADGRA2
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.38295144806604303,-0.9430476173853392,0.5195530726256983,0.85848533090492,1.0,2/10,4.90%,DSE;PXYLP1
prerank,negative regulation of cellular component organization (GO:0051129),0.31789398136596136,0.9428385893055858,0.5803571428571429,1.0,1.0,9/74,11.58%,LGALS3;FAP;VEGFA;IRAK3;CRYAB;SYT11;MCTP1;HDAC6;DNAJB6
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.32293633401897426,-0.9428115216169888,0.5342465753424658,0.8577043994023106,1.0,5/17,21.17%,PODXL;TGFB2;NCKAP1L;SKAP1;FOXC2
prerank,cellular response to interleukin-7 (GO:0098761),0.4066105638398349,0.9427400063488649,0.550624133148405,1.0,1.0,6/17,22.46%,IRS2;SOCS1;STAT3;SMARCA4;STAT5A;BRWD1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4066105638398349,0.9427400063488649,0.550624133148405,1.0,1.0,6/17,22.46%,IRS2;SOCS1;STAT3;SMARCA4;STAT5A;BRWD1
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.3536831150873546,0.942639418133923,0.5470085470085471,1.0,1.0,10/37,17.09%,GTF2H2;ERCC5;ERCC4;DDB2;RPA3;XPA;DDB1;RPA2;UBB;CUL4B
prerank,fatty acid oxidation (GO:0019395),-0.24176539614668255,-0.9425633512161823,0.5906040268456376,0.8569880155614152,1.0,20/57,27.48%,ACAD10;ECHDC1;PEX13;PPARD;PHYH;ACADM;ALDH3A2;BDH2;ECHDC2;ADIPOR2;ECI1;PECR;ECHS1;PEX2;ALOX12;CROT;SLC27A2;ECI2;CPT2;MCAT
prerank,RNA metabolic process (GO:0016070),0.30549804280964943,0.9421539765467891,0.6002098635886673,1.0,1.0,46/127,26.13%,BICD1;DHX8;ELAVL4;RNASE6;RNGTT;ATXN2;POLR2B;METTL3;XRN2;DDX54;PPP1R8;DDX24;POLR2K;APOBEC1;NCBP1;ADARB2;DUSP11;SNRNP40;HNRNPA3;RNASEH2C;ADARB1;POLR2G;NOVA1;PAPOLA;PNPT1;HNRNPU;TP53RK;TENT2;POLR2A;SYNCRIP;HNRNPUL1;HNRNPC;HNRNPH2;HNRNPL;RBFOX2;RBMS1;ALKBH1;PCBP2;POLR2F;TFIP11;SUPV3L1;DROSHA;RBM4;RNASE3;SND1;HNRNPA2B1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.39532386604832603,0.9419265873552025,0.5487977369165488,1.0,1.0,5/18,13.27%,NAALAD2;SMS;GOT2;ASNS;ADI1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.3285725922545215,-0.9419092186129818,0.5492063492063493,0.8573483028838038,1.0,3/17,1.14%,BAIAP2L1;NRP1;TEK
prerank,positive regulation of biosynthetic process (GO:0009891),0.3476292731913043,0.9416095845200544,0.5410628019323671,1.0,1.0,7/40,10.12%,CREB3L1;ZBTB20;SLC5A3;TGFB1;MLXIPL;AMELX;HDAC2
prerank,negative regulation of MAP kinase activity (GO:0043407),0.35098030209181763,0.9408787039736113,0.5772558714462299,1.0,1.0,7/44,11.42%,PTPN22;IRAK3;NF1;UCHL1;PTPN1;PTPRJ;BMP7
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.4216885096368694,0.9408444163707417,0.5389312977099237,1.0,1.0,8/13,29.82%,UBA2;NAE1;UBA3;UBA1;SAE1;ATG10;DESI1;DESI2
prerank,vesicle transport along microtubule (GO:0047496),-0.3035531358415603,-0.9407708911829407,0.5372549019607843,0.8589974710697497,1.0,6/23,8.62%,KIF3B;KIF1C;TRAK1;PAFAH1B1;KIF5B;BICDL1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.37649384110249473,0.9405690770817762,0.5438108484005564,1.0,1.0,2/22,4.99%,LGALS3;PPP1R15A
prerank,regulation of epithelial cell migration (GO:0010632),0.33722346929754105,0.9405609228961067,0.5700934579439252,1.0,1.0,11/51,14.56%,RHOJ;GLIPR2;FGF10;SOX9;DOCK5;DOCK1;HIF1A;CLASP1;HDAC6;BMPER;RTN4
prerank,negative regulation of interleukin-6 production (GO:0032715),0.3686150210525981,0.9400873473563928,0.5404312668463612,1.0,1.0,4/27,9.85%,PTPN22;IRAK3;SYT11;SELENOS
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.2742733028476003,-0.9400236593803716,0.5958333333333333,0.8595263175663933,1.0,7/31,12.51%,SMAD7;ENG;TGFBR1;TPM1;FGFR2;PROX1;TGFB2
prerank,regulation of epithelial cell differentiation (GO:0030856),0.3964173293957714,0.9399251500439892,0.5539772727272727,1.0,1.0,4/17,13.20%,SOX9;PRKX;AJAP1;GATA3
prerank,Notch signaling pathway (GO:0007219),0.327082100893787,0.9392623839230391,0.5785797438882422,1.0,1.0,15/59,18.43%,MAML3;MYC;KAT2B;DTX4;MAML2;PSEN1;HOXD3;NCSTN;APH1A;PSEN2;TRAF7;MIB1;HEYL;MDK;GALNT11
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.4480431800585935,0.9392492306278764,0.5824508320726173,1.0,1.0,3/10,12.70%,VEGFA;DISC1;DRD2
prerank,proteasome assembly (GO:0043248),-0.36669966038188917,-0.9392455646594187,0.5210084033613446,0.8601662214321704,1.0,5/11,29.15%,OTUD6B;PSMG2;PSMG1;ADRM1;PSMD10
prerank,regulation of insulin secretion (GO:0050796),0.3095376932264511,0.9390682443097138,0.5883620689655172,1.0,1.0,11/101,7.97%,PRKCA;CACNA1E;IRS2;STXBP4;PRKN;EFNA5;CACNA1A;RFX3;PPP3CB;RAP1A;ENSA
prerank,cellular response to osmotic stress (GO:0071470),0.38751400530183955,0.9389960837263132,0.5388888888888889,1.0,1.0,4/21,9.19%,SCN2A;WNK3;LRRC8D;STK39
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.3966223677851562,0.938699075446322,0.5308641975308642,1.0,1.0,8/19,24.23%,POLR2B;ATRX;POLR2K;POLR2G;TERF2IP;POLR2A;ACD;POLR2F
prerank,regulation of DNA recombination at telomere (GO:0072695),0.3966223677851562,0.938699075446322,0.5308641975308642,1.0,1.0,8/19,24.23%,POLR2B;ATRX;POLR2K;POLR2G;TERF2IP;POLR2A;ACD;POLR2F
prerank,negative regulation of DNA metabolic process (GO:0051053),0.37631572531235047,0.9384501260259839,0.5658602150537635,1.0,1.0,7/24,16.41%,ZRANB3;KMT2A;ERCC4;MSH6;RTEL1;BLM;TERF2IP
prerank,double-strand break repair via homologous recombination (GO:0000724),0.30828195427580496,0.9380484715023941,0.6008724100327154,1.0,1.0,20/95,17.24%,POLN;MEIOB;AP5S1;ERCC5;REV3L;ERCC4;RPA3;BRCA1;GINS2;FBH1;MCM4;SFPQ;HELQ;XRCC3;EXD2;RPA2;RAD52;BLM;SPIDR;WRN
prerank,organelle disassembly (GO:1903008),-0.27673845861693824,-0.9374128893355105,0.5714285714285714,0.8635424667644318,1.0,10/33,21.19%,MTIF2;TEX264;KIF5B;KLC1;UFM1;GFM2;MTIF3;UFC1;UBA5;ULK1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.292589393164635,0.9373198415157162,0.685370741482966,1.0,1.0,74/348,19.09%,RELN;BMP5;CLDN19;DOCK7;NTRK3;FGF2;FGF10;SOX9;NGF;ERBB2;EGFR;ACVR1;EFNA5;WDFY2;VEGFA;ARAF;WNK3;RPS6KA4;TGFB1;TEC;NTRK2;TRAF4;GDF9;PRNP;MT3;MRNIP;TNIK;NIBAN1;PAK1;ALS2;RALB;RAP1A;UBE2K;ERBB4;EIF4G1;PTPRJ;FBH1;PTPN11;HDAC6;MAPK1;BMP7;MMD2;MYDGF;FGF7;TBK1;XRCC6;AKTIP;BRAT1;SNCA;P2RY1;SH2D3C;CALM1;BMPR1A;IQGAP1;RASSF2;ABL1;CALM2;TP53;CCND2;TGFB3;TERF2IP;APLNR;CD74;RIPK1;CSPG4;JTB;RPTOR;KRAS;MAPRE3;FNIP1;PARK7;SEMA4D;TESK1;S1PR2
prerank,Rap protein signal transduction (GO:0032486),0.4345582078336564,0.9372950345455352,0.5446009389671361,1.0,1.0,2/10,7.42%,RAP2B;RAP1A
prerank,regulation of striated muscle contraction (GO:0006942),0.3668270896067786,0.9369606640128708,0.549492385786802,1.0,1.0,6/27,15.55%,MYBPH;ANK2;TNNT3;PRKACA;CALM1;CALM2
prerank,regulation of microtubule polymerization (GO:0031113),-0.2633193535414265,-0.9369082228801524,0.5604395604395604,0.8635172478023032,1.0,12/40,16.43%,CDH5;MAP2;OCLN;DRG1;CLIP3;CLIP1;EML2;DCTN1;NUMA1;MAPT;PRUNE1;TBCD
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.41790354871880464,0.9365827991090588,0.5548872180451128,1.0,1.0,2/14,7.90%,CARD9;IL18
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.32832264476094575,-0.9364213467409825,0.5394321766561514,0.86333958165677,1.0,4/16,12.70%,RIF1;PARP3;WRAP53;KDM4D
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.32855528461464045,-0.936286451326711,0.546583850931677,0.8623170268216279,1.0,5/17,15.06%,GJA1;KDM1A;PTPRC;HMGA2;TERT
prerank,regulation of monooxygenase activity (GO:0032768),0.3695637568975978,0.9361655167242365,0.5283018867924528,1.0,1.0,9/23,22.12%,POR;EGFR;LYPLA1;GDNF;SNCA;CALM1;NOS1AP;ZDHHC21;DDAH1
prerank,positive regulation of DNA recombination (GO:0045911),-0.289902459203212,-0.9361053075603365,0.5391304347826087,0.8614410052778281,1.0,11/27,24.28%,RIF1;MMS19;PARP1;TFRC;WRAP53;ERCC2;PAXIP1;ERCC6;FANCB;TIMELESS;MAD2L2
prerank,regulation of phosphatase activity (GO:0010921),0.3742048354332834,0.9360917619442053,0.5742705570291777,1.0,1.0,12/24,28.23%,URI1;TSC1;HSP90B1;TIPRL;HTT;ZCCHC9;BMP2;PPP6R2;PPP6R1;CDK5RAP3;GPATCH2;CHP1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.3670869495999419,0.9354644535718701,0.5538656527249683,1.0,1.0,4/29,12.74%,FADD;AP1G1;CADM1;NECTIN2
prerank,phagosome acidification (GO:0090383),0.3675595400170514,0.9352203239572521,0.5735694822888283,1.0,1.0,11/26,27.44%,RAB38;ATP6V1B2;RAB39A;ATP6V1C1;RAB7A;ATP6V0E2;ATP6V0E1;ATP6V1G2;ATP6V1H;TCIRG1;ATP6V1D
prerank,regulation of G0 to G1 transition (GO:0070316),0.3456528266485038,0.935193515662785,0.575682382133995,1.0,1.0,15/38,27.16%,CDKN2B;EED;APAF1;E2F6;BRCA1;EPC1;RBBP4;RBBP7;CBX5;RNF2;CBX3;EHMT2;RHNO1;RBBP8;EZH2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3214348757060253,0.9351845855054653,0.5704545454545454,1.0,1.0,17/67,15.24%,SULF1;VEGFA;MAPKAPK3;NCF1;MAPKAPK2;BAIAP2;FYN;BRK1;VAV3;DOCK1;NCF2;PIK3R1;MAPK14;NRP2;NCK1;CYFIP1;ELMO1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.40486550131448257,0.9351810622896704,0.5497896213183731,1.0,1.0,9/17,26.21%,CARD9;ARL6IP5;TAOK3;KLHDC10;MID1;RNF13;TAOK1;EIF2AK2;SEMA4C
prerank,pore complex assembly (GO:0046931),-0.3066167558645799,-0.9351084184873351,0.5209125475285171,0.8625970627640198,1.0,7/19,19.34%,AFDN;NUP93;NUP107;ADAM10;PDZD11;GSDMD;NUP98
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.3087100535298876,0.9350383003271114,0.5942492012779552,1.0,1.0,40/104,29.30%,SLC27A1;PYCARD;CDKN2B;CCNJ;KSR1;RALB;SLC8A2;PIH1D1;PKMYT1;CDK5R1;SNCA;CALM1;CDK5R2;ABL1;CALM2;BLM;CCND2;RPTOR;HTT;TESK1;CAB39;BCCIP;RB1;PPEF2;CIB1;CCNT2;CCNH;CDC37;CDK5RAP3;CDKN1A;CCND3;EZH2;CCNI;SIRT1;GTPBP4;TELO2;CCNE1;SNF8;CDKN2D;CDKN1B
prerank,cellular response to amyloid-beta (GO:1904646),0.3481513161926273,0.9349739678173551,0.5590452261306532,1.0,1.0,9/35,10.58%,CACNA2D1;LRP1;CACNA1A;PSEN1;PRNP;FYN;GRM5;SNX6;NGFR
prerank,telomere maintenance via recombination (GO:0000722),0.44137510617961506,0.9340666886987896,0.5812101910828026,1.0,1.0,4/11,22.71%,ERCC4;XRCC3;TPRKB;RAD50
prerank,negative regulation of protein transport (GO:0051224),0.3672080881560841,0.9337942090814466,0.5506849315068493,1.0,1.0,5/25,16.93%,PKDCC;CSK;DRD2;NDFIP1;SNX12
prerank,cellular protein modification process (GO:0006464),0.2870925025490054,0.9336580136441055,0.782,1.0,1.0,160/982,14.08%,PTPRH;GPC3;CHRM3;WNK2;CCL11;VCAN;PRKCA;CTH;CEL;ST3GAL4;PTEN;PTPN22;MXRA8;PEAK1;FBXW9;CHRDL1;STK36;DUSP4;PGAP1;ERBB2;LAMC1;RAB38;PTPRT;TGM1;ACVR1;UBE2E2;MAP4K4;PAK4;ARAF;IRAK3;WNK3;SIK2;EIF2AK3;RPS6KA4;SOCS5;FBXW7;MAST2;SPSB4;PRKCSH;NEK1;TGFB1;TEC;ASB8;PAK5;NUCB1;NPC1;SETD3;SDC2;MT3;MAPKAPK2;KLHL13;TESK2;DUSP6;PRKAR1B;TNIK;PTPN13;HLCS;ACVR1C;OBSL1;FBXO7;PAK1;PKN1;WIPI1;FBXL15;YWHAZ;DDB2;CDKL5;ASB5;CDK8;FBXO32;CDKL3;ZBTB16;CDK13;MMP15;EVA1A;TGFBR2;B3GNT9;MAN2A2;CSK;UFL1;PPP3CB;DYRK1B;PDK3;RCN1;LIMK1;CDK6;MEN1;NAE1;FGFR1;ATG5;FYN;STT3A;VWA1;PPP3CA;CDK15;PPM1B;PPM1J;PPP2R3A;TBCK;FBXL16;CDK19;PSMB7;PPP2R2A;COL3A1;PASK;STK39;TLK2;MAPK9;AKT3;FBXO27;SGK3;SGK2;CKAP4;HIF1A;AMELX;PTPN1;CUL3;PXK;DUSP11;PTPRJ;TYK2;ST8SIA1;ARF4;DCLK1;UCHL3;LTBP1;CDC25B;MAPK1;SIRT6;CALU;UBA3;PPP1CA;SLC35A1;TAOK3;FBXO17;PTPRA;RAB1A;FBXL2;FUCA2;TBK1;PRKACA;ALG5;DCAF8;PTPN18;ATG3;RAB3A;BTBD1;CSNK1A1;HSP90B1;NEK7;PTPRZ1;CDK16;DDB1;PTPN21;PENK;TTBK1;SUMF1;NEDD8;PPP3CC;SSH1
prerank,RNA export from nucleus (GO:0006405),0.30747279647343645,0.9335746066315678,0.5967391304347827,1.0,1.0,35/100,26.38%,THOC6;RANBP2;NUP155;MCM3AP;SRSF11;CASC3;ALKBH5;NCBP1;FIP1L1;NUP205;NDC1;NUP160;UPF1;DDX25;NXT1;SRSF6;YTHDC1;POM121;SMG6;AAAS;NXF1;RNPS1;THOC7;SRRM1;SRSF3;FYTTD1;NUP42;GLE1;SYMPK;XPO5;THOC5;MAGOHB;NUP35;HNRNPA2B1;RAE1
prerank,organic cation transport (GO:0015695),0.3811317600704058,0.9335723756565555,0.5316804407713499,1.0,1.0,3/20,9.03%,SLC22A3;SLC44A2;SEC14L1
prerank,mRNA metabolic process (GO:0016071),0.3069558098340908,0.9335424113885558,0.5919037199124726,1.0,1.0,18/90,17.37%,CSTF3;DXO;CPSF6;METTL3;SON;SRSF11;AURKAIP1;ALKBH5;NCBP1;ZFP36L2;SFPQ;LSM3;PRKACA;PRPF18;TP53;PNPT1;SF3A1;SSB
prerank,regulation of macroautophagy (GO:0016241),0.3066686322985314,0.9332200626748737,0.6200873362445415,1.0,1.0,16/105,12.48%,DCN;WAC;CAPN1;ATP6V1B2;TSC1;PRKAB2;BNIP3;LAMTOR2;UCHL1;SNX6;VPS26B;CLEC16A;HDAC6;CDK5R1;TBK1;PRKACA
prerank,retina homeostasis (GO:0001895),-0.28939179911152046,-0.932800595748175,0.5454545454545454,0.8673156812165183,1.0,9/23,39.28%,POC1B;SOD1;ACTG1;HSPB1;TULP1;CDH3;CNGB1;JCHAIN;CRB2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.30469982281323005,0.9325457228299151,0.620616365568544,1.0,1.0,21/119,14.51%,PLEKHA4;INPP4B;SLC27A1;FGF2;PTEN;RAB14;SOCS5;MTMR14;PTPN13;SOCS1;PI4KB;VAC14;PIGC;PIGP;PIK3R1;PI4K2A;MTMR12;RAB4A;PIGN;PIGA;TTC7A
prerank,regulation of histone deacetylation (GO:0031063),-0.35668235341661547,-0.9323870365347847,0.5615615615615616,0.867046475493845,1.0,6/13,26.49%,SAP30BP;ING2;ZBTB7B;SPHK2;NIPBL;PRMT6
prerank,cardiac muscle tissue development (GO:0048738),0.3301265058347293,0.9319966442332139,0.5794504181600956,1.0,1.0,7/50,7.60%,BMP5;AKAP13;SGCD;SCN5A;SGCZ;GATA6;TBX18
prerank,endothelial cell development (GO:0001885),0.3713522099311487,0.9319696314826043,0.551440329218107,1.0,1.0,5/25,15.00%,COL15A1;RAP1A;COL18A1;PDE4D;MET
prerank,intestinal absorption (GO:0050892),-0.34664324715020056,-0.9317838807452472,0.5520231213872833,0.8672053409350711,1.0,4/13,20.92%,TJP2;UGCG;ADRA2A;SLC26A6
prerank,DNA replication checkpoint signaling (GO:0000076),0.41011047547948815,0.931775645579477,0.563768115942029,1.0,1.0,4/16,14.09%,TIPIN;NAE1;ORC1;TOPBP1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.29227646436453725,-0.9315945970980356,0.5371900826446281,0.866358001707874,1.0,9/25,20.37%,ETS1;ARNT;STAT5B;ACVR1B;NCKAP1L;INHBA;TAL1;ANKRD54;HMGB2
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.3062838571700921,-0.9314489308331019,0.5220588235294118,0.8640662558271166,1.0,9/20,31.83%,GSTA4;GSTM1;HPGDS;MGST1;ESD;MGST3;GSTM5;GSTO2;GSTK1
prerank,glutathione derivative metabolic process (GO:1901685),-0.3062838571700921,-0.9314489308331019,0.5220588235294118,0.8640662558271166,1.0,9/20,31.83%,GSTA4;GSTM1;HPGDS;MGST1;ESD;MGST3;GSTM5;GSTO2;GSTK1
prerank,cell chemotaxis (GO:0060326),0.3261186541600284,0.9314116033952108,0.5791962174940898,1.0,1.0,7/60,7.06%,PDGFRA;PRKCQ;LPAR1;VEGFA;EGR3;CCR2;ACKR3
prerank,B cell activation involved in immune response (GO:0002312),0.4120564772105905,0.9312062902990317,0.5587786259541985,1.0,1.0,5/13,27.57%,MSH6;BATF;EXOSC3;LIG4;RNF168
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.2780373204931402,-0.9311833914111063,0.5488372093023256,0.8634038049846721,1.0,5/28,15.46%,PRKAG2;PRKAA2;ADIPOR2;AVIL;FGFR4
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.20554977900680013,-0.9311244329840133,0.6964285714285714,0.8622212876064534,1.0,49/114,33.85%,PSMD14;BIRC3;NFKBIA;TNFRSF11B;PSMB3;AIM2;PSMD12;TNFRSF11A;TNFSF12;TNFRSF1A;COMMD7;PSMD6;TMSB4X;PSMA1;CDIP1;EIF5A;PSMD7;PSMA5;PSMC5;PTK2B;IKBKB;BAG4;PSMC4;PSMB6;PSMA4;EDA2R;CD40;TRADD;PSMB1;ACTN4;PSMB9;TRAF1;ILK;PSMC6;EDAR;TNFSF13;CD27;PSMD3;PSMD10;PSME3;TNFSF8;JAK2;TNFRSF1B;BIRC2;PSMA6;PSME2;TNFSF13B;TNFRSF9;TNFRSF12A
prerank,myofibril assembly (GO:0030239),0.3388558721334692,0.9306822781486324,0.5824175824175825,1.0,1.0,4/42,8.42%,PDGFRA;CSRP1;OBSL1;TNNT3
prerank,endocardial cushion development (GO:0003197),-0.3070944392539674,-0.930403362134239,0.5759717314487632,0.8627096224283295,1.0,5/21,3.78%,ACVRL1;NOS3;BMP4;ENG;BMPR2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.29435764272416565,-0.9302416370491021,0.5739130434782609,0.8617431433646444,1.0,9/25,28.37%,KIT;SLC7A5;CD55;MAP3K7;LAPTM5;SPHK2;LACC1;NOD2;TRIM6
prerank,RNA 3'-end processing (GO:0031123),0.31971581233934887,0.9300111841675645,0.6011494252873564,1.0,1.0,22/69,25.00%,CSTF3;THOC6;RPRD1A;TUT4;SRSF11;CASC3;NCBP1;FIP1L1;SRSF6;PAPOLA;PNPT1;RNPS1;TENT2;THOC7;SRRM1;SRSF3;SYMPK;TUT1;THOC5;SUPV3L1;MAGOHB;CPSF7
prerank,negative regulation of interferon-beta production (GO:0032688),0.4411561152972351,0.929964789798348,0.5714285714285714,1.0,1.0,4/10,20.82%,PYCARD;PPM1B;PTPRS;SIRPA
prerank,regulation of organelle assembly (GO:1902115),0.3150521738903736,0.9299433857873385,0.5896860986547086,1.0,1.0,16/72,14.71%,TBC1D10A;GSN;NPRL2;IFT140;ATXN2;CDKL5;SDCCAG8;ATG5;VPS11;TBC1D19;CEP295NL;USP6NL;ATG3;TBC1D20;CEP76;PDCD6IP
prerank,meiosis I (GO:0007127),0.372178146444704,0.929886401946736,0.5605442176870749,1.0,1.0,7/23,22.36%,MEIOB;SGO1;BCL2L11;FOXJ3;ZSCAN21;PTTG1;DDX4
prerank,regulation of interleukin-4 production (GO:0032673),-0.30345176528386025,-0.9297185544447633,0.556390977443609,0.8616715548285525,1.0,8/21,20.70%,LEF1;SLC7A5;PRKCZ;CD86;RARA;ZFPM1;HAVCR2;FCER1G
prerank,positive regulation of cell differentiation (GO:0045597),0.291271223987235,0.9291592148776484,0.6737804878048781,1.0,1.0,38/237,11.65%,FFAR4;SOX6;GLIPR2;PKDCC;CD34;SOX9;NGF;ACVR1;FRZB;XKR8;WDFY2;NRCAM;GPRC5B;TGFB1;SOX11;PLCB1;CTNNA2;ZEB1;HOXD3;ZBTB16;TGFBR2;LMO3;RAP1A;FGFR1;IL18;PPP1R13L;SOX5;CARM1;MAPK9;BCL9L;GDNF;MAPK14;IL6ST;GPC1;BMP7;ATRAID;EDN3;MMD2
prerank,striated muscle tissue development (GO:0014706),0.3575537577086872,0.9290888062976013,0.5594125500667557,1.0,1.0,3/29,5.86%,BMP5;SGCD;SGCZ
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3881705663068827,0.928207293938797,0.5574468085106383,1.0,1.0,7/17,19.03%,CTNNA2;BRK1;WASF1;CORO1B;CYFIP1;ARFIP1;NCKAP1
prerank,icosanoid secretion (GO:0032309),-0.3689251603489657,-0.9281433817430097,0.5676470588235294,0.8644721140015379,1.0,2/12,6.82%,ABCC4;ACE
prerank,negative regulation of immune response (GO:0050777),0.2969687210276741,0.9280474058330117,0.6294363256784968,1.0,1.0,16/154,12.75%,LGALS3;CRH;DPEP1;IRAK3;PTHLH;CCR2;PRKAR1B;PTH2R;SAMSN1;FYN;TSHR;PPM1B;COL3A1;MAPK14;PRKACA;GLP2R
prerank,translational termination (GO:0006415),0.3134187110334568,0.9280182405981084,0.5924731182795699,1.0,1.0,28/95,22.45%,MRPL47;MRPS18A;ETF1;MRPL14;MRPL32;MRPL16;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;GSPT2;MRPL30;MRPL28;TRMT112;MRPL46;MRPL51;MRPS30;N6AMT1;MRPS14;MRPS9;MRPS31;MRPL1;PTCD3;DAP3;MRPS6;MRPL52;MRPL18
prerank,negative regulation of apoptotic process (GO:0043066),0.28582256340535384,0.9279690398337126,0.7167167167167167,1.0,1.0,97/444,18.99%,FFAR4;PRKCA;ERBB3;SOX8;MYC;RNF157;BCL2;DPEP1;SOX9;CRLF1;NGF;PRKN;EGFR;FMN2;MAP4K4;VEGFA;EGR3;ARAF;THOC6;WNK3;TLE1;ERCC5;PSEN1;FANK1;NTRK2;MT3;WNT5A;YWHAZ;RASA1;NAA35;SON;NAA16;GATA6;CBX4;BNIP3;FLNA;CRYAB;PRDM9;SNX6;ASNS;HDAC2;UBE2Z;PIK3R1;GDNF;NGFR;CBL;ARF4;TAF9;IL6ST;SFPQ;MAPK1;DNAJB6;MYDGF;GRN;TAX1BP1;PRLR;PRDX3;SOD2;ATF5;HSP90B1;PTPRZ1;YME1L1;MALT1;SNCA;PSEN2;CITED2;OPA1;ZFAND6;UBB;ITGB1;CASP2;AREL1;UBE2O;FZD9;PIM2;BNIP1;TP53;CCND2;LRP2;XIAP;HTATIP2;TGFB3;PAX2;CD74;RIPK1;PCID2;MDK;DNAJA1;HSPA9;CAT;NAA15;AATF;FNIP1;PARK7;SEMA4D;CSNK2A2;AXL
prerank,integrated stress response signaling (GO:0140467),0.4116660527180138,0.927950274618409,0.5769230769230769,1.0,1.0,4/14,16.49%,EIF2AK3;HERPUD1;NFE2L2;QRICH1
prerank,cellular response to interferon-beta (GO:0035458),-0.3340604788427278,-0.9274019563144118,0.5438066465256798,0.865056554631839,1.0,7/14,23.06%,AIM2;IRGM;IRF1;IFITM2;UBE2G2;HTRA2;CDC34
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.416518884455377,0.9270510957241752,0.5601851851851852,1.0,1.0,4/13,12.68%,SHISA9;GRIK2;SLC8A2;RAB3A
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.3589002925267917,0.9268421704827919,0.5578947368421052,1.0,1.0,8/29,15.72%,EPHB2;SHISA9;GRIK2;SLC8A2;MCTP1;RAB3A;DRD2;NETO1
prerank,positive regulation of telomerase activity (GO:0051973),0.3523702990121648,0.925705296118779,0.583011583011583,1.0,1.0,6/33,14.19%,PRKCQ;MYC;PARM1;MAPK1;NEK7;MAP3K4
prerank,regulation of protein phosphorylation (GO:0001932),0.29330415559185496,0.9255438172030757,0.6824120603015076,1.0,1.0,42/256,14.02%,CLDN19;NTRK3;FGF2;PIP5KL1;FGF10;PTEN;SOX9;BST1;ERBB2;PRKN;EGFR;EFNA5;WDFY2;VEGFA;EPHB2;CADM4;EIF2AK3;TGFB1;NTRK2;PRNP;MT3;TNIK;PTPN13;NIBAN1;SOCS1;PAK1;RALB;MEN1;FYN;GRM5;ERBB4;FBH1;PID1;BMP7;MYDGF;FGF7;WWTR1;AKTIP;BRAT1;P2RY1;PDCL3;BMPER
prerank,transepithelial transport (GO:0070633),0.40583405317603805,0.9252613936133907,0.5738880918220947,1.0,1.0,4/15,17.07%,SLC1A3;SLC12A2;GPLD1;ABCC1
prerank,brain morphogenesis (GO:0048854),0.41714591588810407,0.9246052251826165,0.5506134969325154,1.0,1.0,4/12,18.47%,PTEN;CTNNA2;PAX2;SLC6A4
prerank,photoperiodism (GO:0009648),-0.269664976347832,-0.9243250075910248,0.5929203539823009,0.8715241216580278,1.0,8/28,13.94%,SIK1;PPP1CB;CLOCK;MTA1;PPP1CC;FBXL17;ID2;PML
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.360385874637096,0.9241478418962663,0.5782664941785253,1.0,1.0,4/30,8.60%,BMP5;FADD;TNFRSF10B;BRCA1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3825277744274318,0.9241462298184137,0.562585969738652,1.0,1.0,4/20,11.37%,PKDCC;TGFB1;CSK;PID1
prerank,stress-activated MAPK cascade (GO:0051403),-0.2333535452094377,-0.9240304228465854,0.6290322580645161,0.8708771013919802,1.0,21/61,25.16%,MAP3K5;TNFRSF19;MAP3K20;MAP2K3;MAP3K8;ZFP36L1;GPS2;ARHGEF6;MAP3K7;UBE2N;IKBKB;IKBKG;TAOK2;MINK1;MAPK10;NOD1;CRKL;MAP3K13;GPS1;MAPK8;UBA52
prerank,cell part morphogenesis (GO:0032990),0.41375196576837747,0.9240254473309142,0.5653450807635829,1.0,1.0,6/13,24.44%,PACSIN2;PID1;WASF1;PNPT1;MTM1;SUPV3L1
prerank,ncRNA export from nucleus (GO:0097064),0.3451508836747901,0.9235989696755628,0.5636588380716935,1.0,1.0,10/36,17.37%,RANBP2;TSC1;NUP155;NUP205;NDC1;NUP160;XPOT;POM121;AAAS;SSB
prerank,response to hydrogen peroxide (GO:0042542),0.33526323071067893,0.9235761007504992,0.5681544028950543,1.0,1.0,14/45,20.82%,APTX;MAPK7;CYP1B1;FYN;NFE2L2;HDAC6;PRDX3;ABL1;PAX2;RIPK1;CAT;PARK7;OSER1;SIRPA
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.37512011713918275,0.9234657855426393,0.556910569105691,1.0,1.0,3/22,10.17%,CRLF3;CYP1B1;ERBB4
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.2599056285444278,-0.922936205161578,0.6551724137931034,0.872373204530844,1.0,14/40,18.11%,PRKCD;PARG;NPAS2;MCL1;POLH;ING2;ARMT1;ETAA1;SMYD2;MAPT;HMGA2;UBE2N;BCLAF1;FXR2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.28860258937047756,0.9228618777682789,0.656441717791411,1.0,1.0,41/186,19.46%,SOSTDC1;TPBGL;TAX1BP3;RBMS3;LRP4;SOX9;VGLL4;PRKN;LRP1;FRZB;JADE1;TLE1;WIF1;GLI1;WNT5A;SHISA2;PSMB7;DKK3;CUL3;SFRP4;TMEM131L;EMD;PRICKLE1;APC2;DVL1;WWTR1;CSNK1A1;KLHL12;PSMD2;SCYL2;PSMC1;DACT1;WWOX;TLE3;PSMB2;TLE4;MDK;PSMD9;RUVBL2;NKD2;PSME4
prerank,positive regulation of ERAD pathway (GO:1904294),0.4247868320991751,0.9226763882817756,0.583963691376702,1.0,1.0,7/13,23.06%,RNFT1;HERPUD1;NFE2L2;USP13;SGTA;UBQLN1;UBQLN2
prerank,"phototransduction, visible light (GO:0007603)",0.40732570959742725,0.92255150932946,0.5636094674556213,1.0,1.0,1/14,1.69%,RHO
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.3808200058455521,0.922322356907965,0.5918079096045198,1.0,1.0,6/22,18.25%,EDEM3;UGGT2;DERL2;EDEM2;UBB;MAN1A2
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.2963685860765308,0.9218884381451383,0.6388888888888888,1.0,1.0,32/166,16.11%,SLC27A1;GLI2;FGF2;MYC;IRS2;ERBB2;EGFR;PTPN2;UPF3A;PLD1;GLI1;NIBAN1;STN1;METTL3;MLXIPL;EIF3C;CPEB3;EIF6;NSUN5;PASK;ELOVL5;HIF1A;PAOX;SP1;PRMT1;DDB1;SMOC2;SNCA;ZEB2;PRR16;RPS27L;GPLD1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3733836099833899,0.9217128681810238,0.5706806282722513,1.0,1.0,5/23,12.38%,CBLB;SOCS5;SNX6;CBL;ZGPAT
prerank,cellular response to interleukin-4 (GO:0071353),-0.3816556504960571,-0.9216509937227576,0.5357142857142857,0.8742776738481858,1.0,1/10,0.63%,LEF1
prerank,endocrine system development (GO:0035270),0.38177056734420967,0.9211764973778085,0.5694822888283378,1.0,1.0,4/21,9.21%,GLI2;NF1;HOXD3;DKK3
prerank,protein autophosphorylation (GO:0046777),0.2948262648735726,0.9205709987963789,0.6326742976066597,1.0,1.0,23/157,10.26%,WNK2;PDGFRA;PEAK1;ERBB2;EGFR;PRKX;MAP3K3;WNK3;SIK2;EIF2AK3;MAPKAPK3;TEC;NTRK2;MAPKAPK2;TNIK;EEF2K;PAK1;CDKL5;FGFR1;PASK;STK39;ERBB4;SLK
prerank,negative regulation of hemostasis (GO:1900047),-0.3461489992253976,-0.9205066571310279,0.5632911392405063,0.8759845714770045,1.0,6/12,18.75%,VTN;THBD;TFPI;SERPINE1;EDN1;APOE
prerank,reticulophagy (GO:0061709),-0.3569258836330319,-0.9202392585559926,0.5269461077844312,0.8753414650945673,1.0,5/12,21.19%,TEX264;UFM1;UFC1;UBA5;ULK1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.3567725674922916,0.9201949182987855,0.5633986928104575,1.0,1.0,11/30,21.71%,FBXW7;VPS11;HUWE1;UBE2J2;SREBF2;CSNK2A2;UBE2L3;MICALL2;RHOU;NPEPPS;UBE2D3
prerank,phosphorylation (GO:0016310),0.286162426160912,0.9198977760588345,0.7211634904714143,1.0,1.0,66/384,13.11%,WNK2;CCL11;PRKCA;PEAK1;STK36;ERBB2;ACVR1;MAP4K4;PAK4;EPHB2;GNPTAB;IRAK3;WNK3;SIK2;EIF2AK3;RPS6KA4;MAST2;NEK1;TGFB1;TEC;PAK5;MAPKAPK2;TESK2;PRKAR1B;TNIK;ACVR1C;PAK1;PKN1;YWHAZ;CDKL5;CDK8;CDKL3;CDK13;TGFBR2;CSK;PPP3CB;DYRK1B;PDK3;LIMK1;CDK6;FGFR1;FYN;CDK15;TBCK;CDK19;PASK;STK39;TLK2;MAPK9;AKT3;SGK3;SGK2;PXK;TYK2;DGKI;DCLK1;CDC25B;TOLLIP;MAPK1;TAOK3;TBK1;PRKACA;CSNK1A1;NEK7;CDK16;SHPK
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.3127226087381308,-0.9198315850417786,0.5986159169550173,0.8750961618540829,1.0,9/20,30.18%,AGO1;ZC3H7B;AGO3;TERT;TARBP2;MRPL44;AGO2;DICER1;AGO4
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.2941275572998637,0.919797648770764,0.661139896373057,1.0,1.0,38/172,20.23%,PLEKHA4;INPP4B;SLC27A1;FGF2;PTEN;RAB14;PLD1;MTMR14;SLC44A2;PTPN13;AGPAT2;PI4KB;VAC14;PLA2G12A;PTDSS1;PIK3R1;PI4K2A;SELENOI;FAR1;MTMR12;PCYT1B;CHPT1;ETNK1;RAB4A;AGPAT5;CHAT;GPAT3;GPAT4;PIP5K1A;CPNE7;AGK;SLC44A1;CSNK2A2;LPCAT2;CPNE1;STARD7;DDHD1;INPP5J
prerank,mammary gland development (GO:0030879),0.38375946865438054,0.9197527256439899,0.5753424657534246,1.0,1.0,6/21,17.72%,GLI2;VEGFA;ERBB4;PRLR;TGFB3;GPAT4
prerank,RNA catabolic process (GO:0006401),0.33081295333074534,0.9197106787483713,0.5875299760191847,1.0,1.0,8/46,12.39%,RNASE6;DXO;METTL3;XRN2;PPP1R8;NCBP1;ZFP36L2;RNASEH2C
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.43174871717732244,0.9193952311449224,0.5496987951807228,1.0,1.0,1/11,1.25%,BACE2
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.32663491049242566,0.919345957056688,0.6037079953650057,1.0,1.0,9/52,15.77%,DDX11;DNAJB9;CXXC1;WIPI1;EXTL3;MYDGF;ARFGAP1;LMNA;KDELR3
prerank,regulation of interleukin-13 production (GO:0032656),-0.33242821260248173,-0.9192435299339236,0.5747800586510264,0.8752029274178059,1.0,5/13,24.24%,LEF1;PRKCZ;RARA;TNFRSF21;SPHK2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.4142909333092021,0.9192367564975685,0.57847533632287,1.0,1.0,4/13,15.48%,SPRED2;SPRED1;SPRED3;ATM
prerank,DNA strand elongation (GO:0022616),-0.31189707343238393,-0.9191205336443449,0.5563380281690141,0.8741760587319115,1.0,11/18,30.85%,POLD3;POLA1;TERT;DCLRE1B;NBN;RFC3;GINS4;POLD2;MRE11;GINS1;MCM3
prerank,synaptic vesicle membrane organization (GO:0048499),0.3906804300542976,0.9190583087089187,0.5931232091690545,1.0,1.0,2/17,5.65%,SNAP23;SNAP29
prerank,steroid metabolic process (GO:0008202),0.3128156940025509,0.918998809879527,0.591812865497076,1.0,1.0,16/72,25.15%,HSD17B7;NPC1;GBA2;CYP39A1;CYP1B1;CYP7B1;PRLR;CYP27A1;LRP2;TSPO;SCP2;HSD17B4;GC;SULT1A1;STARD3;AMACR
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.31405664237049236,0.9186554275914819,0.5974625144175317,1.0,1.0,7/70,6.95%,ERBB3;BCL2;NGF;FADD;TNFRSF10B;TGFB1;DEDD
prerank,histone H2A ubiquitination (GO:0033522),0.3973465616209992,0.9185889439963574,0.5815295815295816,1.0,1.0,8/17,27.85%,DDB2;DDB1;CUL4B;BCOR;RNF2;PCGF1;RNF168;TRIM37
prerank,regulation of cellular senescence (GO:2000772),-0.277370490852062,-0.9182595178920748,0.6129032258064516,0.8750029272802888,1.0,12/28,22.02%,NUAK1;SLC30A10;YBX1;TERF2;ING2;HMGA2;TERT;ABI3;RBL1;TWIST1;EEF1E1;VASH1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.3297347118738628,0.9181231282192399,0.5927710843373494,1.0,1.0,10/47,16.74%,SLC27A1;CD34;ERLIN2;FBXW7;FYN;BRCA1;CRY1;KHSRP;ERLIN1;MPV17L
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.4044050059623874,0.9176508430543976,0.5952380952380952,1.0,1.0,2/15,6.20%,PTPN2;METTL3
prerank,lung epithelium development (GO:0060428),0.4340457148862046,0.9175293362076941,0.5797788309636651,1.0,1.0,4/10,16.83%,FGF10;RCN3;PKD1;FOXJ1
prerank,regulation of cell cycle (GO:0051726),0.28558449172145134,0.9175082534776282,0.6918429003021148,1.0,1.0,67/271,20.05%,FAP;CRLF3;MYC;FGF10;KIF20B;KAT2B;SOX9;CDKN2B;TGM1;TGFB1;NUPR2;PPP1R15A;CKS1B;APBB2;METTL3;TSC1;MLXIPL;SETMAR;SON;GBF1;GATA6;CDK6;MEN1;FOXM1;BIN1;NF2;BRCA1;UHRF2;LIN9;BMP7;MAGI2;ING4;PRKACA;TMEM8B;NEK7;ADARB1;GATA3;RBBP4;PRDM11;RPS6KA2;PKD1;CITED2;IQGAP1;MED25;CDC14A;ATM;FZD9;ABL1;PIM2;TP53;XIAP;TRNP1;PNPT1;HNRNPU;RNF167;NUDT6;CTBP1;MLF1;FBXO5;BOP1;MDM2;CSNK2A2;PDCD4;FBXL12;JUN;STAT3;DUSP1
prerank,ureteric bud development (GO:0001657),0.39647822120333254,0.9172593477638857,0.5839112343966713,1.0,1.0,1/17,0.27%,GPC3
prerank,regulation of RNA export from nucleus (GO:0046831),0.4262658108165838,0.9172265142376638,0.5844748858447488,1.0,1.0,2/11,9.87%,CPSF6;SETD2
prerank,response to cytokine (GO:0034097),0.2938558095135163,0.916803037802836,0.6538060479666319,1.0,1.0,20/141,12.64%,AFF3;PRKCA;KYNU;BCL2;IL1RAPL1;PTPN2;IRAK3;MAPKAPK3;MAPKAPK2;PTPN13;IL1RL2;COL3A1;SETD2;AKAP6;PTPN11;TAF9;IL6ST;PID1;TBK1;PTPN18
prerank,DNA metabolic process (GO:0006259),0.2861896184453188,0.9163976334377296,0.7164328657314629,1.0,1.0,63/270,19.46%,UBE2T;CBS;LRWD1;NUDT15;ZRANB3;MBD4;POLE2;CHRNA4;ERCC5;NSMCE3;ERCC4;MPG;DDB2;STN1;RPA3;NUDT1;SETMAR;MUTYH;MEN1;BRCA1;XPA;REXO4;TDP1;UHRF2;POLE3;NEIL1;ENDOV;MCM4;FANCC;HELLS;ASF1A;MSH6;UPF1;ZBTB1;XRCC6;DDB1;XRCC3;EXD2;RPA2;ORC1;TOPBP1;PDS5B;RTEL1;SUMO1;SMUG1;UBB;ATM;TRRAP;CSNK1E;RAD52;BLM;POLG;TERF2IP;WRN;NSMCE4A;ORC4;DDX23;PARK7;DBF4;LIG3;CNBP;TOP1;PSME4
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.31552066891611547,0.9162521769652693,0.591116173120729,1.0,1.0,7/60,6.18%,PTEN;CBFB;SOX9;CCNC;MED31;ATF7IP;CDK8
prerank,regulation of ATP metabolic process (GO:1903578),-0.23569382554497162,-0.9162319930520535,0.6830985915492958,0.8786839064828432,1.0,15/54,19.34%,PRKAG2;NUP93;NUP107;ATP7A;OGT;SLC25A33;PGAM1;NUP214;NUP43;NUP210;NUP88;PINK1;AK4;BEND3;NUP98
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4342988889613607,0.9161258014860401,0.5616438356164384,1.0,1.0,3/11,14.38%,RASA1;PCBP4;NOVA1
prerank,phagosome maturation (GO:0090382),0.3420475812218907,0.9159433533156417,0.6188630490956072,1.0,1.0,14/35,27.44%,RAB38;RAB14;ATP6V1B2;RAB34;RAB39A;MREG;ATP6V1C1;RAB7A;ATP6V0E2;ATP6V0E1;ATP6V1G2;ATP6V1H;TCIRG1;ATP6V1D
prerank,regulation of necroptotic process (GO:0060544),-0.2985712668077701,-0.9159019147498493,0.5884615384615385,0.8781970068002848,1.0,9/23,18.72%,BIRC3;OGT;STUB1;CASP8;HSP90AA1;FLOT1;ARHGEF2;SPATA2;CFLAR
prerank,protein modification by small protein removal (GO:0070646),0.2853342453021543,0.9155445001383887,0.6847389558232931,1.0,1.0,67/252,22.27%,USP50;MYC;PTEN;RAD23B;USP35;KAT2B;USP11;PRKN;SENP3;DDB2;OTUD7B;UCHL5;INO80E;BRCA1;PSMB7;UCHL1;USP46;HIF1A;TOMM20;MYSM1;USP33;ESR1;UCHL3;NFRKB;USP32;USP48;GATA3;NEDD8;USP40;MDM4;SENP2;PSMD2;USP14;UBB;IL33;PSMC1;TRRAP;TP53;USP1;ASXL2;USP25;USP21;PSMB2;USP2;RIPK1;OTUD4;MDM2;USP37;RHOT1;OTUD7A;PSMD9;ATXN7;USP5;SENP1;PSME4;COPS6;MCRS1;MBD6;USP13;PSMA8;COPS7A;JOSD1;TNIP2;ARRB2;USP31;ACTR5;RNF123
prerank,regulation of viral transcription (GO:0046782),0.33738221009751335,0.9155007185293197,0.5892634207240949,1.0,1.0,12/39,24.42%,MDFIC;POLR2B;TRIM11;POLR2K;MID2;POLR2G;POLR2A;ZFP36;CDK9;TRIM14;POLR2F;UBP1
prerank,regulation of cholesterol efflux (GO:0010874),0.34425707411474443,0.9154936762263715,0.5773195876288659,1.0,1.0,4/30,10.89%,PTCH1;LRP1;ZDHHC8;ABCA5
prerank,response to glucose (GO:0009749),0.3279071383913158,0.9152943751412126,0.5832335329341317,1.0,1.0,11/46,17.90%,IRS2;ZBTB20;TRA2B;PDK3;EIF2B5;SELENOS;PRKACA;GPLD1;PAX2;EIF2B2;PCK2
prerank,embryonic hemopoiesis (GO:0035162),-0.35794426023922565,-0.9147862038144223,0.5727272727272728,0.8795906750899544,1.0,7/12,20.90%,KIT;KDR;KITLG;FLT3LG;TAL1;ZFPM1;ATF4
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.4158949397604,0.9147721755285453,0.5673652694610778,1.0,1.0,3/13,11.11%,CHRDL1;DAND5;LTBP1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.30242689358596625,0.9146980052534625,0.6184782608695653,1.0,1.0,20/94,16.49%,PYCARD;BCL2;SCN2A;TNFRSF10B;PPP1R15A;APAF1;CYP1B1;BNIP3;BRCA1;CUL3;HINT1;MSH6;ARL6IP5;TMEM117;CASP2;ATM;ABL1;TP53;BCL2L11;QRICH1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3707892261601927,0.9143973866475851,0.5807743658210948,1.0,1.0,4/23,12.77%,CRLF3;CYP1B1;ERBB4;PRLR
prerank,lipid translocation (GO:0034204),-0.3116506730615049,-0.9140477731861447,0.6097560975609756,0.8801164859617373,1.0,12/21,21.90%,ATP10A;ABCA1;ATP9A;ABCA4;ATP11A;ATP8B2;ATP11B;ABCB4;ATP10B;ATP8A1;ABCA7;TMEM30A
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.39065768075209834,0.9137990663416875,0.5688202247191011,1.0,1.0,5/17,12.84%,MAPK7;BAG5;NFE2L2;SFPQ;SOD2
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.35824296639015446,-0.9137670455318229,0.5304347826086957,0.879510972789401,1.0,4/11,8.44%,P4HB;OGFOD1;P4HA2;EGLN2
prerank,cytoplasmic microtubule organization (GO:0031122),-0.2399400909572784,-0.91346916449002,0.6081081081081081,0.8789156269169742,1.0,16/54,16.76%,CLIP4;CLIP3;CLIP1;FIGNL2;TUBGCP4;TUBGCP3;TUBGCP6;WDR73;RHOA;DCTN1;NUMA1;MAPT;TRPV4;CCDC88C;VPS4B;TUBGCP2
prerank,mRNA export from nucleus (GO:0006406),0.30059228561052803,0.9132790051576785,0.6205405405405405,1.0,1.0,36/102,26.38%,THOC6;RANBP2;NUP155;MCM3AP;SRSF11;CASC3;ALKBH5;NCBP1;FIP1L1;NUP205;NDC1;NUP160;UPF1;DDX25;NXT1;SRSF6;YTHDC1;POM121;SMG6;AAAS;NXF1;RNPS1;PCID2;THOC7;SRRM1;SRSF3;FYTTD1;NUP42;GLE1;SYMPK;THOC5;MAGOHB;ENY2;NUP35;HNRNPA2B1;RAE1
prerank,regulation of exit from mitosis (GO:0007096),0.34184502195125444,0.9130794493886998,0.5813664596273292,1.0,1.0,14/38,23.63%,ANAPC7;ANAPC2;BUB1B;UBB;CDC14A;CDC23;ANLN;ANAPC16;CDC27;PHB2;UBE2E1;ANAPC4;ANAPC5;CDC16
prerank,mitochondrial translational elongation (GO:0070125),0.3079449148502755,0.9130674561526704,0.645610278372591,1.0,1.0,25/88,22.45%,MRPL47;MRPS18A;TUFM;MRPL14;MRPL32;MRPL16;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;MRPL30;MRPL28;MRPL46;MRPL51;MRPS30;MRPS14;MRPS9;MRPS31;MRPL1;PTCD3;DAP3;MRPS6;MRPL52;MRPL18
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.3998469199710122,0.9125245462340332,0.5808383233532934,1.0,1.0,3/15,9.99%,PABPC1;CPEB3;ZFP36L2
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.3998469199710122,0.9125245462340332,0.5808383233532934,1.0,1.0,3/15,9.99%,PABPC1;CPEB3;ZFP36L2
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.3386042633933265,0.9124654080052678,0.5934861278648975,1.0,1.0,10/39,17.09%,GTF2H2;ERCC5;ERCC4;DDB2;RPA3;XPA;DDB1;RPA2;UBB;CUL4B
prerank,myoblast fusion (GO:0007520),0.41818756354901154,0.9124372422018475,0.5752351097178683,1.0,1.0,4/12,21.92%,ADGRB3;CD9;ADAM12;CACNA1H
prerank,positive regulation of cell growth (GO:0030307),0.30042910962283514,0.9123741334308917,0.6351791530944625,1.0,1.0,25/96,19.95%,RNF157;BCL2;NGF;ERBB2;EGFR;SYT1;CDKL5;LIMK1;DERL2;NCBP1;EIF4G1;EXOSC2;AKAP6;RIMS1;BRAT1;NEDD4L;KLHL22;PLAA;HYAL1;SYT2;RPTOR;RIMS2;SEMA4D;N6AMT1;SHTN1
prerank,hexose biosynthetic process (GO:0019319),-0.24767082469749213,-0.9122678305418929,0.6173469387755102,0.8806597272864577,1.0,13/42,23.62%,RBP4;CHST15;PGK1;PGAM1;GPI;SORD;CRTC2;SLC25A12;ENO1;GOT1;ATF4;GAPDHS;ENO3
prerank,aerobic respiration (GO:0009060),-0.30374279126102327,-0.9118246599135791,0.5536912751677853,0.8804554096341823,1.0,10/20,28.40%,SDHB;SIRT3;OXA1L;UQCRB;ATP5F1D;UQCR10;UQCRH;UQCRC1;SURF1;MTFR2
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.2883478680935485,-0.9117530656913525,0.6008064516129032,0.8793131336092687,1.0,3/22,4.65%,SORBS1;CREBL2;PPARD
prerank,retrograde axonal transport (GO:0008090),-0.3206824167153604,-0.9117127685191562,0.5664556962025317,0.878109588239815,1.0,4/16,11.34%,KIF1C;PAFAH1B1;KIF5B;SOD1
prerank,cellular response to superoxide (GO:0071451),-0.37464987379164344,-0.9116012299518015,0.5605633802816902,0.8770835441669796,1.0,4/10,11.34%,NOS3;ATP7A;ADPRS;SOD1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.42486875155753756,0.9113098771643228,0.5816023738872403,1.0,1.0,2/11,9.88%,DDX11;PIH1D1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.34188220973140193,0.9108665798400519,0.6025316455696202,1.0,1.0,7/35,15.48%,PRKCQ;CCT7;MAPK1;NEK7;MAP3K4;RTEL1;ATM
prerank,ERAD pathway (GO:0036503),0.30460056710508476,0.9101751715478001,0.6256860592755215,1.0,1.0,31/83,26.29%,PRKN;ERLIN2;DNAJB9;RHBDD2;UGGT2;RCN3;FBXO27;DERL2;SELENOS;HERPUD1;UBE2J2;RNF121;FBXO17;TMUB2;HSP90B1;CCDC47;JKAMP;ERLIN1;DNAJC10;USP13;SGTA;UBXN6;RHBDD1;FBXO44;UBQLN1;UBQLN2;MAN1B1;UBXN8;ERLEC1;TMEM67;SGTB
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.332326173084746,-0.9101551642033655,0.6046511627906976,0.8792456844321234,1.0,5/13,14.08%,NFKBIA;GOPC;KEAP1;GET4;MDFI
prerank,regulation of interleukin-8 production (GO:0032677),0.31169951135473467,0.9099266530528424,0.6189402480270575,1.0,1.0,18/69,24.52%,PYCARD;PTPN22;FADD;OTUD7B;TLR1;RAB1A;SSC5D;CD74;RIPK1;MAPKBP1;LBP;PARK7;BCL10;STAT3;PRKD2;BCL3;MAVS;HSPA1A
prerank,activation of protein kinase activity (GO:0032147),0.301743807757576,0.9098968648434287,0.6485042735042735,1.0,1.0,15/106,7.90%,NTRK3;MAP4K4;VEGFA;PAK4;TNFRSF10B;PAK5;MT3;PRKAR1B;TNIK;WNT5A;PAK1;MAPKAP1;TGFBR2;PRRC1;IL18
prerank,regulation of keratinocyte differentiation (GO:0045616),0.3640745836710654,0.9097916574228981,0.5964673913043478,1.0,1.0,4/24,6.64%,ETV4;CBFB;HOXA7;CTSK
prerank,regulation of cellular protein localization (GO:1903827),0.3272270349852213,0.909603209855947,0.6177184466019418,1.0,1.0,11/45,15.98%,GPC3;RALB;GBF1;PTPN1;SETD2;GPC1;DVL1;GPC4;KCNAB2;CSNK1E;SPIDR
prerank,cellular calcium ion homeostasis (GO:0006874),0.29409341803672245,0.9094951241269053,0.6673596673596673,1.0,1.0,23/133,15.54%,CCL11;BCL2;ANK2;LETM1;ATP2B3;PACS2;PSEN1;CCR2;PDZD8;SLC8A2;SLC24A5;SLC10A7;HTR2C;HERPUD1;ANXA6;EDN3;PRKACA;TPCN2;ATP2B1;CCDC47;TRPC5;CCL14;FZD9
prerank,blood vessel morphogenesis (GO:0048514),0.32286761749306236,0.9094253027773372,0.6109785202863962,1.0,1.0,9/54,7.15%,HAS2;GLMN;VEGFA;TGFB1;ITGB8;NF1;RASA1;TGFBR2;CYP1B1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.3191760309187797,0.9093721199779529,0.6257242178447276,1.0,1.0,15/57,17.88%,WAC;TIPIN;MRNIP;BRCA1;ATF2;TAOK3;STK33;MDC1;RPA2;TOPBP1;ATM;BLM;RPS27L;TP53;FBXO31
prerank,membrane depolarization during action potential (GO:0086010),0.35745660463102485,0.9093098174956717,0.6021361815754339,1.0,1.0,4/26,6.94%,SCN7A;SCN2A;SCN5A;SCN3A
prerank,mitotic spindle organization (GO:0007052),0.29012327146106065,0.908779506246533,0.6642636457260556,1.0,1.0,22/153,14.45%,DYNLL1;EFHC1;XPO1;GPSM2;TBCE;RANBP2;EML1;ARHGEF10;NDE1;STAG2;FLNA;DYNC1I1;RCC1;CLASP1;NUP160;SGO1;ZWINT;CKAP5;KPNB1;BUB1B;DYNC1I2;ITGB3BP
prerank,regulation of p38MAPK cascade (GO:1900744),0.3439542853359067,0.9086117188344572,0.6113924050632912,1.0,1.0,12/35,23.35%,PTPN22;VEGFA;NCF1;PRMT1;PER1;MAP3K4;RELL2;EMC10;DUSP1;PJA2;CYLD;BMP2
prerank,superoxide metabolic process (GO:0006801),0.3555677521721515,0.9085546537110799,0.5856777493606138,1.0,1.0,6/29,12.84%,NCF1;MT3;NOX1;TAFA4;NCF2;SOD2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.3460704404082525,0.9082811200018454,0.5957178841309824,1.0,1.0,9/32,17.37%,RANBP2;NUP155;NUP205;NDC1;NUP160;XPOT;POM121;AAAS;SSB
prerank,tRNA export from nucleus (GO:0006409),0.3460704404082525,0.9082811200018454,0.5957178841309824,1.0,1.0,9/32,17.37%,RANBP2;NUP155;NUP205;NDC1;NUP160;XPOT;POM121;AAAS;SSB
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.2687748949104398,-0.9081950709743933,0.6363636363636364,0.8828726750000532,1.0,9/33,13.20%,ACER2;LYN;JAM3;DPP4;EPHA8;SERPINE1;TGFB2;NEXMIF;NCKAP1L
prerank,stem cell differentiation (GO:0048863),-0.25931200800045706,-0.9080607427766207,0.583732057416268,0.8818968860381514,1.0,11/39,14.56%,KIT;OSR1;MLLT3;MTF2;ACE;FBXL17;FGFR2;TGFB2;PTPRC;EEF1AKMT4-ECE2;HMGA2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.4363893148702993,0.907960847974791,0.5837245696400626,1.0,1.0,1/11,1.07%,SLC27A1
prerank,actin polymerization or depolymerization (GO:0008154),0.3201074028392915,0.9079053820141085,0.6284680337756333,1.0,1.0,4/50,3.06%,ENAH;SPIRE1;GSN;GAS7
prerank,cellular respiration (GO:0045333),-0.24402079368868695,-0.9077653346631478,0.6444444444444445,0.8813339449299248,1.0,18/41,28.40%,COQ10B;SDHB;SIRT3;OXA1L;UQCRB;ATP5F1D;ETFRF1;ETFB;SDHA;SDHAF4;UQCR10;UQCRH;UQCRFS1;UQCRC1;CYCS;SURF1;NR4A3;MTFR2
prerank,glycogen metabolic process (GO:0005977),-0.2813670624199881,-0.907715430704923,0.6160714285714286,0.8801414032477325,1.0,6/27,10.00%,PRKAG2;PYGB;GSK3B;AGL;PYGM;GAA
prerank,calcium import into the mitochondrion (GO:0036444),-0.37884064186988176,-0.9075301681721191,0.5887323943661972,0.8792692044248858,1.0,3/10,16.40%,MICU1;MCUB;MICU3
prerank,mitochondrial genome maintenance (GO:0000002),0.427774385218008,0.9074461604382408,0.5966514459665144,1.0,1.0,8/11,27.60%,AKT3;OPA1;TOP3A;MGME1;MEF2A;SLC25A36;MPV17;LONP1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3658244679825968,0.9073814917836142,0.5959731543624162,1.0,1.0,14/24,31.28%,EED;CREBZF;EPC1;JARID2;RBBP4;PHF19;RBBP7;MPHOSPH8;AEBP2;EZH2;DNMT1;SMYD5;DNMT3B;PPHLN1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.29574392414615075,-0.9072930268861168,0.5924657534246576,0.8785700494810111,1.0,4/20,11.63%,IL1R1;CD55;PRKCZ;MAP3K7
prerank,steroid catabolic process (GO:0006706),0.42615335124026293,0.9063198590850186,0.6012861736334405,1.0,1.0,1/10,4.64%,HSD17B11
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.4444149088407011,0.906272349262743,0.6021671826625387,1.0,1.0,2/10,4.45%,CACNA2D1;PDE4B
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.3249553765583117,-0.9061889090451896,0.5977859778597786,0.8801724534637704,1.0,12/16,51.68%,TNFRSF21;TYROBP;DLL1;VSIR;AGER;LILRB1;PDCD1LG2;IL23A;FOXP3;IL23R;TRIB2;IL12B
prerank,positive regulation of TOR signaling (GO:0032008),-0.2549592445636264,-0.9057574260342893,0.627906976744186,0.8799267121318448,1.0,14/40,21.20%,SIK3;WDR59;RICTOR;RRAGC;FLCN;LARS1;PIP4P1;NCKAP1L;RHEB;SMCR8;GPR137;RRAGB;LAMTOR1;HDAC3
prerank,negative regulation of hormone secretion (GO:0046888),-0.37521405394791696,-0.9057498258963669,0.5549738219895288,0.8786536421143111,1.0,1/10,1.42%,GJA1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.41703491470158793,0.905565461189218,0.5799418604651163,1.0,1.0,1/12,2.53%,SLC5A3
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.32340344103306,0.904890517144755,0.6223021582733813,1.0,1.0,22/50,29.72%,CDKN2B;CCNJ;PKMYT1;CDK5R1;TTBK1;CDK5R2;BLM;CCND2;BCCIP;CCNT2;CCNH;CDC37;CDK5RAP3;CDKN1A;CCND3;CCNI;GTPBP4;CCNE1;CDKN1C;CDKN2D;CDKN1B;CAMK2N1
prerank,protein prenylation (GO:0018342),-0.37413079304439656,-0.9046303741772564,0.5859154929577465,0.8800956873507015,1.0,6/10,30.33%,PGGT1B;CHML;FNTB;RCE1;FNTA;RABGGTA
prerank,vascular transport (GO:0010232),0.30517948958895746,0.9041575609602638,0.6524122807017544,1.0,1.0,10/81,5.90%,SLC22A3;SLC1A3;SLC27A1;SLC1A5;SLC5A3;LRP1;SLC27A4;SLC12A2;SLCO2B1;SLC29A1
prerank,negative regulation of protein binding (GO:0032091),-0.21823779564640497,-0.9039734894228081,0.6616541353383458,0.8803408794254987,1.0,22/71,22.56%,DAB2;MAP2;ROCK1;PRKCD;IFIT2;TTBK2;KDM1A;GSK3B;CAMK1;RACK1;ADAM15;PEX14;ATP2A3;CAV1;GTF2F1;ZFPM1;CFHR2;HFE;IFIT1;ADRB2;AKT1;ATP2A2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.3481042317122511,0.903924235414776,0.6097256857855362,1.0,1.0,3/31,3.89%,PTEN;GORASP1;FBXW7
prerank,regulation of fibroblast migration (GO:0010762),0.367108896331093,0.9036731254182081,0.5958620689655172,1.0,1.0,2/20,4.08%,FGF2;TGFB1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.34175676288613616,0.9036143359475389,0.5949197860962567,1.0,1.0,5/31,7.62%,PTCH1;SOX9;TWIST2;CDK6;MEN1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.27708675813795786,0.9035094719101243,0.8128128128128128,1.0,1.0,129/572,22.10%,OSR2;PTCH1;TENM2;MLIP;GLI2;SOX8;AASS;PRDM16;MYC;TGIF2;CBFB;ZNF25;SOX9;PRKN;RIPPLY2;SUV39H1;HIVEP1;OTP;HOXA7;SATB1;VEGFA;NFX1;FOXP2;GATAD2A;PSEN1;EZH1;SOX11;NUPR2;ZEB1;URI1;EED;OTUD7B;ZBTB16;RORC;MTA2;MLX;TRPS1;DRAP1;E2F6;LRRFIP1;GATA6;CBX4;MEN1;FOXM1;CHD3;VPS72;CPEB3;ATRX;KCTD1;RARG;MBD2;RARB;PPID;LDB2;HDAC2;NFATC3;ESR1;SIN3B;SFPQ;SIRT6;DCAF1;EPC1;PER3;ZGPAT;FOXP4;ZBTB1;NR6A1;NRIP1;ZFPM2;PER1;GATA3;NACC2;SNCA;LCOR;MDM4;NEDD4L;SUMO1;CRY1;NCOR2;CITED2;TAF7;CREM;ZEB2;UBB;IL33;MED25;DACT1;RUNX1;TP53;MTA3;SREBF2;HNRNPU;WWOX;FOXJ1;USP2;CDC73;NFIX;CTBP1;SUFU;MDM2;KLF7;FNIP1;TAF1;SEMA4D;CGGBP1;CNBP;BCOR;PPARG;JUN;STAT3;PRDM2;YEATS2;ORC2;SMARCA4;JDP2;ZFP36;NR1D2;GATAD2B;DPF2;NFKB1;MITF;THRA;NSD1;ZMYM5;ZNF8;UBE2D3;CBX5;PPM1A;IRF8
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.396328379999018,0.9034945694462448,0.5778816199376947,1.0,1.0,4/15,13.00%,DERL2;SELENOS;HERPUD1;HSP90B1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.3366026867209157,0.9033694086045703,0.6144430844553244,1.0,1.0,5/40,7.73%,HRK;PYCARD;PRKN;BMF;BNIP3
prerank,motor neuron axon guidance (GO:0008045),-0.33106963148748686,-0.903350870231015,0.6049382716049383,0.8805869771132128,1.0,3/15,6.20%,EPHA4;SLIT2;TMEFF1
prerank,telomere maintenance via telomerase (GO:0007004),-0.26841453590407105,-0.9031604916089484,0.5955555555555555,0.8797665210910279,1.0,11/28,18.97%,TERF2;RFC1;DKC1;WRAP53;HSP90AA1;CDK2;TERT;PINX1;GAR1;HSP90AB1;TINF2
prerank,tRNA transport (GO:0051031),0.33898784075691907,0.90312304586972,0.6012422360248447,1.0,1.0,10/35,17.37%,RANBP2;NUP155;TOMM20;NUP205;NDC1;NUP160;XPOT;POM121;AAAS;SSB
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.31858049380649467,0.9029585320317366,0.634090909090909,1.0,1.0,7/51,11.60%,CXCL10;VEGFA;ANO6;CCR2;PLA2G7;MAPK1;EDN3
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.35446020789986765,0.9029193167179818,0.5983935742971888,1.0,1.0,6/26,19.42%,ANK2;STK39;NEDD4L;ITGB1;NETO1;CAB39
prerank,axonemal dynein complex assembly (GO:0070286),0.35018387927636174,0.9025382696900361,0.599483204134367,1.0,1.0,2/27,2.93%,DNAI4;CCDC39
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.23556487631670084,-0.9022688184029292,0.6827586206896552,0.8806445002187749,1.0,27/57,28.00%,NPM1;RPS16;RPL38;RPS19;NVL;RPL5;RPS25;RPS15;NAF1;RPS6;RPL11;EMG1;SURF6;BYSL;RIOK1;RPL35A;RPL26;PES1;DHX37;CUL4A;RPS17;NOC2L;RPF2;RIOK2;URB2;PAK1IP1;MRPL36
prerank,regulation of protein modification process (GO:0031399),0.32005199695357917,0.9022421849509579,0.6014234875444839,1.0,1.0,9/50,9.89%,KAT2B;CADM4;MT3;SOCS1;SPRED2;SPRED1;RABL3;GRM5;SPRED3
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3241361729944909,0.9019977295826042,0.6188811188811189,1.0,1.0,19/47,26.64%,OLFM4;EFNA5;DOCK5;FLNA;DOCK1;MYOC;ABL1;RAC3;AP1AR;MDK;TESK1;KANK1;TRIOBP;SPRY4;CRK;CIB1;ARHGEF7;CORO1C;LIMS1
prerank,response to muscle stretch (GO:0035994),-0.32214894803292415,-0.901954397937895,0.555205047318612,0.8801288349450255,1.0,2/15,2.36%,CDH2;CTNNB1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.3798915022740123,0.9019403679453486,0.5877192982456141,1.0,1.0,3/20,7.90%,PYCARD;ANO6;IL18
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.28114140353825356,-0.9018935495563721,0.5968379446640316,0.8789815232634131,1.0,10/24,22.04%,XRN1;TERF2;DCP2;PARP1;PINX1;EXOSC10;TEN1;TINF2;TENT4B;HNRNPA1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.22995062559872742,-0.901786321879794,0.6518987341772152,0.8779730291141472,1.0,11/47,12.50%,PRKCD;TLR4;THBS1;AGTR1;DHRS4;PDGFRB;XDH;RNF41;CYBA;SOD1;MAPT
prerank,sensory organ development (GO:0007423),-0.2353866674254541,-0.9016635503529137,0.6848484848484848,0.8769706875994985,1.0,12/51,17.57%,SMOC1;RBP4;SIPA1L3;PBX3;STRA6;ECE1;TGFB2;PBX4;SHROOM2;SMG9;MAFB;PBX2
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.33360263772402365,-0.9011763186268585,0.596875,0.8768283971208363,1.0,3/15,3.26%,ZDHHC3;STXBP1;NLGN2
prerank,regulation of response to external stimulus (GO:0032101),0.2935160893003973,0.9008390478672321,0.6698615548455804,1.0,1.0,24/121,17.79%,ADAMTS12;PDGFRA;RHO;PTPN22;BST1;EPHB2;ELMOD2;CCR2;WNT5A;IL1RL2;UFL1;GATA6;CASP12;GRN;SHPK;P2RY12;CALM1;USP14;AREL1;XIAP;N4BP1;EFNB2;SPAAR;PTGES
prerank,negative regulation of receptor binding (GO:1900121),-0.37292879371663257,-0.9005378551357077,0.5959302325581395,0.8771425704597438,1.0,4/10,22.56%,ADAM15;ATP2A3;HFE;ATP2A2
prerank,regulation of vasculature development (GO:1901342),0.35304814408149415,0.9004954669504093,0.596078431372549,1.0,1.0,3/26,5.06%,FGF2;ERBB2;NF1
prerank,transport across blood-brain barrier (GO:0150104),0.30328276943654464,0.9003368248712436,0.6538882803943045,1.0,1.0,10/83,5.90%,SLC22A3;SLC1A3;SLC27A1;SLC1A5;SLC5A3;LRP1;SLC27A4;SLC12A2;SLCO2B1;SLC29A1
prerank,post-translational protein modification (GO:0043687),0.2801553460469193,0.9002848722011739,0.7437437437437437,1.0,1.0,77/332,21.37%,GPC3;VCAN;MXRA8;FBXW9;CHRDL1;LAMC1;RAB38;SOCS5;FBXW7;SPSB4;PRKCSH;ASB8;NUCB1;SDC2;KLHL13;OBSL1;FBXO7;FBXL15;DDB2;ASB5;FBXO32;ZBTB16;EVA1A;RCN1;MEN1;NAE1;ATG5;STT3A;VWA1;FBXL16;PSMB7;FBXO27;CKAP4;HIF1A;AMELX;CUL3;UCHL3;LTBP1;CALU;UBA3;FBXO17;RAB1A;FUCA2;DCAF8;RAB3A;BTBD1;HSP90B1;DDB1;PENK;SUMF1;NEDD8;DDA1;PSMD2;KLHL22;PSMC1;FBXL4;PSMB2;CUL4B;FBXO31;FBXO22;ELOC;PSMD9;CHM;FBXO11;PSME4;FBXL12;MBTPS1;FAM20C;DCAF7;COPS6;RBBP7;DCAF11;PSMA8;COPS7A;PDIA6;RHBDD1;DCAF6
prerank,regulation of mRNA metabolic process (GO:1903311),0.4214245156159194,0.9002190360833284,0.5918674698795181,1.0,1.0,3/11,24.51%,NCBP1;SLTM;SAFB2
prerank,glycolytic process (GO:0006096),-0.2729799005050314,-0.9000863604552031,0.5587044534412956,0.8769619592955247,1.0,12/28,30.51%,PGK1;PGAM4;PGAM1;GPI;PFKM;PFKL;ENO1;GAPDHS;ENO3;PKM;PFKFB2;LDHA
prerank,regulation of chemotaxis (GO:0050920),0.3467514078254968,0.899740977973359,0.5873850197109067,1.0,1.0,7/30,16.92%,PDGFRA;PTPN2;TGFB1;P2RY12;USP14;ZSWIM8;EFNB2
prerank,sensory perception of mechanical stimulus (GO:0050954),0.30036679715668063,0.8993387184833158,0.6496106785317018,1.0,1.0,13/85,16.13%,ROR1;PIEZO2;LHFPL5;PCDH15;LHFPL3;LHFPL4;HOMER2;LRTOMT;PAX3;COL1A1;CCDC50;CDC14A;LRP2
prerank,neural crest cell differentiation (GO:0014033),0.3774795910773484,0.8989744657482722,0.6036161335187761,1.0,1.0,2/18,4.44%,SOX8;SOX11
prerank,regulation of rRNA processing (GO:2000232),0.401595498435329,0.8989497737735309,0.6065808297567954,1.0,1.0,4/16,12.65%,KAT2B;SHQ1;HEATR1;TRMT112
prerank,cellular senescence (GO:0090398),-0.2778808430656081,-0.8985310895358481,0.6355555555555555,0.8794974606227087,1.0,12/27,26.36%,PRKCD;TBX3;TERF2;MAP2K1;ID2;PML;HMGA2;ECRG4;ULK3;CALR;HRAS;SRF
prerank,positive regulation of macroautophagy (GO:0016239),0.3256874097253461,0.8984281431785516,0.6123662306777645,1.0,1.0,4/48,7.73%,DCN;WAC;RALB;BNIP3
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3108827534256857,0.8983579959877961,0.6339794754846066,1.0,1.0,11/64,15.27%,FADS2;SLC27A4;LTA4H;CYP1B1;AIG1;ACOX1;ELOVL6;ELOVL5;PNPLA8;ACAD9;ACSL3
prerank,cardiac muscle cell action potential (GO:0086001),0.3523415163664215,0.8983287462541387,0.5943152454780362,1.0,1.0,5/30,7.67%,CACNA2D1;ANK2;SCN5A;FGF12;KCND3
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.31592781671664283,-0.8977969998302322,0.5944272445820433,0.8799902917029876,1.0,5/16,14.57%,ATP5MC3;ATP5PD;STOML2;ATP5F1D;ATP5MF
prerank,positive regulation of vasculogenesis (GO:2001214),0.42560792313593876,0.8970462669451704,0.5993975903614458,1.0,1.0,2/10,7.42%,CD34;RAP1A
prerank,mitotic cytokinetic process (GO:1902410),-0.2866222012193824,-0.897042493033073,0.6131386861313869,0.8805567408082146,1.0,7/20,23.97%,CHMP3;RHOA;VPS4A;CHMP1A;VPS4B;CHMP7;CHMP2B
prerank,Golgi ribbon formation (GO:0090161),0.405157653029205,0.8968230142474922,0.5975794251134644,1.0,1.0,2/13,8.69%,VAMP4;TRIP11
prerank,cellular response to UV (GO:0034644),0.3090498510571056,0.8967680116585837,0.6494960806270996,1.0,1.0,17/76,19.24%,MMP2;MYC;NSMCE3;ERCC4;DDB2;METTL3;BMF;XPA;PPID;ZBTB1;DDB1;TP53;HYAL1;N4BP1;CUL4B;TAF1;RUVBL2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.41150309690302594,0.896407001583812,0.6074766355140186,1.0,1.0,7/10,27.67%,EMC10;EMC1;EMC8;EMC3;EMC6;EMC2;EMC7
prerank,negative regulation of inflammatory response (GO:0050728),0.2828560063350617,0.8963667306327118,0.7303370786516854,1.0,1.0,19/182,13.20%,RORA;FFAR4;CRH;DPEP1;PTPN2;MAPK7;PTHLH;TNFAIP8L2;PRKAR1B;PTH2R;OTULIN;FYN;TSHR;SELENOS;MAPK14;GRN;PRKACA;GLP2R;GATA3
prerank,positive regulation of histone modification (GO:0031058),0.3372225269895079,0.8962245796559432,0.6151898734177215,1.0,1.0,3/33,8.60%,FAM47E;RPS6KA4;BRCA1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.36867861616634034,0.896033818995506,0.6180081855388813,1.0,1.0,6/21,15.55%,ANK2;AKAP6;PDE4D;PRKACA;CALM1;CALM2
prerank,regulation of Rho protein signal transduction (GO:0035023),0.306540710837476,0.8958827395529548,0.6328555678059536,1.0,1.0,14/72,15.54%,DLC1;AKAP13;LPAR1;GPR65;ARHGEF28;EPS8L1;COL3A1;CUL3;MYO9B;OPHN1;MYOC;ARHGEF3;MET;ABL1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.37640401387894906,-0.8957627331981853,0.5706521739130435,0.8822885597007838,1.0,2/10,14.78%,PTPRC;CEACAM1
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.3462259062789946,0.8952961626992971,0.6066666666666667,1.0,1.0,3/28,6.20%,EGFR;FBXW7;METTL3
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.3571100717799837,-0.8952753519097413,0.5931232091690545,0.8821925947429512,1.0,2/11,6.75%,NRP1;BCAR1
prerank,regulation of osteoblast proliferation (GO:0033688),-0.31646665734519625,-0.8950518761515492,0.6060606060606061,0.8814546714173507,1.0,7/17,15.61%,NPR3;MN1;FGFR2;CCN1;RHOA;PLXNB1;TMEM119
prerank,nucleocytoplasmic transport (GO:0006913),0.3274214223807684,0.895028930557265,0.6027742749054225,1.0,1.0,9/40,17.77%,XPO1;RSRC1;NCBP1;NUP205;MALT1;NXT1;HTATIP2;AAAS;GEMIN7
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.2725539995692632,-0.8950155745431905,0.6218487394957983,0.8802664506437939,1.0,6/29,14.82%,SMAD7;ENG;TPM1;FGFR2;PROX1;S1PR1
prerank,phospholipid metabolic process (GO:0006644),-0.22122877975755112,-0.8948889459313734,0.7142857142857143,0.8793178153541328,1.0,20/71,23.45%,PLA2G4A;PLPP1;GPAM;PLCD1;GNPAT;MBOAT1;TNFAIP8L3;PIP4P1;ACP6;AGPAT4;PIP4K2B;GPX4;PLA2G15;PGP;ABHD12;PLPPR5;LPL;CLN8;PNPLA3;PLA2G4C
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3365099657194647,0.8948847305197735,0.631578947368421,1.0,1.0,14/36,24.95%,WAC;UCHL5;BAG5;TLK2;TAF9;OPHN1;GABARAPL2;USP25;N4BP1;PARK7;CAMLG;PRKCG;ALAD;FHIT
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.32271712299407573,-0.8948075455334986,0.6346863468634686,0.8782389289919296,1.0,5/16,7.23%,IGF1;ROCK2;ROCK1;MTPN;PARP1
prerank,stem cell development (GO:0048864),0.39040907046186835,0.8947052216812608,0.5946745562130178,1.0,1.0,2/16,4.44%,SOX8;SOX11
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.4282488912841439,0.8946910041188774,0.6080870917573873,1.0,1.0,1/10,0.88%,ETV4
prerank,toll-like receptor signaling pathway (GO:0002224),0.30276801999930325,0.8946746198912094,0.6568946796959826,1.0,1.0,23/84,22.72%,FADD;IRAK3;MAPKAPK3;MAPKAPK2;CTSK;CTSB;TLR1;HSP90B1;UNC93B1;TICAM1;UBB;RIPK1;CHUK;TRIL;LBP;TAB3;BCL10;SCARA3;HSPD1;TNIP2;RPS6KA3;UBE2D3;TAB2
prerank,negative regulation of programmed cell death (GO:0043069),0.27676819721783824,0.8944720260415421,0.7853560682046138,1.0,1.0,81/355,18.99%,FFAR4;SOX8;MYC;RNF157;BCL2;DPEP1;SOX9;NGF;EGFR;FMN2;MAP4K4;VEGFA;EGR3;ARAF;THOC6;WNK3;ERCC5;PSEN1;FANK1;MT3;WNT5A;YWHAZ;RASA1;NAA35;SON;NAA16;GATA6;CBX4;BNIP3;FLNA;CRYAB;PRDM9;ASNS;HDAC2;UBE2Z;PIK3R1;GDNF;NGFR;CBL;ARF4;TAF9;IL6ST;MYDGF;TAX1BP1;PRLR;PRDX3;ATF5;HSP90B1;YME1L1;MALT1;TM7SF3;SNCA;PSEN2;CITED2;OPA1;ZFAND6;MET;UBB;CASP2;AREL1;UBE2O;PIM2;BNIP1;TP53;CCND2;LRP2;XIAP;HTATIP2;PAX2;CD74;RIPK1;PCID2;DNAJA1;HSPA9;CAT;RAB7A;NAA15;AATF;PARK7;SEMA4D;AXL
prerank,intermediate filament organization (GO:0045109),0.38109945757420677,0.8944355385908497,0.6161616161616161,1.0,1.0,6/17,23.97%,BFSP1;DNAJB6;GFAP;PKP2;VIM;MTM1
prerank,calcium ion transport into cytosol (GO:0060402),0.3655187533186769,0.8942291603050506,0.6005586592178771,1.0,1.0,6/21,18.23%,CACNA2D1;GRIN2B;JPH3;GRIN2D;GRIN2A;MS4A1
prerank,protein targeting to mitochondrion (GO:0006626),0.31765713061353645,0.8940587653446039,0.6383495145631068,1.0,1.0,16/52,20.91%,MIPEP;FBXO7;TOMM22;PMPCB;AIP;TOMM20;HSPA4;GDAP1;NDUFA13;DNAJC19;PAM16;AIFM1;AGK;PMPCA;TSPO;HSPD1
prerank,regulation of protein binding (GO:0043393),-0.20737312254428547,-0.8940442808955384,0.7627118644067796,0.8788243486951608,1.0,37/114,22.44%,DAB2;ROCK1;VTN;CLDN5;PRKCD;BMP4;EPB41;IFIT2;KDM1A;PRMT7;NVL;APP;GSK3B;CAMK1;RACK1;MARK2;HDAC4;SNAPIN;PRMT8;RPL11;STK3;PEX14;TERT;FLOT1;HIP1R;CAV1;TRIM21;GTF2F1;ZFPM1;CFHR2;HFE;ADD2;MARK3;IFIT1;GAS8;HDAC5;AKT1
prerank,tRNA 5'-end processing (GO:0099116),0.39209713671561447,0.8935714576787394,0.6008708272859217,1.0,1.0,5/15,17.37%,RPP38;PRORP;POP1;RPP21;SSB
prerank,positive regulation of developmental growth (GO:0048639),0.31844418968321236,0.8935478290613442,0.6166056166056166,1.0,1.0,16/49,23.57%,RNF157;NGF;PLCB1;SYT1;CDKL5;LIMK1;RIMS1;NEDD4L;PLAA;SYT2;RIMS2;SEMA4D;SHTN1;GHR;CPNE5;SYT3
prerank,protein deubiquitination (GO:0016579),0.2796513069964659,0.8925846186693771,0.7343434343434343,1.0,1.0,63/242,22.27%,USP50;MYC;PTEN;RAD23B;USP35;KAT2B;USP11;PRKN;DDB2;OTUD7B;UCHL5;OTULIN;INO80E;BRCA1;PSMB7;UCHL1;USP46;HIF1A;TOMM20;MYSM1;USP33;ESR1;UCHL3;NFRKB;USP32;USP48;GATA3;NEDD8;USP40;MDM4;PSMD2;USP14;UBB;IL33;PSMC1;TRRAP;TP53;USP1;ASXL2;USP25;USP21;PSMB2;USP2;RIPK1;OTUD4;MDM2;USP37;RHOT1;OTUD7A;PSMD9;ATXN7;USP5;PSME4;MCRS1;MBD6;USP13;PSMA8;JOSD1;TNIP2;ARRB2;USP31;ACTR5;RNF123
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3767981189958082,0.8925672362133776,0.6127167630057804,1.0,1.0,6/16,27.27%,POGZ;SGO1;PDS5B;RB1;SMC1A;NAA50
prerank,peptidyl-lysine acetylation (GO:0018394),0.42343088860195316,0.8924119961537211,0.5925925925925926,1.0,1.0,1/10,2.04%,KAT2B
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.33780193805802106,0.8923125334178127,0.6288156288156288,1.0,1.0,9/37,16.07%,BCL2;BMF;FBH1;SFPQ;NACC2;NCK1;UBB;TP53;BCL2L11
prerank,protein modification by small protein conjugation (GO:0032446),0.27681053727794813,0.892246176408814,0.7727727727727728,1.0,1.0,83/361,20.00%,UBE2T;PDZRN3;RNF157;PRKN;DTX4;HACE1;WAC;NFX1;TRIM44;FBXW7;SPSB4;RANBP2;RNF6;KLHL13;UBA2;FBXO7;FBXL15;ASB5;FBXO32;NUP155;UFL1;OTULIN;TRIM11;NAE1;BRCA1;UBE2K;VPS11;HIF1A;PIAS2;CUL3;SELENOS;UHRF2;UBE2Z;HUWE1;ANAPC7;FBXO45;CBL;FBH1;NUP205;NFE2L2;UBE2J2;UCHL3;NDC1;TSPAN17;TRIM41;NUP160;UBA3;FBXL2;MYLIP;ATG3;DDB1;DET1;NEDD8;TRIM23;NEDD4L;SUMO1;TRAF7;UBB;AREL1;RCHY1;CDC23;POM121;RNF111;ZSWIM8;ANAPC16;AAAS;RNF182;MIB1;CUL4B;CDC73;UBA1;MDM2;ELOC;USP5;PCNP;FBXO11;BCL10;UBE2L3;RRAGA;CDC27;TRAIP;TRIM35;UBE2G1
prerank,positive regulation of autophagy (GO:0010508),0.3005598110537144,0.8921501283399093,0.6530837004405287,1.0,1.0,7/81,7.73%,DCN;PRKN;NPRL2;WAC;FBXO7;UFL1;BNIP3
prerank,positive regulation of dephosphorylation (GO:0035306),0.35756644030865053,0.8916362699079515,0.6313725490196078,1.0,1.0,2/27,4.08%,DLC1;TGFB1
prerank,positive regulation of protein polymerization (GO:0032273),0.30647445853281735,0.8915393433539305,0.6324022346368715,1.0,1.0,15/65,16.91%,CCL11;PYCARD;PAK1;BAIAP2;BIN1;ARL2;CLASP1;SLAIN2;CDK5R1;TTBK1;NCK1;MET;CDC42EP1;NAV3;CTTN
prerank,regulation of histone modification (GO:0031056),-0.333516591718328,-0.8915254756808905,0.5856697819314641,0.8835276329221434,1.0,5/13,19.17%,PARG;IGF2;FLCN;UBE2N;MYOCD
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.2832508258937949,-0.8911754113657716,0.6254545454545455,0.8831503116587281,1.0,4/23,7.14%,ACSL1;ELOVL7;FAR2;ACSL5
prerank,carboxylic acid transmembrane transport (GO:1905039),0.33009653136266875,0.8907124688783264,0.6356968215158925,1.0,1.0,10/40,17.07%,SLC27A1;SLC25A21;SLC38A4;SLC36A2;SLC7A7;SLC7A8;SLC25A10;SLC16A1;SLC25A11;ABCC1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.3770729407286414,0.8904107567278748,0.6106442577030813,1.0,1.0,4/19,15.90%,PYCARD;AEN;RPS27L;TP53
prerank,receptor-mediated endocytosis (GO:0006898),0.2855370233495478,0.8901646089086553,0.6828240252897787,1.0,1.0,23/132,16.91%,HSPG2;SGIP1;DNM1;HSPH1;LRP1;PI4KB;AP1G1;ACKR3;EPS15;GAK;AP1S1;SPARC;GPR107;WASF1;TPCN2;HSP90B1;CD9;SNCA;SNX1;ITGB1;LRP2;IGF2R;CTTN
prerank,response to lipopolysaccharide (GO:0032496),0.28769150470591653,0.8900079678490787,0.6907756813417191,1.0,1.0,33/138,23.13%,CXCL10;PYCARD;PTPN22;IRAK3;MAPKAPK3;PDE4B;MAPKAPK2;WNT5A;PELI1;ERBIN;SELENOS;MAPK14;TRIM41;UPF1;PRDX3;SHPK;SRR;SNCA;TICAM1;PLAA;CDC73;LBP;AXL;PDCD4;BCL10;ZFP36;SIRPA;NFKB1;TNIP2;RPS6KA3;VIM;TAB2;CARD16
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.2125325695888702,-0.8899751322656201,0.797752808988764,0.8847634477980776,1.0,24/87,19.43%,KANK2;DCUN1D3;PSMD14;BRD7;FBXL7;USP47;ZFP36L1;PSMB3;PSMD12;RGCC;KLF4;PRMT2;PSMD6;PSMA1;FAM107A;PSMD7;PSMA5;PSMC5;PINX1;PSMC4;CDK4;PSMB6;RBL1;PSMA4
prerank,cellular zinc ion homeostasis (GO:0006882),-0.2746565292144042,-0.8896514379473648,0.6652892561983471,0.8842911451135401,1.0,8/26,24.09%,SLC30A10;SLC39A8;SLC39A6;SLC30A1;SLC39A10;MT2A;SLC39A13;ATP13A2
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3616087444808946,-0.8895967822714032,0.5921787709497207,0.8831798560897435,1.0,5/10,31.44%,CDC42;RACGAP1;ECT2;KNSTRN;SPAG5
prerank,positive regulation of protein maturation (GO:1903319),-0.3652038449377957,-0.8893287359674322,0.6167146974063401,0.8825230650572474,1.0,1/11,1.25%,CCBE1
prerank,sterol transport (GO:0015918),0.36290281098722366,0.8892980034737227,0.6163434903047091,1.0,1.0,2/19,5.43%,NPC1;OSBPL5
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.35680544098396216,0.8892200245691718,0.5969101123595506,1.0,1.0,7/22,24.68%,HMGN1;CDK13;ELL;CDC73;KAT7;THOC5;CCNT2
prerank,mRNA 3'-end processing (GO:0031124),0.2984907338748841,0.8891354012829576,0.6488294314381271,1.0,1.0,23/78,25.00%,CSTF3;THOC6;PABPC1;CPSF6;RPRD1A;SRSF11;CASC3;NCBP1;FIP1L1;AHCYL1;SRSF6;PAPOLA;CDC73;RNPS1;TENT2;THOC7;SRRM1;SRSF3;SYMPK;TUT1;THOC5;MAGOHB;CPSF7
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.3672873880319817,0.8888756938855695,0.6041958041958042,1.0,1.0,3/20,10.32%,GSN;ANO6;SFRP4
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.36299970564064277,0.888711081427189,0.6205479452054794,1.0,1.0,7/23,17.98%,BMF;TOMM22;COX18;HSPA4;BCL2L11;NDUFA13;AGK
prerank,proton transmembrane transport (GO:1902600),-0.2568733716303596,-0.8884088195405185,0.6470588235294118,0.883483197937447,1.0,7/36,15.49%,ATP1A2;ATP6V0C;ATP6V0D1;ATP1A1;ATP6V0A4;ATP5MF;NNT
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3240042644640229,-0.8883706982668965,0.6133333333333333,0.8823136766368198,1.0,2/16,2.10%,ST6GALNAC3;ST8SIA4
prerank,calcium ion import (GO:0070509),-0.2659230950275365,-0.8880722310018865,0.6621004566210046,0.8817670002231472,1.0,4/28,4.38%,CACNA1C;MICU1;CACNB2;CACNA1G
prerank,body fluid secretion (GO:0007589),0.38786495154533007,0.8880532626006308,0.6071428571428571,1.0,1.0,4/15,17.72%,VEGFA;ERBB4;PRLR;GPAT4
prerank,exit from mitosis (GO:0010458),-0.33955887398157103,-0.8877780691749034,0.5906432748538012,0.8812203031915681,1.0,5/12,24.41%,PPP2R2D;EPS8;CTDP1;CHMP7;SIRT7
prerank,replicative senescence (GO:0090399),-0.35196547482107615,-0.8875849885743534,0.6011396011396012,0.8804417122979213,1.0,8/12,29.99%,SERPINE1;TERT;PLA2R1;WNT16;ROMO1;MME;CHEK2;CHEK1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3526909834429566,0.887446596219494,0.6211920529801325,1.0,1.0,1/25,0.13%,ARHGAP24
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.3074664184574515,-0.8874347683497436,0.6292517006802721,0.8795580784068189,1.0,3/16,9.34%,ETS1;NFAT5;RHOA
prerank,organelle assembly (GO:0070925),0.27604786529619657,0.8873422926618969,0.8160804020100503,1.0,1.0,80/384,19.68%,DYNLL1;PTPDC1;RHO;BICD1;CD34;WDPCP;GSN;STK36;RAB38;SQLE;CC2D2A;HAUS3;ARL3;PACS2;NEK1;CCDC57;RFX2;STARD9;TTC39C;IFT140;PCM1;RILPL2;SNAP29;WIPI1;ATXN2;BBS9;RFX3;DISC1;GBF1;CPLANE1;ATG5;BBS5;FLNA;WDR35;TUBGCP5;VPS37B;FARP2;RCC1;ARF4;HDAC6;POGZ;GORASP2;VPS36;SNX10;RAB1A;LSM3;CEP89;ATG3;MVB12A;NEK7;CFAP20;FBF1;TRAPPC14;CCDC28B;RAB11FIP3;PKD1;PDCD6IP;EHD2;GABARAPL2;CCDC65;CHMP4C;EIF4ENIF1;CDC14A;TRAPPC6A;ANLN;FOXJ1;HPS1;CEP63;MYH6;RC3H1;RAB7A;GALNT11;KIF3A;MAPRE3;FLII;UBAP2L;IFT81;CENPC;CCDC66;CHMP1B
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.3649076152257062,0.8873325696852316,0.625,1.0,1.0,10/23,19.42%,WNK3;TGFB1;UBE2K;MAPK1;BMP7;CALM1;CALM2;RPTOR;S1PR2;CAB39
prerank,acute-phase response (GO:0006953),-0.3447980068067663,-0.8870381914995166,0.6360759493670886,0.8792060963560705,1.0,2/12,10.10%,PLSCR1;IL6R
prerank,cellular response to zinc ion (GO:0071294),0.3873178467875242,0.8869066563143256,0.611353711790393,1.0,1.0,9/15,28.19%,MT3;MT1X;MT1M;MT1E;MT1G;MT1H;MT1F;MT1B;MT1A
prerank,regulation of cellular protein catabolic process (GO:1903362),0.37733861318305895,0.8866592287252817,0.6098265895953757,1.0,1.0,8/18,26.63%,VGLL4;VPS11;ATRAID;DACT1;RDX;PTTG1IP;CDK5RAP3;VPS35
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2854136698922821,0.8866267734026216,0.6741214057507987,1.0,1.0,13/117,9.84%,CYP2S1;KYNU;THEM4;SLC27A4;NPC1;GBA2;MCCC1;HLCS;ACOT11;GOT2;FASN;MCCC2;ACSF2
prerank,cellular protein-containing complex assembly (GO:0034622),0.2802978213699981,0.8865561439017773,0.717948717948718,1.0,1.0,23/159,15.07%,STXBP6;SGIP1;DNAI4;CCDC39;VAMP4;TBCE;TGFB1;SHQ1;EPS15;GTF2B;BIN1;HIP1;ARL2;HSPA4;NUP205;NDC1;POGZ;TBCC;PRLR;SNCA;NCK1;RTN4;CCDC65
prerank,purine ribonucleotide catabolic process (GO:0009154),0.36460239431002406,0.8859384258864161,0.6108843537414966,1.0,1.0,6/21,12.51%,NT5C2;PDE9A;HINT1;PDE4D;NUDT10;NUDT3
prerank,response to organic cyclic compound (GO:0014070),0.3109059840589221,0.8854993490591305,0.647887323943662,1.0,1.0,8/52,12.70%,KYNU;TGFB1;HLCS;CYP1B1;IL18;ESR1;ARL6IP5;DRD2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.3837370418830206,0.8852335702574692,0.594017094017094,1.0,1.0,1/16,1.07%,SLC27A1
prerank,negative regulation of potassium ion transport (GO:0043267),0.40125227464266644,0.8850281073219001,0.6045112781954888,1.0,1.0,5/13,19.42%,BIN1;STK39;NEDD4L;KCNH2;CAB39
prerank,neuron projection fasciculation (GO:0106030),0.42640348414472207,0.8848796862630047,0.6226415094339622,1.0,1.0,5/10,18.90%,NRCAM;EPHB2;CDK5R1;RTN4;CNTN4
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.2988466976954861,0.8839896713591758,0.675764192139738,1.0,1.0,28/78,23.13%,PRKN;SOCS5;CBFA2T3;HERPUD1;NFE2L2;SIRT6;PRICKLE1;DVL1;CSNK1A1;DET1;DDA1;SUMO1;RNF19A;RCHY1;CSNK1E;FBXO22;MDM2;ZER1;TAF1;USP5;NKD2;BBS7;SGTA;ELOB;UBQLN1;ZYG11B;UBQLN2;COP1
prerank,regulation of DNA replication (GO:0006275),0.31550990374106275,0.8837501450573966,0.6467065868263473,1.0,1.0,16/49,24.75%,GLI2;EGFR;GLI1;STN1;ZBTB38;BLM;FBXO5;USP37;CCDC88A;BCAR3;CTC1;PPP2R1A;KAT7;ORC3;ATR;EHMT2
prerank,cilium movement (GO:0003341),0.31885936909935403,0.8837357975580277,0.6338199513381995,1.0,1.0,7/47,17.71%,DNAI4;CCDC39;DNHD1;CFAP91;CFAP61;DNAAF2;RSPH9
prerank,programmed necrotic cell death (GO:0097300),0.37804282436320075,0.883369120892081,0.6289655172413793,1.0,1.0,5/18,23.28%,ITPK1;TICAM1;RIPK1;MLKL;CYLD
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3103412204058751,0.8833095720860921,0.6426886792452831,1.0,1.0,8/57,11.10%,CRLF1;PTPN2;VEGFA;SOCS1;IL18;NF2;ERBB4;IL6ST
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.3263222905219849,-0.8830382546942817,0.6095238095238096,0.887334878638662,1.0,6/14,21.65%,PRKCI;THBS1;RGCC;ECSCR;GPER1;CD40
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.33407925033052077,0.8828940505741665,0.6268656716417911,1.0,1.0,14/34,26.64%,OLFM4;DOCK5;FLNA;DOCK1;MYOC;ABL1;RAC3;MDK;TESK1;TRIOBP;CRK;CIB1;ARHGEF7;LIMS1
prerank,regulation of MAP kinase activity (GO:0043405),0.2964511145016495,0.8827799162319104,0.6728060671722643,1.0,1.0,14/92,11.60%,FGF2;ERBB2;EGFR;VEGFA;IRAK3;TGFB1;NF1;KSR1;FGFR1;UCHL1;PTPN1;PTPRJ;BMP7;EDN3
prerank,regulation of stem cell differentiation (GO:2000736),0.2938321217691061,0.8827327203322697,0.6765027322404371,1.0,1.0,20/89,20.76%,PDGFRA;CBFB;KMT2A;METTL3;PSMB7;ZFP36L2;GDNF;GATA3;PUS7;BMPR1A;PSMD2;PSMC1;RUNX1;ABL1;HNRNPU;PSMB2;PSMD9;PSME4;NSUN2;PSMA8
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.3701729174268825,0.8822367959949209,0.6148459383753502,1.0,1.0,4/19,13.26%,PAPSS2;BPNT1;BPNT2;SLC35B3
prerank,establishment of spindle localization (GO:0051293),0.3957198787032078,0.881835178797491,0.6183206106870229,1.0,1.0,5/14,23.73%,CLASP1;KPNB1;LLGL1;DYNC1H1;ZBED3
prerank,response to hexose (GO:0009746),0.3545068578054836,0.8818294778572716,0.6323731138545954,1.0,1.0,5/25,17.19%,IRS2;EIF2B5;SELENOS;GPLD1;EIF2B2
prerank,regulation of calcium-mediated signaling (GO:0050848),0.35454020707175404,0.881620482656025,0.6255088195386703,1.0,1.0,3/25,7.96%,BST1;CCL4;SLC8A2
prerank,regulation of mitotic cell cycle (GO:0007346),0.2814594072033011,0.8806389518022847,0.7169230769230769,1.0,1.0,52/171,25.91%,PRKCA;KIF20B;TGFB1;CCDC57;OBSL1;CKS1B;CDK13;GBF1;PSMB7;ASNS;ANAPC7;RCC1;PKMYT1;CDC25B;ANAPC2;SCRIB;TMEM8B;NEK7;DDB1;SMOC2;BUB1B;PSMD2;IQGAP1;PSMC1;PIM2;CDC23;ANAPC16;HNRNPU;PSMB2;USP2;PKN2;FBXO5;MDM2;PSMD9;PSME4;CDC27;TRIM35;UBE2E1;PSMA8;ANAPC4;HECA;ANAPC5;CDK9;RB1;CYLD;CDC16;BTG3;CUL1;RNF20;PSMD8;PSMD13;DAPK3
prerank,response to ethanol (GO:0045471),0.39169372047297346,0.8803900856708021,0.6186943620178041,1.0,1.0,3/14,14.39%,GRIN2B;GOT2;GRIN2A
prerank,sensory perception (GO:0007600),0.31549751430487055,0.879948340782785,0.6359223300970874,1.0,1.0,8/45,17.79%,KCNA2;CHRNA4;PCDH15;CCR2;PENK;NIPSNAP1;OPRK1;PTGES
prerank,negative regulation of coagulation (GO:0050819),-0.3266538503501074,-0.8796355636265034,0.6254295532646048,0.8939445194095893,1.0,3/14,2.71%,VTN;THBD;TFPI
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3401554387011847,0.8795943933424759,0.6246684350132626,1.0,1.0,3/29,4.08%,PDGFRA;FGF2;TGFB1
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.40969455045729386,0.8795707844432373,0.5925349922239502,1.0,1.0,5/11,18.77%,FYN;ABCD2;MPV17L;TRAP1;PARK7
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.41946536153422276,0.8789717607610851,0.6181533646322379,1.0,1.0,3/10,15.17%,TUT4;NEDD8;UBB
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.3676850014052299,0.8787657229438244,0.6363636363636364,1.0,1.0,5/18,11.47%,FGF2;FGFR1;AKT3;SP1;SIRT6
prerank,negative regulation of chemotaxis (GO:0050922),0.34038030347033116,0.8780723401256896,0.6571798188874515,1.0,1.0,4/31,3.81%,SEMA3E;PTPN2;SEMA6C;SEMA3A
prerank,positive regulation of reproductive process (GO:2000243),0.3416773146945098,0.8779206688684199,0.6396396396396397,1.0,1.0,8/31,23.27%,VEGFA;PLCB1;PRDM9;LHFPL2;CFAP69;CACNA1H;TAC4;INHBB
prerank,cytokine-mediated signaling pathway (GO:0019221),0.2716981750029942,0.877691618130737,0.844,1.0,1.0,52/532,11.25%,RORA;MMP2;CCL11;EDA;CXCL10;IL16;SLC27A1;IL2RA;FGF2;PYCARD;MYC;BCL2;IRS2;CRLF1;IL20RB;HNRNPDL;VEGFA;MAP3K3;IRAK3;RPS6KA4;SOCS5;TGFB1;CCL4;TEC;MT3;PLCB1;CCR2;ZEB1;NUMBL;SOCS1;YWHAZ;RORC;CSK;IL1RL2;CSF3R;ACKR3;IL18;PELI1;FYN;GAB2;PSMB7;HIF1A;AIP;NDN;PIK3R1;PTPRJ;TYK2;CBL;PTPN11;COL1A2;IL6ST;TOLLIP
prerank,purine-containing compound catabolic process (GO:0072523),0.39633404633110647,0.8772923647268771,0.6420118343195266,1.0,1.0,2/13,6.34%,NUDT15;NT5C2
prerank,bile acid metabolic process (GO:0008206),0.3411858238677242,0.8772564471697262,0.6190476190476191,1.0,1.0,10/27,25.15%,NPC1;GBA2;CYP39A1;CYP7B1;CYP27A1;OSBPL1A;ACOT8;SCP2;HSD17B4;AMACR
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.2975156986910783,0.8771650976724217,0.6845637583892618,1.0,1.0,24/76,23.13%,PTEN;PRKN;SOCS5;FBXW7;CBFA2T3;PRICKLE1;DVL1;CSNK1A1;DET1;DDA1;SUMO1;RNF19A;RCHY1;CSNK1E;FBXO22;MDM2;ZER1;TAF1;USP5;NKD2;BBS7;ELOB;ZYG11B;COP1
prerank,double-strand break repair (GO:0006302),0.2781348698133197,0.877155449294661,0.7166666666666667,1.0,1.0,30/158,15.98%,POLN;MEIOB;APTX;AP5S1;ERCC5;REV3L;ERCC4;KDM4B;RPA3;SETMAR;ATP23;BRCA1;TDP1;NHEJ1;FBH1;SFPQ;NSD2;XRCC6;HPF1;MDC1;HELQ;XRCC3;EXD2;RPA2;SUMO1;BAZ1B;ATM;RAD52;BLM;SPIDR
prerank,mRNA processing (GO:0006397),0.27159031365913266,0.87707870562817,0.7819095477386935,1.0,1.0,93/287,26.13%,CSTF3;DHX8;THOC6;TRA2B;GTF2H2;PABPC1;CPSF6;RNGTT;RPRD1A;RSRC1;POLR2B;METTL3;DHX35;SON;RNPC3;SRSF11;CWF19L2;TXNL4A;RBM10;POLR2K;CASC3;AURKAIP1;ALKBH5;NCBP1;SNRPB2;FIP1L1;SFPQ;SNRNP40;HNRNPA3;LSM3;PRKACA;PRPF6;PRPF18;RBM4B;POLR2G;DDX42;NOVA1;SRSF6;YTHDC1;RNMT;PAPOLA;SNRPA;PPIH;SF3A1;HNRNPU;RAVER2;RNPS1;SF1;GEMIN7;FUS;SART1;DDX23;POLR2A;THOC7;CMTR2;PRMT9;SYNCRIP;SRRM1;HNRNPUL1;SF3B3;DBR1;HNRNPC;HNRNPH2;HNRNPL;SNRPN;SRSF3;RBM17;DNAJC8;SNIP1;RBMX2;SYMPK;PLRG1;SNRNP200;SF3B2;WBP4;CTNNBL1;PCBP2;THOC5;POLR2F;TFIP11;CCNH;MAGOHB;CPSF7;U2SURP;SCAF11;SNRPA1;NONO;RBM4;RBM15;SPEN;TRA2A;PRPF38A;HNRNPA2B1
prerank,glycerolipid metabolic process (GO:0046486),-0.35613323347884046,-0.8769729484668161,0.6129943502824858,0.8989424728478719,1.0,6/11,29.07%,GAL3ST1;PLA2G15;PGP;DGKG;PNPLA3;DGKB
prerank,detection of visible light (GO:0009584),0.3825595844184333,0.8768545207961763,0.6230440967283073,1.0,1.0,1/16,1.69%,RHO
prerank,actin filament capping (GO:0051693),0.36966410159411356,0.8768189954609991,0.6313559322033898,1.0,1.0,2/18,2.24%,ADD3;GSN
prerank,barbed-end actin filament capping (GO:0051016),0.36966410159411356,0.8768189954609991,0.6313559322033898,1.0,1.0,2/18,2.24%,ADD3;GSN
prerank,regulation of cell differentiation (GO:0045595),0.28027125007483517,0.8766506350807984,0.7075471698113207,1.0,1.0,23/148,13.20%,LGALS3;PHLDB1;CBFB;NGF;MBOAT2;PTHLH;TGFB1;NF1;NLGN1;RORC;TRPS1;CDK6;KLK6;FGFR1;BIN1;PPP1R13L;GDNF;CLASP1;EDN3;APC2;CDK5R1;PRKACA;GATA3
prerank,negative regulation of protein catabolic process (GO:0042177),0.31776412568390167,0.8766469702128041,0.63,1.0,1.0,16/40,27.47%,EGFR;FMN2;IRAK3;FLNA;ATRAID;SNCA;MDM4;SNX12;AZIN2;SF3B3;AGAP2;PRKCG;HMGCR;CDK5RAP3;PIN1;CYP51A1
prerank,response to interleukin-6 (GO:0070741),-0.3572873586433785,-0.8765925219629693,0.5921787709497207,0.8985916882072428,1.0,3/10,8.50%,PTGIS;ST3GAL6;SBNO2
prerank,negative regulation of cell growth (GO:0030308),0.2807975571735618,0.8765058282929353,0.6901260504201681,1.0,1.0,11/121,6.26%,DCBLD2;FGF13;CRLF3;VGLL4;FRZB;JADE1;TGFB1;RNF6;MT3;APBB2;CDKL3
prerank,activation of protein kinase B activity (GO:0032148),0.3351608687269592,0.8760977345593894,0.6135770234986945,1.0,1.0,5/29,7.90%,NTRK3;MT3;WNT5A;MAPKAP1;IL18
prerank,phosphatidylserine metabolic process (GO:0006658),0.3335846437531759,0.8760790651420822,0.615979381443299,1.0,1.0,6/32,12.36%,SLC27A1;MBOAT2;OSBPL5;PLA2G12A;PTDSS1;PLAAT3
prerank,positive regulation of proteolysis (GO:0045862),-0.22538777665362192,-0.8756346949388846,0.676923076923077,0.8995548506163751,1.0,15/55,18.89%,CTSH;CCBE1;SNX9;CTSC;OGT;STUB1;CASP8;TNIP1;MAPK12;ADRA2A;PERP;FGFR4;NRDC;APOE;PINK1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.34489869591908345,0.8753300708561741,0.6171875,1.0,1.0,9/26,24.20%,STXBP4;EFNA5;PPP3CB;CDK16;GPLD1;KLF7;ADCY8;TRPM4;ADCY5
prerank,regulation of sensory perception of pain (GO:0051930),-0.3535074073665999,-0.8752448799369311,0.6411042944785276,0.899204189852847,1.0,6/11,34.07%,ATPSCKMT;MGLL;TMEM100;ACP3;SPX;F2R
prerank,regulation of RNA metabolic process (GO:0051252),0.30655545436731424,0.8752131692130724,0.6712328767123288,1.0,1.0,16/59,23.90%,PRX;TRA2B;ZNF326;RASA1;SON;PCBP4;NOVA1;RC3H1;FUS;HNRNPH2;HNRNPL;MITF;AHNAK;PTBP2;AFF2;PCBP2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.40491386168014876,0.8750589281974452,0.6291291291291291,1.0,1.0,7/12,26.58%,SEC61G;SEC63;SGTA;SEC61A2;SGTB;CHMP4B;CHMP4A
prerank,mitochondrial translational termination (GO:0070126),0.2963706374828439,0.875035674480576,0.6792656587473002,1.0,1.0,24/88,22.45%,MRPL47;MRPS18A;MRPL14;MRPL32;MRPL16;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;MRPL30;MRPL28;MRPL46;MRPL51;MRPS30;MRPS14;MRPS9;MRPS31;MRPL1;PTCD3;DAP3;MRPS6;MRPL52;MRPL18
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.28029384586635475,0.8747202260644825,0.7025316455696202,1.0,1.0,28/124,20.12%,CDNF;DOCK7;WDPCP;PPP1R9A;ATXN10;GPM6B;PLP1;NLGN1;CNTNAP2;GPM6A;VAPA;GDNF;PRMT1;OPHN1;STMN4;CDK5R1;MYOC;CDK16;CORO1B;CYFIP1;CFAP61;CTTN;CAMSAP1;CNTN4;LRP12;MICALL2;CEP78;NPY
prerank,protein-containing complex subunit organization (GO:0043933),0.28912378315896026,0.8745534115198561,0.7172264355362947,1.0,1.0,33/109,23.87%,REPS2;SOX9;LAMC1;WIPF1;EPRS1;KMT2A;PPID;MAGI1;NUP205;RIMS1;FANCC;NDC1;WASF1;DET1;MDM4;NIFK;TP53;LPXN;PPIH;IL1RAP;CD74;MDM2;SKAP2;KPNA3;NAPG;MITF;LLGL1;DLG4;ELOB;KIFAP3;WASF3;PPP2R1A;NDUFAF1
prerank,histone H3-K4 trimethylation (GO:0080182),0.4104583755544804,0.8745530757317881,0.6305343511450382,1.0,1.0,5/11,23.89%,KMT2A;PRDM9;TET3;KMT2D;TET2
prerank,protein ubiquitination (GO:0016567),0.27032319139200545,0.8745122132431192,0.842,1.0,1.0,112/471,20.50%,UBE2T;PDZRN3;RNF157;BCL2;CBFB;FBXW9;PRKN;DTX4;UBE2E2;HACE1;WAC;NFX1;TRIM44;FBXW7;SPSB4;RNF6;KLHL13;SPOP;FBXO7;ZNRF2;FBXL15;DDB2;ASB5;FBXO32;TRIM2;OTULIN;TRIM11;PELI1;BRCA1;UBE2K;HECTD2;FBXL16;PSMB7;RNFT1;VPS11;FBXO27;HIF1A;LNPEP;CUL3;SELENOS;UHRF2;UBE2Z;HUWE1;ANAPC7;THOP1;FBXO45;CBL;FBH1;NFE2L2;UBE2J2;UCHL3;TSPAN17;TRIM41;FBXO17;FBXL2;MYLIP;ATG3;AKTIP;KLHL12;DDB1;DET1;NEDD8;TRIM23;DDA1;NEDD4L;TRAF7;PSMD2;KLHL22;UBB;AREL1;PSMC1;UBE2O;RNF19A;RCHY1;UBOX5;CDC23;RNF111;FBXL4;ZSWIM8;ANAPC16;UBE2Q1;RNF182;PSMB2;MIB1;CUL4B;RNF10;RC3H1;CDC73;RNF167;UBA1;FBXO31;FBXO22;MDM2;ELOC;RNF4;PSMD9;TAF1;USP5;PCNP;FBXO11;PSME4;BCL10;FBXL12;UBE2L3;RRAGA;CDC27;TRAIP;TRIM35;UBE2G1;RNF13;UBE2E1;NPEPPS
prerank,mitotic DNA replication (GO:1902969),-0.357207342926392,-0.8740771301179491,0.6078431372549019,0.9006141050166718,1.0,7/10,33.47%,POLA1;MCM6;LIG1;CDC45;GINS1;MCM3;MCM2
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3382423646829173,0.8739813713461303,0.6382165605095541,1.0,1.0,9/31,19.19%,GTF2H2;RNGTT;POLR2B;POLR2K;NCBP1;POLR2G;RNMT;POLR2A;CMTR2
prerank,7-methylguanosine RNA capping (GO:0009452),0.3382423646829173,0.8739813713461303,0.6382165605095541,1.0,1.0,9/31,19.19%,GTF2H2;RNGTT;POLR2B;POLR2K;NCBP1;POLR2G;RNMT;POLR2A;CMTR2
prerank,early endosome to late endosome transport (GO:0045022),0.3621565393755517,0.8735318697507231,0.625503355704698,1.0,1.0,13/20,29.70%,AKTIP;STX8;ANKRD27;RAB7A;SNX16;HOOK2;WDR81;HOOK1;HOOK3;PIK3C3;EEA1;SNF8;EMP2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.3249543074998781,-0.8735075479072438,0.6345029239766082,0.9006036392205016,1.0,3/13,4.65%,NFIB;BMP4;PPARD
prerank,DNA damage checkpoint signaling (GO:0000077),-0.26727044874774597,-0.8730973450198688,0.6506550218340611,0.9002637105161708,1.0,15/28,34.76%,MAP3K20;CLOCK;DOT1L;HUS1;CLSPN;DONSON;ERCC6;NBN;E2F1;RAD9A;CHEK2;CHEK1;PRPF19;ATRIP;FBXO6
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.3024482052097803,-0.8729653226475539,0.6449511400651465,0.8993309242699937,1.0,4/16,13.96%,PPARGC1B;DDX5;EGLN2;PADI2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.34732751455839217,0.872803131708895,0.6229508196721312,1.0,1.0,12/24,26.80%,SLC25A38;UROS;RSAD1;SUCLA2;COX10;FECH;PGRMC1;TSPO;CPOX;ALAD;UROD;ABCB10
prerank,RNA stabilization (GO:0043489),-0.2506557820511501,-0.872503140894705,0.7064676616915423,0.899177083884895,1.0,7/33,10.91%,YBX1;NOCT;ZCCHC17;NAF1;ELAVL1;TAF15;DKC1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.29068947449067517,0.8724534208716749,0.6961325966850829,1.0,1.0,25/91,19.83%,OLFM4;STON2;PLD1;PACSIN2;SYT1;STON1;RAB21;HIP1;RAB3D;PTPN1;MAPK1;OPHN1;BET1L;STXBP5;RAB4B;RAB3A;RAB4A;ARFGAP1;ABL1;SNX12;DENND10;RIMS2;RAB3B;MBTPS1;RINT1
prerank,protein O-linked glycosylation (GO:0006493),0.2883788974537575,0.872363936132679,0.6973969631236443,1.0,1.0,23/96,18.62%,ST3GAL4;GALNTL6;TMTC2;GALNT9;GALNT1;PLOD1;POMGNT2;RXYLT1;GALNT15;GALNT7;C1GALT1;GALNT13;GALNT6;TMTC3;GALNT3;MUC3B;MUC3A;TET3;DPM1;FKTN;POGLUT2;GALNT11;FKRP
prerank,relaxation of muscle (GO:0090075),-0.32872081526733754,-0.8719742130798293,0.5988200589970502,0.8991396575560733,1.0,3/13,6.72%,ATP1A2;KCNJ2;ATP1A1
prerank,calcium ion transmembrane transport (GO:0070588),0.2930802880576121,0.8717657469155763,0.689010989010989,1.0,1.0,25/86,21.51%,CACNA2D1;PARL;ANO6;LETM1;ATP2B3;CACNA1A;GRIN2B;SLC8A2;SLC24A5;PMPCB;SLC25A23;ATP2B1;YME1L1;GRIN2D;TRPC5;GRIN2A;PKD1;CACNA2D4;SLC24A4;SLC24A2;PMPCA;RYR3;PHB2;PKD2;P2RX7
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3427451242863078,0.8716836018819812,0.650472334682861,1.0,1.0,3/27,4.08%,PDGFRA;FGF2;TGFB1
prerank,protein localization to cilium (GO:0061512),0.33644690211840067,0.871614729949973,0.648508430609598,1.0,1.0,5/32,11.71%,ARL3;IFT140;BBS9;WDR35;SNX10
prerank,negative regulation of interleukin-12 production (GO:0032695),0.39542861676939633,0.8713213388602289,0.6307922272047832,1.0,1.0,1/14,3.52%,IRAK3
prerank,acylglycerol catabolic process (GO:0046464),-0.2502695009664753,-0.8713193309787255,0.7013574660633484,0.8993187547200168,1.0,9/30,25.43%,MGLL;ABHD2;DAGLA;ABHD12;PNPLA2;LPL;PNPLA3;FAAH;LIPE
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.29053797212467325,0.8712957618542352,0.7003222341568206,1.0,1.0,21/95,21.98%,CXCL10;PYCARD;PDE4B;WNT5A;SELENOS;MAPK14;TRIM41;UPF1;SHPK;TICAM1;PLAA;CDC73;LBP;AXL;PDCD4;BCL10;ZFP36;SIRPA;NFKB1;TNIP2;VIM
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.3239573095124313,-0.8711743400188322,0.6232686980609419,0.89838934769975,1.0,5/13,25.56%,TM9SF4;HSP90AB1;ABCA7;SNX33;TYROBP
prerank,purine ribonucleotide transport (GO:0015868),-0.31021376639955095,-0.8708388985735894,0.6384364820846905,0.8979230222957084,1.0,4/16,13.06%,ABCC4;ABCC6;LRRC8C;LRRC8A
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.30400631698963126,0.8704702718661009,0.6723940435280642,1.0,1.0,18/59,23.23%,PTEN;CBFB;SOX9;CCNC;MED31;CDK8;MED13;MED12;MED25;TP53;MED30;MED8;JUN;NFKB1;MITF;THRA;MED24;CEBPB
prerank,histone H4 deacetylation (GO:0070933),-0.34709846500487895,-0.8704596272525159,0.6033057851239669,0.8974913666427718,1.0,4/10,22.10%,HDAC8;HDAC4;HDAC3;SMARCAD1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.27652636637430705,-0.8699331362145397,0.6462585034013606,0.8974504393566998,1.0,7/22,21.64%,ERI1;EXOSC7;URB1;NOP9;EXOSC10;RPS21;PES1
prerank,histone lysine demethylation (GO:0070076),0.34952690065808306,0.8698223879342678,0.6263736263736264,1.0,1.0,5/25,13.89%,KDM8;KDM5B;KDM4B;PHF8;KDM6A
prerank,lysosome localization (GO:0032418),-0.24473947928869394,-0.8698087528473183,0.7371134020618557,0.8965271497288995,1.0,15/37,21.66%,KIT;MYH9;PLEKHM1;FAM98A;KIF5B;FLCN;BORCS5;SYTL4;SNAPIN;PIP4P1;TMEM106B;PLEKHM2;TFEB;LAMTOR1;DEF8
prerank,oogenesis (GO:0048477),0.38911660482271265,0.869577806058371,0.6277695716395865,1.0,1.0,6/15,23.01%,FMN2;METTL3;MDK;MARF1;KMT2D;MEI4
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.26166684645181,-0.8695382268567073,0.6781115879828327,0.8959616083093238,1.0,10/29,22.08%,RPS14;RPS16;RPS19;NGDN;HELB;RPS8;NOP9;RPS21;DHX37;MRPS11
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.33180010065009635,-0.8694456556928837,0.6329113924050633,0.8949477609761881,1.0,4/12,22.44%,WNK1;ASS1;SKAP1;AKT1
prerank,aromatic amino acid family metabolic process (GO:0009072),0.4119244434355545,0.8692841298103205,0.6243980738362761,1.0,1.0,2/10,9.65%,KYNU;IL4I1
prerank,positive regulation of macrophage migration (GO:1905523),-0.29354788111051694,-0.8692697333937947,0.6288659793814433,0.8941220948542463,1.0,3/19,7.52%,IL34;THBS1;AKIRIN1
prerank,regulation of protein localization to centrosome (GO:1904779),0.41091987070078223,0.8692420081634445,0.6280487804878049,1.0,1.0,1/10,1.79%,BICD1
prerank,negative regulation of T cell differentiation (GO:0045581),-0.34953956402838005,-0.8690988728208615,0.6263157894736842,0.8932610361076686,1.0,3/10,9.67%,BMP4;GLI3;IRF1
prerank,neuromuscular process (GO:0050905),0.3782976572738519,0.8688023816177483,0.6318051575931232,1.0,1.0,2/16,4.74%,KCNA1;NRXN1
prerank,fatty acid beta-oxidation (GO:0006635),0.31086160102618193,0.868784577547862,0.6978922716627635,1.0,1.0,15/51,22.25%,GCDH;IVD;ETFA;HADHA;ACOX1;MTLN;ABCD2;AUH;CRAT;EHHADH;ACAA2;DECR1;ACOT8;ACADS;SCP2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.2657636690091925,-0.8684044105262091,0.6642066420664207,0.8935779795671399,1.0,2/26,0.58%,IGF1;FHL2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.38452321067534545,0.8683569839030014,0.6361031518624641,1.0,1.0,3/14,13.23%,SOCS5;IL18;MALT1
prerank,neutral amino acid transport (GO:0015804),0.33634560905480165,0.8682992325521964,0.6588845654993515,1.0,1.0,6/28,19.25%,SLC1A5;SLC36A2;SLC43A1;SLC7A8;SLC6A15;SLC6A9
prerank,negative regulation of DNA recombination (GO:0045910),0.32245309651847004,0.8682318214401954,0.6637931034482759,1.0,1.0,11/43,16.41%,ZRANB3;POLR2B;ATRX;POLR2K;FBH1;MSH6;POLR2G;RTEL1;CGAS;BLM;TERF2IP
prerank,eye development (GO:0001654),0.3063563956821063,0.8677122499306338,0.6674418604651163,1.0,1.0,4/54,3.76%,EFEMP1;CHRDL1;COL5A2;MAB21L2
prerank,protein modification process (GO:0036211),0.2983573396190734,0.8676814210637438,0.6832579185520362,1.0,1.0,23/76,21.77%,CHRM3;TGM1;ARAF;CDKL3;MMP15;UBA3;SLC35A1;FBXL2;ATG3;NEDD8;ABL1;USP25;FBXO22;CSNK1G3;FBXO11;RPN1;UBE2L3;MCRS1;DUSP12;YES1;PLAT;UBE2D3;ERO1A
prerank,positive regulation of filopodium assembly (GO:0051491),0.342357983686991,0.8674486536944169,0.6532258064516129,1.0,1.0,6/24,16.63%,TENM2;NLGN1;GPM6A;PIK3R1;TGFB3;FSCN1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3663287604281457,0.8674115200424475,0.6367403314917127,1.0,1.0,7/19,16.83%,DLG2;PATJ;ERBIN;SCRIB;PARD3B;FSCN1;FOXJ1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.40543762912555076,0.866965771594239,0.6421725239616614,1.0,1.0,3/10,21.32%,DLGAP1;BEGAIN;DLGAP3
prerank,phosphate-containing compound metabolic process (GO:0006796),0.27011226097432656,0.8669652125863189,0.7596741344195519,1.0,1.0,52/198,23.96%,ITPK1;GFPT2;INPP4B;PLBD1;PTEN;DUSP4;PSPH;EPHB2;TGFB1;PLCB1;ACP2;PAK1;AGPAT2;PPP3CB;PPP3CA;TOLLIP;PPP1CA;PLPPR4;ACYP2;NUDT10;PLAAT3;NUDT3;HDHD2;SHPK;CALM1;PLAA;MINPP1;AGK;DUSP16;NUDT5;NT5C;HK2;BCKDK;TOP1;STAT3;CERKL;PLA2G4E;DUSP12;PLPPR2;INPP5J;PFKFB1;NUDT11;LIMD1;LIMK2;PPM1A;PLPPR1;HK1;SLC20A1;PRKCG;TAOK1;INPP5B;MTOR
prerank,carbohydrate transport (GO:0008643),0.40309902720249846,0.8669322216788746,0.6265432098765432,1.0,1.0,2/11,10.56%,SLC50A1;SLC2A2
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.2825709758330706,-0.8668425747954998,0.6338582677165354,0.8956927071453161,1.0,6/21,19.71%,NPM1;VPS4B;CDK4;CDC7;RAD51C;MECP2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.38987233392280907,0.8668163411926506,0.6422155688622755,1.0,1.0,3/13,12.93%,XPO1;EIF6;SDAD1
prerank,positive regulation of DNA binding (GO:0043388),0.32993830049855943,0.8667056715354454,0.6271637816245007,1.0,1.0,3/31,4.08%,NGF;PRKN;TGFB1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3465293431363279,0.8662319309822085,0.6618985695708712,1.0,1.0,4/27,12.70%,LPAR1;GPR65;HTR2C;DRD2
prerank,dendritic spine organization (GO:0097061),0.33882767426933746,0.8658247875850535,0.6357702349869452,1.0,1.0,6/26,11.38%,PTEN;EPHB2;PRNP;DOCK10;FYN;DIP2A
prerank,synaptic membrane adhesion (GO:0099560),0.3806343106758825,0.8657386427776315,0.6531204644412192,1.0,1.0,6/14,20.14%,LRRC4C;NTNG1;GPC4;PTPRF;LRFN5;PTPRS
prerank,piRNA metabolic process (GO:0034587),0.35661638197804846,0.8655654256549812,0.6395511921458625,1.0,1.0,4/19,22.36%,FKBP6;TEX15;TDRKH;DDX4
prerank,diacylglycerol metabolic process (GO:0046339),-0.27406952432479204,-0.8654017538924003,0.6867924528301886,0.8976262887454637,1.0,10/23,30.51%,GPAM;DGKH;PLA2G15;DAGLA;PNPLA2;DGKG;LIPE;DGKB;ANG;DGAT1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.3568247687552699,0.8653793068540869,0.6488439306358381,1.0,1.0,7/18,24.77%,TGFB1;CLASP1;RUNX1;FSCN1;RB1;BMP2;COLGALT1
prerank,receptor internalization (GO:0031623),0.3105894323039233,0.8650614316633295,0.6552147239263804,1.0,1.0,9/44,15.19%,DNM1;LRP1;GTF2H2;ACKR3;CD9;SNCA;SNX1;SCYL2;ITGB1
prerank,regulation of tissue remodeling (GO:0034103),0.36376496436438005,0.8646657933459682,0.6362297496318114,1.0,1.0,4/18,17.76%,TGFB1;IL18;RUNX1;MDK
prerank,regulation of histone acetylation (GO:0035065),0.3275804926652357,0.8646464162759606,0.6560913705583756,1.0,1.0,9/33,19.24%,KMT2A;RPS6KA4;BRCA1;SETD5;SNCA;TAF7;CTBP1;PARK7;RUVBL2
prerank,positive regulation of defense response to virus by host (GO:0002230),0.3485497569126632,0.8646263835342969,0.6440903054448871,1.0,1.0,2/24,3.80%,PTPN22;TRIM44
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.33258857495607047,-0.8640657126969972,0.6348773841961853,0.8992821333508211,1.0,5/12,13.59%,DKC1;WRAP53;CCT8;CCT6A;CCT4
prerank,regulation of inclusion body assembly (GO:0090083),-0.33781198956306396,-0.8639548550978865,0.6298507462686567,0.8982973070714438,1.0,1/11,0.33%,SNCAIP
prerank,regulation of BMP signaling pathway (GO:0030510),0.2947453951106369,0.8639079914763382,0.7017738359201774,1.0,1.0,14/73,16.36%,SOSTDC1;SULF1;HTRA3;SOX11;FBXL15;PCSK6;SFRP4;DAND5;BMPER;BMPR1A;UBE2O;LRP2;XIAP;VWC2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.30521067726616163,0.8637803845810615,0.6694117647058824,1.0,1.0,12/50,18.77%,DPEP1;NGF;VEGFA;MT3;PIH1D1;NGFR;DNAJB6;SNCA;XIAP;PAX2;FNIP1;PARK7
prerank,regulation of transport (GO:0051049),0.32235541609306717,0.8636354537106158,0.6670902160101652,1.0,1.0,2/36,2.35%,CLDN19;PRKN
prerank,epithelial to mesenchymal transition (GO:0001837),0.3117289637026109,0.8635070156981883,0.6571428571428571,1.0,1.0,10/47,11.42%,S100A4;SOX9;TGFB1;WNT5A;HNRNPAB;LOXL3;FGFR1;HIF1A;AMELX;BMP7
prerank,anion transmembrane transport (GO:0098656),0.2948685564418547,0.8627524114976194,0.6846950517836594,1.0,1.0,11/67,13.12%,SLC1A3;SLC27A1;SLC25A21;LRRC8D;SLC35C2;SLC25A38;ARL6IP5;SLC35A1;SLC7A8;PRAF2;SLC25A10
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.3391450945018866,0.862730847577644,0.6566579634464752,1.0,1.0,10/27,23.18%,DTYMK;AK1;AK5;AK6;AK2;TXNRD1;CTPS2;AK8;GLRX;CMPK1
prerank,transition metal ion homeostasis (GO:0055076),0.3365712458509154,0.8626315721310577,0.6379310344827587,1.0,1.0,3/28,5.56%,PRKN;MT3;CYBRD1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.3789512049129948,0.8624965935523065,0.6351351351351351,1.0,1.0,2/15,6.38%,PDGFRA;TGFBR2
prerank,sarcomere organization (GO:0045214),0.3375972257283032,0.8624354619893912,0.6587301587301587,1.0,1.0,2/27,8.42%,CSRP1;TNNT3
prerank,negative regulation of dephosphorylation (GO:0035305),0.3632257199181303,0.8623956862531349,0.6742857142857143,1.0,1.0,4/18,8.53%,PPP1R15A;URI1;ENSA;PPP1R8
prerank,glucan catabolic process (GO:0009251),0.37845363959267064,0.8623837456885977,0.6237482117310443,1.0,1.0,3/15,14.50%,PYGL;PHKB;CALM1
prerank,regulation of monocyte differentiation (GO:0045655),0.3822493060570683,0.8622919357735797,0.6347569955817378,1.0,1.0,3/14,7.57%,MYC;HOXA7;CDK6
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.4048899899401497,0.8621980042442423,0.6369327073552425,1.0,1.0,6/11,28.29%,ATF7IP;SIRT6;SETDB1;MPHOSPH8;RESF1;DNMT1
prerank,in utero embryonic development (GO:0001701),0.3487339428610841,0.8618292746797042,0.6526458616010855,1.0,1.0,6/25,17.17%,SOX8;VEGFA;EGFL8;PKD1;TGFB3;MYH6
prerank,protein import (GO:0017038),0.28683391527975577,0.8616721483619026,0.6828729281767956,1.0,1.0,23/84,21.12%,ACBD5;PEX3;PXMP2;NUP155;FAM53B;TOMM22;HSPA4;IPO9;PRICKLE1;KPNB1;IPO13;NXT1;EIF4ENIF1;GDAP1;POM121;ABCD2;TNPO3;IPO5;CSE1L;STAT3;PHB2;LAMP2;HEATR3
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.2074367892072935,-0.8615371893003227,0.7717391304347826,0.9022414589123002,1.0,14/76,12.95%,PTGIS;CD200;USP7;MAP2K5;NFKBIA;COMMD1;AIM2;PARP10;ANXA4;KLF4;COMMD7;PRMT2;TMSB4X;LRRC14
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2994503008106148,0.8615168885816845,0.6997663551401869,1.0,1.0,25/62,27.83%,TGFB1;RANBP2;POLR2B;NUP155;POLR2K;EIF4G1;NUP205;NDC1;NUP160;POLR2G;POM121;AAAS;POLR2A;PPARG;STAT3;ZFP36;LIMD1;NUP42;POLR2F;TNRC6A;FMR1;NUP35;RAE1;AJUBA;PUM2
prerank,protein localization to synapse (GO:0035418),0.4000536036768575,0.8610839830631515,0.6471494607087828,1.0,1.0,2/12,5.72%,NRXN1;NLGN1
prerank,regulation of cilium movement (GO:0003352),0.410950224911667,0.8610345367521146,0.6338461538461538,1.0,1.0,2/10,15.07%,CCDC39;CCDC65
prerank,relaxation of cardiac muscle (GO:0055119),-0.32858923079122127,-0.8609681154391582,0.6403508771929824,0.9022738367131624,1.0,3/13,6.72%,ATP1A2;KCNJ2;ATP1A1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.323193015506016,0.8609663442730943,0.6679487179487179,1.0,1.0,5/35,6.44%,PDGFRA;NTRK3;SEMA3E;IQGAP2;BAIAP2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.32900343824071654,0.8608756497977156,0.6871794871794872,1.0,1.0,6/32,15.48%,PRKCQ;CCT7;MAPK1;NEK7;MAP3K4;ATM
prerank,striated muscle cell differentiation (GO:0051146),-0.30147800802946956,-0.8608073651837136,0.6442953020134228,0.9014125692841557,1.0,7/16,19.73%,SIK1;KDM6B;MYEF2;SORT1;CBY1;MYOCD;SDC1
prerank,negative regulation of centrosome duplication (GO:0010826),0.39277796659876013,0.8605229742403642,0.6150442477876106,1.0,1.0,3/11,13.91%,KAT2B;BRCA1;MDM1
prerank,negative regulation of cell division (GO:0051782),0.3983213049556288,0.8605073608288812,0.6331811263318112,1.0,1.0,3/11,15.81%,MYC;CHMP4C;BLM
prerank,nitric oxide metabolic process (GO:0046209),0.38318128198615287,0.8602272802925767,0.6287425149700598,1.0,1.0,2/14,7.15%,NQO1;CYP1B1
prerank,regulation of hydrolase activity (GO:0051336),0.29319663510548516,0.8602135656248973,0.7045707915273133,1.0,1.0,9/71,8.66%,SIPA1L1;PLXNC1;FGD4;EFNA5;NTRK2;NF1;CHN1;ARHGAP9;VAV3
prerank,keratan sulfate catabolic process (GO:0042340),0.40570020754289604,0.8600352063206222,0.64,1.0,1.0,2/11,7.19%,LUM;GALNS
prerank,calcium ion import into cytosol (GO:1902656),0.3817402525817516,0.8594832222115945,0.6392496392496393,1.0,1.0,4/15,18.23%,CACNA2D1;SLC8A2;SLC24A2;MS4A1
prerank,protein stabilization (GO:0050821),0.2735224572252142,0.8593161090143426,0.7663934426229508,1.0,1.0,41/168,21.47%,PTEN;ANK2;STXBP4;PRKN;CCT7;TRIM44;FBXW7;MT3;ATF7IP;TSC1;NAA16;RAB21;RABL3;FLNA;BAG5;HIP1;CRYAB;PIK3R1;USP33;TAF9;GRN;DVL1;PER3;PDCL3;MDM4;SUMO1;RTN4;RASSF2;PIM2;USP2;NAA15;PARK7;TAF1;PHB2;USP13;NAPG;LAMP2;HSPD1;TNIP2;WDR81;DVL3
prerank,DNA conformation change (GO:0071103),0.37395167416130043,0.8591270103685252,0.6582633053221288,1.0,1.0,5/17,21.74%,HAT1;ABL1;NAA10;TOP1;TOP3A
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.30735910609041583,-0.8589814356224458,0.6242236024844721,0.9041483326246043,1.0,4/14,14.08%,NFKBIA;KEAP1;TMSB4X;MDFI
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.3449236091944709,0.8589416868037415,0.661498708010336,1.0,1.0,3/25,5.81%,SULF1;SOX11;FBXL15
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.2930604294904201,0.8586950381229992,0.7105855855855856,1.0,1.0,15/69,15.46%,ERLIN2;DNAJB9;RHBDD2;FBXO27;DERL2;SELENOS;HERPUD1;EDEM2;UBE2J2;RNF121;FBXO17;TMUB2;HSP90B1;JKAMP;ERLIN1
prerank,cellular macromolecule catabolic process (GO:0044265),0.30796219642518224,0.8583163021128911,0.6871239470517448,1.0,1.0,17/49,26.08%,PRKN;RNASE6;XRN2;PPP1R8;FBXO27;NCBP1;FBXO17;RNASEH2C;PNPT1;RIPK1;MAGEC2;UBE2G1;FBXO44;OGA;SUPV3L1;RNASE3;SND1
prerank,positive regulation of cyclase activity (GO:0031281),-0.3164234965039228,-0.8582581046280375,0.6410256410256411,0.9045151806037315,1.0,6/14,24.39%,CACNA1C;NOS3;STIM1;NOS1;CACNA1D;MAPK8
prerank,regulation of axon extension (GO:0030516),0.319683534684369,0.8578852634689937,0.679340937896071,1.0,1.0,13/37,20.14%,NRCAM;SEMA3A;RNF6;MT3;CDKL5;CDKL3;LIMK1;RTN4;ABL1;DIP2B;CTTN;SHTN1;PTPRS
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.4112240260654677,0.8578832469215039,0.6426380368098159,1.0,1.0,3/10,12.25%,ATRX;BRCA1;JARID2
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.24119004030198876,-0.8576195870771217,0.7083333333333334,0.9047594172133822,1.0,14/35,22.58%,NUAK1;PTPA;PPP1R15B;GSK3B;PDGFRB;PPP1R11;ITGA1;CD300A;HSP90AB1;MASTL;CSNK2B;PPP1R2;BOD1;STYXL1
prerank,regulation of stem cell population maintenance (GO:2000036),-0.29324752529734854,-0.8571269363367727,0.6909090909090909,0.9046756335551641,1.0,6/18,14.56%,PTN;WDR43;CNOT1;ELAVL1;TAF6L;HMGA2
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.3425211293974489,0.8569530429710704,0.6585365853658537,1.0,1.0,8/26,16.02%,PAK1;ARL2;CLASP1;SLAIN2;CDK5R1;KATNB1;MET;NAV3
prerank,positive regulation of rRNA processing (GO:2000234),-0.35247776214874826,-0.8567509453668674,0.6147058823529412,0.9042607054960016,1.0,7/10,26.41%,WDR43;UTP15;BUD23;DIMT1;RIOK1;SIRT7;RIOK2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.3958911606630068,0.8564935572409761,0.6585365853658537,1.0,1.0,8/13,31.86%,UNC93B1;TNIP2;IRAK2;IRAK1;PIK3C3;TRAF6;IRAK4;EPG5
prerank,regulation of microglial cell activation (GO:1903978),0.3771466983368793,0.856076093271195,0.6338880484114977,1.0,1.0,3/15,13.71%,SYT11;GRN;TTBK1
prerank,regulation of protein kinase C signaling (GO:0090036),0.3794945964281278,0.8555448679078022,0.6479289940828402,1.0,1.0,2/14,5.52%,VEGFA;WNT5A
prerank,myeloid cell differentiation (GO:0030099),0.31006747813737534,0.8552244250703009,0.6773428232502966,1.0,1.0,7/47,7.38%,CDKN2B;PTPN2;PRKX;SLC25A38;ZBTB16;UFL1;KAT8
prerank,triglyceride biosynthetic process (GO:0019432),0.36195160776787955,0.8549843792316819,0.6516220028208745,1.0,1.0,5/18,17.90%,AGMO;MOGAT3;GPAT3;GPAT4;PCK2
prerank,mitochondrial translation (GO:0032543),0.28417845108380974,0.8547711899720702,0.7334035827186512,1.0,1.0,28/104,22.45%,MRPL47;IARS2;MRPS18A;TUFM;MRPL14;MRPL32;MRPL16;GATB;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;MRPL30;MRPL28;HARS1;MRPL46;MRPL51;MRPS30;MRPS14;MRPS9;MRPS31;MRPL1;PTCD3;DAP3;MRPS6;MRPL52;MRPL18
prerank,response to insulin (GO:0032868),0.29043094069735886,0.8545605010273835,0.7058177826564215,1.0,1.0,10/80,10.37%,SLC27A1;IRS2;KAT2B;C2CD5;EPRS1;PDE3B;TSC1;EIF6;SELENOS;PIK3R1
prerank,signal release from synapse (GO:0099643),0.30708526312257484,0.8542600168985512,0.6854345165238678,1.0,1.0,8/43,13.88%,NRXN1;SYT1;SYN1;RIMS1;DVL1;RAB3A;OTOF;SNCA
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3819184867840193,0.853880107643984,0.6527570789865872,1.0,1.0,1/14,0.94%,MEOX2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3254725730471496,0.8538458378704712,0.6695652173913044,1.0,1.0,5/35,10.17%,CRLF3;SOCS1;CYP1B1;NF2;ERBB4
prerank,ganglioside metabolic process (GO:0001573),-0.2858091459407604,-0.8537559906122987,0.6654275092936803,0.9093175092782028,1.0,2/20,2.10%,ST6GALNAC3;ST8SIA4
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.36507852765797355,0.8535306720712086,0.6620879120879121,1.0,1.0,6/19,15.54%,MAP4K4;VEGFA;TSC1;PTPRJ;MYOC;ABL1
prerank,positive regulation of vasculature development (GO:1904018),0.2850418593695531,0.8533526528306064,0.717948717948718,1.0,1.0,23/94,16.89%,PRKCA;FGF2;CD34;VEGFA;PAK4;ITGB8;HSPB6;WNT5A;CYP1B1;GATA6;BRCA1;HIF1A;SP1;MYDGF;GRN;SMOC2;PDCL3;ITGB1;JUP;RUNX1;GAB1;HYAL1;APLNR
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.29376982721035505,-0.85314427173285,0.6436363636363637,0.9094360198587779,1.0,6/18,12.29%,RAP1B;RAB5A;DTNBP1;GSK3B;SLC4A8;SNAPIN
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.2666736970176818,-0.8530077257528844,0.724,0.908528714636362,1.0,12/25,33.34%,AMPD3;PRPSAP2;PRPS2;DCK;GART;PRPS1;PRPS1L1;APRT;GMPS;PNP;ADA;SHMT2
prerank,nitric oxide biosynthetic process (GO:0006809),0.387161621493325,0.8528546755500958,0.6265243902439024,1.0,1.0,2/13,7.15%,NQO1;CYP1B1
prerank,endocardial cushion morphogenesis (GO:0003203),0.36861051518651766,0.8528517621013911,0.6557610241820768,1.0,1.0,6/18,17.58%,SOX9;ACVR1;TGFBR2;MDM4;BMPR1A;HEYL
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.40376186590734464,0.8525015026295395,0.6528662420382165,1.0,1.0,3/11,14.61%,CD34;GATA6;BMPR1A
prerank,cellular response to fluid shear stress (GO:0071498),0.39144735975814493,0.8522690858467865,0.6369327073552425,1.0,1.0,4/12,16.26%,HAS2;MAPK7;NFE2L2;SREBF2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.29743832222984806,0.8520827045316292,0.7012687427912342,1.0,1.0,11/59,13.71%,PRKCA;ACVR1;WNK3;DYRK4;TGFBR2;DYRK1B;STK39;MAPK1;CDK5R1;TBK1;TTBK1
prerank,striated muscle contraction (GO:0006941),-0.2243959624479275,-0.8517042372064031,0.8029197080291971,0.9102503819429253,1.0,15/53,26.02%,ATP1A2;RCSD1;TPM1;GRK2;GAA;NOS1;ATP1B1;STAC;SCN4B;MYH14;STAC3;DMD;SCN3B;MYL4;CASQ2
prerank,adenine nucleotide transport (GO:0051503),-0.2981956966887554,-0.851449214599588,0.6722408026755853,0.9096221411056795,1.0,4/17,13.06%,ABCC4;ABCC6;LRRC8C;LRRC8A
prerank,regulation of autophagosome assembly (GO:2000785),-0.245669832115281,-0.851299564025605,0.7194570135746606,0.9086991161963137,1.0,11/33,22.35%,RAB5A;TBC1D14;FEZ2;SCFD1;NUPR1;LRSAM1;PIP4K2B;SMCR8;PINK1;ADPRH;SH3GLB1
prerank,mismatch repair (GO:0006298),0.33533109206877665,0.8509205683711286,0.6719160104986877,1.0,1.0,7/27,15.54%,RPA3;MUTYH;SETD2;MSH6;RPA2;MSH5;ABL1
prerank,sterol biosynthetic process (GO:0016126),0.3196378276561197,0.8507386214832796,0.6491002570694088,1.0,1.0,4/33,8.57%,HSD17B7;SQLE;IDI1;ACLY
prerank,positive regulation of interleukin-4 production (GO:0032753),0.36143084816135546,0.8505070386684057,0.657856093979442,1.0,1.0,1/17,1.04%,PRKCQ
prerank,sensory perception of smell (GO:0007608),0.39775771365962,0.8503636161903013,0.6764705882352942,1.0,1.0,4/11,24.44%,DRD2;SLC24A4;UBR3;BBS4
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2814994273800798,0.8497133615043311,0.7188888888888889,1.0,1.0,16/85,21.87%,ROR2;WNT5A;FZD7;PRICKLE2;PSMB7;MAGI2;PRICKLE1;DVL1;PSMD2;PSMC1;PSMB2;PSMD9;PSME4;PSMA8;DVL3;ARRB2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2688458235429703,0.8493923356208405,0.7694704049844237,1.0,1.0,35/161,19.46%,TPBGL;RBMS3;LRP4;SOX9;PRKN;FRZB;JADE1;TLE1;GLI1;WNT5A;TBX18;PSMB7;DKK3;CUL3;SFRP4;TMEM131L;EMD;PRICKLE1;APC2;DVL1;WWTR1;CSNK1A1;KLHL12;PSMD2;SCYL2;PSMC1;DACT1;TLE3;PSMB2;TLE4;MDK;PSMD9;RUVBL2;NKD2;PSME4
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.2848102405647033,0.8493707929087938,0.7323340471092077,1.0,1.0,21/87,18.27%,NDUFAF4;COX20;NDUFS5;NDUFAF6;COX18;SCO1;NDUFB2;NDUFA8;COX19;NDUFS8;ACAD9;NDUFV3;NDUFS6;NDUFV2;NDUFA13;SDHAF1;NDUFA6;NDUFA12;AIFM1;UQCC1;NDUFC1
prerank,apoptotic DNA fragmentation (GO:0006309),-0.3077921615514047,-0.8492891172900514,0.7098765432098766,0.911792878791464,1.0,8/16,29.89%,DFFA;H1-0;DNASE2;HMGB2;CASP3;FOXL2;DICER1;CECR2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.31925141788049893,0.849267116266509,0.680306905370844,1.0,1.0,2/33,2.66%,PRKCA;FADD
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.3598825776844696,0.8492250459571649,0.6504992867332382,1.0,1.0,7/18,22.66%,SLC43A1;BIN1;STK39;NEDD4L;KCNH2;CAB39;CAMK2D
prerank,glycerolipid catabolic process (GO:0046503),0.3564489505024496,0.8491850003846203,0.6435935198821797,1.0,1.0,6/19,19.95%,PRDX6;ENPP6;LYPLA2;ABHD6;GDPD3;PLA2G4E
prerank,mesenchyme morphogenesis (GO:0072132),0.36869347175502026,0.8488880202482915,0.6614285714285715,1.0,1.0,7/17,23.46%,SOX9;ACVR1;MDM4;BMPR1A;HEYL;BMP2;TBX2
prerank,negative regulation of viral life cycle (GO:1903901),0.3740343559638014,0.8487884239369006,0.6477438136826783,1.0,1.0,3/15,10.42%,GSN;TRIM11;MID2
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.217784122235331,-0.8487333635187188,0.7687074829931972,0.9117739844321859,1.0,25/54,27.60%,NSA2;RPL24;NPM1;NVL;RPL5;RPL3;MAK16;MRPL20;NOP53;LAS1L;RPL11;SURF6;RPL7A;RPL35A;RPL26;PES1;RSL24D1;NLE1;SNU13;PPAN;NOC2L;RPF2;RPL6;RPF1;PAK1IP1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.38504134285845015,0.8487299496481565,0.6367713004484304,1.0,1.0,7/13,31.12%,PLCB1;GRB2;STAT3;STAT5A;JAK3;SHC1;IL15RA
prerank,cellular response to interleukin-15 (GO:0071350),0.38504134285845015,0.8487299496481565,0.6367713004484304,1.0,1.0,7/13,31.12%,PLCB1;GRB2;STAT3;STAT5A;JAK3;SHC1;IL15RA
prerank,calcium ion import across plasma membrane (GO:0098703),0.3796347452367148,0.8485776513732659,0.6439942112879884,1.0,1.0,2/14,7.96%,CACNA2D1;SLC8A2
prerank,embryonic heart tube morphogenesis (GO:0003143),0.30800064727519433,0.848525968177987,0.6890756302521008,1.0,1.0,5/43,8.64%,ACVR1;CCDC39;TGFBR2;BBS5;SMO
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.3910073382267477,0.848294048575191,0.6571428571428571,1.0,1.0,3/12,13.51%,PRNP;RCAN1;HOMER2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.3910073382267477,0.848294048575191,0.6571428571428571,1.0,1.0,3/12,13.51%,PRNP;RCAN1;HOMER2
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.3302704473175292,0.8481121843175534,0.6894803548795945,1.0,1.0,3/32,4.99%,DLC1;TGFB1;PPP1R15A
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.2890303835574769,-0.8480475491917949,0.6931034482758621,0.9119948681504806,1.0,7/17,18.90%,PTPA;PPP1R15B;PDGFRB;ITGA1;PTPRC;CD300A;HSP90AB1
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.2376922982630875,-0.8479994456685137,0.7450980392156863,0.9109275983882681,1.0,10/39,14.04%,MYO1D;WASL;FNBP1L;TRAK1;PAFAH1B1;KIF5B;BICDL1;MYO1E;MYO5B;MYO1C
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.28563421335948425,-0.8479232454093953,0.6909090909090909,0.9098981270883467,1.0,8/20,26.48%,OSR1;ACTN2;GOPC;ADRA2A;HECW2;TCAF2;CASQ2;PLN
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.3346804692035462,-0.847824558716338,0.671875,0.9077062443945055,1.0,5/11,13.59%,DKC1;LARP7;CCT8;CCT6A;CCT4
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.3346804692035462,-0.847824558716338,0.671875,0.9077062443945055,1.0,5/11,13.59%,DKC1;LARP7;CCT8;CCT6A;CCT4
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.34249953667676925,0.8478064328951838,0.6720430107526881,1.0,1.0,10/23,22.03%,ZBTB20;PSEN1;MLXIPL;HIF1A;PFKFB1;NFKB1;P2RX7;PRKAA1;PRXL2C;SLC4A4
prerank,regulation of autophagy (GO:0010506),0.26458650222907165,0.8475493496778564,0.7889908256880734,1.0,1.0,37/216,15.59%,DCN;PTPN22;BCL2;PRKN;NPRL2;CAPN1;FBXW7;ATP6V1B2;MT3;VPS29;PRKAB2;UFL1;BMF;KAT8;BNIP3;LAMTOR2;UCHL1;TLK2;SNX6;VPS26B;EIF4G1;MID2;USP33;HDAC6;CDK5R1;FBXL2;PRKACA;TPCN2;DRAM1;GFAP;WASHC1;TICAM1;MET;KLHL22;ATM;ABL1;PIM2
prerank,B cell mediated immunity (GO:0019724),0.4010315537952869,0.8475442850824726,0.6677367576243981,1.0,1.0,2/10,17.15%,CARD9;CD74
prerank,glycogen catabolic process (GO:0005980),0.37338319646039925,0.8468092898499356,0.6537356321839081,1.0,1.0,3/15,14.50%,PYGL;PHKB;CALM1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.2685143902699858,0.8467002077844862,0.7761806981519507,1.0,1.0,23/175,17.27%,CCL11;ADAMTS12;EDA;HAS2;PYCARD;CCL4;BRCA1;ERBIN;PSMB7;ZFP36L2;NFE2L2;PID1;GATA3;PSMD2;ZFAND6;CCL14;PSMC1;TP53;HYAL1;PYDC1;PSMB2;RIPK1;CHUK
prerank,mitotic nuclear membrane organization (GO:0101024),0.30017012030083384,0.8466699239562652,0.6982456140350877,1.0,1.0,28/51,31.23%,NUP155;PPP2R2A;RCC1;NUP205;NDC1;NUP160;EMD;KPNB1;SUMO1;LMNA;CHMP4C;POM121;AHCTF1;PPP2R1A;REEP3;IST1;NUP35;UBE2I;CHMP4B;CHMP4A;SPAST;VRK1;SIRT2;CC2D1B;SEC13;ANKLE2;NUP85;RANGAP1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.30017012030083384,0.8466699239562652,0.6982456140350877,1.0,1.0,28/51,31.23%,NUP155;PPP2R2A;RCC1;NUP205;NDC1;NUP160;EMD;KPNB1;SUMO1;LMNA;CHMP4C;POM121;AHCTF1;PPP2R1A;REEP3;IST1;NUP35;UBE2I;CHMP4B;CHMP4A;SPAST;VRK1;SIRT2;CC2D1B;SEC13;ANKLE2;NUP85;RANGAP1
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.22852374705255402,-0.8466482562806611,0.78,0.9088458843141604,1.0,9/41,12.51%,SMAD7;BMP4;ENG;TPM1;FGFR2;JAG1;GSK3A;PROX1;TGFB2
prerank,carboxylic acid metabolic process (GO:0019752),0.31814373890292047,0.8463813883752288,0.6902313624678663,1.0,1.0,3/33,7.77%,CYP2S1;DAO;CSGALNACT1
prerank,ion transport (GO:0006811),0.27920108954911066,0.846022771245299,0.7419354838709677,1.0,1.0,9/111,5.24%,PIEZO2;SLC1A3;VDAC2;SLC12A3;SLC17A5;ANO6;CHRNA4;SLC36A2;SLC12A2
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.2901052748173054,-0.8457183962543141,0.6889632107023411,0.9095895156278759,1.0,3/18,7.14%,ACSL1;ELOVL7;ACSL5
prerank,cellular response to nutrient levels (GO:0031669),0.2940628394139751,0.8455571919411954,0.7150964812712827,1.0,1.0,20/62,24.75%,CDKN2B;NUPR2;WIPI1;TSC1;RALB;EIF4G1;USP33;CLEC16A;VPS41;SREBF2;WRN;RPTOR;FNIP1;RRAGA;LAMP2;PRKAA1;INHBB;MTOR;WDR45B;EHMT2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.3356260739452273,0.8454594525256662,0.6913907284768211,1.0,1.0,8/24,22.66%,JPH3;AKAP6;PDE4D;PRKACA;CALM1;CALM2;PKD2;CAMK2D
prerank,DNA replication (GO:0006260),0.27508862363220643,0.8454475567605965,0.7561235356762513,1.0,1.0,33/105,24.76%,POLE2;BAZ1A;TIPIN;REV3L;RPA3;BRCA1;POLE3;MCM4;UPF1;ING4;RPA2;ORC1;TOPBP1;POLG2;ATM;BLM;POLG;FAM111A;WRN;REV1;ORC4;DBF4;TOP1;WRNIP1;ORC2;TOP3A;RBMS1;RAD50;KAT7;BARD1;ORC3;ATR;RHNO1
prerank,positive regulation of cell cycle (GO:0045787),0.2969614700214881,0.8453154356856925,0.6892980437284235,1.0,1.0,14/62,18.57%,PRKCA;EGFR;TGM1;CCDC57;ASNS;CDC25B;SMOC2;PKD1;CITED2;CCND2;USP2;PKN2;MDM2;MAPRE3
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.378503619818405,0.8452983811381172,0.65424739195231,1.0,1.0,2/13,8.26%,AP1G1;GAB2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.4077818831936305,0.8452820824975351,0.6561014263074485,1.0,1.0,1/10,1.74%,PTPN22
prerank,macroautophagy (GO:0016236),0.27352542660005075,0.8452535398374386,0.7579281183932347,1.0,1.0,21/118,15.22%,DYNLL1;PRKN;MTMR14;VPS33A;LIX1;ACBD5;SNAP29;WIPI1;PRKAB2;VPS39;ATG5;TOMM22;TOMM20;VPS37B;VPS36;ATG3;MVB12A;GABARAPL2;PLAA;VPS41;CHMP4C
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3220855789894578,0.8451531286248817,0.688212927756654,1.0,1.0,4/31,7.57%,PTEN;CDKN2B;JADE1;CDK6
prerank,negative regulation of developmental process (GO:0051093),-0.2110381001703775,-0.845148454884367,0.8076923076923077,0.9096041150900064,1.0,19/69,16.75%,ROCK2;ROCK1;NFIB;NOS3;BMP4;PARP3;TBX1;ARHGEF15;TFRC;IL17D;VAT1;NOTCH4;MAPT;SINHCAF;ARPIN;FUZ;HEY2;RPS6KA6;SUZ12
prerank,establishment of mitotic spindle localization (GO:0040001),0.3280776909073911,0.8447002143630694,0.6593830334190232,1.0,1.0,7/28,18.48%,GPSM2;INSC;NDE1;CLASP1;KPNB1;ITGB1;HTT
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.2957769735045225,0.8446813118215449,0.7249417249417249,1.0,1.0,12/59,10.12%,TENM3;PTPRT;DSG2;OBSL1;CADM3;KIRREL3;HMCN1;CNTN6;CADM1;CNTN2;DSCAM;PALLD
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.36382145960380524,0.8445826931313869,0.6782608695652174,1.0,1.0,3/16,10.58%,FGF2;VEGFA;NGFR
prerank,response to UV (GO:0009411),0.2847953594407589,0.8444027885411085,0.7370689655172413,1.0,1.0,24/95,19.98%,MYC;EGFR;ZRANB3;GTF2H2;ERCC5;NSMCE3;ERCC4;DDB2;METTL3;BMF;MEN1;XPA;MSH6;ZBTB1;MAP3K4;TP53;USP1;N4BP1;WRN;REV1;CAT;TAF1;RUVBL2;SCARA3
prerank,regulation of trophoblast cell migration (GO:1901163),0.37795508541918077,0.8442960288211198,0.6407914764079148,1.0,1.0,2/14,5.43%,VEGFA;ACVR1C
prerank,lipid homeostasis (GO:0055088),0.29584074153873147,0.8442442401247474,0.7013888888888888,1.0,1.0,7/57,9.74%,IRS2;ZBTB20;FBXW7;MLXIPL;ACOX1;RCN3;THADA
prerank,positive regulation of nervous system process (GO:0031646),-0.29175669392233683,-0.8438862943958498,0.67,0.9110723999580184,1.0,4/18,10.71%,NLGN2;PARD3;ATPSCKMT;UNC13B
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.37478149939681793,0.843812536613459,0.6686217008797654,1.0,1.0,5/14,21.54%,ADSS1;ADK;RFK;ADSL;PFAS
prerank,regulation of catabolic process (GO:0009894),0.3555899861274923,0.8437290724465,0.675561797752809,1.0,1.0,6/18,21.63%,FAP;NEDD4L;ITGB1;MDM2;FURIN;RARRES2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.38753268225932447,0.8433518740531263,0.6671802773497689,1.0,1.0,7/11,27.83%,STAT3;ZFP36;LIMD1;XPO5;FMR1;AJUBA;PUM2
prerank,transferrin transport (GO:0033572),-0.23987464188972932,-0.8433062699100378,0.7450980392156863,0.9110604697070355,1.0,9/33,15.42%,RAB11B;ATP6V0C;ATP6V0D1;MCOLN1;TFRC;DNM2;ATP6V0A4;ATP6AP1;ATP6V0A2
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.33492058988745793,0.8432764700463878,0.6711409395973155,1.0,1.0,9/25,24.68%,HMGN1;ZNF326;SETD5;ELL;TCEA2;ZMYND11;KAT7;THOC5;CCNT2
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.3555046772433068,-0.8431303148190797,0.6396648044692738,0.910233431370958,1.0,4/10,22.11%,HSP90AA1;NAB2;HSP90AB1;CLU
prerank,negative regulation of bone mineralization (GO:0030502),-0.3130465831314827,-0.843086853771296,0.652317880794702,0.9091434279365839,1.0,8/13,40.38%,SRGN;ENPP1;PTK2B;RFLNA;GREM1;ECM1;AHSG;RFLNB
prerank,base-excision repair (GO:0006284),0.30194968624278445,0.8429476584877675,0.7033898305084746,1.0,1.0,12/48,17.24%,MBD4;ERCC5;MPG;RPA3;MUTYH;XPA;HUWE1;NEIL1;RPA2;SMUG1;POLG;WRN
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.353207835389242,0.8424714092094627,0.656984785615491,1.0,1.0,6/18,17.76%,NF1;TMEM98;DAAM2;PTPRZ1;OPALIN;MDK
prerank,regulation of receptor recycling (GO:0001919),-0.29831036320778825,-0.8423059241268315,0.6927899686520376,0.9095081833013453,1.0,6/16,21.55%,NSF;OPTN;ECE1;TBC1D16;LAMTOR1;INPP5F
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.3465011606946489,-0.8414457329886911,0.6694444444444444,0.9101263610285188,1.0,6/10,31.83%,RIOK3;UFD1;GPATCH3;RNF125;TKFC;TSPAN6
prerank,protein export from nucleus (GO:0006611),0.33088806350303734,0.8412642971893303,0.667578659370725,1.0,1.0,3/27,4.08%,CCHCR1;XPO1;TGFB1
prerank,dendrite morphogenesis (GO:0048813),0.31335705108296064,0.8412077910883028,0.6944099378881987,1.0,1.0,8/35,12.17%,LRP4;PTEN;EPHB2;SDC2;CTNNA2;DOCK10;DIP2A;DVL1
prerank,regulation of chromatin binding (GO:0035561),0.40255607830758233,0.8411274875438617,0.6544585987261147,1.0,1.0,1/10,1.37%,DDX11
prerank,nuclear export (GO:0051168),0.28607141173277323,0.8408761988399224,0.7313432835820896,1.0,1.0,17/80,19.64%,CCHCR1;XPO1;THOC6;TGFB1;NUP155;SRSF11;CASC3;NCBP1;MALT1;SRSF6;PKD1;POM121;NXF1;RNPS1;THOC7;CSE1L;SRRM1
prerank,calcium-ion regulated exocytosis (GO:0017156),0.3295415500699439,0.840833164512075,0.6811594202898551,1.0,1.0,11/27,23.60%,SYT1;PPP3CB;SYT11;SYT12;RIMS1;DOC2B;SYT2;RIMS2;SYT13;SYT3;ARL8B
prerank,regulation of establishment of planar polarity (GO:0090175),0.2771412087340682,0.8407317237530355,0.7411894273127754,1.0,1.0,16/88,21.87%,ROR2;WNT5A;FZD7;PRICKLE2;PSMB7;PRICKLE1;DVL1;PSMD2;PSMC1;DACT1;PSMB2;PSMD9;PSME4;PSMA8;DVL3;ARRB2
prerank,positive regulation of glycolytic process (GO:0045821),0.34933356281399786,0.8405233224357909,0.6819444444444445,1.0,1.0,9/20,22.03%,ZBTB20;PSEN1;MLXIPL;HIF1A;PFKFB1;P2RX7;PRKAA1;PRXL2C;SLC4A4
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.34933356281399786,0.8405233224357909,0.6819444444444445,1.0,1.0,9/20,22.03%,ZBTB20;PSEN1;MLXIPL;HIF1A;PFKFB1;P2RX7;PRKAA1;PRXL2C;SLC4A4
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.2977873105501164,0.8403189119623362,0.7077844311377246,1.0,1.0,15/52,21.71%,BCL2;FBXW7;YWHAZ;VPS11;HUWE1;UBE2J2;PPP3CC;TP53;SREBF2;CSNK2A2;UBE2L3;MICALL2;RHOU;NPEPPS;UBE2D3
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.26519425409201824,0.8401474897575478,0.8228105906313645,1.0,1.0,41/234,20.24%,RELN;ROR1;EDA;PRKCQ;PYCARD;PTEN;STK36;VEGFA;IRAK3;CRTC1;RPS6KA4;FANK1;WNT5A;CARD9;IL18;SMO;MID2;ATF2;ESR1;TRIM41;RTKN2;PRDX3;MALT1;DHX33;TICAM1;UBB;JUP;TERF2IP;IL1RAP;RIPK1;CHUK;RAB7B;PARK7;TAB3;TAF1;BCL10;PPARG;STAT3;PHB2;ADCY8;SMARCA4
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.40124020894314405,0.8398099830591716,0.6589861751152074,1.0,1.0,1/11,1.66%,PTEN
prerank,inositol phosphate dephosphorylation (GO:0046855),0.40124020894314405,0.8398099830591716,0.6589861751152074,1.0,1.0,1/11,1.66%,PTEN
prerank,cellular response to acid chemical (GO:0071229),0.3322091762309944,0.8392598859594275,0.7093908629441624,1.0,1.0,11/27,26.30%,VEGFA;CPEB3;LAMTOR2;CPEB1;SPAAR;RPTOR;IPO5;RRAGA;MTOR;SLC38A9;CPEB4
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.36646234571865005,0.8391621635487526,0.6742209631728046,1.0,1.0,3/17,5.51%,CACNA2D1;ANK2;SCN5A
prerank,regulation of chromosome organization (GO:0033044),0.34094806475765005,0.8391373798240028,0.6746478873239437,1.0,1.0,6/22,17.74%,MYC;SETMAR;UPF1;SMG6;TERF2IP;CENPV
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3621183598427327,0.8388170030704315,0.6581560283687943,1.0,1.0,3/16,14.50%,PYGL;PHKB;CALM1
prerank,protein transport (GO:0015031),0.2612895011260415,0.8384308975477147,0.8501006036217303,1.0,1.0,95/332,24.31%,TMED6;ANK3;TBC1D10A;RAB38;LRP1;STEAP3;VAMP4;RAB14;ATP6V1B2;BLZF1;VPS33A;COPZ2;SNX15;VPS29;SCAMP2;SPTBN1;ARL1;RAB21;COPB2;RAB34;SEC31B;COPG2;RABL3;TBCK;MTTP;RCN3;TMED10;RAB3D;NEURL1B;SLC10A7;SNX6;VPS26B;ARL5C;NGFR;ARF4;NDC1;HDAC6;ARL6IP5;RAB22A;SYS1;RAB1A;USP6NL;RAB3A;HSP90B1;STX8;SYNDIG1;RAB3GAP2;TMED3;TMED2;TRIM23;COPA;ARFGAP3;SNX1;SEC23IP;UNC93B1;SGSM1;COPG1;STX1B;LRP2;TANGO6;CTTN;AP4M1;CD74;DENND10;ATP6V1C1;RAB7A;KIF3A;STX17;RAB3B;ARFIP1;CHMP1B;PPARG;TBC1D12;NAPG;ATP6V0E2;LAMP2;VMP1;TANGO2;TBC1D8B;TBC1D9B;KIF13A;ATP6V0E1;RAB18;FAM91A1;SNX4;RAB6A;UNC119B;TVP23A;SCFD2;STX2;ACD;STX7;ATP6V1G2;MIA3;ARRDC2
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.3136394330770854,-0.8379876758539191,0.7027027027027027,0.9158380708918553,1.0,2/13,2.11%,ABCA1;CDH13
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.30289108967440553,0.8369210003346198,0.7168037602820212,1.0,1.0,10/49,16.25%,PYCARD;BCL2;EIF2AK3;URI1;BMF;HERPUD1;RTKN2;TP53;BCL2L11;NDUFA13
prerank,response to iron ion (GO:0010039),-0.32342488870340724,-0.8360240250637012,0.6923076923076923,0.9184876109365194,1.0,1/12,0.02%,BMP6
prerank,histone modification (GO:0016570),0.27601257167201415,0.8359542532992723,0.7564377682403434,1.0,1.0,25/109,19.24%,RCOR2;RPS6KA4;MT3;HLCS;MTA2;UFL1;KAT8;CARM1;BRD8;MORF4L2;HDAC2;HUWE1;PHF20;SIN3B;PRMT1;HDAC6;MIDEAS;BAZ1B;TRRAP;MSL3;MTA3;USP21;ATXN7;PARK7;RUVBL2
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.26809191758212825,-0.8358587006680837,0.7159533073929961,0.9176330517762603,1.0,10/22,26.32%,MMS19;ISCA1;LYRM4;FXN;CIAO3;ABCB7;NDOR1;CIAPIN1;GLRX5;NUBP1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.29596217576978956,0.8355519031602745,0.7265160523186682,1.0,1.0,11/48,16.73%,PRDM16;RANBP2;NUP155;EIF6;HIF1A;NUP205;NDC1;NUP160;POM121;PNPT1;AAAS
prerank,postreplication repair (GO:0006301),-0.22298239445103848,-0.8351691279266383,0.7967032967032966,0.9178829913165638,1.0,23/45,31.34%,POLD3;TRIM25;PRIMPOL;PARP10;RFC1;POLH;UBE2A;PCNA;UBE2N;RAD18;POLK;ISG15;FAAP20;NSMCE1;RFC3;UBA52;USP43;POLD2;VCP;PCLAF;MSH2;POLD4;POLD1
prerank,cellular response to unfolded protein (GO:0034620),0.3269410965314756,0.8351432621476783,0.6802096985583224,1.0,1.0,7/26,21.23%,PRKN;PACRG;PTPN1;TM7SF3;HSPA9;HSPD1;RHBDD1
prerank,genitalia development (GO:0048806),0.38443863448222837,0.8351280618156354,0.6854103343465046,1.0,1.0,4/12,16.71%,WNT5A;PTPN11;PKD1;DNAJC19
prerank,release of cytochrome c from mitochondria (GO:0001836),0.36114261140570775,0.8349572708614679,0.6782106782106783,1.0,1.0,4/17,15.54%,BCL2;SOD2;GGCT;FZD9
prerank,neuron projection extension (GO:1990138),0.32209928144829486,0.8349535203185595,0.6963151207115629,1.0,1.0,9/32,14.94%,MAP1B;SEMA3A;AUTS2;CDKL3;PPP3CB;SPG11;NRP2;IQGAP1;CYFIP1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.39300951773631987,0.8349281591198601,0.6885496183206107,1.0,1.0,3/11,17.15%,BCL2;TAF9;CD74
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.37688191637648727,0.8347849381726027,0.6705370101596516,1.0,1.0,7/14,25.15%,ACOX1;CRAT;EHHADH;ACOT8;SCP2;HSD17B4;AMACR
prerank,histone H3-K9 demethylation (GO:0033169),-0.33421519703172986,-0.8347446612821445,0.6942148760330579,0.9175325893802244,1.0,5/11,19.86%,KDM1A;KDM4C;KDM4D;KDM3B;HR
prerank,negative regulation of cell aging (GO:0090344),0.36637872429228974,0.834701598027755,0.6884272997032641,1.0,1.0,4/16,9.26%,MAP3K3;CDK6;FOXM1;AKT3
prerank,negative regulation of cholesterol transport (GO:0032375),0.4000980909129721,0.8343205825679546,0.6671974522292994,1.0,1.0,2/10,21.18%,SREBF2;NFKB1
prerank,regulation of chromatin organization (GO:1902275),-0.30543880593761086,-0.8343028089563534,0.6925373134328359,0.9172358518631346,1.0,3/14,5.00%,MLLT3;PARG;IGF2
prerank,inorganic anion transmembrane transport (GO:0098661),0.2918285263107577,0.8341076575282513,0.7348571428571429,1.0,1.0,10/63,16.03%,ANO2;SLC1A3;SLC12A3;ANO6;SLC12A2;SLC12A4;SLC25A10;XPR1;GABRG2;SLC25A11
prerank,electron transport chain (GO:0022900),0.36749682691960556,0.834003395329555,0.6694214876033058,1.0,1.0,2/15,5.93%,POR;ETFA
prerank,modulation by symbiont of host process (GO:0044003),-0.34816520378932125,-0.833562727901103,0.6472222222222223,0.9175394570118386,1.0,4/10,25.16%,PGK1;ENO1;MRC1;UBA52
prerank,positive regulation of protein modification process (GO:0031401),0.2669948813086394,0.8334807126900933,0.8453713123092573,1.0,1.0,18/203,6.54%,DLC1;CLDN19;NTRK3;FGF2;FGF10;SOX9;ERBB2;EGFR;EFNA5;WDFY2;VEGFA;TGFB1;NTRK2;MT3;TNIK;NIBAN1;PAK1;RALB
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.2857430963581491,0.8330301629110458,0.7471783295711061,1.0,1.0,22/73,24.88%,GLMN;KAT2B;TAF1A;EED;POLR2K;HDAC6;CREBZF;EPC1;JARID2;RBBP4;POLR1B;BAZ1B;PHF19;POLR1C;POLR1G;CGGBP1;RBBP7;TDG;MPHOSPH8;AEBP2;POLR2F;TBP
prerank,response to X-ray (GO:0010165),0.36360080972222947,0.8329200034608396,0.6710914454277286,1.0,1.0,6/14,29.34%,XRCC6;ATM;BLM;LIG4;XRCC4;NUCKS1
prerank,intracellular protein transport (GO:0006886),0.2574411210523207,0.8327911092317315,0.8694779116465864,1.0,1.0,75/304,21.19%,TMED6;CCHCR1;TBC1D10A;XPO1;RAB38;C2CD5;RAB14;TGFB1;VPS33A;COPZ2;SNX15;VPS29;NLGN1;NUP155;ARL1;RAB21;COPB2;SEC31B;FAM53B;RABL3;TBCK;TMED10;SNX6;COX18;VPS26B;ARL5C;NGFR;AKAP6;ARF4;IPO9;HDAC6;RAB22A;PRICKLE1;VPS36;RAB1A;KATNB1;USP6NL;KPNB1;STX8;SYNDIG1;IPO13;NXT1;RAB3GAP2;TMED3;TMED2;TRIM23;COPA;ARFGAP3;SNX1;PKD1;SEC23IP;UNC93B1;SGSM1;EIF4ENIF1;STX1B;POM121;CTTN;AP4M1;SURF4;CD74;TRAK2;RAB7A;TNPO3;STX17;ARFIP1;IPO5;CSE1L;STAT3;TBC1D12;PHB2;NAPG;LAMP2;HEATR3;TBC1D8B;TBC1D9B
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.33540595560231024,0.8327410190671156,0.6977363515312917,1.0,1.0,12/23,24.27%,DYNC1I1;KIF5C;CCDC186;DYNC1I2;MAP6D1;TUBA1A;HOOK2;MAP6;CCDC88A;HOOK1;HOOK3;TUBA1B
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.25202503401140175,-0.8326578464327933,0.75,0.9181239083700309,1.0,13/29,30.18%,DGCR8;AGO1;ZC3H7B;TUT7;AGO3;SRRT;TARBP2;LIN28B;MRPL44;PUS10;AGO2;DICER1;AGO4
prerank,autophagy of peroxisome (GO:0030242),0.3840302060861976,0.8322613540745262,0.6779661016949152,1.0,1.0,3/12,18.07%,ACBD5;ATM;NBR1
prerank,protein oxidation (GO:0018158),-0.3236708507762261,-0.8321435288004032,0.659942363112392,0.9179681863623075,1.0,3/11,10.30%,LOXL1;LOX;TMX3
prerank,microtubule depolymerization (GO:0007019),0.34879212974880197,0.8320578589177297,0.6450704225352113,1.0,1.0,4/17,13.07%,KIF19;STMN4;KATNB1;CKAP5
prerank,hematopoietic stem cell proliferation (GO:0071425),0.39132371140388933,0.8314598691741527,0.6888544891640866,1.0,1.0,2/11,5.52%,CD34;WNT5A
prerank,synaptic vesicle cycle (GO:0099504),0.31312692267925724,0.8311561690025306,0.7088772845953003,1.0,1.0,6/30,13.88%,NLGN1;RIMS1;RAB3A;OTOF;SYNDIG1;SNCA
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.32599689296742124,0.8311028543505863,0.6875,1.0,1.0,4/29,9.44%,SLC27A1;ZBTB20;MLXIPL;ELOVL5
prerank,cGMP metabolic process (GO:0046068),0.38234229579209855,0.8307186473248933,0.6883720930232559,1.0,1.0,3/12,17.10%,NPR2;PDE9A;NPPC
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.2759527590022505,-0.8303503962524253,0.6980392156862745,0.9204218699941228,1.0,4/20,6.58%,PPIC;PPIL2;CWC27;PPIA
prerank,primary alcohol metabolic process (GO:0034308),-0.257607457949374,-0.8296995348723916,0.7469879518072289,0.9205016461003497,1.0,3/25,8.09%,IGF1;RBP4;ALDH3A2
prerank,cellular response to glucagon stimulus (GO:0071377),-0.28828082283507517,-0.8294748816839144,0.734006734006734,0.9198184872053863,1.0,7/17,25.13%,ADCY9;PRKAR1A;ADCY4;ADCY3;CYSLTR2;PRKAR2A;PRKACB
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.2974338706517115,-0.8293264791396474,0.7092651757188498,0.9189476914334831,1.0,6/16,20.00%,SIK3;FLCN;LARS1;PIP4P1;GPR137;RRAGB
prerank,protein polyubiquitination (GO:0000209),0.25624890482185425,0.8284852374440005,0.8598598598598599,1.0,1.0,90/297,26.06%,UBE2T;BCL2;CBFB;FBXW9;PRKN;UBE2E2;HACE1;FBXW7;RNF6;SPOP;FBXO7;FBXO38;ZNRF2;FBXL15;DDB2;FBXO32;TRIM2;PELI1;BRCA1;UBE2K;HECTD2;FBXL16;PSMB7;FBXO27;LNPEP;CUL3;HUWE1;ANAPC7;THOP1;UBE2J2;FBXO17;ANAPC2;MYLIP;AKTIP;DDA1;NEDD4L;PSMD2;UBB;AREL1;PSMC1;UBE2O;RNF19A;UBOX5;CDC23;FBXL4;UBE2Q1;PSMB2;RC3H1;RNF167;FBXO31;FBXO22;MDM2;ANKRD39;RNF4;PSMD9;TAF1;FBXO11;PSME4;FBXL12;UBE2L3;CDC27;UBE2G1;UBE2E1;NPEPPS;PSMA8;ANAPC4;MKRN1;RNF114;UBE2D3;TTC3;FBXO44;TPP2;ANAPC5;SIAH1;RNF187;UBE3C;CDC16;BARD1;TRIM14;WSB1;ANAPC13;UBE2Q2;FBXW8;CUL1;PELI2;RNF20;PSMD8;PSMD13;TOPORS;UBE2R2
prerank,establishment of protein localization to organelle (GO:0072594),0.2808081223294104,0.8280336627113619,0.7423382519863791,1.0,1.0,20/72,21.12%,NUP155;LAMP5;FAM53B;NEURL1B;IPO9;TSPAN17;PRICKLE1;KPNB1;IPO13;NXT1;EIF4ENIF1;POM121;TNPO3;HK2;IPO5;CSE1L;STAT3;PHB2;LAMP2;HEATR3
prerank,protein targeting to membrane (GO:0006612),-0.19683666336250266,-0.8276929669468494,0.8017241379310345,0.9207595156380771,1.0,31/83,27.25%,ZDHHC14;ZDHHC3;PEX13;PRKCI;PARD3;VPS37C;PEX19;ALDH3A2;ZDHHC18;ZDHHC7;SRPRA;AQP11;SRP14;ZDHHC20;MYO1C;SSR2;PEX14;ZDHHC4;PEX26;MICALL1;TAOK2;PEX2;ATAD1;ICMT;SIL1;ZDHHC2;RTP4;GET3;SRP19;VPS37D;PEX16
prerank,regulation of protein metabolic process (GO:0051246),-0.2239717567612999,-0.8275876511665827,0.815028901734104,0.919771324881126,1.0,17/44,24.54%,ROCK2;MAP2K5;MTPN;KLF2;ACE;APP;KLF4;CENATAC;ODC1;TMEM9;APOE;HSP90AB1;ABCA7;CHRNA7;PLAUR;MAPK8;ZDHHC2
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.2759226350051971,-0.8275480579959099,0.7354085603112841,0.9186786455059122,1.0,4/21,10.70%,ADCY9;NPR1;ADCY4;GUCY1B1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.37854887892360856,0.8268570603061355,0.6484848484848484,1.0,1.0,3/12,14.88%,KLF15;MAGI2;IQGAP1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3184535520369026,0.8268110867357541,0.7094682230869002,1.0,1.0,10/30,22.67%,WAC;UCHL5;BAG5;TLK2;TAF9;USP14;N4BP1;PARK7;SGTA;CAMLG
prerank,keratan sulfate biosynthetic process (GO:0018146),0.32880733873728746,0.8267278112908543,0.6857506361323156,1.0,1.0,2/26,1.60%,LUM;ST3GAL4
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.2755276990173891,0.8267039369893986,0.7703296703296704,1.0,1.0,17/86,16.91%,CCL11;PYCARD;PSEN1;PAK1;BAIAP2;LIMK1;BIN1;ARL2;CLASP1;SLAIN2;CDK5R1;KATNB1;NCK1;MET;CDC42EP1;NAV3;CTTN
prerank,cellular response to hexose stimulus (GO:0071331),0.33398056750435373,0.8266195192055915,0.6912378303198887,1.0,1.0,8/23,21.95%,ZBTB20;TRA2B;PDK3;PRKACA;PAX2;PCK2;ADCY8;PRKAA1
prerank,negative regulation of transmembrane transport (GO:0034763),0.396628368600008,0.8264497611930913,0.6722306525037937,1.0,1.0,1/10,1.98%,IRS2
prerank,cytosolic calcium ion transport (GO:0060401),0.3219178240214906,0.8259683000227936,0.7070967741935484,1.0,1.0,6/28,12.92%,CACNA2D1;ATP2B3;JPH3;SLC8A2;SLC25A23;ATP2B1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.3773538457067688,0.8249242437788888,0.6723646723646723,1.0,1.0,2/13,5.19%,NUDT15;ENTPD2
prerank,cellular response to alkaloid (GO:0071312),0.3492315635428275,0.8246219953844681,0.6864406779661016,1.0,1.0,5/17,19.10%,CASP6;BLM;SPIDR;CASP7;RYR3
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.39614334475858287,0.8244721727931115,0.6724683544303798,1.0,1.0,4/10,18.77%,GPR37;NFE2L2;RIPK1;PARK7
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.31265246477763103,0.8244547668346759,0.7104930467762326,1.0,1.0,7/31,15.91%,EXOSC8;DCP1B;EXOSC2;EDC4;LSM3;POLR2G;NT5C3B
prerank,positive regulation of chemokine production (GO:0032722),0.2997755649889103,0.8234989602152702,0.71875,1.0,1.0,7/44,19.04%,PYCARD;WNT5A;IL18;HIF1A;IL33;CD74;EGR1
prerank,negative regulation of proteolysis (GO:0045861),-0.23446008290297538,-0.8234516198778127,0.7647058823529411,0.9254151298818863,1.0,4/34,6.64%,EPHA4;ROCK1;GAS1;TIMP3
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.3917654990564674,0.8233212314938272,0.6824877250409165,1.0,1.0,2/10,7.41%,LAPTM4B;GATA6
prerank,glycoprotein metabolic process (GO:0009100),0.29191366790129947,0.8232380164154025,0.7311320754716981,1.0,1.0,9/53,11.74%,ST3GAL4;PRKCSH;PCSK6;MAN2A2;ST6GALNAC6;FBXO27;HIF1A;ST8SIA1;FBXO17
prerank,skeletal muscle contraction (GO:0003009),-0.27062654524130647,-0.8232221378006166,0.7437722419928826,0.9247140867330317,1.0,8/19,37.74%,RCSD1;STAC;MYH14;STAC3;TNNI1;TNNC1;TNNI3;CCDC78
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.31216531987498236,0.8227879561495669,0.7288776796973518,1.0,1.0,10/35,18.86%,SEMA3E;SEMA6C;SEMA3A;FLNA;FARP2;NRP2;SEMA6D;MET;SEMA4B;SEMA4D
prerank,axon extension (GO:0048675),0.33434695706154755,0.8227713742960915,0.6908602150537635,1.0,1.0,7/23,14.94%,MAP1B;SEMA3A;AUTS2;PPP3CB;SPG11;NRP2;CYFIP1
prerank,UV-damage excision repair (GO:0070914),0.3840304499654919,0.8227177731433015,0.6911076443057722,1.0,1.0,5/12,22.06%,DDB2;XPA;DDB1;CUL4B;ACTR5
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.2910452857258939,0.8224038644781739,0.7257876312718786,1.0,1.0,3/51,2.11%,SOSTDC1;HTRA3;CHRDL1
prerank,positive regulation of chromatin organization (GO:1905269),-0.32223936966205785,-0.8222602157247473,0.7217391304347827,0.9253851068318661,1.0,5/12,18.97%,TERF2;UBE2N;TAL1;SIN3A;TINF2
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.34970561726793525,0.822242898146199,0.7053941908713693,1.0,1.0,6/18,20.37%,DLC1;CUL3;MYOC;MET;KANK1;HEG1
prerank,endodermal cell differentiation (GO:0035987),0.31562229094976835,0.8221690501052608,0.6871859296482412,1.0,1.0,4/31,9.87%,MMP2;COL4A2;MMP15;SETD2
prerank,response to acidic pH (GO:0010447),-0.30629483967110277,-0.8216860932088886,0.6710963455149501,0.9253218255408489,1.0,4/13,14.95%,RAB11B;GPR4;LGMN;CTSS
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.33062298249077726,0.8216791026679997,0.6851119894598156,1.0,1.0,7/24,15.54%,MAP4K4;VEGFA;TSC1;PIK3R1;PTPRJ;MYOC;ABL1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.3923345709492527,0.8214929919377063,0.680577849117175,1.0,1.0,3/10,16.67%,MLXIPL;ELOVL5;ABCD2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3011990439262248,0.8213934441000039,0.749112426035503,1.0,1.0,5/43,7.90%,MMP2;FGF2;NOX1;ADAMTS1;IL18
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.2756414749838164,0.821389570409578,0.7735644637053087,1.0,1.0,16/86,16.30%,BMP5;SULF1;CDKN2B;ACVR1;TGFB1;SOX11;GDF9;FBXL15;MEN1;BMP7;BMPR1A;CITED2;ZEB2;UBE2O;TGFB3;RNF111
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.2694462286439886,-0.820983574348206,0.724025974025974,0.9255133230068092,1.0,9/20,29.15%,PSMG2;PSMG1;HSP90AA1;HSP90AB1;PSMG3;CLU;HOPX;PFDN6;PTGES3L
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.3871402378528842,0.8207019452300603,0.6869300911854104,1.0,1.0,2/11,8.06%,PRKN;FYN
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.31971366423707653,0.8203218566699285,0.716931216931217,1.0,1.0,7/30,16.10%,CACNA2D1;ANK2;SCN5A;FGF12;NEDD4L;PKP2;KCNH2
prerank,acidic amino acid transport (GO:0015800),0.3530120199261987,0.820168233371464,0.7082152974504249,1.0,1.0,4/17,12.95%,SLC1A3;LRRC8D;ARL6IP5;PRAF2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2852868117534151,0.8200136646548435,0.7212543554006968,1.0,1.0,13/54,19.90%,PYCARD;PRKN;FADD;PTPN2;OTULIN;UBE2K;TAX1BP1;PYDC1;RIPK1;CHUK;CPNE1;SPPL2B;TRAIP
prerank,positive regulation of protein processing (GO:0010954),-0.27253990546556717,-0.819799460710762,0.7543859649122807,0.9266362972888402,1.0,2/19,1.47%,CCBE1;MYH9
prerank,histone deubiquitination (GO:0016578),-0.2817896036697474,-0.8193485282071473,0.7375886524822695,0.9262549050322252,1.0,6/18,28.16%,USP7;USP3;USP15;KAT2A;TAF10;UIMC1
prerank,neurotransmitter secretion (GO:0007269),0.2938772821935413,0.8192526175951335,0.7527405602923264,1.0,1.0,8/44,13.88%,NRXN1;SYT1;SYN1;RIMS1;DVL1;RAB3A;OTOF;SNCA
prerank,fatty acid metabolic process (GO:0006631),0.27030955972826815,0.8191628658028212,0.7816826411075612,1.0,1.0,19/115,18.05%,CEL;ACACA;THEM4;SLC27A4;OXSM;ACBD5;ACOT11;ACOX1;ACLY;FASN;ACSF2;ALOX5AP;PNPLA8;ACAD9;LIPC;ACSL3;ABCD2;ACSL6;CRAT
prerank,UV protection (GO:0009650),0.39552361565761807,0.8190462942832868,0.6955177743431221,1.0,1.0,4/10,19.98%,ERCC5;XPA;CAT;SCARA3
prerank,ceramide catabolic process (GO:0046514),0.36596241598400503,0.8187166146852636,0.6943231441048034,1.0,1.0,2/14,6.02%,NAGA;GM2A
prerank,cellular response to radiation (GO:0071478),0.3056280253994209,0.8186670569862754,0.7224287484510533,1.0,1.0,7/40,15.98%,RHO;NSMCE3;MAPK14;GPR88;BLM;TP53;SPIDR
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3030373754441338,0.8185208336603946,0.73875,1.0,1.0,12/37,22.67%,WAC;UCHL5;BAG5;TLK2;TAF9;PDCL3;N4BP1;PARK7;TAF1;CSNK2A2;SGTA;CAMLG
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.3571632790943872,0.8184388996450876,0.7105643994211288,1.0,1.0,3/15,15.00%,FGF2;SMOC2;MET
prerank,protein-DNA complex assembly (GO:0065004),0.26472739856227323,0.8184064065045555,0.793717277486911,1.0,1.0,25/116,20.76%,RAD23B;SOX9;GTF2H2;ERCC5;DDB2;RPA3;ATRX;XPA;PSMB7;MCM4;ASF1A;DDB1;RPA2;ORC1;PSMD2;UBB;PSMC1;PSMB2;CUL4B;CENPV;ORC4;PSMD9;PSME4;ORC2;PSMA8
prerank,early endosome to Golgi transport (GO:0034498),0.3915503723374739,0.8182982005999336,0.7229102167182663,1.0,1.0,6/11,24.05%,SNX1;SURF4;RBSN;LMAN1;RAB6A;TRAPPC10
prerank,androgen receptor signaling pathway (GO:0030521),-0.3378540104752954,-0.8182619153310209,0.7040498442367601,0.92709258876493,1.0,2/11,7.09%,PLPP1;DDX5
prerank,response to nutrient levels (GO:0031667),-0.2995435801020726,-0.818252975056445,0.7312925170068028,0.9259390353836577,1.0,6/17,21.19%,RPS6KB1;PRKAA2;KCNB1;FAM107A;ATF4;ULK1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.32961273061522156,0.8181636111961517,0.7063389391979301,1.0,1.0,5/24,12.11%,FBXW7;PRNP;NF1;CDK5R1;GRN
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.2183333166951308,-0.8181121277564568,0.8344370860927153,0.9250427885668345,1.0,19/50,27.62%,SASH1;NFAT5;TLR4;APP;NR3C2;RHOA;NMI;SPHK1;IFI35;CD86;LAPTM5;NOD1;TCIM;TRADD;ACTN4;ILK;CCL19;NOD2;CD27
prerank,positive regulation of growth (GO:0045927),0.28593914048669666,0.8178965682219439,0.7655172413793103,1.0,1.0,13/64,18.03%,BCL2;ERBB2;EGFR;PLCB1;DERL2;NCBP1;EIF4G1;EXOSC2;AKAP6;BRAT1;KLHL22;HYAL1;RPTOR
prerank,actin filament network formation (GO:0051639),0.38100114914265176,0.8178403366850494,0.7044410413476263,1.0,1.0,2/11,14.10%,SPIRE1;COBL
prerank,positive regulation of macrophage activation (GO:0043032),0.35024406444534906,0.8175781049543186,0.6899862825788752,1.0,1.0,6/17,21.41%,WNT5A;TTBK1;IL33;LBP;HSPD1;TNIP2
prerank,phospholipid translocation (GO:0045332),0.324834026093631,0.817429188923425,0.7013157894736842,1.0,1.0,4/28,3.64%,ATP8B1;PLSCR4;ANO6;ATP9B
prerank,lymphocyte proliferation (GO:0046651),0.33077741924325876,0.8171525161967118,0.7014725568942436,1.0,1.0,7/22,25.18%,BCL2;PPP3CB;HELLS;MS4A1;HSPD1;CR2;LMBR1L
prerank,nucleotide catabolic process (GO:0009166),0.3537555913786002,0.8171438385953859,0.710267229254571,1.0,1.0,4/16,18.58%,NUDT15;NT5C2;NUDT3;NT5C
prerank,positive regulation of angiogenesis (GO:0045766),0.2693026464627199,0.8170225132808744,0.7625523012552301,1.0,1.0,27/108,17.95%,PRKCA;FGF2;CD34;VEGFA;PAK4;ITGB8;HSPB6;WNT5A;CYP1B1;GATA6;BRCA1;HIF1A;SP1;SIRT6;MYDGF;GRN;SMOC2;PDCL3;BMPER;ITGB1;JUP;RUNX1;GAB1;HYAL1;APLNR;MDK;EMC10
prerank,cellular response to virus (GO:0098586),0.3150785164353015,0.8167515150221397,0.6968503937007874,1.0,1.0,4/30,10.79%,CXCL10;GBF1;HIF1A;MAPK14
prerank,positive regulation of intracellular transport (GO:0032388),0.3065243568665879,0.8162626226407887,0.7201492537313433,1.0,1.0,10/38,23.75%,KIF20B;PGAP1;PCM1;TBC1D20;EHD2;PLA2G4E;PCNT;DYNC1H1;EIPR1;STX18
prerank,inositol phosphate catabolic process (GO:0071545),0.37681611866155756,0.8160248120464438,0.6794682422451994,1.0,1.0,4/12,23.64%,PTEN;NUDT3;INPP5J;INPP5B
prerank,sensory perception of light stimulus (GO:0050953),0.2734429268745623,0.8158610255797342,0.7573131094257854,1.0,1.0,15/87,20.73%,EFEMP1;CRYBG3;PCDH15;RDH10;DHRS3;COL18A1;OAT;MYO9A;COL1A1;OPA1;DNAJC19;PAX2;ATXN7;RGS16;COL11A1
prerank,translational elongation (GO:0006414),0.2709668882365254,0.8156685535194657,0.7795358649789029,1.0,1.0,26/101,22.45%,MRPL47;MRPS18A;EEF2K;TUFM;MRPL14;MRPL32;MRPL16;MRPL58;MRPS35;MRPS28;AURKAIP1;MRPL35;MRPL30;MRPL28;MRPL46;MRPL51;MRPS30;MRPS14;MRPS9;MRPS31;MRPL1;PTCD3;DAP3;MRPS6;MRPL52;MRPL18
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.29586453179211814,-0.8156295019572368,0.7209302325581395,0.9287571743934561,1.0,1/15,0.23%,OSBPL8
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2766444906030039,0.8152855160297695,0.7769145394006659,1.0,1.0,30/78,29.30%,PTEN;CDKN2B;EGFR;CCNJ;MEN1;PKMYT1;CDK5R1;PKD1;CDK5R2;BLM;CCND2;MAPRE3;IPO5;BCCIP;PKD2;NR2F2;CCNY;CCNT2;CCNH;CDC37;APC;CDK5RAP3;CDKN1A;CCND3;CCNI;GTPBP4;CCNE1;CDKN1C;CDKN2D;CDKN1B
prerank,regulation of protein processing (GO:0070613),0.33430053609541655,0.8150257266305043,0.7228260869565217,1.0,1.0,6/21,21.23%,PRNP;SERPINE2;RUNX1;SNX12;NKD2;RHBDD1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.3194188581991372,0.8147179171119072,0.7281167108753316,1.0,1.0,8/28,16.02%,PAK1;ARL2;CLASP1;SLAIN2;CDK5R1;CKAP5;MET;NAV3
prerank,lipoprotein localization (GO:0044872),0.3809145312474556,0.8138464734821332,0.656671664167916,1.0,1.0,6/11,25.43%,LRP1;PPARG;VMP1;UNC119B;MIA3;ZDHHC17
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.32173313590117764,-0.8137352921278245,0.7052023121387283,0.931031138042635,1.0,6/11,33.94%,DCK;SLC19A3;SLC25A19;ENPP3;TPK1;DCTD
prerank,nucleosome assembly (GO:0006334),0.3156965817279541,0.8135907856738276,0.7222946544980443,1.0,1.0,5/31,13.34%,SOX9;HAT1;ATRX;ASF1A;RBBP4
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2607744365299705,0.8130515978060144,0.8341968911917098,1.0,1.0,18/152,14.52%,CXCL10;GNA14;LPAR1;PTGER3;GPR65;PTHLH;PTGFR;PTH2R;LGR5;TSHR;ADGRB3;GPR37;S1PR3;ADGRL3;GLP2R;GNAI1;P2RY12;ADGRG2
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.23366615167404176,-0.8128098599894296,0.8125,0.9315681477841996,1.0,12/33,24.69%,ETS1;ARNT;STAT5B;ACVR1B;PITHD1;NCKAP1L;INHBA;TAL1;ANKRD54;HMGB2;FES;ACVR2A
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.33208213914093665,0.8127131258511189,0.7277701778385773,1.0,1.0,6/23,18.37%,TGFB1;SOX11;DKK3;BCL9;NREP;EID2
prerank,regulation of vasoconstriction (GO:0019229),0.3221150311847518,0.8126880260085904,0.7241379310344828,1.0,1.0,3/27,12.92%,CHRM3;KCNMB2;ATP2B1
prerank,canonical Wnt signaling pathway (GO:0060070),0.2788593307598451,0.8124023620092563,0.7684331797235023,1.0,1.0,15/68,15.64%,PTEN;FRZB;WNT5A;FZD7;RARG;BCL9L;SFRP4;PPP1CA;BCL9;DVL1;CSNK1A1;GATA3;SCYL2;FZD9;CSNK1E
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.2512090164845775,-0.8122811713947109,0.76171875,0.9313623753325986,1.0,10/26,21.83%,MFHAS1;WDFY1;CYBA;TIRAP;FLOT1;CAV1;IFI35;NINJ1;NR1H3;RSAD2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3639595298159098,0.8121937952351884,0.6769911504424779,1.0,1.0,2/13,10.78%,BMS1;RCL1
prerank,melanosome localization (GO:0032400),0.3292063985966185,0.8119127813663871,0.7024456521739131,1.0,1.0,8/21,25.47%,VPS33A;BBS5;MREG;BBS7;MYO5A;BLOC1S6;BBS4;RAB27B
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.35752217647274726,0.8117915051317202,0.7181409295352323,1.0,1.0,5/15,20.39%,PABPC1;CPEB3;POLR2G;EIF4ENIF1;ZFP36
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.28124687392616304,0.8116759623489082,0.7613504074505238,1.0,1.0,8/66,9.49%,SULF1;SOX9;CDKN2B;FBXW7;TGFB1;NF1;CDK6;SPARC
prerank,regulation of astrocyte differentiation (GO:0048710),-0.30431493920882485,-0.8113799475260496,0.6986301369863014,0.9318548044835108,1.0,1/12,0.34%,EPHA4
prerank,positive regulation of actin nucleation (GO:0051127),0.3766074140401313,0.8110713841044755,0.7024,1.0,1.0,5/11,19.03%,GSN;BRK1;WASF1;CYFIP1;NCKAP1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.2767659524214981,-0.8109253149017561,0.7254237288135593,0.9315181026833366,1.0,3/18,5.73%,NUP93;DDX19B;DDX19A
prerank,regulation of primary metabolic process (GO:0080090),0.26099620446468075,0.8107166517502636,0.8052631578947368,1.0,1.0,29/126,20.76%,IRS2;NQO1;NCOA1;C1QTNF2;SQLE;ACACA;IDI1;PRKAB2;ELOVL6;FASN;PSMB7;CARM1;NCOA2;CHD9;SIN3B;TGS1;SP1;NCOR2;PSMD2;PSMC1;SREBF2;PSMB2;PSMD9;SC5D;PSME4;PPARG;CERS2;NR1D2;PSMA8
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.32892246313809304,0.8105774298858586,0.7088948787061995,1.0,1.0,3/23,12.74%,AP1G1;CADM1;NECTIN2
prerank,reverse cholesterol transport (GO:0043691),-0.3066237171089173,-0.8100803689209953,0.7477744807121661,0.9319333163437021,1.0,4/13,22.11%,ABCA1;ABCG1;APOE;CLU
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.3487538407300491,0.8098406236434221,0.7115942028985507,1.0,1.0,4/18,15.17%,UGGT2;DERL2;EDEM2;UBB
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2716898613777683,0.8092345955552566,0.7830802603036876,1.0,1.0,20/93,18.74%,PYCARD;VEGFA;SEMA3A;NCF1;TRAF4;PLCB1;CARD9;FZD7;MTURN;PRMT1;ARL6IP5;TAOK3;MAP3K4;RASSF2;KLHDC10;RELL2;RIPK1;EMC10;MAP3K11;MID1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.3107840199686977,-0.8090691749255943,0.7360703812316716,0.9314560577824411,1.0,3/12,16.89%,IGF1;CHERP;PTBP1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.3107840199686977,-0.8090691749255943,0.7360703812316716,0.9314560577824411,1.0,3/12,16.89%,IGF1;CHERP;PTBP1
prerank,fatty acid biosynthetic process (GO:0006633),0.2787345832591681,0.8082659502942278,0.7559863169897377,1.0,1.0,7/63,9.44%,ACACA;OXSM;LTA4H;SCD5;ELOVL6;ACLY;ELOVL5
prerank,synaptic vesicle localization (GO:0097479),0.36276152297099207,0.8080676225326289,0.6980854197349042,1.0,1.0,4/13,13.45%,NLGN1;SPG11;KIF5C;SYNDIG1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.3807730604195601,0.807568058441013,0.734789391575663,1.0,1.0,3/10,16.77%,NAGK;GNE;GNPDA1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.2556390987767062,-0.807337301806944,0.7607843137254902,0.9333773603579736,1.0,12/24,31.34%,POLD3;XRCC1;RFC1;PCNA;LIG1;POLK;RFC3;UBA52;POLD2;POLE;POLD4;POLD1
prerank,N-glycan processing (GO:0006491),0.34529142628658077,0.807218044103733,0.7151162790697675,1.0,1.0,6/18,18.25%,GNPTAB;PRKCSH;MAN2A2;ST8SIA1;GANC;MAN1A2
prerank,cellular response to fatty acid (GO:0071398),0.37980106750147596,0.8071559923820419,0.7258805513016845,1.0,1.0,2/12,11.37%,PDK3;PID1
prerank,positive regulation of translational initiation (GO:0045948),-0.27111521445542897,-0.8068545588964969,0.7491289198606271,0.9330326299441509,1.0,6/18,22.88%,YTHDF1;HABP4;RPS6KB1;RPS6KB2;KHDRBS1;POLR2D
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.32476774997620084,0.8065201547183815,0.7086720867208672,1.0,1.0,7/24,21.77%,FGF2;HTR2C;ANXA6;DRD2;RYR3;PKD2;ERO1A
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.2740570862912702,0.8063083255436564,0.7878103837471784,1.0,1.0,7/76,8.10%,CCL11;NTRK3;PYCARD;GPSM2;BAIAP2;LIMK1;BIN1
prerank,cardiolipin metabolic process (GO:0032048),0.3656745209331618,0.8062275189948214,0.7071320182094082,1.0,1.0,3/13,13.50%,SLC27A1;HADHA;PNPLA8
prerank,positive regulation of exocytosis (GO:0045921),0.3051795895422975,0.8060375154653121,0.7291399229781772,1.0,1.0,9/35,18.13%,SDC4;RAB3D;CLASP1;STXBP5;RAB3A;SNCA;PDCD6IP;UNC13D;RAB7A
prerank,regulation of actin nucleation (GO:0051125),0.3684175152166646,0.8051264069423735,0.7134328358208956,1.0,1.0,3/12,19.00%,GSN;CORO1B;ARFIP1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.3478698786436312,0.8050367861482054,0.6955882352941176,1.0,1.0,5/15,18.77%,LIMK1;BAG5;ABL1;FBXO5;PARK7
prerank,regulation of neuron projection arborization (GO:0150011),0.3452224585468232,0.8049985342361219,0.7120115774240231,1.0,1.0,5/15,12.17%,WNT5A;NTNG2;NTNG1;MYO9A;DVL1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.3232315167303359,0.8049763105679784,0.7146666666666667,1.0,1.0,3/23,6.12%,GPSM2;INSC;NDE1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.2743365047230396,-0.8048379704591525,0.734982332155477,0.9354759022552516,1.0,7/19,30.00%,TLR4;TIRAP;NMI;PIK3AP1;NR1H4;ITGB2;ITGAM
prerank,regulation of RNA splicing (GO:0043484),0.2768948300268654,0.8047188550376768,0.7968397291196389,1.0,1.0,17/69,22.99%,PRX;QKI;TRA2B;ZNF326;SON;KHDRBS3;PIK3R1;YTHDC1;SF1;FUS;POLR2A;HNRNPH2;HNRNPL;SRSF3;AHNAK;PTBP2;AFF2
prerank,mitotic metaphase plate congression (GO:0007080),-0.2020063928066382,-0.804054241493154,0.8671875,0.9356506083247901,1.0,25/51,34.92%,CHMP3;BECN1;NUDC;VPS4A;CHMP1A;KIF18A;PINX1;VPS4B;PIBF1;CHMP7;BOD1;CHMP2B;EML4;DCTN2;CENPE;EML3;ZW10;KIFC1;NUP62;NDC80;KIF14;SPDL1;MAD1L1;CDCA8;CEP55
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.25615729337724363,0.8033731383701944,0.8409090909090909,1.0,1.0,33/163,21.50%,PRKCQ;PTPN22;BCL2;TEC;PDE4B;PAK1;CSK;EIF2B5;FYN;LAX1;VAV3;PSMB7;PIK3R1;PTPRJ;PDE4D;GATA3;MALT1;NCK1;PSMD2;PSMC1;LAT2;PSMB2;EIF2B2;RC3H1;CHUK;MS4A1;PSMD9;PSME4;BCL10;CD38;PSMA8;NFKB1;PRKD2
prerank,negative regulation of cell death (GO:0060548),0.26850035055553306,0.8032887815422705,0.7935135135135135,1.0,1.0,15/88,14.38%,FGF2;CD34;PRKN;SOX11;MT3;BNIP3;ATG5;FYN;PACRG;EIF4G1;BMP7;TM7SF3;SNCA;NCK1;SRSF6
prerank,response to zinc ion (GO:0010043),0.3133390958424575,0.8032831799396613,0.716,1.0,1.0,12/25,30.17%,MT3;SLC30A4;D2HGDH;MT1X;MT1M;MT1E;MT1G;MT1H;MT1F;MT1B;MT1A;CRIP1
prerank,regulation of mitotic nuclear division (GO:0007088),0.2781699223450615,0.8025572742745303,0.7634285714285715,1.0,1.0,9/55,11.60%,KIF20B;OBSL1;CDK13;BTC;AURKAIP1;RCC1;PKMYT1;BMP7;EDN3
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.286236943042984,0.8021697581322976,0.7713598074608905,1.0,1.0,18/50,26.38%,RANBP2;POLR2B;NUP155;POLR2K;EIF4G1;NUP205;NDC1;NUP160;POLR2G;POM121;AAAS;POLR2A;NUP42;POLR2F;TNRC6A;FMR1;NUP35;RAE1
prerank,regulation of gene silencing by RNA (GO:0060966),0.286236943042984,0.8021697581322976,0.7713598074608905,1.0,1.0,18/50,26.38%,RANBP2;POLR2B;NUP155;POLR2K;EIF4G1;NUP205;NDC1;NUP160;POLR2G;POM121;AAAS;POLR2A;NUP42;POLR2F;TNRC6A;FMR1;NUP35;RAE1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.35695607638924615,0.8017983304113613,0.7002967359050445,1.0,1.0,2/13,9.11%,BPNT1;BPNT2
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.31676841705845155,-0.8016506933504582,0.7167630057803468,0.938763643299315,1.0,4/11,15.30%,BMP4;JAG1;TGFB2;HEY2
prerank,negative regulation of actin filament polymerization (GO:0030837),0.32445689886367907,0.8011713261414427,0.728882833787466,1.0,1.0,3/22,6.02%,KANK4;GSN;SSH3
prerank,midbody abscission (GO:0061952),-0.27081463750533974,-0.800271174368797,0.7857142857142857,0.9400650795740956,1.0,6/17,23.97%,CHMP3;VPS4A;CHMP1A;VPS4B;CHMP7;CHMP2B
prerank,negative regulation of gene expression (GO:0010629),0.24886055101218058,0.8002090847465378,0.9099099099099099,1.0,1.0,49/302,16.93%,FFAR4;CLDN19;CREB3L1;FGF2;RBMS3;PTPN22;CD34;KAT2B;PRKN;EPRS1;VEGFA;EIF2AK3;RPS6KA4;FBXW7;TGFB1;PSEN1;DXO;SOX11;ITGB8;EED;METTL3;TSC1;SHQ1;CPEB3;SMO;HIF1A;SYT11;ZFP36L2;ESR1;HELLS;DIP2A;CREBZF;EPC1;JARID2;ATP2B1;NDFIP1;RBBP4;TTBK1;PUS7;NCOR2;BMPR1A;CITED2;EIF4ENIF1;RUNX1;PHF19;PNPT1;APLNR;N4BP1;SNX12
prerank,fatty acid elongation (GO:0030497),-0.30752765031566476,-0.8000846067706485,0.7555555555555555,0.9392358764235349,1.0,2/13,3.24%,ELOVL7;HACD4
prerank,lipid modification (GO:0030258),0.2987186525443432,0.7999573630244754,0.7553058676654182,1.0,1.0,15/37,28.53%,MBOAT2;PLA2G7;DGKI;PLPP4;PLPPR4;PLPPR2;PLPPR1;PORCN;EPHX2;DGKA;DGKK;SGPP1;DGKD;DGKZ;DGKQ
prerank,cellular metal ion homeostasis (GO:0006875),0.26487601460232696,0.7999324205662378,0.8138528138528138,1.0,1.0,20/102,18.11%,CCL11;ANK2;LETM1;ATP2B3;MT3;CCR2;SLC12A2;SLC8A2;SLC24A5;SLC10A7;HTR2C;EDN3;TPCN2;ATP2B1;NEDD4L;CCL14;KCNMA1;SLC9A1;SLC24A4;SLC24A2
prerank,dicarboxylic acid catabolic process (GO:0043649),0.35682803789313083,0.7997439378476984,0.7205882352941176,1.0,1.0,4/13,21.03%,GOT2;ASPA;ACOT8;GLUD1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.2700180914409163,0.7995032697103752,0.7905181918412348,1.0,1.0,16/80,16.98%,PYCARD;MYC;DPEP1;NGF;VEGFA;MT3;ACVR1C;CARD9;NGFR;ARL6IP5;DNAJB6;MALT1;SNCA;XIAP;NDUFA13;PAX2
prerank,negative regulation of interleukin-17 production (GO:0032700),0.3764517175373373,0.7994061456036079,0.7138314785373608,1.0,1.0,1/10,4.80%,PRNP
prerank,dendrite self-avoidance (GO:0070593),0.34632591160474463,0.7993700973772465,0.723342939481268,1.0,1.0,4/16,10.12%,CNTN6;CNTN2;DSCAM;PALLD
prerank,vacuolar acidification (GO:0007035),-0.25465604686450205,-0.799303436239365,0.8068181818181818,0.9394364123225715,1.0,11/21,30.50%,ATP6V0D1;ATP6V0A4;DMXL2;TMEM9;ATP6V0A2;CLN5;TMEM199;ATP6AP2;CCDC115;PPT1;SLC11A1
prerank,centromere complex assembly (GO:0034508),0.29789580625077483,0.7992604182855946,0.7471839799749687,1.0,1.0,12/36,22.40%,HELLS;POGZ;HJURP;OIP5;RBBP4;ITGB3BP;CENPV;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.30333418297177084,0.7991414950976024,0.7447335811648079,1.0,1.0,7/33,17.24%,PTEN;CDKN2B;JADE1;CDK6;NACC2;DACT1;CDC73
prerank,phosphate ion homeostasis (GO:0055062),0.37810309160107913,0.7980298438970043,0.7094395280235988,1.0,1.0,2/10,14.89%,SFRP4;XPR1
prerank,negative regulation of viral release from host cell (GO:1902187),-0.30644168327241295,-0.7977624690365512,0.7192429022082019,0.9409660706998136,1.0,4/13,17.26%,CHMP3;TRIM5;PML;TRIM21
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3558254707116693,0.7977192255655814,0.7335329341317365,1.0,1.0,3/15,13.42%,TIPIN;ATF2;MDC1
prerank,arachidonic acid metabolic process (GO:0019369),0.3010576759716153,0.7973834648725403,0.7411167512690355,1.0,1.0,3/35,7.29%,CYP2S1;CYP1B1;PTGES2
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.26002432222775834,-0.7972679239061519,0.7572463768115942,0.9407063965943538,1.0,7/22,17.86%,CACNA1C;ADGRV1;STIM1;CAP1;GNAI3;GRM3;EDNRB
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3623230801628623,0.7969398464073875,0.7331334332833583,1.0,1.0,5/13,19.75%,ALG9;ALG1;ALG8;DPAGT1;ALG6
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.39096118131682017,0.7968457394336613,0.7133858267716535,1.0,1.0,6/10,22.77%,PTPN1;PRLR;STAT3;STAT5A;GHR;STAT6
prerank,lipid droplet organization (GO:0034389),-0.25949438250301055,-0.7961059334136016,0.7553191489361702,0.9415336711885238,1.0,9/22,26.24%,ZFYVE1;CDS1;PPIA;BSCL2;AUP1;PNPLA3;FAF2;PLA2G4C;FITM2
prerank,telomere organization (GO:0032200),-0.21577668949739737,-0.7960468368951219,0.8636363636363636,0.9404788242351044,1.0,10/43,15.14%,SP100;POLD3;RIF1;PARP3;TERF2;PARP1;DOT1L;HUS1;TERT;PCNA
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.3724881341308758,0.7959985075875814,0.7164634146341463,1.0,1.0,3/11,9.28%,PRKN;RAB21;VPS11
prerank,protein hydroxylation (GO:0018126),-0.2894393721869041,-0.7959163168166897,0.7401812688821753,0.9395239608828538,1.0,6/15,23.85%,OGFOD1;PLOD3;VIPAS39;EGLN3;JMJD4;VPS33B
prerank,regulation of JNK cascade (GO:0046328),0.26144829396701996,0.7954441242523697,0.8051668460710442,1.0,1.0,20/101,18.71%,PYCARD;PRKN;EGFR;MAP4K4;SEMA3A;NCF1;TRAF4;PLCB1;CARD9;FZD7;MEN1;MTURN;TAOK3;PER1;DACT1;RASSF2;RIPK1;FKTN;ZMYND11;MAP3K11
prerank,negative regulation of nuclear division (GO:0051784),0.37656546623236603,0.7951427345799389,0.7175226586102719,1.0,1.0,3/11,17.87%,AURKAIP1;BMP7;FBXO5
prerank,cardiac ventricle development (GO:0003231),0.32196862892271155,0.7950435231853705,0.7211948790896159,1.0,1.0,6/20,17.58%,SCN5A;TMEM65;DAND5;GATA3;MDM4;HEYL
prerank,acylglycerol biosynthetic process (GO:0046463),-0.2553044649582624,-0.7945263284119475,0.7910447761194029,0.9407523186908303,1.0,3/23,6.03%,PLA2G4A;GPAM;LPIN2
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.19532546999396122,-0.7941884654256317,0.9540229885057471,0.9401894793899923,1.0,22/84,22.29%,DAPK1;IGF1;SAMD4A;ROCK1;YBX1;CAPRIN1;IGFBP5;CNOT1;RACK1;EIF4A3;BTG2;ORMDL3;SPHK1;FXR2;CNOT9;IGF2BP3;APOE;ABCA7;CHRNA7;PCIF1;CLU;ORMDL1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.3082034199647197,0.7940195794490559,0.7323037323037324,1.0,1.0,6/28,19.30%,TGFB1;PSEN1;FLNA;PIK3R1;JUP;IPO5
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.3156206039155739,0.7938309745321247,0.7345844504021448,1.0,1.0,7/26,21.77%,FGF2;LETM1;HTR2C;DRD2;RYR3;PKD2;ERO1A
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.21254349579478737,-0.793527833683938,0.8709677419354839,0.940210322487335,1.0,14/48,19.64%,ADCY9;SLC26A2;AMPD3;NPR1;PANK1;PANK2;ADCY4;GUCY1B1;PANK3;PPCDC;PANK4;ADCY3;IMPDH1;IMPDH2
prerank,negative regulation of TORC1 signaling (GO:1904262),0.361231686459459,0.7934072828421537,0.7181008902077152,1.0,1.0,6/13,24.80%,CASTOR2;ATM;SPAAR;DEPDC5;SESN1;ITFG2
prerank,microtubule bundle formation (GO:0001578),0.2974261130929313,0.7930006115173198,0.758830694275274,1.0,1.0,11/42,19.60%,RSPH1;NAV1;CFAP46;CAPN6;CFAP74;CLASP1;AAAS;FOXJ1;RSPH9;DCX;CCDC66
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.3181551793793549,0.792951251000038,0.761969904240766,1.0,1.0,7/24,15.17%,NUDT15;UCHL5;TMF1;PRKACA;PKD1;USP14;UBB
prerank,positive regulation of binding (GO:0051099),0.2645266952518004,0.7929310794380383,0.8033333333333333,1.0,1.0,14/84,15.39%,DDX11;NGF;PRKN;LRP1;PSEN1;RALB;MEN1;NCBP1;USP33;AKTIP;PKD1;MET;MED25;DACT1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.3490597365775816,0.7929194821191331,0.7177541729893778,1.0,1.0,2/13,10.09%,DERL2;EDEM2
prerank,visual system development (GO:0150063),-0.22183973174876653,-0.7927214736632594,0.8306010928961749,0.9404828746825451,1.0,9/37,19.44%,SMOC1;RBP4;SIPA1L3;PBX3;TGFB2;PBX4;SMG9;PBX2;C1QA
prerank,ether lipid metabolic process (GO:0046485),0.349029345578176,0.7924797182184083,0.7234678624813154,1.0,1.0,4/14,12.36%,AGMO;PLA2G7;FAR1;PLAAT3
prerank,GPI anchor biosynthetic process (GO:0006506),0.3068204208067805,0.7923255569250462,0.7590673575129534,1.0,1.0,8/30,19.96%,PGAP1;PIGC;PIGP;PIGN;PIGA;PIGU;DPM1;PIGO
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.2960708560746326,0.7922205104959388,0.7569974554707379,1.0,1.0,11/38,20.11%,HAT1;ATRX;ASF1A;HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPC;RBBP7
prerank,regulation of oxidoreductase activity (GO:0051341),-0.29763269381749136,-0.7918586876997015,0.7530120481927711,0.9408233437657653,1.0,5/13,16.88%,ABL2;ATP7A;ECSIT;OXA1L;SIRT4
prerank,regulation of defense response (GO:0031347),0.26940857140297125,0.7917260417340115,0.7957110609480813,1.0,1.0,8/76,6.81%,ADAMTS12;PTPN22;BST1;ELMOD2;CCR2;WNT5A;IL1RL2;UFL1
prerank,catecholamine biosynthetic process (GO:0042423),0.3701656706691827,0.7915363524244784,0.7235294117647059,1.0,1.0,3/11,13.88%,DAO;GATA3;SNCA
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.3206527113754734,0.7915107671718212,0.753120665742025,1.0,1.0,5/23,15.84%,SETMAR;REXO4;FBH1;KPNB1;KPNA1
prerank,negative regulation of protein kinase activity (GO:0006469),0.263853245258703,0.7914878151200875,0.8227571115973742,1.0,1.0,18/88,18.99%,UBASH3B;PYCARD;PTPRT;DEPTOR;NF1;SPRED1;PTPN1;DVL1;WWTR1;ADARB1;SNCA;TAF7;ABL1;PYDC1;DBNDD2;PPM1E;PARK7;TESK1
prerank,ganglion development (GO:0061548),0.36578071990244443,0.7914370604402596,0.7331240188383046,1.0,1.0,3/11,12.10%,SEMA3A;NRP2;UNC5C
prerank,vitamin D metabolic process (GO:0042359),-0.30597712444493563,-0.7914362812904716,0.746268656716418,0.9403947657057925,1.0,3/13,18.62%,CUBN;LGMN;CYP2R1
prerank,I-kappaB phosphorylation (GO:0007252),-0.3262889151813041,-0.7914107299401012,0.75,0.9393018815020412,1.0,2/10,11.63%,TLR4;MAP3K7
prerank,positive regulation of phagocytosis (GO:0050766),-0.20473215147838233,-0.7913743209085983,0.85625,0.9382236984806825,1.0,25/47,37.82%,APPL2;RAB31;CAMK1D;CYBA;DOCK2;GATA2;NCKAP1L;PTPRC;C2;ABCA7;TUB;FCER1G;CALR;TULP1;LYAR;RAB27A;C4B;SLC11A1;GAS6;CD300LF;CCL2;TREM2;IL2RG;AHSG;PLA2G5
prerank,cholesterol transport (GO:0030301),0.28513435726444086,0.7913662625597401,0.75,1.0,1.0,7/45,16.67%,CEL;NPC1;OSBPL5;RELCH;ABCA5;LIPC;ABCG4
prerank,regulation of GTPase activity (GO:0043087),0.24999043553767086,0.7909964289403116,0.8837448559670782,1.0,1.0,20/177,9.97%,SIPA1L1;CCL11;ERBB2;PLXNC1;FGD4;EFNA5;MAP4K4;CCL4;NTRK2;NF1;CHN1;ALS2;CDKL5;DOCK10;RAP1A;ARHGAP9;ZC3H15;VAV3;ARHGAP11A;ARL2
prerank,transcription by RNA polymerase III (GO:0006383),0.31105742420101923,0.7907906935379168,0.728,1.0,1.0,11/27,25.21%,SNAPC2;IVNS1ABP;ZC3H8;POLR2K;ELL;GTF3C1;POLR3G;SNAPC3;POLR3K;TBP;GTF3C5
prerank,endothelial cell migration (GO:0043542),0.30312631347871827,0.7903921725430225,0.7691358024691358,1.0,1.0,5/37,7.15%,FAP;PRKX;VEGFA;EGR3;CYP1B1
prerank,positive regulation of organelle assembly (GO:1902117),0.2888966742316228,0.7903589426741846,0.7601977750309024,1.0,1.0,16/44,26.23%,GPSM2;RALB;SDC4;RAB3GAP2;PDCD6IP;FSCN1;HTT;CCDC88A;RAB3GAP1;CNOT6L;DYNC1H1;STX18;G3BP2;BBS4;ENTR1;TAPT1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.3788968328185442,0.7903019244293433,0.7369230769230769,1.0,1.0,6/10,28.83%,NCK1;CITED2;JUN;HSPA1A;HIF1AN;SIRT2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.32980661641053105,0.7901075880508536,0.7342281879194631,1.0,1.0,4/22,12.70%,HPCA;PDE4B;CACNB4;DRD2
prerank,fatty acid transmembrane transport (GO:1902001),0.3336442530564822,0.7898161994363537,0.7496503496503496,1.0,1.0,3/19,6.74%,SLC27A1;ACACA;PRKAB2
prerank,intracellular pH reduction (GO:0051452),0.29812729341224253,0.7896754937906266,0.7560050568900126,1.0,1.0,12/33,27.44%,RAB38;ATP6V1B2;RAB39A;DMXL1;ATP6V1C1;RAB7A;ATP6V0E2;ATP6V0E1;ATP6V1G2;ATP6V1H;TCIRG1;ATP6V1D
prerank,chromatin remodeling at centromere (GO:0031055),0.3019343568686875,0.7894127130843832,0.7565104166666666,1.0,1.0,11/31,22.40%,HELLS;HJURP;OIP5;RBBP4;ITGB3BP;CENPV;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,positive regulation of interleukin-13 production (GO:0032736),0.37096177674615727,0.7891881268293465,0.7049441786283892,1.0,1.0,2/10,13.20%,IL18;GATA3
prerank,protein localization to cell surface (GO:0034394),0.30520432785541424,0.7891416670940802,0.75,1.0,1.0,6/26,15.88%,FGF10;ANK2;FLNA;FGF7;RIC3;PIGU
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.24506160965781865,0.7888675328506668,0.8949494949494949,1.0,1.0,76/241,26.13%,CSTF3;DHX8;TRA2B;PABPC1;RSRC1;POLR2B;METTL3;DHX35;RNPC3;SRSF11;CWF19L2;TXNL4A;RBM10;POLR2K;CASC3;NCBP1;SNRPB2;FIP1L1;SFPQ;SNRNP40;HNRNPA3;LSM3;PRPF6;RBM4B;POLR2G;DDX42;NOVA1;SRSF6;YTHDC1;PAPOLA;SNRPA;PPIH;SF3A1;HNRNPU;RAVER2;RNPS1;SF1;GEMIN7;FUS;SART1;DDX23;POLR2A;SYNCRIP;SRRM1;HNRNPUL1;SF3B3;DBR1;HNRNPC;HNRNPH2;HNRNPL;SNRPN;SRSF3;RBM17;DNAJC8;SNIP1;RBMX2;SYMPK;PLRG1;SNRNP200;SF3B2;WBP4;CTNNBL1;PCBP2;POLR2F;TFIP11;MAGOHB;CPSF7;U2SURP;SNRPA1;NONO;RBM4;RBM15;SPEN;TRA2A;PRPF38A;HNRNPA2B1
prerank,membrane repolarization during action potential (GO:0086011),-0.2921693725646267,-0.7885909477771275,0.7192982456140351,0.9417742043480014,1.0,5/13,24.76%,KCNJ2;ATP1A1;ATP1B1;KCNIP2;KCNE4
prerank,visual perception (GO:0007601),0.2671006247792152,0.788443904603098,0.806979280261723,1.0,1.0,15/84,20.73%,EFEMP1;CRYBG3;RDH10;DHRS3;COL18A1;OAT;MYO9A;COL1A1;OPA1;DNAJC19;PAX2;CACNA2D4;ATXN7;RGS16;COL11A1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.3153162671224806,-0.7881224262427837,0.7198795180722891,0.9413866441606807,1.0,4/11,19.84%,SMAD7;PTPRC;CEACAM1;HFE
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.2771217761215313,0.7881025563281739,0.7825086306098964,1.0,1.0,15/56,19.89%,NDUFAF4;NDUFS5;NDUFAF6;NDUFB2;NDUFA8;NDUFS8;ACAD9;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.2771217761215313,0.7881025563281739,0.7825086306098964,1.0,1.0,15/56,19.89%,NDUFAF4;NDUFS5;NDUFAF6;NDUFB2;NDUFA8;NDUFS8;ACAD9;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1;NDUFA5
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.2996510090004164,0.7876362913411963,0.758043758043758,1.0,1.0,5/33,10.65%,FBXW7;NCF1;HIP1;BTC;CBL
prerank,regulation of actin filament polymerization (GO:0030833),0.2698651766217637,0.787609365198857,0.7953020134228188,1.0,1.0,8/69,8.10%,CCL11;PYCARD;KANK4;GBA2;RASA1;SSH3;BAIAP2;BIN1
prerank,cell junction organization (GO:0034330),0.26634261612776433,0.7874552363501625,0.7871396895787139,1.0,1.0,13/71,12.17%,LRP4;SEMA3E;TGFB1;PSEN1;CLDN1;APBB2;SLC8A2;FLNA;GRM5;PPFIA2;MYO9A;OPHN1;DVL1
prerank,regulation of protein localization to nucleus (GO:1900180),-0.2117266543775981,-0.7874130607448334,0.8527918781725888,0.9414098488567316,1.0,12/43,18.78%,MFHAS1;BMP4;LATS2;NVL;GSK3B;FLCN;TFRC;SESN2;SUMO3;ORMDL3;BYSL;SIN3A
prerank,regulation of regulated secretory pathway (GO:1903305),0.29691352945955407,0.7872733691516699,0.7719298245614035,1.0,1.0,11/34,20.03%,SYT1;RAB3D;SYN1;SYT11;SYT12;RIMS1;RAB3A;UNC13D;SYT2;RIMS2;SYT13
prerank,atrial septum development (GO:0003283),-0.2958649084238491,-0.7872062113574286,0.75625,0.9406263221862265,1.0,2/13,3.78%,NOTCH2;BMPR2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3035136607163106,0.78709261519794,0.7597402597402597,1.0,1.0,9/28,23.23%,BCL2;TNFRSF10B;PPP1R15A;TMEM117;QRICH1;AIFM1;DNAJC10;ERO1A;CEBPB
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.34573568064969457,0.7870444810863945,0.7386861313868613,1.0,1.0,4/16,13.94%,PIGC;PIGP;PIGN;PIGA
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.2877464515097721,0.7869538875721538,0.762545899632803,1.0,1.0,5/41,9.44%,FADS2;CYP1B1;SCD5;ACOX1;ELOVL5
prerank,defense response to virus (GO:0051607),0.26216710073814303,0.7865428788877936,0.8412526997840173,1.0,1.0,10/100,10.48%,CXCL10;PYCARD;BCL2;FADD;NDUFAF4;RNASE6;BNIP3;FLNA;SETD2;AGBL4
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3028156812776695,0.7863786399459205,0.7597977243994943,1.0,1.0,12/32,24.88%,GTF2H2;TAF1A;POLR2K;POLR1B;POLR1C;POLR1G;TAF1;UBTF;RRN3;POLR2F;CCNH;TBP
prerank,coenzyme A metabolic process (GO:0015936),-0.2945381745419543,-0.786177608260502,0.7361963190184049,0.9411937370667346,1.0,6/14,22.43%,PANK1;PANK2;PANK3;PPCDC;PANK4;CROT
prerank,positive regulation of lipid catabolic process (GO:0050996),0.3318169980128418,0.7860714612554087,0.74,1.0,1.0,3/19,16.67%,IRS2;MTLN;ABCD2
prerank,endothelial cell proliferation (GO:0001935),0.3437539784499519,0.7859034483567802,0.7270194986072424,1.0,1.0,2/17,2.85%,CD34;PRKX
prerank,protein localization to centrosome (GO:0071539),0.33664704848534255,0.785839198269784,0.7450980392156863,1.0,1.0,3/17,11.71%,PCM1;GOLGB1;SNX10
prerank,steroid biosynthetic process (GO:0006694),-0.2072293746528795,-0.7857646328003162,0.8944099378881988,0.9407329163931782,1.0,19/56,29.42%,PRKAG2;OSBP;LBR;OSBPL9;OSBPL2;INSIG2;DHRS11;OSBPL7;OSBPL3;FDXR;EBP;SLC27A2;OSBPL6;STAR;TM7SF2;HSD11B1;SRD5A1;HSD17B10;CH25H
prerank,positive regulation of insulin secretion (GO:0032024),-0.22934005969271415,-0.7857082824417595,0.8075117370892019,0.9397045806564089,1.0,10/36,19.65%,MYRIP;RBP4;ANO1;NLGN2;NNAT;AACS;LRRC8A;C2CD2L;GPER1;BAIAP3
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.3198512347166853,0.7854599100028216,0.7441558441558441,1.0,1.0,4/24,9.76%,CADM4;MT3;HIF1A;PTPN1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.2945650611636749,0.7852757129823255,0.7772277227722773,1.0,1.0,5/38,12.70%,PTEN;THEM4;PTPRJ;MAGI2;DRD2
prerank,negative regulation of telomere maintenance (GO:0032205),0.35055728937985514,0.7849996878469406,0.7221418234442837,1.0,1.0,7/15,25.09%,ERCC4;RTEL1;ATM;SMG6;TERF2IP;RAD50;SLX4
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.2698041858889914,0.78497632544853,0.7865296803652968,1.0,1.0,19/66,25.62%,CCT7;EIF2AK3;TGFB1;PSEN1;FLNA;PIK3R1;NGFR;WWTR1;JUP;MEPCE;PARK7;TESK1;IPO5;MCRS1;LIMK2;KAT7;MAVS;TCP1;CARD10
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.34947377599619994,0.7849680459463969,0.7257824143070045,1.0,1.0,2/13,9.61%,NAGK;MGAT3
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.24307687368816028,0.7846997497294683,0.8994974874371859,1.0,1.0,86/264,27.01%,CSTF3;DHX8;TRA2B;PABPC1;RSRC1;POLR2B;METTL3;CDK13;DHX35;RNPC3;SRSF11;CWF19L2;TXNL4A;RBM10;POLR2K;CASC3;NCBP1;SNRPB2;FIP1L1;TGS1;CLNS1A;SFPQ;SNRNP40;HNRNPA3;LSM3;PRPF6;RBM4B;POLR2G;DDX42;NOVA1;SRSF6;YTHDC1;PAPOLA;SNRPA;PPIH;SF3A1;HNRNPU;RAVER2;RNPS1;SF1;GEMIN7;FUS;SART1;DDX23;POLR2A;SYNCRIP;SRRM1;HNRNPUL1;SF3B3;DBR1;HNRNPC;CELF4;HNRNPH2;HNRNPL;SNRPN;SRSF3;RBM17;DNAJC8;SNIP1;RBMX2;SYMPK;PLRG1;SNRNP200;SF3B2;WDR77;WBP4;CTNNBL1;PCBP2;POLR2F;TFIP11;MAGOHB;CPSF7;U2SURP;SCAF11;SNRPA1;NONO;RBM4;RBM15;SPEN;TRA2A;PRPF38A;HNRNPA2B1;DDX1;PPWD1;PRPF40A;UBL5
prerank,purine nucleotide metabolic process (GO:0006163),-0.24813502695604403,-0.7846378763618984,0.8143459915611815,0.9403055617800585,1.0,10/24,22.67%,PRPSAP2;ITPA;XDH;GPX1;PRPS2;GUK1;GART;PRPS1;PRPS1L1;NT5C1A
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.2833663585142242,-0.7844951869562002,0.768025078369906,0.9394259884399165,1.0,2/14,4.93%,PKIA;PRKAR1A
prerank,positive regulation of transmembrane transport (GO:0034764),0.35370032438011123,0.7841467867708689,0.7442922374429224,1.0,1.0,2/13,3.47%,C2CD5;ANO6
prerank,regulation of protein localization to cell surface (GO:2000008),0.29434965352688075,0.7839659854888076,0.7583120204603581,1.0,1.0,6/33,15.31%,TAX1BP3;GPM6B;GBF1;KCNAB2;NEDD4L;RIC3
prerank,regulation of transferase activity (GO:0051338),0.3396379824768158,0.7839491889202002,0.7295774647887324,1.0,1.0,5/17,16.26%,BAG5;LDB2;PPP1R3F;ATM;SMG6
prerank,cellular response to pH (GO:0071467),-0.26936663271656514,-0.7837053345657634,0.7934782608695652,0.939604901180527,1.0,10/17,36.94%,RAB11B;MCOLN1;GPR68;PKD2L1;PKD1L3;IMPACT;HVCN1;RAB11FIP5;KCNK4;ASIC1
prerank,cellular response to glucose stimulus (GO:0071333),0.3070529628642364,0.7836372635087524,0.7529880478087649,1.0,1.0,10/30,21.95%,ZBTB20;TRA2B;MLXIPL;PDK3;PRKACA;PAX2;PCK2;ADCY8;PTPRN2;PRKAA1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.292898678386731,-0.7835537990913741,0.7580645161290323,0.938738840852977,1.0,6/14,23.35%,MMS19;PARP1;WRAP53;ERCC6;FANCB;TIMELESS
prerank,water transport (GO:0006833),0.3594159156908242,0.7835530743417602,0.7451274362818591,1.0,1.0,1/12,5.26%,AQP4
prerank,ethanol metabolic process (GO:0006067),0.36174727945248175,0.7834328527600622,0.7427258805513017,1.0,1.0,2/12,7.11%,ACSS2;ACSS1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.3275771217000945,0.7833770252388726,0.7346368715083799,1.0,1.0,5/18,22.48%,NAGA;FBXO27;FBXO17;FBXO44;OGA
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.26987072368136744,0.781887724965005,0.8141304347826087,1.0,1.0,10/75,11.42%,PYCARD;PTEN;IRAK3;NF1;PRKAR1B;MEN1;UCHL1;PTPN1;PTPRJ;BMP7
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.2562079158965404,0.781429643716618,0.8454157782515992,1.0,1.0,12/110,12.70%,CXCL10;LPAR1;PTGER3;GPR65;PTHLH;PTGFR;LGR5;TSHR;ADGRB3;S1PR3;ADGRL3;DRD2
prerank,negative regulation of translational initiation (GO:0045947),-0.2930682181175481,-0.7813846887136395,0.7514792899408284,0.9410998339378432,1.0,5/13,28.82%,EIF2AK1;EIF4EBP2;EIF3E;EIF2AK4;AGO2
prerank,regulation of defense response to virus by host (GO:0050691),0.30145224599837406,0.7811099191664376,0.7487244897959183,1.0,1.0,2/30,3.80%,PTPN22;TRIM44
prerank,histone H3 deacetylation (GO:0070932),0.34698433732774736,0.7807811692152263,0.7359307359307359,1.0,1.0,4/15,13.12%,HDAC2;SFPQ;SIRT6;PER1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.2783096669636374,0.78026460362284,0.779236276849642,1.0,1.0,8/53,10.68%,MYC;FGF10;EGFR;SPRED2;SPRED1;BRCA1;SPRED3;FBH1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.3101777140050071,0.7800821558051104,0.7619663648124192,1.0,1.0,5/23,17.46%,SLC12A3;SLC12A2;SLC12A4;KCNH2;SLC9A1
prerank,positive regulation of immune system process (GO:0002684),0.3399241364074417,0.7798824083589111,0.7391304347826086,1.0,1.0,1/16,3.14%,VEGFA
prerank,regulation of cholesterol metabolic process (GO:0090181),0.32940439178456177,0.7798700802745644,0.7666666666666667,1.0,1.0,8/20,28.93%,KPNB1;SREBF2;MBTPS1;SEC14L2;EPHX2;LDLRAP1;DGKQ;MBTPS2
prerank,positive regulation of response to stimulus (GO:0048584),0.287160029610978,0.7798128718545563,0.7772397094430993,1.0,1.0,8/40,17.49%,MYC;WNT5A;TAF9;YPEL3;GATA3;CGAS;HOMER1;NSMCE4A
prerank,axonal fasciculation (GO:0007413),0.35983366275085116,0.7797469233697213,0.7458646616541353,1.0,1.0,5/12,18.90%,NRCAM;EPHB2;CDK5R1;RTN4;CNTN4
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.33667901160345043,0.7796411491403022,0.7426273458445041,1.0,1.0,6/18,18.77%,POR;GDNF;EDN3;RFK;ABL1;PARK7
prerank,receptor metabolic process (GO:0043112),0.2747556686418034,0.7795973681876057,0.7726218097447796,1.0,1.0,10/53,15.19%,DNM1;LRP1;TGFB1;ACKR3;PHETA2;MVB12A;CD9;SNCA;SNX1;ITGB1
prerank,Golgi localization (GO:0051645),0.3588554938340634,0.7793738706806905,0.7433903576982893,1.0,1.0,5/11,24.93%,YWHAZ;ARHGAP21;COPG1;HOOK3;ARCN1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.3565638769245939,0.7792488110801631,0.7313868613138687,1.0,1.0,5/12,26.40%,EFNA5;AP1AR;KANK1;SPRY4;CORO1C
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.3565638769245939,0.7792488110801631,0.7313868613138687,1.0,1.0,5/12,26.40%,EFNA5;AP1AR;KANK1;SPRY4;CORO1C
prerank,plasma membrane tubulation (GO:0097320),-0.2918394312362281,-0.7791358762926462,0.7897897897897898,0.9436148121239873,1.0,4/13,17.03%,SNX9;FNBP1L;WHAMM;MICALL1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.28408921002889376,0.7789920477626178,0.7855421686746988,1.0,1.0,15/44,21.51%,LPAR1;GPR65;ARHGEF10;PAK1;LIMK1;NF2;ARHGEF10L;RHOC;MYOC;ABL1;TGFB3;PPM1E;TESK1;CCDC88A;PXN
prerank,positive regulation of receptor internalization (GO:0002092),0.31724079638232133,0.7789272993005032,0.7536423841059603,1.0,1.0,8/22,25.98%,VEGFA;SFRP4;MAGI2;SCYL2;CD63;ARRB2;FMR1;AHI1
prerank,positive regulation of cell aging (GO:0090343),0.360921881793402,0.7786181644909019,0.7287581699346405,1.0,1.0,3/11,15.22%,YPEL3;LMNA;CGAS
prerank,long-chain fatty acid transport (GO:0015909),0.29944248140439633,0.7785989123883129,0.768542199488491,1.0,1.0,4/30,6.74%,SLC27A1;ACACA;SLC27A4;PRKAB2
prerank,regulation of translation (GO:0006417),0.25018228418612,0.7781150297610508,0.8713991769547325,1.0,1.0,58/173,26.81%,ERBB2;EPRS1;EIF2AK3;UPF3A;PLD1;ETF1;NIBAN1;ATXN2;METTL3;TSC1;EIF1B;EIF3C;CPEB3;EIF6;NSUN5;PASK;GRM5;NCBP1;EIF4G1;UPF1;MTG1;DDX25;RBM4B;PUS7;EIF1;CYFIP1;EIF4ENIF1;PRR16;RPS27L;EIF4A2;EIF2B2;TRAP1;GIGYF2;SYNCRIP;CSDE1;PYM1;RPS6KA3;EIF4G3;DDX6;METAP1;VIM;RIDA;GLE1;BCL3;PAIP2B;ALKBH1;MTOR;FMR1;PRKDC;SOX4;CIRBP;EIF2AK2;RBM4;YTHDF3;DAPK3;KLHL25;DDX1;MTG2
prerank,regulation of cell cycle process (GO:0010564),0.2584346876853998,0.7779856733116783,0.8382978723404255,1.0,1.0,15/104,15.55%,KIF20B;SOX9;CDKN2B;TIPIN;KLHL13;OBSL1;CDK13;SETD2;RCC1;PKMYT1;MYO19;ATF5;RAB11FIP3;CALM1;CALM2
prerank,protein import into peroxisome membrane (GO:0045046),0.3164809855909483,0.7778094057213687,0.7420689655172413,1.0,1.0,5/22,16.67%,ACBD5;PEX3;PXMP2;GDAP1;ABCD2
prerank,establishment of spindle orientation (GO:0051294),0.30642571586495654,0.7776429121211177,0.774869109947644,1.0,1.0,8/28,22.49%,GPSM2;INSC;NDE1;CLASP1;ITGB1;HTT;LLGL1;CDK5RAP2
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.2948156892199465,-0.7774377316559958,0.7631578947368421,0.9451897063896466,1.0,7/12,27.40%,IFIH1;FLOT1;CAV1;IFIT1;COLEC12;MUL1;ZCCHC3
prerank,regulation of store-operated calcium entry (GO:2001256),-0.3184938581191554,-0.7773959661217256,0.7454068241469817,0.9441329497406705,1.0,3/10,13.35%,SLC8B1;SARAF;STIM1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.3610717664517169,0.7771156838209936,0.7631184407796102,1.0,1.0,3/12,17.15%,BCL2;TAF9;CD74
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.2545996965441351,-0.7766788617057231,0.8159722222222222,0.9440947066293356,1.0,6/21,18.17%,SAMD4A;CNOT1;TUT7;PAN2;CNOT11;CNOT9
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.2879051488157318,0.7765679057929612,0.7708592777085927,1.0,1.0,13/36,27.16%,EED;APAF1;E2F6;BRCA1;EPC1;RBBP4;RBBP7;CBX5;RNF2;CBX3;EHMT2;RBBP8;EZH2
prerank,liver development (GO:0001889),0.2964366115078829,0.7763840932805972,0.7653846153846153,1.0,1.0,10/32,23.90%,CCDC39;PRKCSH;NF1;COBL;CITED2;MET;PCK2;PKD2;CEBPB;TGFBR3
prerank,positive regulation of inflammatory response (GO:0050729),0.25895359882409297,0.7759311232066618,0.8130530973451328,1.0,1.0,16/86,19.49%,IL16;GPRC5B;CCR2;WNT5A;PLA2G7;IL18;IL6ST;GRN;SNCA;IL33;ABCC1;RIPK1;MDK;LBP;SETD4;PDCD4
prerank,cell cycle G1/S phase transition (GO:0044843),0.2679835213957825,0.7756464110608106,0.8022988505747126,1.0,1.0,13/61,19.26%,CRLF3;MYC;ACVR1;CDK6;CUL3;RCC1;PHF8;PIM2;CUL4B;NASP;USP37;MAP3K11;DBF4
prerank,regulation of intracellular protein transport (GO:0033157),0.29776800768203526,0.7752713307330036,0.7772020725388601,1.0,1.0,4/32,9.76%,KIF20B;TGFB1;PCM1;PTPN1
prerank,regulation of glycogen metabolic process (GO:0070873),-0.289943519995863,-0.774895564043194,0.7507598784194529,0.9458314740929262,1.0,8/12,42.39%,PPP1R3B;PPP1R3C;AKT1;RUBCNL;KHK;PPP1R3E;PPP1R3D;GCGR
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2394379503796358,0.774878313312714,0.9174219536757301,1.0,1.0,82/314,23.25%,ZFAND2B;RAD23B;PRKN;ERLIN2;HACE1;DNAJB9;FBXW7;SPSB4;RHBDD2;SPOP;FBXO38;FBXL15;TRIM2;HECTD3;PELI1;UBE2K;FBXL16;PSMB7;UCHL1;FBXO27;DERL2;CUL3;SELENOS;HERPUD1;HUWE1;ANAPC7;FBXO45;NFE2L2;UBE2J2;RNF121;FBXO17;ANAPC2;FBXL2;TMUB2;HSP90B1;DDB1;BUB1B;NEDD4L;JKAMP;PSMD2;KLHL22;PLAA;UBB;AREL1;PSMC1;ERLIN1;CDC23;FBXL4;ZSWIM8;ANAPC16;PSMB2;CUL4B;FBXO5;FBXO31;TRIM9;MDM2;RNF4;PSMD9;TAF1;DNAJC10;PCNP;PSME4;FBXL12;CDC27;UBE2G1;UBE2E1;DCAF11;SGTA;PSMA8;PTTG1;ANAPC4;UBE2D3;ARRB2;UBR3;FBXO44;ANAPC5;UBQLN1;SIAH1;RNF187;UBQLN2;COP1;RB1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.35217312596191175,0.7746377723717741,0.7575757575757576,1.0,1.0,5/13,22.12%,DAO;GLS2;GLS;GLUD1;DDAH1
prerank,B cell proliferation (GO:0042100),0.33218311119167104,0.7743473612603635,0.7510791366906475,1.0,1.0,1/17,1.76%,BCL2
prerank,rRNA catabolic process (GO:0016075),-0.2719347722076424,-0.7743414889253212,0.7720364741641338,0.9455762652629984,1.0,5/16,18.23%,XRN1;EXOSC7;DIS3;EXOSC10;DEDD2
prerank,tRNA modification (GO:0006400),0.26884003155528874,0.774153391550246,0.8094144661308841,1.0,1.0,20/62,23.77%,THUMPD3;DTWD1;PUSL1;TRMT12;THADA;DTWD2;TRMT112;PUS7;THUMPD2;ELP5;PUS1;SSB;TPRKB;TRIT1;NSUN2;LCMT2;ALKBH8;ALKBH1;TRMT1;MOCS3
prerank,microglial cell activation (GO:0001774),-0.25210115821698564,-0.7741094177317608,0.8105263157894737,0.9448370681574404,1.0,11/21,35.27%,APP;MAPT;C1QA;CLU;TYROBP;ITGB2;ITGAM;JAK2;AGER;AIF1;TREM2
prerank,calcium ion homeostasis (GO:0055074),0.2576338013752282,0.7740174024606779,0.8383620689655172,1.0,1.0,14/95,15.18%,CCL11;ANK2;TMTC2;ATP2B3;CCR2;SLC8A2;SLC24A5;SLC10A7;HTR2C;EDN3;TPCN2;ATP2B1;SNCA;CCL14
prerank,cellular response to cAMP (GO:0071320),-0.22892522012171068,-0.7736742026759268,0.8553191489361702,0.9444580525463175,1.0,4/30,7.01%,RAP1B;IGFBP5;ZFP36L1;SLC5A5
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.2817043048598297,0.7734036010394799,0.7796610169491526,1.0,1.0,7/46,17.72%,SLC27A1;PLD1;AGPAT2;PLA2G12A;AGPAT5;GPAT3;GPAT4
prerank,protein secretion (GO:0009306),0.2727442908615771,0.7732192539623836,0.8020954598370198,1.0,1.0,23/56,28.76%,STEAP3;COPG2;MTTP;RCN3;RAB3D;RAB3A;ARFGAP3;COPG1;TANGO6;RIMS2;PARK7;RAB3B;TANGO2;PORCN;TVP23A;MIA3;SNX19;MON1A;SCG2;SEL1L;LTBP2;PREB;RAB13
prerank,smooth muscle cell differentiation (GO:0051145),-0.29571995857221095,-0.7731819989114548,0.7630057803468208,0.944099530111619,1.0,6/12,19.17%,BMP4;TMEM204;HEY2;EDNRB;MRTFB;MYOCD
prerank,negative regulation of peptidase activity (GO:0010466),-0.20121870927102217,-0.7731749572970142,0.8993288590604027,0.9430070927173596,1.0,8/47,13.74%,VTN;TIMP3;SERPIND1;SPOCK2;SERPINB9;SERPINE1;TIMP2;SERPINI1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.28536860503820993,0.7728856897384208,0.7963636363636364,1.0,1.0,9/42,15.54%,UTRN;MAP4K4;VEGFA;TSC1;CDK6;PTPRJ;MYOC;JUP;ABL1
prerank,protein localization to mitochondrion (GO:0070585),0.3630301085025927,0.7728152231322318,0.7410296411856474,1.0,1.0,5/11,27.46%,COX18;DNAJA1;HK2;HK1;RALA
prerank,peptidyl-lysine methylation (GO:0018022),0.31102763926611876,0.772603270070041,0.7576564580559254,1.0,1.0,6/26,19.53%,SUV39H1;SETD3;SETD2;TRMT112;SETD4;N6AMT1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3028291331381855,0.7712787844307617,0.7576974564926372,1.0,1.0,9/25,20.26%,TRA2B;TXNL4A;SNRNP40;PRPF6;KHSRP;DDX23;SRRM1;SF3B3;DBR1
prerank,vitamin transport (GO:0051180),0.2925520533211749,0.7712197720399397,0.7658473479948253,1.0,1.0,2/29,3.90%,SLC27A1;CD320
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.279803893116592,-0.7709997032034056,0.7636363636363637,0.9452699402028947,1.0,8/16,28.92%,RIF1;HELB;POLQ;KLHL15;FANCB;MAD2L2;RMI2;PARPBP
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.33390461843576535,0.7707886570628218,0.7440828402366864,1.0,1.0,5/15,20.39%,ZFP36L2;BCL2L11;HNRNPU;UBE2L3;ZFP36
prerank,regulation of cellular localization (GO:0060341),0.2810002928111998,0.7706220807541754,0.7944038929440389,1.0,1.0,4/46,2.90%,STXBP4;GSN;PRKN;EFNA5
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.24362579332911163,0.7695464331124008,0.8954918032786885,1.0,1.0,47/184,23.72%,DYNLL1;HAUS3;CNTRL;PCM1;NDE1;SDCCAG8;CEP57;PSMB7;CUL3;ZFP36L2;ANAPC7;CLASP1;ANAPC2;PRKACA;CKAP5;DDB1;CEP76;BUB1B;DYNC1I2;PKD1;PSMD2;UBB;PSMC1;CDC14A;CSNK1E;CDC23;ANLN;ANAPC16;PSMB2;CEP63;FBXO5;TUBA1A;PSMD9;PSME4;CDC27;CEP78;SSNA1;UBE2E1;PSMA8;PCNT;ANAPC4;CDK5RAP2;ANAPC5;DYNC1H1;PPP2R1A;CDC16;PLK5
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2663446466904802,0.769116053085761,0.8117913832199547,1.0,1.0,14/63,18.13%,WAC;CARM1;PCBP4;PRMT1;CNOT3;RPA2;MDM4;CASP2;CRADD;ATM;RPS27L;TP53;FBXO31;MDM2
prerank,protein palmitoylation (GO:0018345),-0.23338634356111898,-0.768878582733662,0.8445378151260504,0.9473256577476289,1.0,7/30,15.14%,ZDHHC14;ZDHHC3;CLIP3;ZDHHC18;ZDHHC7;ZDHHC20;ZDHHC4
prerank,cellular protein metabolic process (GO:0044267),0.23988351308653902,0.7685239399389774,0.9629629629629629,1.0,1.0,52/396,14.33%,GPC3;CHRM3;MMP2;VCAN;MXRA8;CHRDL1;HM13;PRKN;LAMC1;TGM1;MRPS18A;PARL;ARAF;PRKCSH;PSEN1;NUCB1;SDC2;RPL23A;LTA4H;MRPL32;CDKL3;MMP15;EVA1A;ATP23;RCN1;GATA6;MEN1;FARSB;SRBD1;VWA1;SPCS3;CKAP4;AMELX;MRPL35;EIF4G1;NCSTN;LTBP1;GSPT2;MRPL28;CALU;UBA3;SLC35A1;FBXL2;FUCA2;APH1A;ATG3;HSP90B1;YME1L1;PENK;NEDD8;HARS1;PSEN2
prerank,neuron remodeling (GO:0016322),0.3684448697551791,0.7675696762274642,0.7515923566878981,1.0,1.0,3/10,12.08%,ADGRB3;FARP2;ANKS1A
prerank,response to estrogen (GO:0043627),-0.2204674485706385,-0.7675589875023209,0.8541666666666666,0.9481397896135706,1.0,8/31,19.29%,TRIM25;PELP1;SERPINB9;SRA1;CAV1;ARID5A;RBBP5;RARA
prerank,mammary gland epithelium development (GO:0061180),-0.2836773258672688,-0.767361340272987,0.7757009345794392,0.9473166230364217,1.0,7/14,30.90%,WNT4;ID2;EPHA2;AKT1;CSF1R;LATS1;JAK2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.3187156703146184,-0.7673014941344478,0.762532981530343,0.9463202301029319,1.0,2/10,5.34%,OSR1;COMMD1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.37136166404826904,0.7671498610164422,0.7646153846153846,1.0,1.0,3/10,18.87%,SETD3;SETD2;SETD4
prerank,atrioventricular valve morphogenesis (GO:0003181),0.3213614960421498,0.7657077980369875,0.7524893314366998,1.0,1.0,8/19,25.25%,ACVR1;TGFBR2;MDM4;BMPR1A;HEYL;BMP2;EFNA1;SOX4
prerank,"base-excision repair, gap-filling (GO:0006287)",0.28579525968370667,0.7656676380443841,0.7835443037974683,1.0,1.0,8/35,16.11%,MBD4;MPG;RPA3;MUTYH;NEIL1;RPA2;SMUG1;POLG
prerank,cell junction maintenance (GO:0034331),-0.2787453691335033,-0.7652495475657884,0.7980132450331126,0.948423418275827,1.0,8/14,34.61%,NLGN2;DCTN1;CSF1R;CBLN2;MYADM;F2R;CBLN1;PRTN3
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.2635790772390324,0.7651868908854316,0.8154020385050963,1.0,1.0,10/65,13.39%,MVB12B;EGFR;PTPN2;EPS15;HIP1;BTC;PTPRJ;CBL;MVB12A;SH3KBP1
prerank,transcription by RNA polymerase I (GO:0006360),0.2910042983565391,0.7650154898566192,0.7965043695380774,1.0,1.0,13/34,26.51%,GTF2H2;TAF1A;POLR2K;POLR1B;POLR1C;POLR1G;TAF1;UBTF;RRN3;POLR2F;CCNH;TBP;TTF1
prerank,megakaryocyte differentiation (GO:0030219),0.3604422862521713,0.7648833928776965,0.7458646616541353,1.0,1.0,1/11,2.40%,CDKN2B
prerank,protein N-linked glycosylation (GO:0006487),0.2625969433674163,0.7648384391547415,0.8170454545454545,1.0,1.0,15/66,19.75%,GFPT2;UGGT2;ALG9;STT3A;MGAT3;MAGT1;ALG5;TUSC3;ALG1;MOGS;ALG8;DPM1;DPAGT1;RPN1;ALG6
prerank,polyol biosynthetic process (GO:0046173),0.32604877950527134,0.7646821212964622,0.737151248164464,1.0,1.0,1/16,1.27%,FGF2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.3652540819656846,0.7643850396839356,0.7782874617737003,1.0,1.0,1/11,4.10%,CCL4
prerank,positive regulation of leukocyte activation (GO:0002696),0.3284143530135777,0.7639596906592029,0.7806896551724138,1.0,1.0,6/18,21.41%,WNT5A;NECTIN2;IL33;LBP;HSPD1;TNIP2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.24424833512141655,0.7638519213636884,0.8766839378238342,1.0,1.0,35/149,24.52%,ROR1;EDA;PRKCQ;PYCARD;IRAK3;RPS6KA4;WNT5A;CARD9;IL18;MID2;RTKN2;PRDX3;MALT1;DHX33;TICAM1;UBB;TERF2IP;IL1RAP;RIPK1;CHUK;RAB7B;TAB3;BCL10;STAT3;NFKB1;PRKD2;CARD11;TAB2;CARD16;ERC1;FLOT2;IRAK2;TRIM14;CIB1;HSPA1A
prerank,heart trabecula morphogenesis (GO:0061384),0.32608432983201985,0.7633532021338316,0.7597684515195369,1.0,1.0,1/18,0.52%,BMP5
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.24478544026412238,-0.7632086696968503,0.8431372549019608,0.9503094097542977,1.0,12/25,28.53%,POMT2;RNF185;STUB1;FBXL17;UBE2W;AUP1;UFD1;KLHL15;UGGT1;RNF5;OMA1;VCP
prerank,cellular glucan metabolic process (GO:0006073),0.3524381004419736,0.7628432573901945,0.7619783616692427,1.0,1.0,2/11,9.06%,PYGL;PHKB
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.3352879933168752,0.7627690934660493,0.7449567723342939,1.0,1.0,7/15,28.68%,IRS2;GPLD1;PPARG;PRKCE;LDLRAP1;PPARA;ADM
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2548954079112808,0.7625101561966906,0.8392070484581498,1.0,1.0,23/85,20.33%,PRKN;SOCS5;FBXW7;CBFA2T3;RNFT1;PRICKLE1;DVL1;CSNK1A1;DET1;TMTC3;DDA1;SUMO1;RNF19A;RCHY1;CSNK1E;FBXO22;MDM2;ZER1;TAF1;USP5;NKD2;BBS7;USP13
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.32833289996345427,0.7621623246234696,0.7619738751814223,1.0,1.0,3/16,13.74%,ACKR3;FBH1;NACC2
prerank,positive regulation of protein depolymerization (GO:1901881),0.34815134925634184,0.7619987522164345,0.7524271844660194,1.0,1.0,4/11,26.16%,KATNB1;NES;CFL2;WDR1
prerank,positive regulation of peptidase activity (GO:0010952),0.31659709230575483,0.7618605109092252,0.7597840755735492,1.0,1.0,5/20,16.25%,RCN3;NCSTN;GRN;APH1A;NDUFA13
prerank,actin filament depolymerization (GO:0030042),0.35167745457756316,0.761229488701344,0.7646153846153846,1.0,1.0,1/11,2.24%,GSN
prerank,rRNA methylation (GO:0031167),0.30935678300038094,0.7611697524554611,0.7777777777777778,1.0,1.0,5/22,12.65%,NOP2;NSUN5;FDXACB1;FBL;TRMT112
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.2504225772649201,0.7608707039820698,0.8643162393162394,1.0,1.0,17/101,16.03%,SLC27A1;FGF2;ERBB2;EGFR;VEGFA;TGFB1;WNT5A;RALB;FGFR1;SLC8A2;PIH1D1;EDN3;SNCA;CALM1;PKD1;CALM2;CCND2
prerank,eye photoreceptor cell development (GO:0042462),0.33562645202723596,0.7608537839896098,0.7686676427525623,1.0,1.0,1/15,3.14%,VEGFA
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.30761716074309586,-0.7597510914450082,0.774798927613941,0.9541665454521938,1.0,5/10,37.45%,LYN;CCL19;RAPGEF2;GAS6;LILRB1
prerank,response to glucocorticoid (GO:0051384),-0.2365009088338805,-0.7596214872589176,0.8488372093023255,0.9532339663667084,1.0,6/26,20.37%,SLIT2;ZFP36L1;FAM107A;ANXA1;PDCD7;GOT1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.252640886932141,0.7595380564245107,0.8529411764705882,1.0,1.0,16/83,19.26%,CRLF3;MYC;ACVR1;CDK6;CDK15;CUL3;RCC1;PHF8;CDK16;ORC1;PIM2;CUL4B;FBXO5;NASP;USP37;DBF4
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.29512605328007746,0.7593257473395252,0.7814136125654451,1.0,1.0,10/30,24.46%,SLC27A4;ACOX1;ELOVL6;ELOVL5;ABCD2;ACSL6;HACD2;TECRL;ELOVL1;HACD3
prerank,regulation of chemokine production (GO:0032642),0.2811127332795073,0.7591582855959452,0.7965260545905707,1.0,1.0,7/36,19.04%,PYCARD;WNT5A;IL18;HIF1A;IL33;CD74;EGR1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.29230369181734944,0.7589688114202205,0.7571059431524548,1.0,1.0,8/29,16.35%,KANK4;PRKN;SSH3;CLASP1;FKBP4;PLEKHH2;SSH1;ARFGEF1
prerank,mesoderm development (GO:0007498),0.3260122405556871,0.7589253575318446,0.7713884992987378,1.0,1.0,2/18,5.00%,VEGFA;MEST
prerank,regulation of mitochondrion organization (GO:0010821),0.2718578115649847,0.75863150072045,0.8317422434367542,1.0,1.0,7/47,11.37%,PRKN;PARL;FBXW7;RHOT2;MYO19;HDAC6;PID1
prerank,glucose homeostasis (GO:0042593),0.25572552378796104,0.7584697107559397,0.8509249183895539,1.0,1.0,15/83,20.08%,PYGL;BACE2;PTPN2;LRRC8D;MLXIPL;HIF1A;PIK3R1;NGFR;CRY1;KLF7;PARK7;HK2;PPARG;STAT3;ADCY8
prerank,heterochromatin organization (GO:0070828),0.3389027485005263,0.7584573570841491,0.751453488372093,1.0,1.0,3/14,10.07%,PRDM16;EZH1;POLE3
prerank,phosphatidic acid metabolic process (GO:0046473),0.2746272230456261,0.7584125266000292,0.8043478260869565,1.0,1.0,7/48,17.72%,SLC27A1;PLD1;AGPAT2;PLA2G12A;AGPAT5;GPAT3;GPAT4
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.28861514350132894,-0.7580017989858134,0.7885196374622356,0.9545440907485266,1.0,6/13,23.94%,CACNA1G;SYT10;KCNB1;STX1A;SYT4;CACNA1I
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.26597014958504145,0.757043559054328,0.8230593607305936,1.0,1.0,10/55,17.22%,PYCARD;BCL2;FADD;BMF;TRAF7;CRADD;TP53;BCL2L11;WWOX;RIPK1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.2825133043620926,0.7569899918917697,0.7975308641975308,1.0,1.0,6/37,11.46%,PHLDB1;BICD1;EFNA5;CLASP1;BICD2;STMN4
prerank,negative regulation of lyase activity (GO:0051350),0.33326714190792556,0.7569141401311115,0.7758369723435226,1.0,1.0,3/16,12.70%,CCR2;MTRR;DRD2
prerank,Wnt signaling pathway (GO:0016055),0.2503856637874439,0.7567766935137163,0.8566775244299675,1.0,1.0,19/92,15.84%,PTEN;FRZB;VPS29;WNT5A;FZD7;RARG;BCL9L;SFRP4;BCL9;DVL1;CSNK1G1;GPC4;CSNK1A1;STRN;KLHL12;UBB;FZD9;CSNK1E;CSNK1G2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.34506117010985093,0.7565146020276383,0.7723935389133627,1.0,1.0,1/14,1.85%,ANK2
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.30722092788511696,0.7560398051605558,0.7832369942196532,1.0,1.0,5/23,17.04%,DERL2;SELENOS;HERPUD1;HSP90B1;SURF4
prerank,response to progesterone (GO:0032570),-0.26118670840049263,-0.755853498194915,0.7993421052631579,0.9565765297777552,1.0,6/18,20.71%,THBS1;TGFB2;CAV1;ABHD2;CATSPER3;NR1H3
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2720641930402653,-0.7558193020914307,0.8290322580645161,0.9555157120593167,1.0,6/16,19.64%,AMPD3;LHPP;ATIC;IMPDH1;GART;IMPDH2
prerank,clathrin-dependent endocytosis (GO:0072583),0.30010221736992865,0.7558103381069607,0.7891156462585034,1.0,1.0,4/26,11.36%,SGIP1;ITSN1;GAK;GPR107
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.33008227123773365,0.7557666975234114,0.7716312056737589,1.0,1.0,6/15,30.82%,ZC3H12B;POP1;ZC3H12C;RPP30;KHNYN;ZC3H12A
prerank,positive regulation of cellular metabolic process (GO:0031325),0.24955821954756277,0.7555361457365112,0.8624862486248625,1.0,1.0,22/98,19.69%,VEGFA;ACACA;TGFB1;MT3;TGFBR2;ACLY;FASN;EIF4G1;SFRP4;MAPK14;PID1;MAGI2;RAB1A;SCRIB;GATA3;SNCA;SCYL2;TP53;RIPK1;CD63;GRB2;PPARG
prerank,negative regulation of phagocytosis (GO:0050765),-0.253444144839383,-0.7552684191601237,0.845679012345679,0.9551810341099891,1.0,4/17,17.74%,PLSCR1;RACK1;CD300A;APPL1
prerank,peptide catabolic process (GO:0043171),0.30407370220143876,0.7552503373974404,0.7805212620027435,1.0,1.0,4/23,9.82%,DPEP1;LTA4H;TRHDE;LNPEP
prerank,miRNA metabolic process (GO:0010586),-0.2575417991139325,-0.7549306736159549,0.7839721254355401,0.9545300066271933,1.0,9/20,29.54%,DGCR8;TUT7;TENT4B;TARBP2;LIN28B;DDX17;BCDIN3D;AGO2;DICER1
prerank,regulation of protein acetylation (GO:1901983),-0.29588109797467993,-0.7546748486104264,0.8051575931232091,0.9538304717147253,1.0,4/12,20.83%,GSK3B;CAMK1;KAT5;CEP295
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.21413412294825762,-0.7545108665406817,0.883177570093458,0.9529634702876127,1.0,12/33,18.97%,TERF2;RFC1;DKC1;WRAP53;HSP90AA1;CDK2;TERT;PINX1;DCLRE1B;GAR1;HSP90AB1;TINF2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.32539635258396993,0.7542641738989011,0.7836338418862691,1.0,1.0,4/16,15.55%,ANK2;PRKACA;CALM1;CALM2
prerank,melanosome transport (GO:0032402),0.31391779353348387,0.753825290867297,0.7588152327221439,1.0,1.0,7/18,25.47%,BBS5;MREG;BBS7;MYO5A;BLOC1S6;BBS4;RAB27B
prerank,pigment granule transport (GO:0051904),0.31391779353348387,0.753825290867297,0.7588152327221439,1.0,1.0,7/18,25.47%,BBS5;MREG;BBS7;MYO5A;BLOC1S6;BBS4;RAB27B
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.3427189160932578,0.7538244905724979,0.7674772036474165,1.0,1.0,6/12,28.29%,ATF7IP;APOBEC1;SETDB1;MPHOSPH8;RESF1;DNMT1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3218590893119375,0.7537376142355586,0.7676348547717843,1.0,1.0,6/17,20.40%,ALG9;ALG1;ALG8;DPAGT1;ALG6;DHDDS
prerank,protein depolymerization (GO:0051261),-0.22760057209937895,-0.7536733600190411,0.8695652173913043,0.9530235205854841,1.0,7/27,16.60%,NCKAP5;MICAL3;MICAL2;NCKAP5L;DSTN;KIF18A;VPS4B
prerank,prostaglandin metabolic process (GO:0006693),0.2997139674144571,0.7531793591918023,0.7997293640054127,1.0,1.0,6/26,17.79%,CYP2S1;ACOX1;PNPLA8;PLAA;CD74;PTGES
prerank,regulation of interferon-alpha production (GO:0032647),0.3040601374933774,0.7529893863748145,0.7914438502673797,1.0,1.0,8/23,25.42%,SETD2;TBK1;CHUK;IRF3;PTPRS;HSPD1;MAVS;IRF5
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.2604536331049885,-0.7528341137805097,0.8184615384615385,0.9531038801035964,1.0,5/18,13.59%,DKC1;WRAP53;CCT8;CCT6A;CCT4
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.3269539312597579,0.7527535845224991,0.7727272727272727,1.0,1.0,1/16,2.66%,FADD
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.3109534600087778,0.752647537177108,0.78125,1.0,1.0,9/20,24.49%,PARL;LETM1;PMPCB;SLC25A23;YME1L1;PMPCA;PHB2;MCUR1;SMDT1
prerank,keratan sulfate metabolic process (GO:0042339),0.2933221361798016,0.7520682240163951,0.8064516129032258,1.0,1.0,3/31,7.19%,LUM;ST3GAL4;GALNS
prerank,regulation of DNA biosynthetic process (GO:2000278),0.295002688843081,0.7519635002038685,0.7767624020887729,1.0,1.0,2/27,1.47%,FGF2;MYC
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.35235236397119063,0.75187232770182,0.7464566929133858,1.0,1.0,4/12,25.11%,TSPOAP1;TSPO;CACNA1H;STARD3
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.314926162658483,0.7514881996892309,0.7647058823529411,1.0,1.0,3/21,6.11%,EPHB2;SYNGAP1;MAPKAP1
prerank,cellular response to starvation (GO:0009267),0.24075971440405552,0.751067933426396,0.8918918918918919,1.0,1.0,54/147,28.01%,MIOS;NPRL2;SIK2;EIF2AK3;ATP6V1B2;NUPR2;AOC1;WIPI1;RALB;TBL2;ATG5;LAMTOR2;CASTOR2;ASNS;ATF2;USP33;CLEC16A;MAPK1;XPR1;GABARAPL2;VPS41;GCN1;TP53;SREBF2;WRN;ATP6V1C1;RPTOR;FNIP1;RRAGA;ATP6V0E2;LAMP2;DEPDC5;PRKAA1;ATP6V0E1;CEBPB;INHBB;RRP8;MTOR;ATP6V1G2;WDR45B;EHMT2;SESN1;ITFG2;EIF2AK2;SLC38A9;ATP6V1H;CPEB4;CDKN1A;TCIRG1;PPARA;SIRT1;ATP6V1D;PIK3C3;PRKAG1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3171313705354346,0.7509050856383129,0.800557880055788,1.0,1.0,7/19,25.42%,SETD2;TBK1;CHUK;IRF3;HSPD1;MAVS;IRF5
prerank,positive regulation of T cell proliferation (GO:0042102),0.26059095062450477,0.7508409673362519,0.8150765606595995,1.0,1.0,6/55,14.00%,PYCARD;FADD;CCR2;IL18;IL6ST;NCK1
prerank,negative regulation of hydrolase activity (GO:0051346),0.2692679306601452,0.750758353097991,0.8385542168674699,1.0,1.0,10/49,20.84%,MAPK7;CSTB;URI1;ARL2;NEIL1;TMED2;ARFGEF1;FICD;RDX;ZCCHC9
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.2657370780434743,0.7498815221684105,0.8366164542294322,1.0,1.0,15/51,21.51%,LPAR1;GPR65;ARHGEF10;PAK1;LIMK1;NF2;ARHGEF10L;RHOC;MYOC;ABL1;TGFB3;PPM1E;TESK1;CCDC88A;PXN
prerank,regulation of Notch signaling pathway (GO:0008593),0.2518632125056674,0.749568996021471,0.8440567066521265,1.0,1.0,11/76,16.26%,MAML3;KAT2B;EGFR;MAML2;FBXW7;METTL3;ZMIZ1;IL6ST;RFNG;TM2D3;SREBF2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.33879875880341426,0.7495688772092797,0.7857142857142857,1.0,1.0,6/13,24.46%,ELOVL6;ELOVL5;HACD2;TECRL;ELOVL1;HACD3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.30236678840467274,0.7495396734135387,0.7789613848202397,1.0,1.0,5/22,15.09%,MVB12B;VPS37B;VPS36;MVB12A;PLAA
prerank,negative regulation of TOR signaling (GO:0032007),0.2838733807899139,0.7485667242482031,0.801007556675063,1.0,1.0,11/36,24.80%,NPRL2;DEPTOR;TSC1;CASTOR2;ATM;SPAAR;FNIP1;DEPDC5;PRKAA1;SESN1;ITFG2
prerank,tRNA methylation (GO:0030488),0.28263846516302815,0.7485585854611225,0.8280657395701644,1.0,1.0,11/34,23.39%,THUMPD3;TRMT12;THADA;PRORP;TRMT112;DALRD3;THUMPD2;NSUN2;LCMT2;ALKBH8;TRMT1
prerank,mesenchymal to epithelial transition (GO:0060231),0.35706290530700474,0.7483307783566876,0.7884322678843226,1.0,1.0,3/10,16.98%,FZD7;GATA3;PAX2
prerank,regulation of vasculogenesis (GO:2001212),0.33224426018210906,0.7481384644838782,0.7908689248895434,1.0,1.0,2/14,7.42%,CD34;RAP1A
prerank,regulation of plasminogen activation (GO:0010755),0.3391495949220183,0.7480164916625525,0.7485207100591716,1.0,1.0,3/12,15.49%,SERPINE2;PLGRKT;RUNX1
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.3082533079660147,-0.7478207738387829,0.7723577235772358,0.958832618751537,1.0,7/10,37.87%,TLR4;AKT1;MYD88;CD68;TREM2;CD36;TLR6
prerank,antibacterial humoral response (GO:0019731),0.32696188626011147,0.7477087821440423,0.7673048600883653,1.0,1.0,1/16,3.93%,RNASE6
prerank,negative regulation of interleukin-8 production (GO:0032717),0.31883693603131735,0.7468253279767673,0.7739628040057225,1.0,1.0,2/17,6.17%,PTPN22;OTUD7B
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.26892886156654133,0.7467604189214817,0.8351648351648352,1.0,1.0,8/46,15.90%,TGFB1;PSEN1;CPSF6;FLNA;PIK3R1;EMD;JUP;TP53
prerank,protein-containing complex disassembly (GO:0032984),0.2609166715494946,0.7466916354899304,0.8246445497630331,1.0,1.0,15/54,22.81%,MYC;VPS33A;LIX1;SNAP29;PPP1CA;DVL1;CSNK1A1;GABARAPL2;STX17;SNX14;LAMP2;PYM1;DVL3;VPS16;UBQLN1
prerank,positive regulation of JNK cascade (GO:0046330),0.2577597588797682,0.7466902674500231,0.8574660633484162,1.0,1.0,9/70,11.67%,PYCARD;SEMA3A;NCF1;TRAF4;PLCB1;CARD9;FZD7;MTURN;TAOK3
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.294903232282273,-0.7464909992611755,0.8111111111111111,0.959627782717073,1.0,3/11,9.08%,BIRC3;NUPR1;CASP8
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2851946541892296,0.7464223414276779,0.788339670468948,1.0,1.0,6/29,15.91%,EXOSC8;DCP1B;EXOSC2;EDC4;LSM3;NT5C3B
prerank,central nervous system neuron differentiation (GO:0021953),0.2819071670364893,0.7463274713945777,0.7989756722151088,1.0,1.0,5/33,11.43%,NTRK2;GBA2;GRID2;MDGA2;OPHN1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.23875861377569113,0.7461544460978958,0.8985200845665962,1.0,1.0,16/124,15.54%,ROR2;FRZB;PLCB1;WNT5A;PPP3CB;FZD7;PPP3CA;PRICKLE2;PSMB7;SFRP4;PRICKLE1;DVL1;CALM1;PSMD2;PSMC1;FZD9
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2548623828143519,0.7460632495831122,0.8568232662192393,1.0,1.0,15/78,19.15%,DYNLL1;SEC24D;AP1G1;AP1S1;SEC24C;DYNC1I1;DCTN4;DYNC1I2;KIF22;CD74;SEC24A;RAB7A;OSBPL1A;KIF3A;KIF2A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2548623828143519,0.7460632495831122,0.8568232662192393,1.0,1.0,15/78,19.15%,DYNLL1;SEC24D;AP1G1;AP1S1;SEC24C;DYNC1I1;DCTN4;DYNC1I2;KIF22;CD74;SEC24A;RAB7A;OSBPL1A;KIF3A;KIF2A
prerank,T cell activation (GO:0042110),0.25327034382574953,0.745771217881518,0.8502252252252253,1.0,1.0,11/69,17.76%,PTPN22;PTPN2;PPP3CB;PPP3CA;NHEJ1;RHOH;SCRIB;GATA3;NCK1;CD74;MDK
prerank,regulation of TORC1 signaling (GO:1903432),-0.21881326465705672,-0.7455068719334353,0.8762376237623762,0.9598836691434784,1.0,13/33,26.39%,SIK3;RRAGC;FLCN;SESN2;LARS1;PIP4P1;SMCR8;KPTN;GPR137;RRAGB;CASTOR1;SZT2;STK11
prerank,peptidyl-lysine modification (GO:0018205),0.2466415966969552,0.7451732447017965,0.8739224137931034,1.0,1.0,13/99,11.29%,CTH;KAT2B;SENP3;RANBP2;UBA2;NUP155;LOXL3;PLOD1;PIAS2;NUP205;NDC1;HDAC6;NUP160
prerank,positive regulation of RNA metabolic process (GO:0051254),0.2710830047665172,0.7450526694062855,0.831942789034565,1.0,1.0,15/45,24.52%,EGFR;TGFB1;DXO;HEATR1;PIK3R1;ZC3H18;TRMT112;TP53;PNPT1;RIPK1;POLR2A;NFKB1;WDR75;SUPV3L1;HSPA1A
prerank,response to amino acid (GO:0043200),0.29031106724040845,0.7449929263740825,0.8234536082474226,1.0,1.0,12/31,27.62%,CPEB3;LAMTOR2;CPEB1;SPAAR;RPTOR;IPO5;RRAGA;GLRB;MTOR;SLC38A9;CPEB4;GLRA3
prerank,regulation of protein secretion (GO:0050708),0.23948054418410938,0.7447187091795692,0.8936842105263157,1.0,1.0,15/119,12.70%,PRKCA;CACNA1E;FRMD4A;CACNA1A;TGFB1;SLC12A2;RFX3;PPP3CB;RAP1A;ENSA;PPID;TMED10;SLC2A2;STXBP5;DRD2
prerank,maintenance of protein localization in organelle (GO:0072595),0.31110935126047284,0.7444773977703654,0.7746870653685675,1.0,1.0,9/19,26.23%,ARL2;HNRNPU;HK2;TAF8;BCL3;HK1;BBS4;TOPORS;TAPT1
prerank,cGMP biosynthetic process (GO:0006182),0.3509643097206563,0.7444705100922523,0.7623456790123457,1.0,1.0,1/10,3.32%,NPR2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.2950696463984345,0.7443667442716592,0.8138925294888598,1.0,1.0,9/27,19.58%,CRTC1;PPP1CA;PER3;PER1;RBM4B;CRY1;TP53;USP2;FBXL12
prerank,organophosphate biosynthetic process (GO:0090407),0.2754736854490798,0.7442007553483997,0.83375,1.0,1.0,6/37,17.75%,FGF2;PNPO;GPHN;AGPAT5;NFS1;PIP5K1A
prerank,regulation of protein sumoylation (GO:0033233),0.3187441024837695,0.7441033348018159,0.7991391678622669,1.0,1.0,7/17,25.96%,UBA2;ZMIZ1;PARK7;EGR1;GNL3L;GNL3;SAE1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.28829846866372216,0.7440804985621339,0.8005284015852048,1.0,1.0,5/27,12.95%,SLC1A3;SLC25A38;ARL6IP5;SLC7A8;PRAF2
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.32891400587395025,0.7440181472713258,0.7820895522388059,1.0,1.0,3/15,15.39%,ACVR1;MAGI2;DACT1
prerank,positive regulation of locomotion (GO:0040017),-0.23022697753085575,-0.7439602512658149,0.8932384341637011,0.9607801139571405,1.0,7/27,19.58%,CCDC25;THBS1;SPOCK2;PDGFRB;PPM1F;CAVIN1;TWIST1
prerank,negative regulation of B cell proliferation (GO:0030889),-0.29177428584218085,-0.7439266316611464,0.7867435158501441,0.9597278574895317,1.0,4/11,25.56%,LYN;CD300A;TNFRSF21;TYROBP
prerank,ribosomal large subunit assembly (GO:0000027),0.30406874993918476,0.7436751142317551,0.7872340425531915,1.0,1.0,4/24,7.70%,RPL23A;NOP2;BRIX1;DHX30
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.2210363477304857,-0.7435553705787724,0.8678414096916299,0.9591146167099449,1.0,7/31,12.58%,SYT9;STXBP1;CACNA1G;ADRA2A;SYT10;KCNB1;SYT6
prerank,negative regulation of protein processing (GO:0010955),0.3441025308937806,0.7434788405847914,0.7714285714285715,1.0,1.0,3/12,16.93%,PRNP;SERPINE2;SNX12
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.23816437149817288,-0.743415112450926,0.8622047244094488,0.9582175358225506,1.0,9/24,27.18%,RNF34;CASP8;MAP3K7;UBE2N;IKBKG;NOD1;TNFAIP3;UBA52;NOD2
prerank,receptor catabolic process (GO:0032801),-0.23567884059247424,-0.7432177867634198,0.8850574712643678,0.9573617606936763,1.0,6/24,16.17%,ZNRF3;BECN1;LGMN;UVRAG;RNF43;CLTA
prerank,carbohydrate catabolic process (GO:0016052),-0.20696932071748417,-0.7430701909267202,0.8436018957345972,0.9564763180377265,1.0,12/38,23.62%,MANBA;MAN2B1;PGK1;PGAM4;PGAM1;GPI;PFKM;PFKL;ENO1;MAN2B2;GAPDHS;ENO3
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.25358688547652375,0.7430453493003608,0.8662207357859532,1.0,1.0,15/79,19.15%,DYNLL1;SEC24D;AP1G1;AP1S1;SEC24C;DYNC1I1;DCTN4;DYNC1I2;KIF22;CD74;SEC24A;RAB7A;OSBPL1A;KIF3A;KIF2A
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.34222096088687004,0.7429514617419437,0.7772727272727272,1.0,1.0,5/12,18.29%,SYT1;RIMS1;DOC2B;SYT2;RIMS2
prerank,sodium ion homeostasis (GO:0055078),0.3046476885660907,0.7429218179854805,0.7880434782608695,1.0,1.0,4/21,17.46%,SLC12A3;SLC12A2;NEDD4L;SLC9A1
prerank,histone exchange (GO:0043486),0.27260241871967245,0.742845697987315,0.8042929292929293,1.0,1.0,11/37,22.40%,VPS72;ANP32E;HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,glucose transmembrane transport (GO:1904659),0.31369691049076703,0.7427844917272173,0.8056338028169014,1.0,1.0,3/18,12.42%,SLC5A3;SLC2A2;RAB4B
prerank,epithelial cell development (GO:0002064),-0.24545947737024218,-0.7426655037583487,0.8422818791946308,0.9558999037055592,1.0,3/20,7.45%,WNT5B;RILPL1;SIPA1L3
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.20462427643369496,-0.7422038507274504,0.9371428571428572,0.9554043066794096,1.0,8/49,13.33%,SMAD6;JAM3;GSK3B;RIOK3;PRKCZ;NOP53;LCMT1;CDC42
prerank,t-circle formation (GO:0090656),0.3512837415262542,0.7419305188933929,0.7850467289719626,1.0,1.0,4/10,25.09%,XRCC3;BLM;WRN;SLX4
prerank,telomere maintenance via telomere trimming (GO:0090737),0.3512837415262542,0.7419305188933929,0.7850467289719626,1.0,1.0,4/10,25.09%,XRCC3;BLM;WRN;SLX4
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.3512837415262542,0.7419305188933929,0.7850467289719626,1.0,1.0,4/10,25.09%,XRCC3;BLM;WRN;SLX4
prerank,protein glycosylation (GO:0006486),0.24191861099454617,0.7416275868398253,0.9033970276008493,1.0,1.0,26/125,19.75%,GFPT2;ST3GAL4;NPC1;ALG9;B3GNT9;GALNT9;GALNT1;STT3A;PLOD1;MGAT3;MAGT1;ST8SIA1;POMGNT2;GALNT7;ALG5;GALNT6;TUSC3;ALG1;MOGS;TET3;ALG8;DPM1;FKTN;DPAGT1;RPN1;ALG6
prerank,regulation of blood circulation (GO:1903522),-0.21497259633676025,-0.7414546700372544,0.9270833333333334,0.9553094275696038,1.0,11/34,26.48%,TPM1;ACE;AGTR1;ECE1;DES;SRI;ACE2;DMPK;AGT;KCNIP2;PLN
prerank,positive regulation of secretion (GO:0051047),0.34732173911813446,0.741120937603497,0.7574334898278561,1.0,1.0,2/11,16.11%,ACSL3;GPLD1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.35098863525717094,0.7404928372488057,0.7808823529411765,1.0,1.0,2/10,9.78%,MPG;ALKBH5
prerank,DNA dealkylation (GO:0035510),0.35098863525717094,0.7404928372488057,0.7808823529411765,1.0,1.0,2/10,9.78%,MPG;ALKBH5
prerank,positive regulation of translation (GO:0045727),0.2481888243891241,0.7397063121056192,0.8846153846153846,1.0,1.0,12/94,9.18%,ERBB2;UPF3A;PLD1;NIBAN1;NGRN;METTL3;EIF3C;EIF2B5;CPEB3;EIF6;NSUN5;PASK
prerank,embryonic organ development (GO:0048568),0.25867467641722053,0.7396813659743912,0.85,1.0,1.0,11/61,14.61%,GLI2;PKDCC;KMT2A;TGFB1;TGFBR2;RARB;GDNF;GATA3;COBL;NES;BMPR1A
prerank,triglyceride metabolic process (GO:0006641),0.2663309368659298,0.7396601190973523,0.830568720379147,1.0,1.0,7/48,17.72%,AGMO;LMF1;MOGAT3;PLAAT3;LIPC;GPAT3;GPAT4
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.1808257880345373,-0.7393357589562796,0.9433962264150944,0.9569586241398916,1.0,18/74,19.43%,PSMD14;ARNT;PSMB3;PSMD12;EGLN2;HIGD1A;PSMD6;PSMA1;VHL;PSMD7;PSMA5;PSMC5;PSMC4;CREBBP;PSMB6;CUL2;EGLN3;PSMA4
prerank,T cell proliferation (GO:0042098),0.33342568296057096,0.7391070876226427,0.7811594202898551,1.0,1.0,2/13,8.17%,PPP3CB;CADM1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.2780946884246394,0.7388109548307966,0.8124191461836999,1.0,1.0,3/34,4.08%,PDGFRA;FGF2;TGFB1
prerank,tRNA processing (GO:0008033),-0.18642210766328254,-0.73848649184425,0.9538461538461539,0.9569125031766471,1.0,21/61,22.84%,TRMT9B;FTSJ1;SARS1;URM1;TSEN15;METTL1;AARS1;KARS1;TYW5;PUS3;WDR4;ZBTB8OS;TRMT10A;CDKAL1;CPSF4;POP5;QTRT2;TRNT1;CLP1;NSUN6;ANKRD16
prerank,innate immune response in mucosa (GO:0002227),-0.31125457966355013,-0.7379886021286977,0.7914438502673797,0.95648584316322,1.0,1/10,6.09%,DEFA6
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.18414117044468944,-0.7378677730971054,0.9925373134328358,0.9555607284280843,1.0,20/67,23.97%,ITGB5;PSMD14;TAPBP;PSMB3;PSMD12;CYBA;PSMD6;PSMA1;PSMD7;PSMA5;PSMC5;IKBKB;IKBKG;PSMC4;PSMB6;PSMA4;VAMP8;CALR;PSMB1;PSMB9
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.32608251542227673,0.7375177530868866,0.7745504840940526,1.0,1.0,5/15,23.63%,ANAPC7;CDC23;CDC27;PTTG1;CDC16
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.34190500604708834,0.7374145834958914,0.7909090909090909,1.0,1.0,4/12,22.66%,PDE4D;CALM1;CALM2;CAMK2D
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.30014518652593997,0.737204899886012,0.8027397260273973,1.0,1.0,5/22,15.48%,SPRED2;SPRED1;SPRED3;UBB;ATM
prerank,negative regulation of platelet activation (GO:0010544),0.3270367544294032,0.7370439555416196,0.7855072463768116,1.0,1.0,3/16,13.84%,PDGFRA;SERPINE2;CD9
prerank,protein mannosylation (GO:0035268),0.2991220158362815,0.7368341696950577,0.8149717514124294,1.0,1.0,9/22,19.09%,TMTC2;POMGNT2;RXYLT1;TMTC3;DPY19L2;DPM1;FKTN;FKRP;DPY19L3
prerank,translesion synthesis (GO:0019985),0.2656988538141233,0.7367150566407743,0.8416565164433617,1.0,1.0,9/42,17.26%,POLN;POLE2;REV3L;RPA3;ZBTB1;RPA2;UBB;RCHY1;REV1
prerank,ncRNA 3'-end processing (GO:0043628),0.3250897615291921,0.7366042158008578,0.7997118155619597,1.0,1.0,4/14,17.37%,INTS6;INTS2;INTS8;SSB
prerank,ventricular septum development (GO:0003281),0.27655258965311497,0.7365994276671036,0.8365261813537676,0.9999930301844843,1.0,11/37,17.58%,ACVR1;SOX11;TGFBR2;DAND5;ZFPM2;GATA3;MDM4;BMPR1A;CITED2;APLNR;HEYL
prerank,T cell receptor signaling pathway (GO:0050852),0.2378739120727472,0.7365026058387215,0.9109947643979057,0.9997002871670392,1.0,29/138,22.72%,PRKCQ;PTPN22;TEC;PDE4B;PAK1;CSK;EIF2B5;FYN;PSMB7;PIK3R1;PTPRJ;PDE4D;GATA3;MALT1;NCK1;PSMD2;PSMC1;PSMB2;EIF2B2;RC3H1;CHUK;PSMD9;PSME4;BCL10;PSMA8;NFKB1;PRKD2;CARD11;TAB2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.2318414873843895,-0.7364082591272574,0.8645418326693227,0.9562959647290038,1.0,6/23,19.17%,IGF1;MAML1;PROX1;ATP11A;EDN1;MYOCD
prerank,nuclear membrane reassembly (GO:0031468),0.2593252981795607,0.7363218724685331,0.8414918414918415,0.9994994507047961,1.0,28/54,31.23%,NUP155;PPP2R2A;RCC1;NUP205;NDC1;NUP160;EMD;KPNB1;SUMO1;LMNA;CHMP4C;POM121;AHCTF1;PPP2R1A;REEP3;IST1;NUP35;UBE2I;CHMP4B;CHMP4A;SPAST;VRK1;SIRT2;CC2D1B;SEC13;ANKLE2;NUP85;RANGAP1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.326368290431528,0.736177897146255,0.8054711246200608,0.9992519289896261,1.0,4/14,14.00%,PPP3CA;PPP2R2A;PPP1CA;NCK1
prerank,modification-dependent protein catabolic process (GO:0019941),0.23244890541273583,0.7352591024711641,0.9287190082644629,1.0,1.0,57/193,23.63%,PRKN;HACE1;SPSB4;RNF6;FBXO7;UBE2K;CUL3;HERPUD1;ANAPC7;FBXO45;CBL;USP33;TOLLIP;ANAPC2;PCYOX1L;MYLIP;DDB1;NDFIP1;NEDD8;BUB1B;NEDD4L;UBB;AREL1;RNF19A;RCHY1;CDC23;RNF111;FBXL4;ANAPC16;MIB1;RC3H1;RNF167;UBA1;FBXO22;MDM2;ELOC;PSMD9;TAF1;FBXO11;UBE2L3;CDC27;UBE2G1;RNF13;UBE2E1;PTTG1;ANAPC4;WDR81;RNF114;UBQLN4;TTC3;UBR3;ANAPC5;UBQLN1;SIAH1;UBQLN2;UBE3C;CDC16
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.25224503187001496,0.7350314196698946,0.8759864712514093,0.9999579772210798,1.0,17/72,20.97%,HMGN1;GTF2H2;ERCC5;ERCC4;POLR2B;RPA3;XPA;POLR2K;DDB1;RPA2;POLR2G;UBB;CUL4B;POLR2A;LIG3;COPS6;COPS7A
prerank,sulfation (GO:0051923),-0.29408020260210666,-0.7350027219775837,0.788235294117647,0.95694190009915,1.0,5/11,44.31%,UST;SULT4A1;CHST5;SULT2B1;SULT6B1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.32431539866490844,0.7346081656163396,0.8069164265129684,1.0,1.0,2/15,4.19%,EGFR;TEC
prerank,positive regulation by host of viral transcription (GO:0043923),-0.26984741797740686,-0.7344836641955502,0.8308605341246291,0.9565233860269493,1.0,3/15,12.15%,LEF1;SNW1;CTDP1
prerank,long-term memory (GO:0007616),0.30239753502328004,0.7336335182834091,0.7825503355704698,1.0,1.0,6/19,25.35%,PRNP;CPEB3;SGK1;PJA2;NFATC4;SHANK1
prerank,synaptonemal complex assembly (GO:0007130),0.32310668945807014,0.7333501579723803,0.7873651771956857,1.0,1.0,3/15,22.25%,TEX11;SYCE2;SYCP2
prerank,synaptonemal complex organization (GO:0070193),0.32310668945807014,0.7333501579723803,0.7873651771956857,1.0,1.0,3/15,22.25%,TEX11;SYCE2;SYCP2
prerank,hexose transmembrane transport (GO:0008645),0.29873830099817855,0.7332683250388781,0.8301630434782609,1.0,1.0,3/21,10.56%,SLC5A3;SLC50A1;SLC2A2
prerank,cellular response to light stimulus (GO:0071482),0.254669232364257,0.7330179516931561,0.8555304740406321,1.0,1.0,6/66,6.89%,MYC;RHO;NSMCE3;ERCC4;METTL3;BMF
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3086032425331731,0.7329307116605377,0.7934472934472935,0.9997512978682255,1.0,4/18,19.14%,VGLL4;VPS11;DACT1;RDX
prerank,leukotriene biosynthetic process (GO:0019370),0.3273577530650358,0.7328024760581181,0.7997032640949555,0.9994954959422998,1.0,3/14,13.17%,LTA4H;ALOX5AP;GGTA1
prerank,multivesicular body assembly (GO:0036258),-0.21256239552166262,-0.7327471012512402,0.8809523809523809,0.9575710898698464,1.0,5/30,9.91%,CHMP3;TSG101;VPS37C;VPS4A;CHMP1A
prerank,spindle assembly (GO:0051225),0.2548148881231132,0.7326648927325021,0.8747178329571106,0.9992348746565036,1.0,15/67,20.16%,HAUS3;STARD9;ARHGEF10;STAG2;FLNA;TUBGCP5;RCC1;CLASP1;NEK7;KPNB1;AAAS;CEP63;MAPRE3;KIF2A;BCCIP
prerank,ribonucleoprotein complex assembly (GO:0022618),0.236472554125892,0.7326312917944535,0.8966597077244259,0.9988510095721417,1.0,27/132,18.61%,CELF5;CPSF6;RPL23A;NOP2;BRIX1;LUC7L2;SHQ1;EIF6;TXNL4A;NCBP1;TGS1;CLNS1A;PRPF6;PRPF18;CELF6;SRSF6;YTHDC1;TRAF7;LUC7L;RPS27L;CDC73;SF1;GEMIN7;BOP1;SART1;DDX23;RPSA
prerank,microtubule polymerization or depolymerization (GO:0031109),0.2854287783655796,0.732493375273661,0.7997329773030708,0.9986022288705932,1.0,4/24,13.07%,FGF13;STMN4;KATNB1;CKAP5
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.2780327844300024,0.7322371125856221,0.8136020151133502,0.9984975878368637,1.0,9/32,18.73%,FGF13;CLASP1;FKBP4;APC2;KATNB1;SNCA;NAV3;ATXN7;CAMSAP1
prerank,cellular iron ion homeostasis (GO:0006879),0.2562949783694804,0.7321456367959972,0.830568720379147,0.9981745196780328,1.0,3/55,5.56%,SCARA5;MYC;CYBRD1
prerank,regulation of TOR signaling (GO:0032006),0.2524789422437782,0.7319380987314287,0.8633754305396096,0.9980198463994965,1.0,8/67,9.88%,MIOS;NPRL2;ARAF;DEPTOR;TSC1;LAMTOR2;TBCK;PIH1D1
prerank,neuron projection organization (GO:0106027),0.3139545306746596,0.731898972170909,0.7892441860465116,0.9976406929838458,1.0,2/15,4.80%,PSEN1;PRNP
prerank,fibrinolysis (GO:0042730),-0.2759133337275282,-0.7316309986518081,0.8263473053892215,0.9579039622369613,1.0,9/13,52.53%,SERPINE1;PLAUR;PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA;F2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.31952008162465306,0.7312773937983487,0.7959770114942529,0.9980103976367141,1.0,4/15,19.77%,CARD9;HIF1A;TICAM1;STAT3
prerank,neutrophil activation (GO:0042119),-0.28860067201915396,-0.7310277579751421,0.8065476190476191,0.9575842405614338,1.0,1/12,2.60%,PRKCD
prerank,signal transduction in response to DNA damage (GO:0042770),-0.19516610531871215,-0.7304778849386122,0.9235668789808917,0.9571942747851039,1.0,24/49,32.85%,MAP3K20;ACER2;CLOCK;NDRG1;DOT1L;SESN2;HUS1;BID;CLSPN;PAXIP1;DONSON;ERCC6;NBN;E2F1;MAD2L2;CASP9;RAD9A;CHEK2;CHEK1;GADD45A;PRPF19;E2F7;TRIAP1;ATRIP
prerank,apoptotic nuclear changes (GO:0030262),-0.23151710270215642,-0.7304217016016088,0.8773234200743495,0.9561871349218074,1.0,11/24,29.89%,ACIN1;DFFA;H1-0;DNASE2;DEDD2;GPER1;HMGB2;CASP3;FOXL2;DICER1;CECR2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.3566725756745255,0.7301077585291477,0.8021472392638037,0.999120450491751,1.0,2/10,14.50%,DRD2;CALM1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.3201754351950753,0.7299198113148535,0.8052325581395349,0.9989388507200775,1.0,2/15,10.32%,ETV4;SFRP4
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.3226535955975877,0.7298587695728631,0.7979942693409742,0.9985754342517427,1.0,5/14,19.56%,GPRC5B;WNT5A;TICAM1;CD74;BCL10
prerank,regulation of ERAD pathway (GO:1904292),-0.2924235927704225,-0.7296751487837798,0.8088642659279779,0.9560753706437938,1.0,4/11,12.56%,USP19;RNF185;AQP11;TMEM259
prerank,regulation of protein transport (GO:0051223),0.285643010323734,0.7295889036754734,0.8099606815203145,0.9985008556879034,1.0,9/27,22.51%,PTPN1;STXBP5;NDFIP1;SNX12;DNAJA1;ARFIP1;DISP1;LLGL1;P3H1
prerank,cellular response to amino acid starvation (GO:0034198),0.24652970039020833,0.7294482301807963,0.8706411698537683,0.9982670954546391,1.0,26/71,27.44%,MIOS;NPRL2;EIF2AK3;ATP6V1B2;LAMTOR2;CASTOR2;ATF2;MAPK1;GCN1;ATP6V1C1;RPTOR;RRAGA;ATP6V0E2;DEPDC5;ATP6V0E1;CEBPB;MTOR;ATP6V1G2;SESN1;ITFG2;EIF2AK2;SLC38A9;ATP6V1H;CDKN1A;TCIRG1;ATP6V1D
prerank,monoacylglycerol metabolic process (GO:0046462),-0.27546502330814493,-0.7294080128565,0.8366197183098592,0.9553372652551907,1.0,6/13,31.03%,PLA2G4A;MGLL;ABHD12;FAAH;DGAT1;AWAT2
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.25936663660391884,0.7293243215238472,0.8547418967587035,0.9979959364033082,1.0,16/51,25.06%,PRKCQ;CCT7;STN1;MAPK1;NEK7;MAP3K4;ATM;SMG6;HNRNPU;HNRNPC;CTC1;GNL3L;ACD;ATR;TCP1;PKIB
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.31653640241978165,0.7292833911479326,0.8068669527896996,0.9976172689205567,1.0,6/16,23.16%,PSIP1;PRPF39;SART1;DDX23;SNRNP200;WBP4
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.2981718177855447,0.729239069345094,0.8127544097693351,0.9972418505717313,1.0,2/22,5.52%,CCR2;WNT5A
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.23622263078314606,-0.7290030956181102,0.8571428571428571,0.9547867191894425,1.0,5/23,18.13%,UACA;C1QTNF3;TMSB4X;NMI;IFI35
prerank,embryonic heart tube development (GO:0035050),0.32929400579080326,0.7287458204969105,0.7867647058823529,0.9974917925822966,1.0,2/14,14.78%,ACVR1;CITED2
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.1949063362721715,-0.7286343950237303,0.9485714285714286,0.9541482672205447,1.0,20/42,31.34%,POLD3;TRIM25;PRIMPOL;PARP10;RFC1;POLH;POLA1;PCNA;POLK;ISG15;FAAP20;RFC3;UBA52;USP43;POLD2;VCP;PCLAF;POLE;POLD4;POLD1
prerank,nucleotide-excision repair (GO:0006289),0.24088821781547348,0.728550814183104,0.8978494623655914,0.9973269542241062,1.0,21/101,19.83%,RAD23B;HMGN1;GTF2H2;ERCC5;ERCC4;POLR2B;DDB2;RPA3;XPA;POLR2K;FANCC;DDB1;RPA2;POLR2G;UBB;TP53;RNF111;CUL4B;POLR2A;LIG3;COPS6
prerank,regulation of glycolytic process (GO:0006110),0.24933879101618475,0.7280861419534775,0.8590909090909091,0.9974928495602962,1.0,11/68,11.29%,ZBTB20;PSEN1;RANBP2;NUP155;MLXIPL;CBFA2T3;EIF6;HIF1A;NUP205;NDC1;NUP160
prerank,positive regulation of histone deacetylation (GO:0031065),0.33439312911497876,0.727721522186055,0.7839046199701938,0.9975185881590203,1.0,4/12,21.50%,VEGFA;APLNR;CTBP1;PRKD2
prerank,positive regulation of glial cell differentiation (GO:0045687),0.3113673987392913,0.7265895035216038,0.7980085348506402,0.9985627148296925,1.0,5/17,17.76%,TGFB1;BIN1;SERPINE2;PTPRZ1;MDK
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3094075777913511,0.7264313554605306,0.7796852646638054,0.9983348305613192,1.0,5/18,20.33%,RNFT1;PIK3R1;NCK1;BCL2L11;USP13
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.2900976530715396,0.7263786647123205,0.7981029810298103,0.9979660613024797,1.0,3/24,11.06%,BCL2;ACKR3;TAF9
prerank,regulation of receptor internalization (GO:0002090),0.27247011413286365,0.7263278886140169,0.8383084577114428,0.9976050973539494,1.0,9/35,22.43%,VEGFA;ATXN2;MKLN1;SFRP4;MAGI2;SCYL2;CD63;ARRB2;DLG4
prerank,response to amino acid starvation (GO:1990928),0.24561990949019766,0.726222616209396,0.8807649043869517,0.9973134686382332,1.0,26/72,27.44%,MIOS;NPRL2;EIF2AK3;ATP6V1B2;LAMTOR2;CASTOR2;ATF2;MAPK1;GCN1;ATP6V1C1;RPTOR;RRAGA;ATP6V0E2;DEPDC5;ATP6V0E1;CEBPB;MTOR;ATP6V1G2;SESN1;ITFG2;EIF2AK2;SLC38A9;ATP6V1H;CDKN1A;TCIRG1;ATP6V1D
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.2940598900005225,-0.7255341048050625,0.8104395604395604,0.9567672627055258,1.0,2/10,6.15%,RIF1;TERF2
prerank,response to cAMP (GO:0051591),-0.20292226540853087,-0.7248720091279423,0.9317073170731708,0.9564566006973024,1.0,4/37,7.01%,RAP1B;IGFBP5;ZFP36L1;SLC5A5
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.334188160956547,0.7247137067807968,0.7866043613707165,0.9988712373552302,1.0,2/11,16.92%,TGFB1;EFNB2
prerank,protein sumoylation (GO:0016925),0.2587454530409898,0.724615075655832,0.865315852205006,0.9985693441744764,1.0,10/49,16.73%,RANBP2;UBA2;NUP155;PIAS2;NUP205;NDC1;NUP160;SUMO1;POM121;AAAS
prerank,protein K63-linked deubiquitination (GO:0070536),0.27686873024527153,0.7241846992401194,0.8254172015404364,0.9987029183803747,1.0,7/31,20.33%,USP50;OTUD7B;USP33;USP25;OTUD4;OTUD7A;USP13
prerank,ncRNA processing (GO:0034470),0.22850439787915852,0.7241765282142872,0.9600818833162743,0.9982830544010514,1.0,37/200,17.37%,WDR55;C1D;INTS11;WDR36;SENP3;RPL23A;METTL3;NOB1;XRN2;NOL8;INTS6;BMS1;TUT4;EXOSC8;MRTO4;DDX54;UTP6;HEATR1;FARS2;PIH1D1;EXOSC2;INTS4;RCL1;FBL;EBNA1BP2;INTS2;HELQ;INTS8;WDR46;TEX10;DDX10;DDX27;NOP56;NOC4L;POP1;RPP21;SSB
prerank,regulation of mitotic spindle organization (GO:0060236),-0.20474930039279235,-0.7240232731888194,0.9277777777777778,0.9564020409618369,1.0,6/35,10.63%,CHMP3;DRG1;PARP3;CHMP1A;DCTN1;NUMA1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.30706460489156295,0.7238468252760855,0.8051948051948052,0.9983104177875183,1.0,1/18,1.40%,PYCARD
prerank,positive regulation of lipid transport (GO:0032370),0.32974772138964825,0.7233957167991151,0.7996965098634294,0.9984580322980685,1.0,1/12,2.54%,LRP1
prerank,regulation of B cell differentiation (GO:0045577),-0.2521969405144879,-0.723328610318125,0.8193979933110368,0.9561158937220026,1.0,4/17,13.28%,ZFP36L1;ID2;NCKAP1L;INHBA
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.20443733720521381,-0.7231798762735454,0.8783068783068783,0.9552406736713928,1.0,18/36,32.85%,MAP3K20;CLOCK;DOT1L;HUS1;CLSPN;DONSON;ERCC6;DNA2;NBN;TIMELESS;E2F1;RAD9B;RAD9A;CDC45;CHEK2;CHEK1;PRPF19;ATRIP
prerank,"DNA-templated transcription, termination (GO:0006353)",0.24891675897146337,0.7228932719864412,0.8934707903780069,0.998684286957589,1.0,19/68,25.00%,CSTF3;GTF2H2;TAF1A;POLR2K;NCBP1;FIP1L1;POLR1B;PAPOLA;POLR1C;POLR1G;POLR2A;UBTF;MTERF2;SYMPK;POLR3K;POLR2F;CCNH;TBP;CPSF7
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.2828966294814541,0.7228103080736425,0.819538670284939,0.9983654321579447,1.0,6/24,19.03%,AUTS2;BRK1;PIK3R1;CYFIP1;FSCN1;NCKAP1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.2505946273895378,0.722522775703188,0.872093023255814,0.998306972526577,1.0,11/59,18.77%,ACACA;OXSM;CYP39A1;ACLY;CYP7B1;SRR;CYP27A1;LIPC;ALDH1A3;OSBPL1A;PARK7
prerank,intracellular protein transmembrane transport (GO:0065002),0.267172521215586,0.7225043541801169,0.850383631713555,0.9979020204973406,1.0,9/42,18.30%,ZFAND2B;C2CD5;TOMM20;SEC61G;SEC63;DNAJC19;PAM16;AIFM1;PEX1
prerank,B cell receptor signaling pathway (GO:0050853),0.2773208357768213,0.7218699285940994,0.8438709677419355,0.9982816647615886,1.0,9/32,26.11%,BCL2;TEC;VAV3;LAT2;MS4A1;CD38;PLEKHA1;NFAM1;SYK
prerank,hepaticobiliary system development (GO:0061008),0.2994100977238377,0.7216304244249134,0.8128491620111732,0.9981695383441717,1.0,5/20,15.00%,PRKCSH;NF1;COBL;CITED2;MET
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.2498819249616671,-0.7214924628412198,0.8384879725085911,0.9561308696875495,1.0,4/18,20.30%,ROCK1;SLC39A8;VCAM1;ADD2
prerank,cellular response to topologically incorrect protein (GO:0035967),0.27367024726943845,0.7213814416922981,0.8236057068741893,0.9980595753731887,1.0,5/31,13.48%,PRKN;PACRG;PTPN1;HDAC6;TM7SF3
prerank,positive regulation of protein binding (GO:0032092),0.2526287170279326,0.7213375292560442,0.8682352941176471,0.9976992339943643,1.0,10/56,15.54%,PRKN;LRP1;PSEN1;RALB;MEN1;USP33;AKTIP;PKD1;DACT1;ABL1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.31272937024505587,0.7210969845548603,0.8131241084165478,0.9975974158596014,1.0,4/17,21.05%,PCSK6;LMF1;LIPC;FURIN
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.24678006240117945,0.7207992097615131,0.8831018518518519,0.9975506094460601,1.0,14/70,20.76%,CBFB;KMT2A;METTL3;PSMB7;GATA3;PUS7;PSMD2;PSMC1;RUNX1;ABL1;PSMB2;PSMD9;PSME4;PSMA8
prerank,determination of bilateral symmetry (GO:0009855),-0.2272677707189973,-0.7206378381086389,0.9128787878787878,0.9561113080789182,1.0,11/24,34.69%,KIF3B;TBX1;ZIC3;DNAH11;DNAH5;STIL;NPHP3;CFAP53;DLL1;ODAD2;ODAD3
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.29854980522858415,0.7204821065689703,0.8335664335664336,0.997522005835534,1.0,7/20,23.71%,EGFR;TTBK1;PKD1;CCND2;MAPRE3;PKD2;CCNY
prerank,phospholipid biosynthetic process (GO:0008654),0.2704119636272778,0.7203930187131875,0.8524804177545692,0.9972099601565866,1.0,12/36,21.55%,IDI1;FAR1;AGPAT5;SGMS2;PIP5K1A;CPNE7;AGK;DPAGT1;CPNE1;DHDDS;CPNE3;FDPS
prerank,phosphatidylcholine catabolic process (GO:0034638),0.3441143275549461,0.7202776123838908,0.7881219903691814,0.996939424729869,1.0,3/10,15.20%,PLA2G7;PNPLA8;LIPC
prerank,RNA modification (GO:0009451),0.256187488962485,0.7201205669509957,0.8684516880093132,0.9967383803068239,1.0,15/54,23.39%,DTWD1;NOP2;METTL3;NSUN5;DTWD2;ADARB1;PUS7;ELP5;MEPCE;SSB;TRIT1;NSUN2;LCMT2;ALKBH1;TRMT1
prerank,nucleus organization (GO:0006997),0.2592759070611199,0.719714385310357,0.8748538011695907,0.9968288529440062,1.0,8/47,15.22%,SPAG4;PITPNB;NUP155;BIN1;NUP205;NDC1;PDCD6IP;CHMP4C
prerank,cardiocyte differentiation (GO:0035051),0.3446114485676436,0.7193907928936882,0.8036529680365296,0.9968261564608955,1.0,2/10,7.41%,AKAP13;GATA6
prerank,positive regulation of DNA metabolic process (GO:0051054),0.25110129612244503,0.7192544751271478,0.8610792192881745,0.9965887727788729,1.0,9/61,14.21%,FGF2;MYC;FGF10;EGFR;ATRX;BRCA1;SIRT6;SMOC2;RTEL1
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.3393149392616813,0.7190434716527334,0.8042488619119879,0.9964417230696884,1.0,3/11,16.10%,KCND3;KCNJ3;KCNH2
prerank,cellular response to hydrogen peroxide (GO:0070301),0.27332137320634503,0.7189866473827876,0.8440721649484536,0.9960936311036263,1.0,10/33,20.82%,MAPK7;CYP1B1;NFE2L2;HDAC6;ABL1;PAX2;RIPK1;PARK7;OSER1;SIRPA
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.26116878665183113,0.7186626608670618,0.8609431680773881,0.996084672705211,1.0,10/45,17.21%,ATXN2;TSC1;GRM5;DDX25;PER1;SPOUT1;RBM4B;YTHDC1;CYFIP1;RC3H1
prerank,sensory perception of taste (GO:0050909),-0.2934985752738352,-0.7185624815989154,0.8174157303370787,0.9574501169943936,1.0,8/10,50.76%,PKD2L1;PKD1L3;ASIC1;CD36;ASIC3;TAS1R1;TAS1R2;GNAT3
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.26407358103932077,-0.7184480160407907,0.8456375838926175,0.9565111071211536,1.0,7/15,25.53%,IGF1;GPX1;FXN;HGF;CLU;AKT1;PPIF
prerank,response to exogenous dsRNA (GO:0043330),0.3084109349683101,0.7179808306251361,0.8208333333333333,0.9965056649876051,1.0,4/18,15.22%,IRAK3;RALB;TICAM1;CGAS
prerank,peptidyl-methionine modification (GO:0018206),-0.2825943333374203,-0.7165262134382201,0.8277945619335347,0.957599202364808,1.0,2/12,5.31%,NAA25;NAA30
prerank,C4-dicarboxylate transport (GO:0015740),0.3201340716353924,0.7161926202869269,0.8002936857562408,0.9982985739216224,1.0,6/14,28.86%,LRRC8D;SLC25A10;SLC25A11;SLC1A6;SLC1A2;SLC25A13
prerank,positive regulation of histone acetylation (GO:0035066),0.28451589005481737,0.7159592594015205,0.8393574297188755,0.998160555817289,1.0,3/23,9.88%,RPS6KA4;BRCA1;PIH1D1
prerank,negative regulation of GTPase activity (GO:0034260),0.2921471816567658,0.7156851488189592,0.8363636363636363,0.9980735584134368,1.0,5/22,19.14%,ARL2;TMED2;ARFGEF1;FICD;RDX
prerank,amide biosynthetic process (GO:0043604),0.25613260864453363,0.7156420819204825,0.8544378698224852,0.9977047331808562,1.0,9/47,21.05%,SLC25A2;CERS3;CERS6;SPTSSA;SLC25A15;SGMS2;AGK;CERS2;FURIN
prerank,cellular defense response (GO:0006968),-0.20039654632155107,-0.7148536367167578,0.936046511627907,0.9583180041888181,1.0,7/40,15.38%,CCR9;DCDC2;LSP1;BECN1;ADORA2A;LGALS3BP;PTK2B
prerank,nucleoside salvage (GO:0043174),-0.283548549618442,-0.7148239686730375,0.8351648351648352,0.9572895215818379,1.0,4/10,31.99%,TK2;DCK;CDA;TK1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.3317925780893076,0.7145959158519026,0.8176382660687593,0.9985884490291959,1.0,3/11,21.49%,AKAP6;NOS1AP;LRRC55
prerank,multivesicular body organization (GO:0036257),-0.20571911983044844,-0.7135047453812934,0.9174757281553398,0.9576605223309242,1.0,5/31,9.91%,CHMP3;TSG101;VPS37C;VPS4A;CHMP1A
prerank,regulation of cellular amide metabolic process (GO:0034248),0.27422185930228415,0.7133843922665697,0.8514724711907811,0.999667389799839,1.0,7/32,14.94%,ATXN2;TSC1;TMED10;GRM5;DDX25;RBM4B;CYFIP1
prerank,positive regulation of myelination (GO:0031643),-0.2777617632648368,-0.7132019015953219,0.8567335243553008,0.9569300082493106,1.0,5/11,31.41%,PARD3;MYRF;TPPP;DICER1;TNFRSF1B
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.2927843685301975,0.7131014657417843,0.8317373461012312,0.9995770322371913,1.0,6/20,21.95%,RPS6KA4;BRCA1;DIP2A;DIP2B;RUVBL2;PRKAA1
prerank,maturation of 5.8S rRNA (GO:0000460),-0.25259117102543416,-0.7126430889487401,0.8666666666666667,0.956461665189891,1.0,5/17,15.66%,NSA2;URB1;MAK16;LAS1L;EXOSC10
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.27936582204678534,-0.7122440256687432,0.8226744186046512,0.9558301553298668,1.0,2/11,9.46%,ATL2;VAPB
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.2249492672271079,-0.7120536155124877,0.91796875,0.9549752691214859,1.0,6/25,19.84%,EPHA4;RPL5;RPL11;PML;HSP90AB1;HFE
prerank,chromatin assembly or disassembly (GO:0006333),0.3299725955616198,0.7114682659824856,0.7915407854984894,1.0,1.0,3/11,15.90%,MTA2;RBBP4;TP53
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3048319543699952,0.7111663924557674,0.8427128427128427,1.0,1.0,6/17,23.71%,EGFR;PKD1;CCND2;MAPRE3;PKD2;CCNY
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.25932867238626056,-0.7108041665428678,0.8535031847133758,0.9553127922235427,1.0,2/15,7.87%,PRKCH;AGTR1
prerank,calcium ion transport (GO:0006816),0.2336796295073843,0.710579176592433,0.927427961579509,1.0,1.0,11/113,9.39%,CACNA1E;CACNA2D1;ANK2;CACNG7;ANO6;CACNA1A;CHRNA4;PSEN1;SLC8A2;FYN;SLC24A5
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.2781720618663473,0.7102644525596211,0.8533163265306123,1.0,1.0,7/29,18.16%,FADD;TBK1;TICAM1;UBB;RIPK1;CHUK;IRF3
prerank,stress granule assembly (GO:0034063),0.2985978680359147,0.7102485608677332,0.8375184638109305,1.0,1.0,8/20,25.85%,BICD1;ATXN2;UBAP2L;CSDE1;DDX6;DYNC1H1;CIRBP;YTHDF3
prerank,positive regulation of cytokinesis (GO:0032467),0.27071850271349895,0.7102388468512892,0.8386683738796414,1.0,1.0,8/32,20.28%,KIF20B;CUL3;CDC25B;DRD2;CDC14A;CENPV;PKN2;SVIL
prerank,cellular response to interleukin-6 (GO:0071354),0.2821150784457317,0.7100955175457021,0.8450520833333334,1.0,1.0,8/26,21.18%,PTPRT;CBL;PTPN11;IL6ST;PID1;SELPLG;STAT3;NFKB1
prerank,regulation of cell division (GO:0051302),0.24559732081843702,0.7099280114632041,0.8819599109131403,1.0,1.0,11/72,17.41%,EFHC1;MYC;INSC;KLHL13;SETD2;MYO19;RAB11FIP3;CALM1;CALM2;BLM;NCOA3
prerank,mitochondrion morphogenesis (GO:0070584),0.33041875199440307,0.7097050371454966,0.8290076335877863,0.9999736492286195,1.0,5/11,24.44%,PID1;WASF1;PNPT1;MTM1;SUPV3L1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.2665359264896237,0.7095875976547742,0.8493670886075949,0.9996941926637666,1.0,2/31,3.65%,EPHB2;DNAJB9
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.2602871483905234,-0.7089288100296989,0.8524590163934426,0.9562799556718727,1.0,7/15,29.86%,TSEN15;ERN1;ZBTB8OS;CPSF4;CLP1;TRPT1;TSEN54
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.2694345872426987,-0.7089108171938493,0.84472049689441,0.955256637926726,1.0,3/13,12.50%,PRKCD;SOD1;MAPT
prerank,"transcription, DNA-templated (GO:0006351)",0.22413339126179338,0.7082588620198047,0.9432624113475178,1.0,1.0,62/207,24.88%,CBFB;NFX1;GTF2H2;SNAPC2;MBD1;RNGTT;TAF1A;HOXD3;POLR2B;TAF5L;DRAP1;IVNS1ABP;GTF2B;TFAM;TRIP11;SOX5;POLR2K;NCBP1;TAF9;TAF11;TAF2;EPC1;KLF13;POLRMT;POLR2G;TAF7;RNMT;ELL;GTF3C1;GTF2E2;GTF2E1;TAF4;TP53;TAF4B;CDC73;NFIX;RNPS1;POLR1C;TCEA2;MLF1;ELOC;TAF1;POLR2A;MLLT1;UBTF;POLR3G;FUBP3;SSRP1;NFKB1;THRA;ARRB2;BCL3;ELOB;CDK9;SNAPC3;PKNOX1;POLR3K;MEF2A;POLR2F;CCNT2;CCNH;TBP
prerank,positive regulation of ruffle assembly (GO:1900029),0.31946474052424345,0.7078039243559783,0.8153153153153153,1.0,1.0,3/13,13.84%,NLGN1;EPS8L1;P2RY12
prerank,positive regulation of neuron death (GO:1901216),0.2567254335848728,0.7077985586721784,0.8863636363636364,1.0,1.0,8/46,13.88%,PRNP;GRIN2B;NF1;WNT5A;FYN;CDK5R1;GRN;SNCA
prerank,mitotic sister chromatid segregation (GO:0000070),-0.16072356159441759,-0.7072106731224381,1.0,0.9560390983088835,1.0,46/98,34.92%,CHMP3;BECN1;NUDC;VPS4A;CHMP1A;KIF18A;NCAPH2;PINX1;VPS4B;TENT4A;PIBF1;TUBG1;KIF23;CHMP7;CENPK;CSNK2B;BOD1;MCPH1;CHMP2B;NCAPD3;EML4;DCTN2;DSN1;NUSAP1;NIPBL;CENPE;EML3;KMT5A;NCAPD2;ZW10;KNSTRN;NCAPH;SPAG5;KIF18B;TTN;KIFC1;NUP62;NSL1;NDC80;REC8;KIF14;SPDL1;TUBG2;RAD21;CDCA8;CEP55
prerank,nuclear envelope organization (GO:0006998),0.2901326818370014,0.7068625071716065,0.8358413132694938,1.0,1.0,3/20,11.39%,SPAG4;NUP155;EMD
prerank,termination of RNA polymerase I transcription (GO:0006363),0.27363632382146325,0.7067599246937446,0.8663303909205549,1.0,1.0,11/30,26.51%,GTF2H2;TAF1A;POLR2K;POLR1B;POLR1C;POLR1G;UBTF;POLR2F;CCNH;TBP;TTF1
prerank,histone methylation (GO:0016571),0.27936782680478506,0.7054531145303936,0.8610747051114024,1.0,1.0,5/26,12.65%,SUV39H1;CARM1;FBL;PRMT1;TRMT112
prerank,regulation of cellular protein metabolic process (GO:0032268),0.2536458689383478,0.704951725114926,0.8690909090909091,1.0,1.0,9/47,14.94%,TGFB1;ATXN2;TSC1;GRM5;EIF4G1;DDX25;RBM4B;SSH1;CYFIP1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.2897345678721536,0.7047281674133012,0.8431105047748977,1.0,1.0,8/22,23.35%,VEGFA;NCF1;PRMT1;MAP3K4;RELL2;EMC10;PJA2;BMP2
prerank,regulation of T cell cytokine production (GO:0002724),-0.2472603927619919,-0.7038741460094686,0.8980263157894737,0.9585743054022228,1.0,3/15,11.63%,SMAD7;CD55;MAP3K7
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.29225356167637256,0.7035099440923835,0.8305322128851541,1.0,1.0,7/20,24.52%,PRKN;ZMIZ1;HIF1A;WASHC1;EGR1;UBQLN1;HSPA1A
prerank,glycerophospholipid metabolic process (GO:0006650),0.23627925661168395,0.7030598990625434,0.8945578231292517,1.0,1.0,17/75,19.95%,PRDX6;PLCB1;PLA2G7;PIGC;PIGP;FAR1;ENPP6;PIGN;PIGA;GPLD1;ABHD6;PIP5K1A;CPNE7;AGK;CPNE1;GDPD3;PLA2G4E
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.27378689756956276,0.7029749254693854,0.8660714285714286,1.0,1.0,7/30,18.16%,FADD;TBK1;TICAM1;UBB;RIPK1;CHUK;IRF3
prerank,positive regulation of phosphatase activity (GO:0010922),0.28741019133973766,0.7028589634110735,0.8489795918367347,1.0,1.0,5/21,16.11%,PPP1R15A;MAGI2;CALM1;CALM2;GPLD1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.22812776230271134,0.7020254311981567,0.9193205944798302,1.0,1.0,11/116,12.75%,CRH;DPEP1;PTHLH;PRKAR1B;PTH2R;FYN;TSHR;SELENOS;MAPK14;PRKACA;GLP2R
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.26576407345598285,-0.7019818322868411,0.8787878787878788,0.9594624896736953,1.0,5/14,18.97%,TERF2;BRCA2;TERT;PINX1;TINF2
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.29666834237623935,0.7016571799919825,0.8290598290598291,1.0,1.0,4/17,14.56%,NTRK2;PRNP;BIN1;RTN4
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.22726028479140975,-0.7013093364622508,0.926530612244898,0.9590948425915895,1.0,1/22,0.09%,PDGFD
prerank,negative regulation of cellular senescence (GO:2000773),0.3147729257801746,0.7004920635014825,0.826865671641791,1.0,1.0,3/13,9.26%,MAP3K3;CDK6;AKT3
prerank,membrane raft organization (GO:0031579),-0.2538999211027624,-0.7003423705454686,0.8990536277602523,0.9590170413924536,1.0,8/15,31.81%,RFTN1;FLOT1;ABCA7;NAXE;S100A10;YJEFN3;PPT1;MYADM
prerank,regulation of presynapse assembly (GO:1905606),0.2924247602105769,0.7002598831970379,0.8393632416787264,1.0,1.0,6/18,21.80%,IL1RAPL1;EIF4G1;GPC4;SNCA;LRFN5;IL1RAPL2
prerank,regulation of presynapse organization (GO:0099174),0.2924247602105769,0.7002598831970379,0.8393632416787264,1.0,1.0,6/18,21.80%,IL1RAPL1;EIF4G1;GPC4;SNCA;LRFN5;IL1RAPL2
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.2287352048315444,-0.6997834854226008,0.8869257950530035,0.9585303709949752,1.0,3/19,9.91%,CHMP3;DRG1;CHMP1A
prerank,positive regulation of innate immune response (GO:0045089),0.26833696646394395,0.699631718169609,0.8575063613231552,1.0,1.0,3/30,8.78%,FADD;WNT5A;UBE2K
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.2978869043529999,0.6992882104146931,0.8314447592067988,1.0,1.0,5/17,17.35%,NLGN1;RAB3D;RAB3A;DOC2B;UNC13D
prerank,fluid transport (GO:0042044),0.3175711609468271,0.6990312504150797,0.8377976190476191,1.0,1.0,1/12,5.26%,AQP4
prerank,negative regulation of growth (GO:0045926),0.22420246588323933,0.6985689638763104,0.9313621964097148,1.0,1.0,8/121,5.87%,DCBLD2;CRLF3;VGLL4;FRZB;JADE1;TGFB1;MT3;APBB2
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.31918223736626555,0.6983830199161292,0.8290854572713643,1.0,1.0,1/13,2.58%,PTPRT
prerank,positive regulation of organelle organization (GO:0010638),0.26492574708576033,0.6981301705241361,0.8611464968152867,1.0,1.0,13/32,27.59%,C2CD5;ATL3;RAB3GAP2;DOC2B;SURF4;RAB3GAP1;P2RX7;LMAN1;STX18;SORBS3;PFDN2;LIG4;FYCO1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.3301038112729471,0.698129898235472,0.8294930875576036,1.0,1.0,3/11,21.50%,CALM1;CALM2;PKD2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.3301038112729471,0.698129898235472,0.8294930875576036,1.0,1.0,3/11,21.50%,CALM1;CALM2;PKD2
prerank,histone H2B ubiquitination (GO:0033523),0.33972340902568415,0.6979496638549182,0.8179012345679012,1.0,1.0,4/10,25.76%,WAC;CDC73;UBE2E1;RNF20
prerank,establishment of epithelial cell polarity (GO:0090162),0.29165243247080863,0.697614116402411,0.8518518518518519,1.0,1.0,5/19,15.76%,CLASP1;MYO9A;OPHN1;FBF1;CYTH3
prerank,positive regulation of isotype switching (GO:0045830),-0.2513139418624924,-0.6974574179549805,0.8735294117647059,0.9599170805156861,1.0,7/15,26.83%,RIF1;TFRC;PAXIP1;CD40;MAD2L2;CLCF1;TNFSF13
prerank,male meiosis I (GO:0007141),-0.2478436436545706,-0.6972049047870919,0.8600682593856656,0.9591231752200051,1.0,5/16,26.85%,ING2;MYBL1;FOXJ2;BRDT;HSF2BP
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.2952114211817426,0.6968098900795177,0.8424753867791842,1.0,1.0,8/17,23.30%,EMC10;EMC1;SGTA;EMC8;EMC3;CAMLG;EMC6;EMC2
prerank,mitochondrion localization (GO:0051646),-0.24109241817227006,-0.6964694766608974,0.8610169491525423,0.9587986558037772,1.0,6/19,23.11%,MARK1;TRAK1;MARK2;ATCAY;MSTO1;MUL1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.29124192392087506,0.6959481016659725,0.832258064516129,1.0,1.0,2/20,8.85%,ST3GAL4;ST6GALNAC6
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.305498623717503,0.6958276694838943,0.8430232558139535,1.0,1.0,2/15,10.03%,SMOX;PAOX
prerank,negative regulation of establishment of protein localization (GO:1904950),0.3327352528248123,0.6955160943320898,0.8417721518987342,1.0,1.0,3/10,18.00%,NDFIP1;SNX12;DNAJA1
prerank,mitochondrial membrane organization (GO:0007006),0.26655337534748047,0.6948809450208128,0.8713375796178344,1.0,1.0,6/32,18.01%,BCL2;APOOL;BNIP3;RCC1L;OPA1;HSPA9
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3289786224978553,0.6947527947428287,0.8320126782884311,1.0,1.0,4/11,17.24%,NCBP1;AHCYL1;PAPOLA;CDC73
prerank,carbohydrate biosynthetic process (GO:0016051),0.2880083082431769,0.6943773152244541,0.8303108808290155,1.0,1.0,2/21,8.85%,ST3GAL4;ST6GALNAC6
prerank,positive regulation of lamellipodium organization (GO:1902745),0.2615150344618342,0.69394318123366,0.8772845953002611,1.0,1.0,7/32,19.03%,AUTS2;BRK1;PIK3R1;CORO1B;CYFIP1;FSCN1;NCKAP1
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.2259225558930355,-0.6935771111118867,0.889763779527559,0.9604500943216903,1.0,7/23,25.63%,TLR4;INHBA;RARA;HAVCR2;LAPTM5;NR1H4;INHA
prerank,heme biosynthetic process (GO:0006783),0.2805444940018924,0.6932740407621811,0.8321775312066574,1.0,1.0,10/22,26.80%,SLC25A38;UROS;COX10;FECH;PGRMC1;TSPO;CPOX;ALAD;UROD;ABCB10
prerank,oxoacid metabolic process (GO:0043436),0.26836291055423195,0.6926869811787886,0.8409669211195929,1.0,1.0,3/27,9.11%,DAO;BPNT1;BPNT2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.2886050418930297,0.6923557016905363,0.8417462482946794,1.0,1.0,5/20,17.46%,ANK2;PRKACA;CALM1;CALM2;SLC9A1
prerank,positive regulation of protein import (GO:1904591),0.26601820289119754,0.6922860553094041,0.8656527249683144,1.0,1.0,4/30,10.37%,TGFB1;PSEN1;FLNA;PIK3R1
prerank,sensory perception of sound (GO:0007605),0.23064314268627095,0.6914700820817882,0.9168514412416852,1.0,1.0,12/88,16.13%,ROR1;LHFPL5;PCDH15;LHFPL3;LHFPL4;HOMER2;LRTOMT;PAX3;COL1A1;CCDC50;CDC14A;LRP2
prerank,protein localization to nucleus (GO:0034504),0.22631340204385827,0.691292130765108,0.924892703862661,1.0,1.0,28/102,22.59%,NUP155;NOL8;FAM53B;XPA;ARL2;IPO9;BMP7;PRICKLE1;DVL1;KPNB1;IPO13;NXT1;COL1A1;LMNA;EIF4ENIF1;POM121;HNRNPU;WRN;MDM2;TNPO3;IPO5;CSE1L;TAF8;STAT3;PHB2;HEATR3;GBP2;BCL3
prerank,regulation of complement activation (GO:0030449),0.25399200350116125,0.6911561522865919,0.8742368742368742,1.0,1.0,1/40,0.78%,C7
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.2753438827930905,0.6908128095429581,0.8430079155672823,1.0,1.0,2/25,5.90%,PSEN1;ATXN2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.22077815347373395,0.6907541790108107,0.9472595656670114,1.0,1.0,27/145,21.18%,DYNLL1;HAUS3;CNTRL;PCM1;NDE1;SDCCAG8;CEP57;PSMB7;CLASP1;CDC25B;PRKACA;CKAP5;CEP76;DYNC1I2;PSMD2;PSMC1;CSNK1E;PSMB2;CEP63;FBXO5;TUBA1A;PSMD9;PSME4;CEP78;SSNA1;PSMA8;PCNT
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.2769341479729567,0.6906073792598957,0.863013698630137,1.0,1.0,6/22,17.76%,TAFA1;SHCBP1;PTPRZ1;NES;FZD9;MDK
prerank,protein lipidation (GO:0006497),0.24061522479146566,0.6903828807656823,0.8890160183066361,1.0,1.0,23/59,28.08%,WIPI1;ATG5;ZDHHC8;PIGC;PIGP;HHAT;PIGN;PIGA;PIGU;GPLD1;DPM1;PIGO;ZDHHC21;PORCN;ZDHHC13;WDR45B;ATG12;ZDHHC15;ZDHHC17;ATG10;PIK3C3;ZDHHC5;PIGM
prerank,zinc ion homeostasis (GO:0055069),0.268794756454541,0.6897108948790901,0.8798397863818425,1.0,1.0,2/28,4.84%,PRKN;MT3
prerank,lipid biosynthetic process (GO:0008610),0.23476979234087483,0.689506250664198,0.9205448354143019,1.0,1.0,11/77,17.75%,ACSS2;ACACA;OXSM;SCD5;ACLY;PRLR;AGPAT5;LIPC;ACSL6;GPAT4;PIP5K1A
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.2691146997777662,-0.6891807363035245,0.8492753623188406,0.9635996455637419,1.0,5/12,24.31%,INSIG2;RER1;GPAA1;KDELR1;OS9
prerank,protein neddylation (GO:0045116),0.3040736088866157,0.6890931164809887,0.8348765432098766,1.0,1.0,3/13,13.91%,NAE1;UBA3;NEDD8
prerank,chromatin disassembly (GO:0031498),0.301924423299968,0.6888390852091224,0.8239644970414202,1.0,1.0,4/14,20.24%,SMARCC2;SMARCC1;SMARCE1;SMARCA4
prerank,nucleosome disassembly (GO:0006337),0.301924423299968,0.6888390852091224,0.8239644970414202,1.0,1.0,4/14,20.24%,SMARCC2;SMARCC1;SMARCE1;SMARCA4
prerank,regulation of establishment of protein localization (GO:0070201),-0.26068943848635967,-0.6886649730199221,0.8575498575498576,0.9630227319283402,1.0,7/13,36.00%,SCFD1;GAPVD1;CEP295;CORO2B;CTSD;TREM2;PTP4A3
prerank,determination of heart left/right asymmetry (GO:0061371),0.2527754654278408,0.6885359066060044,0.8784933171324423,1.0,1.0,5/42,11.00%,CCDC39;TGFBR2;BBS5;SMO;DAND5
prerank,defense response to symbiont (GO:0140546),0.23101223814428448,0.6884270095368082,0.9226579520697168,1.0,1.0,9/92,10.48%,PYCARD;BCL2;FADD;NDUFAF4;RNASE6;BNIP3;FLNA;SETD2;AGBL4
prerank,regulation of immune effector process (GO:0002697),0.25257304737678266,0.6880047999267379,0.8748466257668711,1.0,1.0,1/41,0.78%,C7
prerank,mitochondrial transport (GO:0006839),0.23909585786712137,0.6878573509619245,0.9043062200956937,1.0,1.0,10/53,16.71%,BCL2;FBXO7;BNIP3;TOMM22;AIP;TOMM20;COX18;GDAP1;SLC25A24;DNAJC19
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.29608873247683254,0.6872951967455135,0.8517964071856288,1.0,1.0,2/15,7.29%,CCT7;SHQ1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.2507436364601575,-0.686969833639063,0.8628048780487805,0.9636099968168288,1.0,4/14,24.28%,RIF1;TFRC;PAXIP1;MAD2L2
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.2626872757409567,-0.6868386411062717,0.8333333333333334,0.9627110941404362,1.0,5/11,30.00%,CAMK4;TYROBP;ITGB2;SPI1;ITGAM
prerank,aerobic electron transport chain (GO:0019646),0.23554277059228157,0.6866142686277568,0.917420814479638,1.0,1.0,16/68,18.27%,UQCRQ;SDHC;NDUFS5;AFG1L;NDUFA4;NDUFB2;NDUFA8;NDUFS8;COX10;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1
prerank,negative regulation of neuron differentiation (GO:0045665),0.2828869662031832,0.686454625690439,0.8654891304347826,1.0,1.0,2/22,11.42%,SOX9;BMP7
prerank,protein targeting to peroxisome (GO:0006625),0.26814188371865744,0.6861917801489653,0.876,1.0,1.0,7/29,18.30%,ACBD5;PEX3;PXMP2;ZFAND6;GDAP1;ABCD2;PEX1
prerank,eye photoreceptor cell differentiation (GO:0001754),0.3183451980074191,0.6860128486032103,0.8462732919254659,1.0,1.0,2/12,9.78%,VEGFA;DSCAM
prerank,regulation of translational initiation (GO:0006446),0.23863110163359003,0.6854552243057473,0.9149659863945578,1.0,1.0,23/63,27.38%,EIF2AK3;EIF1B;EIF2B5;NCBP1;EIF4G1;POLR2G;NCK1;EIF1;EIF4A2;EIF2B2;CSDE1;EIF4G3;GLE1;PAIP2B;ALKBH1;CEBPB;NCK2;FMR1;RBM4;YTHDF3;KLHL25;DDX1;PAIP2
prerank,RNA methylation (GO:0001510),0.23748147240712691,0.6852921415114228,0.9036697247706422,1.0,1.0,11/60,15.74%,THUMPD3;NOP2;METTL3;TRMT12;NSUN5;THADA;TGS1;FBL;TRMT112;THUMPD2;MEPCE
prerank,negative regulation of cellular catabolic process (GO:0031330),0.23833673839633066,0.6844793427837941,0.9049826187717266,1.0,1.0,14/63,19.80%,PTPN22;BCL2;MT3;BMF;TLK2;EIF4G1;ATRAID;WASHC1;MET;KLHL22;GPLD1;TAB3;STAT3;RRAGA
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2379814566439292,0.6841779410092725,0.9149700598802395,1.0,1.0,12/58,19.27%,ERCC4;SETMAR;ATP23;BRCA1;NHEJ1;NSD2;XRCC6;MDC1;SUMO1;ATM;CYREN;LIG3
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.23137971905163315,0.6836519442635117,0.9019165727170236,1.0,1.0,15/76,16.41%,FBXW7;NSMCE3;UBA2;BRCA1;CUL3;HUWE1;PRICKLE1;MALT1;NDFIP1;SENP2;CRY1;UBB;RCHY1;XIAP;FANCI
prerank,aminoglycan metabolic process (GO:0006022),-0.27775507726750137,-0.6831663076483209,0.8522727272727273,0.9652191770079931,1.0,4/10,29.55%,B4GALT7;B3GAT1;B3GALT6;CHST9
prerank,mitotic chromosome condensation (GO:0007076),-0.21264015614579218,-0.6831305833443568,0.9382716049382716,0.9642145552585689,1.0,11/26,31.75%,CHMP1A;NCAPH2;TENT4A;CSNK2B;MCPH1;NCAPD3;NUSAP1;KMT5A;NCAPD2;NCAPH;TTN
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.27138775670535265,-0.6830977395987896,0.8649425287356322,0.9632144670583043,1.0,1/10,2.50%,SMAD7
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.30165373216696045,0.6829836358143055,0.8644578313253012,1.0,1.0,7/14,27.89%,UMPS;NT5C;DHODH;DPYD;NT5C3A;NT5E;CAD
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.24053643864319324,-0.6828397224810393,0.89419795221843,0.9624409752936861,1.0,3/17,11.53%,ADCY9;ADRA1B;ADRA2A
prerank,alanine transport (GO:0032328),0.3283688907634901,0.6828184372304813,0.8438948995363215,1.0,1.0,1/10,5.20%,SLC36A2
prerank,negative regulation of catalytic activity (GO:0043086),0.2705723461178935,0.6824813255018005,0.8709256844850065,1.0,1.0,4/24,15.90%,MT3;HDAC6;NES;TP53
prerank,ribosome biogenesis (GO:0042254),0.21675336492885452,0.682382598394389,0.9784394250513347,1.0,1.0,31/187,16.33%,WDR55;XPO1;C1D;WDR36;SENP3;RPL23A;NOB1;TSC1;XRN2;NOL8;BMS1;EXOSC8;MRTO4;DDX54;UTP6;EIF6;HEATR1;PIH1D1;EXOSC2;RCL1;FBL;EBNA1BP2;SDAD1;HELQ;WDR46;TEX10;DDX10;DDX27;NIP7;NOP56;NOC4L
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.2423299539109846,-0.6822046850252634,0.9292307692307692,0.9619953746717484,1.0,3/15,18.75%,PLTP;ABCG1;APOE
prerank,mesenchyme development (GO:0060485),0.30391497251027333,0.6821877063883165,0.8636363636363636,1.0,1.0,1/15,0.85%,MEOX1
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.2302235571487574,-0.6809849238905806,0.9158249158249159,0.9620733297325682,1.0,6/18,24.54%,VTI1B;ZDHHC7;VPS4A;APPL1;VAMP8;ZDHHC2
prerank,maintenance of protein location in nucleus (GO:0051457),-0.22718569056436766,-0.68074245883396,0.9233449477351916,0.9612644717407828,1.0,4/20,17.78%,SP100;SUPT7L;PML;TAF3
prerank,regulation of humoral immune response (GO:0002920),0.2463551084001191,0.6805057310219349,0.8879518072289156,1.0,1.0,3/44,12.85%,C7;GATA6;PROS1
prerank,negative regulation by host of viral transcription (GO:0043922),0.32056627914100105,0.6804486572533398,0.8374613003095975,1.0,1.0,1/12,4.10%,CCL4
prerank,glutathione biosynthetic process (GO:0006750),0.31904954123072304,0.6803749255032753,0.8614457831325302,1.0,1.0,2/11,12.99%,GSS;GGCT
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.23835619164724883,0.6802780101961146,0.9191343963553531,1.0,1.0,22/64,24.78%,GTF2H2;POLR2B;CDK13;POLR2K;NCBP1;SETD2;ELP2;ELP4;POLR2G;ELL;CDC73;PCID2;TCEA2;ELOC;POLR2A;MLLT1;SSRP1;ELOB;CDK9;POLR2F;CCNT2;CCNH
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.26723864389111274,0.6799690082314103,0.8819628647214854,1.0,1.0,2/29,2.66%,PYCARD;FADD
prerank,pre-replicative complex assembly (GO:0036388),-0.1684726108908529,-0.6791110335081576,0.990909090909091,0.9617285388151078,1.0,26/64,34.31%,PSMD14;PSMB3;PSMD12;MCM6;PSMD6;PSMA1;ORC6;PSMD7;PSMA5;PSMC5;PSMC4;PSMB6;PSMA4;PSMB1;PSMB9;UBA52;PSMC6;MCM8;PSMD3;PSMD10;PSME3;MCM3;PSMA6;PSME2;MCM2;MCM5
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.22983122205112344,0.6789848401034354,0.9285714285714286,1.0,1.0,16/72,19.39%,FGF13;KANK4;PRKN;SSH3;CRYAB;CLASP1;APC2;PLEKHH2;KATNB1;SNCA;SSH1;NAV3;ARFGEF1;ATXN7;CAMSAP1;KANK1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.2655336981803486,-0.6786475137826122,0.865546218487395,0.9611355792323695,1.0,3/11,17.46%,PDPN;ARPIN;RREB1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.28735122918247447,0.6785226994195224,0.8655692729766804,1.0,1.0,3/18,11.10%,CBL;PTPN11;IL6ST
prerank,carbohydrate homeostasis (GO:0033500),0.23272431335959073,0.6783436098765053,0.9159192825112108,1.0,1.0,4/67,6.40%,PYGL;BACE2;PTPN2;MLXIPL
prerank,cellular response to leucine starvation (GO:1990253),-0.28387726984986755,-0.6780954690623134,0.8854748603351955,0.9605840023254274,1.0,5/10,31.37%,SESN2;LARS1;RRAGB;EIF2AK4;IMPACT
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.2314185174124554,0.6773601084893307,0.9268018018018018,1.0,1.0,16/69,18.27%,UQCRQ;SDHC;NDUFS5;AFG1L;NDUFA4;NDUFB2;NDUFA8;NDUFS8;COX10;NDUFV3;NDUFS6;NDUFV2;NDUFA13;NDUFA6;NDUFA12;NDUFC1
prerank,receptor signaling pathway via STAT (GO:0097696),-0.20865739471584302,-0.6773391971374934,0.9441860465116279,0.9602375203730884,1.0,7/25,21.10%,IL31RA;CTR9;STAT5B;NMI;STAT2;IFNAR1;IFNAR2
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.22002536289568014,-0.6771563157231202,0.9077490774907749,0.9593901667779821,1.0,5/21,20.04%,CTNNB1;GSK3B;FZD1;CAV1;DVL2
prerank,pseudouridine synthesis (GO:0001522),0.3044082097375579,0.6770932617136476,0.8564814814814815,1.0,1.0,3/13,15.72%,PUSL1;PUS7;PUS1
prerank,DNA-dependent DNA replication (GO:0006261),0.21798038463986247,0.6768744539104767,0.9505263157894737,1.0,1.0,29/128,20.99%,LRWD1;POLE2;BAZ1A;REV3L;RPA3;PSMB7;GINS2;POLE3;MCM4;RPA2;ORC1;TOPBP1;POLG2;PSMD2;UBB;PSMC1;BLM;POLG;PSMB2;WRN;ORC4;DDX23;PSMD9;DBF4;PSME4;WRNIP1;ORC2;PSMA8;SSBP1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.2545389764313572,0.6768112840520658,0.9001280409731114,1.0,1.0,3/33,10.21%,CSTF3;NCBP1;FIP1L1
prerank,regulation of lysosomal lumen pH (GO:0035751),0.3098578741379193,0.6767748052043424,0.8418674698795181,1.0,1.0,2/12,12.11%,VPS33A;GRN
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.28325616408162246,0.6767666907160808,0.8652291105121294,1.0,1.0,2/20,7.62%,PTEN;MEN1
prerank,tyrosine metabolic process (GO:0006570),0.30902776062951776,0.6765402755332012,0.8623853211009175,1.0,1.0,2/11,17.26%,IL4I1;GSTZ1
prerank,response to molecule of bacterial origin (GO:0002237),0.23278884064665353,0.6763285329478282,0.911036036036036,1.0,1.0,9/69,13.88%,PTPN22;IRAK3;MAPKAPK3;MAPKAPK2;PELI1;ERBIN;PRDX3;SRR;SNCA
prerank,rRNA metabolic process (GO:0016072),0.2150514259115427,0.676217455269982,0.9710444674250258,1.0,1.0,27/160,16.33%,WDR55;C1D;WDR36;SENP3;RPL23A;NOB1;XRN2;NOL8;BMS1;EXOSC8;MRTO4;DDX54;UTP6;HEATR1;PIH1D1;EXOSC2;RCL1;FBL;EBNA1BP2;HELQ;WDR46;TEX10;DDX10;DDX27;NIFK;NOP56;NOC4L
prerank,axonal transport of mitochondrion (GO:0019896),0.312087405217485,0.6761563133949121,0.8529862174578867,1.0,1.0,6/11,29.62%,HIF1A;OPA1;TRAK2;SYBU;SPAST;ACTR10
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.31933012949696266,0.6761078649588701,0.8480620155038759,1.0,1.0,2/11,15.20%,PLA2G7;LIPC
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.24885945145092672,0.6758505049018099,0.9090909090909091,1.0,1.0,10/42,17.91%,MRNIP;SETD2;FBH1;SIRT6;RPA2;RTEL1;CGAS;SPIDR;TERF2IP;FUS
prerank,membrane lipid metabolic process (GO:0006643),0.2705595555166249,0.6755238128273401,0.8732970027247956,1.0,1.0,3/22,8.13%,AGMO;CYP1B1;TEX2
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.2731830156041809,0.6755053783517694,0.8648275862068966,1.0,1.0,5/22,18.17%,MED13;ESR1;MED12;TP53;MED30
prerank,regulation of phagocytosis (GO:0050764),0.23715817092247254,0.6748151346670295,0.9148191365227538,1.0,1.0,2/53,1.52%,PYCARD;OLFM4
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.2615116781730346,0.6743417857443428,0.8785900783289817,1.0,1.0,8/29,19.66%,FBXW7;LIMK1;BAG5;ABL1;FBXO5;PARK7;MAGEC2;UBE2L3
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.29380913999236313,0.6742702333306781,0.8601398601398601,1.0,1.0,5/15,23.18%,ENTPD2;AK1;AK5;AK8;CMPK1
prerank,nuclear pore complex assembly (GO:0051292),0.3187030891953404,0.6739232230844715,0.8286163522012578,1.0,1.0,4/10,20.92%,NUP205;NDC1;RTN4;AHCTF1
prerank,response to glucagon (GO:0033762),-0.2286706913630581,-0.6734252973499222,0.8913043478260869,0.961598114957869,1.0,7/19,25.13%,ADCY9;PRKAR1A;ADCY4;ADCY3;CYSLTR2;PRKAR2A;PRKACB
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.27534324901031965,0.6733454818050431,0.8821022727272727,1.0,1.0,4/20,18.77%,TGFB1;GTF2B;GATA3;PARK7
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.24488274686759323,0.673219714664071,0.8968446601941747,1.0,1.0,9/41,16.73%,RANBP2;NUP155;EIF6;HIF1A;NUP205;NDC1;NUP160;POM121;AAAS
prerank,regulation of cellular response to stress (GO:0080135),0.22083533051980353,0.6728143768628112,0.9497326203208556,1.0,1.0,21/115,16.73%,HSPH1;PRKN;RANBP2;MAPKAPK2;RPA3;NUP155;BAG5;CRYAB;EIF4G1;NUP205;FKBP4;NDC1;NUP160;MAPK1;DNAJB6;RPA2;ATM;ABL1;POM121;PNPT1;AAAS
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.28982069865180915,0.6724732434357099,0.8624260355029586,1.0,1.0,3/15,16.77%,NAGK;MGAT3;GNPDA1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.2575109681899744,0.6719774288622481,0.9119170984455959,1.0,1.0,10/32,22.03%,ZBTB20;PSEN1;MLXIPL;HIF1A;PID1;PFKFB1;P2RX7;PRKAA1;PRXL2C;SLC4A4
prerank,iron-sulfur cluster assembly (GO:0016226),-0.2097455009355224,-0.6715189442204211,0.934156378600823,0.9622233736086542,1.0,10/24,26.32%,MMS19;ISCA1;LYRM4;FXN;CIAO3;ABCB7;NDOR1;CIAPIN1;GLRX5;NUBP1
prerank,activation of adenylate cyclase activity (GO:0007190),-0.19139569173012394,-0.6713946962083341,0.9577464788732394,0.9613050109731331,1.0,15/35,37.50%,ADCY9;LGR4;ADCY4;CAP1;ADCY3;ADCYAP1;ADRB2;CAP2;ADRB1;LHCGR;ADCY7;ACR;GIPR;CRHR1;GLP1R
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.2961445198607525,0.671383790942124,0.8841010401188707,1.0,1.0,4/14,23.13%,PTPN2;PYDC1;TRAIP;CARD16
prerank,regulation of vacuole organization (GO:0044088),0.27976625695172275,0.6711900605283906,0.8768115942028986,1.0,1.0,2/20,6.23%,NPRL2;LAPTM4B
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.31406543757474875,0.6706337192685712,0.8606431852986217,1.0,1.0,1/11,3.97%,GTF2H2
prerank,response to chemokine (GO:1990868),0.30074432157827263,0.6704063604397081,0.848714069591528,1.0,1.0,2/13,9.19%,SLC12A2;STK39
prerank,protein O-linked mannosylation (GO:0035269),0.28181492532023245,0.6699034546683247,0.8633720930232558,1.0,1.0,7/18,18.62%,TMTC2;POMGNT2;RXYLT1;TMTC3;DPM1;FKTN;FKRP
prerank,cell differentiation in hindbrain (GO:0021533),0.30725467205233803,0.6693888569249637,0.8393393393393394,1.0,1.0,4/11,23.49%,GRID2;OPHN1;FAIM2;KNDC1
prerank,regulation of type I interferon production (GO:0032479),0.2239516590701047,0.6686449985577649,0.9355191256830601,1.0,1.0,28/84,27.87%,PTPN22;DTX4;NLRX1;LRRFIP1;POLR2K;TAX1BP1;TBK1;XRCC6;DHX33;CGAS;POLR1C;IRF3;POLR3G;NFKB1;IRF8;STAT6;CYLD;PCBP2;POLR3K;MAVS;POLR2F;PRKDC;IRF5;POLR3F;IRAK1;PIN1;RELA;ACOD1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.27692910751191047,0.668313000647669,0.8946648426812586,1.0,1.0,5/20,21.54%,ADSS1;NT5C2;AK3;ADSL;PFAS
prerank,response to ionizing radiation (GO:0010212),0.22678381608967965,0.668117711663073,0.9276169265033407,1.0,1.0,13/70,15.98%,MYC;MRNIP;MEN1;BRCA1;NHEJ1;MAPK14;BRAT1;TOPBP1;AEN;ATM;BLM;TP53;SPIDR
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.28403030059186507,0.6675004998897558,0.8702290076335878,1.0,1.0,7/17,23.35%,ACVR1;TGFB1;BMPR1A;HEYL;GALNT11;SNAI1;BMP2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.3203485906259889,0.667478646983982,0.8496,1.0,1.0,4/10,15.90%,FOXM1;ING4;RPS27L;TP53
prerank,AMP metabolic process (GO:0046033),0.30110395370735915,0.667148022576153,0.8691176470588236,1.0,1.0,5/13,26.68%,ADSS1;AK3;ADSL;NUDT2;NT5E
prerank,melanosome organization (GO:0032438),0.264217049359826,0.6668450718871852,0.8925729442970822,1.0,1.0,6/26,23.25%,RAB38;AP1G1;TRAPPC6A;HPS1;KIF13A;BLOC1S6
prerank,establishment of melanosome localization (GO:0032401),0.27419348905787316,0.6657869215676807,0.8802228412256268,1.0,1.0,7/19,25.47%,BBS5;MREG;BBS7;MYO5A;BLOC1S6;BBS4;RAB27B
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.3073024858745355,0.6649735665414215,0.8493975903614458,1.0,1.0,4/12,23.20%,PPP3CB;GPLD1;ADCY8;TRPM4
prerank,rRNA processing (GO:0006364),0.2108850149246549,0.6649593098246425,0.9682702149437052,1.0,1.0,29/172,16.53%,WDR55;C1D;WDR36;SENP3;RPL23A;NOP2;NOB1;XRN2;NOL8;BMS1;EXOSC8;MRTO4;DDX54;UTP6;EIF6;HEATR1;PIH1D1;EXOSC2;RCL1;FBL;EBNA1BP2;HELQ;WDR46;TEX10;DDX10;DDX27;NOP56;NOC4L;RRP15
prerank,double-strand break repair via break-induced replication (GO:0000727),0.30006942045341206,0.6648768234184692,0.8670605612998523,1.0,1.0,2/12,10.84%,GINS2;MCM4
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.27652820815341506,0.6645392065378507,0.8847795163584637,1.0,1.0,3/19,8.10%,NTRK2;PRNP;BIN1
prerank,heart looping (GO:0001947),0.24551409360354626,0.6643547160190519,0.8958333333333334,1.0,1.0,4/39,8.64%,CCDC39;TGFBR2;BBS5;SMO
prerank,autophagosome maturation (GO:0097352),0.25669722847286064,0.6639789306799355,0.9051282051282051,1.0,1.0,11/32,22.81%,VPS33A;LIX1;SNAP29;CALM1;GABARAPL2;STX17;SNX14;LAMP2;VMP1;VPS16;UBQLN1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.23305059992977395,0.663676726290615,0.9348571428571428,1.0,1.0,21/62,24.78%,GTF2H2;POLR2B;CDK13;POLR2K;NCBP1;SETD2;ELP2;ELP4;POLR2G;ELL;CDC73;PCID2;ELOC;POLR2A;MLLT1;SSRP1;ELOB;CDK9;POLR2F;CCNT2;CCNH
prerank,negative regulation of stem cell differentiation (GO:2000737),0.30412692363568866,0.6634305786695257,0.8509984639016898,1.0,1.0,2/12,16.44%,ZFP36L2;HNRNPU
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.26707026024711045,0.6632138049816005,0.8876860622462788,0.9999790494594273,1.0,4/23,15.22%,SETMAR;ZWINT;BUB1B;CHMP4C
prerank,lipoprotein catabolic process (GO:0042159),0.30218117904278985,0.6630937594168431,0.8641975308641975,0.9997108894289918,1.0,3/11,17.89%,LYPLA1;LYPLA2;ABHD10
prerank,positive regulation of protein acetylation (GO:1901985),0.3051096936820855,0.6630110234686621,0.8368580060422961,0.9993914112464597,1.0,5/12,23.28%,DIP2A;TERF2IP;DIP2B;PRKAA1;TAOK1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.1951964668733894,-0.6622770866938191,0.966824644549763,0.9677765121887733,1.0,7/29,21.10%,IL31RA;CTR9;STAT5B;NMI;STAT2;IFNAR1;IFNAR2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.24148548755595334,0.6618097572581071,0.9036585365853659,1.0,1.0,9/41,16.73%,RANBP2;NUP155;EIF6;HIF1A;NUP205;NDC1;NUP160;POM121;AAAS
prerank,negative regulation of viral transcription (GO:0032897),0.30085363208729404,0.6617148552385076,0.8610271903323263,0.9998601052066455,1.0,5/13,24.42%,TRIM11;MID2;ZFP36;TRIM14;UBP1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.271161548904266,0.6614820164459883,0.8865153538050734,0.9996864638980129,1.0,2/23,5.68%,PTPN2;SOCS1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.2375069221412655,0.6610454067202183,0.9241126070991432,0.9997199248636254,1.0,15/44,26.18%,SQLE;PSAT1;CYP39A1;PNPO;CYP7B1;CYP27A1;OSBPL1A;SC5D;PARK7;ACOT8;SCP2;HMGCR;HSD17B4;AMACR;PER2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.20768656494907223,-0.6609034180123977,0.9568627450980393,0.9678661898197394,1.0,8/24,23.41%,ERAP1;TAPBP;ACE;SAR1B;HFE;TAPBPL;FCER1G;CALR
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.2676908731476771,-0.6605548157300342,0.9085714285714286,0.9671015609761996,1.0,5/10,27.97%,LYN;MAP2K1;MAP2K2;FAS;GREM1
prerank,lipid phosphorylation (GO:0046834),0.31851314748697374,0.6604642998598508,0.8706624605678234,0.9998713002303576,1.0,6/10,28.53%,DGKI;DGKA;DGKK;DGKD;DGKZ;DGKQ
prerank,histone H2A monoubiquitination (GO:0035518),-0.2373940092929424,-0.6603594170849788,0.9352750809061489,0.9662251727215425,1.0,6/17,18.35%,PCGF3;PCGF2;PCGF5;BMI1;RING1;PCGF6
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.2444559517805755,-0.6601047533626235,0.92,0.96539383107004,1.0,8/14,29.34%,FASTKD1;SLC25A33;EARS2;MRPL12;TEFM;TFB2M;TWNK;FASTKD5
prerank,peroxisomal membrane transport (GO:0015919),0.2606626711115504,0.659718606191089,0.8862115127175368,1.0,1.0,6/27,18.30%,ACBD5;PEX3;PXMP2;GDAP1;ABCD2;PEX1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.26358498557149307,0.6595738265874602,0.8847184986595175,0.9999383804605981,1.0,3/26,10.50%,POR;HIF1A;GDNF
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.21399453882013877,0.6587226759587868,0.9674027339642481,1.0,1.0,23/136,17.79%,PTCH1;PYCARD;IRAK3;PRNP;UFL1;CYP1B1;OTULIN;MEN1;FLNA;ERBIN;HDAC2;SFRP4;ESR1;MTURN;BMP7;TAX1BP1;SUMO1;PKD1;PYDC1;FOXJ1;CHUK;HEYL;SUFU
prerank,maturation of LSU-rRNA (GO:0000470),-0.2004078947263587,-0.6584872954033503,0.9464285714285714,0.9656127690125109,1.0,12/26,30.82%,NSA2;URB1;MAK16;LAS1L;RPL7A;PES1;SNU13;RPF2;RPF1;NHP2;DDX18;ZNHIT3
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.28932047856638876,0.658483822098144,0.8658008658008658,1.0,1.0,4/15,19.16%,KCND3;KCNJ3;KCNH2;KCNA5
prerank,filopodium assembly (GO:0046847),0.2819586744004938,0.6581404825646474,0.8626292466765141,1.0,1.0,4/16,19.09%,FGD4;SPATA13;ARHGEF4;S1PR2
prerank,mitochondrial fusion (GO:0008053),-0.2238197744569495,-0.6581370239047558,0.93,0.9648397445751467,1.0,3/18,11.42%,SPG7;STOML2;MFF
prerank,mitochondrion organization (GO:0007005),0.20857796107981152,0.6576280235490605,0.9803921568627451,1.0,1.0,42/165,22.68%,DNM1;PRKN;RAB38;FBXO7;ATP23;BNIP3;TFAM;TOMM22;AKT3;AIP;TOMM20;RHOT2;AFG1L;PID1;WASF1;PRDX3;YME1L1;POLRMT;POLG2;OPA1;GDAP1;PNPT1;DNAJC19;GABPB1;TRAK2;ADCK1;AIFM1;RHOT1;CLUH;PARK7;HK2;TSPO;PHB2;HSPD1;SSBP1;WDR81;AIFM2;MTFR1;BNIP3L;MIGA2;MGME1;IMMP2L
prerank,neuromuscular synaptic transmission (GO:0007274),-0.2291614282014563,-0.6569473191375498,0.9322709163346613,0.9646921829173174,1.0,2/18,7.47%,FCHSD2;KIF1B
prerank,ovarian follicle development (GO:0001541),0.30297504720296126,0.6567526309994988,0.8577586206896551,1.0,1.0,5/13,23.27%,VEGFA;EIF2B5;EIF2B2;CEBPB;INHBB
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2686841281806366,0.656342250102961,0.8973684210526316,1.0,1.0,2/22,7.62%,PTEN;MEN1
prerank,secondary palate development (GO:0062009),0.2933357430673849,0.655252546389923,0.8695652173913043,1.0,1.0,2/14,6.38%,WNT5A;TGFBR2
prerank,positive regulation of defense response (GO:0031349),0.21752576129900542,0.6544479209568499,0.9449339207048458,1.0,1.0,15/89,20.10%,IL16;GPRC5B;CCR2;WNT5A;PLA2G7;IL18;GRN;SNCA;IL33;ABCC1;RIPK1;MDK;SETD4;PDCD4;POLR3G
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2094725006618902,0.6543241196759856,0.9760914760914761,1.0,1.0,30/151,21.50%,SLC27A1;SLC25A2;CERS3;ST3GAL4;SLC44A2;CERS6;ELOVL6;ELOVL5;SPTSSA;VAPA;PCYT1B;CHPT1;GPHN;SLC25A15;NFS1;CHAT;CSNK1G2;SGMS2;GSTZ1;GPAT4;SLC44A1;GSTT1;CSNK2A2;LPCAT2;STARD7;HACD2;CERS2;LCMT2;FURIN;PRKD2
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.21587967694461585,0.6542902736850549,0.953862660944206,1.0,1.0,12/107,12.92%,CCL11;ANK2;ATP2B3;MT3;CCR2;SLC8A2;SLC24A5;SLC10A7;HTR2C;EDN3;TPCN2;ATP2B1
prerank,heterotypic cell-cell adhesion (GO:0034113),0.2630170286738158,0.6539529937583805,0.8897849462365591,1.0,1.0,6/25,17.05%,DSG2;CTNNA3;PKP2;ITGB1;JUP;ITGB7
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.2170266352453773,0.653697206427499,0.9479956663055255,1.0,1.0,33/94,29.39%,MAP3K3;IRAK3;RPS6KA4;PLCB1;PELI1;PSMB7;TOLLIP;PSMD2;UBB;PSMC1;IL1RAP;PSMB2;CHUK;PSMD9;TAB3;EGR1;PSME4;PSMA8;NFKB1;TNIP2;TAB2;IRAK2;CUL1;PELI2;PSMD8;PSMD13;IRAK1;RELA;TRAF6;TAB1;PSMD4;PSMD5;IRAK4
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.22042109532100346,0.6522660803991002,0.9511918274687855,1.0,1.0,14/73,20.76%,CBFB;KMT2A;METTL3;PSMB7;GATA3;PUS7;PSMD2;PSMC1;RUNX1;ABL1;PSMB2;PSMD9;PSME4;PSMA8
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.20897806501661073,0.651958569483763,0.9727748691099476,1.0,1.0,53/148,27.01%,NOP2;MAPKAP1;MTA2;RPA3;PRKAB2;CHD3;PPP1R13L;BRCA1;HDAC2;PHF20;MAPK14;TAF9;TAF11;TAF2;CDK5R1;RBBP4;RPA2;TOPBP1;MDM4;TAF7;ATM;TAF4;BLM;TP53;TAF4B;SGK1;USP2;WRN;TP53RK;BOP1;MDM2;TAF1;CSNK2A2;RBBP7;TTC5;SSRP1;TOP3A;PRKAA1;RAD50;BARD1;MTOR;ATR;EHMT2;RHNO1;TBP;BRPF1;RBBP8;RFC2;PPP2R5C;CDK5RAP3;MAP2K6;HDAC1;PIN1
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.24638499772297,-0.6517213590106047,0.9135135135135135,0.9674050672558577,1.0,6/12,30.01%,VBP1;APOE;CLU;PFDN5;PFDN6;LDLR
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.31476125569635627,0.6510636389055066,0.8728682170542635,1.0,1.0,2/10,8.79%,RARG;RARB
prerank,arachidonate transport (GO:1903963),0.3062617699286524,0.6508903098854696,0.8786936236391913,1.0,1.0,2/10,13.50%,DRD2;PNPLA8
prerank,arachidonic acid secretion (GO:0050482),0.3062617699286524,0.6508903098854696,0.8786936236391913,1.0,1.0,2/10,13.50%,DRD2;PNPLA8
prerank,negative regulation of endopeptidase activity (GO:0010951),0.23540058491646604,0.6505538088010862,0.9352941176470588,1.0,1.0,4/47,8.22%,RECK;MT3;BIN1;SERPINE2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.20064241625872412,0.6502975865984639,0.9939819458375125,1.0,1.0,85/341,23.13%,ZFAND2B;RAD23B;PRKN;MVB12B;HACE1;FBXW7;SPSB4;RNF6;SPOP;FBXO7;OTUD7B;TRIM2;HECTD3;PELI1;UBE2K;PSMB7;UCHL1;CUL3;HERPUD1;HUWE1;VPS37B;ANAPC7;FBXO45;CBL;USP33;NFE2L2;TOLLIP;ANAPC2;MYLIP;MVB12A;DDB1;NDFIP1;NEDD8;BUB1B;NEDD4L;PSMD2;KLHL22;PLAA;AREL1;PSMC1;RNF19A;RCHY1;CDC23;RNF111;FBXL4;ZSWIM8;ANAPC16;PSMB2;MIB1;RC3H1;RNF167;UBA1;TRIM9;FBXO22;MDM2;ELOC;OTUD7A;RNF4;PSMD9;TAF1;PCNP;FBXO11;PSME4;UBE2L3;CDC27;UBE2G1;RNF13;UBE2E1;DCAF11;PSMA8;PTTG1;ANAPC4;WDR81;RNF114;UBE2D3;UBQLN4;ARRB2;TTC3;UBR3;ANAPC5;UBQLN1;SIAH1;RNF187;UBQLN2;COP1
prerank,sterol metabolic process (GO:0016125),0.2227108885690068,0.6499266764604285,0.9520958083832335,1.0,1.0,7/60,10.89%,SQLE;GBA2;CYP39A1;OSBPL5;CYP1B1;CYP7B1;ABCA5
prerank,negative regulation of ATP metabolic process (GO:1903579),0.279557398978316,0.6498669031662437,0.8776671408250356,1.0,1.0,3/17,11.37%,MLXIPL;CBFA2T3;PID1
prerank,protein targeting (GO:0006605),0.20991153773789478,0.6496213080612621,0.9741379310344828,1.0,1.0,27/118,20.74%,ZFAND2B;NCF1;FBXO7;NLGN1;GOLGA7B;TOMM22;SPCS3;AIP;TOMM20;VPS37B;NACA;AKAP6;KATNB1;ATG3;ZDHHC24;ZFAND6;SEC61G;GDAP1;SEC63;DNAJC19;AP4M1;TRAK2;PEX1;CHM;TSPO;ZDHHC21;LAMP2
prerank,import into nucleus (GO:0051170),0.21957119149525273,0.6492195200960815,0.9410430839002267,1.0,1.0,17/73,21.12%,NUP155;FAM53B;IPO9;PRICKLE1;KPNB1;IPO13;NXT1;EIF4ENIF1;POM121;HTATIP2;GEMIN7;TNPO3;IPO5;CSE1L;STAT3;PHB2;HEATR3
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.305002207300956,0.648695809108529,0.8657187993680885,1.0,1.0,1/11,3.88%,SOCS5
prerank,positive regulation of type I interferon production (GO:0032481),0.2210213964674888,0.6485892074252914,0.9497206703910615,1.0,1.0,23/73,26.59%,PTPN22;LRRFIP1;POLR2K;SETD2;PTPN11;TBK1;XRCC6;DHX33;CGAS;CHUK;POLR1C;IRF3;POLR3G;HSPD1;NFKB1;STAT6;POLR3K;MAVS;POLR2F;PRKDC;IRF5;POLR3F;IRAK1
prerank,regulation of exosomal secretion (GO:1903541),0.2757879759551035,0.6483365950232998,0.8979020979020979,0.9999827908247976,1.0,4/19,18.13%,PRKN;SDC4;PDCD6IP;RAB7A
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.2972295566251754,0.6480746199985734,0.8761329305135952,0.999823080239318,1.0,1/12,2.71%,ADSS1
prerank,lipoprotein biosynthetic process (GO:0042158),0.2971228361017551,0.6465318821231117,0.8778979907264297,1.0,1.0,5/11,27.79%,WIPI1;PORCN;WDR45B;ATG10;PIK3C3
prerank,telomere capping (GO:0016233),0.27968630618795953,0.6460430132438397,0.8927536231884058,1.0,1.0,7/16,25.23%,STN1;TERF2IP;CTC1;RAD50;ACD;TFIP11;PRKDC
prerank,regulation of viral entry into host cell (GO:0046596),0.2480392274481097,0.6450556240640574,0.9022164276401564,1.0,1.0,4/30,12.74%,GSN;TRIM11;MID2;NECTIN2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2605229810329832,0.6450022171751467,0.9059139784946236,1.0,1.0,7/23,24.20%,PTEN;MTMR12;INPP5J;MTMR7;INPP5B;MTM1;MTMR1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.25381057608474134,0.6446077474045796,0.9236947791164659,1.0,1.0,4/26,19.75%,ST3GAL4;SCCPDH;ALG8;ALG6
prerank,positive regulation of viral life cycle (GO:1903902),0.266204310179676,0.6444653009675172,0.9045643153526971,1.0,1.0,6/22,18.99%,TRIM11;VPS37B;DDB1;KPNA6;CD74;AXL
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.22978079450917044,0.6440863644838766,0.9372037914691943,1.0,1.0,9/48,17.83%,KAT2B;TAF1A;ZMIZ1;POLR2K;ASF1A;POLR1B;BAZ1B;POLR1C;POLR1G
prerank,rRNA 3'-end processing (GO:0031125),0.3094492823261324,0.6439245403627644,0.8842443729903537,1.0,1.0,2/10,10.32%,EXOSC8;EXOSC2
prerank,regulation of mRNA catabolic process (GO:0061013),0.2067900271921519,0.6432433009255791,0.9745762711864406,1.0,1.0,24/121,20.76%,PRKCA;XPO1;PABPC1;MAPKAPK2;YWHAZ;EXOSC8;PSMB7;ZFP36L2;EIF4G1;EXOSC2;PCBP4;UPF1;PSMD2;KHSRP;UBB;PSMC1;PNPT1;PSMB2;RC3H1;PCID2;PSMD9;PSME4;ZFP36;PSMA8
prerank,glycosphingolipid metabolic process (GO:0006687),0.23265253659629737,0.6432000161100366,0.9307411907654921,1.0,1.0,6/42,13.72%,GBA2;GM2A;ST6GALNAC6;GALC;ST8SIA1;SUMF1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.23429949913572773,0.6428442143614211,0.9340659340659341,1.0,1.0,8/43,15.81%,MRNIP;NAE1;BRCA1;TAOK3;ORC1;TOPBP1;ATM;BLM
prerank,regulation of multicellular organismal development (GO:2000026),0.25458145427231776,0.6423109339737316,0.9138817480719794,1.0,1.0,5/25,17.52%,RAB14;DUSP6;MYSM1;GATA3;SPAAR
prerank,cellular response to leucine (GO:0071233),0.31304835058087466,0.6423056386677258,0.8796747967479674,0.999431514299709,1.0,5/10,29.16%,KLHL22;RPTOR;MTOR;SESN1;UBR1
prerank,response to leucine (GO:0043201),0.31304835058087466,0.6423056386677258,0.8796747967479674,0.999431514299709,1.0,5/10,29.16%,KLHL22;RPTOR;MTOR;SESN1;UBR1
prerank,establishment of vesicle localization (GO:0051650),0.2709795885534675,0.6420373747451166,0.8774373259052924,0.9992722025528904,1.0,6/18,22.00%,SPG11;SYT11;KIF5C;CCDC186;TESK1;LIMK2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.2935404980196569,0.6417628294002438,0.8819969742813918,0.9991076981187084,1.0,4/13,18.77%,GPR37;NFE2L2;MET;PARK7
prerank,positive regulation of protein sumoylation (GO:0033235),0.306308610631789,0.6415500049120709,0.8850574712643678,0.9989083902792695,1.0,1/10,5.36%,UBA2
prerank,purine-containing compound salvage (GO:0043101),0.2871726748432364,0.6414624973330658,0.8828696925329429,0.9985881613028325,1.0,2/12,12.60%,ADK;DGUOK
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.22780246697843926,0.6410901505867627,0.9376498800959233,0.9985201086399428,1.0,14/52,23.08%,TUT4;EXOSC8;DCP1B;PNLDC1;EXOSC2;EDC4;LSM3;CNOT3;NT5C3B;RC3H1;ZFP36;CNOT6L;DDX6;EXOSC3
prerank,nucleotide metabolic process (GO:0009117),-0.20286631890605109,-0.6409709525153703,0.9453781512605042,0.9738973916967212,1.0,8/23,22.03%,RNASEH2B;NMNAT2;ME1;NMNAT1;GUK1;DCK;AK4;NME2
prerank,proteasomal protein catabolic process (GO:0010498),0.19942131483869016,0.6401297728942745,0.9826707441386341,0.9989360400536735,1.0,46/201,23.13%,ZFAND2B;RAD23B;PRKN;HACE1;FBXW7;SPSB4;SPOP;TRIM2;HECTD3;PELI1;UBE2K;PSMB7;UCHL1;RCN3;CUL3;HUWE1;FBXO45;NFE2L2;DDB1;CCDC47;NEDD4L;PSMD2;KLHL22;PLAA;AREL1;PSMC1;ZSWIM8;PSMB2;CUL4B;TRIM9;MDM2;RNF4;PSMD9;PCNP;PSME4;UBE2G1;DCAF11;PSMA8;UBXN6;RHBDD1;UBE2D3;ARRB2;FBXO44;SIAH1;RNF187;COP1
prerank,fatty acid catabolic process (GO:0009062),0.2202889660115442,0.6397884461120222,0.9517241379310345,0.9988493280561674,1.0,19/67,24.83%,CEL;SLC27A4;ACBD5;HADHA;AIG1;ACOX1;MTLN;ABCD2;ILVBL;AUH;EHHADH;ACAA2;DECR1;ACOT8;ACADS;SCP2;ABHD3;HSD17B4;NUDT19
prerank,regulation of amyloid-beta clearance (GO:1900221),0.2725477734549726,0.639511044251682,0.8995568685376661,0.9986937136124235,1.0,1/16,2.54%,LRP1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.20816495066236798,0.6392748546747166,0.967948717948718,0.9985090528017971,1.0,10/117,12.75%,CRH;DPEP1;PTHLH;PRKAR1B;PTH2R;FYN;TSHR;MAPK14;PRKACA;GLP2R
prerank,oligosaccharide metabolic process (GO:0009311),0.23577233746840232,0.6389016537901803,0.9370546318289786,0.9984320765921627,1.0,5/46,10.58%,ST3GAL4;NAGA;MAN2C1;ST6GALNAC6;ST8SIA1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.2144185356817115,0.6386553417809068,0.9579180509413068,0.9982378215813568,1.0,23/84,23.63%,PSMB7;CUL3;ANAPC7;ANAPC2;BUB1B;PSMD2;UBB;PSMC1;CDC23;ANAPC16;PSMB2;FBXO5;FBXO31;PSMD9;PSME4;CDC27;UBE2E1;PSMA8;PTTG1;ANAPC4;ANAPC5;RB1;CDC16
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.2574785543311305,-0.6385906392356069,0.9078947368421053,0.9734570632152943,1.0,6/11,30.18%,AGO1;NOTCH4;AGO3;TNRC6C;AGO2;AGO4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.2574785543311305,-0.6385906392356069,0.9078947368421053,0.9734570632152943,1.0,6/11,30.18%,AGO1;NOTCH4;AGO3;TNRC6C;AGO2;AGO4
prerank,negative regulation of type I interferon production (GO:0032480),0.23876705022070557,0.6380393962532218,0.92336217552534,0.9983585183968737,1.0,11/40,24.10%,PYCARD;NLRX1;PPM1B;TAX1BP1;TBK1;IRF3;PTPRS;SIRPA;CYLD;PCBP2;MAVS
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.22111058553270418,-0.6379846354014359,0.9523809523809523,0.9728450958092826,1.0,5/18,19.71%,VPS4B;CDK4;CDC7;RAD51C;MECP2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.2972260777276733,0.6377558566727781,0.8857589984350548,0.9982041570139794,1.0,4/11,15.90%,FOXM1;ING4;RPS27L;TP53
prerank,autophagosome assembly (GO:0000045),0.22648497089024852,0.6377354156450146,0.9318181818181818,0.9978317706169534,1.0,15/52,24.69%,PACS2;WIPI1;ATG5;RAB1A;ATG3;GABARAPL2;RAB7A;STX17;VMP1;TMEM41B;UBQLN1;UBQLN2;EMC6;WDR45B;ATG12
prerank,protein targeting to lysosome (GO:0006622),0.26424186339733835,0.6374432898141179,0.9046242774566474,0.9976826489471585,1.0,5/20,20.74%,GNPTAB;AP4M1;RAB7A;SNX16;LAMP2
prerank,positive regulation of cilium assembly (GO:0045724),-0.22299053635608415,-0.6373395726947257,0.9169435215946844,0.9722448152970532,1.0,4/18,18.16%,ARHGAP35;CCP110;FUZ;CROCC
prerank,regulation of chromosome segregation (GO:0051983),-0.22318017969051107,-0.6371749571933973,0.9221183800623053,0.9713349886849738,1.0,9/16,43.89%,NUMA1;RAD18;RMI2;SMC6;MKI67;CDC6;BUB1;IHO1;KIF2C
prerank,cellular response to ionizing radiation (GO:0071479),0.22911145525448662,0.6368675124645289,0.9345238095238095,0.9977674855895857,1.0,20/47,30.09%,CRYAB;TLK2;MAPK14;XRCC6;ATM;BLM;TP53;SPIDR;WRN;MDM2;GRB2;ATR;RHNO1;TNKS1BP1;LIG4;CDKN1A;SIRT1;INTS7;NUCKS1;RAD1
prerank,icosanoid biosynthetic process (GO:0046456),0.30288073021907375,0.6367613475535508,0.8866459627329193,0.9974648119072191,1.0,2/10,12.51%,LTA4H;ALOX5AP
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.28759532041306335,0.6363609738818149,0.8922852983988355,0.9974224571965014,1.0,5/14,27.55%,NECTIN2;BCL10;PRKD2;CARD11;RELA
prerank,mitochondrion distribution (GO:0048311),-0.24384930943197516,-0.6363019836813838,0.898876404494382,0.9709291255545657,1.0,5/12,20.06%,TRAK1;MAPT;ATCAY;DNM1L;MSTO1
prerank,positive regulation of immune response (GO:0050778),0.21721523686397126,0.636039428317637,0.9615384615384616,0.9972937267987861,1.0,2/64,2.66%,PYCARD;FADD
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.2904370211980334,0.6360262961898793,0.8902255639097745,0.9969154013724747,1.0,6/14,23.18%,AK1;AK5;AK3;NMNAT3;AK8;CMPK1
prerank,positive regulation of wound healing (GO:0090303),0.2378914214956976,0.6356720593280881,0.919454770755886,0.9968084603393716,1.0,10/36,24.02%,ST3GAL4;CLDN1;SMOC2;ITGB1;ARFGEF1;HBEGF;KANK1;INSL3;MTOR;PRKCE
prerank,female gonad development (GO:0008585),0.27316340095779473,0.6353368792230549,0.914364640883978,0.9967019796129624,1.0,7/19,23.55%,VEGFA;EIF2B5;EIF2B2;NR5A1;CEBPB;INHBB;NR2F2
prerank,mucosal immune response (GO:0002385),0.27494184754064793,0.6347655620401497,0.8702865761689291,0.9967801856961327,1.0,1/15,6.17%,OTUD7B
prerank,regulation of superoxide anion generation (GO:0032928),-0.234436791701017,-0.6340607982757328,0.917981072555205,0.9712516364081445,1.0,3/14,12.50%,PRKCD;SOD1;MAPT
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.25349970544793765,0.6338105731933965,0.9153005464480874,0.99679110579593,1.0,4/23,15.90%,BCL2;YWHAZ;PPP3CC;TP53
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.25349970544793765,0.6338105731933965,0.9153005464480874,0.99679110579593,1.0,4/23,15.90%,BCL2;YWHAZ;PPP3CC;TP53
prerank,regulation of centrosome duplication (GO:0010824),-0.1877896876070451,-0.6327317667145425,0.9684684684684685,0.9710378991581285,1.0,13/29,32.45%,CHMP3;NPM1;CHMP1A;CENATAC;VPS4B;SPICE1;CEP295;CHMP2B;STIL;CCNF;GEN1;CEP131;PLK2
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.25578312511804574,0.6325469190684745,0.9040902679830748,0.9974238553947199,1.0,2/23,4.53%,TGFB1;DSG2
prerank,protein homotetramerization (GO:0051289),0.22563016040984543,0.6322752298887281,0.9512195121951219,0.9972552766534057,1.0,10/49,21.50%,CTH;ACACA;AQP4;SOD2;ALDH1A3;GLS;RYR3;HCN1;SSBP1;PKD2
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.29387173615152296,0.6322468804824934,0.8940298507462686,0.996890552166911,1.0,1/12,6.45%,B3GNT9
prerank,adrenergic receptor signaling pathway (GO:0071875),0.2625749288598486,0.6322322484128333,0.9167842031029619,0.996514459642996,1.0,3/20,12.70%,AKAP13;PDE4D;DRD2
prerank,regulation of biosynthetic process (GO:0009889),-0.25145414349513495,-0.6318679573396309,0.9239130434782609,0.9705461645374103,1.0,3/11,24.24%,SLC25A33;MID1IP1;SPHK2
prerank,positive regulation of cell development (GO:0010720),0.24031974745762028,0.6317112517521054,0.9224030037546934,0.9965519483441299,1.0,3/31,6.19%,SOX11;NUMBL;RFX3
prerank,regulation of JUN kinase activity (GO:0043506),0.24229426038280505,0.631691400155785,0.9305912596401028,0.9961792843251661,1.0,10/33,24.04%,PTPN22;PAK1;TAOK3;MAP3K4;DNAJA1;MAP3K11;PDCD4;DVL3;AIDA;PPEF2
prerank,DNA recombination (GO:0006310),0.23493894393883707,0.6313382877699019,0.9360100376411543,0.9960723354365151,1.0,12/37,26.09%,FBH1;XRCC3;RTEL1;RAD52;BLM;WRN;RAD50;SUPV3L1;RECQL;RHNO1;LIG4;TSN
prerank,negative regulation of protein ubiquitination (GO:0031397),0.22826756143511073,0.6311855034607496,0.9454329774614472,0.9958119803655908,1.0,19/50,26.18%,UFL1;LIMK1;IVNS1ABP;BAG5;SENP2;CRY1;ABL1;N4BP1;FBXO5;DNAJA1;PARK7;TAF1;ARRB2;CAMLG;PRKCG;GNL3L;HSPA1A;SOX4;PER2
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.2521657724697451,0.6310787988383969,0.908843537414966,0.9955053108604345,1.0,6/25,24.52%,DNAJB4;GAK;SDF2;HSPA9;ERO1A;HSPA1A
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.2614857096954151,0.6306975604002814,0.9166666666666666,0.9954186223783907,1.0,6/19,26.15%,ZC3H8;ELL;RPTOR;POLR3G;MTOR;POLR3F
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.24014025465064326,-0.629629947307783,0.935064935064935,0.9709289866699157,1.0,2/13,7.09%,MMS19;ISCA1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.21473117236686778,-0.629552786126771,0.9553264604810997,0.9699710670056769,1.0,2/18,6.75%,LYN;BCAR1
prerank,CENP-A containing chromatin organization (GO:0061641),0.24339444965308876,0.6295165836028817,0.9152317880794701,0.9955684361526453,1.0,9/29,22.40%,HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.24339444965308876,0.6295165836028817,0.9152317880794701,0.9955684361526453,1.0,9/29,22.40%,HJURP;OIP5;RBBP4;ITGB3BP;NASP;CENPL;CENPC;RBBP7;CENPU
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2751377335247672,0.6293520323791806,0.8970588235294118,0.9953166465487202,1.0,4/16,16.26%,ERCC4;RTEL1;ATM;SMG6
prerank,dendritic cell chemotaxis (GO:0002407),0.27938411502181454,0.6289235144832457,0.8949704142011834,0.9952706014615721,1.0,1/14,5.22%,CCR2
prerank,phospholipid dephosphorylation (GO:0046839),0.2356370614861694,0.6288384382616519,0.9387755102040817,0.9949513808337485,1.0,13/37,26.73%,PTEN;MTMR12;PLPP4;PLPPR4;PLPPR2;INPP5J;PLPPR1;MTMR7;INPP5B;MTM1;MTMR1;EPHX2;SGPP1
prerank,cellular response to interleukin-12 (GO:0071349),0.22335507881082356,0.6276311975673369,0.9397590361445783,0.9955486199901126,1.0,14/48,26.13%,HNRNPDL;PLCB1;AIP;TYK2;SOD2;MTAP;HSPA9;PDCD4;TALDO1;SIRPA;BOLA2;TCP1;SNRPA1;HNRNPA2B1
prerank,polarized epithelial cell differentiation (GO:0030859),0.27920699566605833,0.6260073726744602,0.9041095890410958,0.9963847391276034,1.0,3/13,12.73%,MYO9A;OPHN1;SCRIB
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.28220425146264905,0.6257089082894955,0.9028571428571428,0.9962183534480767,1.0,2/14,13.23%,TNFRSF10B;MALT1
prerank,activation of protein kinase A activity (GO:0034199),0.2690603015622041,0.6256128176451661,0.8984263233190272,0.99591458109816,1.0,3/16,12.48%,PRKAR1B;PRRC1;PRKACA
prerank,defense response to Gram-negative bacterium (GO:0050829),0.22587689796062965,0.6255967966700968,0.9449877750611247,0.9955374564940321,1.0,2/42,3.93%,PYCARD;RNASE6
prerank,regulation of immune response (GO:0050776),0.20271754796380836,0.6249791055001442,0.9853556485355649,0.9956105633914822,1.0,17/135,17.59%,PTPN22;CD34;FGL1;ELMOD2;CSK;COL3A1;IL4I1;COL1A2;NECTIN2;AHR;COL1A1;ITGB1;CD300LB;XIAP;N4BP1;ITGB7;CLEC2D
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.24676114524564102,0.6227680801687066,0.9275549805950841,0.9968836126212489,1.0,12/27,30.57%,IRAK3;TLR1;UBB;TAB3;HSPD1;TAB2;IRAK2;IRAK1;TRAF6;TAB1;IRAK4;BTK
prerank,mitochondrial transcription (GO:0006390),0.2921822493409809,0.6194946299374784,0.8936170212765957,0.9989921822423423,1.0,3/10,21.11%,TFAM;POLRMT;MTERF2
prerank,telomere maintenance (GO:0000723),0.22158087531377169,0.6191431751031428,0.9494117647058824,0.9988684390982525,1.0,12/50,17.93%,ERCC4;STN1;RPA3;XRCC6;XRCC3;RPA2;RTEL1;ATM;BLM;TERF2IP;WRN;TPRKB
prerank,regulation of amyloid fibril formation (GO:1905906),0.2719117468714632,0.6184435533890554,0.8961832061068702,0.9990378263951628,1.0,2/15,8.99%,PSEN1;CRYAB
prerank,T cell activation involved in immune response (GO:0002286),-0.2423012000800249,-0.6183633980553759,0.9327485380116959,0.9755278563252124,1.0,5/12,30.50%,ICAM1;FCER1G;LCP1;EIF2AK4;SLC11A1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.20873697555919937,0.6176230549029365,0.9596864501679732,0.9992413690721939,1.0,19/80,20.77%,FBXW7;SPSB4;NSMCE3;BRCA1;CUL3;HUWE1;PRICKLE1;MALT1;NDFIP1;SENP2;CRY1;UBB;RCHY1;XIAP;FANCI;MAGEC2;BCL10;UBE2L3;PEF1
prerank,response to peptide hormone (GO:0043434),0.22468091568369547,0.6175583388581406,0.934052757793765,0.9989120361020134,1.0,13/43,25.04%,SLC27A1;TSC1;EIF2B5;EIF6;GNAI1;CRY1;EIF2B2;STAT3;STAT5A;STAT6;ZBED3;TGFBR3;EPM2AIP1
prerank,regulation of cytokinesis (GO:0032465),0.21090491331599182,0.6171974106259164,0.9678848283499446,0.9987955899368618,1.0,20/78,24.44%,KIF20B;KLHL13;CUL3;SETD2;MYO19;CDC25B;DRD2;RAB11FIP3;CALM1;CHMP4C;CDC14A;CALM2;CENPV;PKN2;SVIL;AHCTF1;KIF13A;PLK5;PRKCE;BBS4
prerank,regulation of mRNA stability (GO:0043488),0.1973187769825554,0.6170198039024061,0.9833506763787722,0.9985396421466212,1.0,33/145,22.20%,PRKCA;XPO1;PABPC1;MAPKAPK2;YWHAZ;METTL3;EXOSC8;PSMB7;ZFP36L2;EIF4G1;EXOSC2;GDNF;PCBP4;PSMD2;KHSRP;UBB;EIF4ENIF1;PSMC1;HNRNPU;PSMB2;RC3H1;PCID2;FUS;PSMD9;TENT5D;GIGYF2;PSME4;TENT5A;ZFP36;PSMA8;VIM;TENT5C;RIDA
prerank,peptide cross-linking (GO:0018149),0.2443561748558685,0.6157186945934207,0.9363143631436315,0.9990846511607401,1.0,2/25,9.12%,TGM1;COL3A1
prerank,negative regulation of receptor internalization (GO:0002091),-0.23462117993002088,-0.6138519317597598,0.9333333333333333,0.9769378726761913,1.0,4/12,20.36%,RIN3;MTMR2;ANKRD13B;ANKRD13A
prerank,high-density lipoprotein particle assembly (GO:0034380),0.2887593490190786,0.6130615350827011,0.9083728278041074,1.0,1.0,2/10,12.48%,ZDHHC8;PRKACA
prerank,regulation of cell aging (GO:0090342),0.28740135146118145,0.612955248172181,0.9010494752623688,1.0,1.0,3/11,16.29%,FOXM1;LMNA;PNPT1
prerank,cardiac cell development (GO:0055006),0.2857264101888732,0.6119720150130711,0.8669724770642202,1.0,1.0,1/11,3.14%,VEGFA
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.23764596576872254,0.6094580913759036,0.949535192563081,1.0,1.0,10/27,27.43%,SPRED2;SPRED1;SPRED3;ATM;CD74;MDM2;SNAI1;ATR;PTTG1IP;SIRT1
prerank,histone ubiquitination (GO:0016574),0.25230145146788524,0.6093381532993453,0.9225634178905207,1.0,1.0,4/21,20.34%,WAC;HUWE1;CDC73;UBE2E1
prerank,gene expression (GO:0010467),0.189687209643577,0.6093270810137578,0.9959839357429718,1.0,1.0,78/348,22.59%,BICD1;DHX8;MRPS18A;THOC6;ELAVL4;RANBP2;TSPAN32;RPL23A;RNGTT;HOXD3;MRPL32;POLR2B;NUP155;XRN2;FARSB;SRBD1;DDX54;MCM3AP;SRSF11;LMF1;POLR2K;CASC3;APOBEC1;ALKBH5;NCBP1;ADARB2;MRPL35;FIP1L1;EIF4G1;DUSP11;NUP205;NDC1;TSPAN17;GSPT2;MRPL28;NUP160;UPF1;SNRNP40;DDX25;EPC1;ADARB1;NXT1;POLR2G;HARS1;NOVA1;SRSF6;YTHDC1;MRPL51;POM121;SMG6;HNRNPU;AAAS;ABCF1;NXF1;RNPS1;MLF1;RPSA;POLR2A;THOC7;SYNCRIP;SRRM1;HNRNPUL1;MRPS14;FUBP3;HSPD1;HNRNPL;MRPS6;HARS2;SRSF3;RBMS1;FYTTD1;MRPL52;RPS11;NUP42;MRPL18;GLE1;SYMPK;BCL3
prerank,regulation of centrosome cycle (GO:0046605),-0.19658405287049105,-0.6092062415069219,0.9552845528455285,0.9783461204109067,1.0,3/21,9.91%,CHMP3;NPM1;CHMP1A
prerank,regulation of organelle organization (GO:0033043),0.20401726055280037,0.6081277300641365,0.9687848383500557,1.0,1.0,22/80,24.10%,PRKN;PARL;VPS11;SYT11;RHOT2;CAPN6;CLEC16A;TMEM33;MAPK1;USP6NL;ZEB2;SURF4;RBSN;CENPV;RHOT1;RDX;MYO5A;LMAN1;TAOK1;STX18;MTM1;MAVS
prerank,negative regulation of transposition (GO:0010529),0.2627827657052626,0.6079829883377476,0.9216524216524217,1.0,1.0,2/16,9.32%,TUT4;TEX15
prerank,regulation of secretion by cell (GO:1903530),0.21512544250078813,0.6069973622143112,0.9740871613663133,1.0,1.0,14/54,22.51%,SYT1;RAB21;RAB3D;SYN1;MCTP1;RIMS1;STXBP5;RAB3A;RIMS2;RAB3B;ARFIP1;DISP1;LLGL1;P3H1
prerank,negative regulation of insulin secretion (GO:0046676),0.2582045896919777,0.6045349667690919,0.9279661016949152,1.0,1.0,1/17,2.35%,PRKN
prerank,negative regulation of cell cycle (GO:0045786),0.20589534372821752,0.6037589196114697,0.9786516853932584,1.0,1.0,20/73,23.55%,PTEN;TGFB1;NUPR2;CDK6;MEN1;BMP7;SCRIB;GATA3;RPS6KA2;NPPC;RNF167;NUDT6;IPO5;PDCD4;TRIM35;DUSP1;HECA;RB1;BMP2;NR2F2
prerank,positive regulation of mitochondrial translation (GO:0070131),0.26805075735051825,0.6033456610270836,0.9184861717612809,1.0,1.0,2/14,12.07%,NGRN;RCC1L
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.2428113391126804,0.6027672695042725,0.9196185286103542,1.0,1.0,6/21,22.79%,MED13;MED12;MED30;JUN;MITF;MED24
prerank,regulation of spindle assembly (GO:0090169),0.2397356620297787,0.6026756847365705,0.9262187088274044,1.0,1.0,9/25,24.52%,GPSM2;PDCD6IP;CHMP4C;HNRNPU;RNF4;CHMP1B;DYNC1H1;CEP97;HSPA1A
prerank,regulation of acute inflammatory response (GO:0002673),0.2563579574414354,0.6019773257320012,0.9369501466275659,1.0,1.0,2/18,17.79%,IL6ST;PTGES
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.2154225280733279,0.6018330792385891,0.9481302774427021,1.0,1.0,5/49,11.10%,CRLF1;VEGFA;IL18;ERBB4;IL6ST
prerank,pancreas development (GO:0031016),0.27569236555049054,0.6014289985384559,0.9089529590288316,1.0,1.0,1/12,2.93%,CCDC39
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.27407634509975587,0.6012553656364449,0.9191176470588235,1.0,1.0,5/14,23.18%,AK1;AK5;AK3;AK8;CMPK1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.24177189213581607,0.6008982475326672,0.9401595744680851,1.0,1.0,11/26,28.02%,ALPK1;UBB;TAB3;AAMP;TAB2;CYLD;IRAK2;IRAK1;MAP2K6;TRAF6;TAB1
prerank,regulation of cell cycle phase transition (GO:1901987),0.1997588429199167,0.600094179889699,0.9858233369683751,1.0,1.0,33/91,29.30%,FBXW7;PSMB7;ANAPC7;ANAPC2;DDB1;BUB1B;PSMD2;PSMC1;TP53;CDC23;ANAPC16;PSMB2;FBXO5;PSMD9;TAF1;DBF4;PSME4;CDC27;UBE2E1;PSMA8;ANAPC4;ANAPC5;CDC16;CUL1;PSMD8;PSMD13;CDKN1A;TRIM39;PSMD4;UBE2S;ATP2B4;PSMD5;CDKN1B
prerank,error-free translesion synthesis (GO:0070987),0.23933632271864758,0.5999196861139959,0.921595598349381,1.0,1.0,5/22,17.26%,RPA3;RPA2;UBB;RCHY1;REV1
prerank,regulation of protein ubiquitination (GO:0031396),0.1982377159996421,0.5998046540838898,0.9848812095032398,1.0,1.0,36/108,26.61%,PRKN;FBXW7;NSMCE3;UFL1;IVNS1ABP;BAG5;BRCA1;CUL3;HUWE1;PRICKLE1;MALT1;NDFIP1;SENP2;CRY1;WASHC1;UBB;RCHY1;XIAP;FANCI;N4BP1;DNAJA1;PARK7;BCL10;UBE2L3;ARRB2;CAMLG;UBQLN1;PRKCG;GNL3L;HSPA1A;SOX4;MYCBP2;PER2;CENPX;PTTG1IP;CDK5RAP3
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.21499121444779962,0.5989868187061816,0.9612590799031477,1.0,1.0,13/46,26.13%,HNRNPDL;PLCB1;AIP;TYK2;SOD2;MTAP;HSPA9;PDCD4;TALDO1;BOLA2;TCP1;SNRPA1;HNRNPA2B1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.27447128561696105,0.5988397290269262,0.9254385964912281,1.0,1.0,1/13,6.45%,B3GNT9
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.2806929450163195,0.5987655932537863,0.9284603421461898,1.0,1.0,11/11,71.95%,IL6ST;STAT3;EBI3;IL12A;IL27RA;STAT1;STAT4;JAK1;IL12RB2;JAK2;CANX
prerank,regulation of cholesterol transport (GO:0032374),0.2438767788489623,0.5980075854539183,0.9393103448275862,1.0,1.0,4/20,21.18%,LRP1;ABCA5;TSPO;NFKB1
prerank,ncRNA catabolic process (GO:0034661),0.22776095884942613,0.5979662892032924,0.9380888290713324,1.0,1.0,5/28,16.60%,TUT4;EXOSC8;EXOSC2;RBM7;POP1
prerank,protein catabolic process (GO:0030163),0.20612424911666344,0.5972897223262751,0.9690011481056258,1.0,1.0,17/59,23.96%,PRKN;FBXO27;UCHL3;FBXO17;DDB1;CUL4B;RIPK1;MAGEC2;UBE2G1;LAMP2;PSMA8;FBXO44;OGA;SIAH1;TPP1;CLN6;MTOR
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.236192512720106,0.5963272703834376,0.9431664411366711,1.0,1.0,2/26,8.39%,IRAK3;PPM1B
prerank,negative regulation of cell cycle process (GO:0010948),0.2070114213059027,0.5956486559227034,0.9723820483314154,1.0,1.0,18/61,27.22%,EED;APAF1;E2F6;BRCA1;AURKAIP1;BMP7;EPC1;RBBP4;CHMP4C;FBXO5;RBBP7;CBX5;RNF2;CBX3;EHMT2;RBBP8;EZH2;NME6
prerank,acute inflammatory response (GO:0002526),0.23974851337972558,0.5952001721614276,0.9365079365079365,1.0,1.0,1/23,3.47%,ANO6
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.23974386828927974,0.5948784484609467,0.9395604395604396,1.0,1.0,1/23,1.69%,RHO
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.2349430394475232,0.5947739157513423,0.9428950863213812,1.0,1.0,5/26,18.77%,SLC5A3;SNCA;ABCD2;TRAP1;PARK7
prerank,tRNA metabolic process (GO:0006399),0.25888068252728236,0.5944710801755853,0.9362606232294618,1.0,1.0,7/17,24.17%,FARS2;POP1;RPP21;SSB;DTD1;RPP30;DARS2
prerank,renal water homeostasis (GO:0003091),0.2404168483658906,0.5931450249995242,0.927891156462585,1.0,1.0,3/23,12.48%,PRKAR1B;AQP4;PRKACA
prerank,ncRNA metabolic process (GO:0034660),0.2202572154840417,0.5915990854176074,0.9539227895392279,1.0,1.0,9/37,23.26%,FKBP6;TUT4;KHSRP;MEPCE;NIFK;DTD1;TDRKH;DDX4;XPO5
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.22077054338052135,-0.5908355640532146,0.9651898734177216,0.9860839397052333,1.0,8/14,37.99%,TSEN15;ZBTB8OS;CPSF4;CLP1;TRPT1;TSEN54;CSTF2;RTRAF
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.27230799041368287,0.5896335766136291,0.9155354449472096,1.0,1.0,2/12,15.27%,MTTP;ACSL3
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.22441029639445495,0.5878857155418347,0.952258064516129,1.0,1.0,9/32,24.97%,PYCARD;HINT1;AEN;RPS27L;TP53;BCL3;RRP8;FHIT;USP28
prerank,cristae formation (GO:0042407),0.23284854272175803,0.5870932742716314,0.9419354838709677,1.0,1.0,10/27,27.66%,LETM1;APOOL;ATP5MG;DMAC2L;CHCHD6;ATP5MC2;ATP5PO;ATP5ME;ATP5PF;ATP5F1B
prerank,heart contraction (GO:0060047),0.21630116700126295,0.5870063007509249,0.9562043795620438,1.0,1.0,3/41,5.86%,SGCD;SCN5A;SGCZ
prerank,positive regulation of hormone secretion (GO:0046887),0.2497051000359733,0.5865482065397223,0.9315068493150684,1.0,1.0,2/17,11.60%,SOX11;EDN3
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.23662270179978862,0.5850615449646979,0.938255033557047,1.0,1.0,2/23,8.18%,LTA4H;ELOVL6
prerank,regulation of lipid catabolic process (GO:0050994),0.24380567619038368,0.5844720559026721,0.9483500717360115,1.0,1.0,4/19,21.95%,PDE3B;TYSND1;RARRES2;PRKAA1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.2708488452527646,0.5844062471163658,0.9329268292682927,1.0,1.0,2/12,12.99%,GSS;GGCT
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.24081965784983578,0.5834211239019903,0.9330601092896175,1.0,1.0,5/21,17.87%,ZWINT;BUB1B;KLHL22;ATM;FBXO5
prerank,cholesterol efflux (GO:0033344),0.23835405301177076,0.5831522628735131,0.9575342465753425,1.0,1.0,3/20,16.67%,NPC1;ABCA5;ABCG4
prerank,autophagosome organization (GO:1905037),0.2080002689813373,0.5829235756028194,0.9797377830750894,1.0,1.0,14/50,24.69%,PACS2;WIPI1;ATG5;RAB1A;ATG3;GABARAPL2;RAB7A;VMP1;TMEM41B;UBQLN1;UBQLN2;EMC6;WDR45B;ATG12
prerank,thyroid hormone generation (GO:0006590),0.28035926479971257,0.5829119831884062,0.9275147928994083,1.0,1.0,1/10,6.64%,CTSK
prerank,negative regulation of mitochondrion organization (GO:0010823),0.22329680156076614,0.5827944609515856,0.9573400250941029,1.0,1.0,8/33,18.81%,PRKN;BNIP3;HUWE1;OPA1;FZD9;MPV17L;ADCK1;ACAA2
prerank,mitotic recombination (GO:0006312),0.2571843797044755,0.5825000365438258,0.9185185185185185,1.0,1.0,4/15,22.71%,XRCC3;RAD52;TPRKB;RAD50
prerank,mitotic spindle assembly (GO:0090307),0.21393296358863176,0.5812625895541554,0.9783653846153846,1.0,1.0,11/42,24.02%,ARHGEF10;STAG2;FLNA;CLASP1;KPNB1;AAAS;KIF2A;BCCIP;SMC1A;WRAP73;KIFC2
prerank,bile acid biosynthetic process (GO:0006699),0.22987525555850194,0.581228274728589,0.9558823529411765,1.0,1.0,8/24,25.15%,CYP39A1;CYP7B1;CYP27A1;OSBPL1A;ACOT8;SCP2;HSD17B4;AMACR
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.2683374372548851,0.5803374505501208,0.9227129337539433,1.0,1.0,2/11,11.13%,EXOSC2;FBL
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.2598218830560841,0.5789909541959039,0.9344512195121951,1.0,1.0,1/13,6.38%,TGFBR2
prerank,acylglycerol metabolic process (GO:0006639),0.21574778894523883,0.5776305811525961,0.9693877551020408,1.0,1.0,14/37,28.53%,LMF1;DGKI;PLAAT3;LYPLA2;ABHD6;DGAT2;DGKA;DGKK;PGS1;DGKD;GK;DGKZ;SEL1L;DGKQ
prerank,glutathione metabolic process (GO:0006749),0.21378956107083913,0.5775510032133535,0.9742647058823529,1.0,1.0,6/38,18.77%,DPEP1;GSS;GGCT;GSTZ1;GSTT1;PARK7
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.19258912765295624,0.5773995587744865,0.9955654101995566,1.0,1.0,18/88,20.76%,FBXW7;FBXO38;FBXL15;FBXL16;PSMB7;FBXO27;FBXO17;FBXL2;PSMD2;PSMC1;FBXL4;PSMB2;CUL4B;FBXO31;PSMD9;PSME4;FBXL12;PSMA8
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.20273679756122176,0.5773239738187771,0.9801169590643275,1.0,1.0,10/54,18.13%,CARM1;PCBP4;PRMT1;CNOT3;MDM4;CASP2;CRADD;ATM;TP53;MDM2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.27348337117042465,0.5772242223733245,0.9379968203497615,1.0,1.0,2/10,11.43%,MYO9A;OPHN1
prerank,positive regulation of cell division (GO:0051781),0.21477854048661907,0.5762363334857241,0.9648682559598495,1.0,1.0,8/38,20.28%,KIF20B;CUL3;CDC25B;DRD2;CDC14A;CENPV;PKN2;SVIL
prerank,innate immune response (GO:0045087),0.18087397969948749,0.5748749206657633,0.998991935483871,1.0,1.0,39/217,24.38%,CXCL10;KYNU;ALPK1;RNASE6;NCF1;ANKHD1;CARD9;OTULIN;TRIM11;FYN;NCF2;SETD2;MID2;STYK1;TBK1;MALT1;SNCA;CD300LB;CLPB;PYDC1;CD74;AKAP1;CHUK;LBP;MASP2;BCL10;PPARG;TRIM35;PHB2;YES1;RARRES2;CR2;PJA2;RNF187;CYLD;MAVS;TRIM14;HCK;RPL39
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.22154276631584482,0.5745087935387378,0.9552845528455285,1.0,1.0,2/25,4.44%,TGFB1;SOX11
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.26770022596033116,0.5743283231304346,0.94,1.0,1.0,11/11,73.25%,SELENOS;AXL;MERTK;CCR7;CXCL12;LILRB1;GAS6;IRF7;HCLS1;NOD2;CCL19
prerank,protein acylation (GO:0043543),0.21469677891170658,0.5732457380410689,0.9698492462311558,1.0,1.0,5/38,12.20%,KAT2B;GTF2B;ZDHHC8;ING4;HHAT
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.164819271876316,-0.5725151349241534,0.9906542056074766,0.9926029832861045,1.0,12/32,32.16%,POLA1;TFDP2;ID2;PCNA;NPAT;ZPR1;E2F1;KLF11;CDC45;CDK14;CDK18;E2F7
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.204341165763215,0.5712110509462703,0.9786967418546366,1.0,1.0,18/46,29.25%,FBXO7;TOMM22;AIP;TOMM20;GDAP1;DNAJC19;PAM16;AIFM1;HK2;TSPO;HSPD1;HK1;CHCHD4;TIMM13;RALA;TOMM34;TIMM50;FIS1
prerank,positive regulation of cellular senescence (GO:2000774),0.2677366598613873,0.570526153511195,0.9481361426256077,1.0,1.0,2/10,15.22%,YPEL3;CGAS
prerank,glycine metabolic process (GO:0006544),0.26230467622611275,0.5698543495699293,0.9354354354354354,1.0,1.0,3/12,22.20%,GLYAT;AMT;RIDA
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.20693147297490228,0.5697911500015246,0.9743589743589743,1.0,1.0,7/45,13.93%,TGFB1;AURKAIP1;ZFP36L2;BMP7;ZWINT;SCRIB;BUB1B
prerank,positive regulation of heart rate (GO:0010460),-0.19959767312892485,-0.5694480653898459,0.9775280898876404,0.9927127104524032,1.0,2/17,6.22%,ADRA1B;TPM1
prerank,negative regulation of defense response to virus (GO:0050687),0.27177447110583913,0.5693071757685446,0.9391575663026521,1.0,1.0,1/10,8.39%,PPM1B
prerank,gluconeogenesis (GO:0006094),0.20834637147729118,0.5685125087741836,0.9625468164794008,1.0,1.0,7/39,20.53%,PGM1;GOT2;SLC25A10;CRY1;SLC25A11;PCK2;PFKFB1
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.21438222322418332,0.5683939962269624,0.9613899613899614,1.0,1.0,6/32,15.81%,MRNIP;BRCA1;TAOK3;TOPBP1;ATM;BLM
prerank,protein deacylation (GO:0035601),0.23285831553035738,0.5681370254761255,0.9578804347826086,1.0,1.0,5/23,17.89%,LYPLA1;HDAC6;SIRT6;LYPLA2;ABHD10
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.18514697920981915,0.5668431050839248,0.9924487594390508,1.0,1.0,28/104,26.11%,PAK1;CARD9;FYN;PSMB7;PRKACA;MALT1;PSMD2;MUC3B;MUC3A;PSMC1;PSMB2;CHUK;NRAS;KRAS;PSMD9;TAB3;PSME4;BCL10;PSMA8;NFKB1;CARD11;TAB2;CUL1;PAK3;RAF1;PSMD8;PSMD13;SYK
prerank,cellular response to lectin (GO:1990858),0.18514697920981915,0.5668431050839248,0.9924487594390508,1.0,1.0,28/104,26.11%,PAK1;CARD9;FYN;PSMB7;PRKACA;MALT1;PSMD2;MUC3B;MUC3A;PSMC1;PSMB2;CHUK;NRAS;KRAS;PSMD9;TAB3;PSME4;BCL10;PSMA8;NFKB1;CARD11;TAB2;CUL1;PAK3;RAF1;PSMD8;PSMD13;SYK
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.2258159706699458,0.5658265142370509,0.962059620596206,1.0,1.0,7/25,21.02%,LAPTM4B;TMEM50B;MVB12A;CHMP4C;DENND10;CHMP1B;UBXN6
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.18417595649767673,0.5650557751726623,0.9924892703862661,1.0,1.0,28/105,26.11%,PAK1;CARD9;FYN;PSMB7;PRKACA;MALT1;PSMD2;MUC3B;MUC3A;PSMC1;PSMB2;CHUK;NRAS;KRAS;PSMD9;TAB3;PSME4;BCL10;PSMA8;NFKB1;CARD11;TAB2;CUL1;PAK3;RAF1;PSMD8;PSMD13;SYK
prerank,kinetochore organization (GO:0051383),0.2519263619642029,0.5640024698393661,0.9369369369369369,1.0,1.0,3/13,19.46%,POGZ;NUF2;CENPC
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.244483814161094,0.5636612920370421,0.9613733905579399,1.0,1.0,3/16,15.22%,VPS36;TMEM50B;CHMP4C
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.2363526994649595,0.5630569997228442,0.9533898305084746,1.0,1.0,1/18,3.89%,FBXW7
prerank,negative regulation of biosynthetic process (GO:0009890),0.24386785110063833,0.5622870240670613,0.9405797101449276,1.0,1.0,4/16,18.77%,ASXL3;ABCD2;TRAP1;PARK7
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.22827962513696498,0.5615419984170331,0.9701280227596017,0.9999884496878833,1.0,5/22,20.76%,PSMB7;NFE2L2;PSMB2;PSME4;PSMA8
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.26566424788063975,0.5607932289138264,0.9406392694063926,0.9999524450097287,1.0,3/10,20.99%,ATRX;DBF4;SSBP1
prerank,modulation by host of symbiont process (GO:0051851),0.21730942747427037,0.560293469019544,0.9654255319148937,0.9997996405022457,1.0,4/31,11.33%,CCL4;CARD9;SP1;TAF11
prerank,regulation of microtubule nucleation (GO:0010968),0.2594865098030141,0.5589487174139,0.9358372456964006,1.0,1.0,2/10,13.07%,PAK1;CKAP5
prerank,regulation of lipid kinase activity (GO:0043550),-0.22463466912913188,-0.5579371340584411,0.9532967032967034,0.9957039554002929,1.0,1/11,1.96%,PIK3R3
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.18918575542291682,0.5577258728609585,0.9910913140311804,1.0,1.0,15/72,18.78%,FOXM1;ATRX;CARM1;PCBP4;PRMT1;ING4;CNOT3;MDM4;CASP2;CRADD;ATM;RPS27L;TP53;MDM2;BATF
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.25257108388695526,0.5576976249455304,0.9342301943198804,0.9998533561466397,1.0,2/13,12.70%,CCR2;DRD2
prerank,negative regulation of inclusion body assembly (GO:0090084),0.26498462310927,0.5574961239736048,0.9419847328244275,0.999566881828695,1.0,10/10,73.52%,DNAJB6;HSPA1A;DNAJB2;SACS;DNAJB8;DNAJA4;HSPA2;SORL1;HSPA1B;DNAJB1
prerank,signal transduction by p53 class mediator (GO:0072331),0.21224199038470193,0.5559949274681786,0.9641943734015346,0.9998420723340832,1.0,9/30,24.95%,PYCARD;ATRX;HINT1;MDM4;TP53;BATF;BCL3;RRP8;FHIT
prerank,leukocyte tethering or rolling (GO:0050901),-0.19808174727785982,-0.5558875592627114,0.9688581314878892,0.9953524890266341,1.0,1/17,1.73%,ROCK1
prerank,macromolecule catabolic process (GO:0009057),0.2195941706822582,0.5543688282013367,0.9627659574468085,1.0,1.0,7/26,23.96%,TGFB1;UCHL3;MVB12A;SIAH1;TPP1;CLN6;MTOR
prerank,positive regulation of lipid storage (GO:0010884),0.22947029741132305,0.5532668207642113,0.9635343618513323,1.0,1.0,1/21,3.85%,PLIN3
prerank,negative regulation of cyclase activity (GO:0031280),0.2483754254239763,0.5529336662654786,0.9524517087667161,1.0,1.0,2/14,12.70%,CCR2;DRD2
prerank,protein localization to microtubule organizing center (GO:1905508),0.24067875364033295,0.5521880818205095,0.9590973201692524,0.9999288033596894,1.0,2/15,11.71%,PCM1;SNX10
prerank,regulation of DNA damage checkpoint (GO:2000001),0.2602647180693002,0.5521835367242629,0.9409937888198758,0.9995585195581373,1.0,2/10,14.48%,RPA2;CRY1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.2151151842320005,-0.5521532517535518,0.9666666666666667,0.9954624680915342,1.0,12/12,78.51%,ABCC9;KCNJ8;PKD2L1;ABCC8;P2RX3;KCNJ11;RHAG;ATP1B4;ASIC2;TRPM4;CACNA1H;PKD2
prerank,sensory perception of chemical stimulus (GO:0007606),0.2439751908077021,0.5519726803484842,0.9523099850968704,0.9992603314187315,1.0,4/15,24.44%,DRD2;SLC24A4;UBR3;BBS4
prerank,response to prostaglandin E (GO:0034695),0.2676834243394214,0.5510308592038622,0.952922077922078,0.9992664114795963,1.0,10/10,73.25%,TGFBR3;ADCY6;GNG2;PTGER4;TNFSF4;CCR7;PTGER2;SFRP1;GNB1;CCL19
prerank,regulation of mitochondrial translation (GO:0070129),0.2246672166522844,0.5497648943992459,0.9675675675675676,0.9994271451726646,1.0,3/21,12.07%,NGRN;MTG1;RCC1L
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.19932580614786022,-0.5479785810418436,0.9635761589403974,0.9957131379765269,1.0,6/15,29.56%,CAMK1;FLOT1;CD53;RIPOR2;TYROBP;EHD1
prerank,positive regulation of exosomal secretion (GO:1903543),0.24239330067383508,0.5477921791758114,0.9619326500732065,0.9997943721275011,1.0,3/15,18.13%,SDC4;PDCD6IP;RAB7A
prerank,regulation of membrane depolarization (GO:0003254),0.2292312527924924,0.5474125098587213,0.9513888888888888,0.9995782928561893,1.0,2/18,14.27%,SCN5A;NEDD4L
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.18575523700956806,0.5471734540784281,0.9954285714285714,0.9992906866187463,1.0,13/70,20.96%,SNAP23;NCF1;PSMB7;NCF2;LNPEP;PSMD2;PSMC1;PSMB2;CHUK;PSMD9;PSME4;PSMA8;TAP1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.23127601007618542,0.5469794555924321,0.9678362573099415,0.9990086682110835,1.0,5/16,24.63%,MCM4;BLM;WRN;SSBP1;RECQL
prerank,cAMP metabolic process (GO:0046058),0.24661532545575549,0.5455024097984505,0.9748520710059172,0.9991985695494774,1.0,2/13,12.06%,PTHLH;PDE4D
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.26138606006994525,0.5450725037853201,0.9440993788819876,0.998988043794212,1.0,5/10,26.56%,GABRG2;GABRA3;GABRA2;GABRG3;GABRA4
prerank,primary miRNA processing (GO:0031053),0.26239764458672704,0.5436444994299799,0.9518633540372671,0.999154548259454,1.0,1/10,6.20%,METTL3
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.22672910198336843,0.5426990990535012,0.9585635359116023,0.9991484829506563,1.0,3/18,10.84%,GINS2;POLE3;MCM4
prerank,phosphate ion transmembrane transport (GO:0035435),0.24658032266482316,0.5417549222413113,0.9559939301972686,0.9991223942702941,1.0,4/12,23.02%,SLC25A10;XPR1;SLC25A11;SLC20A1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.1801766397516732,0.5415987999480216,0.9944258639910813,0.9988117484747324,1.0,16/86,20.99%,VEGFA;MAPK7;PSMB7;HIF1A;NFE2L2;PSMD2;UBB;PSMC1;GCN1;TP53;PSMB2;ELOC;PSMD9;PSME4;PSMA8;LIMD1
prerank,regulation of DNA metabolic process (GO:0051052),0.1951192509433897,0.5415809479254787,0.9888613861386139,0.9984473686935459,1.0,17/44,31.00%,MYC;UPF1;KPNA1;SMG6;TERF2IP;USP1;WRNIP1;CDK9;MPHOSPH8;KAT7;WDR18;SMG1;MPV17;NUCKS1;HNRNPD;UBE2V1;ALYREF
prerank,regulation of spindle organization (GO:0090224),0.22930453951399887,0.5410684875033541,0.9664429530201343,0.998270811283911,1.0,4/18,22.87%,GPSM2;GNAI1;RNF4;DYNC1H1
prerank,TOR signaling (GO:0031929),0.21366328385187672,0.5409221640852497,0.9756756756756757,0.9979533252408083,1.0,8/26,23.96%,MAPKAP1;GATA3;TIPRL;RPTOR;FNIP1;CCDC88A;CARD11;MTOR
prerank,cellular response to ketone (GO:1901655),0.20525601051656234,0.539861467032121,0.9799749687108886,0.9979727057079998,1.0,6/35,20.08%,PTGFR;GNAI1;AHR;KLF9;PCK2;ADCY8
prerank,organelle fusion (GO:0048284),0.21752801511991735,0.5394909953983835,0.9696551724137931,0.9977369255648921,1.0,7/22,29.25%,VPS11;OPA1;GDAP1;MIGA2;VPS18;EEA1;FIS1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.20737466379137476,0.5391278124506492,0.9738562091503268,0.9974927583037255,1.0,12/30,30.43%,ACKR3;RTEL1;CD74;FBXO5;MDM2;SNAI1;THOC5;PTTG1IP;SIRT1;CDKN2D;BCL2L1;TMEM161A
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.22354988386191293,-0.5382661912621515,0.9694444444444444,0.9963977960296372,1.0,3/10,18.16%,NUPR1;HDAC4;GIT1
prerank,negative regulation of glycolytic process (GO:0045820),-0.22354988386191293,-0.5382661912621515,0.9694444444444444,0.9963977960296372,1.0,3/10,18.16%,NUPR1;HDAC4;GIT1
prerank,cellular response to purine-containing compound (GO:0071415),0.2557578790873011,0.5376239588570831,0.9638932496075353,0.9976574172041547,1.0,2/10,19.10%,P2RY1;RYR3
prerank,nuclear pore organization (GO:0006999),0.23642249448274477,0.535865935255553,0.9531478770131772,0.9978886113556281,1.0,4/14,20.92%,NUP205;NDC1;RTN4;AHCTF1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.23606159181606437,0.5327750351624526,0.9660766961651918,0.9985789336079314,1.0,2/15,9.44%,MLXIPL;ELOVL5
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.22251243984614866,0.5325628483086592,0.9707927677329624,0.9975424459198485,1.0,4/20,15.48%,ZWINT;BUB1B;KLHL22;ATM
prerank,spindle assembly checkpoint signaling (GO:0071173),0.22251243984614866,0.5325628483086592,0.9707927677329624,0.9975424459198485,1.0,4/20,15.48%,ZWINT;BUB1B;KLHL22;ATM
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.22251243984614866,0.5325628483086592,0.9707927677329624,0.9975424459198485,1.0,4/20,15.48%,ZWINT;BUB1B;KLHL22;ATM
prerank,mitotic nuclear division (GO:0140014),0.18472784077486254,0.5323991076430109,0.9955156950672646,0.9972310223589419,1.0,13/71,20.16%,ARHGEF10;NDE1;STAG2;FLNA;CLASP1;SGO1;ZWINT;KPNB1;KLHL22;AAAS;SMC4;KIF2A;BCCIP
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.21202270589996022,0.5314387133975309,0.979328165374677,0.9971780414944416,1.0,7/26,25.03%,THADA;DRD2;CALM1;CALM2;PKD2;UBQLN1;FMR1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.24445240390092368,0.5312500711424127,0.9477020602218701,0.9968662700906192,1.0,1/10,9.31%,DERL2
prerank,regulation of myoblast fusion (GO:1901739),0.2519940938552132,0.5310577764720505,0.968798751950078,0.9965707212083617,1.0,2/11,14.87%,MAPK14;EHD2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.22552051398718476,0.5306249295778088,0.9778761061946902,0.9963414705381816,1.0,1/17,2.35%,PRKN
prerank,regulation of response to stress (GO:0080134),-0.2159660883807712,-0.5298680903223799,0.9791044776119403,0.9975247666157124,1.0,5/10,29.79%,OPRM1;SLC38A2;MLC1;STOX1;CORO2B
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.19600478807753802,-0.5291117546193829,0.9847094801223242,0.9967050376814677,1.0,6/15,28.84%,ATL2;ZFYVE27;REEP1;RAB10;REEP2;REEP4
prerank,mRNA methylation (GO:0080009),-0.19235750458657264,-0.5290648223578064,0.9880597014925373,0.9957015592204747,1.0,2/15,6.60%,WTAP;METTL14
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.20682131579070617,0.5286165788085334,0.9821656050955414,0.9966209532503775,1.0,12/28,28.02%,OTULIN;UBB;TAB3;AAMP;TAB2;CYLD;IRAK2;IRAK1;MAP2K6;RELA;TRAF6;TAB1
prerank,cardiac muscle contraction (GO:0060048),0.20080852947524555,0.5284729881169619,0.9779141104294479,0.9963023893938143,1.0,2/34,5.51%,GSN;SCN5A
prerank,rRNA transcription (GO:0009303),0.2269316909713447,0.5264800104633518,0.96,0.9965525808402868,1.0,4/17,17.83%,SPIN1;GTF3C1;NIFK;POLR1G
prerank,response to UV-B (GO:0010224),-0.20317458939772695,-0.525025253170015,0.9880239520958084,0.995590150625171,1.0,6/12,36.07%,MFAP4;STK11;HYAL2;MME;MSH2;HYAL3
prerank,phosphate ion transport (GO:0006817),0.22557776471364904,0.5248094903305494,0.9750733137829912,0.9966851656990487,1.0,3/16,16.03%,SLC25A10;XPR1;SLC25A11
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.18591071764927483,-0.5246809606484272,0.9804560260586319,0.9946473956510306,1.0,16/16,81.43%,UPB1;NT5M;DPYSL5;NT5C1A;UPP1;DPYSL4;DPYS;CRMP1;DPYSL3;UPP2;DPYSL2;NT5E;TET2;NT5C3A;DPYD;NT5C
prerank,dendritic cell migration (GO:0036336),0.22527111936927646,0.5236477208797192,0.9681159420289855,0.9966584280775559,1.0,1/16,5.22%,CCR2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.17698612981328868,0.5233831801180012,0.9977900552486187,0.996365486827606,1.0,15/76,23.28%,PTPN22;EGFR;TRIM44;PPM1B;TRIP6;BMP7;RTKN2;RASSF2;TERF2IP;CPNE1;PDCD4;PHB2;PPM1A;BCL3;CYLD
prerank,protein autoprocessing (GO:0016540),-0.18302704408879059,-0.5228343715582265,0.9771986970684039,0.9940548555976325,1.0,5/17,26.14%,CASP4;FXN;MYRF;HTRA2;OMA1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.2527518408594023,0.5222681339713888,0.9654088050314465,0.9963250659375263,1.0,1/10,11.95%,MTHFD2L
prerank,response to purine-containing compound (GO:0014074),-0.17879939983928378,-0.5213378216613244,0.989247311827957,0.9933813198049025,1.0,4/17,25.42%,ABCC9;TRPC3;TRPM2;VGF
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.25067470030753763,0.5202328741601067,0.9669291338582677,0.9961890731185764,1.0,10/10,74.95%,CACNA2D4;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;TULP1;CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.25067470030753763,0.5202328741601067,0.9669291338582677,0.9961890731185764,1.0,10/10,74.95%,CACNA2D4;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;TULP1;CEP250
prerank,macrophage activation involved in immune response (GO:0002281),0.23296011594360844,0.5193861606897879,0.9561270801815431,0.9960443394479149,1.0,3/13,18.62%,GRN;DYSF;LBP
prerank,negative regulation of macroautophagy (GO:0016242),0.20410093322154776,0.5189645859925398,0.9788639365918098,0.9957893128614493,1.0,12/26,29.24%,TSC1;CLEC16A;UBQLN4;NRBP2;MTOR;MTM1;CHMP4B;CHMP4A;SMG1;PIK3CA;TMEM39A;SEC22B
prerank,regulation of peptidase activity (GO:0052547),0.21711655936046967,0.5180886197721224,0.9725274725274725,0.9956639319798037,1.0,4/19,21.05%,CSTB;RCN3;NDUFA13;FURIN
prerank,cell cycle checkpoint signaling (GO:0000075),0.239603325277565,0.5168106282403327,0.9611197511664075,0.9956401213779832,1.0,2/12,13.93%,ZWINT;BUB1B
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.17333791183509342,0.5167680358801386,0.9989035087719298,0.9952911501575579,1.0,17/88,22.71%,EPRS1;EIF2AK3;CSTB;TSC1;CPEB3;SERPINE2;HDAC6;ATRAID;PUS7;EIF4ENIF1;GIGYF2;SYNCRIP;PLAT;NFKB1;DDX6;RIDA;PAIP2B
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.25012240634518673,0.5146588677393178,0.968503937007874,0.995493974691703,1.0,3/10,19.14%,SERPINE2;CD9;RDX
prerank,B cell homeostasis (GO:0001782),0.24498611981048907,0.5143501596630544,0.9639097744360903,0.9952145384022627,1.0,1/10,6.74%,DOCK10
prerank,heterocycle biosynthetic process (GO:0018130),0.22813339978274239,0.512079137259441,0.9721407624633431,0.9954659659599948,1.0,2/14,14.16%,GPHN;NFS1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.2283628570794064,0.5049071638325264,0.9597523219814241,0.9968730818722981,1.0,4/12,22.69%,UMPS;CTPS2;ALDH6A1;DPYD
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.1919741001412953,-0.5036474786456396,0.9853372434017595,0.9959488216665935,1.0,2/13,11.04%,KDM1A;YJU2
prerank,protein kinase A signaling (GO:0010737),0.23093207425774293,0.5002487080416269,0.9734375,0.9975933093057536,1.0,2/12,19.14%,PRKACA;RDX
prerank,nucleoside catabolic process (GO:0009164),-0.1952473803964693,-0.5000310487172701,0.9892183288409704,0.9955050988536998,1.0,3/11,22.67%,UPB1;NT5M;NT5C1A
prerank,peptidyl-amino acid modification (GO:0018193),0.2373080141247892,0.4987860037129139,0.9723076923076923,0.9975596856912275,1.0,3/10,23.11%,TTLL4;METAP1;METAP1D
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.2256735429285932,0.495794527096459,0.9641255605381166,0.9978384474446798,1.0,5/12,27.89%,UMPS;DHODH;UCK1;UCK2;CAD
prerank,regulation of phosphate metabolic process (GO:0019220),0.21249563121360948,0.49323458518032465,0.9753623188405797,0.9980179749637307,1.0,1/16,4.32%,PSEN1
prerank,negative regulation of phosphatase activity (GO:0010923),0.19570525249595286,0.49294549078742067,0.9907894736842106,0.9977207168875408,1.0,2/25,5.64%,PPP1R15A;URI1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.19973881209806266,-0.49242610603614845,0.9893048128342246,0.9957582909184424,1.0,3/10,22.67%,UPB1;NT5M;NT5C1A
prerank,regulation of actin filament depolymerization (GO:0030834),-0.19015291532113832,-0.4907457165889131,0.9780821917808219,0.9949994046921137,1.0,2/12,13.74%,MTPN;LIMA1
prerank,regulation of protein kinase A signaling (GO:0010738),0.19894018622129223,0.4872852402523488,0.9864314789687924,0.998471018014317,1.0,2/20,10.70%,PRKAR1B;AKAP6
prerank,'de novo' posttranslational protein folding (GO:0051084),0.18839995155514347,0.48618429208872255,0.9858064516129033,0.9983364530302687,1.0,7/30,25.40%,DNAJB4;GAK;SDF2;HSPA9;ERO1A;HSPA1A;CHCHD4
prerank,regulation of Golgi organization (GO:1903358),0.20490810032214934,0.48419570595356987,0.9789325842696629,0.9983490843483924,1.0,5/17,23.75%,MAPK1;USP6NL;RBSN;MYO5A;STX18
prerank,chromosome condensation (GO:0030261),0.184798819626205,0.48393448623559787,0.9897959183673469,0.9980324388103659,1.0,5/36,18.94%,BANF2;PHF8;SMC4;AIFM1;CSNK2A2
prerank,negative regulation of lipid catabolic process (GO:0050995),0.2043773718668231,0.4806728525804702,0.9795918367346939,0.998244559199635,1.0,3/17,21.95%,PDE3B;GPLD1;PRKAA1
prerank,triglyceride catabolic process (GO:0019433),0.20302687766892752,0.48004433189089474,0.9902642559109874,0.9979956750006728,1.0,19/19,79.72%,LIPC;FABP7;APOC3;FABP6;PNPLA5;PNLIPRP2;LIPI;PNPLA1;FABP2;CPS1;LIPG;FABP5;FABP12;FABP4;LIPH;FABP3;PNPLA3;LPL;PNPLA2
prerank,non-motile cilium assembly (GO:1905515),0.1854948165446474,0.478132671697281,0.9897828863346104,0.9979665955120741,1.0,4/30,15.65%,PCM1;DISC1;CEP89;IFT57
prerank,mRNA modification (GO:0016556),0.1964179332630736,0.47809037676625366,0.9929873772791024,0.997611207156824,1.0,5/22,20.18%,METTL3;PUS7;PUS1;VIRMA;NSUN2
prerank,defense response to protozoan (GO:0042832),0.21649613960203384,0.4772480476157752,0.9775112443778111,0.9973779235426637,1.0,12/12,78.37%,BATF;GBP2;GBP4;LYST;GBP7;IRF4;GBP6;PF4;BATF2;SLC11A1;MYD88;CD40
prerank,ruffle organization (GO:0031529),0.2064338460597376,0.4760368718512567,0.9838472834067548,0.9972248408245272,1.0,4/16,23.94%,CORO1B;CYFIP1;PIP5K1A;PLEKHA1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.21226200231774028,0.47526227365128804,0.9806835066864784,0.9969911651424542,1.0,4/13,22.49%,XRCC3;PCID2;DUSP1;CDK5RAP2
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.19936484151809383,-0.47192303482928294,0.9765013054830287,0.9963650895616625,1.0,1/10,8.12%,ACTN2
prerank,homeostasis of number of cells (GO:0048872),0.21835972223287994,0.4690962587201891,0.9804216867469879,0.9975552877474365,1.0,1/12,6.84%,CARD9
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.2167472223965853,0.4670705540262894,0.9883381924198251,0.9974955756630913,1.0,12/12,78.34%,NUF2;CENPC;MIS12;CDT1;CHAMP1;KIF2C;RMDN1;SEH1L;MAD1L1;NDC80;CENPE;BOD1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.17964792244854608,0.45959007766117604,0.9932795698924731,0.998195452811228,1.0,9/28,26.93%,MRNIP;SETMAR;CYREN;TFIP11;PRKDC;SMCHD1;ACTR2;KMT5B;KMT5C
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.1661516635201015,-0.44904537426815416,0.9966777408637874,0.9974459760132156,1.0,5/14,30.82%,URB1;PES1;RPF2;DDX18;ZNHIT3
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.1770264958837368,0.448011212120081,0.9973579920739762,0.9992616688729925,1.0,5/25,20.45%,HIP1;CBL;RTN4;CCDC88A;BCAR3
prerank,protein deneddylation (GO:0000338),0.21702303064410516,0.446261919189363,0.9901960784313726,0.9991061347903042,1.0,5/10,31.91%,COPS6;COPS7A;COPS2;TOR1A;COPS4
prerank,defense response to Gram-positive bacterium (GO:0050830),0.1632707380635507,0.44579954961635354,0.9963547995139733,0.9987931572782289,1.0,10/40,26.38%,RNASE6;MR1;LBP;RARRES2;GBP2;RPL39;DROSHA;RNASE3;GBP4;RNASE7
prerank,sister chromatid segregation (GO:0000819),0.17219512606749304,0.44479161803741857,0.9949109414758269,0.9985441061033236,1.0,7/31,23.58%,SGO1;ZWINT;KLHL22;SMC4;RB1;SMC1A;WRAP73
prerank,C21-steroid hormone metabolic process (GO:0008207),0.18470137536896314,0.43948943321576034,0.9902912621359223,0.9987287257051359,1.0,20/20,81.55%,TSPOAP1;TSPO;STARD3;STARD3NL;FDX1;DHRS2;HSD3B1;CYP17A1;AKR1B1;CYP11A1;CYP11B1;AKR1D1;DHRS9;AKR1C1;HSD3B2;FDX2;CYP46A1;HSD17B10;STAR;FDXR
prerank,positive regulation of type 2 immune response (GO:0002830),0.19286089662386313,0.43859359247247703,0.9939301972685888,0.9984543467706587,1.0,2/14,17.15%,IL18;CD74
prerank,regulation of transposition (GO:0010528),0.19649440025156065,0.4352603702272268,0.982274741506647,0.9984042715451934,1.0,1/13,9.32%,TEX15
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.20931368982135315,0.4311545527539608,0.993660855784469,0.9980432538716018,1.0,1/10,12.50%,MYLIP
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.20931368982135315,0.4311545527539608,0.993660855784469,0.9980432538716018,1.0,1/10,12.50%,MYLIP
prerank,regulation of mast cell degranulation (GO:0043304),0.18411621204804446,0.4193157643009887,0.9881831610044313,0.9986391244076759,1.0,3/14,20.83%,GAB2;UNC13D;CD84
prerank,ATP transport (GO:0015867),0.1922250046473223,0.41559798487887734,0.9984051036682615,0.9985146937588659,1.0,4/10,31.30%,SLC25A24;SLC17A9;SLC25A17;CD47
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.16028741907835714,0.4148191380833648,0.9986945169712794,0.9982169065719936,1.0,7/31,28.38%,PRLR;GPHN;NFS1;SCP2;MOCS3;CYP51A1;PYCR2
prerank,dendritic cell differentiation (GO:0097028),0.1604161637644995,0.397038599241076,0.9986522911051213,0.9988354427411126,1.0,4/22,22.10%,TGFBR2;BATF;AXL;IRF8
prerank,natural killer cell activation (GO:0030101),0.15725769926977035,0.3872481677781265,0.9986772486772487,0.9988707965243689,1.0,4/23,23.68%,RABL3;AXL;PBX1;KAT7
